Created
April 1, 2015 19:25
-
-
Save khadley/3f8823b278682579d72f to your computer and use it in GitHub Desktop.
GWAS_catalog_SNPs_Pval5E08_hg19_040115.txt
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| Chr Position (GRCh37) Strongest SNP-Risk Allele Chr Position (GRCh38) Disease/Phenotype P-value Odds ratio or beta PUBMEDID | |
| 1 1247494 rs12103-A 1:1247494 Inflammatory bowel disease 8.00E-13 1.1 23128233 | |
| 1 2069172 rs425277-T 1:2069172 Height 2.00E-08 0.02 20881960 | |
| 1 2392648 rs2477686-? 1:2392648 Non-obstructive azoospermia 6.00E-12 1.39 22197933 | |
| 1 2501338 rs10797432-C 1:2501338 Ulcerative colitis 3.00E-12 1.08 23128233 | |
| 1 2513216 rs734999-C 1:2513216 Ulcerative colitis 3.00E-09 1.05 21297633 | |
| 1 2526746 rs3748816-? 1:2526746 Celiac disease 3.00E-09 1.12 20190752 | |
| 1 2709164 rs4648356-C 1:2709164 Multiple sclerosis 1.00E-14 1.14 21833088 | |
| 1 3083712 rs2651899-C 1:3083712 Migraine 4.00E-14 1.09 23793025 | |
| 1 3083712 rs2651899-C 1:3083712 Migraine 4.00E-09 1.11 21666692 | |
| 1 3691528 rs1175550-A 1:3691528 Blood trace element (Cu levels) 5.00E-10 0.2 23720494 | |
| 1 4183006 rs10915437-? 1:4183006 Migraine - clinic-based 3.00E-08 1.16 23793025 | |
| 1 4668670 rs3896439-? 1:4668670 Dental caries 2.00E-08 NR 23064961 | |
| 1 6279370 rs846111-C 1:6279370 QT interval 1.00E-16 1.75 19305408 | |
| 1 6279370 rs846111-C 1:6279370 QT interval 4.00E-16 1.49 19305409 | |
| 1 7879063 rs2797685-A 1:7879063 Crohn's disease 7.00E-09 1.05 21102463 | |
| 1 7961206 rs227163-C 1:7961206 Rheumatoid arthritis 3.00E-09 1.11 24390342 | |
| 1 8021973 rs35675666-G 1:8021973 Inflammatory bowel disease 1.00E-15 1.11 23128233 | |
| 1 8021973 rs35675666-G 1:8021973 Ulcerative colitis 5.00E-09 1.08 21297633 | |
| 1 8526142 rs4908760-G 1:8526142 Vitiligo 7.00E-15 1.36 20410501 | |
| 1 9317604 rs6662509-T 1:9317604 Height 3.00E-10 1.23 23563607 | |
| 1 9408959 rs11121380-? 1:9408959 Response to tocilizumab in rheumatoid arthritis 5.00E-08 11.11 22491018 | |
| 1 10286176 rs17396340-A 1:10286176 Mean platelet volume 3.00E-08 0.01 22139419 | |
| 1 10353112 rs10492972-C 1:10353112 Multiple sclerosis 3.00E-10 1.34 18997785 | |
| 1 10385471 rs17401966-A 1:10385471 Hepatocellular carcinoma 2.00E-18 1.64 20676096 | |
| 1 10566215 rs616488-A 1:10566215 Breast cancer 2.00E-10 1.06 23535729 | |
| 1 10566215 rs616488-A 1:10566215 Breast cancer 1.00E-08 1.1 23535733 | |
| 1 10796866 rs880315-C 1:10796866 Blood pressure 3.00E-10 0.56 21572416 | |
| 1 11033082 rs12565727-A 1:11033082 Male-pattern baldness 9.00E-11 1.33 22693459 | |
| 1 11046855 rs9430161-G 1:11046855 Ewing sarcoma 1.00E-20 2.2 22327514 | |
| 1 11171226 rs17036350-T 1:11171226 Corneal curvature 4.00E-13 0.18 21665993 | |
| 1 11280994 rs74225573-C 1:11280994 Corneal curvature 6.00E-18 0.16 24963161 | |
| 1 11838646 rs12134663-A 1:11838646 Homocysteine levels 3.00E-21 0.1 23824729 | |
| 1 11856378 rs1801133-A 1:11856378 Homocysteine levels 4.00E-104 0.16 23824729 | |
| 1 11856378 rs1801133-A 1:11856378 Homocysteine levels 8.00E-35 0.05 20031578 | |
| 1 11862778 rs17367504-G 1:11862778 Blood pressure 2.00E-16 0.53 21909110 | |
| 1 11862778 rs17367504-G 1:11862778 Systolic blood pressure 2.00E-13 0.85 19430483 | |
| 1 11899033 rs1023252-T 1:11899033 Natriuretic peptide levels 4.00E-16 0.2 21273288 | |
| 1 11958723 rs12085006-? 1:11958723 Folate pathway vitamin levels 6.00E-10 0.04 19744961 | |
| 1 12046063 rs2336384-G 1:12046063 Platelet counts 1.00E-08 2.17 22139419 | |
| 1 16299312 rs10927875-? 1:16299312 Dilated cardiomyopathy 1.00E-09 1.32 21459883 | |
| 1 16505320 rs1497406-G 1:16505320 Liver enzyme levels (gamma-glutamyl transferase) 3.00E-19 3.8 22001757 | |
| 1 16505320 rs1497406-T 1:16505320 Gamma gluatamyl transferase levels 4.00E-08 0.08 22010049 | |
| 1 17306675 rs2284746-C 1:17306675 Height 4.00E-29 0.04 20881960 | |
| 1 17306675 rs2284746-G 1:17306675 Pulmonary function 8.00E-16 0.04 21946350 | |
| 1 17306675 rs2284746-G 1:17306675 Height 5.00E-15 1.17 23563607 | |
| 1 17306675 rs2284746-? 1:17306675 Pulmonary function (interaction) 2.00E-11 NR 23284291 | |
| 1 17672730 rs2301888-G 1:17672730 Rheumatoid arthritis 1.00E-18 1.13 24390342 | |
| 1 17672730 rs2301888-G 1:17672730 Rheumatoid arthritis 8.00E-13 1.19 24390342 | |
| 1 17672730 rs2301888-G 1:17672730 Rheumatoid arthritis 6.00E-09 1.11 24390342 | |
| 1 17674537 rs2240335-? 1:17674537 Rheumatoid arthritis 2.00E-08 NR 21505073 | |
| 1 17674537 rs2240335-? 1:17674537 Rheumatoid arthritis 2.00E-08 1.5 21452313 | |
| 1 17722363 rs7538876-A 1:17722363 Basal cell carcinoma 7.00E-14 1.25 24403052 | |
| 1 17722363 rs7538876-A 1:17722363 Basal cell carcinoma 4.00E-12 1.28 18849993 | |
| 1 18425011 rs9804128-G x rs4784379-A 1:18425011 Venous thromboembolism (gene x gene interaction) 2.00E-09 1.71 23509962 | |
| 1 18979874 rs742071-T 1:18979874 Orofacial clefts 7.00E-09 1.32 22863734 | |
| 1 19765518 rs12045440-T 1:19765518 Thyroid volume 3.00E-14 0.07 21565293 | |
| 1 19765518 rs12045440-T 1:19765518 Thyroid volume 2.00E-11 1.38 21565293 | |
| 1 19839115 rs12138950-A 1:19839115 Thyroid volume 3.00E-18 0.1 21565293 | |
| 1 19841174 rs10799824-A 1:19841174 Thyroid hormone levels 4.00E-21 0.11 23408906 | |
| 1 19841174 rs10799824-A 1:19841174 Thyroid hormone levels 3.00E-14 0.12 23408906 | |
| 1 19841174 rs10799824-A 1:19841174 Thyroid hormone levels 1.00E-08 0.1 23408906 | |
| 1 19843354 rs10917468-C 1:19843354 Thyroid volume 1.00E-14 1.52 21565293 | |
| 1 19861106 rs10917477-A 1:19861106 Thyroid function 2.00E-08 0.06 22494929 | |
| 1 20140036 rs1317209-T 1:20140036 Ulcerative colitis 2.00E-10 1.17 20228799 | |
| 1 20142866 rs3806308-? 1:20142866 Ulcerative colitis 7.00E-09 1.28 19122664 | |
| 1 20171860 rs6426833-A 1:20171860 Ulcerative colitis 2.00E-68 1.27 23128233 | |
| 1 20171860 rs6426833-A 1:20171860 Ulcerative colitis 4.00E-35 1.3 21297633 | |
| 1 20171860 rs6426833-A 1:20171860 Ulcerative colitis 2.00E-21 1.3 20228799 | |
| 1 20171860 rs6426833-G 1:20171860 Ulcerative colitis 5.00E-13 1.37 19122664 | |
| 1 20171860 rs6426833-? 1:20171860 Ulcerative colitis 2.00E-11 NR 19915572 | |
| 1 20200990 rs4654903-? 1:20200990 Ulcerative colitis 7.00E-09 1.56 23511034 | |
| 1 20227723 rs4654925-G 1:20227723 Ulcerative colitis 9.00E-22 1.41 20228798 | |
| 1 20892931 rs10916814-? x rs690140-? 1:20892931 Age-related hearing impairment (interaction) 5.00E-10 NR 24939585 | |
| 1 21766453 rs1976403-C 1:21766453 Liver enzyme levels (alkaline phosphatase) 2.00E-50 3.6 22001757 | |
| 1 21786068 rs4654748-C 1:21786068 Folate pathway vitamin levels 8.00E-18 1.45 19303062 | |
| 1 21786068 rs4654748-? 1:21786068 Folate pathway vitamin levels 4.00E-11 0.1 19744961 | |
| 1 21820990 rs10799701-A 1:21820990 Metabolic traits 3.00E-20 0.13 21886157 | |
| 1 21821757 rs1780324-T 1:21821757 Liver enzyme levels 7.00E-15 0.03 18940312 | |
| 1 21823292 rs1697421-A 1:21823292 Phosphorus levels 1.00E-27 0.05 20558539 | |
| 1 21823292 rs1697421-T 1:21823292 Blood metabolite ratios 2.00E-20 0.06 24816252 | |
| 1 21823292 rs1697421-T 1:21823292 Blood metabolite ratios 3.00E-14 0.04 24816252 | |
| 1 21890386 rs1256335-? 1:21890386 Folate pathway vitamin levels 1.00E-15 0.14 19744961 | |
| 1 21904529 rs2242420-T 1:21904529 Hematological and biochemical traits 5.00E-13 0.16 20139978 | |
| 1 22447316 rs3765350-A 1:22447316 "Bone mineral density (paediatric, total body less head)" 7.00E-10 0.11 24945404 | |
| 1 22447316 rs3765350-A 1:22447316 "Bone mineral density (paediatric, total body less head)" 4.00E-09 0.12 24945404 | |
| 1 22447316 rs3765350-A 1:22447316 "Bone mineral density (paediatric, lower limb)" 3.00E-08 0.1 24945404 | |
| 1 22450487 rs2235529-A 1:22450487 Endometriosis 3.00E-09 1.3 23472165 | |
| 1 22450487 rs2235529-C 1:22450487 "Bone mineral density (paediatric, upper limb)" 1.00E-08 0.12 24945404 | |
| 1 22490724 rs7521902-A 1:22490724 Endometriosis 3.00E-11 1.19 23104006 | |
| 1 22490724 rs7521902-A 1:22490724 Bone mineral density 1.00E-10 0.05 22504420 | |
| 1 22492887 rs3920498-G 1:22492887 "Bone mineral density (paediatric, skull)" 2.00E-12 0.13 24945404 | |
| 1 22492887 rs3920498-G 1:22492887 "Bone mineral density (paediatric, skull)" 1.00E-10 0.14 24945404 | |
| 1 22698447 rs7524102-A 1:22698447 Bone mineral density (hip) 1.00E-16 0.15 19079262 | |
| 1 22698447 rs7524102-A 1:22698447 Bone mineral density (hip) 5.00E-16 0.15 18445777 | |
| 1 22698447 rs7524102-A 1:22698447 Ulcerative colitis 2.00E-13 1.1 21297633 | |
| 1 22698447 rs7524102-G 1:22698447 Bone mineral density (spine) 3.00E-10 0.09 19801982 | |
| 1 22698447 rs7524102-G 1:22698447 Dupuytren's disease 3.00E-09 1.28 21732829 | |
| 1 22698447 rs7524102-A 1:22698447 Bone mineral density (spine) 9.00E-09 0.11 18445777 | |
| 1 22700351 rs34920465-? 1:22700351 Bone mineral density 3.00E-13 NR 24249740 | |
| 1 22700351 rs34920465-? 1:22700351 Bone mineral density 3.00E-08 NR 24249740 | |
| 1 22702231 rs12568930-T 1:22702231 Inflammatory bowel disease 1.00E-17 1.1 23128233 | |
| 1 22702858 rs6696981-G 1:22702858 Bone mineral density (spine) 2.00E-08 0.12 19079262 | |
| 1 22711473 rs6426749-C 1:22711473 Bone mineral density 7.00E-57 0.11 22504420 | |
| 1 23536891 rs1738475-C 1:23536891 Height 3.00E-12 0.03 20881960 | |
| 1 23766233 rs1077514-C 1:23766233 "Cholesterol, total" 6.00E-09 0.03 24097068 | |
| 1 25044111 rs4601530-T 1:25044111 Height 2.00E-12 0.03 20881960 | |
| 1 25297184 rs11249215-A 1:25297184 Ankylosing spondylitis 9.00E-11 NR 21743469 | |
| 1 25303576 rs10903122-? 1:25303576 Celiac disease 2.00E-10 1.12 20190752 | |
| 1 25570081 rs1043879-? 1:25570081 Erythrocyte sedimentation rate 2.00E-09 0.09 21700265 | |
| 1 25674785 rs3091242-? 1:25674785 Erythrocyte sedimentation rate 2.00E-13 0.1 21700265 | |
| 1 25768937 rs10903129-? 1:25768937 Erythrocyte sedimentation rate 5.00E-13 0.1 21700265 | |
| 1 25768937 rs10903129-G 1:25768937 "Cholesterol, total" 5.00E-10 0.06 19060911 | |
| 1 25775733 rs12027135-A 1:25775733 LDL cholesterol 2.00E-14 0.03 24097068 | |
| 1 25775733 rs12027135-A 1:25775733 "Cholesterol, total" 5.00E-12 0.03 24097068 | |
| 1 25775733 rs12027135-A 1:25775733 "Cholesterol, total" 4.00E-11 1.22 20686565 | |
| 1 25775733 rs12027135-A 1:25775733 LDL cholesterol 1.00E-10 1.1 20686565 | |
| 1 26741544 rs7532866-A 1:26741544 Height 3.00E-08 0.02 20881960 | |
| 1 27138393 rs12748152-T 1:27138393 HDL cholesterol 1.00E-15 0.05 24097068 | |
| 1 27138393 rs12748152-T 1:27138393 LDL cholesterol 3.00E-12 0.05 24097068 | |
| 1 27138393 rs12748152-T 1:27138393 Triglycerides 1.00E-09 0.04 24097068 | |
| 1 31883925 rs4478858-G 1:31883925 Alcohol dependence 3.00E-08 1.26 23455491 | |
| 1 32242206 rs877674-? x rs6952893-? 1:32242206 Age-related hearing impairment (interaction) 4.00E-11 NR 24939585 | |
| 1 35908451 rs2275247-? 1:35908451 Systemic lupus erythematosus and Systemic sclerosis 1.00E-10 1.51 23740937 | |
| 1 36571920 rs96067-A 1:36571920 Corneal structure 3.00E-11 0.03 23291589 | |
| 1 38092723 rs4074961-T 1:38092723 Axial length 4.00E-13 0.07 24144296 | |
| 1 38278579 rs28411352-T 1:38278579 Rheumatoid arthritis 3.00E-12 1.11 24390342 | |
| 1 38278579 rs28411352-T 1:38278579 Rheumatoid arthritis 6.00E-09 1.1 24390342 | |
| 1 38633879 rs12140275-A 1:38633879 Rheumatoid arthritis 2.00E-09 1.11 24390342 | |
| 1 38633879 rs12140275-A 1:38633879 Rheumatoid arthritis 4.00E-09 1.11 24390342 | |
| 1 39380385 rs4246511-T 1:39380385 Menopause (age at onset) 9.00E-17 0.24 22267201 | |
| 1 40028180 rs4660293-G 1:40028180 HDL cholesterol 3.00E-18 0.04 24097068 | |
| 1 40028180 rs4660293-G 1:40028180 HDL cholesterol 4.00E-10 0.48 20686565 | |
| 1 40064961 rs12037222-A 1:40064961 C-reactive protein 6.00E-11 0.05 21300955 | |
| 1 40069939 rs3916164-G 1:40069939 Red blood cell traits 3.00E-10 0.01 23222517 | |
| 1 40953300 rs12022452-? x rs269427-? 1:40953300 Age-related hearing impairment (interaction) 1.00E-09 NR 24939585 | |
| 1 41530871 rs6686842-C 1:41530871 Height 2.00E-08 0.05 18391952 | |
| 1 41688938 rs11209718-T 1:41688938 Height 3.00E-09 1.12 23563607 | |
| 1 41745770 rs2154319-T 1:41745770 Height 2.00E-12 0.03 20881960 | |
| 1 45978675 rs4660306-T 1:45978675 Homocysteine levels 2.00E-09 0.04 23824729 | |
| 1 46084383 rs1053941-T 1:46084383 Blood metabolite levels 5.00E-11 0.02 24816252 | |
| 1 46779764 rs11588062-? x rs8004687-? 1:46779764 Age-related hearing impairment (interaction) 5.00E-09 NR 24939585 | |
| 1 46990681 rs7542172-A 1:46990681 Blood metabolite levels 2.00E-12 0.02 24816252 | |
| 1 47331966 rs6678639-A 1:47331966 Blood metabolite ratios 8.00E-86 0.09 24816252 | |
| 1 47347427 rs6663731-A 1:47347427 Blood metabolite levels 1.00E-14 0.06 24816252 | |
| 1 47347427 rs6663731-A 1:47347427 Blood metabolite levels 5.00E-11 0.05 24816252 | |
| 1 47396162 rs9333029-A 1:47396162 Blood metabolite levels 2.00E-61 0.07 24816252 | |
| 1 47404186 rs9332998-C 1:47404186 Metabolic traits 5.00E-32 0.16 21886157 | |
| 1 47854514 rs17103186-C 1:47854514 Corneal curvature 3.00E-12 0.11 24963161 | |
| 1 50909985 rs17106184-G 1:50909985 Type 2 diabetes 4.00E-09 1.1 24509480 | |
| 1 51546140 rs17391905-G 1:51546140 QRS duration 3.00E-10 1.35 21076409 | |
| 1 53695882 rs13375749-T 1:53695882 Blood metabolite levels 3.00E-28 0.03 24816252 | |
| 1 54375570 rs2235544-A 1:54375570 Thyroid hormone levels 8.00E-32 0.14 23408906 | |
| 1 54375570 rs2235544-A 1:54375570 Thyroid hormone levels 3.00E-18 0.13 23408906 | |
| 1 54375570 rs2235544-A 1:54375570 Thyroid hormone levels 5.00E-15 0.14 23408906 | |
| 1 55496039 rs11206510-T 1:55496039 LDL cholesterol 4.00E-11 3.04 18193043 | |
| 1 55496039 rs11206510-T 1:55496039 LDL cholesterol 1.00E-10 0.03 20864672 | |
| 1 55496039 rs11206510-T 1:55496039 Myocardial infarction (early onset) 1.00E-08 1.15 19198609 | |
| 1 55496039 rs11206510-C 1:55496039 LDL cholesterol 4.00E-08 0.09 19060906 | |
| 1 55504650 rs2479409-G 1:55504650 LDL cholesterol 3.00E-50 0.06 24097068 | |
| 1 55504650 rs2479409-G 1:55504650 "Cholesterol, total" 2.00E-39 0.05 24097068 | |
| 1 55504650 rs2479409-G 1:55504650 LDL cholesterol 2.00E-28 2.01 20686565 | |
| 1 55504650 rs2479409-G 1:55504650 "Cholesterol, total" 4.00E-24 1.96 20686565 | |
| 1 55505647 rs11591147-T 1:55505647 LDL cholesterol 2.00E-44 0.47 18193044 | |
| 1 55505647 rs11591147-? 1:55505647 Response to statin therapy (LDL-C) 5.00E-09 5 22331829 | |
| 1 55625548 rs17111684-A 1:55625548 LDL cholesterol 2.00E-17 9.01 23726366 | |
| 1 55958030 rs1998013-? 1:55958030 Metabolite levels 5.00E-13 NR 22916037 | |
| 1 56116505 rs72669744-? 1:56116505 Lipid metabolism phenotypes 1.00E-19 0.59 22286219 | |
| 1 56962821 rs17114036-A 1:56962821 Coronary heart disease 4.00E-19 1.17 21378990 | |
| 1 56962821 rs17114036-G 1:56962821 Coronary artery disease 1.00E-08 1.15 24262325 | |
| 1 56962821 rs17114036-? 1:56962821 Coronary artery disease or large artery stroke 2.00E-08 NR 24262325 | |
| 1 56962821 rs17114036-? 1:56962821 Coronary artery disease or ischemic stroke 3.00E-08 NR 24262325 | |
| 1 61041875 rs12565755-? 1:61041875 Response to tocilizumab in rheumatoid arthritis 5.00E-08 0.39 22491018 | |
| 1 61620496 rs334699-A 1:61620496 Thyroid hormone levels 5.00E-12 0.14 23408906 | |
| 1 61897967 rs2207790-A 1:61897967 Electrocardiographic conduction measures 6.00E-18 0.6 23463857 | |
| 1 62931632 rs1167998-C 1:62931632 Triglycerides 2.00E-12 0.09 19060911 | |
| 1 62931632 rs1167998-? 1:62931632 Lipid metabolism phenotypes 4.00E-09 1.51 19936222 | |
| 1 62950858 rs10889332-? 1:62950858 Metabolite levels 8.00E-15 NR 22916037 | |
| 1 62969402 rs1168029-? 1:62969402 Lipid metabolism phenotypes 3.00E-13 0.13 22286219 | |
| 1 63025942 rs2131925-G 1:63025942 "Cholesterol, total" 4.00E-80 0.08 24097068 | |
| 1 63025942 rs2131925-G 1:63025942 Triglycerides 3.00E-74 0.07 24097068 | |
| 1 63025942 rs2131925-G 1:63025942 Triglycerides 9.00E-43 4.94 20686565 | |
| 1 63025942 rs2131925-G 1:63025942 "Cholesterol, total" 5.00E-41 2.6 20686565 | |
| 1 63025942 rs2131925-G 1:63025942 LDL cholesterol 3.00E-32 0.05 24097068 | |
| 1 63025942 rs2131925-G 1:63025942 LDL cholesterol 3.00E-18 1.59 20686565 | |
| 1 63049551 rs11207995-C 1:63049551 Lipid traits 6.00E-10 0.01 24386095 | |
| 1 63049593 rs1748195-C 1:63049593 Triglycerides 2.00E-10 7.12 18193043 | |
| 1 63118196 rs10889353-? 1:63118196 Lipid metabolism phenotypes 1.00E-14 2.97 19936222 | |
| 1 63118196 rs10889353-? 1:63118196 Lipid metabolism phenotypes 1.00E-13 0.03 19936222 | |
| 1 63118196 rs10889353-? 1:63118196 Lipid metabolism phenotypes 1.00E-12 2.69 19936222 | |
| 1 63118196 rs10889353-C 1:63118196 "Cholesterol, total" 4.00E-12 0.08 19060911 | |
| 1 63118196 rs10889353-? 1:63118196 Lipid metabolism phenotypes 2.00E-11 0.04 19936222 | |
| 1 63118196 rs10889353-? 1:63118196 Lipid metabolism phenotypes 3.00E-10 1.32 19936222 | |
| 1 63118196 rs10889353-? 1:63118196 Lipid metabolism phenotypes 7.00E-10 1.32 19936222 | |
| 1 63118196 rs10889353-C 1:63118196 Triglycerides 2.00E-09 0.13 20139978 | |
| 1 63191777 rs12130333-T 1:63191777 Triglycerides 2.00E-08 0.11 18193044 | |
| 1 63199936 rs6679002-T 1:63199936 Blood metabolite levels 2.00E-15 0.01 24816252 | |
| 1 64127468 rs2749097-G 1:64127468 Alcohol consumption (transferrin glycosylation) 2.00E-09 0.12 21665994 | |
| 1 65695930 rs1336472-A x rs4715555-G 1:65695930 Venous thromboembolism (gene x gene interaction) 4.00E-10 1.54 23509962 | |
| 1 65979280 rs11208659-C 1:65979280 Obesity (early onset extreme) 2.00E-09 1.42 23563609 | |
| 1 65992625 rs1751492-C 1:65992625 Soluble leptin receptor levels 6.00E-13 7.6 20167575 | |
| 1 66086194 rs10889569-T 1:66086194 C-reactive protein 9.00E-09 0.05 23844046 | |
| 1 66089782 rs6700896-T 1:66089782 C-reactive protein 3.00E-14 14.8 19567438 | |
| 1 66102257 rs1805096-A 1:66102257 C-reactive protein 2.00E-09 0.11 22939635 | |
| 1 66105944 rs1892534-A 1:66105944 C-reactive protein 7.00E-21 0.17 18439548 | |
| 1 66117829 rs1938492-A 1:66117829 Fibrinogen 5.00E-14 0.01 23969696 | |
| 1 66161461 rs4420065-C 1:66161461 C-reactive protein 4.00E-62 0.09 21300955 | |
| 1 67597119 rs3762318-A 1:67597119 Leprosy 3.00E-11 1.45 22019778 | |
| 1 67648596 rs76418789-G 1:67648596 Crohn's disease 2.00E-10 2.06 23850713 | |
| 1 67675516 rs11805303-T 1:67675516 Crohn's disease 6.00E-12 1.39 17554300 | |
| 1 67681669 rs7517847-? 1:67681669 Crohn's disease 3.00E-12 NR 17435756 | |
| 1 67694202 rs2201841-A 1:67694202 Ulcerative colitis 1.00E-13 1.27 20228799 | |
| 1 67694202 rs2201841-G 1:67694202 Psoriasis 3.00E-08 1.13 19169254 | |
| 1 67702526 rs11465804-T 1:67702526 Crohn's disease 7.00E-63 2.5 18587394 | |
| 1 67705958 rs11209026-G 1:67705958 Inflammatory bowel disease 8.00E-161 2.01 23128233 | |
| 1 67705958 rs11209026-G 1:67705958 Crohn's disease 1.00E-64 2.66 21102463 | |
| 1 67705958 rs11209026-G 1:67705958 Ulcerative colitis 5.00E-28 1.74 21297633 | |
| 1 67705958 rs11209026-? 1:67705958 Crohn's disease 4.00E-21 3.18 22293688 | |
| 1 67705958 rs11209026-G 1:67705958 Crohn's disease 1.00E-18 2.2 22412388 | |
| 1 67705958 rs11209026-? 1:67705958 Crohn's disease 2.00E-18 2.92 17447842 | |
| 1 67705958 rs11209026-G 1:67705958 Ankylosing spondylitis 2.00E-17 NR 21743469 | |
| 1 67705958 rs11209026-G 1:67705958 Crohn's disease 4.00E-14 2.84 22936669 | |
| 1 67705958 rs11209026-? 1:67705958 Ankylosing spondylitis 9.00E-14 1.89 20062062 | |
| 1 67705958 rs11209026-? 1:67705958 Inflammatory bowel disease 7.00E-11 2.56 18758464 | |
| 1 67705958 rs11209026-? 1:67705958 Ulcerative colitis 3.00E-10 NR 19915572 | |
| 1 67705958 rs11209026-? 1:67705958 Ulcerative colitis 1.00E-08 1.79 19122664 | |
| 1 67725120 rs10889677-A 1:67725120 Ulcerative colitis 1.00E-08 1.29 19122664 | |
| 1 67753508 rs1495965-G 1:67753508 Behcet's disease 2.00E-11 1.35 20622879 | |
| 1 67760140 rs924080-? 1:67760140 Behcet's disease 7.00E-09 1.28 20622878 | |
| 1 67822377 rs3790567-A 1:67822377 Primary biliary cirrhosis 8.00E-12 1.48 20639880 | |
| 1 67822377 rs3790567-A 1:67822377 Primary biliary cirrhosis 3.00E-11 1.51 19458352 | |
| 1 68635075 rs1430742-C 1:68635075 Bone mineral density (spine) 3.00E-13 0.11 19801982 | |
| 1 68635390 rs2566755-C 1:68635390 Bone mineral density (hip) 2.00E-12 0.1 19801982 | |
| 1 68647716 rs12407028-T 1:68647716 Bone mineral density 3.00E-45 0.08 22504420 | |
| 1 68657510 rs1430740-? 1:68657510 Bone mineral density 1.00E-11 NR 24249740 | |
| 1 69889691 rs11209454-? x rs9533623-? 1:69889691 Age-related hearing impairment (interaction) 5.00E-09 NR 24939585 | |
| 1 70335682 rs2226284-? 1:70335682 Hypertension risk in short sleep duration 3.00E-08 5.91 22322875 | |
| 1 70995562 rs2651244-G 1:70995562 Inflammatory bowel disease 2.00E-08 1.02 23128233 | |
| 1 72751185 rs3101336-C 1:72751185 Obesity 1.00E-13 1.12 23563607 | |
| 1 72751185 rs3101336-C 1:72751185 Obesity (early onset extreme) 2.00E-08 1.21 23563609 | |
| 1 72765116 rs2568958-A 1:72765116 Obesity 4.00E-16 1.06 23563607 | |
| 1 72765116 rs2568958-A 1:72765116 Body mass index 2.00E-14 1.16 23563607 | |
| 1 72765116 rs2568958-A 1:72765116 Body mass index 1.00E-11 3.77 19079260 | |
| 1 72765116 rs2568958-A 1:72765116 Weight 2.00E-08 3.37 19079260 | |
| 1 72812440 rs2815752-A 1:72812440 Body mass index 2.00E-22 0.13 20935630 | |
| 1 72837239 rs7531118-C 1:72837239 Obesity 2.00E-17 1.08 23563607 | |
| 1 72838529 rs1993709-G 1:72838529 Obesity (early onset extreme) 5.00E-13 1.38 23563609 | |
| 1 73824909 rs10789369-A 1:73824909 Schizophrenia 4.00E-10 1.1 23974872 | |
| 1 74991402 rs1514177-C 1:74991402 Obesity 5.00E-09 1.06 23563607 | |
| 1 74991644 rs1514175-A 1:74991644 Body mass index 8.00E-14 0.07 20935630 | |
| 1 74991644 rs1514175-A 1:74991644 Body mass index 3.00E-11 0.06 23669352 | |
| 1 74993063 rs1514174-C 1:74993063 Obesity 1.00E-08 1.04 23563607 | |
| 1 75235317 rs3931020-C 1:75235317 Resistin levels 6.00E-12 0.05 22843503 | |
| 1 76106675 rs211718-T 1:76106675 Metabolic traits 2.00E-71 0.16 21886157 | |
| 1 76106675 rs211718-C 1:76106675 Metabolite levels 1.00E-63 14.6 20037589 | |
| 1 76135946 rs7552404-A 1:76135946 Blood metabolite levels 1.00E-77 0.08 24816252 | |
| 1 76135946 rs7552404-A 1:76135946 Blood metabolite levels 3.00E-43 0.06 24816252 | |
| 1 76161889 rs4949874-T 1:76161889 Blood metabolite ratios 2.00E-172 0.07 24816252 | |
| 1 76216330 rs11161521-T 1:76216330 Blood metabolite levels 6.00E-100 0.07 24816252 | |
| 1 76216330 rs11161521-T 1:76216330 Blood metabolite levels 1.00E-63 0.06 24816252 | |
| 1 78048331 rs17381664-C 1:78048331 Obesity 3.00E-08 1.09 23563607 | |
| 1 78623626 rs17391694-T 1:78623626 Height 2.00E-11 0.04 20881960 | |
| 1 78623626 rs17391694-C 1:78623626 Crohn's disease 3.00E-09 1.13 23128233 | |
| 1 79238015 rs4650608-? 1:79238015 Schizophrenia or bipolar disorder 8.00E-09 NR 24280982 | |
| 1 79238015 rs4650608-T 1:79238015 Bipolar disorder 8.00E-09 NR 22182935 | |
| 1 85531711 rs6695223-C x rs1763510-T 1:85531711 Venous thromboembolism (gene x gene interaction) 5.00E-09 1.86 23509962 | |
| 1 85797110 rs28489187-G 1:85797110 Serum dimethylarginine levels (asymmetric) 1.00E-40 0.37 24159190 | |
| 1 85797110 rs28489187-G 1:85797110 Serum dimethylarginine levels (asymmetric/symetric ratio) 1.00E-20 0.26 24159190 | |
| 1 85845998 rs1884139-T 1:85845998 Serum dimethylarginine levels (symmetric) 1.00E-18 0.18 24159190 | |
| 1 89123443 rs6699417-T 1:89123443 Height 5.00E-09 0.02 20881960 | |
| 1 89146234 rs12145922-A 1:89146234 Liver enzyme levels (gamma-glutamyl transferase) 4.00E-11 2.8 22001757 | |
| 1 92077097 rs1192415-G 1:92077097 Optic disc parameters 3.00E-28 0.06 20548946 | |
| 1 92077097 rs1192415-G 1:92077097 Optic disc parameters 8.00E-17 0.1 21307088 | |
| 1 93009438 rs7515577-C 1:93009438 "Cholesterol, total" 2.00E-08 0.04 24097068 | |
| 1 93009438 rs7515577-C 1:93009438 "Cholesterol, total" 3.00E-08 1.18 20686565 | |
| 1 93148377 rs11810217-A 1:93148377 Multiple sclerosis 6.00E-15 1.15 21833088 | |
| 1 93323971 rs10874746-T 1:93323971 Height 7.00E-11 0.02 20881960 | |
| 1 94553438 rs560426-G 1:94553438 Orofacial clefts 3.00E-12 1.42 22863734 | |
| 1 94553438 rs560426-G 1:94553438 Orofacial clefts 5.00E-10 NR 22863734 | |
| 1 95052476 rs2022309-G 1:95052476 End-stage coagulation 4.00E-08 0.24 23381943 | |
| 1 95053353 rs12029080-G 1:95053353 D-dimer levels 6.00E-52 10.4 21502573 | |
| 1 95387208 rs860873-A 1:95387208 Stearic acid (18:0) plasma levels 2.00E-14 0.15 23362303 | |
| 1 95485825 rs2391388-C 1:95485825 Palmitic acid (16:0) plasma levels 3.00E-11 0.18 23362303 | |
| 1 95515637 rs6675668-T 1:95515637 Stearic acid (18:0) plasma levels 2.00E-18 0.17 23362303 | |
| 1 95549536 rs9437689-? 1:95549536 Phospholipid levels (plasma) 5.00E-08 0.7 22359512 | |
| 1 95697529 rs6671200-A 1:95697529 Stearic acid (18:0) plasma levels 2.00E-15 0.25 23362303 | |
| 1 96944797 rs1555543-C 1:96944797 Body mass index 4.00E-10 0.06 20935630 | |
| 1 98502934 rs1625579-? 1:98502934 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 2.00E-11 NR 23453885 | |
| 1 98502934 rs1625579-T 1:98502934 Schizophrenia 2.00E-11 1.12 21926974 | |
| 1 98552832 rs1198588-T 1:98552832 Schizophrenia 2.00E-12 1.12 23974872 | |
| 1 99524047 rs10747502-? 1:99524047 Myopia (pathological) 1.00E-09 NR 23049088 | |
| 1 101331536 rs12048904-A 1:101331536 Multiple sclerosis 4.00E-08 1.09 21833088 | |
| 1 101331536 rs12048904-A 1:101331536 Multiple sclerosis 4.00E-08 1.09 21833088 | |
| 1 101407519 rs11581062-G 1:101407519 Multiple sclerosis 3.00E-10 1.12 21833088 | |
| 1 101880005 rs2338971-C 1:101880005 Parkinson's disease 4.00E-10 1.35 24511991 | |
| 1 101880005 rs2338971-C 1:101880005 Parkinson's disease 5.00E-10 1.32 24511991 | |
| 1 103379918 rs3753841-G 1:103379918 Glaucoma (primary open-angle) 9.00E-10 1.2 22922875 | |
| 1 106835943 rs1330225-C 1:106835943 Blood pressure measurement (low sodium intervention) 7.00E-09 5.16 24165912 | |
| 1 106835943 rs1330225-C 1:106835943 Blood pressure measurement (low sodium intervention) 1.00E-08 5.48 24165912 | |
| 1 107336301 rs12097821-? 1:107336301 Non-obstructive azoospermia 6.00E-10 1.25 22197933 | |
| 1 107546375 rs17496332-A 1:107546375 Sex hormone-binding globulin levels 1.00E-11 0.03 22829776 | |
| 1 108356820 rs12126655-G 1:108356820 Plasma thyroid-stimulating hormone levels 2.00E-08 0.14 24722205 | |
| 1 108366016 rs4915077-C 1:108366016 Hypothyroidism 8.00E-10 1.3 22493691 | |
| 1 109817192 rs7528419-A 1:109817192 Lipoprotein-associated phospholipase A2 activity and mass 1.00E-17 0.04 22003152 | |
| 1 109817590 rs12740374-T 1:109817590 LDL cholesterol 2.00E-42 0.23 19060906 | |
| 1 109817590 rs12740374-T 1:109817590 Coronary heart disease 9.00E-29 0.18 21347282 | |
| 1 109817590 rs12740374-T 1:109817590 Lipoprotein-associated phospholipase A2 activity and mass 2.00E-22 0.03 23118302 | |
| 1 109817838 rs660240-A 1:109817838 LDL cholesterol 1.00E-26 0.04 20864672 | |
| 1 109817838 rs660240-T 1:109817838 Cardiovascular disease risk factors 2.00E-22 0.17 21943158 | |
| 1 109818306 rs629301-G 1:109818306 LDL cholesterol 5.00E-241 0.17 24097068 | |
| 1 109818306 rs629301-G 1:109818306 LDL cholesterol 1.00E-170 5.65 20686565 | |
| 1 109818306 rs629301-G 1:109818306 "Cholesterol, total" 2.00E-170 0.13 24097068 | |
| 1 109818306 rs629301-G 1:109818306 "Cholesterol, total" 6.00E-131 5.41 20686565 | |
| 1 109818530 rs646776-? 1:109818530 Lipid metabolism phenotypes 2.00E-53 5.21 19936222 | |
| 1 109818530 rs646776-? 1:109818530 Lipid metabolism phenotypes 4.00E-39 5.25 19936222 | |
| 1 109818530 rs646776-G 1:109818530 Progranulin levels 2.00E-30 0.18 21087763 | |
| 1 109818530 rs646776-C 1:109818530 LDL cholesterol 3.00E-29 0.16 18193044 | |
| 1 109818530 rs646776-? 1:109818530 Lipid metabolism phenotypes 2.00E-27 0.04 19936222 | |
| 1 109818530 rs646776-G 1:109818530 LDL cholesterol 8.00E-23 0.16 19060911 | |
| 1 109818530 rs646776-G 1:109818530 "Cholesterol, total" 9.00E-22 0.13 19060911 | |
| 1 109818530 rs646776-? 1:109818530 Lipid metabolism phenotypes 2.00E-20 0.04 19936222 | |
| 1 109818530 rs646776-G 1:109818530 LDL cholesterol 2.00E-12 0.16 19060910 | |
| 1 109818530 rs646776-T 1:109818530 Myocardial infarction (early onset) 8.00E-12 1.19 19198609 | |
| 1 109818530 rs646776-T 1:109818530 Coronary heart disease 6.00E-10 1.14 21378988 | |
| 1 109819296 rs3902354-A 1:109819296 "Cholesterol, total" 1.00E-08 0.15 24886709 | |
| 1 109821511 rs602633-T 1:109821511 Coronary artery disease 1.00E-08 1.11 24262325 | |
| 1 109822166 rs599839-G 1:109822166 LDL cholesterol 1.00E-33 0.16 18262040 | |
| 1 109822166 rs599839-A 1:109822166 LDL cholesterol 6.00E-33 5.48 18193043 | |
| 1 109822166 rs599839-G 1:109822166 Metabolite levels 2.00E-19 5.23 21909109 | |
| 1 109822166 rs599839-? 1:109822166 Coronary artery disease or large artery stroke 8.00E-17 NR 24262325 | |
| 1 109822166 rs599839-G 1:109822166 Lipoprotein-associated phospholipase A2 activity and mass 3.00E-15 5.5 20442857 | |
| 1 109822166 rs599839-A 1:109822166 Coronary heart disease 3.00E-10 1.11 21378990 | |
| 1 109822166 rs599839-A 1:109822166 Coronary heart disease 4.00E-09 1.29 17634449 | |
| 1 109822166 rs599839-? 1:109822166 Coronary artery disease or ischemic stroke 1.00E-08 NR 24262325 | |
| 1 110147321 rs17024258-T 1:110147321 Obesity 9.00E-12 1.25 23563607 | |
| 1 110352477 rs10494112-G 1:110352477 Paget's disease 7.00E-35 1.72 21623375 | |
| 1 110366083 rs484959-? 1:110366083 Paget's disease 5.00E-24 1.82 20436471 | |
| 1 110618730 rs1466788-A 1:110618730 Blood metabolite levels 3.00E-16 0.01 24816252 | |
| 1 111684276 rs1335645-A 1:111684276 Liver enzyme levels (gamma-glutamyl transferase) 7.00E-09 4.3 22001757 | |
| 1 112192122 rs494453-C 1:112192122 Osteoporosis-related phenotypes 4.00E-08 NR 20548944 | |
| 1 112392360 rs12044963-A 1:112392360 Immune reponse to smallpox (secreted IFN-alpha) 9.00E-10 NR 22610502 | |
| 1 112416363 rs2788612-? 1:112416363 Response to radiotherapy in cancer (late toxicity) 6.00E-16 0.18 24785509 | |
| 1 112437344 rs2798334-T 1:112437344 P wave duration 8.00E-11 0.92 24850809 | |
| 1 113190807 rs17030613-C 1:113190807 Blood pressure 1.00E-08 0.38 21572416 | |
| 1 113216543 rs2932538-G 1:113216543 Diastolic blood pressure 1.00E-09 0.24 21909115 | |
| 1 113216543 rs2932538-G 1:113216543 Systolic blood pressure 1.00E-09 0.39 21909115 | |
| 1 114173410 rs1230666-A 1:114173410 Thyroid peroxidase antibody levels 2.00E-08 0.03 24586183 | |
| 1 114303808 rs6679677-? 1:114303808 Rheumatoid arthritis 6.00E-42 1.79 18794853 | |
| 1 114303808 rs6679677-A 1:114303808 Type 1 diabetes 1.00E-40 NR 18978792 | |
| 1 114303808 rs6679677-A 1:114303808 Type 1 diabetes 5.00E-26 1.82 17554300 | |
| 1 114303808 rs6679677-A 1:114303808 Rheumatoid arthritis 6.00E-25 1.98 17554300 | |
| 1 114303808 rs6679677-A 1:114303808 Type 1 diabetes 8.00E-24 1.89 17554260 | |
| 1 114303808 rs6679677-C 1:114303808 Crohn's disease 2.00E-15 1.2 23128233 | |
| 1 114303808 rs6679677-A 1:114303808 Hypothyroidism 3.00E-13 1.36 22493691 | |
| 1 114377568 rs2476601-A 1:114377568 Rheumatoid arthritis 9.00E-170 1.8 24390342 | |
| 1 114377568 rs2476601-A 1:114377568 Type 1 diabetes autoantibodies 2.00E-111 2 21829393 | |
| 1 114377568 rs2476601-? 1:114377568 Type 1 diabetes 9.00E-85 NR 19430480 | |
| 1 114377568 rs2476601-T 1:114377568 Type 1 diabetes 2.00E-80 1.98 17554260 | |
| 1 114377568 rs2476601-A 1:114377568 Rheumatoid arthritis 9.00E-74 1.94 20453842 | |
| 1 114377568 rs2476601-? 1:114377568 Rheumatoid arthritis 5.00E-33 1.77 24449572 | |
| 1 114377568 rs2476601-? 1:114377568 Rheumatoid arthritis 5.00E-33 1.77 24449572 | |
| 1 114377568 rs2476601-? 1:114377568 Rheumatoid arthritis 2.00E-21 NR 19503088 | |
| 1 114377568 rs2476601-? 1:114377568 Rheumatoid arthritis 2.00E-11 1.72 17804836 | |
| 1 114377568 rs2476601-A 1:114377568 Myasthenia gravis 8.00E-10 1.71 23055271 | |
| 1 114377568 rs2476601-G 1:114377568 Crohn's disease 4.00E-09 1.26 21102463 | |
| 1 114377568 rs2476601-? 1:114377568 Rheumatoid arthritis 1.00E-08 NR 21156761 | |
| 1 114377568 rs2476601-G 1:114377568 Crohn's disease 1.00E-08 1.31 18587394 | |
| 1 114448389 rs11552449-T 1:114448389 Breast cancer 2.00E-08 1.07 23535729 | |
| 1 114948281 rs6537825-A 1:114948281 Autism 3.00E-08 1.4 24189344 | |
| 1 115239816 rs926938-A 1:115239816 Autism 4.00E-08 1.27 24189344 | |
| 1 115677946 rs12134493-A 1:115677946 Migraine 5.00E-14 1.14 23793025 | |
| 1 115677946 rs12134493-A 1:115677946 Migraine without aura 5.00E-08 1.18 23793025 | |
| 1 117100957 rs1335532-A 1:117100957 Multiple sclerosis 3.00E-16 1.22 21833088 | |
| 1 117104215 rs2300747-A 1:117104215 Multiple sclerosis 3.00E-10 1.3 19525953 | |
| 1 117104215 rs2300747-A 1:117104215 Multiple sclerosis 6.00E-09 1.37 22190364 | |
| 1 117263790 rs624988-T 1:117263790 Rheumatoid arthritis 8.00E-10 1.09 24390342 | |
| 1 118855587 rs9428104-A 1:118855587 Height 6.00E-23 0.04 20881960 | |
| 1 118864616 rs7534091-A 1:118864616 Height 2.00E-16 1.22 23563607 | |
| 1 118883973 rs12735613-A 1:118883973 Height 4.00E-11 0.08 18391952 | |
| 1 118902978 rs2474937-C 1:118902978 Congenital heart malformation 8.00E-10 1.4 23708190 | |
| 1 119952776 rs12141041-T 1:119952776 Blood metabolite levels 2.00E-12 0.03 24816252 | |
| 1 120209755 rs1163251-T 1:120209755 Blood metabolite levels 7.00E-27 0.02 24816252 | |
| 1 120255126 rs478093-G 1:120255126 Metabolite levels 2.00E-14 NR 23378610 | |
| 1 120257576 rs477992-A 1:120257576 Metabolic traits 3.00E-14 0.05 21886157 | |
| 1 120451190 rs3897478-T 1:120451190 Crohn's disease 2.00E-11 1.16 23128233 | |
| 1 120517959 rs10923931-T 1:120517959 Type 2 diabetes 4.00E-08 1.13 18372903 | |
| 1 121280613 rs11249433-G 1:121280613 Breast cancer 2.00E-26 1.09 23535729 | |
| 1 121280613 rs11249433-C 1:121280613 Breast cancer 7.00E-10 1.16 19330030 | |
| 1 145723643 rs1967017-T 1:145723643 Urate levels 4.00E-08 3.33 20884846 | |
| 1 145723737 rs1471633-A 1:145723737 Urate levels 1.00E-29 0.06 23263486 | |
| 1 145725687 rs12129861-A 1:145725687 Uric acid levels 3.00E-09 0.06 19503597 | |
| 1 145727681 rs1797052-? 1:145727681 Contrast sensitivity 8.00E-09 5.72 24152035 | |
| 1 149892872 rs11205277-A 1:149892872 Height 5.00E-32 0.05 20881960 | |
| 1 149892872 rs11205277-G 1:149892872 Height 1.00E-10 5.1 18391951 | |
| 1 149906413 rs11205303-C 1:149906413 Height 4.00E-23 1.25 23563607 | |
| 1 150727539 rs2230061-A 1:150727539 Fat body mass 4.00E-08 0.06 24064335 | |
| 1 150860471 rs7412746-T 1:150860471 Melanoma 9.00E-11 1.15 21983785 | |
| 1 150951477 rs267734-C 1:150951477 Chronic kidney disease 1.00E-12 0.01 20383146 | |
| 1 150958836 rs267733-G 1:150958836 LDL cholesterol 5.00E-09 0.03 24097068 | |
| 1 151344741 rs2769264-G 1:151344741 Blood trace element (Cu levels) 3.00E-20 0.31 23720494 | |
| 1 151801680 rs4845604-G 1:151801680 Inflammatory bowel disease 4.00E-16 1.14 23128233 | |
| 1 151839838 rs12566232-A 1:151839838 Blood metabolite levels 6.00E-19 0.05 24816252 | |
| 1 151858888 rs6685187-A 1:151858888 Blood metabolite levels 3.00E-26 0.04 24816252 | |
| 1 151882856 rs10788817-G 1:151882856 Serum metabolite levels 3.00E-13 0.11 24625756 | |
| 1 151895093 rs10788819-T 1:151895093 Hair morphology 2.00E-08 NR 19896111 | |
| 1 151930645 rs6693388-T 1:151930645 Blood metabolite ratios 4.00E-38 0.04 24816252 | |
| 1 152062767 rs17646946-A 1:152062767 Common traits (Other) 2.00E-42 0.29 20585627 | |
| 1 152083325 rs11803731-A 1:152083325 Hair morphology 3.00E-31 6.11 19896111 | |
| 1 152300817 rs3126085-A 1:152300817 Atopic dermatitis 6.00E-12 1.22 21666691 | |
| 1 152442289 rs6661961-T 1:152442289 Atopic dermatitis 9.00E-11 0.34 23886662 | |
| 1 152493154 rs499697-G 1:152493154 Common traits (Other) 1.00E-10 0.13 20585627 | |
| 1 152550018 rs4085613-A 1:152550018 Psoriasis 7.00E-30 1.32 19169255 | |
| 1 152551276 rs4112788-? 1:152551276 Psoriasis 3.00E-10 1.29 20953190 | |
| 1 154418879 rs4537545-T 1:154418879 C-reactive protein 2.00E-14 11.5 19567438 | |
| 1 154426264 rs4129267-? 1:154426264 Protein quantitative trait loci 2.00E-57 NR 18464913 | |
| 1 154426264 rs4129267-C 1:154426264 C-reactive protein 2.00E-48 0.08 21300955 | |
| 1 154426264 rs4129267-T 1:154426264 Fibrinogen 6.00E-27 0.01 23969696 | |
| 1 154426264 rs4129267-T 1:154426264 Asthma 2.00E-08 1.09 21907864 | |
| 1 154426970 rs8192284-C 1:154426970 Fibrinogen 2.00E-11 5.3 20031577 | |
| 1 154426970 rs2228145-A 1:154426970 Rheumatoid arthritis 4.00E-09 1.08 24390342 | |
| 1 154426970 rs8192284-? 1:154426970 C-reactive protein 2.00E-08 0.1 18439548 | |
| 1 154814268 rs6666258-C 1:154814268 Atrial fibrillation 2.00E-14 1.18 22544366 | |
| 1 154814353 rs13376333-T 1:154814353 Atrial fibrillation 2.00E-21 1.52 20173747 | |
| 1 154834183 rs1218582-G 1:154834183 Prostate cancer 2.00E-08 1.06 23535732 | |
| 1 154855055 rs1630500-? 1:154855055 Parkinson's disease 2.00E-08 1.75 24842889 | |
| 1 155108167 rs12726330-? 1:155108167 Parkinson's disease 5.00E-08 1.71 22451204 | |
| 1 155126948 rs10908458-T 1:155126948 Liver enzyme levels (gamma-glutamyl transferase) 2.00E-15 3.7 22001757 | |
| 1 155151493 rs11264341-T 1:155151493 Urate levels 6.00E-19 0.05 23263486 | |
| 1 155162067 rs4072037-C 1:155162067 Magnesium levels 2.00E-36 0.01 20700443 | |
| 1 155194980 rs2049805-T 1:155194980 Renal function-related traits (BUN) 2.00E-12 0.01 22797727 | |
| 1 155230131 rs3180018-A 1:155230131 Crohn's disease 2.00E-13 1.13 21102463 | |
| 1 155878732 rs670523-A 1:155878732 Inflammatory bowel disease 6.00E-11 1.06 23128233 | |
| 1 156030037 rs34372695-T 1:156030037 Parkinson's disease 4.00E-12 1.47 21292315 | |
| 1 156169610 rs2072499-G 1:156169610 Testicular germ cell tumor 3.00E-08 1.19 23666240 | |
| 1 156197380 rs2984613-C 1:156197380 Intracerebral hemorrhage 2.00E-10 1.33 24656865 | |
| 1 156255456 rs6684514-G 1:156255456 Glycated hemoglobin levels 1.00E-23 0.09 24647736 | |
| 1 156255456 rs6684514-A 1:156255456 Mean corpuscular hemoglobin concentration 3.00E-09 0.09 20139978 | |
| 1 156446242 rs2274316-C 1:156446242 Migraine 1.00E-08 1.07 23793025 | |
| 1 156456301 rs3790455-C 1:156456301 Migraine 7.00E-11 1.2 22683712 | |
| 1 156700651 rs12145743-G 1:156700651 HDL cholesterol 2.00E-08 0.02 24097068 | |
| 1 156869047 rs12566888-A 1:156869047 Platelet aggregation 5.00E-19 NR 20526338 | |
| 1 156869047 rs12566888-A 1:156869047 Platelet aggregation 4.00E-16 NR 20526338 | |
| 1 157669278 rs3761959-A 1:157669278 Graves' disease 2.00E-13 1.23 21841780 | |
| 1 157670816 rs7528684-T 1:157670816 Type 1 diabetes autoantibodies 1.00E-11 1.52 21829393 | |
| 1 158575729 rs857684-C 1:158575729 Red blood cell traits 4.00E-16 0.01 23222517 | |
| 1 158585415 rs2779116-T 1:158585415 Glycated hemoglobin levels 3.00E-09 0.02 20858683 | |
| 1 158612548 rs857721-A 1:158612548 Other erythrocyte phenotypes 1.00E-10 0 19862010 | |
| 1 158932555 rs1101999-? 1:158932555 Asthma 4.00E-09 NR 21804549 | |
| 1 158971086 rs4657616-G 1:158971086 Hematology traits 5.00E-47 0.06 23263863 | |
| 1 159147452 rs3026968-T 1:159147452 Inflammatory biomarkers 9.00E-14 NR 22291609 | |
| 1 159174683 rs2814778-? 1:159174683 White blood cell count 7.00E-55 1.35 22037903 | |
| 1 159174683 rs2814778-? 1:159174683 Neutrophil count 1.00E-08 NR 21507922 | |
| 1 159175354 rs12075-A 1:159175354 Inflammatory biomarkers 4.00E-51 NR 22291609 | |
| 1 159175354 rs12075-? 1:159175354 White blood cell count 5.00E-24 1.27 22037903 | |
| 1 159175354 rs12075-A 1:159175354 Obesity-related traits 1.00E-21 0.1 23251661 | |
| 1 159175354 rs12075-A 1:159175354 Monocyte chemoattractant protein-1 1.00E-21 NR 23017229 | |
| 1 159175527 rs13962-A 1:159175527 IgE levels 2.00E-11 0.09 22075330 | |
| 1 159218266 rs3845624-C 1:159218266 Inflammatory biomarkers 2.00E-11 NR 22291609 | |
| 1 159272060 rs2251746-C 1:159272060 IgE levels 5.00E-26 0.09 22075330 | |
| 1 159272060 rs2251746-C 1:159272060 IgE levels 2.00E-20 19.2 18846228 | |
| 1 159278251 rs2494250-? 1:159278251 Select biomarker traits 1.00E-14 NR 17903293 | |
| 1 159326880 rs4656784-G 1:159326880 IgE levels 2.00E-16 0.08 22075330 | |
| 1 159405959 rs4128725-? 1:159405959 Select biomarker traits 4.00E-12 NR 17903293 | |
| 1 159649700 rs16827466-T 1:159649700 C-reactive protein 4.00E-73 0.42 22939635 | |
| 1 159655518 rs726640-? 1:159655518 C-reactive protein 2.00E-13 0.44 22492993 | |
| 1 159674933 rs876537-C 1:159674933 C-reactive protein 1.00E-09 0.29 21647738 | |
| 1 159676171 rs16842559-T 1:159676171 C-reactive protein 4.00E-21 0.11 23844046 | |
| 1 159678816 rs2794520-C 1:159678816 C-reactive protein 2.00E-186 0.16 21300955 | |
| 1 159678816 rs2794520-A 1:159678816 Metabolic traits 3.00E-22 0.47 19060910 | |
| 1 159678816 rs2794520-? 1:159678816 Select biomarker traits 3.00E-08 NR 17903293 | |
| 1 159684665 rs3091244-? 1:159684665 C-reactive protein 6.00E-28 0.2 18439548 | |
| 1 159685136 rs3093059-G 1:159685136 C-reactive protein 4.00E-21 0.16 21196492 | |
| 1 159691559 rs1341665-A 1:159691559 Inflammatory biomarkers 2.00E-20 NR 22291609 | |
| 1 159692573 rs2808634-T 1:159692573 C-reactive protein 3.00E-10 0.15 22939635 | |
| 1 159698549 rs7553007-A 1:159698549 C-reactive protein 8.00E-44 20.7 19567438 | |
| 1 159698549 rs7553007-T 1:159698549 C-reactive protein 1.00E-37 0.27 22939635 | |
| 1 159698549 rs7553007-C 1:159698549 C-reactive protein levels 2.00E-16 0.16 24763700 | |
| 1 159698549 rs7553007-G 1:159698549 C-reactive protein 1.00E-09 0.13 22939635 | |
| 1 159856429 rs2501324-? 1:159856429 Bilirubin levels 2.00E-10 0.14 20639394 | |
| 1 160464911 rs1265883-C 1:160464911 Graves' disease 2.00E-18 1.34 23612905 | |
| 1 160852046 rs2274910-C 1:160852046 Crohn's disease 1.00E-09 1.14 18587394 | |
| 1 160856964 rs4656958-G 1:160856964 Inflammatory bowel disease 7.00E-09 1.06 23128233 | |
| 1 161200487 rs4073054-A 1:161200487 Blood metabolite levels 4.00E-19 0.02 24816252 | |
| 1 161472158 rs10800309-A 1:161472158 Ulcerative colitis 3.00E-09 1.2 20228799 | |
| 1 161479745 rs1801274-A 1:161479745 Inflammatory bowel disease 2.00E-38 1.12 23128233 | |
| 1 161479745 rs1801274-A 1:161479745 Ulcerative colitis 2.00E-20 1.21 21297633 | |
| 1 161479745 rs1801274-? 1:161479745 Ulcerative colitis 2.00E-12 1.59 19915573 | |
| 1 161479745 rs1801274-A 1:161479745 Kawasaki disease 7.00E-11 1.32 22081228 | |
| 1 161484210 rs368433-C 1:161484210 Helicobacter pylori serologic status 2.00E-08 1.37 23652523 | |
| 1 161540857 rs67418890-? 1:161540857 Lipid metabolism phenotypes 1.00E-10 0.19 22286219 | |
| 1 161946727 rs2340727-A 1:161946727 Hematology traits 2.00E-23 0.02 23263863 | |
| 1 162014632 rs2880058-G 1:162014632 QT interval 2.00E-10 0.19 20031603 | |
| 1 162033890 rs12143842-T 1:162033890 QT interval 1.00E-83 0.18 19587794 | |
| 1 162033890 rs12143842-T 1:162033890 QT interval 2.00E-78 3.15 19305408 | |
| 1 162033890 rs12143842-T 1:162033890 QT interval 2.00E-78 2.88 19305409 | |
| 1 162033890 rs12143842-C 1:162033890 QT interval 2.00E-15 3.14 23166209 | |
| 1 162085309 rs1415259-A 1:162085309 Electrocardiographic traits 7.00E-10 2.53 20062061 | |
| 1 162085685 rs10494366-G 1:162085685 Electrocardiographic traits 5.00E-22 12.2 20062063 | |
| 1 162085685 rs10494366-? 1:162085685 QT interval 1.00E-10 4.9 16648850 | |
| 1 162112910 rs16857031-G 1:162112910 QT interval 1.00E-34 2.63 19305408 | |
| 1 162133117 rs12029454-A 1:162133117 QT interval 3.00E-45 2.98 19305408 | |
| 1 162195738 rs4657175-? 1:162195738 QT interval 1.00E-09 1.71 22726844 | |
| 1 162210610 rs4657178-T 1:162210610 QT interval 7.00E-33 2.19 19305409 | |
| 1 165394882 rs466639-T 1:165394882 Menarche (age at onset) 1.00E-13 4.2 21102462 | |
| 1 165687205 rs4656461-G 1:165687205 Glaucoma 6.00E-14 1.51 21532571 | |
| 1 165718979 rs7555523-C 1:165718979 Intraocular pressure 2.00E-08 0.28 22570627 | |
| 1 165873392 rs3790672-C 1:165873392 Testicular germ cell tumor 2.00E-08 1.2 23666240 | |
| 1 167411384 rs864537-? 1:167411384 Celiac disease and Rheumatoid arthritis 2.00E-11 NR 21383967 | |
| 1 167420425 rs2056626-? 1:167420425 Systemic sclerosis 3.00E-09 1.16 20383147 | |
| 1 167903079 rs10489202-A 1:167903079 Schizophrenia 1.00E-08 1.23 22037555 | |
| 1 168618641 rs1412337-? 1:168618641 Morbidity-free survival 2.00E-09 NR 17903295 | |
| 1 169073346 rs1320976-A 1:169073346 QT interval 2.00E-10 2.06 23166209 | |
| 1 169099483 rs10919071-A 1:169099483 QT interval 1.00E-15 2.05 19305409 | |
| 1 169135127 rs16861990-C 1:169135127 Venous thromboembolism 2.00E-12 2.02 22672568 | |
| 1 169477574 rs6687813-A 1:169477574 D-dimer levels 2.00E-14 10.1 21502573 | |
| 1 169481223 rs6427196-C 1:169481223 Venous thromboembolism 4.00E-51 2.07 23650146 | |
| 1 169491555 rs2420371-G 1:169491555 Hemostatic factors and hematological phenotypes 4.00E-80 1.16 22443383 | |
| 1 169514006 rs1018827-A 1:169514006 Venous thromboembolism 2.00E-26 2.52 21980494 | |
| 1 169519049 rs6025-T 1:169519049 Venous thromboembolism 2.00E-22 3.57 22672568 | |
| 1 169550963 rs6703865-A 1:169550963 Hippocampal atrophy 1.00E-09 NR 22745009 | |
| 1 169551682 rs6028-C 1:169551682 Activated partial thromboplastin time 3.00E-09 0.23 22703881 | |
| 1 169563951 rs6136-T 1:169563951 Soluble levels of adhesion molecules 4.00E-61 22.6 20167578 | |
| 1 169580290 rs2235302-T 1:169580290 Soluble levels of adhesion molecules 4.00E-16 7.3 20167578 | |
| 1 169651044 rs7531806-A 1:169651044 Acne (severe) 1.00E-08 1.22 24399259 | |
| 1 169995802 rs1541160-C 1:169995802 Amyotrophic lateral sclerosis 2.00E-08 0.58 19451621 | |
| 1 170569317 rs3903239-G 1:170569317 Atrial fibrillation 8.00E-14 1.14 22544366 | |
| 1 171080615 rs7061710-C 1:171080615 Blood metabolite levels 8.00E-14 0.05 24816252 | |
| 1 171091875 rs1795240-A 1:171091875 Lentiform nucleus volume 5.00E-08 112.27 22903471 | |
| 1 171949750 rs10914144-C 1:171949750 Mean platelet volume 1.00E-24 0.01 22139419 | |
| 1 171949750 rs10914144-C 1:171949750 Mean platelet volume 2.00E-14 0.01 19820697 | |
| 1 171949750 rs10914144-T 1:171949750 Platelet counts 2.00E-12 3.42 22139419 | |
| 1 171949750 rs10914144-T 1:171949750 Mean platelet volume 2.00E-08 0.11 24026423 | |
| 1 172053287 rs17346452-T 1:172053287 Height 1.00E-23 0.04 20881960 | |
| 1 172189889 rs678962-G 1:172189889 Height 3.00E-08 5.4 18391951 | |
| 1 172199573 rs479336-T 1:172199573 Bone mineral density 9.00E-15 0.04 22504420 | |
| 1 172219995 rs12075079-G 1:172219995 Height 7.00E-12 1.2 23563607 | |
| 1 172241251 rs2421992-? 1:172241251 Height 5.00E-08 NR 20881960 | |
| 1 172853460 rs7517810-T 1:172853460 Crohn's disease 2.00E-15 1.22 21102463 | |
| 1 172862234 rs9286879-G 1:172862234 Crohn's disease 6.00E-22 1.13 23128233 | |
| 1 172862234 rs9286879-G 1:172862234 Crohn's disease 2.00E-09 1.19 18587394 | |
| 1 173191475 rs2205960-A 1:173191475 Systemic lupus erythematosus 3.00E-32 1.46 19838193 | |
| 1 173191475 rs2205960-T 1:173191475 Systemic lupus erythematosus 3.00E-12 1.36 23273568 | |
| 1 173349725 rs2105325-C 1:173349725 Rheumatoid arthritis 7.00E-13 1.12 24390342 | |
| 1 173349725 rs2105325-C 1:173349725 Rheumatoid arthritis 3.00E-11 1.12 24390342 | |
| 1 176684432 rs4507975-? x rs9914518-? 1:176684432 Venous thromboembolism (gene x gene interaction) 4.00E-09 1.54 23509962 | |
| 1 176792249 rs1325598-A 1:176792249 Height 1.00E-09 0.02 20881960 | |
| 1 177852580 rs633715-C 1:177852580 Obesity 9.00E-23 1.12 23563607 | |
| 1 177852580 rs633715-C 1:177852580 Obesity 7.00E-20 1.08 23563607 | |
| 1 177852580 rs633715-C 1:177852580 Obesity 4.00E-19 1.19 23563607 | |
| 1 177852580 rs633715-C 1:177852580 Body mass index 5.00E-12 1.21 23563607 | |
| 1 177852580 rs633715-C 1:177852580 Menarche (age at onset) 2.00E-08 2.6 21102462 | |
| 1 177855517 rs516636-A 1:177855517 Body mass index 3.00E-09 0.05 22344221 | |
| 1 177873210 rs574367-T 1:177873210 Body mass index 2.00E-19 0.06 24861553 | |
| 1 177889480 rs543874-G 1:177889480 Body mass index 4.00E-23 0.22 20935630 | |
| 1 177889480 rs543874-G 1:177889480 Body mass index 2.00E-13 0.06 23583978 | |
| 1 177889480 rs543874-G 1:177889480 Body mass index 4.00E-11 0.08 23669352 | |
| 1 177913519 rs10913469-C 1:177913519 Weight 1.00E-08 3.82 19079260 | |
| 1 178515312 rs4650994-G 1:178515312 HDL cholesterol 7.00E-09 0.02 24097068 | |
| 1 180962282 rs1411478-? 1:180962282 Progressive supranuclear palsy 4.00E-11 1.27 21685912 | |
| 1 182081960 rs10911021-C 1:182081960 Cardiovascular heart disease in diabetics 2.00E-08 1.36 23982368 | |
| 1 182168885 rs1689800-G 1:182168885 HDL cholesterol 5.00E-20 0.03 24097068 | |
| 1 182168885 rs1689800-G 1:182168885 HDL cholesterol 3.00E-10 0.47 20686565 | |
| 1 182549019 rs533259-? 1:182549019 Multiple sclerosis 6.00E-09 NR 23412934 | |
| 1 184007119 rs3814333-T 1:184007119 Height 2.00E-13 1.17 23563607 | |
| 1 184020945 rs2274432-T 1:184020945 Height 8.00E-09 5.3 18391951 | |
| 1 184023529 rs1046934-A 1:184023529 Height 2.00E-31 0.04 20881960 | |
| 1 184068508 rs971572-? x rs10828151-? 1:184068508 Venous thromboembolism (gene x gene interaction) 9.00E-09 2.38 23509962 | |
| 1 184649503 rs10911628-A 1:184649503 Systemic lupus erythematosus 2.00E-13 1.95 24871463 | |
| 1 191559356 rs10801047-? 1:191559356 Crohn's disease 3.00E-08 1.47 17554261 | |
| 1 192536813 rs2816316-? 1:192536813 Celiac disease 2.00E-17 1.25 20190752 | |
| 1 192536813 rs2816316-C 1:192536813 Celiac disease 3.00E-11 1.39 18311140 | |
| 1 192541021 rs1323292-A 1:192541021 Multiple sclerosis 2.00E-08 1.12 21833088 | |
| 1 196620917 rs3753394-C 1:196620917 Complement C3 and C4 levels 7.00E-11 0.05 23028341 | |
| 1 196642233 rs800292-A 1:196642233 Circulating myeloperoxidase levels (serum) 5.00E-41 0.15 23620142 | |
| 1 196646176 rs1329424-T 1:196646176 Age-related macular degeneration 2.00E-31 1.41 23326517 | |
| 1 196646176 rs1329424-T 1:196646176 Age-related macular degeneration 6.00E-16 1.88 20385819 | |
| 1 196654324 rs1061147-A 1:196654324 Age-related macular degeneration 7.00E-32 1.4 23326517 | |
| 1 196659237 rs1061170-C 1:196659237 Age-related macular degeneration 1.00E-261 2.41 21665990 | |
| 1 196659237 rs1061170-? 1:196659237 Age-related macular degeneration 4.00E-117 NR 20385826 | |
| 1 196659237 rs1061170-? 1:196659237 Age-related macular degeneration (CNV) 1.00E-108 2.78 22705344 | |
| 1 196659237 rs1061170-? 1:196659237 Age-related macular degeneration (GA) 5.00E-67 2.78 22705344 | |
| 1 196660261 rs10801555-A 1:196660261 Age-related macular degeneration 2.00E-47 2.33 22694956 | |
| 1 196673993 rs1831282-? 1:196673993 Age-related macular degeneration 1.00E-31 2.38 23577725 | |
| 1 196673993 rs1831282-? 1:196673993 Age-related macular degeneration (extreme sampling) 9.00E-24 2.63 23577725 | |
| 1 196679455 rs10737680-A 1:196679455 Age-related macular degeneration 2.00E-76 3.11 20385819 | |
| 1 196686918 rs6677604-? 1:196686918 Nephropathy 3.00E-10 1.47 21399633 | |
| 1 196696933 rs1410996-? 1:196696933 Age-related macular degeneration 2.00E-111 NR 20385826 | |
| 1 196696933 rs1410996-G 1:196696933 End-stage coagulation 1.00E-09 0.2 23381943 | |
| 1 196701051 rs380390-C 1:196701051 Age-related macular degeneration 4.00E-08 4.6 15761122 | |
| 1 196702810 rs1329428-? 1:196702810 Age-related macular degeneration 3.00E-64 2.78 20861866 | |
| 1 196760417 rs426736-? 1:196760417 Meningococcal disease 5.00E-13 1.59 20694013 | |
| 1 196886770 rs4915559-T 1:196886770 End-stage coagulation 7.00E-19 0.34 23381943 | |
| 1 196973183 rs12116643-T 1:196973183 End-stage coagulation 5.00E-30 0.52 23381943 | |
| 1 197070776 rs10922162-C 1:197070776 End-stage coagulation 2.00E-30 0.52 23381943 | |
| 1 197155021 rs7410943-A 1:197155021 End-stage coagulation 3.00E-19 0.3 23381943 | |
| 1 197325908 rs2786098-? 1:197325908 Asthma 2.00E-13 1.43 20032318 | |
| 1 197631141 rs2488389-A 1:197631141 Inflammatory bowel disease 8.00E-13 1.12 23128233 | |
| 1 197727642 rs1998598-G 1:197727642 Crohn's disease 9.00E-09 1.04 21102463 | |
| 1 197781198 rs12134279-T 1:197781198 Primary biliary cirrhosis 2.00E-14 1.34 21399635 | |
| 1 198595506 rs12127588-A 1:198595506 Mean corpuscular hemoglobin 7.00E-10 0.09 20139978 | |
| 1 199007208 rs7529925-C 1:199007208 Red blood cell traits 8.00E-09 0.01 23222517 | |
| 1 200007432 rs3790844-T 1:200007432 Pancreatic cancer 2.00E-10 1.3 20101243 | |
| 1 200101920 rs2816958-G 1:200101920 Ulcerative colitis 2.00E-17 1.23 23128233 | |
| 1 200826769 rs2292096-? 1:200826769 Epilepsy 1.00E-08 1.59 22116939 | |
| 1 200877562 rs7554511-C 1:200877562 Inflammatory bowel disease 1.00E-32 1.16 23128233 | |
| 1 200877562 rs7554511-C 1:200877562 Ulcerative colitis 2.00E-13 1.19 21297633 | |
| 1 200881595 rs7522462-G 1:200881595 Multiple sclerosis 2.00E-09 1.11 21833088 | |
| 1 200892137 rs296547-? 1:200892137 Celiac disease 4.00E-09 1.12 20190752 | |
| 1 200935866 rs11584383-T 1:200935866 Crohn's disease 1.00E-11 1.18 18587394 | |
| 1 200960307 rs2297909-G 1:200960307 Ankylosing spondylitis 5.00E-12 NR 21743469 | |
| 1 201081943 rs2281845-T 1:201081943 Permanent tooth development 8.00E-17 0.1 21931568 | |
| 1 201262432 rs860554-? 1:201262432 Panic disorder 5.00E-08 NR 19165232 | |
| 1 201345487 rs12564445-A 1:201345487 Cardiac Troponin-T levels 5.00E-08 2.33 23247143 | |
| 1 201345487 rs12564445-A 1:201345487 Cardiac Troponin-T levels 5.00E-08 2.33 23247143 | |
| 1 201952574 rs4950806-T 1:201952574 Butyrylcholinesterase levels 9.00E-16 0.14 21862451 | |
| 1 202187176 rs6678914-? 1:202187176 Breast cancer 1.00E-08 1.1 23535733 | |
| 1 203155882 rs4950928-G 1:203155882 YKL-40 levels 1.00E-13 0.3 18403759 | |
| 1 203654024 rs10900585-T 1:203654024 Malaria 2.00E-10 1.64 22895189 | |
| 1 204518842 rs4245739-? 1:204518842 Breast cancer 2.00E-12 1.14 23535733 | |
| 1 204518842 rs4245739-A 1:204518842 Prostate cancer 2.00E-11 1.1 23535732 | |
| 1 204576983 rs11584700-? 1:204576983 Educational attainment 8.00E-12 1.09 23722424 | |
| 1 205235990 rs1668873-G 1:205235990 Mean platelet volume 1.00E-20 0.01 19820697 | |
| 1 205237137 rs1668871-C 1:205237137 Platelet counts 3.00E-14 2.8 22139419 | |
| 1 205244953 rs1172130-G 1:205244953 Mean platelet volume 4.00E-27 0.01 22139419 | |
| 1 205249450 rs9660992-A 1:205249450 Mean platelet volume 3.00E-13 0.11 24026423 | |
| 1 205638222 rs12409639-A 1:205638222 Prostate-specific antigen levels 2.00E-19 0.2 23269536 | |
| 1 205638464 rs16856139-? 1:205638464 Prostate-specific antigen levels 2.00E-11 0.08 24919509 | |
| 1 205676263 rs12748961-T 1:205676263 White blood cell types 4.00E-08 0.06 21738478 | |
| 1 205752665 rs947211-? 1:205752665 Parkinson's disease 2.00E-12 1.3 19915576 | |
| 1 205914757 rs4077468-A 1:205914757 Cystic fibrosis-related diabetes 1.00E-09 1.39 23670970 | |
| 1 206939904 rs3024505-A 1:206939904 Inflammatory bowel disease 7.00E-42 1.21 23128233 | |
| 1 206939904 rs3024505-A 1:206939904 Ulcerative colitis 6.00E-17 1.25 21297633 | |
| 1 206939904 rs3024505-T 1:206939904 Crohn's disease 2.00E-14 1.12 21102463 | |
| 1 206939904 rs3024505-T 1:206939904 Ulcerative colitis 1.00E-12 1.46 18836448 | |
| 1 206939904 rs3024505-G 1:206939904 Type 1 diabetes autoantibodies 5.00E-10 1.2 21829393 | |
| 1 206939904 rs3024505-? 1:206939904 Type 1 diabetes 2.00E-09 1.19 19430480 | |
| 1 206939904 rs3024505-T 1:206939904 Ulcerative colitis 1.00E-08 1.23 20228799 | |
| 1 206943968 rs3024493-T 1:206943968 Ulcerative colitis 1.00E-12 1.35 20228798 | |
| 1 206944645 rs1518111-? 1:206944645 Behcet's disease 4.00E-18 1.45 20622878 | |
| 1 206946634 rs1800871-T 1:206946634 Behcet's disease 1.00E-14 1.45 20622879 | |
| 1 207269858 rs3813948-C 1:207269858 C4b binding protein levels 4.00E-10 NR 20212171 | |
| 1 207692049 rs6656401-A 1:207692049 Alzheimer's disease (late onset) 6.00E-24 1.18 24162737 | |
| 1 207757515 rs12034598-A 1:207757515 Inflammatory biomarkers 9.00E-14 NR 22291609 | |
| 1 207784968 rs3818361-? 1:207784968 Alzheimer's disease 4.00E-14 1.18 21460840 | |
| 1 207786289 rs6701713-A 1:207786289 Alzheimer's disease (late onset) 5.00E-10 1.16 21460841 | |
| 1 207803595 rs12034383-G 1:207803595 Erythrocyte sedimentation rate 2.00E-28 0.13 21700265 | |
| 1 207872290 rs7527798-? 1:207872290 Erythrocyte sedimentation rate 2.00E-09 0.1 21700265 | |
| 1 207940853 rs11118555-A 1:207940853 Heart rate 4.00E-26 0.61 23583979 | |
| 1 208024820 rs12731740-T 1:208024820 Biomedical quantitative traits 3.00E-09 1.09 19396169 | |
| 1 208129065 rs11578508-A 1:208129065 Heart rate 4.00E-10 0.51 23583979 | |
| 1 209712889 rs6703183-A 1:209712889 Amyotrophic lateral sclerosis 3.00E-08 1.31 23624525 | |
| 1 209977111 rs861020-A 1:209977111 Orofacial clefts 3.00E-12 1.44 22863734 | |
| 1 209988047 rs10863790-? 1:209988047 Cleft lip 1.00E-14 1.72 20436469 | |
| 1 210536025 rs7527939-C 1:210536025 Schizophrenia 6.00E-09 2.63 23142968 | |
| 1 211918244 rs11119805-A 1:211918244 Stearic acid (18:0) plasma levels 3.00E-09 0.17 23362303 | |
| 1 212155008 rs17018311-? 1:212155008 Temperament (bipolar disorder) 2.00E-08 4.21 22365631 | |
| 1 212237798 rs10863936-A 1:212237798 Height 2.00E-09 0.02 20881960 | |
| 1 214159256 rs340874-C 1:214159256 Fasting glucose-related traits 7.00E-12 NR 20081858 | |
| 1 214159256 rs340874-? 1:214159256 Fasting glucose-related traits (interaction with BMI) 4.00E-09 NR 22581228 | |
| 1 214676121 rs4129059-? x rs1499503-? 1:214676121 Age-related hearing impairment (interaction) 8.00E-09 NR 24939585 | |
| 1 218598469 rs4846480-A 1:218598469 Chronic obstructive pulmonary disease (severe) 8.00E-09 NR 24621683 | |
| 1 218609702 rs6684205-A 1:218609702 Height 2.00E-12 0.03 20881960 | |
| 1 218844906 rs1159268-A 1:218844906 Acne (severe) 4.00E-08 1.17 24927181 | |
| 1 218860068 rs993925-T 1:218860068 Pulmonary function 1.00E-08 0.03 21946350 | |
| 1 218995273 rs7552186-C 1:218995273 Height 3.00E-08 1.12 23563607 | |
| 1 219644224 rs2605100-G 1:219644224 Adiposity 3.00E-08 0.04 19557161 | |
| 1 219657163 rs11118316-A 1:219657163 Visceral adipose tissue/subcutaneous adipose tissue ratio 3.00E-09 NR 22589738 | |
| 1 219693220 rs2820464-G 1:219693220 Waist-hip ratio 7.00E-09 1.16 23563607 | |
| 1 219700519 rs2785980-? 1:219700519 Fasting insulin-related traits (interaction with BMI) 2.00E-08 NR 22581228 | |
| 1 219727779 rs3001032-T 1:219727779 Adiponectin levels 4.00E-08 0.02 22479202 | |
| 1 219743719 rs11118346-T 1:219743719 Height 2.00E-12 0.03 20881960 | |
| 1 219753509 rs2820443-T 1:219753509 Sexual dimorphism in anthropometric traits 7.00E-16 NR 23754948 | |
| 1 219775432 rs994767-A 1:219775432 Axial length 1.00E-11 0.07 24144296 | |
| 1 220973563 rs2642442-T 1:220973563 "Cholesterol, total" 5.00E-13 1.38 20686565 | |
| 1 220973563 rs2642442-C 1:220973563 "Cholesterol, total" 3.00E-11 0.04 24097068 | |
| 1 220973563 rs2642442-C 1:220973563 LDL cholesterol 5.00E-11 0.04 24097068 | |
| 1 220973563 rs2642442-T 1:220973563 LDL cholesterol 6.00E-11 1.09 20686565 | |
| 1 222045446 rs6691170-T 1:222045446 Colorectal cancer 1.00E-09 1.06 20972440 | |
| 1 222164948 rs6687758-G 1:222164948 Colorectal cancer 2.00E-09 1.09 20972440 | |
| 1 222164948 rs6687758-G 1:222164948 Colorectal cancer 9.00E-09 1.12 24836286 | |
| 1 222271767 rs873549-C 1:222271767 Keloid 6.00E-23 1.77 20711176 | |
| 1 222823529 rs17465637-C 1:222823529 Myocardial infarction (early onset) 1.00E-09 1.14 19198609 | |
| 1 222823529 rs17465637-C 1:222823529 Coronary heart disease 1.00E-08 1.14 21378990 | |
| 1 227797950 rs1390401-A 1:227797950 Height 5.00E-09 0.04 18391952 | |
| 1 227911883 rs10799445-A 1:227911883 Height 2.00E-13 0.03 20881960 | |
| 1 228997835 rs801114-G 1:228997835 Basal cell carcinoma 2.00E-13 1.25 24403052 | |
| 1 228997835 rs801114-G 1:228997835 Basal cell carcinoma 6.00E-12 1.28 18849993 | |
| 1 230294916 rs2144300-T 1:230294916 HDL cholesterol 3.00E-14 1.11 18193043 | |
| 1 230295691 rs4846914-G 1:230295691 HDL cholesterol 4.00E-41 0.05 24097068 | |
| 1 230295691 rs4846914-G 1:230295691 Triglycerides 7.00E-31 0.04 24097068 | |
| 1 230295691 rs4846914-G 1:230295691 HDL cholesterol 4.00E-21 0.61 20686565 | |
| 1 230295691 rs4846914-G 1:230295691 Triglycerides 7.00E-15 0.08 18193044 | |
| 1 230295691 rs4846914-G 1:230295691 Triglycerides 2.00E-14 2.76 20686565 | |
| 1 230295691 rs4846914-G 1:230295691 HDL cholesterol 2.00E-13 0.07 18193044 | |
| 1 230295691 rs4846914-G 1:230295691 HDL cholesterol 4.00E-08 0.05 19060906 | |
| 1 230295789 rs10127775-? 1:230295789 Metabolite levels 1.00E-09 NR 22916037 | |
| 1 230304988 rs10489615-G 1:230304988 HDL cholesterol 4.00E-09 0.02 20864672 | |
| 1 230307182 rs4846922-T 1:230307182 Metabolic syndrome 4.00E-08 0.08 22399527 | |
| 1 231816842 rs12042938-C 1:231816842 Neuranatomic and neurocognitive phenotypes 4.00E-36 NR 21483430 | |
| 1 234858597 rs514230-A 1:234858597 "Cholesterol, total" 5.00E-14 0.04 24097068 | |
| 1 234858597 rs514230-A 1:234858597 "Cholesterol, total" 5.00E-14 1.36 20686565 | |
| 1 234858597 rs514230-A 1:234858597 LDL cholesterol 9.00E-12 0.04 24097068 | |
| 1 234858597 rs514230-A 1:234858597 LDL cholesterol 9.00E-12 1.13 20686565 | |
| 1 235092600 rs908327-C 1:235092600 Immune reponse to smallpox (secreted IL-2) 5.00E-10 NR 22610502 | |
| 1 237048676 rs2275565-T 1:237048676 Homocysteine levels 2.00E-10 0.05 23824729 | |
| 1 238308602 rs1361277-? 1:238308602 White matter microstructure (global fractional anisotropy) 2.00E-08 NR 24736177 | |
| 1 239970097 rs12059546-G 1:239970097 Epilepsy (generalized) 4.00E-08 1.42 22949513 | |
| 1 240045908 rs536477-? x rs1937920-? 1:240045908 Venous thromboembolism (gene x gene interaction) 3.00E-09 1.59 23509962 | |
| 1 240597214 rs9287237-T 1:240597214 Bone mineral density 2.00E-09 0.19 23437003 | |
| 1 242040775 rs1635501-C 1:242040775 Menopause (age at onset) 8.00E-10 0.16 22267201 | |
| 1 243544827 rs1538774-G 1:243544827 Schizophrenia 3.00E-08 1.09 23974872 | |
| 1 243608967 rs6703335-? 1:243608967 "Schizophrenia, schizoaffective disorder or bipolar disorder" 4.00E-09 NR 24166486 | |
| 1 243608967 rs6703335-? 1:243608967 Schizophrenia 5.00E-08 1.09 21926974 | |
| 1 243663893 rs14403-C 1:243663893 Schizophrenia 2.00E-08 1.1 23974872 | |
| 1 247600301 rs1539019-A 1:247600301 Fibrinogen 1.00E-08 0.04 20031576 | |
| 1 247601595 rs12239046-C 1:247601595 C-reactive protein 1.00E-15 0.05 21300955 | |
| 1 247605599 rs10157379-T 1:247605599 Fibrinogen 1.00E-19 0.01 23969696 | |
| 1 247675559 rs7550918-T 1:247675559 Platelet counts 3.00E-11 3.13 22139419 | |
| 1 248039451 rs3811444-T 1:248039451 Red blood cell traits 5.00E-10 0.02 23222517 | |
| 1 248039451 rs3811444-C 1:248039451 Platelet counts 6.00E-09 3.35 22139419 | |
| 1 248046272 rs11204538-C 1:248046272 Mean corpuscular volume 2.00E-08 0.09 20139978 | |
| 1 248496863 rs4481887-G 1:248496863 Common traits (Other) 7.00E-24 1.67 20585627 | |
| 1 249168436 rs12032643-? 1:249168436 Myopia (pathological) 1.00E-09 NR 23049088 | |
| 2 112496 rs300774-A 2:112496 Suicide attempts in bipolar disorder 5.00E-08 1.22 21423239 | |
| 2 614168 rs2947411-A 2:614168 Menarche (age at onset) 2.00E-08 2.8 21102462 | |
| 2 622827 rs2867125-C 2:622827 Body mass index 3.00E-49 0.31 20935630 | |
| 2 624034 rs6711012-C 2:624034 Obesity 3.00E-40 1.18 23563607 | |
| 2 624034 rs6711012-C 2:624034 Obesity 6.00E-35 1.11 23563607 | |
| 2 624678 rs2903492-A 2:624678 Body mass index 6.00E-15 1.26 23563607 | |
| 2 629244 rs12463617-A 2:629244 Body mass index 3.00E-17 0.1 23669352 | |
| 2 629244 rs12463617-C 2:629244 Obesity (early onset extreme) 2.00E-13 1.42 23563609 | |
| 2 629244 rs12463617-C 2:629244 Body mass index 2.00E-12 0.06 24861553 | |
| 2 634905 rs6548238-C 2:634905 Body mass index 1.00E-18 0.26 19079261 | |
| 2 644953 rs7561317-G 2:644953 Weight 2.00E-18 6.47 19079260 | |
| 2 644953 rs7561317-G 2:644953 Body mass index 4.00E-17 6.12 19079260 | |
| 2 646364 rs10189761-A 2:646364 Obesity 6.00E-24 1.24 23563607 | |
| 2 1407815 rs11675434-T 2:1407815 Thyroid peroxidase antibody positivity 2.00E-16 1.21 24586183 | |
| 2 1407815 rs11675434-T 2:1407815 Thyroid peroxidase antibody levels 7.00E-13 0.02 24586183 | |
| 2 1417244 rs2071403-? 2:1417244 Thyroid peroxidase antibody positivity 1.00E-10 1.65 24722205 | |
| 2 5664008 rs11894081-T 2:5664008 Crohn's disease 4.00E-09 1.22 23266558 | |
| 2 6461421 rs7591996-C 2:6461421 Osteosarcoma 1.00E-08 1.39 23727862 | |
| 2 7032618 rs16865717-T x rs2009579-T 2:7032618 Venous thromboembolism (gene x gene interaction) 9.00E-09 1.56 23509962 | |
| 2 10117868 rs11902236-A 2:10117868 Prostate cancer 3.00E-08 1.07 23535732 | |
| 2 11727507 rs13394619-G 2:11727507 Endometriosis 6.00E-09 1.15 23104006 | |
| 2 12964497 rs10198628-? 2:12964497 Pericardial fat 5.00E-14 NR 22589742 | |
| 2 15729820 rs3755132-G 2:15729820 Wilms tumor 1.00E-14 1.45 22544364 | |
| 2 15782471 rs807624-A 2:15782471 Wilms tumor 1.00E-14 1.33 22544364 | |
| 2 15863002 rs6431731-? 2:15863002 Chronic kidney disease 4.00E-08 0.01 22479191 | |
| 2 19320803 rs12710696-? 2:19320803 Breast cancer 5.00E-08 1.1 23535733 | |
| 2 19945577 rs2123536-T 2:19945577 Coronary heart disease 7.00E-11 1.12 22751097 | |
| 2 20903015 rs4971516-? 2:20903015 LDL cholesterol 2.00E-52 NR 21059979 | |
| 2 20903015 rs4971516-? 2:20903015 LDL cholesterol 2.00E-40 NR 21059979 | |
| 2 21123352 rs6711016-C 2:21123352 Metabolic syndrome 4.00E-08 0.08 22399527 | |
| 2 21206183 rs6754295-? 2:21206183 Lipid metabolism phenotypes 4.00E-47 4.13 19936222 | |
| 2 21206183 rs6754295-C 2:21206183 Triglycerides 3.00E-08 0.08 19060911 | |
| 2 21206183 rs6754295-C 2:21206183 HDL cholesterol 4.00E-08 0.07 19060911 | |
| 2 21208211 rs7557067-G 2:21208211 Triglycerides 9.00E-12 0.08 19060906 | |
| 2 21225281 rs1042034-C 2:21225281 Triglycerides 1.00E-45 5.99 20686565 | |
| 2 21225281 rs1042034-C 2:21225281 HDL cholesterol 1.00E-30 0.9 20686565 | |
| 2 21231524 rs676210-? 2:21231524 Lipid metabolism phenotypes 4.00E-64 4.22 19936222 | |
| 2 21231524 rs676210-? 2:21231524 Lipid metabolism phenotypes 9.00E-56 6.38 19936222 | |
| 2 21231524 rs676210-G 2:21231524 LDL (oxidized) 3.00E-47 10.5 23247145 | |
| 2 21231524 rs676210-? 2:21231524 Lipid metabolism phenotypes 2.00E-09 0.05 19936222 | |
| 2 21232195 rs693-G 2:21232195 "Cholesterol, total" 9.00E-23 0.1 19060911 | |
| 2 21232195 rs693-A 2:21232195 LDL cholesterol 1.00E-21 0.12 18193044 | |
| 2 21232195 rs693-G 2:21232195 LDL cholesterol 4.00E-17 0.1 19060911 | |
| 2 21232195 rs693-A 2:21232195 LDL cholesterol 3.00E-11 0.12 19060910 | |
| 2 21237544 rs673548-? 2:21237544 Lipid metabolism phenotypes 5.00E-42 6.62 19936222 | |
| 2 21237544 rs673548-? 2:21237544 Metabolite levels 1.00E-13 NR 22916037 | |
| 2 21237544 rs673548-G 2:21237544 Metabolic syndrome 1.00E-10 0.11 22399527 | |
| 2 21237544 rs673548-? 2:21237544 Lipid metabolism phenotypes 4.00E-10 0.04 19936222 | |
| 2 21237544 rs673548-A 2:21237544 Metabolic traits 2.00E-08 0.08 19060910 | |
| 2 21241505 rs12713956-G 2:21241505 LDL cholesterol 4.00E-08 4.86 23726366 | |
| 2 21244000 rs10199768-T 2:21244000 Cardiovascular disease risk factors 8.00E-15 0.11 21943158 | |
| 2 21263900 rs1367117-A 2:21263900 LDL cholesterol 1.00E-182 0.12 24097068 | |
| 2 21263900 rs1367117-A 2:21263900 "Cholesterol, total" 3.00E-139 0.1 24097068 | |
| 2 21263900 rs1367117-A 2:21263900 LDL cholesterol 4.00E-114 4.05 20686565 | |
| 2 21263900 rs1367117-A 2:21263900 "Cholesterol, total" 4.00E-96 4.16 20686565 | |
| 2 21263900 rs1367117-? 2:21263900 Lipid metabolism phenotypes 6.00E-25 4.03 19936222 | |
| 2 21263900 rs1367117-? 2:21263900 Lipid metabolism phenotypes 2.00E-17 3.92 19936222 | |
| 2 21286057 rs515135-T 2:21286057 LDL cholesterol 5.00E-29 0.16 19060906 | |
| 2 21286057 rs515135-A 2:21286057 LDL cholesterol 2.00E-20 0.04 20864672 | |
| 2 21288321 rs562338-G 2:21288321 LDL cholesterol 6.00E-22 4.89 18193043 | |
| 2 21288321 rs562338-T 2:21288321 LDL cholesterol 1.00E-09 0.04 18262040 | |
| 2 21378805 rs312985-? 2:21378805 Lipid metabolism phenotypes 1.00E-17 0.04 19936222 | |
| 2 21397182 rs506585-? 2:21397182 Lipid metabolism phenotypes 3.00E-31 4.09 19936222 | |
| 2 21397182 rs506585-? 2:21397182 Lipid metabolism phenotypes 1.00E-25 4.36 19936222 | |
| 2 21397182 rs506585-? 2:21397182 Lipid metabolism phenotypes 2.00E-22 0.04 19936222 | |
| 2 22297003 rs7600502-G 2:22297003 C-reactive protein and white blood cell count 3.00E-09 0.39 22788528 | |
| 2 24413298 rs2288073-G x rs10771022-T 2:24413298 Venous thromboembolism (gene x gene interaction) 2.00E-09 1.6 23509962 | |
| 2 25036858 rs11895026-A 2:25036858 Height 1.00E-13 1.19 23563607 | |
| 2 25116977 rs7586879-T 2:25116977 Body mass index 4.00E-08 0.05 23583978 | |
| 2 25118885 rs6545800-T 2:25118885 Inflammatory bowel disease 6.00E-16 1.11 23128233 | |
| 2 25131316 rs6545814-G 2:25131316 Body mass index 1.00E-13 3.26 22344219 | |
| 2 25131316 rs6545814-G 2:25131316 Body mass index 1.00E-10 0.03 24861553 | |
| 2 25150296 rs10182181-G 2:25150296 Obesity 1.00E-17 1.08 23563607 | |
| 2 25150296 rs10182181-G 2:25150296 Obesity 3.00E-14 1.05 23563607 | |
| 2 25158008 rs713586-C 2:25158008 Body mass index 6.00E-22 0.14 20935630 | |
| 2 25169200 rs1172294-G 2:25169200 Pubertal anthropometrics 1.00E-08 0.08 23449627 | |
| 2 25187599 rs4665736-T 2:25187599 Height 7.00E-16 0.03 20881960 | |
| 2 25301755 rs478222-? 2:25301755 Type 1 diabetes 4.00E-09 1.22 21980299 | |
| 2 25369002 rs1561288-T 2:25369002 Body mass index 5.00E-08 0.06 23669352 | |
| 2 25373298 rs13428823-G 2:25373298 Height 6.00E-12 1.17 23563607 | |
| 2 25492467 rs13428812-G 2:25492467 Crohn's disease 9.00E-10 1.06 21102463 | |
| 2 27152874 rs1371614-? 2:27152874 Fasting glucose-related traits (interaction with BMI) 2.00E-12 NR 22581228 | |
| 2 27424636 rs1395-A 2:27424636 Blood metabolite levels 8.00E-11 0.02 24816252 | |
| 2 27598097 rs4665972-T 2:27598097 Triglycerides 1.00E-08 0.07 23726366 | |
| 2 27635463 rs1728918-A 2:27635463 Crohn's disease 5.00E-16 1.12 23128233 | |
| 2 27715416 rs2303369-T 2:27715416 Menopause (age at onset) 2.00E-12 0.18 22267201 | |
| 2 27730940 rs1260326-T 2:27730940 Triglycerides 2.00E-239 0.12 24097068 | |
| 2 27730940 rs1260326-T 2:27730940 Blood metabolite ratios 3.00E-148 0.04 24816252 | |
| 2 27730940 rs1260326-T 2:27730940 Triglycerides 6.00E-133 8.76 20686565 | |
| 2 27730940 rs1260326-T 2:27730940 Blood metabolite levels 1.00E-77 0.04 24816252 | |
| 2 27730940 rs1260326-T 2:27730940 Urate levels 1.00E-44 0.07 23263486 | |
| 2 27730940 rs1260326-T 2:27730940 "Cholesterol, total" 3.00E-42 0.05 24097068 | |
| 2 27730940 rs1260326-T 2:27730940 C-reactive protein 5.00E-40 0.07 21300955 | |
| 2 27730940 rs1260326-? 2:27730940 Lipid metabolism phenotypes 1.00E-37 0.07 19936222 | |
| 2 27730940 rs1260326-? 2:27730940 Lipid metabolism phenotypes 3.00E-35 0.05 19936222 | |
| 2 27730940 rs1260326-? 2:27730940 Lipid metabolism phenotypes 4.00E-32 0.08 19936222 | |
| 2 27730940 rs1260326-T 2:27730940 Triglycerides 2.00E-31 0.12 19060906 | |
| 2 27730940 rs1260326-? 2:27730940 Lipid metabolism phenotypes 3.00E-29 0.06 19936222 | |
| 2 27730940 rs1260326-? 2:27730940 Lipid metabolism phenotypes 3.00E-28 0.34 19936222 | |
| 2 27730940 rs1260326-T 2:27730940 "Cholesterol, total" 7.00E-27 1.91 20686565 | |
| 2 27730940 rs1260326-? 2:27730940 Lipid metabolism phenotypes 4.00E-24 0.36 19936222 | |
| 2 27730940 rs1260326-T 2:27730940 Serum albumin level 4.00E-19 0.01 23022100 | |
| 2 27730940 rs1260326-? 2:27730940 Metabolite levels 3.00E-18 0.15 22286219 | |
| 2 27730940 rs1260326-T 2:27730940 Serum albumin level 3.00E-14 0.01 23022100 | |
| 2 27730940 rs1260326-T 2:27730940 Chronic kidney disease 3.00E-14 0.01 20383146 | |
| 2 27730940 rs1260326-T 2:27730940 Blood metabolite levels 6.00E-14 0.01 24816252 | |
| 2 27730940 rs1260326-? 2:27730940 Hypertriglyceridemia 2.00E-13 1.41 23505323 | |
| 2 27730940 rs1260326-T 2:27730940 Liver enzyme levels (gamma-glutamyl transferase) 4.00E-13 3.2 22001757 | |
| 2 27730940 rs1260326-T 2:27730940 Glycemic traits (pregnancy) 6.00E-13 0 23903356 | |
| 2 27730940 rs1260326-? 2:27730940 Metabolite levels 1.00E-12 NR 22916037 | |
| 2 27730940 rs1260326-C 2:27730940 Triglycerides 1.00E-11 0.1 20139978 | |
| 2 27730940 rs1260326-T 2:27730940 Glycemic traits (pregnancy) 6.00E-11 0.01 23903356 | |
| 2 27730940 rs1260326-T 2:27730940 Two-hour glucose challenge 3.00E-10 0.07 20081857 | |
| 2 27730940 rs1260326-A 2:27730940 Metabolic traits 4.00E-10 0.09 19060910 | |
| 2 27730940 rs1260326-T 2:27730940 Platelet counts 9.00E-10 2.33 22139419 | |
| 2 27730940 rs1260326-C 2:27730940 Non-albumin protein levels 3.00E-09 0.08 22558069 | |
| 2 27730940 rs1260326-C 2:27730940 Hematological and biochemical traits 4.00E-09 0.09 20139978 | |
| 2 27730940 rs1260326-T 2:27730940 Hypertriglyceridemia 7.00E-09 1.75 20657596 | |
| 2 27730940 rs1260326-T 2:27730940 Serum albumin level 2.00E-08 0.03 23022100 | |
| 2 27730940 rs1260326-T 2:27730940 Cardiovascular disease risk factors 2.00E-08 0.08 21943158 | |
| 2 27730940 rs1260326-? 2:27730940 Waist circumference and related phenotypes 4.00E-08 NR 18454146 | |
| 2 27741237 rs780094-T 2:27741237 Metabolic traits 6.00E-53 0.1 21886157 | |
| 2 27741237 rs780094-C 2:27741237 Fasting glucose-related traits 6.00E-38 NR 20081858 | |
| 2 27741237 rs780094-T 2:27741237 Triglycerides 6.00E-32 8.59 18193043 | |
| 2 27741237 rs780094-C 2:27741237 Fasting glucose-related traits 3.00E-24 NR 20081858 | |
| 2 27741237 rs780094-C 2:27741237 Fasting insulin-related traits 3.00E-24 NR 20081858 | |
| 2 27741237 rs780094-? 2:27741237 Fasting glucose-related traits (interaction with BMI) 4.00E-24 NR 22581228 | |
| 2 27741237 rs780094-G 2:27741237 Triglycerides 3.00E-20 0.1 19060911 | |
| 2 27741237 rs780094-C 2:27741237 Fasting glucose-related traits 4.00E-20 NR 20081858 | |
| 2 27741237 rs780094-C 2:27741237 Fasting insulin-related traits 4.00E-20 NR 20081858 | |
| 2 27741237 rs780094-A 2:27741237 Metabolic syndrome 6.00E-20 0.13 22399527 | |
| 2 27741237 rs780094-A 2:27741237 C-reactive protein 7.00E-15 0.14 18439548 | |
| 2 27741237 rs780094-T 2:27741237 Triglycerides 3.00E-14 0.13 18193044 | |
| 2 27741237 rs780094-T 2:27741237 Calcium levels 1.00E-10 0.02 24068962 | |
| 2 27741237 rs780094-? 2:27741237 Fasting insulin-related traits (interaction with BMI) 3.00E-10 NR 22581228 | |
| 2 27741237 rs780094-T 2:27741237 Uric acid levels 1.00E-09 0.05 19503597 | |
| 2 27741237 rs780094-C 2:27741237 Triglycerides 7.00E-09 0.07 23726366 | |
| 2 27741237 rs780094-T 2:27741237 Phospholipid levels (plasma) 9.00E-09 0.02 21829377 | |
| 2 27742603 rs780093-T 2:27742603 Urate levels 4.00E-17 5.15 20884846 | |
| 2 27742603 rs780093-T 2:27742603 Sex hormone-binding globulin levels 2.00E-16 0.03 22829776 | |
| 2 27742603 rs780093-A 2:27742603 Waist Circumference - Triglycerides (WC-TG) 2.00E-12 0.19 21386085 | |
| 2 27742603 rs780093-T 2:27742603 Crohn's disease 5.00E-11 1.15 21102463 | |
| 2 27742603 rs780093-T 2:27742603 Sex hormone-binding globulin levels 9.00E-11 0.04 22829776 | |
| 2 27742603 rs780093-A 2:27742603 Triglycerides-Blood Pressure (TG-BP) 3.00E-10 0.18 21386085 | |
| 2 27742603 rs780093-T 2:27742603 Palmitoleic acid (16:1n-7) plasma levels 1.00E-09 0.02 23362303 | |
| 2 27743154 rs780092-G 2:27743154 Triglycerides 5.00E-27 0.05 21909109 | |
| 2 27743154 rs780092-G 2:27743154 Metabolite levels 5.00E-18 0.02 21909109 | |
| 2 27743154 rs780092-A 2:27743154 Lipid traits 2.00E-09 0.08 24023260 | |
| 2 27748624 rs1260333-C 2:27748624 Triglycerides 2.00E-19 0.05 20864672 | |
| 2 27801759 rs1919128-A 2:27801759 Waist Circumference - Triglycerides (WC-TG) 2.00E-09 0.18 21386085 | |
| 2 27815510 rs13022873-A 2:27815510 Waist Circumference - Triglycerides (WC-TG) 5.00E-09 0.17 21386085 | |
| 2 27840640 rs4666002-? 2:27840640 Phospholipid levels (plasma) 7.00E-11 0 22359512 | |
| 2 27851918 rs3749147-C 2:27851918 Waist Circumference - Triglycerides (WC-TG) 1.00E-09 0.18 21386085 | |
| 2 27995781 rs3736594-? 2:27995781 Fasting glucose-related traits (interaction with BMI) 1.00E-15 NR 22581228 | |
| 2 28614794 rs925255-C 2:28614794 Inflammatory bowel disease 3.00E-15 1.09 23128233 | |
| 2 30445026 rs7579944-? 2:30445026 Celiac disease and Rheumatoid arthritis 1.00E-08 NR 21383967 | |
| 2 30449594 rs10175798-A 2:30449594 Rheumatoid arthritis 1.00E-09 1.08 24390342 | |
| 2 30449594 rs10175798-A 2:30449594 Rheumatoid arthritis 4.00E-08 1.09 24390342 | |
| 2 31464385 rs649729-T 2:31464385 Mean platelet volume 1.00E-12 0.01 22139419 | |
| 2 31464829 rs647316-A 2:31464829 Mean platelet volume 3.00E-11 0.01 19820697 | |
| 2 31482300 rs625132-G 2:31482300 Platelet counts 9.00E-14 4.24 22139419 | |
| 2 31810974 rs559555-A 2:31810974 Blood metabolite ratios 1.00E-44 0.04 24816252 | |
| 2 31810974 rs559555-A 2:31810974 Blood metabolite levels 4.00E-22 0.03 24816252 | |
| 2 31810974 rs559555-A 2:31810974 Blood metabolite levels 7.00E-19 0.03 24816252 | |
| 2 32278782 rs7577696-G 2:32278782 Inflammatory biomarkers 3.00E-19 0.08 24182552 | |
| 2 33121504 rs6728021-G 2:33121504 Immune response to smallpox vaccine (IL-6) 4.00E-08 NR 22610502 | |
| 2 33360338 rs1545552-G 2:33360338 Height 2.00E-10 1.15 23563607 | |
| 2 33361425 rs6714546-A 2:33361425 Height 2.00E-09 0.03 20881960 | |
| 2 33701890 rs13385731-A 2:33701890 Systemic lupus erythematosus 1.00E-15 1.43 19838193 | |
| 2 37592628 rs2373000-T 2:37592628 Schizophrenia 7.00E-09 1.09 23974872 | |
| 2 37960613 rs17511102-A 2:37960613 Height 2.00E-18 0.06 20881960 | |
| 2 37960613 rs17511102-T 2:37960613 Height 2.00E-08 1.4 23563607 | |
| 2 40757791 rs13017846-G 2:40757791 QT interval 8.00E-14 0.07 22726844 | |
| 2 42080624 rs4305317-? 2:42080624 Rheumatoid arthritis 4.00E-08 NR 21156761 | |
| 2 42250549 rs7584262-T 2:42250549 Bone mineral density 1.00E-09 0.04 22504420 | |
| 2 43325570 rs6718520-A 2:43325570 Multiple sclerosis 3.00E-08 1.17 22190364 | |
| 2 43359061 rs12466022-C 2:43359061 Multiple sclerosis 6.00E-10 1.11 21833088 | |
| 2 43540125 rs7590268-G 2:43540125 Orofacial clefts 1.00E-08 1.42 22863734 | |
| 2 43553949 rs1465618-? x rs2604169-? 2:43553949 Age-related hearing impairment (interaction) 4.00E-09 NR 24939585 | |
| 2 43553949 rs1465618-? 2:43553949 Prostate cancer 2.00E-08 1.08 19767753 | |
| 2 43638838 rs13429458-A 2:43638838 Polycystic ovary syndrome 2.00E-23 1.49 21151128 | |
| 2 43638838 rs13429458-A 2:43638838 Polycystic ovary syndrome 4.00E-13 1.49 22885925 | |
| 2 43687879 rs17030845-C 2:43687879 Platelet counts 1.00E-10 3.58 22139419 | |
| 2 43721508 rs12478601-C 2:43721508 Polycystic ovary syndrome 3.00E-23 1.39 21151128 | |
| 2 43732823 rs7578597-T 2:43732823 Type 2 diabetes 1.00E-09 1.15 18372903 | |
| 2 43806918 rs10495903-T 2:43806918 Crohn's disease 2.00E-14 1.14 21102463 | |
| 2 43806918 rs10495903-T 2:43806918 Inflammatory bowel disease 8.00E-12 1.09 23128233 | |
| 2 44065090 rs6756629-G 2:44065090 "Cholesterol, total" 2.00E-11 0.15 19060911 | |
| 2 44065090 rs6756629-G 2:44065090 LDL cholesterol 3.00E-10 0.16 19060911 | |
| 2 44066247 rs11887534-C 2:44066247 Gallstones 1.00E-14 2.2 17632509 | |
| 2 44072576 rs4299376-G 2:44072576 "Cholesterol, total" 3.00E-73 0.08 24097068 | |
| 2 44072576 rs4299376-G 2:44072576 LDL cholesterol 4.00E-72 0.08 24097068 | |
| 2 44072576 rs4299376-G 2:44072576 LDL cholesterol 2.00E-47 2.75 20686565 | |
| 2 44072576 rs4299376-G 2:44072576 "Cholesterol, total" 4.00E-45 3.01 20686565 | |
| 2 44072576 rs4299376-? 2:44072576 Lipid metabolism phenotypes 2.00E-08 2.6 19936222 | |
| 2 44073656 rs41360247-C 2:44073656 Phytosterol levels 6.00E-25 14 20529992 | |
| 2 44073881 rs6544713-T 2:44073881 LDL cholesterol 2.00E-20 0.15 19060906 | |
| 2 44074431 rs4245791-C 2:44074431 Phytosterol levels 2.00E-50 12 20529992 | |
| 2 44074431 rs4245791-G 2:44074431 LDL cholesterol 1.00E-09 5.97 23726366 | |
| 2 44480950 rs4953076-G 2:44480950 Height 4.00E-09 1.15 23563607 | |
| 2 44768202 rs2341459-T 2:44768202 Height 8.00E-10 0.03 20881960 | |
| 2 45188353 rs895636-A 2:45188353 Metabolite levels 1.00E-12 0.04 21909109 | |
| 2 45646824 rs3213787-A 2:45646824 Glaucoma 3.00E-09 2.8 20363506 | |
| 2 46353166 rs10495928-G 2:46353166 Hemoglobin 7.00E-13 0.06 19862010 | |
| 2 46353166 rs10495928-G 2:46353166 Red blood cell count 4.00E-08 0.09 20139978 | |
| 2 46355051 rs4953318-A 2:46355051 Red blood cell traits 3.00E-19 0.15 23222517 | |
| 2 46355848 rs13008603-A 2:46355848 Red blood cell traits 4.00E-09 0.28 23446634 | |
| 2 46360907 rs10168349-C 2:46360907 Hematocrit 4.00E-15 0.19 19862010 | |
| 2 46537604 rs7579899-? 2:46537604 Renal cell carcinoma 2.00E-09 1.15 21131975 | |
| 2 46921285 rs12474201-A 2:46921285 Height 3.00E-13 0.03 20881960 | |
| 2 48978159 rs13405728-A 2:48978159 Polycystic ovary syndrome 8.00E-21 1.41 21151128 | |
| 2 48978159 rs13405728-A 2:48978159 Polycystic ovary syndrome 4.00E-09 1.35 22885925 | |
| 2 49201328 rs2268363-? 2:49201328 Erectile dysfunction and prostate cancer treatment 5.00E-08 7.03 20932654 | |
| 2 49201612 rs2268361-C 2:49201612 Polycystic ovary syndrome 1.00E-12 1.15 22885925 | |
| 2 53687730 rs1402901-? x rs2173318-? 2:53687730 Age-related hearing impairment (interaction) 9.00E-09 NR 24939585 | |
| 2 53782559 rs13407662-T 2:53782559 Stroke (ischemic) 5.00E-08 1.95 23041239 | |
| 2 54347750 rs1559040-? 2:54347750 Sudden cardiac arrest 4.00E-08 1.54 21658281 | |
| 2 54475866 rs11125529-C 2:54475866 Telomere length 8.00E-10 0.06 23535734 | |
| 2 54659707 rs4233949-C 2:54659707 Bone mineral density 2.00E-18 0.05 22504420 | |
| 2 54684557 rs11898505-G 2:54684557 Bone properties (heel) 4.00E-13 0.06 24430505 | |
| 2 54684557 rs11898505-A 2:54684557 Bone mineral density (spine) 2.00E-08 0.07 19801982 | |
| 2 55516323 rs2589113-T 2:55516323 Height 2.00E-08 0.04 21998595 | |
| 2 55843413 rs782590-T 2:55843413 Metabolic syndrome 4.00E-08 0.09 22399527 | |
| 2 56089540 rs1367226-? 2:56089540 Height 4.00E-08 NR 20881960 | |
| 2 56096892 rs3791679-A 2:56096892 Height 8.00E-16 1.22 23563607 | |
| 2 56096892 rs3791679-T 2:56096892 Height 6.00E-11 5.8 18391951 | |
| 2 56096892 rs3791679-A 2:56096892 Height 6.00E-09 0.07 20189936 | |
| 2 56111309 rs3791675-T 2:56111309 Height 3.00E-35 0.05 20881960 | |
| 2 56111309 rs3791675-C 2:56111309 Height 2.00E-12 0.09 18391952 | |
| 2 56111309 rs3791675-G 2:56111309 Height 2.00E-09 0.42 19396169 | |
| 2 56112440 rs1367228-A x rs3905075-T 2:56112440 Venous thromboembolism (gene x gene interaction) 2.00E-09 1.49 23509962 | |
| 2 56120853 rs1430193-T 2:56120853 Forced vital capacity 2.00E-12 21.13 24929828 | |
| 2 56592083 rs17268785-G 2:56592083 Menarche (age at onset) 1.00E-10 3.2 21102462 | |
| 2 57934055 rs13026414-C 2:57934055 Epilepsy (generalized) 2.00E-09 1.23 22949513 | |
| 2 58833493 rs6731302-A 2:58833493 Obesity 2.00E-09 1.04 23563607 | |
| 2 59302877 rs887912-T 2:59302877 Body mass index 2.00E-12 0.1 20935630 | |
| 2 59302877 rs887912-T 2:59302877 Obesity 1.00E-10 1.07 23563607 | |
| 2 59302877 rs887912-T 2:59302877 Obesity 6.00E-09 1.1 23563607 | |
| 2 60584819 rs243021-A 2:60584819 Type 2 diabetes 3.00E-15 1.08 20581827 | |
| 2 60608759 rs2540917-C 2:60608759 Mean corpuscular volume 1.00E-14 0 19862010 | |
| 2 60620286 rs243070-T 2:60620286 Red blood cell traits 4.00E-13 0.18 23222517 | |
| 2 60718043 rs1427407-? 2:60718043 F-cell distribution 6.00E-31 13.1 17767159 | |
| 2 60719970 rs766432-C 2:60719970 Fetal hemoglobin levels 1.00E-29 0.23 20018918 | |
| 2 60719970 rs766432-? 2:60719970 Beta thalassemia/hemoglobin E disease 1.00E-10 2.8 20183929 | |
| 2 60720246 rs11886868-T 2:60720246 Fetal hemoglobin levels 7.00E-35 0.48 18245381 | |
| 2 61066666 rs1432295-G 2:61066666 Hodgkin's lymphoma 2.00E-08 1.22 21037568 | |
| 2 61081542 rs702873-G 2:61081542 Psoriasis 4.00E-09 1.12 20953190 | |
| 2 61124850 rs34695944-C 2:61124850 Rheumatoid arthritis 4.00E-16 1.13 24390342 | |
| 2 61124850 rs34695944-C 2:61124850 Rheumatoid arthritis 2.00E-15 1.12 24390342 | |
| 2 61164331 rs13017599-A 2:61164331 Rheumatoid arthritis 2.00E-12 1.21 19503088 | |
| 2 61164331 rs13017599-? 2:61164331 Psoriatic arthritis 1.00E-08 1.27 22170493 | |
| 2 61186829 rs13003464-G 2:61186829 Celiac disease 4.00E-13 1.15 20190752 | |
| 2 61186829 rs13003464-G 2:61186829 Crohn's disease 5.00E-09 1.05 22412388 | |
| 2 61186829 rs13003464-G 2:61186829 Ulcerative colitis 7.00E-09 1.13 20228799 | |
| 2 61204856 rs7608910-G 2:61204856 Inflammatory bowel disease 9.00E-32 1.14 23128233 | |
| 2 61204856 rs7608910-G 2:61204856 Ulcerative colitis 2.00E-14 1.19 21297633 | |
| 2 61217542 rs10188217-C 2:61217542 Crohn's disease and celiac disease 1.00E-11 NR 21298027 | |
| 2 61224259 rs10181042-T 2:61224259 Crohn's disease 7.00E-09 1.14 21102463 | |
| 2 61876965 rs2421332-C 2:61876965 Homeostasis model assessment of beta-cell function (interaction) 3.00E-09 NR 24204828 | |
| 2 62452661 rs11900673-T 2:62452661 Rheumatoid arthritis 1.00E-08 1.11 22446963 | |
| 2 62551472 rs10865331-A 2:62551472 Ankylosing spondylitis 7.00E-34 NR 21743469 | |
| 2 62551472 rs10865331-A 2:62551472 Ankylosing spondylitis 2.00E-19 1.27 20062062 | |
| 2 62551472 rs10865331-A 2:62551472 Crohn's disease 1.00E-09 1.1 23128233 | |
| 2 62713533 rs6545946-C 2:62713533 Crohn's disease 7.00E-09 1.16 22412388 | |
| 2 63131731 rs721048-A 2:63131731 Prostate cancer 8.00E-09 1.15 18264098 | |
| 2 63149557 rs2710642-G 2:63149557 LDL cholesterol 6.00E-09 0.02 24097068 | |
| 2 65208074 rs10211524-A 2:65208074 Blood metabolite levels 6.00E-16 0.02 24816252 | |
| 2 65208074 rs10211524-? 2:65208074 Metabolite levels 3.00E-10 NR 22916037 | |
| 2 65220910 rs2160387-? 2:65220910 Metabolite levels 3.00E-22 0.17 22286219 | |
| 2 65595586 rs934734-G 2:65595586 Rheumatoid arthritis 5.00E-10 1.13 20453842 | |
| 2 65595586 rs934734-G 2:65595586 Rheumatoid arthritis 2.00E-08 1.14 24782177 | |
| 2 65598300 rs1858037-T 2:65598300 Rheumatoid arthritis 3.00E-15 1.11 24390342 | |
| 2 65598300 rs1858037-T 2:65598300 Rheumatoid arthritis 2.00E-09 1.09 24390342 | |
| 2 65598300 rs1858037-T 2:65598300 Rheumatoid arthritis 1.00E-08 1.19 24390342 | |
| 2 65608909 rs1876518-? 2:65608909 Celiac disease and Rheumatoid arthritis 2.00E-08 NR 21383967 | |
| 2 65667272 rs6740462-A 2:65667272 Inflammatory bowel disease 2.00E-08 1.08 23128233 | |
| 2 66275308 rs1320851-? x rs1258569-? 2:66275308 Age-related hearing impairment (interaction) 9.00E-09 NR 24939585 | |
| 2 66756976 rs3891585-A 2:66756976 PR interval 1.00E-11 2.13 23139255 | |
| 2 66760079 rs11678354-A 2:66760079 PR segment 5.00E-09 1.26 24850809 | |
| 2 66772000 rs11897119-C 2:66772000 PR interval 5.00E-11 1.36 20062060 | |
| 2 66781453 rs2300478-G 2:66781453 Restless legs syndrome 3.00E-49 1.68 21779176 | |
| 2 66781453 rs2300478-G 2:66781453 Restless legs syndrome 3.00E-28 1.74 17637780 | |
| 2 68070225 rs6747972-A 2:68070225 Restless legs syndrome 9.00E-11 1.23 21779176 | |
| 2 68359897 rs4078978-A 2:68359897 Immune reponse to smallpox (secreted IFN-alpha) 2.00E-18 NR 22610502 | |
| 2 68570772 rs9309413-? 2:68570772 Metabolite levels 2.00E-09 NR 19043545 | |
| 2 68598955 rs17035378-? 2:68598955 Celiac disease 8.00E-09 1.14 20190752 | |
| 2 68647095 rs7595037-A 2:68647095 Multiple sclerosis 5.00E-11 1.11 21833088 | |
| 2 69287943 rs4315565-A 2:69287943 Height 1.00E-08 0.06 21998595 | |
| 2 71525785 rs12612930-C 2:71525785 Height 2.00E-10 0.1 23456168 | |
| 2 73743982 rs9309473-G 2:73743982 Metabolite levels 1.00E-11 1.1 21931564 | |
| 2 73746923 rs11884776-C 2:73746923 Urinary metabolites (H-NMR features) 6.00E-17 0.35 24586186 | |
| 2 73752368 rs10469966-A 2:73752368 Blood metabolite levels 1.00E-51 0.1 24816252 | |
| 2 73785358 rs6546847-A 2:73785358 Urinary metabolites (H-NMR features) 5.00E-161 0.91 24586186 | |
| 2 73785358 rs6546847-A 2:73785358 Urinary metabolites (H-NMR features) 1.00E-17 0.34 24586186 | |
| 2 73818936 rs13391552-A 2:73818936 Metabolic traits 5.00E-252 0.37 21886157 | |
| 2 73837955 rs6546857-A 2:73837955 Metabolite levels (X-11787) 1.00E-23 0.09 23934736 | |
| 2 73868328 rs13538-A 2:73868328 Blood metabolite levels 8.00E-157 0.12 24816252 | |
| 2 73868328 rs13538-A 2:73868328 Serum metabolite levels 4.00E-66 0.3 24625756 | |
| 2 73868328 rs13538-A 2:73868328 Metabolite levels (X-11787) 2.00E-23 0.09 23934736 | |
| 2 73868328 rs13538-G 2:73868328 Chronic kidney disease 5.00E-14 0.01 20383146 | |
| 2 73900900 rs10206899-T 2:73900900 Blood metabolite levels 8.00E-123 0.04 24816252 | |
| 2 73900900 rs10206899-G 2:73900900 Creatinine levels 1.00E-15 1 20383145 | |
| 2 73900900 rs10206899-T 2:73900900 Blood metabolite levels 2.00E-14 0.03 24816252 | |
| 2 73900900 rs10206899-C 2:73900900 Glomerular filtration rate 2.00E-09 1.1 23535967 | |
| 2 73900900 rs10206899-C 2:73900900 Glomerular filtration rate 6.00E-09 1.1 23535967 | |
| 2 73900900 rs10206899-C 2:73900900 Glomerular filtration rate 4.00E-08 1.17 23535967 | |
| 2 74202578 rs4852324-T 2:74202578 Systemic lupus erythematosus 6.00E-14 1.27 23273568 | |
| 2 74208362 rs6705628-C 2:74208362 Systemic lupus erythematosus 7.00E-17 1.33 23273568 | |
| 2 74789700 rs11126435-? x rs263655-? 2:74789700 Age-related hearing impairment (interaction) 9.00E-09 NR 24939585 | |
| 2 75419714 rs3771863-? 2:75419714 Brain connectivity 3.00E-09 NR 23471985 | |
| 2 75926565 rs2298948-C 2:75926565 Hippocampal atrophy 5.00E-08 NR 22745009 | |
| 2 80281173 rs6738962-? 2:80281173 Alzheimer's disease (cognitive decline) 1.00E-08 0.18 23535033 | |
| 2 81668808 rs10496265-? 2:81668808 Aging traits 1.00E-08 NR 17903295 | |
| 2 81855725 rs6736587-C 2:81855725 Orthostatic hypotension 5.00E-08 1.38 24124408 | |
| 2 83029469 rs17022444-? 2:83029469 Response to antipsychotic therapy (extrapyramidal side effects) 1.00E-10 NR 19875103 | |
| 2 85794297 rs10187424-A 2:85794297 Prostate cancer 3.00E-15 1.09 21743467 | |
| 2 87044316 rs6547705-? 2:87044316 Progressive supranuclear palsy 1.00E-08 1.28 21685912 | |
| 2 88659588 rs1659258-A 2:88659588 Visceral fat 2.00E-08 NR 22589738 | |
| 2 88895351 rs7571971-? 2:88895351 Progressive supranuclear palsy 4.00E-13 1.33 21685912 | |
| 2 88924622 rs11684404-T 2:88924622 Height 1.00E-13 0.03 20881960 | |
| 2 97405440 rs2271893-G 2:97405440 Bipolar disorder 2.00E-10 NR 22182935 | |
| 2 100460654 rs7583877-C 2:100460654 Type 1 diabetes nephropathy 1.00E-08 1.29 23028342 | |
| 2 100806940 rs11676922-T 2:100806940 Rheumatoid arthritis 1.00E-14 1.12 20453842 | |
| 2 100806940 rs11676922-T 2:100806940 Rheumatoid arthritis 2.00E-08 1.13 24782177 | |
| 2 100818479 rs4851266-T 2:100818479 Educational attainment 5.00E-11 1.05 23722424 | |
| 2 100825367 rs9653442-C 2:100825367 Rheumatoid arthritis 2.00E-18 1.11 24390342 | |
| 2 100825367 rs9653442-C 2:100825367 Rheumatoid arthritis 1.00E-14 1.12 24390342 | |
| 2 101424331 rs7565981-? 2:101424331 Creutzfeldt-Jakob disease (variant) 4.00E-08 2.98 22137330 | |
| 2 102663628 rs2310173-T 2:102663628 Ulcerative colitis 3.00E-12 1.09 21297633 | |
| 2 102726661 rs12712127-A 2:102726661 Fibrinogen 3.00E-08 0.01 23969696 | |
| 2 102776202 rs13019803-T 2:102776202 Serum protein levels (sST2) 6.00E-20 0.14 23999434 | |
| 2 102810168 rs1558648-G 2:102810168 Serum protein levels (sST2) 4.00E-16 0.13 23999434 | |
| 2 102851708 rs2302612-C 2:102851708 Serum protein levels (sST2) 2.00E-11 0.08 23999434 | |
| 2 102879464 rs10189629-A 2:102879464 Self-reported allergy 2.00E-16 0.14 23817569 | |
| 2 102915662 rs11693697-C 2:102915662 Serum protein levels (sST2) 7.00E-11 0.08 23999434 | |
| 2 102932562 rs950880-A 2:102932562 Serum protein levels (sST2) 7.00E-94 0.18 23999434 | |
| 2 102948632 rs1420103-A 2:102948632 Serum protein levels (sST2) 1.00E-35 0.13 23999434 | |
| 2 102953444 rs17639215-A 2:102953444 Serum protein levels (sST2) 2.00E-30 0.15 23999434 | |
| 2 102953617 rs3771180-? 2:102953617 Asthma 2.00E-15 NR 21804549 | |
| 2 102955082 rs13408661-G 2:102955082 Asthma 1.00E-09 1.23 23028483 | |
| 2 102957291 rs13029918-G 2:102957291 Serum protein levels (sST2) 2.00E-39 0.29 23999434 | |
| 2 102957716 rs1420101-A 2:102957716 Eosinophil counts 5.00E-14 6.4 19198610 | |
| 2 102960210 rs3771175-T 2:102960210 Allergic sensitization 5.00E-11 1.2 23817571 | |
| 2 102965392 rs12999542-C 2:102965392 Serum protein levels (sST2) 2.00E-27 0.15 23999434 | |
| 2 102966549 rs10197862-A 2:102966549 Asthma and hay fever 4.00E-11 1.24 24388013 | |
| 2 102971865 rs13015714-G 2:102971865 Atopic dermatitis 8.00E-18 1.27 23042114 | |
| 2 102971865 rs13015714-C 2:102971865 Celiac disease 4.00E-09 1.28 18311140 | |
| 2 102986222 rs3771166-G 2:102986222 Asthma 3.00E-09 1.15 20860503 | |
| 2 103054449 rs2058660-G 2:103054449 Crohn's disease 2.00E-12 1.19 21102463 | |
| 2 103054767 rs11465699-A 2:103054767 Serum protein levels (sST2) 2.00E-08 0.14 23999434 | |
| 2 103070568 rs917997-T 2:103070568 Inflammatory bowel disease 3.00E-20 1.1 23128233 | |
| 2 103070568 rs917997-A 2:103070568 Celiac disease 1.00E-15 1.19 20190752 | |
| 2 103149100 rs1014286-G 2:103149100 Serum protein levels (sST2) 3.00E-33 0.11 23999434 | |
| 2 106457291 rs2377339-G 2:106457291 Addiction 1.00E-11 13.87 23533358 | |
| 2 106457291 rs2377339-G 2:106457291 Addiction 2.00E-08 NR 23533358 | |
| 2 109635257 rs4676049-A 2:109635257 Alzheimer's disease (late onset) 4.00E-08 1.76 20885792 | |
| 2 111607832 rs6732565-A 2:111607832 Rheumatoid arthritis 9.00E-09 1.1 24390342 | |
| 2 111607832 rs6732565-A 2:111607832 Rheumatoid arthritis 3.00E-08 1.07 24390342 | |
| 2 111616104 rs13401811-G 2:111616104 Chronic lymphocytic leukemia 2.00E-18 1.41 23770605 | |
| 2 111797458 rs17483466-G 2:111797458 Chronic lymphocytic leukemia 4.00E-17 1.37 23770605 | |
| 2 111797458 rs17483466-G 2:111797458 Chronic lymphocytic leukemia 2.00E-10 1.39 18758461 | |
| 2 111797458 rs17483466-? 2:111797458 Chronic lymphocytic leukemia 5.00E-09 1.43 22700719 | |
| 2 111849659 rs10207392-G 2:111849659 Red blood cell traits 4.00E-11 0.13 23222517 | |
| 2 111871897 rs1439287-A 2:111871897 Chronic lymphocytic leukemia 5.00E-15 1.37 24292274 | |
| 2 111949327 rs6738028-G 2:111949327 Dehydroepiandrosterone sulphate levels 2.00E-08 0.04 21533175 | |
| 2 111989372 rs6720394-? 2:111989372 Primary sclerosing cholangitis 4.00E-08 1.29 21151127 | |
| 2 112500035 rs17040773-A 2:112500035 Bone mineral density 2.00E-09 0.04 22504420 | |
| 2 112665201 rs17174870-G 2:112665201 Multiple sclerosis 1.00E-08 1.11 21833088 | |
| 2 112770770 rs4374383-A 2:112770770 Hepatitis C induced liver fibrosis 1.00E-09 NR 22841784 | |
| 2 113832333 rs6743376-A 2:113832333 Inflammatory biomarkers 2.00E-26 0.13 24182552 | |
| 2 113841030 rs6734238-A 2:113841030 Fibrinogen 6.00E-19 0.01 23969696 | |
| 2 113841030 rs6734238-G 2:113841030 C-reactive protein 2.00E-17 0.05 21300955 | |
| 2 113841030 rs6734238-G 2:113841030 C-reactive protein 9.00E-10 0.11 22939635 | |
| 2 113978940 rs11123170-G 2:113978940 Renal function-related traits (BUN) 3.00E-10 0.01 22797727 | |
| 2 118835841 rs10490626-A 2:118835841 LDL cholesterol 2.00E-12 0.05 24097068 | |
| 2 118835841 rs10490626-A 2:118835841 "Cholesterol, total" 6.00E-09 0.04 24097068 | |
| 2 119038598 rs1878526-A 2:119038598 Bone mineral density 1.00E-10 0.04 22504420 | |
| 2 121089731 rs17625845-C 2:121089731 Breast size 5.00E-10 0.13 22747683 | |
| 2 121245122 rs4849887-T 2:121245122 Breast size 3.00E-11 0.17 22747683 | |
| 2 121245122 rs4849887-C 2:121245122 Breast cancer 4.00E-11 1.1 23535729 | |
| 2 121306440 rs17050272-A 2:121306440 Urate levels 2.00E-10 0.04 23263486 | |
| 2 121309488 rs2030746-T 2:121309488 LDL cholesterol 9.00E-09 0.02 24097068 | |
| 2 121341281 rs1869026-? x rs9395969-? 2:121341281 Age-related hearing impairment (interaction) 4.00E-10 NR 24939585 | |
| 2 122018763 rs17006292-? 2:122018763 Behcet's disease 5.00E-09 4.17 23001997 | |
| 2 123225623 rs17007761-A 2:123225623 Immune reponse to smallpox (secreted IFN-alpha) 1.00E-08 NR 22610502 | |
| 2 127887985 rs12989701-? 2:127887985 Alzheimer's disease (late onset) 3.00E-10 1.23 21390209 | |
| 2 127889637 rs7561528-A 2:127889637 Alzheimer's disease (late onset) 4.00E-14 1.17 21460841 | |
| 2 127889637 rs7561528-? 2:127889637 Alzheimer's disease 6.00E-11 1.25 22832961 | |
| 2 127892810 rs6733839-T 2:127892810 Alzheimer's disease (late onset) 7.00E-44 1.22 24162737 | |
| 2 127894615 rs744373-? 2:127894615 Alzheimer's disease 3.00E-14 1.17 21460840 | |
| 2 127894615 rs744373-? 2:127894615 Alzheimer's disease (late onset) 1.00E-10 1.19 21390209 | |
| 2 127894615 rs744373-? 2:127894615 Alzheimer's disease 2.00E-09 1.18 21627779 | |
| 2 128177377 rs1158867-C 2:128177377 Protein C levels 4.00E-36 0.12 20802025 | |
| 2 134434824 rs7567288-T 2:134434824 Height 2.00E-12 0.03 20881960 | |
| 2 134529091 rs6722456-A 2:134529091 Palmitoleic acid (16:1n-7) plasma levels 4.00E-08 0.05 23362303 | |
| 2 135592381 rs6710823-G 2:135592381 Parkinson's disease 7.00E-09 1.1 21292315 | |
| 2 135631400 rs6430553-T 2:135631400 Blood metabolite levels 6.00E-12 0.02 24816252 | |
| 2 135803425 rs4954218-? 2:135803425 Corneal structure 1.00E-09 1.61 21979947 | |
| 2 135837906 rs7570971-A 2:135837906 Blood metabolite levels 8.00E-45 0.04 24816252 | |
| 2 135837906 rs7570971-A 2:135837906 "Cholesterol, total" 1.00E-13 0.03 24097068 | |
| 2 135837906 rs7570971-T 2:135837906 "Cholesterol, total" 1.00E-08 1.18 20686565 | |
| 2 141721142 rs12474609-? 2:141721142 Aging 6.00E-09 NR 19367585 | |
| 2 142959931 rs2890652-C 2:142959931 Body mass index 1.00E-10 0.09 20935630 | |
| 2 145141541 rs12991836-C 2:145141541 Schizophrenia 1.00E-08 1.08 23974872 | |
| 2 145208193 rs12105918-? 2:145208193 Renal cell carcinoma 2.00E-08 1.45 23184150 | |
| 2 145223620 rs13382811-T 2:145223620 Myopia (severe) 6.00E-10 1.26 23933737 | |
| 2 145359909 rs10496964-C 2:145359909 Epilepsy (generalized) 9.00E-09 1.47 22949513 | |
| 2 146125523 rs10427255-C 2:146125523 Common traits (Other) 1.00E-11 1.32 20585627 | |
| 2 148716428 rs2307394-T 2:148716428 Urate levels 2.00E-08 0.03 23263486 | |
| 2 151637936 rs7560163-C 2:151637936 Type 2 diabetes 7.00E-09 1.33 22238593 | |
| 2 151725792 rs10195263-G 2:151725792 Immune reponse to smallpox (secreted IFN-alpha) 3.00E-08 NR 22610502 | |
| 2 152957411 rs3820706-G 2:152957411 Adverse response to chemotherapy in breast cancer (alopecia) 2.00E-09 2.38 24025145 | |
| 2 152981335 rs16830728-T 2:152981335 Adverse response to chemotherapy in breast cancer (alopecia) 3.00E-08 3.61 24025145 | |
| 2 157096776 rs17188434-C 2:157096776 Menarche (age at onset) 1.00E-09 4.5 21102462 | |
| 2 159899489 rs7582141-T 2:159899489 Response to radiotherapy in prostate cancer (toxicity) 5.00E-11 0.37 24974847 | |
| 2 160190209 rs4665058-A 2:160190209 Sudden cardiac arrest 2.00E-10 1.92 21738491 | |
| 2 160867059 rs2667011-? 2:160867059 Bilirubin levels 2.00E-13 0.04 20639394 | |
| 2 160917497 rs4664308-? 2:160917497 Nephropathy (idiopathic membranous) 9.00E-29 2.28 21323541 | |
| 2 161171454 rs7593730-? 2:161171454 Type 2 diabetes 4.00E-08 1.11 20418489 | |
| 2 162029113 rs7568498-? 2:162029113 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) 2.00E-08 NR 24554482 | |
| 2 162092640 rs7309-A 2:162092640 Educational attainment 4.00E-08 0.09 23722424 | |
| 2 162851147 rs12617656-T 2:162851147 Rheumatoid arthritis 2.00E-21 1.56 24782177 | |
| 2 162851147 rs12617656-T 2:162851147 Rheumatoid arthritis 1.00E-08 1.24 24782177 | |
| 2 163110536 rs2111485-G 2:163110536 Vitiligo 5.00E-15 1.3 22561518 | |
| 2 163110536 rs2111485-A 2:163110536 Inflammatory bowel disease 2.00E-08 1.07 23128233 | |
| 2 163124051 rs1990760-C 2:163124051 Type 1 diabetes autoantibodies 2.00E-14 1.2 21829393 | |
| 2 163124051 rs1990760-A 2:163124051 Type 1 diabetes 2.00E-11 1.18 17554260 | |
| 2 163124051 rs1990760-? 2:163124051 Immunoglobulin A 7.00E-10 1.49 20694011 | |
| 2 163124051 rs1990760-? 2:163124051 Type 1 diabetes 7.00E-09 NR 19430480 | |
| 2 163260691 rs17716942-A 2:163260691 Psoriasis 1.00E-13 1.29 20953190 | |
| 2 163781787 rs1424760-? 2:163781787 Phospholipid levels (plasma) 4.00E-08 0.7 22359512 | |
| 2 164906820 rs16849225-C 2:164906820 Blood pressure 4.00E-11 0.75 21572416 | |
| 2 164915208 rs13002573-G 2:164915208 Blood pressure 2.00E-08 0.31 21909110 | |
| 2 164963486 rs1446468-T 2:164963486 Blood pressure 6.00E-12 0.34 21909110 | |
| 2 165501849 rs3923113-A 2:165501849 Type 2 diabetes 1.00E-08 1.09 21874001 | |
| 2 165513091 rs10195252-C 2:165513091 Triglycerides 2.00E-10 2.01 20686565 | |
| 2 165528876 rs13389219-C 2:165528876 Waist-hip ratio 3.00E-08 1.13 23563607 | |
| 2 165539661 rs6717858-T 2:165539661 Sexual dimorphism in anthropometric traits 6.00E-16 NR 23754948 | |
| 2 165540800 rs12328675-C 2:165540800 HDL cholesterol 2.00E-15 0.05 24097068 | |
| 2 165540800 rs12328675-C 2:165540800 HDL cholesterol 3.00E-10 0.68 20686565 | |
| 2 165551201 rs7607980-? 2:165551201 Fasting insulin-related traits (interaction with BMI) 4.00E-20 NR 22581228 | |
| 2 166578114 rs6726821-T 2:166578114 "Bone mineral density (paediatric, total body less head)" 4.00E-10 0.09 24945404 | |
| 2 166578114 rs6726821-T 2:166578114 "Bone mineral density (paediatric, upper limb)" 1.00E-08 0.08 24945404 | |
| 2 166583244 rs6710518-T 2:166583244 Bone mineral density 5.00E-10 0.06 21533022 | |
| 2 166601046 rs1346004-A 2:166601046 Bone mineral density 4.00E-30 0.06 22504420 | |
| 2 166978750 rs7587026-A 2:166978750 Mesial temporal lobe epilepsy with hippocampal sclerosis 3.00E-09 1.42 24014518 | |
| 2 166978750 rs7587026-A 2:166978750 Mesial temporal lobe epilepsy with hippocampal sclerosis 4.00E-08 1.24 24014518 | |
| 2 168159351 rs10497324-A 2:168159351 DNA methylation (parent-of-origin) 2.00E-09 NR 23725790 | |
| 2 169117025 rs2102808-C 2:169117025 Parkinson's disease 4.00E-10 1.18 21292315 | |
| 2 169757354 rs1402837-A 2:169757354 Glycated hemoglobin levels 5.00E-10 0.02 19096518 | |
| 2 169763148 rs560887-C 2:169763148 Fasting glucose-related traits 9.00E-218 NR 20081858 | |
| 2 169763148 rs560887-? 2:169763148 Fasting glucose-related traits (interaction with BMI) 2.00E-113 NR 22581228 | |
| 2 169763148 rs560887-C 2:169763148 Fasting glucose-related traits 2.00E-66 NR 20081858 | |
| 2 169763148 rs560887-C 2:169763148 Fasting plasma glucose 1.00E-57 0.06 19060907 | |
| 2 169763148 rs560887-G 2:169763148 Metabolic syndrome 5.00E-26 0.15 22399527 | |
| 2 169763148 rs560887-A 2:169763148 Fasting plasma glucose 4.00E-23 0.06 18451265 | |
| 2 169763148 rs560887-T 2:169763148 Glycated hemoglobin levels 1.00E-17 0.03 24405752 | |
| 2 169763148 rs560887-? 2:169763148 Metabolite levels 2.00E-17 0.15 22286219 | |
| 2 169763148 rs560887-T 2:169763148 Glycemic traits (pregnancy) 2.00E-16 0.01 23903356 | |
| 2 169763148 rs560887-? 2:169763148 Metabolite levels 4.00E-15 NR 22916037 | |
| 2 169763148 rs560887-A 2:169763148 Metabolic traits 6.00E-10 0.06 19060910 | |
| 2 169784413 rs16856247-T 2:169784413 Metabolite levels 2.00E-15 0.06 21909109 | |
| 2 169791438 rs552976-G 2:169791438 Glycated hemoglobin levels 8.00E-18 0.05 20858683 | |
| 2 169792171 rs3755157-T 2:169792171 Glycated hemoglobin levels 3.00E-11 0.07 24647736 | |
| 2 169830155 rs2287623-G 2:169830155 "Cholesterol, total" 4.00E-12 0.03 24097068 | |
| 2 169840574 rs16856332-T 2:169840574 Liver enzyme levels (alkaline phosphatase) 2.00E-09 3.9 22001757 | |
| 2 170204846 rs2544390-C 2:170204846 Urate levels 4.00E-08 0.08 20139978 | |
| 2 171990971 rs10183486-T 2:171990971 Menopause (age at onset) 2.00E-14 0.2 22267201 | |
| 2 172972971 rs2016394-G 2:172972971 Breast cancer 1.00E-08 1.05 23535729 | |
| 2 173311553 rs12621278-? 2:173311553 Prostate cancer 9.00E-23 1.33 19767753 | |
| 2 174212894 rs1550623-A 2:174212894 Breast cancer 3.00E-08 1.06 23535729 | |
| 2 174297659 rs10497394-G 2:174297659 Otitis media (chronic/recurrent) 2.00E-08 1.51 23974705 | |
| 2 174326845 rs10930597-T 2:174326845 Blood pressure measurement (high sodium and potassium intervention) 1.00E-08 3.48 24165912 | |
| 2 174326845 rs10930597-T 2:174326845 Blood pressure measurement (high sodium and potassium intervention) 4.00E-08 3.2 24165912 | |
| 2 174326845 rs10930597-T 2:174326845 Blood pressure measurement (low sodium intervention) 4.00E-08 3.37 24165912 | |
| 2 174462854 rs4972593-A 2:174462854 End-stage renal disease in Type 1 diabetics 4.00E-08 1.81 24029427 | |
| 2 177042633 rs2072590-T 2:177042633 Ovarian cancer 5.00E-14 1.16 20852632 | |
| 2 177042633 rs2072590-? 2:177042633 Ovarian cancer 5.00E-11 1.11 23535730 | |
| 2 177042633 rs2072590-? 2:177042633 Ovarian cancer 3.00E-10 1.13 23535730 | |
| 2 178684720 rs7567851-C 2:178684720 Height 3.00E-08 0.04 20881960 | |
| 2 179721046 rs17362588-A 2:179721046 Heart rate 4.00E-26 0.74 23583979 | |
| 2 180566678 rs16866933-? 2:180566678 Sudden cardiac arrest 6.00E-14 1.69 21658281 | |
| 2 181996045 rs13010713-G 2:181996045 Celiac disease 5.00E-11 1.13 20190752 | |
| 2 182319301 rs1449263-T 2:182319301 White blood cell count 3.00E-23 0.04 21738480 | |
| 2 182323665 rs12988934-T 2:182323665 White blood cell types 2.00E-14 0.11 21738478 | |
| 2 182328214 rs2124440-G 2:182328214 Monocyte count 5.00E-17 0.22 23314186 | |
| 2 188333064 rs4140885-A 2:188333064 Heart rate 5.00E-08 0.22 23583979 | |
| 2 188626214 rs4667193-? x rs11951611-? 2:188626214 Age-related hearing impairment (interaction) 2.00E-09 NR 24939585 | |
| 2 190985680 rs13034723-A 2:190985680 Body mass index 2.00E-08 0.07 22344221 | |
| 2 191538562 rs10931468-A 2:191538562 Primary biliary cirrhosis 2.00E-19 1.5 21399635 | |
| 2 191902758 rs3821236-? 2:191902758 Systemic lupus erythematosus 8.00E-11 1.49 19165918 | |
| 2 191902758 rs3821236-A 2:191902758 Systemic sclerosis 3.00E-09 1.3 20383147 | |
| 2 191931464 rs1517352-C 2:191931464 Inflammatory bowel disease 3.00E-11 1.08 23128233 | |
| 2 191935804 rs10168266-T 2:191935804 Sj��gren's syndrome 2.00E-17 1.44 24097066 | |
| 2 191940451 rs7601754-? 2:191940451 Systemic lupus erythematosus and Systemic sclerosis 3.00E-11 1.32 23740937 | |
| 2 191943742 rs11889341-T 2:191943742 Rheumatoid arthritis 4.00E-19 1.13 24390342 | |
| 2 191943742 rs11889341-T 2:191943742 Rheumatoid arthritis 1.00E-12 1.12 24390342 | |
| 2 191943742 rs11889341-T 2:191943742 Rheumatoid arthritis 2.00E-08 1.16 24390342 | |
| 2 191964633 rs7574865-A 2:191964633 Systemic lupus erythematosus 5.00E-42 1.51 19838193 | |
| 2 191964633 rs7574865-T 2:191964633 Systemic lupus erythematosus 1.00E-21 1.63 23273568 | |
| 2 191964633 rs7574865-T 2:191964633 Systemic lupus erythematosus 2.00E-20 1.77 21408207 | |
| 2 191964633 rs7574865-T 2:191964633 Systemic lupus erythematosus 4.00E-14 1.48 23053960 | |
| 2 191964633 rs7574865-T 2:191964633 Systemic lupus erythematosus 9.00E-14 NR 18204098 | |
| 2 191964633 rs7574865-T 2:191964633 Systemic sclerosis 2.00E-13 1.38 21750679 | |
| 2 191964633 rs7574865-G 2:191964633 Hepatocellular carcinoma (hepatitis B virus related) 2.00E-10 1.21 23242368 | |
| 2 191964633 rs7574865-T 2:191964633 Celiac disease and Rheumatoid arthritis 4.00E-10 NR 21383967 | |
| 2 191964633 rs7574865-T 2:191964633 Systemic lupus erythematosus 5.00E-09 1.51 24871463 | |
| 2 192010488 rs7574070-A 2:192010488 Behcet's disease 1.00E-09 1.27 23291587 | |
| 2 192017771 rs897200-A 2:192017771 Behcet's disease 6.00E-09 1.45 23001997 | |
| 2 192117238 rs13030978-T 2:192117238 Liver enzyme levels (gamma-glutamyl transferase) 1.00E-11 3.7 22001757 | |
| 2 192587204 rs11903757-C 2:192587204 Colorectal cancer 4.00E-08 1.16 23266556 | |
| 2 193984621 rs17662626-? 2:193984621 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 5.00E-08 NR 23453885 | |
| 2 193984621 rs17662626-A 2:193984621 Schizophrenia 5.00E-08 1.2 21926974 | |
| 2 195547393 rs801350-? 2:195547393 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) 2.00E-08 NR 24554482 | |
| 2 195559997 rs801378-? 2:195559997 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) 2.00E-08 NR 24554482 | |
| 2 198631714 rs700651-G 2:198631714 Intracranial aneurysm 4.00E-08 1.24 18997786 | |
| 2 198881668 rs1016883-G 2:198881668 Ulcerative colitis 3.00E-08 1.1 23128233 | |
| 2 198896895 rs6738825-A 2:198896895 Crohn's disease 4.00E-09 1.06 21102463 | |
| 2 198914072 rs10497813-G 2:198914072 Self-reported allergy 6.00E-10 0.07 23817569 | |
| 2 199523122 rs17229285-C 2:199523122 Ulcerative colitis 2.00E-13 1.12 23128233 | |
| 2 199632565 rs12617311-A 2:199632565 Menarche (age at onset) 6.00E-13 3 21102462 | |
| 2 200676926 rs7605378-? 2:200676926 Osteoporosis 2.00E-08 1.25 21573128 | |
| 2 200715388 rs2949006-T 2:200715388 Schizophrenia 1.00E-08 1.1 23974872 | |
| 2 202111380 rs3769825-T 2:202111380 Chronic lymphocytic leukemia 3.00E-09 1.19 23770605 | |
| 2 202154397 rs6715284-G 2:202154397 Rheumatoid arthritis 2.00E-09 1.15 24390342 | |
| 2 202154397 rs6715284-G 2:202154397 Rheumatoid arthritis 3.00E-09 1.15 24390342 | |
| 2 202162811 rs13016963-A 2:202162811 Melanoma 9.00E-10 1.14 21983787 | |
| 2 203532304 rs11694172-G 2:203532304 "Cholesterol, total" 2.00E-09 0.03 24097068 | |
| 2 203745885 rs6725887-C 2:203745885 Coronary heart disease 1.00E-09 1.14 21378990 | |
| 2 203745885 rs6725887-C 2:203745885 Myocardial infarction (early onset) 1.00E-08 1.17 19198609 | |
| 2 203745885 rs6725887-C 2:203745885 Coronary artery disease 2.00E-08 1.14 24262325 | |
| 2 203753072 rs7582720-? 2:203753072 Coronary artery disease or ischemic stroke 4.00E-09 NR 24262325 | |
| 2 203753072 rs7582720-? 2:203753072 Coronary artery disease or large artery stroke 3.00E-08 NR 24262325 | |
| 2 204249399 rs11675251-A 2:204249399 Butyrylcholinesterase levels 4.00E-18 0.15 21862451 | |
| 2 204610396 rs1980422-C 2:204610396 Rheumatoid arthritis 3.00E-14 1.12 24390342 | |
| 2 204610396 rs1980422-C 2:204610396 Rheumatoid arthritis 2.00E-13 1.13 24390342 | |
| 2 204693876 rs231735-T 2:204693876 Rheumatoid arthritis 6.00E-09 1.17 19503088 | |
| 2 204721752 rs1024161-T 2:204721752 Graves' disease 2.00E-17 1.3 21841780 | |
| 2 204721752 rs1024161-A 2:204721752 Alopecia areata 4.00E-13 1.44 20596022 | |
| 2 204738919 rs3087243-G 2:204738919 Rheumatoid arthritis 3.00E-25 1.14 24390342 | |
| 2 204738919 rs3087243-G 2:204738919 Rheumatoid arthritis 4.00E-22 1.15 24390342 | |
| 2 204738919 rs3087243-A 2:204738919 Type 1 diabetes autoantibodies 2.00E-17 1.2 21829393 | |
| 2 204738919 rs3087243-? 2:204738919 Type 1 diabetes 1.00E-15 NR 19430480 | |
| 2 204738919 rs3087243-A 2:204738919 Type 1 diabetes 8.00E-11 NR 18978792 | |
| 2 204738919 rs3087243-G 2:204738919 Rheumatoid arthritis 1.00E-08 1.15 20453842 | |
| 2 204802578 rs4675374-A 2:204802578 Celiac disease 6.00E-09 1.14 20190752 | |
| 2 206318593 rs11884476-? 2:206318593 AIDS progression 3.00E-09 3.32 21502085 | |
| 2 210874246 rs3738934-T 2:210874246 Blood metabolite levels 1.00E-134 0.11 24816252 | |
| 2 211060050 rs2286963-T 2:211060050 Metabolite levels 3.00E-60 13.8 20037589 | |
| 2 211074909 rs3764913-T 2:211074909 Metabolite levels 4.00E-29 NR 23281178 | |
| 2 211132415 rs1509569-A 2:211132415 Urinary metabolites (H-NMR features) 3.00E-18 0.32 24586186 | |
| 2 211540507 rs7422339-A 2:211540507 Homocysteine levels 5.00E-27 0.09 23824729 | |
| 2 211540507 rs7422339-A 2:211540507 Chronic kidney disease 1.00E-15 0.01 20383146 | |
| 2 211540507 rs1047891-A 2:211540507 Plasma homocysteine levels (post-methionine load test) 9.00E-13 0.19 24651765 | |
| 2 211540507 rs7422339-A 2:211540507 Serum metabolite levels 4.00E-12 0.1 24625756 | |
| 2 211540507 rs1047891-A 2:211540507 HDL cholesterol 9.00E-10 0.03 24097068 | |
| 2 211540507 rs7422339-A 2:211540507 Homocysteine levels 5.00E-09 0.05 20154341 | |
| 2 211540507 rs7422339-A 2:211540507 Fibrinogen 9.00E-09 4.84 20031577 | |
| 2 211543055 rs715-T 2:211543055 Blood metabolite levels 2.00E-147 0.08 24816252 | |
| 2 211543055 rs715-T 2:211543055 Blood metabolite levels 7.00E-58 0.09 24816252 | |
| 2 211543055 rs715-T 2:211543055 Metabolite levels 3.00E-50 0.61 23378610 | |
| 2 211543055 rs715-T 2:211543055 Blood metabolite levels 7.00E-35 0.03 24816252 | |
| 2 211543055 rs715-T 2:211543055 Blood metabolite levels 1.00E-24 0.05 24816252 | |
| 2 211543055 rs715-T 2:211543055 Blood metabolite levels 3.00E-21 0.02 24816252 | |
| 2 211543055 rs715-T 2:211543055 Blood metabolite levels 2.00E-19 0.02 24816252 | |
| 2 211543055 rs715-T 2:211543055 Blood metabolite levels 2.00E-16 0.04 24816252 | |
| 2 211543055 rs715-T 2:211543055 Blood metabolite levels 4.00E-16 0.02 24816252 | |
| 2 211543055 rs715-T 2:211543055 Fibrinogen 2.00E-11 0.01 23969696 | |
| 2 211616894 rs2216405-G 2:211616894 Metabolic traits 2.00E-27 0.12 21886157 | |
| 2 213296863 rs13393577-T 2:213296863 Breast cancer 9.00E-14 1.53 22452962 | |
| 2 213824045 rs12619285-G 2:213824045 Eosinophil counts 5.00E-10 6.3 19198610 | |
| 2 215635794 rs3768716-C 2:215635794 Neuroblastoma 5.00E-13 1.39 21124317 | |
| 2 215653887 rs7587476-T 2:215653887 Neuroblastoma 4.00E-14 1.37 22941191 | |
| 2 215672546 rs6435862-G 2:215672546 Neuroblastoma (high-risk) 9.00E-18 1.68 19412175 | |
| 2 216304384 rs1250229-T 2:216304384 LDL cholesterol 3.00E-08 0.02 24097068 | |
| 2 216898658 rs7590720-G 2:216898658 Alcohol dependence 1.00E-08 1.35 19581569 | |
| 2 217481271 rs9288520-? 2:217481271 Esophageal cancer (alcohol interaction) 4.00E-11 1.33 22960999 | |
| 2 217625523 rs13015993-A 2:217625523 Thyroid hormone levels 3.00E-15 0.08 23408906 | |
| 2 217625523 rs13015993-A 2:217625523 Thyroid hormone levels 8.00E-11 0.1 23408906 | |
| 2 217863481 rs10932688-G 2:217863481 Primary tooth development (number of teeth) 3.00E-08 0.14 23704328 | |
| 2 217894756 rs4491709-T 2:217894756 Permanent tooth development 2.00E-14 0.1 21931568 | |
| 2 217905832 rs13387042-A 2:217905832 Breast cancer 2.00E-57 1.14 23535729 | |
| 2 217905832 rs13387042-A 2:217905832 Breast cancer 1.00E-13 1.2 17529974 | |
| 2 217905832 rs13387042-A 2:217905832 Breast cancer 2.00E-10 1.16 21263130 | |
| 2 217905832 rs13387042-A 2:217905832 Breast cancer 2.00E-10 1.21 20453838 | |
| 2 217905832 rs13387042-A 2:217905832 Breast cancer 2.00E-08 1.25 19330030 | |
| 2 218271719 rs6759952-T 2:218271719 Thyroid cancer 6.00E-10 1.25 23894154 | |
| 2 218271898 rs1351164-T 2:218271898 Height 2.00E-14 0.03 20881960 | |
| 2 218296508 rs16857609-T 2:218296508 Breast cancer 1.00E-15 1.08 23535729 | |
| 2 218310340 rs966423-C 2:218310340 Thyroid cancer 1.00E-09 1.34 22267200 | |
| 2 218683154 rs2571445-G 2:218683154 Pulmonary function 1.00E-12 0.07 20010834 | |
| 2 218683154 rs2571445-? 2:218683154 Pulmonary function (interaction) 8.00E-09 NR 23284291 | |
| 2 219010146 rs11676348-T 2:219010146 Ulcerative colitis 1.00E-10 1.07 21297633 | |
| 2 219151218 rs2382817-A 2:219151218 Inflammatory bowel disease 4.00E-12 1.07 23128233 | |
| 2 219756383 rs7349332-T 2:219756383 Common traits (Other) 3.00E-14 0.19 20585627 | |
| 2 219908369 rs12470505-T 2:219908369 Height 9.00E-12 0.04 20881960 | |
| 2 219943846 rs6724465-A 2:219943846 Height 2.00E-08 0.06 18391952 | |
| 2 223068286 rs7559271-G 2:223068286 Facial morphology 4.00E-16 0.39 22341974 | |
| 2 223937559 rs960246-T 2:223937559 C-reactive protein and white blood cell count 1.00E-09 0.22 22788528 | |
| 2 225047744 rs2629046-T 2:225047744 Height 8.00E-12 0.02 20881960 | |
| 2 227020653 rs7578326-A 2:227020653 Type 2 diabetes 5.00E-20 1.11 20581827 | |
| 2 227068080 rs2943634-? 2:227068080 Fasting insulin-related traits (interaction with BMI) 2.00E-14 NR 22581228 | |
| 2 227093585 rs2943640-C 2:227093585 Type 2 diabetes 7.00E-09 1.09 24509480 | |
| 2 227093745 rs2943641-C 2:227093745 Type 2 diabetes and other traits 9.00E-12 1.19 19734900 | |
| 2 227100698 rs2972146-G 2:227100698 HDL cholesterol 2.00E-17 0.03 24097068 | |
| 2 227100698 rs2972146-G 2:227100698 Triglycerides 3.00E-15 0.03 24097068 | |
| 2 227100698 rs2972146-C 2:227100698 HDL cholesterol 2.00E-09 0.46 20686565 | |
| 2 227100698 rs2972146-C 2:227100698 Triglycerides 2.00E-08 1.89 20686565 | |
| 2 227105921 rs2943650-T 2:227105921 Adiposity 4.00E-11 0.03 21706003 | |
| 2 227179630 rs925735-G 2:227179630 Adiponectin levels 2.00E-08 0.02 22479202 | |
| 2 227915924 rs2272205-G 2:227915924 Immune reponse to smallpox (secreted IFN-alpha) 3.00E-09 NR 22610502 | |
| 2 228135180 rs7606754-A 2:228135180 Corneal structure 1.00E-09 0.07 23291589 | |
| 2 229510929 rs1435867-? 2:229510929 Pulmonary function (interaction) 2.00E-09 NR 23284291 | |
| 2 230224031 rs7594321-T 2:230224031 Pulmonary function (interaction) 5.00E-11 0 23284291 | |
| 2 230224031 rs7594321-T 2:230224031 Pulmonary function (interaction) 3.00E-09 0.02 23284291 | |
| 2 231091223 rs13397985-G 2:231091223 Chronic lymphocytic leukemia 1.00E-22 1.45 23770605 | |
| 2 231091223 rs13397985-G 2:231091223 Chronic lymphocytic leukemia 5.00E-13 1.43 24292274 | |
| 2 231091223 rs13397985-G 2:231091223 Chronic lymphocytic leukemia 6.00E-10 1.41 18758461 | |
| 2 231097129 rs6716753-C 2:231097129 Crohn's disease 1.00E-16 1.13 23128233 | |
| 2 231106724 rs10201872-A 2:231106724 Multiple sclerosis 2.00E-10 1.14 21833088 | |
| 2 231116874 rs7423615-T 2:231116874 Crohn's disease 3.00E-13 1.12 21102463 | |
| 2 232271284 rs13030174-A 2:232271284 Heart rate 1.00E-10 0.3 23583979 | |
| 2 232318754 rs16828074-? 2:232318754 Attention deficit hyperactivity disorder 6.00E-09 NR 23728934 | |
| 2 232378231 rs6750795-T 2:232378231 Height 2.00E-08 1.12 23563607 | |
| 2 232797966 rs2580816-T 2:232797966 Height 6.00E-22 0.05 20881960 | |
| 2 232988582 rs3103267-C 2:232988582 Height 3.00E-08 1.16 23563607 | |
| 2 233077064 rs7571816-A 2:233077064 Height 9.00E-09 0.06 20189936 | |
| 2 233155110 rs6717918-T 2:233155110 Height 3.00E-09 0.44 19570815 | |
| 2 233379941 rs1656404-A 2:233379941 Refractive error 8.00E-11 0.15 23396134 | |
| 2 233406998 rs1881492-T 2:233406998 Refractive error 5.00E-11 0.14 23396134 | |
| 2 233513175 rs2140773-A 2:233513175 Liver enzyme levels (gamma-glutamyl transferase) 1.00E-09 2.9 22001757 | |
| 2 233743109 rs778371-G 2:233743109 Schizophrenia 2.00E-08 1.09 23974872 | |
| 2 234068476 rs35349669-T 2:234068476 Alzheimer's disease (late onset) 3.00E-08 1.08 24162737 | |
| 2 234158839 rs10210302-T 2:234158839 Crohn's disease 5.00E-14 1.19 17554300 | |
| 2 234173503 rs12994997-A 2:234173503 Crohn's disease 4.00E-70 1.23 23128233 | |
| 2 234180410 rs3828309-G 2:234180410 Crohn's disease 2.00E-32 1.25 18587394 | |
| 2 234183368 rs2241880-G 2:234183368 Crohn's disease 1.00E-13 1.45 17435756 | |
| 2 234183368 rs2241880-G 2:234183368 Crohn's disease 1.00E-12 1.32 22412388 | |
| 2 234184417 rs3792109-A 2:234184417 Crohn's disease 7.00E-41 1.34 21102463 | |
| 2 234184417 rs3792109-A 2:234184417 Crohn's disease 5.00E-09 1.38 22936669 | |
| 2 234264848 rs1550532-? 2:234264848 Bilirubin levels 3.00E-19 0.04 20639394 | |
| 2 234264848 rs1550532-C 2:234264848 Calcium levels 8.00E-11 0.02 24068962 | |
| 2 234639310 rs11891311-? 2:234639310 Bilirubin levels 1.00E-41 0.14 23371916 | |
| 2 234668570 rs887829-T 2:234668570 Blood metabolite levels 3.00E-168 0.11 24816252 | |
| 2 234668570 rs887829-T 2:234668570 Blood metabolite levels 2.00E-152 0.17 24816252 | |
| 2 234668570 rs887829-T 2:234668570 Blood metabolite levels 2.00E-140 0.11 24816252 | |
| 2 234668570 rs887829-T 2:234668570 Blood metabolite levels 3.00E-114 0.09 24816252 | |
| 2 234668570 rs887829-T 2:234668570 Blood metabolite levels 4.00E-95 0.13 24816252 | |
| 2 234668570 rs887829-T 2:234668570 Metabolic traits 3.00E-74 0.29 21886157 | |
| 2 234668570 rs887829-T 2:234668570 Bilirubin levels 1.00E-69 0.57 19419973 | |
| 2 234668570 rs887829-T 2:234668570 Blood metabolite levels 2.00E-56 0.08 24816252 | |
| 2 234668570 rs887829-A 2:234668570 Cholelithiasis-related traits in sickle cell anemia 5.00E-25 0.19 22558097 | |
| 2 234668570 rs887829-T 2:234668570 Metabolite levels 9.00E-25 NR 23281178 | |
| 2 234668570 rs887829-T 2:234668570 Serum metabolite levels 8.00E-23 0.32 24625756 | |
| 2 234668570 rs887829-T 2:234668570 Bilirubin levels 2.00E-22 0.23 22085899 | |
| 2 234668570 rs887829-T 2:234668570 Bilirubin levels 9.00E-20 NR 23642732 | |
| 2 234668570 rs887829-T 2:234668570 Serum metabolite levels 1.00E-17 0.32 24625756 | |
| 2 234668570 rs887829-T 2:234668570 Serum metabolite levels 6.00E-13 0.34 24625756 | |
| 2 234669144 rs4148323-? 2:234669144 Bilirubin levels 3.00E-139 0.14 20639394 | |
| 2 234669144 rs4148323-? 2:234669144 Bilirubin levels 5.00E-69 0.11 23371916 | |
| 2 234669144 rs4148323-? 2:234669144 Bilirubin levels 2.00E-62 0.12 23371916 | |
| 2 234669144 rs4148323-? 2:234669144 Bilirubin levels 7.00E-30 0.09 23371916 | |
| 2 234672639 rs6742078-? 2:234672639 Bilirubin levels 1.00E-158 0.18 20639394 | |
| 2 234672639 rs6742078-? 2:234672639 Bilirubin levels 1.00E-89 0.15 23371916 | |
| 2 234672639 rs6742078-? 2:234672639 Bilirubin levels 2.00E-78 0.17 23371916 | |
| 2 234672639 rs6742078-? 2:234672639 Bilirubin levels 6.00E-40 0.13 23371916 | |
| 2 234672639 rs6742078-T 2:234672639 Circulating cell-free DNA 2.00E-23 0.34 22511988 | |
| 2 234672722 rs4148324-T 2:234672722 Blood metabolite levels 5.00E-117 0.11 24816252 | |
| 2 234672722 rs4148324-T 2:234672722 Blood metabolite levels 2.00E-116 0.11 24816252 | |
| 2 234673309 rs4148325-? 2:234673309 Bilirubin levels 5.00E-62 0.17 21646302 | |
| 2 234679384 rs11563251-T 2:234679384 "Cholesterol, total" 1.00E-09 0.04 24097068 | |
| 2 234679384 rs11563251-T 2:234679384 LDL cholesterol 5.00E-08 0.03 24097068 | |
| 2 234698790 rs2361502-? 2:234698790 Bilirubin levels 7.00E-23 0.1 21646302 | |
| 2 234818869 rs7577262-A 2:234818869 Blood pressure measurement (cold pressor test) 3.00E-08 1.71 24165912 | |
| 2 234825093 rs10166942-? 2:234825093 Migraine 1.00E-12 1.28 22683712 | |
| 2 234825093 rs10166942-T 2:234825093 Migraine 6.00E-12 1.18 21666692 | |
| 2 234827661 rs6741751-? 2:234827661 Migraine 9.00E-14 1.15 23793025 | |
| 2 234827661 rs6741751-? 2:234827661 Migraine without aura 9.00E-11 1.25 23793025 | |
| 2 234827661 rs6741751-? 2:234827661 Migraine - clinic-based 1.00E-08 1.27 23793025 | |
| 2 235302810 rs11887188-T 2:235302810 Blood pressure measurement (high sodium and potassium intervention) 2.00E-08 3.28 24165912 | |
| 2 237058144 rs11687170-T 2:237058144 Educational attainment 3.00E-08 0.11 23722424 | |
| 2 237105518 rs13401104-? 2:237105518 Educational attainment 5.00E-09 1.1 23722424 | |
| 2 238387228 rs7584330-C 2:238387228 Prostate cancer 3.00E-09 1.06 21743467 | |
| 2 238443226 rs2292884-G 2:238443226 Prostate cancer 4.00E-08 1.14 21743057 | |
| 2 239095422 rs12472274-? 2:239095422 Phospholipid levels (plasma) 2.00E-08 0.8 22359512 | |
| 2 239306268 rs3739070-A 2:239306268 Iris characteristics 2.00E-12 0.25 21835309 | |
| 2 239694631 rs9287638-A 2:239694631 Male-pattern baldness 1.00E-12 1.31 22693459 | |
| 2 239877148 rs12477314-T 2:239877148 Pulmonary function 2.00E-12 0.04 21946350 | |
| 2 240900121 rs13424612-? 2:240900121 Odorant perception (isobutyraldehyde) 6.00E-10 6.62 23910658 | |
| 2 241495013 rs4305276-G 2:241495013 Mean platelet volume 2.00E-11 0.01 22139419 | |
| 2 241563739 rs4676410-A 2:241563739 Sclerosing cholangitis and ulcerative colitis (combined) 2.00E-09 1.38 22821403 | |
| 2 241569692 rs3749171-T 2:241569692 Inflammatory bowel disease 3.00E-21 1.14 23128233 | |
| 2 241579108 rs4676406-T 2:241579108 Ulcerative colitis 8.00E-11 1.14 21297633 | |
| 2 241819796 rs4675874-A 2:241819796 Blood metabolite levels 3.00E-20 0.02 24816252 | |
| 2 242262986 rs12694997-A 2:242262986 Height 1.00E-08 0.02 20881960 | |
| 2 242296449 rs1476698-A 2:242296449 Fibrinogen 2.00E-09 0.01 23969696 | |
| 2 242382864 rs3771570-A 2:242382864 Prostate cancer 5.00E-09 1.12 23535732 | |
| 3 108993 rs9841287-? 3:108993 Fasting insulin-related traits (interaction with BMI) 7.00E-09 NR 22581228 | |
| 3 1897973 rs2727943-? 3:1897973 Bipolar disorder 3.00E-08 NR 22205951 | |
| 3 3055247 rs17024684-? 3:3055247 Brain connectivity 2.00E-09 NR 23471985 | |
| 3 3614887 rs9815663-T 3:3614887 Asthma (childhood onset) 2.00E-08 0.17 22560479 | |
| 3 3679852 rs17034687-C 3:3679852 Disc degeneration (lumbar) 2.00E-09 0.23 22993228 | |
| 3 4035443 rs4685724-? x rs9682918-? 3:4035443 Age-related hearing impairment (interaction) 1.00E-09 NR 24939585 | |
| 3 4742276 rs6762644-G 3:4742276 Breast cancer 2.00E-12 1.07 23535729 | |
| 3 11400249 rs2606736-C 3:11400249 HDL cholesterol 5.00E-08 0.03 24097068 | |
| 3 12267648 rs7616006-A 3:12267648 Platelet counts 5.00E-08 2 22139419 | |
| 3 12330411 rs17036170-? 3:12330411 Drug-induced liver injury 2.00E-08 11.3 22968431 | |
| 3 12393125 rs1801282-C 3:12393125 Type 2 diabetes 6.00E-10 1.16 24509480 | |
| 3 12628920 rs2290159-C 3:12628920 "Cholesterol, total" 2.00E-09 0.04 24097068 | |
| 3 12628920 rs2290159-C 3:12628920 "Cholesterol, total" 4.00E-09 1.42 20686565 | |
| 3 13555836 rs2597513-T 3:13555836 Height 7.00E-10 0.04 20881960 | |
| 3 13743132 rs9846232-? 3:13743132 Personality dimensions 1.00E-08 NR 21368711 | |
| 3 16625048 rs10510452-A 3:16625048 Testicular germ cell tumor 1.00E-08 1.24 23666240 | |
| 3 16955259 rs1372072-A 3:16955259 Primary biliary cirrhosis 2.00E-08 1.2 21399635 | |
| 3 17047032 rs4452313-T 3:17047032 Rheumatoid arthritis 5.00E-11 1.11 24390342 | |
| 3 17047032 rs4452313-T 3:17047032 Rheumatoid arthritis 2.00E-10 1.09 24390342 | |
| 3 17124384 rs4618210-G 3:17124384 Myocardial infarction 3.00E-09 1.1 24916648 | |
| 3 18311412 rs7641175-A 3:18311412 Platelet counts 3.00E-11 2.76 22139419 | |
| 3 18706858 rs13073817-A 3:18706858 Crohn's disease 7.00E-09 1.08 21102463 | |
| 3 18767404 rs4256159-T 3:18767404 Inflammatory bowel disease 9.00E-15 1.11 23128233 | |
| 3 23336450 rs7612463-C 3:23336450 Type 2 diabetes 7.00E-09 1.1 24509480 | |
| 3 24350811 rs9310736-A 3:24350811 Red blood cell traits 6.00E-16 0.21 23222517 | |
| 3 24350811 rs9310736-A 3:24350811 Mean corpuscular hemoglobin 4.00E-10 0.08 20139978 | |
| 3 24350811 rs9310736-A 3:24350811 Mean corpuscular volume 3.00E-08 0.07 20139978 | |
| 3 25520582 rs1529672-C 3:25520582 Pulmonary function 4.00E-14 0.05 21946350 | |
| 3 25520582 rs1529672-? 3:25520582 Pulmonary function (interaction) 7.00E-11 NR 23284291 | |
| 3 27343644 rs653465-? 3:27343644 Breast cancer (early onset) 5.00E-12 1.18 24493630 | |
| 3 27416013 rs4973768-T 3:27416013 Breast cancer 2.00E-30 1.1 23535729 | |
| 3 27416013 rs4973768-C 3:27416013 Breast cancer 2.00E-08 1.14 21263130 | |
| 3 27537909 rs13082711-T 3:27537909 Diastolic blood pressure 4.00E-09 0.24 21909115 | |
| 3 27537909 rs13082711-T 3:27537909 Blood pressure 5.00E-09 0.34 21909110 | |
| 3 27764623 rs3806624-G 3:27764623 Hodgkin's lymphoma 1.00E-12 1.26 24149102 | |
| 3 27764623 rs3806624-G 3:27764623 Rheumatoid arthritis 9.00E-09 1.08 24390342 | |
| 3 27764623 rs3806624-G 3:27764623 Rheumatoid arthritis 3.00E-08 1.08 24390342 | |
| 3 27788780 rs11129295-A 3:27788780 Multiple sclerosis 1.00E-09 1.11 21833088 | |
| 3 28071444 rs669607-C 3:28071444 Multiple sclerosis 2.00E-15 1.13 21833088 | |
| 3 28079085 rs170934-T 3:28079085 Multiple sclerosis 2.00E-08 1.17 22190364 | |
| 3 30462403 rs7640543-A 3:30462403 Migraine 1.00E-09 1.19 22683712 | |
| 3 30480085 rs6790925-T 3:30480085 Migraine - clinic-based 2.00E-08 1.15 23793025 | |
| 3 30682939 rs12493607-C 3:30682939 Breast cancer 2.00E-08 1.06 23535729 | |
| 3 30753573 rs6804368-A 3:30753573 Blood metabolite levels 8.00E-21 0.02 24816252 | |
| 3 32533010 rs7640978-T 3:32533010 LDL cholesterol 1.00E-08 0.04 24097068 | |
| 3 32533010 rs7640978-T 3:32533010 "Cholesterol, total" 2.00E-08 0.04 24097068 | |
| 3 32941852 rs7648704-G x rs4868644-T 3:32941852 Venous thromboembolism (gene x gene interaction) 1.00E-09 1.56 23509962 | |
| 3 33015469 rs13314993-C 3:33015469 Celiac disease 3.00E-09 1.13 20190752 | |
| 3 33065339 rs7613051-A 3:33065339 Atopic dermatitis 6.00E-21 1.29 23042114 | |
| 3 36856030 rs9834970-C 3:36856030 Bipolar disorder 1.00E-12 NR 22182935 | |
| 3 36856030 rs9834970-? 3:36856030 Schizophrenia or bipolar disorder 1.00E-10 NR 24280982 | |
| 3 36864489 rs6550435-G 3:36864489 Bipolar disorder 2.00E-08 1.13 24618891 | |
| 3 37515827 rs197770-? 3:37515827 Phospholipid levels (plasma) 2.00E-08 0.8 22359512 | |
| 3 37574024 rs267567-A 3:37574024 PR interval 4.00E-11 2.73 23139255 | |
| 3 37604012 rs9825420-? 3:37604012 Amyotrophic lateral sclerosis (sporadic) 3.00E-08 3.03 24529757 | |
| 3 38589163 rs11129795-A 3:38589163 QT interval 5.00E-14 1.27 19305409 | |
| 3 38589163 rs11129795-G 3:38589163 Electrocardiographic traits 5.00E-10 8.24 20062063 | |
| 3 38592406 rs1805126-A 3:38592406 Electrocardiographic conduction measures 3.00E-20 0.66 23463857 | |
| 3 38593393 rs12053903-C 3:38593393 QT interval 1.00E-14 1.23 19305408 | |
| 3 38624253 rs3922844-T 3:38624253 PR interval 5.00E-43 4.54 23139255 | |
| 3 38624253 rs3922844-C 3:38624253 PR interval 3.00E-23 5.11 21347284 | |
| 3 38633923 rs11708996-C 3:38633923 PR interval 6.00E-26 3.04 20062060 | |
| 3 38633923 rs11708996-C 3:38633923 QRS duration 1.00E-16 0.79 21076409 | |
| 3 38633923 rs11708996-C 3:38633923 Brugada syndrome 1.00E-14 1.73 23872634 | |
| 3 38657899 rs11710077-T 3:38657899 QRS duration 6.00E-22 0.84 21076409 | |
| 3 38681394 rs6763048-A 3:38681394 PR interval 4.00E-12 2.62 23139255 | |
| 3 38719935 rs9851724-C 3:38719935 QRS duration 2.00E-20 0.66 21076409 | |
| 3 38766675 rs6795970-A 3:38766675 Electrocardiographic traits 1.00E-58 14.81 20062063 | |
| 3 38766675 rs6795970-A 3:38766675 Electrocardiographic conduction measures 5.00E-27 0.75 23463857 | |
| 3 38766675 rs6795970-A 3:38766675 Electrocardiographic traits 3.00E-15 3.33 20062061 | |
| 3 38766675 rs6795970-A 3:38766675 Electrocardiographic traits 4.00E-09 5.17 20062063 | |
| 3 38767315 rs6801957-T 3:38767315 PR segment 7.00E-41 2.94 24850809 | |
| 3 38767315 rs6801957-T 3:38767315 QRS duration 1.00E-28 0.77 21076409 | |
| 3 38767315 rs6801957-T 3:38767315 P wave duration 8.00E-27 1.44 24850809 | |
| 3 38767315 rs6801957-T 3:38767315 PR interval 9.00E-09 3.36 23139255 | |
| 3 38774832 rs6800541-C 3:38774832 PR interval 2.00E-74 3.77 20062060 | |
| 3 38777554 rs10428132-T 3:38777554 Brugada syndrome 1.00E-68 2.55 23872634 | |
| 3 38882519 rs4453791-C 3:38882519 Social communication problems 9.00E-09 0.23 24564958 | |
| 3 39523003 rs1768208-? 3:39523003 Progressive supranuclear palsy 5.00E-17 1.37 21685912 | |
| 3 39555580 rs864643-? 3:39555580 Attention deficit hyperactivity disorder 1.00E-08 NR 18839057 | |
| 3 41128564 rs430727-T 3:41128564 Bone mineral density 4.00E-25 0.06 22504420 | |
| 3 41137672 rs87938-A 3:41137672 Bone mineral density (hip) 8.00E-10 0.07 19801982 | |
| 3 41786009 rs6599175-G 3:41786009 Multiple myeloma (hyperdiploidy) 1.00E-09 1.48 23502783 | |
| 3 41912651 rs9815354-A 3:41912651 Diastolic blood pressure 3.00E-09 0.49 19430479 | |
| 3 41925398 rs1052501-G 3:41925398 Multiple myeloma 2.00E-08 1.32 22120009 | |
| 3 41987920 rs1717027-T 3:41987920 Blood pressure 5.00E-13 0.49 23972371 | |
| 3 41996136 rs2272007-A 3:41996136 Multiple myeloma (hyperdiploidy) 2.00E-09 1.47 23502783 | |
| 3 45809329 rs4327428-A 3:45809329 Blood metabolite levels 3.00E-12 0.03 24816252 | |
| 3 45814094 rs17279437-A 3:45814094 Blood metabolite ratios 2.00E-35 0.09 24816252 | |
| 3 45814094 rs17279437-A 3:45814094 Blood metabolite levels 1.00E-20 0.06 24816252 | |
| 3 45814094 rs17279437-A 3:45814094 Urinary metabolites 3.00E-19 NR 21572414 | |
| 3 46205686 rs7616215-C 3:46205686 Behcet's disease 4.00E-13 1.39 23291587 | |
| 3 46235201 rs13098911-A 3:46235201 Celiac disease 3.00E-17 1.3 20190752 | |
| 3 46281744 rs13096142-? 3:46281744 Celiac disease 4.00E-08 1.3 24999842 | |
| 3 46282391 rs12636651-G 3:46282391 Obesity-related traits 7.00E-09 0.05 23251661 | |
| 3 46282391 rs12636651-? 3:46282391 Monocyte chemoattractant protein-1 7.00E-09 NR 23017229 | |
| 3 47061183 rs2290547-A 3:47061183 HDL cholesterol 4.00E-09 0.03 24097068 | |
| 3 47927484 rs319690-T 3:47927484 Blood pressure 3.00E-08 0.3 21909110 | |
| 3 49210732 rs7617480-A 3:49210732 Menarche (age at onset) 3.00E-08 2.4 21102462 | |
| 3 49701983 rs9858542-? 3:49701983 Ulcerative colitis 7.00E-09 NR 19915572 | |
| 3 49701983 rs9858542-A 3:49701983 Crohn's disease 4.00E-08 1.09 17554300 | |
| 3 49701983 rs9858542-? 3:49701983 Crohn's disease 5.00E-08 1.17 17554261 | |
| 3 49719729 rs9822268-A 3:49719729 Ulcerative colitis 2.00E-17 1.21 21297633 | |
| 3 49721532 rs3197999-A 3:49721532 Inflammatory bowel disease 1.00E-47 1.18 23128233 | |
| 3 49721532 rs3197999-A 3:49721532 Crohn's disease 6.00E-17 1.22 21102463 | |
| 3 49721532 rs3197999-? 3:49721532 Primary sclerosing cholangitis 1.00E-16 1.39 21151127 | |
| 3 49721532 rs3197999-A 3:49721532 Crohn's disease 1.00E-12 1.2 18587394 | |
| 3 49721532 rs3197999-T 3:49721532 Ulcerative colitis 4.00E-09 1.2 20228799 | |
| 3 50093209 rs6762477-G 3:50093209 Menarche (age at onset) 2.00E-08 2.5 21102462 | |
| 3 50129399 rs2013208-T 3:50129399 HDL cholesterol 9.00E-12 0.03 24097068 | |
| 3 51071713 rs13088462-T 3:51071713 Height 4.00E-10 0.05 20881960 | |
| 3 51917015 rs1605070-? 3:51917015 Amyotrophic lateral sclerosis (sporadic) 2.00E-09 3.95 24529757 | |
| 3 52279594 rs7618915-G 3:52279594 Bipolar disorder 3.00E-10 NR 22182935 | |
| 3 52506426 rs6784615-T 3:52506426 Waist-hip ratio 4.00E-10 0.04 20935629 | |
| 3 52532118 rs13326165-A 3:52532118 HDL cholesterol 9.00E-11 0.03 24097068 | |
| 3 52584787 rs2251219-? 3:52584787 Major mood disorders 2.00E-09 1.14 20081856 | |
| 3 52622086 rs2590838-G 3:52622086 Adiponectin levels 2.00E-13 0.03 22479202 | |
| 3 52720080 rs1108842-C 3:52720080 Adiponectin levels 1.00E-13 0.03 22479202 | |
| 3 52721305 rs11177-A 3:52721305 Osteoarthritis 5.00E-09 1.09 22763110 | |
| 3 52815905 rs2710323-? 3:52815905 "Schizophrenia, schizoaffective disorder or bipolar disorder" 3.00E-08 NR 24166486 | |
| 3 52833219 rs2535629-? 3:52833219 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 3.00E-12 1.1 23453885 | |
| 3 52838402 rs4687552-T 3:52838402 Schizophrenia 1.00E-08 1.09 23974872 | |
| 3 52844534 rs17331151-A 3:52844534 Immune reponse to smallpox (secreted IL-2) 2.00E-09 NR 22610502 | |
| 3 52859630 rs2535633-G 3:52859630 Body mass index 2.00E-10 0.03 24861553 | |
| 3 53062661 rs9847710-C 3:53062661 Ulcerative colitis 1.00E-08 1.06 23128233 | |
| 3 53100214 rs6770152-T 3:53100214 Urate levels 3.00E-16 0.04 23263486 | |
| 3 53118739 rs2336725-T 3:53118739 Height 1.00E-12 0.03 20881960 | |
| 3 53125585 rs2564921-T 3:53125585 Height 2.00E-12 1.15 23563607 | |
| 3 53147576 rs13088281-A 3:53147576 Immune reponse to smallpox (secreted IL-2) 3.00E-11 NR 22610502 | |
| 3 53282188 rs4687717-T 3:53282188 Blood metabolite ratios 9.00E-23 0.02 24816252 | |
| 3 53282188 rs4687717-T 3:53282188 Blood metabolite levels 1.00E-13 0.01 24816252 | |
| 3 53847408 rs14165-A 3:53847408 Refractive error 2.00E-08 0.1 23396134 | |
| 3 56667682 rs9835332-C 3:56667682 Height 5.00E-13 0.03 20881960 | |
| 3 56849749 rs1354034-T 3:56849749 Mean platelet volume 3.00E-69 0.02 22139419 | |
| 3 56849749 rs1354034-C 3:56849749 Platelet counts 3.00E-54 6.85 22139419 | |
| 3 56849749 rs1354034-C 3:56849749 Mean platelet volume 9.00E-34 0.19 24026423 | |
| 3 56849749 rs1354034-T 3:56849749 Platelet counts 6.00E-24 7.97 24026423 | |
| 3 56849749 rs1354034-T 3:56849749 Platelet counts 1.00E-19 10.44 23263863 | |
| 3 56849749 rs1354034-C 3:56849749 Platelet counts 9.00E-13 11.44 23263863 | |
| 3 56849749 rs1354034-T 3:56849749 Platelet counts 4.00E-09 9.44 23263863 | |
| 3 56865776 rs12485738-A 3:56865776 Mean platelet volume 6.00E-31 0.02 19820697 | |
| 3 56865776 rs12485738-A 3:56865776 Mean platelet volume 4.00E-27 0.02 19110211 | |
| 3 58302935 rs73081554-T 3:58302935 Rheumatoid arthritis 5.00E-08 1.18 24390342 | |
| 3 58331186 rs2176082-? 3:58331186 Systemic lupus erythematosus and Systemic sclerosis 5.00E-11 1.21 23740937 | |
| 3 58370177 rs6445975-C 3:58370177 Systemic lupus erythematosus 7.00E-09 1.25 18204446 | |
| 3 58381287 rs13315871-A 3:58381287 "Cholesterol, total" 4.00E-08 0.04 24097068 | |
| 3 58556841 rs13315591-C 3:58556841 Rheumatoid arthritis 5.00E-08 1.29 20453842 | |
| 3 64048297 rs831571-c 3:64048297 Type 2 diabetes 8.00E-11 1.09 22158537 | |
| 3 64705365 rs6795735-T 3:64705365 Age-related macular degeneration 5.00E-09 1.1 23455636 | |
| 3 64711904 rs4607103-C 3:64711904 Type 2 diabetes 1.00E-08 1.09 18372903 | |
| 3 66431602 rs2242285-A 3:66431602 QRS duration 1.00E-08 0.37 21076409 | |
| 3 66798950 rs13069000-G 3:66798950 Renal function-related traits (BUN) 1.00E-19 0.01 22797727 | |
| 3 66809942 rs13069049-T 3:66809942 Metabolite levels 3.00E-18 0.02 21909109 | |
| 3 66823157 rs11709625-A 3:66823157 Hematological and biochemical traits 1.00E-10 0.1 20139978 | |
| 3 67416322 rs17806888-T 3:67416322 Blood metabolite levels 7.00E-11 0.02 24816252 | |
| 3 67416322 rs17806888-T 3:67416322 Height 2.00E-09 0.04 20881960 | |
| 3 70928930 rs2687201-T 3:70928930 Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined) 5.00E-09 1.18 24121790 | |
| 3 72140532 rs6771316-A x rs10986432-C 3:72140532 Venous thromboembolism (gene x gene interaction) 5.00E-09 2.13 23509962 | |
| 3 72393141 rs9832740-G 3:72393141 Height 5.00E-13 1.15 23563607 | |
| 3 72437413 rs9863706-T 3:72437413 Height 4.00E-13 0.03 20881960 | |
| 3 80865764 rs9850224-A 3:80865764 Erectile dysfunction 5.00E-08 NR 22704111 | |
| 3 85884150 rs13078807-G 3:85884150 Obesity 3.00E-11 1.06 23563607 | |
| 3 85884150 rs13078807-G 3:85884150 Body mass index 4.00E-11 0.1 20935630 | |
| 3 86255672 rs7428796-? 3:86255672 Myopia (pathological) 2.00E-18 NR 23049088 | |
| 3 86850618 rs7628864-G 3:86850618 Pubertal anthropometrics 3.00E-09 0.11 23449627 | |
| 3 86916882 rs7642134-A 3:86916882 Menarche (age at onset) 4.00E-10 2.4 21102462 | |
| 3 87110674 rs2660753-T 3:87110674 Prostate cancer 3.00E-08 1.18 18264097 | |
| 3 87152169 rs9284813-? 3:87152169 Prostate cancer 5.00E-09 NR 20676098 | |
| 3 87173324 rs17181170-? 3:87173324 Prostate cancer 3.00E-08 NR 19767753 | |
| 3 87495550 rs9834692-? 3:87495550 Brain connectivity 3.00E-09 NR 23471985 | |
| 3 87525449 rs9883474-? 3:87525449 Brain connectivity 3.00E-09 NR 23471985 | |
| 3 89534377 rs7632427-T 3:89534377 Orofacial clefts 4.00E-08 1.37 22863734 | |
| 3 89534377 rs7632427-? 3:89534377 Orofacial clefts 4.00E-08 NR 22863734 | |
| 3 99481539 rs13081855-T 3:99481539 Age-related macular degeneration 4.00E-13 1.23 23455636 | |
| 3 99844293 rs9811920-A 3:99844293 Axial length 5.00E-11 0.08 24144296 | |
| 3 101748638 rs771767-A 3:101748638 Multiple sclerosis 9.00E-09 1.1 21833088 | |
| 3 104418573 rs2685056-? 3:104418573 Amyotrophic lateral sclerosis (sporadic) 4.00E-08 2.58 24529757 | |
| 3 105586714 rs9657904-T 3:105586714 Multiple sclerosis 2.00E-10 1.4 20453840 | |
| 3 109789570 rs10934011-G 3:109789570 DNA methylation (parent-of-origin) 1.00E-09 NR 23725790 | |
| 3 112376308 rs12634229-G 3:112376308 Atopic dermatitis 2.00E-19 1.29 23042114 | |
| 3 113275624 rs7611694-A 3:113275624 Prostate cancer 4.00E-13 1.1 23535732 | |
| 3 113370010 rs1026364-T 3:113370010 Bone mineral density 4.00E-10 0.03 22504420 | |
| 3 114362764 rs9841504-? 3:114362764 Gastric cancer 2.00E-09 1.32 22037551 | |
| 3 117574822 rs6438424-A 3:117574822 Menarche (age at onset) 1.00E-13 2.7 21102462 | |
| 3 119118796 rs11712165-C 3:119118796 Celiac disease 8.00E-09 1.13 20190752 | |
| 3 119147958 rs16829840-T 3:119147958 Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid) 3.00E-08 0.46 24823311 | |
| 3 119219934 rs2293370-G 3:119219934 Primary biliary cirrhosis 3.00E-11 1.35 21399635 | |
| 3 119219934 rs2293370-C 3:119219934 Primary biliary cirrhosis 3.00E-09 1.48 23000144 | |
| 3 119219934 rs2293370-G 3:119219934 Multiple sclerosis 3.00E-09 1.13 21833088 | |
| 3 119260944 rs6804441-A 3:119260944 Systemic lupus erythematosus 3.00E-16 1.27 23273568 | |
| 3 119288414 rs59374417-C 3:119288414 Vitiligo 4.00E-10 1.34 22561518 | |
| 3 119560606 rs6805251-T 3:119560606 HDL cholesterol 1.00E-08 0.02 24097068 | |
| 3 120585315 rs322458-G 3:120585315 Aging (facial) 2.00E-08 NR 23223146 | |
| 3 121660664 rs4285028-A 3:121660664 Multiple sclerosis 2.00E-08 1.1 21833088 | |
| 3 121796768 rs9282641-G 3:121796768 Multiple sclerosis 1.00E-11 1.21 21833088 | |
| 3 121993247 rs17251221-G 3:121993247 Calcium levels 2.00E-22 0.06 20705733 | |
| 3 122003757 rs1801725-T 3:122003757 Calcium levels 9.00E-86 0.07 24068962 | |
| 3 122003757 rs1801725-T 3:122003757 Calcium levels 6.00E-37 0 20661308 | |
| 3 122048644 rs17265703-G 3:122048644 Phosphorus levels 4.00E-09 0.04 20558539 | |
| 3 122839876 rs3792366-G 3:122839876 Platelet counts 4.00E-09 2.15 22139419 | |
| 3 123065778 rs11708067-A 3:123065778 Fasting glucose-related traits 7.00E-22 NR 20081858 | |
| 3 123065778 rs11708067-A 3:123065778 Fasting glucose-related traits 3.00E-12 NR 20081858 | |
| 3 123065778 rs11708067-? 3:123065778 Fasting glucose-related traits (interaction with BMI) 3.00E-10 NR 22581228 | |
| 3 123082398 rs11717195-T 3:123082398 Type 2 diabetes 2.00E-08 1.09 24509480 | |
| 3 123094451 rs2877716-C 3:123094451 Two-hour glucose challenge 7.00E-16 0.09 20081857 | |
| 3 123096820 rs9883204-C 3:123096820 Birth weight 6.00E-20 0.06 23202124 | |
| 3 123096820 rs9883204-C 3:123096820 Birth weight 7.00E-15 0.06 20372150 | |
| 3 124300257 rs2010099-C 3:124300257 Thyroid peroxidase antibody levels 3.00E-08 0.02 24586183 | |
| 3 124340222 rs10512627-C 3:124340222 Mean platelet volume 5.00E-10 0.01 22139419 | |
| 3 124692689 rs2270778-? x rs300238-? 3:124692689 Age-related hearing impairment (interaction) 7.00E-09 NR 24939585 | |
| 3 125906179 rs10934753-A 3:125906179 Plasma homocysteine levels (post-methionine load test) 7.00E-13 0.19 24651765 | |
| 3 127474030 rs664910-G x rs877228-A 3:127474030 Venous thromboembolism (gene x gene interaction) 7.00E-09 1.5 23509962 | |
| 3 128038373 rs10934853-A 3:128038373 Prostate cancer 3.00E-10 1.12 19767754 | |
| 3 128260550 rs4857855-T 3:128260550 Eosinophil counts 9.00E-17 9.4 19198610 | |
| 3 128297569 rs9880192-C 3:128297569 White blood cell count 6.00E-13 0.03 21738480 | |
| 3 128316435 rs4328821-A 3:128316435 White blood cell types 5.00E-40 0.16 21738478 | |
| 3 128316435 rs4328821-A 3:128316435 White blood cell types 3.00E-17 0.1 21738478 | |
| 3 128316435 rs4328821-A 3:128316435 White blood cell count 4.00E-13 0.01 21738480 | |
| 3 128338600 rs2712381-A 3:128338600 Monocyte count 2.00E-16 0.23 23314186 | |
| 3 129050756 rs6439167-T 3:129050756 Height 9.00E-15 0.03 20881960 | |
| 3 130137471 rs1542829-? 3:130137471 Body mass index 1.00E-08 5.89 24348519 | |
| 3 132163200 rs17404153-T 3:132163200 LDL cholesterol 2.00E-09 0.03 24097068 | |
| 3 132163200 rs17404153-T 3:132163200 HDL cholesterol 5.00E-09 0.03 24097068 | |
| 3 132610752 rs6439371-G 3:132610752 Menarche (age at onset) 1.00E-08 2.3 21102462 | |
| 3 133475812 rs1799899-A 3:133475812 Alcohol consumption (transferrin glycosylation) 1.00E-09 0.4 21665994 | |
| 3 133484029 rs3811647-A 3:133484029 Iron levels 3.00E-47 15.34 21208937 | |
| 3 133484029 rs3811647-A 3:133484029 Alcohol consumption (transferrin glycosylation) 1.00E-35 0.36 21665994 | |
| 3 133484029 rs3811647-? 3:133484029 Hepcidin levels 2.00E-16 0.34 21785125 | |
| 3 133484029 rs3811647-? 3:133484029 Iron status biomarkers 3.00E-15 0.46 19084217 | |
| 3 133484029 rs3811647-A 3:133484029 Iron status biomarkers 5.00E-10 21.49 21483845 | |
| 3 133494354 rs1049296-T 3:133494354 Alcohol consumption (transferrin glycosylation) 5.00E-43 0.29 21665994 | |
| 3 133508464 rs1830084-A 3:133508464 Iron status biomarkers 1.00E-09 0.43 19084217 | |
| 3 133537067 rs1534166-A 3:133537067 Alcohol consumption (transferrin glycosylation) 2.00E-17 0.29 21665994 | |
| 3 135925191 rs1154988-A 3:135925191 Fibrinogen 1.00E-16 0.01 23969696 | |
| 3 135926622 rs645040-G 3:135926622 Triglycerides 2.00E-12 0.03 24097068 | |
| 3 135926622 rs645040-G 3:135926622 Triglycerides 3.00E-08 2.22 20686565 | |
| 3 135950921 rs511154-A 3:135950921 Fibrinogen 6.00E-10 0.05 20031576 | |
| 3 135974216 rs9844666-A 3:135974216 Height 4.00E-09 0.02 20881960 | |
| 3 136402060 rs9826828-A 3:136402060 Rheumatoid arthritis 9.00E-10 1.44 24390342 | |
| 3 138119952 rs2306374-C 3:138119952 Coronary heart disease 3.00E-08 1.12 21378990 | |
| 3 138122122 rs9818870-T 3:138122122 Coronary heart disease 7.00E-13 1.15 19198612 | |
| 3 138713704 rs1511412-A 3:138713704 Keloid 2.00E-13 1.87 20711176 | |
| 3 138903985 rs7638110-? 3:138903985 Obesity and blood pressure 5.00E-08 NR 22013104 | |
| 3 140370012 rs72977016-? 3:140370012 Bipolar disorder (body mass index interaction) 7.00E-09 NR 24322204 | |
| 3 140417446 rs79436609-? 3:140417446 Bipolar disorder (body mass index interaction) 3.00E-08 NR 24322204 | |
| 3 141094209 rs6440003-A 3:141094209 Height 2.00E-24 0.07 18391952 | |
| 3 141094209 rs6440003-A 3:141094209 Height 2.00E-10 0.07 21998595 | |
| 3 141102833 rs6763931-A 3:141102833 Height 1.00E-27 7.4 18391951 | |
| 3 141102833 rs6763931-? 3:141102833 Height 3.00E-12 0.07 19343178 | |
| 3 141102833 rs6763931-T 3:141102833 Prostate cancer 2.00E-08 1.04 21743467 | |
| 3 141105570 rs724016-A 3:141105570 Height 3.00E-86 0.07 20881960 | |
| 3 141105570 rs724016-G 3:141105570 Height 8.00E-22 0.37 18391950 | |
| 3 141133450 rs1991431-A 3:141133450 Height 4.00E-47 1.33 23563607 | |
| 3 141137035 rs9825379-A 3:141137035 Height 6.00E-09 0.07 20189936 | |
| 3 141143430 rs10513137-A 3:141143430 Height 6.00E-12 0.46 19396169 | |
| 3 141266493 rs6776003-A 3:141266493 Red blood cell traits 4.00E-11 0.14 23222517 | |
| 3 141463298 rs16851720-C 3:141463298 Hepatitis C induced liver fibrosis 9.00E-09 NR 22841784 | |
| 3 141807137 rs347685-C 3:141807137 Chronic kidney disease 3.00E-11 1.09 20383146 | |
| 3 142649110 rs9832727-? 3:142649110 Phospholipid levels (plasma) 6.00E-29 0 22359512 | |
| 3 143902027 rs4839680-? 3:143902027 Myopia (pathological) 1.00E-15 NR 23049088 | |
| 3 148913126 rs13072552-T 3:148913126 Serum ceruloplasmin levels 2.00E-11 1.5 22075249 | |
| 3 151830309 rs11712066-A 3:151830309 Infantile hypertrophic pyloric stenosis 3.00E-21 1.55 23989729 | |
| 3 151830309 rs11712066-A 3:151830309 Infantile hypertrophic pyloric stenosis 2.00E-17 1.61 22306654 | |
| 3 152643911 rs16864714-? x rs197167-? 3:152643911 Age-related hearing impairment (interaction) 2.00E-09 NR 24939585 | |
| 3 153184656 rs6778194-C 3:153184656 Immune reponse to smallpox (secreted IFN-alpha) 2.00E-09 NR 22610502 | |
| 3 153472163 rs573872-G 3:153472163 Infantile hypertrophic pyloric stenosis 5.00E-14 1.37 23989729 | |
| 3 153472163 rs573872-G 3:153472163 Infantile hypertrophic pyloric stenosis 4.00E-12 1.41 22306654 | |
| 3 156105084 rs7615568-G 3:156105084 Age-related nuclear cataracts 1.00E-08 0.11 24951543 | |
| 3 156406997 rs7651446-? 3:156406997 Ovarian cancer 2.00E-34 1.59 23535730 | |
| 3 156406997 rs7651446-? 3:156406997 Ovarian cancer 2.00E-29 1.44 23535730 | |
| 3 156470955 rs13068223-? x rs884272-? 3:156470955 Age-related hearing impairment (interaction) 5.00E-09 NR 24939585 | |
| 3 156555984 rs344081-T 3:156555984 Bone mineral density 4.00E-12 0.06 22504420 | |
| 3 156798473 rs1482853-C 3:156798473 Adiposity in newborns 6.00E-21 0.06 23575227 | |
| 3 156798473 rs1482853-C 3:156798473 Adiposity in newborns 3.00E-13 0.47 23575227 | |
| 3 156798775 rs900400-C 3:156798775 Birth weight 4.00E-38 0.07 23202124 | |
| 3 156798775 rs900400-C 3:156798775 Birth weight 2.00E-35 0.09 20372150 | |
| 3 158109379 rs2362965-T 3:158109379 Height 2.00E-09 1.12 23563607 | |
| 3 159665050 rs17810546-G 3:159665050 Celiac disease 4.00E-28 1.36 20190752 | |
| 3 159665050 rs17810546-G 3:159665050 Celiac disease 1.00E-09 1.35 18311140 | |
| 3 159728878 rs6441286-G 3:159728878 Primary biliary cirrhosis 2.00E-14 1.54 19458352 | |
| 3 159728878 rs6441286-G 3:159728878 Primary biliary cirrhosis 8.00E-12 1.44 20639880 | |
| 3 159745863 rs485499-T 3:159745863 Primary biliary cirrhosis 2.00E-16 1.38 21399635 | |
| 3 163737250 rs16833934-G 3:163737250 Blood pressure 1.00E-08 1.63 24954895 | |
| 3 164589939 rs2168784-T 3:164589939 Alcohol dependence (age at onset) 5.00E-09 1.46 24962325 | |
| 3 165480100 rs6445035-A 3:165480100 Aspirin hydrolysis (plasma) 9.00E-17 NR 23508960 | |
| 3 165491280 rs1803274-T 3:165491280 Butyrylcholinesterase levels 6.00E-262 0.71 21862451 | |
| 3 165491280 rs1803274-T 3:165491280 Cardiovascular disease risk factors 6.00E-92 0.37 21943158 | |
| 3 166014469 rs509208-G 3:166014469 Alzheimer's disease biomarkers 3.00E-08 NR 23419831 | |
| 3 168971231 rs784288-A 3:168971231 Osteoporosis 4.00E-08 1.39 23349225 | |
| 3 169082633 rs6774494-? 3:169082633 Nasopharyngeal carcinoma 1.00E-08 1.19 20512145 | |
| 3 169100886 rs419076-T 3:169100886 Systolic blood pressure 2.00E-13 0.41 21909115 | |
| 3 169100886 rs419076-T 3:169100886 Blood pressure 8.00E-13 0.34 21909110 | |
| 3 169100886 rs419076-T 3:169100886 Diastolic blood pressure 2.00E-12 0.24 21909115 | |
| 3 169100899 rs448378-G 3:169100899 Magnesium levels 1.00E-08 0 20700443 | |
| 3 169150632 rs16853722-C 3:169150632 Renal function-related traits (BUN) 3.00E-14 0.01 22797727 | |
| 3 169300219 rs1344555-T 3:169300219 Pulmonary function 3.00E-08 0.03 21946350 | |
| 3 169481271 rs12696304-G 3:169481271 Telomere length 2.00E-14 0.03 21573004 | |
| 3 169481271 rs12696304-G 3:169481271 Telomere length 4.00E-14 0.11 20139977 | |
| 3 169492101 rs10936599-T 3:169492101 Telomere length 3.00E-31 0.1 23535734 | |
| 3 169492101 rs10936599-G 3:169492101 Multiple myeloma 9.00E-14 1.26 23955597 | |
| 3 169492101 rs10936599-C 3:169492101 Chronic lymphocytic leukemia 2.00E-09 1.26 24292274 | |
| 3 169492101 rs10936599-C 3:169492101 Bladder cancer 5.00E-09 1.18 24163127 | |
| 3 169492101 rs10936599-C 3:169492101 Colorectal cancer 3.00E-08 1.04 20972440 | |
| 3 169497585 rs1317082-G 3:169497585 Telomere length 1.00E-08 0.07 23001564 | |
| 3 169518455 rs6793295-C 3:169518455 Interstitial lung disease 8.00E-13 1.3 23583980 | |
| 3 169528449 rs10936601-? 3:169528449 Telomere length 4.00E-15 0 23900074 | |
| 3 169579971 rs1920116-G 3:169579971 Glioma (high-grade) 8.00E-09 1.3 24908248 | |
| 3 170130102 rs10936632-A 3:170130102 Prostate cancer 7.00E-22 1.11 21743467 | |
| 3 170717521 rs11920090-T 3:170717521 Fasting glucose-related traits 8.00E-13 NR 20081858 | |
| 3 170717521 rs11920090-? 3:170717521 Fasting glucose-related traits (interaction with BMI) 8.00E-11 NR 22581228 | |
| 3 170725542 rs10513686-A 3:170725542 Liver enzyme levels (gamma-glutamyl transferase) 6.00E-11 4.9 22001757 | |
| 3 171785168 rs9647379-C 3:171785168 Heart rate 1.00E-09 0.21 23583979 | |
| 3 171926373 rs4535251-T 3:171926373 Height 4.00E-16 1.18 23563607 | |
| 3 171969077 rs7652177-? 3:171969077 Height 7.00E-11 NR 20881960 | |
| 3 172165727 rs572169-T 3:172165727 Height 3.00E-18 0.03 20881960 | |
| 3 172165727 rs572169-T 3:172165727 Height 1.00E-12 1.17 23563607 | |
| 3 173453868 rs1488564-? x rs2961030-? 3:173453868 Age-related hearing impairment (interaction) 8.00E-09 NR 24939585 | |
| 3 175075109 rs6771725-T x rs10507246-T 3:175075109 Venous thromboembolism (gene x gene interaction) 9.00E-09 2.22 23509962 | |
| 3 177304298 rs7620503-T 3:177304298 Corneal structure 1.00E-08 0.06 23291589 | |
| 3 179172979 rs7612445-G 3:179172979 Heart rate 2.00E-14 0.36 23583979 | |
| 3 179664102 rs9842133-T 3:179664102 Blood metabolite levels 4.00E-12 0.01 24816252 | |
| 3 182755209 rs2270968-T 3:182755209 Blood metabolite levels 1.00E-16 0.03 24816252 | |
| 3 182760073 rs10513789-T 3:182760073 Parkinson's disease 3.00E-10 1.25 21738487 | |
| 3 182821275 rs11711441-G 3:182821275 Parkinson's disease 8.00E-12 1.19 21292315 | |
| 3 183678342 rs1401999-C 3:183678342 Anterior chamber depth 8.00E-09 0.05 24603532 | |
| 3 184090266 rs6141-T 3:184090266 Platelet counts 5.00E-11 0.08 20139978 | |
| 3 185511687 rs4402960-T 3:185511687 Type 2 diabetes 1.00E-17 1.13 24509480 | |
| 3 185511687 rs4402960-T 3:185511687 Type 2 diabetes 9.00E-16 1.14 17463248 | |
| 3 185511687 rs4402960-T 3:185511687 Type 2 diabetes 9.00E-16 1.14 17463249 | |
| 3 185511687 rs4402960-T 3:185511687 Type 2 diabetes 2.00E-09 1.17 17463246 | |
| 3 185511687 rs4402960-T 3:185511687 Type 2 diabetes 3.00E-09 1.15 22693455 | |
| 3 185529080 rs1470579-C 3:185529080 Type 2 diabetes 2.00E-19 1.08 23300278 | |
| 3 185529080 rs1470579-C 3:185529080 Type 2 diabetes 5.00E-14 1.19 23945395 | |
| 3 185529080 rs1470579-C 3:185529080 Type 2 diabetes 2.00E-13 1.06 23300278 | |
| 3 185529080 rs1470579-C 3:185529080 Type 2 diabetes 2.00E-09 1.14 20581827 | |
| 3 185529080 rs1470579-C 3:185529080 Type 2 diabetes 4.00E-09 1.06 23300278 | |
| 3 185530290 rs6769511-C 3:185530290 Type 2 diabetes 1.00E-09 1.23 18711366 | |
| 3 185548683 rs720390-A 3:185548683 Height 2.00E-14 0.03 20881960 | |
| 3 185629568 rs2002675-G 3:185629568 Menarche (age at onset) 1.00E-09 2.2 21102462 | |
| 3 185824004 rs1516725-C 3:185824004 Obesity 3.00E-09 1.15 23563607 | |
| 3 185824004 rs1516725-C 3:185824004 Body mass index 4.00E-08 1.21 23563607 | |
| 3 185834290 rs7647305-C 3:185834290 Body mass index 7.00E-11 4.42 19079260 | |
| 3 185834290 rs7647305-C 3:185834290 Weight 4.00E-09 4 19079260 | |
| 3 185834499 rs9816226-T 3:185834499 Body mass index 2.00E-18 0.14 20935630 | |
| 3 185834499 rs9816226-T 3:185834499 Obesity 2.00E-14 1.07 23563607 | |
| 3 185834499 rs9816226-T 3:185834499 Obesity 2.00E-13 1.1 23563607 | |
| 3 186220063 rs1868152-A 3:186220063 Illicit drug use 5.00E-08 15.68 23942779 | |
| 3 186390627 rs9898-C 3:186390627 Activated partial thromboplastin time 1.00E-111 1 22703881 | |
| 3 186390627 rs9898-T 3:186390627 Activated partial thromboplastin time 1.00E-11 0.26 20303064 | |
| 3 186433099 rs11924390-C 3:186433099 Adiponectin levels 2.00E-09 0.06 20876611 | |
| 3 186454180 rs5030062-A 3:186454180 Blood metabolite levels 6.00E-13 0.07 24816252 | |
| 3 186459927 rs710446-C 3:186459927 Activated partial thromboplastin time 2.00E-203 1.18 22703881 | |
| 3 186459927 rs710446-G 3:186459927 Activated partial thromboplastin time 1.00E-21 0.36 20303064 | |
| 3 186466252 rs1656966-? 3:186466252 Myopia (pathological) 4.00E-21 NR 23049088 | |
| 3 186480206 rs822354-A 3:186480206 Adiponectin levels 4.00E-08 NR 21700879 | |
| 3 186530484 rs266717-C 3:186530484 Adiponectin levels 9.00E-19 1.07 20011104 | |
| 3 186548565 rs6810075-T 3:186548565 Adiponectin levels 2.00E-42 0.06 22479202 | |
| 3 186549695 rs10937273-A 3:186549695 Adiponectin levels 2.00E-22 0.12 24105470 | |
| 3 186551711 rs1648707-C 3:186551711 Adiponectin levels 3.00E-12 0.94 20011104 | |
| 3 186554292 rs864265-G 3:186554292 Adiponectin levels 1.00E-19 0.13 20876611 | |
| 3 186560782 rs182052-G 3:186560782 Adiponectin levels 5.00E-44 0.06 22479202 | |
| 3 186570453 rs17366568-G 3:186570453 Adiponectin levels 1.00E-41 0.13 20018283 | |
| 3 186573705 rs6773957-A 3:186573705 Adiponectin levels 5.00E-08 NR 19165155 | |
| 3 186650790 rs10937275-? 3:186650790 Drug-induced liver injury (flucloxacillin) 1.00E-08 4.1 19483685 | |
| 3 186666461 rs16861329-G 3:186666461 Type 2 diabetes 3.00E-08 1.09 21874001 | |
| 3 186722944 rs7652995-G 3:186722944 IgG glycosylation 3.00E-40 0.58 23382691 | |
| 3 186722944 rs7652995-G 3:186722944 IgG glycosylation 2.00E-20 0.4 23382691 | |
| 3 186722944 rs7652995-G 3:186722944 IgG glycosylation 5.00E-19 0.39 23382691 | |
| 3 186722944 rs7652995-G 3:186722944 IgG glycosylation 7.00E-17 0.37 23382691 | |
| 3 186722944 rs7652995-G 3:186722944 IgG glycosylation 4.00E-16 0.35 23382691 | |
| 3 186722944 rs7652995-G 3:186722944 IgG glycosylation 9.00E-15 0.34 23382691 | |
| 3 186722944 rs7652995-G 3:186722944 IgG glycosylation 5.00E-08 0.24 23382691 | |
| 3 186722944 rs7652995-G 3:186722944 IgG glycosylation 5.00E-08 0.24 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 6.00E-75 0.64 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 2.00E-45 0.5 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 5.00E-44 0.49 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 3.00E-37 0.45 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 9.00E-37 0.44 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 4.00E-31 0.4 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 5.00E-17 0.29 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 6.00E-17 0.29 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 8.00E-17 0.29 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 2.00E-13 0.26 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 6.00E-11 0.23 23382691 | |
| 3 186725887 rs11710456-G 3:186725887 IgG glycosylation 1.00E-08 0.2 23382691 | |
| 3 186793242 rs2239612-T 3:186793242 Esophageal cancer (squamous cell) 6.00E-14 1.21 22960999 | |
| 3 187649419 rs6773854-C 3:187649419 B cell non-Hodgkin lymphoma 3.00E-13 1.44 23749188 | |
| 3 187687074 rs9820070-C 3:187687074 Hematological and biochemical traits 1.00E-11 0.09 20139978 | |
| 3 187713718 rs10937329-T 3:187713718 Renal function-related traits (BUN) 9.00E-30 0.01 22797727 | |
| 3 187717540 rs4686914-T 3:187717540 Metabolite levels 3.00E-21 0.02 21909109 | |
| 3 187740523 rs6808574-C 3:187740523 Type 2 diabetes 6.00E-09 1.07 24509480 | |
| 3 188072513 rs9865818-G 3:188072513 Allergic sensitization 3.00E-10 1.12 23817571 | |
| 3 188112554 rs1464510-A 3:188112554 Celiac disease 3.00E-40 1.29 20190752 | |
| 3 188112554 rs1464510-T 3:188112554 Vitiligo 1.00E-11 1.31 20410501 | |
| 3 188112554 rs1464510-A 3:188112554 Celiac disease 5.00E-09 1.23 18311140 | |
| 3 188128979 rs9860547-A 3:188128979 Self-reported allergy 1.00E-09 0.07 23817569 | |
| 3 189356261 rs4488809-C 3:189356261 Lung cancer 7.00E-26 1.26 21725308 | |
| 3 189356261 rs4488809-C 3:189356261 Lung cancer 4.00E-09 1.19 23143601 | |
| 3 189357602 rs13314271-T 3:189357602 Lung cancer 7.00E-10 1.13 24880342 | |
| 3 189383183 rs10937405-C 3:189383183 Lung adenocarcinoma 7.00E-17 1.25 22797724 | |
| 3 189383183 rs10937405-C 3:189383183 Lung adenocarcinoma 7.00E-12 1.31 20871597 | |
| 3 189401776 rs17505102-? 3:189401776 Acute lymphoblastic leukemia (childhood) 9.00E-09 NR 22076464 | |
| 3 189401776 rs17505102-? 3:189401776 Acute lymphoblastic leukemia (childhood) 2.00E-08 1.47 22076464 | |
| 3 189645933 rs710521-A 3:189645933 Bladder cancer 2.00E-11 1.14 24163127 | |
| 3 189645933 rs710521-A 3:189645933 Bladder cancer 2.00E-10 1.18 20972438 | |
| 3 190669518 rs9877502-A 3:190669518 Alzheimer's disease biomarkers 5.00E-09 0.05 23562540 | |
| 3 190981868 rs7637404-? x rs12457810-? 3:190981868 Age-related hearing impairment (interaction) 1.00E-09 NR 24939585 | |
| 3 194858374 rs2131877-G 3:194858374 Non-small cell lung cancer 2.00E-08 1.3 20876614 | |
| 3 195800547 rs9859260-C 3:195800547 Mean corpuscular volume 8.00E-14 0 19862010 | |
| 3 195809139 rs11915082-A 3:195809139 Mean corpuscular hemoglobin 8.00E-13 0 19862010 | |
| 3 195834357 rs11717368-C 3:195834357 Red blood cell traits 7.00E-19 0.01 23222517 | |
| 3 195907653 rs4916483-C 3:195907653 Mean corpuscular hemoglobin 4.00E-11 0.08 20139978 | |
| 3 195907653 rs4916483-C 3:195907653 Mean corpuscular volume 2.00E-08 0.07 20139978 | |
| 3 195941216 rs7642243-C 3:195941216 Blood metabolite levels 8.00E-16 0.05 24816252 | |
| 4 858332 rs11248051-T 4:858332 Parkinson's disease 3.00E-09 1.46 20711177 | |
| 4 939087 rs6599388-T 4:939087 Parkinson's disease 4.00E-12 1.16 21292315 | |
| 4 939113 rs6599389-A 4:939113 Parkinson's disease 4.00E-08 1.31 21738487 | |
| 4 964359 rs11248060-? 4:964359 Parkinson's disease 3.00E-12 1.21 22438815 | |
| 4 964359 rs11248060-? 4:964359 Parkinson's disease 3.00E-09 1.26 22451204 | |
| 4 994414 rs3755955-A 4:994414 Bone mineral density 5.00E-15 0.06 22504420 | |
| 4 999445 rs6827815-? 4:999445 Bone mineral density 5.00E-12 NR 24249740 | |
| 4 1078187 rs1670533-C 4:1078187 Recombination rate (females) 2.00E-12 88.2 18239089 | |
| 4 1095281 rs3796619-T 4:1095281 Recombination rate (males) 3.00E-24 70.7 18239089 | |
| 4 1254535 rs7656416-? 4:1254535 Type 2 diabetes 1.00E-08 1.15 22456796 | |
| 4 1309901 rs6815464-C 4:1309901 Type 2 diabetes 2.00E-20 1.13 22158537 | |
| 4 1701317 rs2247341-A 4:1701317 Height 2.00E-11 0.03 20881960 | |
| 4 1734239 rs798766-T 4:1734239 Bladder cancer 7.00E-25 1.22 24163127 | |
| 4 1734239 rs798766-T 4:1734239 Bladder cancer 4.00E-13 1.2 20972438 | |
| 4 1734239 rs798766-T 4:1734239 Urinary bladder cancer 1.00E-11 1.24 20348956 | |
| 4 3449652 rs16844401-A 4:3449652 Fibrinogen 2.00E-08 0.02 23969696 | |
| 4 3473139 rs6831256-G 4:3473139 Triglycerides 2.00E-12 0.03 24097068 | |
| 4 3473139 rs6831256-G 4:3473139 "Cholesterol, total" 1.00E-10 0.03 24097068 | |
| 4 3473139 rs6831256-G 4:3473139 LDL cholesterol 2.00E-08 0.02 24097068 | |
| 4 4648047 rs870142-A 4:4648047 Congenital heart disease 3.00E-10 1.46 23708191 | |
| 4 4654357 rs2063413-? x rs877549-? 4:4654357 Age-related hearing impairment (interaction) 5.00E-09 NR 24939585 | |
| 4 6270056 rs4689388-T 4:6270056 Type 2 diabetes and other traits 1.00E-08 1.16 19734900 | |
| 4 6289986 rs4458523-G 4:6289986 Type 2 diabetes 2.00E-09 1.09 24509480 | |
| 4 6303022 rs1801214-T 4:6303022 Type 2 diabetes 3.00E-08 1.13 20581827 | |
| 4 6891519 rs11734132-G 4:6891519 Mean platelet volume 1.00E-11 0.01 22139419 | |
| 4 7219933 rs4234798-T 4:7219933 Insulin-like growth factors 5.00E-10 NR 21216879 | |
| 4 9915741 rs11722228-T 4:9915741 Serum uric acid levels 9.00E-31 0.04 24513273 | |
| 4 9915741 rs11722228-T 4:9915741 Urate levels 7.00E-24 0.16 20139978 | |
| 4 9922167 rs16890979-T 4:9922167 Urate levels 7.00E-168 0.34 18834626 | |
| 4 9922167 rs16890979-? 4:9922167 Uric acid levels 1.00E-11 0.44 18759275 | |
| 4 9923004 rs734553-T 4:9923004 Uric acid levels 1.00E-192 0.4 19503597 | |
| 4 9923004 rs734553-T 4:9923004 Serum uric acid levels 1.00E-80 0.24 21983786 | |
| 4 9923004 rs734553-T 4:9923004 Uric acid levels 1.00E-41 0.22 19503597 | |
| 4 9924319 rs6832439-A 4:9924319 Serum uric acid levels 3.00E-08 NR 24379826 | |
| 4 9925692 rs938554-C 4:9925692 Blood metabolite levels 6.00E-93 0.04 24816252 | |
| 4 9926967 rs13129697-G 4:9926967 Urate levels 2.00E-242 22.21 20884846 | |
| 4 9926967 rs13129697-G 4:9926967 Uric acid levels 2.00E-19 28.99 22229870 | |
| 4 9926967 rs13129697-T 4:9926967 Urate levels 4.00E-13 1.52 20884846 | |
| 4 9926967 rs13129697-C 4:9926967 Biochemical measures 1.00E-09 0.29 19260141 | |
| 4 9927620 rs6838021-A 4:9927620 Blood metabolite ratios 6.00E-68 0.04 24816252 | |
| 4 9934744 rs737267-C 4:9934744 Urate levels 3.00E-09 0.88 18327257 | |
| 4 9935910 rs6855911-A 4:9935910 Urate levels 2.00E-16 0.32 17997608 | |
| 4 9946656 rs4475146-A 4:9946656 Gout 4.00E-26 0.47 23263486 | |
| 4 9956079 rs4481233-T 4:9956079 Metabolic traits 6.00E-34 0.07 21886157 | |
| 4 9966380 rs7442295-C 4:9966380 Urate levels 3.00E-70 0.35 18327256 | |
| 4 9966380 rs7442295-A 4:9966380 Urate levels 2.00E-15 0.02 18179892 | |
| 4 9978305 rs16868246-C 4:9978305 Blood metabolite levels 2.00E-14 0.01 24816252 | |
| 4 9994215 rs6449213-? 4:9994215 Uric acid levels 3.00E-12 NR 23703922 | |
| 4 9995182 rs3775948-C 4:9995182 Renal function-related traits (urea) 2.00E-65 0.18 22797727 | |
| 4 9995182 rs3775948-G 4:9995182 Uric acid levels 1.00E-09 0.18 21294900 | |
| 4 10056376 rs7671266-T 4:10056376 Cardiovascular disease risk factors 9.00E-71 0.31 21943158 | |
| 4 10286301 rs4698014-? 4:10286301 Uric acid levels 8.00E-13 NR 23703922 | |
| 4 10331294 rs4698036-G 4:10331294 Cardiovascular disease risk factors 2.00E-52 0.26 21943158 | |
| 4 10726853 rs16872571-? 4:10726853 Myopia (pathological) 2.00E-10 NR 23049088 | |
| 4 10726853 rs16872571-C 4:10726853 Vitiligo 2.00E-08 1.21 22561518 | |
| 4 10727357 rs13142500-C 4:10727357 Rheumatoid arthritis 3.00E-09 1.1 24390342 | |
| 4 15397364 rs16891867-G 4:15397364 Conduct disorder (symptom count) 3.00E-09 0.15 20585324 | |
| 4 15737101 rs11724635-A 4:15737101 Parkinson's disease 1.00E-16 1.15 21292315 | |
| 4 15737937 rs4538475-? 4:15737937 Parkinson's disease 3.00E-09 1.24 19915576 | |
| 4 17797966 rs7678436-A 4:17797966 Height 8.00E-15 0.09 20189936 | |
| 4 17919811 rs925098-G 4:17919811 Height 3.00E-14 0.06 22021425 | |
| 4 17944840 rs16896068-A 4:17944840 Height 2.00E-13 0.07 18391952 | |
| 4 17946432 rs2724475-? 4:17946432 Height 2.00E-09 NR 20881960 | |
| 4 17952208 rs6845078-C 4:17952208 Height 3.00E-22 1.38 23563607 | |
| 4 17993410 rs724577-A 4:17993410 Height 1.00E-15 0.07 21998595 | |
| 4 17993410 rs724577-C 4:17993410 Birth weight 5.00E-11 0.04 23202124 | |
| 4 18017730 rs6830062-T 4:18017730 Height 1.00E-10 6.3 18391951 | |
| 4 18017730 rs6830062-? 4:18017730 Height 5.00E-09 0.1 19343178 | |
| 4 18033488 rs6449353-T 4:18033488 Height 7.00E-46 0.08 20881960 | |
| 4 22068673 rs4697263-? x rs2141322-? 4:22068673 Age-related hearing impairment (interaction) 9.00E-09 NR 24939585 | |
| 4 22824021 rs3099557-A 4:22824021 Blood metabolite levels 2.00E-39 0.15 24816252 | |
| 4 24515631 rs7698250-T 4:24515631 Pulmonary emphysema 2.00E-10 0.46 24383474 | |
| 4 24578097 rs6841898-? 4:24578097 Myopia (pathological) 3.00E-26 NR 23049088 | |
| 4 26062990 rs10019888-G 4:26062990 HDL cholesterol 5.00E-08 0.03 24097068 | |
| 4 26085511 rs10517086-A 4:26085511 Type 1 diabetes 5.00E-10 1.09 19430480 | |
| 4 26108197 rs874040-C 4:26108197 Rheumatoid arthritis 1.00E-16 1.14 20453842 | |
| 4 26120001 rs11933540-C 4:26120001 Rheumatoid arthritis 1.00E-16 1.15 24390342 | |
| 4 31397618 rs6448771-? 4:31397618 Lipid traits 5.00E-09 0.03 22028671 | |
| 4 38325036 rs6856616-C 4:38325036 Crohn's disease 4.00E-14 1.43 23850713 | |
| 4 38335823 rs1487630-T 4:38335823 Crohn's disease 1.00E-11 1.33 23266558 | |
| 4 38784724 rs10004195-A 4:38784724 Helicobacter pylori serologic status 1.00E-18 1.43 23652523 | |
| 4 38799710 rs4833095-T 4:38799710 Asthma and hay fever 5.00E-12 1.2 24388013 | |
| 4 38811551 rs2101521-A 4:38811551 Self-reported allergy 5.00E-21 0.14 23817569 | |
| 4 38812876 rs17616434-T 4:38812876 Allergic sensitization 5.00E-11 1.23 23817571 | |
| 4 40303633 rs6832151-G 4:40303633 Graves' disease 1.00E-13 1.24 21841780 | |
| 4 45175691 rs13130484-T 4:45175691 Obesity 4.00E-28 1.08 23563607 | |
| 4 45175691 rs13130484-T 4:45175691 Obesity 3.00E-18 1.14 23563607 | |
| 4 45175691 rs13130484-T 4:45175691 Body mass index 6.00E-09 0.05 23669352 | |
| 4 45175804 rs16858082-T 4:45175804 Body mass index 4.00E-09 0.03 24861553 | |
| 4 45182527 rs10938397-G 4:45182527 Obesity 3.00E-34 1.12 23563607 | |
| 4 45182527 rs10938397-G 4:45182527 Body mass index 4.00E-31 0.18 20935630 | |
| 4 45182527 rs10938397-G 4:45182527 Body mass index 3.00E-16 0.19 19079261 | |
| 4 45182527 rs10938397-G 4:45182527 Body mass index 2.00E-13 1.16 23563607 | |
| 4 45184442 rs348495-G 4:45184442 Body mass index 2.00E-10 0.05 23583978 | |
| 4 47551863 rs13106975-? 4:47551863 Sphingolipid levels 2.00E-19 0 22359512 | |
| 4 47563448 rs10938494-A 4:47563448 Sphingolipid levels 8.00E-19 0.06 19798445 | |
| 4 48220839 rs2664035-A 4:48220839 Rheumatoid arthritis 3.00E-08 1.08 24390342 | |
| 4 48363983 rs6837335-G 4:48363983 Crohn's disease 2.00E-08 1.09 23128233 | |
| 4 54799245 rs871606-T 4:54799245 Blood pressure 1.00E-08 0.43 21909110 | |
| 4 55087581 rs17084051-A 4:55087581 Corneal curvature 5.00E-14 0.13 23401653 | |
| 4 55092626 rs2114039-C 4:55092626 Corneal curvature 1.00E-09 0.13 21665993 | |
| 4 55094467 rs1800813-G 4:55094467 Corneal curvature 8.00E-09 0.1 24963161 | |
| 4 55124460 rs7677751-T 4:55124460 Corneal astigmatism 8.00E-09 1.26 22144915 | |
| 4 55394172 rs218237-T 4:55394172 Mean corpuscular volume 2.00E-29 0.15 20139978 | |
| 4 55394172 rs218237-T 4:55394172 Mean corpuscular hemoglobin 3.00E-25 0.14 20139978 | |
| 4 55394172 rs218237-T 4:55394172 Red blood cell count 2.00E-17 0.11 20139978 | |
| 4 55395024 rs218238-A 4:55395024 Red blood cell traits 3.00E-39 0.03 23222517 | |
| 4 55407762 rs172629-C 4:55407762 Mean corpuscular volume 1.00E-27 0.7 20139978 | |
| 4 55407762 rs172629-G 4:55407762 Mean corpuscular volume 1.00E-15 0 19862010 | |
| 4 56751740 rs13117307-T 4:56751740 Cervical cancer 3.00E-10 1.28 23817570 | |
| 4 57786450 rs1713985-G 4:57786450 Age-related macular degeneration 2.00E-08 1.3 21909106 | |
| 4 57823476 rs17081935-T 4:57823476 Height 4.00E-11 0.03 20881960 | |
| 4 59213845 rs17218161-? 4:59213845 Asthma (childhood onset) 2.00E-08 NR 23829686 | |
| 4 69591782 rs293428-A 4:69591782 Sex hormone-binding globulin levels 3.00E-08 0.03 22829776 | |
| 4 72608115 rs705117-G 4:72608115 Serum vitamin D-binding protein levels 5.00E-91 NR 24740207 | |
| 4 72608383 rs2282679-? 4:72608383 Vitamin D insufficiency 2.00E-109 NR 20541252 | |
| 4 72608383 rs2282679-C 4:72608383 Vitamin D levels 2.00E-49 0.38 20418485 | |
| 4 72608383 rs2282679-? 4:72608383 Vitamin D levels 2.00E-14 NR 22673963 | |
| 4 72618334 rs7041-T 4:72618334 Serum vitamin D-binding protein levels 1.00E-246 NR 24740207 | |
| 4 72707821 rs1851024-? 4:72707821 Metabolite levels 1.00E-14 NR 22916037 | |
| 4 73322565 rs115136538-? 4:73322565 Lipid metabolism phenotypes 5.00E-18 0.51 22286219 | |
| 4 73515313 rs7697556-T 4:73515313 Height 2.00E-14 0.03 20881960 | |
| 4 73645351 rs12507628-? 4:73645351 Metabolite levels 3.00E-09 NR 22916037 | |
| 4 74319283 rs12506899-G 4:74319283 Tumor biomarkers 3.00E-18 0.07 23300138 | |
| 4 74349158 rs1894292-G 4:74349158 Prostate cancer 5.00E-13 1.1 23535732 | |
| 4 74857708 rs2472649-G 4:74857708 Inflammatory bowel disease 3.00E-08 1.1 23128233 | |
| 4 74872445 rs16850360-? 4:74872445 Metabolite levels 3.00E-10 NR 22916037 | |
| 4 74977837 rs1371799-? 4:74977837 White blood cell count 2.00E-17 NR 21738479 | |
| 4 75160824 rs16850864-A 4:75160824 Immune reponse to smallpox (secreted IL-1beta) 7.00E-09 NR 22610502 | |
| 4 75170140 rs16850885-A 4:75170140 Immune reponse to smallpox (secreted IL-1beta) 7.00E-09 NR 22610502 | |
| 4 75223711 rs2168889-? 4:75223711 Metabolite levels 6.00E-14 NR 22916037 | |
| 4 75502487 rs62314947-T 4:75502487 Breast size 5.00E-08 0.1 22747683 | |
| 4 77198986 rs6812193-C 4:77198986 Parkinson's disease 8.00E-10 1.19 21738487 | |
| 4 77360431 rs9992101-? 4:77360431 Creatinine levels 6.00E-09 NR 20383145 | |
| 4 77368847 rs17319721-A 4:77368847 Chronic kidney disease 1.00E-19 NR 20383146 | |
| 4 77368847 rs17319721-A 4:77368847 Renal function and chronic kidney disease 1.00E-12 0.01 19430482 | |
| 4 77398015 rs10032549-A 4:77398015 Glomerular filtration rate 1.00E-08 0.93 23535967 | |
| 4 77410318 rs4859682-A 4:77410318 Glomerular filtration rate 2.00E-09 0.96 23535967 | |
| 4 77412140 rs13146355-G 4:77412140 Magnesium levels 6.00E-13 0.01 20700443 | |
| 4 77412140 rs13146355-A 4:77412140 Renal function-related traits (sCR) 9.00E-12 0 22797727 | |
| 4 77412140 rs13146355-A 4:77412140 Renal function-related traits (eGRFcrea) 7.00E-11 0.01 22797727 | |
| 4 79513215 rs2867461-A 4:79513215 Rheumatoid arthritis 1.00E-12 1.13 22446963 | |
| 4 79589045 rs10007186-C 4:79589045 Non-albumin protein levels 1.00E-09 0.09 22558069 | |
| 4 80530671 rs9307551-A 4:80530671 Refractive error 1.00E-08 0.1 23396134 | |
| 4 81164723 rs1458038-T 4:81164723 Diastolic blood pressure 9.00E-25 0.46 21909115 | |
| 4 81164723 rs1458038-T 4:81164723 Systolic blood pressure 2.00E-23 0.71 21909115 | |
| 4 81164723 rs1458038-T 4:81164723 Blood pressure 3.00E-14 0.4 21909110 | |
| 4 81169912 rs11099098-T 4:81169912 Blood pressure 2.00E-11 0.97 24954895 | |
| 4 81184341 rs16998073-T 4:81184341 Diastolic blood pressure 1.00E-21 0.5 19430483 | |
| 4 82149831 rs710841-? 4:82149831 Height 2.00E-08 0.07 19343178 | |
| 4 82150006 rs788867-T 4:82150006 Height 9.00E-28 0.04 20881960 | |
| 4 82165790 rs994014-T 4:82165790 Height 8.00E-10 0.05 21998595 | |
| 4 82184234 rs1878528-G 4:82184234 Height 4.00E-18 1.2 23563607 | |
| 4 84373622 rs4693089-G 4:84373622 Menopause (age at onset) 2.00E-19 0.23 22267201 | |
| 4 84374480 rs1494961-C 4:84374480 Upper aerodigestive tract cancers 1.00E-08 1.12 21437268 | |
| 4 86641149 rs7692808-A 4:86641149 PR interval 6.00E-20 2.01 20062060 | |
| 4 86651464 rs7660702-T 4:86651464 Electrocardiographic traits 3.00E-17 8.46 20062063 | |
| 4 86674199 rs13137008-T 4:86674199 PR segment 1.00E-14 1.76 24850809 | |
| 4 86683560 rs11732231-C 4:86683560 PR interval 3.00E-09 2.28 23139255 | |
| 4 87958395 rs340630-A 4:87958395 Systemic lupus erythematosus 8.00E-09 1.21 22291604 | |
| 4 88030261 rs442177-G 4:88030261 Triglycerides 1.00E-18 0.03 24097068 | |
| 4 88030261 rs442177-G 4:88030261 Triglycerides 9.00E-12 2.25 20686565 | |
| 4 88030261 rs442177-A 4:88030261 Triglycerides 3.00E-10 0.02 20864672 | |
| 4 88186509 rs7694379-A 4:88186509 Platelet counts 9.00E-09 2.13 22139419 | |
| 4 88213808 rs6834314-A 4:88213808 Liver enzyme levels (alanine transaminase) 3.00E-09 2.6 22001757 | |
| 4 88773849 rs6532023-T 4:88773849 Bone mineral density 1.00E-27 0.06 22504420 | |
| 4 88775243 rs1471403-T 4:88775243 Bone mineral density (spine) 2.00E-08 0.07 19801982 | |
| 4 88799710 rs1463104-? 4:88799710 Bone mineral density 2.00E-09 NR 24249740 | |
| 4 88959922 rs2725220-C 4:88959922 Renal function-related traits (urea) 4.00E-30 0.14 22797727 | |
| 4 89039082 rs1481012-A 4:89039082 Gout 2.00E-32 0.55 23263486 | |
| 4 89039082 rs1481012-? 4:89039082 Response to statin therapy (LDL-C) 2.00E-15 5.1 22331829 | |
| 4 89052323 rs2231142-T 4:89052323 Urate levels 1.00E-134 0.22 23263486 | |
| 4 89052323 rs2231142-? 4:89052323 Urate levels 3.00E-60 0.24 18834626 | |
| 4 89052323 rs2231142-T 4:89052323 Serum uric acid levels 3.00E-42 0.05 24513273 | |
| 4 89052323 rs2231142-T 4:89052323 Serum uric acid levels 2.00E-20 0.16 21983786 | |
| 4 89052323 rs2231142-T 4:89052323 Uric acid levels 2.00E-18 0.22 19503597 | |
| 4 89052323 rs2231142-T 4:89052323 Gout 3.00E-12 1.67 21983786 | |
| 4 89052323 rs2231142-T 4:89052323 Uric acid levels 1.00E-10 0.14 19503597 | |
| 4 89054667 rs4148155-G 4:89054667 Urate levels 1.00E-13 0.12 20139978 | |
| 4 89060909 rs4148152-C 4:89060909 Serum uric acid levels 3.00E-18 0.03 24513273 | |
| 4 89064581 rs3114018-T 4:89064581 Serum uric acid levels 4.00E-20 0.03 24513273 | |
| 4 89226422 rs1440581-T 4:89226422 Blood metabolite levels 1.00E-19 0.01 24816252 | |
| 4 89226422 rs1440581-T 4:89226422 Blood metabolite levels 1.00E-16 0.01 24816252 | |
| 4 89226422 rs1440581-? 4:89226422 Metabolite levels 2.00E-16 0.13 22286219 | |
| 4 89226422 rs1440581-T 4:89226422 Blood metabolite levels 3.00E-12 0.01 24816252 | |
| 4 89226422 rs1440581-? 4:89226422 Metabolite levels 1.00E-10 NR 22916037 | |
| 4 89243818 rs10022462-T 4:89243818 Blood metabolite levels 5.00E-11 0.01 24816252 | |
| 4 89741269 rs3822072-A 4:89741269 HDL cholesterol 4.00E-12 0.03 24097068 | |
| 4 89811195 rs2609255-G 4:89811195 Interstitial lung disease 2.00E-11 1.29 23583980 | |
| 4 89866713 rs4416442-C 4:89866713 Chronic obstructive pulmonary disease (severe) 9.00E-15 1.36 24621683 | |
| 4 89866713 rs4416442-C 4:89866713 Chronic obstructive pulmonary disease (moderate to severe) 1.00E-14 1.28 24621683 | |
| 4 89869332 rs2869967-? 4:89869332 Pulmonary function (interaction) 5.00E-11 NR 23284291 | |
| 4 89875909 rs1964516-? 4:89875909 Chronic obstructive pulmonary disease 2.00E-09 1.37 22080838 | |
| 4 89883979 rs7671167-? 4:89883979 Chronic obstructive pulmonary disease 1.00E-11 1.32 20173748 | |
| 4 90637601 rs356219-? 4:90637601 Parkinson's disease 6.00E-65 1.29 22438815 | |
| 4 90637601 rs356219-G 4:90637601 Parkinson's disease 2.00E-47 1.29 21292315 | |
| 4 90639515 rs11931074-? 4:90639515 Parkinson's disease 7.00E-17 1.37 19915576 | |
| 4 90641340 rs356220-? 4:90641340 Parkinson's disease 8.00E-35 1.38 22451204 | |
| 4 90641340 rs356220-T 4:90641340 Parkinson's disease 2.00E-19 1.29 21738487 | |
| 4 90641340 rs356220-A 4:90641340 Parkinson's disease 9.00E-16 1.27 21044948 | |
| 4 90641340 rs356220-T 4:90641340 Parkinson's disease 3.00E-11 1.38 24511991 | |
| 4 90641340 rs356220-T 4:90641340 Parkinson's disease 3.00E-11 1.38 20711177 | |
| 4 90641340 rs356220-T 4:90641340 Parkinson's disease 1.00E-09 1.37 24511991 | |
| 4 90641340 rs356220-T 4:90641340 Parkinson's disease 3.00E-08 1.37 21084426 | |
| 4 90678541 rs2736990-C 4:90678541 Parkinson's disease 2.00E-16 1.23 19915575 | |
| 4 90780902 rs6532194-? 4:90780902 Parkinson's disease 5.00E-11 1.29 22438815 | |
| 4 92415529 rs11933531-A 4:92415529 DNA methylation (variation) 3.00E-08 NR 23725790 | |
| 4 95224812 rs17021463-T 4:95224812 Testicular germ cell tumor 1.00E-08 1.19 23666239 | |
| 4 95514609 rs12500426-? 4:95514609 Prostate cancer 1.00E-11 1.08 19767753 | |
| 4 95562877 rs17021918-? 4:95562877 Prostate cancer 4.00E-15 1.11 19767753 | |
| 4 100014805 rs2602836-A 4:100014805 HDL cholesterol 5.00E-08 0.02 24097068 | |
| 4 100071924 rs17028615-A 4:100071924 Serum metabolite levels 2.00E-15 0.19 24625756 | |
| 4 100239319 rs1229984-G 4:100239319 Esophageal cancer 8.00E-24 1.79 19698717 | |
| 4 100239319 rs1229984-? 4:100239319 Alcohol dependence 3.00E-21 2.35 23456092 | |
| 4 100239319 rs1229984-T 4:100239319 Upper aerodigestive tract cancers 1.00E-20 1.56 21437268 | |
| 4 100239319 rs1229984-? 4:100239319 Alcohol consumption 2.00E-08 NR 23743675 | |
| 4 100250419 rs1789891-? 4:100250419 Alcohol dependence 1.00E-08 1.46 22004471 | |
| 4 100341861 rs971074-G 4:100341861 Upper aerodigestive tract cancers 9.00E-17 1.33 21437268 | |
| 4 101931826 rs1405687-? 4:101931826 Response to antipsychotic treatment 5.00E-08 NR 20195266 | |
| 4 102402215 rs6846071-G 4:102402215 C-reactive protein and white blood cell count 1.00E-11 0.22 22788528 | |
| 4 102751076 rs10516487-G 4:102751076 Systemic lupus erythematosus 4.00E-10 1.38 18204447 | |
| 4 102865304 rs13126505-A 4:102865304 Crohn's disease 2.00E-12 1.17 23128233 | |
| 4 103188709 rs13107325-T 4:103188709 Diastolic blood pressure 2.00E-17 0.68 21909115 | |
| 4 103188709 rs13107325-T 4:103188709 HDL cholesterol 1.00E-15 0.07 24097068 | |
| 4 103188709 rs13107325-T 4:103188709 Systolic blood pressure 3.00E-14 0.98 21909115 | |
| 4 103188709 rs13107325-T 4:103188709 Body mass index 2.00E-13 0.19 20935630 | |
| 4 103188709 rs13107325-T 4:103188709 HDL cholesterol 7.00E-11 0.84 20686565 | |
| 4 103188709 rs13107325-T 4:103188709 Blood pressure 1.00E-10 0.63 21909110 | |
| 4 103511114 rs3774959-A 4:103511114 Ulcerative colitis 4.00E-12 1.12 23128233 | |
| 4 103551603 rs7665090-C 4:103551603 Primary biliary cirrhosis 4.00E-12 1.26 21399635 | |
| 4 104054686 rs2720460-A 4:104054686 Testicular germ cell tumor 2.00E-10 1.24 23666240 | |
| 4 106061534 rs7679673-? 4:106061534 Prostate cancer 3.00E-14 1.1 19767753 | |
| 4 106084778 rs9790517-T 4:106084778 Breast cancer 4.00E-08 1.05 23535729 | |
| 4 106106353 rs10010325-A 4:106106353 Height 4.00E-11 0.02 20881960 | |
| 4 106134316 rs6855629-G 4:106134316 Height 2.00E-08 1.14 23563607 | |
| 4 106619140 rs11727189-T 4:106619140 Pulmonary function 5.00E-17 64.7 20010835 | |
| 4 106688904 rs10516526-G 4:106688904 Pulmonary function 2.00E-23 0.14 20010834 | |
| 4 106808107 rs17331332-? 4:106808107 Pulmonary function (interaction) 1.00E-16 NR 23284291 | |
| 4 108304199 rs7680468-T 4:108304199 Telomere length 5.00E-08 NR 24478790 | |
| 4 109016824 rs898518-A 4:109016824 Chronic lymphocytic leukemia 4.00E-10 1.2 23770605 | |
| 4 110590479 rs4698775-G 4:110590479 Age-related macular degeneration 7.00E-11 1.14 23455636 | |
| 4 110659067 rs10033900-T 4:110659067 Age-related macular degeneration 4.00E-10 1.18 21665990 | |
| 4 110659067 rs10033900-T 4:110659067 Age-related macular degeneration (CNV) 6.00E-09 1.31 22705344 | |
| 4 110659067 rs10033900-? 4:110659067 Age-related macular degeneration 9.00E-09 NR 20385826 | |
| 4 111334730 rs2087160-G 4:111334730 Metabolic traits 7.00E-13 0.12 21886157 | |
| 4 111381638 rs6825911-C 4:111381638 Blood pressure 9.00E-09 0.39 21572416 | |
| 4 111699326 rs12646447-C 4:111699326 Ischemic stroke 3.00E-08 1.14 24262325 | |
| 4 111705768 rs6817105-C 4:111705768 Atrial fibrillation 2.00E-74 1.64 22544366 | |
| 4 111708287 rs17042171-A 4:111708287 Atrial fibrillation 4.00E-63 1.65 19597492 | |
| 4 111710169 rs2200733-T 4:111710169 Atrial fibrillation/atrial flutter 3.00E-41 1.72 17603472 | |
| 4 111710169 rs2200733-? 4:111710169 Atrial fibrillation 1.00E-14 1.42 19597491 | |
| 4 111710169 rs2200733-T 4:111710169 Stroke (ischemic) 2.00E-10 1.26 18991354 | |
| 4 111718067 rs6843082-G 4:111718067 Atrial fibrillation 3.00E-28 2.03 20173747 | |
| 4 111718067 rs6843082-G 4:111718067 Stroke (ischemic) 3.00E-16 1.36 23041239 | |
| 4 111720761 rs10033464-T 4:111720761 Atrial fibrillation/atrial flutter 7.00E-11 1.39 17603472 | |
| 4 112611750 rs10034228-? 4:112611750 Myopia (pathological) 8.00E-13 1.23 21505071 | |
| 4 113855477 rs12500579-G 4:113855477 Fractional exhaled nitric oxide (childhood) 5.00E-13 0.42 24315451 | |
| 4 114683844 rs6858698-C 4:114683844 Chronic lymphocytic leukemia 3.00E-09 1.31 24292274 | |
| 4 116196306 rs13144478-T 4:116196306 Resistin levels 6.00E-18 0.13 22843503 | |
| 4 118646907 rs11098403-G 4:118646907 Schizophrenia 3.00E-08 1.15 24253340 | |
| 4 123115502 rs13151961-? 4:123115502 Celiac disease 2.00E-27 1.35 20190752 | |
| 4 123115502 rs13151961-? 4:123115502 Celiac disease 3.00E-11 1.54 24999842 | |
| 4 123132492 rs4505848-? 4:123132492 Type 1 diabetes 5.00E-13 NR 19430480 | |
| 4 123161619 rs7657746-A 4:123161619 Inflammatory bowel disease 3.00E-13 1.12 23128233 | |
| 4 123329362 rs17388568-A 4:123329362 Self-reported allergy 4.00E-08 0.07 23817569 | |
| 4 123353432 rs17454584-G 4:123353432 Allergic sensitization 6.00E-10 1.15 23817571 | |
| 4 123509421 rs6822844-G 4:123509421 Celiac disease 1.00E-14 1.59 17558408 | |
| 4 123509421 rs6822844-C 4:123509421 Celiac disease 3.00E-13 1.44 18311140 | |
| 4 123523875 rs7682241-A 4:123523875 Alopecia areata 4.00E-08 1.34 20596022 | |
| 4 137526584 rs10012307-T 4:137526584 DNA methylation (parent-of-origin) 2.00E-08 NR 23725790 | |
| 4 140795327 rs1531070-A 4:140795327 Congenital heart malformation 5.00E-12 1.4 23708190 | |
| 4 144003159 rs7686660-T 4:144003159 Asthma 2.00E-12 1.16 21804548 | |
| 4 145436324 rs12504628-T 4:145436324 Pulmonary function 6.00E-13 0.27 20010834 | |
| 4 145460230 rs13147758-G 4:145460230 Pulmonary function 8.00E-11 0.1 19300500 | |
| 4 145485738 rs1980057-T 4:145485738 Pulmonary function 3.00E-20 0.52 20010835 | |
| 4 145485738 rs1980057-? 4:145485738 Pulmonary function (interaction) 5.00E-18 NR 23284291 | |
| 4 145506456 rs13141641-T 4:145506456 Chronic obstructive pulmonary disease (severe) 4.00E-15 1.39 24621683 | |
| 4 145506456 rs13141641-T 4:145506456 Chronic obstructive pulmonary disease (moderate to severe) 2.00E-12 1.27 24621683 | |
| 4 145522758 rs2353398-? 4:145522758 Height 2.00E-09 NR 20881960 | |
| 4 145568352 rs7689420-T 4:145568352 Height 6.00E-51 0.07 20881960 | |
| 4 145568352 rs7689420-C 4:145568352 Height 4.00E-21 1.33 23563607 | |
| 4 145574844 rs1812175-C 4:145574844 Height 1.00E-11 8.3 18391951 | |
| 4 145574844 rs1812175-C 4:145574844 Height 1.00E-09 0.12 20397748 | |
| 4 145643079 rs6854783-A 4:145643079 Height 2.00E-09 0.06 18391952 | |
| 4 145650021 rs1492820-G 4:145650021 Height 1.00E-11 0.29 18391950 | |
| 4 146794621 rs4547811-C 4:146794621 Liver enzyme levels (gamma-glutamyl transferase) 3.00E-27 6.4 22001757 | |
| 4 146821410 rs4835265-T 4:146821410 Gamma glutamyl transpeptidase 1.00E-14 0 21909109 | |
| 4 146853165 rs2048161-A 4:146853165 Immune reponse to smallpox (secreted IFN-alpha) 6.00E-12 NR 22610502 | |
| 4 148393664 rs1878406-T 4:148393664 Carotid intima media thickness 7.00E-12 0.2 21909108 | |
| 4 148400819 rs6842241-C 4:148400819 Intracranial aneurysm 1.00E-08 1.25 22286173 | |
| 4 148401190 rs6841581-? 4:148401190 Coronary artery disease or large artery stroke 2.00E-08 NR 24262325 | |
| 4 148884189 rs7658486-A 4:148884189 Immune reponse to smallpox (secreted IL-12p40) 1.00E-08 NR 22610502 | |
| 4 149079497 rs3931397-T 4:149079497 Corneal structure 4.00E-08 0.12 23291589 | |
| 4 149652610 rs10028213-C 4:149652610 Thyroid function 3.00E-10 0.08 22494929 | |
| 4 149669506 rs10032216-T 4:149669506 Thyroid hormone levels 9.00E-16 0.09 23408906 | |
| 4 149669506 rs10032216-T 4:149669506 Thyroid hormone levels 2.00E-13 0.11 23408906 | |
| 4 153520475 rs6813195-C 4:153520475 Type 2 diabetes 4.00E-14 1.08 24509480 | |
| 4 154864750 rs13135284-C 4:154864750 DNA methylation (parent-of-origin) 5.00E-08 NR 23725790 | |
| 4 155301059 rs12651106-A 4:155301059 Fibrinogen 2.00E-12 0.14 21757653 | |
| 4 155389247 rs17031671-? 4:155389247 Bilirubin levels 6.00E-11 0.12 20639394 | |
| 4 155451759 rs12511469-A 4:155451759 Fibrinogen 2.00E-36 0.18 21757653 | |
| 4 155482743 rs1800789-A 4:155482743 Fibrinogen 2.00E-127 0.03 23969696 | |
| 4 155482743 rs1800789-A 4:155482743 Fibrinogen 2.00E-30 0.09 20031576 | |
| 4 155483914 rs1800788-T 4:155483914 Fibrinogen 1.00E-39 0.19 21757653 | |
| 4 155488821 rs6056-A 4:155488821 Fibrinogen 8.00E-39 12.94 20031577 | |
| 4 155507590 rs6050-C 4:155507590 Fibrinogen 9.00E-90 0.26 21757653 | |
| 4 155514879 rs13109457-A 4:155514879 D-dimer levels 3.00E-18 6.3 21502573 | |
| 4 155520930 rs7659024-A 4:155520930 Venous thromboembolism 2.00E-13 1.53 21980494 | |
| 4 155542248 rs7681423-T 4:155542248 Fibrinogen 1.00E-109 0.29 21757653 | |
| 4 155543369 rs6536024-C 4:155543369 Venous thromboembolism 2.00E-13 1.25 23650146 | |
| 4 156511459 rs1842896-T 4:156511459 Coronary heart disease 1.00E-11 1.14 22751097 | |
| 4 156645513 rs13139571-C 4:156645513 Diastolic blood pressure 2.00E-10 0.26 21909115 | |
| 4 156808288 rs13122250-T 4:156808288 Blood metabolite levels 9.00E-12 0.01 24816252 | |
| 4 156998541 rs4234898-T 4:156998541 Speech perception in dyslexia 5.00E-08 NR 19786962 | |
| 4 157720124 rs4691380-? 4:157720124 Fasting insulin-related traits (interaction with BMI) 5.00E-09 NR 22581228 | |
| 4 159629151 rs4690909-C 4:159629151 Blood metabolite ratios 2.00E-57 0.06 24816252 | |
| 4 159630817 rs8396-T 4:159630817 Blood metabolite levels 9.00E-38 0.05 24816252 | |
| 4 159630817 rs8396-T 4:159630817 Blood metabolite levels 1.00E-31 0.05 24816252 | |
| 4 159630817 rs8396-T 4:159630817 Metabolite levels 4.00E-24 5.6 20037589 | |
| 4 159630817 rs8396-C 4:159630817 Metabolic traits 6.00E-15 0.1 21886157 | |
| 4 159630817 rs8396-T 4:159630817 Blood metabolite levels 9.00E-13 0.03 24816252 | |
| 4 161506897 rs17291045-? 4:161506897 HIV-1 control 5.00E-08 NR 20041166 | |
| 4 165908721 rs4691139-G 4:165908721 Ovarian cancer in BRCA1 mutation carriers 3.00E-08 1.2 23544013 | |
| 4 166255704 rs17046216-A 4:166255704 Insulin-related traits 2.00E-08 0.18 22791750 | |
| 4 166255704 rs17046216-A 4:166255704 Insulin-related traits 3.00E-08 0.19 22791750 | |
| 4 166872536 rs6812849-? 4:166872536 Post-traumatic stress disorder 3.00E-09 NR 23726511 | |
| 4 168264249 rs13111850-G 4:168264249 Immune reponse to smallpox (secreted IL-10) 3.00E-11 NR 22610502 | |
| 4 171053519 rs11726248-A 4:171053519 Thyroid hormone levels 5.00E-09 0.11 23408906 | |
| 4 175816129 rs6858430-T x rs4800250-G 4:175816129 Venous thromboembolism (gene x gene interaction) 1.00E-08 1.62 23509962 | |
| 4 175846426 rs6828523-C 4:175846426 Breast cancer 4.00E-16 1.11 23535729 | |
| 4 181240134 rs2309322-? x rs1334782-? 4:181240134 Age-related hearing impairment (interaction) 1.00E-09 NR 24939585 | |
| 4 182553043 rs6815916-G x rs6092326-T 4:182553043 Venous thromboembolism (gene x gene interaction) 7.00E-10 2.1 23509962 | |
| 4 184215675 rs955748-A 4:184215675 Height 4.00E-08 0.02 20881960 | |
| 4 185639169 rs2130392-A 4:185639169 Kawasaki disease 3.00E-08 1.42 22446962 | |
| 4 187148387 rs4253238-C 4:187148387 Circulating vasoactive peptide levels 1.00E-122 5.14 23381795 | |
| 4 187148387 rs4253238-C 4:187148387 Circulating vasoactive peptide levels 4.00E-52 0.03 23381795 | |
| 4 187149540 rs1912826-? 4:187149540 Metabolite levels 4.00E-12 NR 22916037 | |
| 4 187152327 rs4241816-? 4:187152327 Metabolite levels 6.00E-13 0.12 22286219 | |
| 4 187157458 rs4253252-T 4:187157458 Blood metabolite levels 3.00E-22 0.09 24816252 | |
| 4 187157458 rs4253252-T 4:187157458 Metabolic traits 7.00E-18 0.24 21886157 | |
| 4 187158034 rs3733402-A 4:187158034 Serum metabolite levels 9.00E-27 0.44 24625756 | |
| 4 187158034 rs3733402-A 4:187158034 Serum metabolite levels 7.00E-25 0.28 24625756 | |
| 4 187174683 rs4253311-A 4:187174683 Blood metabolite levels 4.00E-48 0.14 24816252 | |
| 4 187185385 rs3756008-T 4:187185385 Venous thromboembolism 6.00E-11 1.4 21980494 | |
| 4 187188094 rs4253399-G 4:187188094 Venous thromboembolism 3.00E-14 1.24 23650146 | |
| 4 187195551 rs1593-A 4:187195551 Activated partial thromboplastin time 2.00E-18 0.54 22703881 | |
| 4 187207381 rs2289252-C 4:187207381 Activated partial thromboplastin time 6.00E-43 0.48 22703881 | |
| 4 189120911 rs6857559-? 4:189120911 Myopia (pathological) 3.00E-21 NR 23049088 | |
| 4 189191111 rs71607999-? 4:189191111 Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) 7.00E-09 NR 24528284 | |
| 5 583442 rs4957048-C 5:583442 Ulcerative colitis 1.00E-09 1.3 20228799 | |
| 5 594083 rs11739663-T 5:594083 Ulcerative colitis 2.00E-08 1.07 23128233 | |
| 5 594083 rs11739663-T 5:594083 Ulcerative colitis 3.00E-08 1.15 21297633 | |
| 5 1113244 rs4580814-T 5:1113244 Mean corpuscular hemoglobin concentration 5.00E-10 0.08 20139978 | |
| 5 1279790 rs10069690-T 5:1279790 Breast cancer 5.00E-12 1.15 23535733 | |
| 5 1279790 rs10069690-T 5:1279790 Breast cancer 1.00E-10 1.18 22037553 | |
| 5 1279790 rs10069690-T 5:1279790 Breast cancer 7.00E-09 1.06 23535729 | |
| 5 1280028 rs2242652-G 5:1280028 Prostate cancer 3.00E-24 1.15 21743467 | |
| 5 1286516 rs2736100-C 5:1286516 Lung cancer 1.00E-27 1.27 21725308 | |
| 5 1286516 rs2736100-G 5:1286516 Lung cancer 4.00E-27 1.38 23143601 | |
| 5 1286516 rs2736100-G 5:1286516 Lung adenocarcinoma 2.00E-22 1.46 20700438 | |
| 5 1286516 rs2736100-A 5:1286516 Interstitial lung disease 2.00E-19 1.37 23583980 | |
| 5 1286516 rs2736100-G 5:1286516 Glioma 2.00E-17 1.27 19578367 | |
| 5 1286516 rs2736100-C 5:1286516 Glioma (high-grade) 1.00E-15 1.39 24908248 | |
| 5 1286516 rs2736100-T 5:1286516 Testicular germ cell cancer 8.00E-15 1.33 20543847 | |
| 5 1286516 rs2736100-? 5:1286516 Glioma 1.00E-14 1.25 21531791 | |
| 5 1286516 rs2736100-C 5:1286516 Lung adenocarcinoma 3.00E-11 1.27 20871597 | |
| 5 1286516 rs2736100-G 5:1286516 Lung adenocarcinoma 2.00E-10 1.12 19836008 | |
| 5 1286516 rs2736100-G 5:1286516 Glioma 4.00E-09 1.3 22886559 | |
| 5 1286516 rs2736100-? 5:1286516 Glioma 7.00E-09 NR 21827660 | |
| 5 1286516 rs2736100-G 5:1286516 Red blood cell count 3.00E-08 0.07 20139978 | |
| 5 1286516 rs2736100-A 5:1286516 Idiopathic pulmonary fibrosis 3.00E-08 2.11 18835860 | |
| 5 1287194 rs2853677-C 5:1287194 Lung adenocarcinoma 3.00E-40 1.41 22797724 | |
| 5 1288547 rs2853676-A 5:1288547 Glioma 4.00E-14 1.26 19578367 | |
| 5 1308552 rs4635969-T 5:1308552 Testicular germ cell tumor 5.00E-24 1.39 23666240 | |
| 5 1308552 rs4635969-T 5:1308552 Testicular germ cell cancer 1.00E-23 1.54 20543847 | |
| 5 1315660 rs4975616-? 5:1315660 Lung cancer 3.00E-09 1.15 19654303 | |
| 5 1322087 rs401681-C 5:1322087 Basal cell carcinoma 2.00E-12 1.23 24403052 | |
| 5 1322087 rs401681-C 5:1322087 Basal cell carcinoma 4.00E-12 1.25 19151717 | |
| 5 1322087 rs401681-C 5:1322087 Bladder cancer 4.00E-11 1.12 24163127 | |
| 5 1322087 rs401681-C 5:1322087 Serum prostate-specific antigen levels 1.00E-10 7 21160077 | |
| 5 1322087 rs401681-G 5:1322087 Lung cancer 8.00E-09 1.15 18978787 | |
| 5 1322087 rs401681-A 5:1322087 Melanoma 3.00E-08 1.2 21983787 | |
| 5 1342714 rs31489-C 5:1342714 Lung adenocarcinoma 2.00E-10 1.12 19836008 | |
| 5 1895829 rs12653946-T 5:1895829 Prostate cancer 4.00E-18 1.26 20676098 | |
| 5 4029789 rs11748327-? 5:4029789 Myocardial infarction 5.00E-13 1.25 21107343 | |
| 5 5792507 rs32566-? 5:5792507 Morbidity-free survival 2.00E-09 NR 17903295 | |
| 5 6324293 rs12518614-A 5:6324293 End-stage coagulation 2.00E-09 0.46 23381943 | |
| 5 6821914 rs1566039-? 5:6821914 Sphingolipid levels 1.00E-08 0.8 22359512 | |
| 5 7368845 rs13172324-? 5:7368845 Myopia (pathological) 3.00E-10 NR 23049088 | |
| 5 7519298 rs17826816-G 5:7519298 Bipolar disorder 1.00E-08 1.14 24618891 | |
| 5 7649860 rs4702484-? 5:7649860 Capecitabine sensitivity 5.00E-08 NR 22864933 | |
| 5 10695526 rs2930047-C 5:10695526 Inflammatory bowel disease 1.00E-08 1.07 23128233 | |
| 5 10752315 rs267939-C 5:10752315 Ulcerative colitis 6.00E-12 1.1 21297633 | |
| 5 11084712 rs11744876-? 5:11084712 Amyotrophic lateral sclerosis (sporadic) 3.00E-08 NR 24529757 | |
| 5 14876569 rs835154-A 5:14876569 Blood metabolite levels 1.00E-10 0.01 24816252 | |
| 5 16812638 rs17651119-C 5:16812638 Major depressive disorder 2.00E-08 3.18 23377640 | |
| 5 19441735 rs10520861-? x rs9380696-? 5:19441735 Age-related hearing impairment (interaction) 7.00E-09 NR 24939585 | |
| 5 23542711 rs2914276-G 5:23542711 Recombination measurement (females) 1.00E-100 NR 20981099 | |
| 5 23542711 rs2914276-G 5:23542711 Recombination measurement (males) 1.00E-50 NR 20981099 | |
| 5 23907573 rs1910358-C x rs9981595-G 5:23907573 Venous thromboembolism (gene x gene interaction) 7.00E-09 2.03 23509962 | |
| 5 25967703 rs4307059-T 5:25967703 Autism 2.00E-10 1.19 19404256 | |
| 5 27611431 rs12054895-T 5:27611431 Major depressive disorder 3.00E-08 0.24 23377640 | |
| 5 31020521 rs6888304-A 5:31020521 Liver enzyme levels (gamma-glutamyl transferase) 1.00E-09 2.7 22001757 | |
| 5 32689718 rs6450922-C 5:32689718 Height 1.00E-10 1.2 23563607 | |
| 5 32768634 rs3792752-? 5:32768634 Height 7.00E-10 NR 20881960 | |
| 5 32804528 rs1173766-C 5:32804528 Blood pressure 2.00E-08 0.63 21572416 | |
| 5 32815028 rs1173771-G 5:32815028 Systolic blood pressure 2.00E-16 0.5 21909115 | |
| 5 32815028 rs1173771-G 5:32815028 Diastolic blood pressure 9.00E-12 0.26 21909115 | |
| 5 32815028 rs1173771-G 5:32815028 Hypertension 3.00E-10 0.06 21909115 | |
| 5 32815028 rs1173771-G 5:32815028 Blood pressure 4.00E-09 0.28 21909110 | |
| 5 32815028 rs1173771-G 5:32815028 Blood pressure 5.00E-09 0.28 21909110 | |
| 5 32819073 rs9292468-T 5:32819073 Height 2.00E-16 1.18 23563607 | |
| 5 32830521 rs1173727-T 5:32830521 Height 2.00E-21 0.03 20881960 | |
| 5 33951693 rs16891982-C 5:33951693 Hair color 4.00E-20 1.1 20585627 | |
| 5 33951693 rs16891982-? 5:33951693 Hair color 4.00E-20 NR 20585627 | |
| 5 33951693 rs16891982-C 5:33951693 Eye color 1.00E-12 0.84 20585627 | |
| 5 33951693 rs16891982-C 5:33951693 Skin pigmentation 3.00E-11 4.86 17999355 | |
| 5 33955673 rs35391-T 5:33955673 Tanning 3.00E-10 0.44 19340012 | |
| 5 33958959 rs28777-C 5:33958959 Black vs. blond hair color 1.00E-17 0.46 18483556 | |
| 5 33958959 rs28777-C 5:33958959 Black vs. red hair color 9.00E-14 0.46 18483556 | |
| 5 35000795 rs7717823-C 5:35000795 Urinary metabolites (H-NMR features) 3.00E-29 0.44 24586186 | |
| 5 35003112 rs468327-G 5:35003112 Urinary metabolites (H-NMR features) 4.00E-15 0.39 24586186 | |
| 5 35037115 rs37369-T 5:35037115 Urinary metabolites 2.00E-182 NR 21572414 | |
| 5 35037115 rs37369-C 5:35037115 Urinary metabolites (H-NMR features) 1.00E-63 0.77 24586186 | |
| 5 35037115 rs37369-T 5:35037115 Serum dimethylarginine levels (symmetric) 1.00E-40 0.47 24159190 | |
| 5 35037115 rs37369-T 5:35037115 Serum dimethylarginine levels (asymmetric/symetric ratio) 2.00E-32 0.41 24159190 | |
| 5 35037115 rs37369-C 5:35037115 Urinary metabolites (H-NMR features) 2.00E-31 0.56 24586186 | |
| 5 35037115 rs37369-C 5:35037115 Urinary metabolites (H-NMR features) 3.00E-26 0.52 24586186 | |
| 5 35037115 rs37369-C 5:35037115 Urinary metabolites (H-NMR features) 3.00E-23 0.49 24586186 | |
| 5 35037115 rs37369-C 5:35037115 Urinary metabolites (H-NMR features) 3.00E-16 0.42 24586186 | |
| 5 35037115 rs37369-C 5:35037115 Urinary metabolites (H-NMR features) 6.00E-15 0.43 24586186 | |
| 5 35037115 rs37369-C 5:35037115 Urinary metabolites (H-NMR features) 8.00E-15 0.41 24586186 | |
| 5 35045745 rs40200-G 5:35045745 Urinary metabolites (H-NMR features) 9.00E-37 0.67 24586186 | |
| 5 35852311 rs6890853-G 5:35852311 Primary biliary cirrhosis 4.00E-08 1.47 23000144 | |
| 5 35874575 rs6897932-G 5:35874575 Multiple sclerosis 2.00E-08 1.11 21833088 | |
| 5 35876274 rs3194051-G 5:35876274 Ulcerative colitis 4.00E-08 1.07 21297633 | |
| 5 35943042 rs860413-A 5:35943042 Primary biliary cirrhosis 1.00E-11 1.3 21399635 | |
| 5 35968000 rs10491431-A 5:35968000 Blood metabolite levels 2.00E-11 0.08 24816252 | |
| 5 39394989 rs2255280-T 5:39394989 Pancreatic cancer 4.00E-10 1.23 22158540 | |
| 5 39979172 rs10053502-? 5:39979172 Myopia (pathological) 1.00E-16 NR 23049088 | |
| 5 40392728 rs4613763-C 5:40392728 Crohn's disease 7.00E-27 1.32 18587394 | |
| 5 40392728 rs4613763-G 5:40392728 Multiple sclerosis 3.00E-16 1.2 21833088 | |
| 5 40401509 rs17234657-G 5:40401509 Crohn's disease 2.00E-12 1.54 17554300 | |
| 5 40410584 rs11742570-C 5:40410584 Inflammatory bowel disease 2.00E-82 1.2 23128233 | |
| 5 40410584 rs11742570-C 5:40410584 Crohn's disease 7.00E-36 1.33 21102463 | |
| 5 40410935 rs6451493-T 5:40410935 Ulcerative colitis 3.00E-09 1.08 21297633 | |
| 5 40431183 rs1373692-? 5:40431183 Crohn's disease 2.00E-12 1.46 17447842 | |
| 5 40437948 rs9292777-? 5:40437948 Crohn's disease 3.00E-18 1.34 17554261 | |
| 5 40437948 rs9292777-T 5:40437948 Crohn's disease 2.00E-11 1.37 22412388 | |
| 5 40437948 rs9292777-T 5:40437948 Multiple sclerosis 1.00E-09 1.19 22570697 | |
| 5 40486896 rs7720838-G 5:40486896 Self-reported allergy 8.00E-11 0.08 23817569 | |
| 5 40791884 rs13361707-? 5:40791884 Gastric cancer 8.00E-29 1.41 22037551 | |
| 5 44365545 rs2121875-G 5:44365545 Prostate cancer 4.00E-08 1.05 21743467 | |
| 5 44662515 rs4415084-T 5:44662515 Breast cancer 8.00E-11 1.17 21263130 | |
| 5 44706498 rs10941679-G 5:44706498 Breast cancer 2.00E-37 1.13 23535729 | |
| 5 52193125 rs4074793-G 5:52193125 Liver enzyme levels (gamma-glutamyl transferase) 3.00E-10 5.5 22001757 | |
| 5 52560644 rs38055-A 5:52560644 Acne (severe) 5.00E-09 1.18 24927181 | |
| 5 53271420 rs702634-A 5:53271420 Type 2 diabetes 7.00E-09 1.06 24509480 | |
| 5 53298025 rs6450176-A 5:53298025 HDL cholesterol 7.00E-10 0.03 24097068 | |
| 5 53298025 rs6450176-A 5:53298025 HDL cholesterol 5.00E-08 0.49 20686565 | |
| 5 53300662 rs4311394-G 5:53300662 Adiponectin levels 3.00E-08 0.96 20011104 | |
| 5 53592361 rs35951-G 5:53592361 Alcohol dependence (age at onset) 1.00E-08 1.43 24962325 | |
| 5 55001899 rs11958779-A 5:55001899 Height 2.00E-12 0.03 20881960 | |
| 5 55322895 rs17348299-C 5:55322895 IgG glycosylation 7.00E-11 0.29 23382691 | |
| 5 55322895 rs17348299-C 5:55322895 IgG glycosylation 1.00E-10 0.29 23382691 | |
| 5 55322895 rs17348299-C 5:55322895 IgG glycosylation 1.00E-10 0.29 23382691 | |
| 5 55322895 rs17348299-C 5:55322895 IgG glycosylation 1.00E-10 0.29 23382691 | |
| 5 55322895 rs17348299-C 5:55322895 IgG glycosylation 3.00E-10 0.28 23382691 | |
| 5 55322895 rs17348299-C 5:55322895 IgG glycosylation 2.00E-09 0.27 23382691 | |
| 5 55438580 rs6859219-C 5:55438580 Rheumatoid arthritis 1.00E-11 1.28 20453842 | |
| 5 55438851 rs10065637-C 5:55438851 Crohn's disease 4.00E-12 1.12 23128233 | |
| 5 55444683 rs7731626-G 5:55444683 Rheumatoid arthritis 8.00E-23 1.21 24390342 | |
| 5 55510656 rs4700060-? 5:55510656 Alzheimer's disease (cognitive decline) 1.00E-08 0.21 23535033 | |
| 5 55861786 rs9686661-T 5:55861786 Triglycerides 3.00E-16 0.04 24097068 | |
| 5 55861786 rs9686661-T 5:55861786 Triglycerides 1.00E-10 2.57 20686565 | |
| 5 55983856 rs16886034-? 5:55983856 Breast cancer (early onset) 2.00E-09 1.36 24493630 | |
| 5 55995035 rs16886113-? 5:55995035 Breast cancer (early onset) 4.00E-11 1.35 24493630 | |
| 5 56029243 rs16886181-? 5:56029243 Breast cancer (early onset) 9.00E-14 1.26 24493630 | |
| 5 56031884 rs889312-C 5:56031884 Breast cancer 3.00E-36 1.12 23535729 | |
| 5 56031884 rs889312-C 5:56031884 Breast cancer 7.00E-20 1.13 17529967 | |
| 5 56031884 rs889312-C 5:56031884 Breast cancer 5.00E-09 1.22 20453838 | |
| 5 56031884 rs889312-? 5:56031884 Breast cancer (early onset) 1.00E-08 1.29 24493630 | |
| 5 56122344 rs16886364-? 5:56122344 Breast cancer (early onset) 5.00E-12 1.36 24493630 | |
| 5 56134276 rs16886397-? 5:56134276 Breast cancer (early onset) 4.00E-12 1.36 24493630 | |
| 5 56153392 rs1017226-? 5:56153392 Breast cancer (early onset) 6.00E-11 1.33 24493630 | |
| 5 56168712 rs2229882-? 5:56168712 Breast cancer (early onset) 1.00E-14 1.45 24493630 | |
| 5 56170813 rs16886448-? 5:56170813 Breast cancer (early onset) 2.00E-12 1.37 24493630 | |
| 5 56178111 rs3822625-? 5:56178111 Breast cancer (early onset) 5.00E-12 1.36 24493630 | |
| 5 56195790 rs12655019-? 5:56195790 Breast cancer (early onset) 3.00E-10 1.27 24493630 | |
| 5 56256483 rs7726354-? 5:56256483 Breast cancer (early onset) 7.00E-11 1.37 24493630 | |
| 5 57172078 rs4432842-C 5:57172078 Birth weight 5.00E-08 0.03 23202124 | |
| 5 57355531 rs6859725-? x rs12535348-? 5:57355531 Age-related hearing impairment (interaction) 6.00E-09 NR 24939585 | |
| 5 58184061 rs10472076-C 5:58184061 Breast cancer 3.00E-08 1.05 23535729 | |
| 5 58337481 rs1353747-T 5:58337481 Breast cancer 3.00E-08 1.09 23535729 | |
| 5 58407771 rs10052657-C 5:58407771 Esophageal cancer 2.00E-19 1.49 21642993 | |
| 5 58560717 rs17444059-G 5:58560717 Immune response to smallpox vaccine (IL-6) 2.00E-08 NR 22610502 | |
| 5 58676049 rs1823068-? 5:58676049 Sleep-related phenotypes 3.00E-08 NR 17903308 | |
| 5 58979946 rs17382202-T 5:58979946 Response to antipsychotic treatment 4.00E-08 NR 23241943 | |
| 5 59369794 rs1588265-C 5:59369794 Asthma 3.00E-08 1.18 19426955 | |
| 5 60499131 rs171748-A 5:60499131 Schizophrenia 4.00E-08 1.08 23974872 | |
| 5 60731458 rs7709645-? 5:60731458 Schizophrenia 4.00E-08 1.11 22688191 | |
| 5 61984853 rs1423386-G x rs6491679-G 5:61984853 Venous thromboembolism (gene x gene interaction) 2.00E-09 1.73 23509962 | |
| 5 62074718 rs16891077-A 5:62074718 Fasting insulin (interaction) 9.00E-10 NR 24204828 | |
| 5 62074718 rs16891077-A 5:62074718 Homeostasis model assessment of insulin resistance (interaction) 1.00E-09 NR 24204828 | |
| 5 62193486 rs1402915-? x rs2514750-? 5:62193486 Age-related hearing impairment (interaction) 1.00E-09 NR 24939585 | |
| 5 62586301 rs7445832-A 5:62586301 Alcohol and nictotine co-dependence 1.00E-09 1.15 23216389 | |
| 5 64625512 rs2307121-T 5:64625512 Corneal structure 6.00E-11 0.09 23291589 | |
| 5 72431482 rs17632159-C 5:72431482 Urate levels 4.00E-11 0.04 23263486 | |
| 5 72551134 rs7702331-A 5:72551134 Crohn's disease 6.00E-12 1.12 21102463 | |
| 5 72551134 rs7702331-A 5:72551134 Crohn's disease 6.00E-10 1.09 23128233 | |
| 5 73072354 rs7714670-C x rs12880735-A 5:73072354 Venous thromboembolism (gene x gene interaction) 2.00E-09 1.52 23509962 | |
| 5 74625487 rs7703051-A 5:74625487 LDL cholesterol 1.00E-08 18 18802019 | |
| 5 74636484 rs10045497-C 5:74636484 Lipid traits 1.00E-12 0.1 24386095 | |
| 5 74636484 rs10045497-C 5:74636484 Lipid traits 2.00E-08 0.02 24386095 | |
| 5 74648603 rs12654264-T 5:74648603 Metabolite levels 1.00E-20 2.71 21909109 | |
| 5 74648603 rs12654264-T 5:74648603 LDL cholesterol 1.00E-20 0.1 18193044 | |
| 5 74651084 rs3846662-G 5:74651084 "Cholesterol, total" 3.00E-19 0.09 19060911 | |
| 5 74651084 rs3846662-G 5:74651084 LDL cholesterol 2.00E-11 0.08 19060911 | |
| 5 74655726 rs3846663-T 5:74655726 LDL cholesterol 8.00E-12 0.07 19060906 | |
| 5 74656539 rs12916-C 5:74656539 LDL cholesterol 8.00E-78 0.07 24097068 | |
| 5 74656539 rs12916-C 5:74656539 "Cholesterol, total" 5.00E-74 0.68 24097068 | |
| 5 74656539 rs12916-C 5:74656539 "Cholesterol, total" 9.00E-47 2.84 20686565 | |
| 5 74656539 rs12916-C 5:74656539 LDL cholesterol 5.00E-45 2.45 20686565 | |
| 5 74656539 rs12916-T 5:74656539 LDL cholesterol 1.00E-11 0.02 20864672 | |
| 5 75003678 rs2307111-T 5:75003678 Obesity 3.00E-12 1.07 23563607 | |
| 5 75015242 rs2112347-T 5:75015242 Body mass index 2.00E-13 0.1 20935630 | |
| 5 75015242 rs2112347-T 5:75015242 Obesity 4.00E-09 1.09 23563607 | |
| 5 75015242 rs2112347-T 5:75015242 Obesity 1.00E-08 1.04 23563607 | |
| 5 76023494 rs2227831-G 5:76023494 Mean platelet volume 1.00E-15 0.02 22139419 | |
| 5 76046939 rs17568628-T 5:76046939 Platelet counts 1.00E-09 6.07 22139419 | |
| 5 76424949 rs4457053-G 5:76424949 Type 2 diabetes 3.00E-12 1.08 20581827 | |
| 5 76518442 rs4704397-A 5:76518442 Thyroid stimulating hormone 2.00E-20 0.25 18514160 | |
| 5 76530349 rs6885099-A 5:76530349 Thyroid hormone levels 3.00E-38 0.17 23408906 | |
| 5 76530349 rs6885099-A 5:76530349 Thyroid hormone levels 2.00E-26 0.14 23408906 | |
| 5 76530349 rs6885099-A 5:76530349 Thyroid hormone levels 6.00E-24 0.12 23408906 | |
| 5 76535811 rs2046045-T 5:76535811 Thyroid function 3.00E-27 0.12 22494929 | |
| 5 78316476 rs921943-T 5:78316476 Blood trace element (Se levels) 9.00E-28 0.25 23720494 | |
| 5 78341297 rs17823642-C 5:78341297 Metabolite levels 2.00E-09 0.38 23378610 | |
| 5 78346769 rs16876394-T 5:78346769 Blood metabolite levels 1.00E-19 0.03 24816252 | |
| 5 78414337 rs506500-? 5:78414337 Blood trace element (Se levels) 8.00E-12 NR 23720494 | |
| 5 83173593 rs4552569-C 5:83173593 Ankylosing spondylitis 9.00E-10 1.21 22138694 | |
| 5 85707469 rs10514279-? x rs4869993-? 5:85707469 Age-related hearing impairment (interaction) 2.00E-09 NR 24939585 | |
| 5 87798236 rs2194025-G 5:87798236 Retinal arteriolar caliber 2.00E-12 1.6 23776548 | |
| 5 87847586 rs17421627-G 5:87847586 Retinal vascular caliber 7.00E-16 3 21060863 | |
| 5 88099951 rs4521516-G 5:88099951 Mean platelet volume 2.00E-09 0.01 22139419 | |
| 5 88138731 rs11951031-T 5:88138731 Bone mineral density 9.00E-09 0.2 23572186 | |
| 5 88152117 rs700585-C 5:88152117 Platelet counts 1.00E-09 2.7 22139419 | |
| 5 88223420 rs190982-A 5:88223420 Alzheimer's disease (late onset) 3.00E-08 1.08 24162737 | |
| 5 88327782 rs6894139-? 5:88327782 Bone mineral density 7.00E-18 NR 24249740 | |
| 5 88354675 rs10037512-T 5:88354675 Height 2.00E-18 0.03 20881960 | |
| 5 88376061 rs1366594-A 5:88376061 Bone mineral density 4.00E-61 0.08 22504420 | |
| 5 88376061 rs1366594-C 5:88376061 Bone mineral density (hip) 1.00E-13 0.09 19801982 | |
| 5 88376061 rs1366594-C 5:88376061 Bone mineral density 8.00E-10 0.14 21533022 | |
| 5 90299223 rs1967256-? 5:90299223 Response to antipsychotic treatment 3.00E-08 NR 20195266 | |
| 5 91893792 rs1027643-T 5:91893792 Wilms tumor 5.00E-10 1.43 22544364 | |
| 5 93557702 rs17376456-A 5:93557702 Diabetic retinopathy 3.00E-15 NR 21310492 | |
| 5 95036700 rs153916-T 5:95036700 Pulmonary function 2.00E-08 0.03 21946350 | |
| 5 95234791 rs3777200-T 5:95234791 Serum total protein level 1.00E-08 0.02 23022100 | |
| 5 95542726 rs13179048-? 5:95542726 Fasting glucose-related traits (interaction with BMI) 2.00E-10 NR 22581228 | |
| 5 95728898 rs6235-G 5:95728898 Proinsulin levels 1.00E-26 NR 21873549 | |
| 5 95728898 rs6235-G 5:95728898 Glycemic traits (pregnancy) 5.00E-15 0.01 23903356 | |
| 5 95850250 rs261967-C 5:95850250 Body mass index 8.00E-13 0.04 24861553 | |
| 5 95850250 rs261967-C 5:95850250 Body mass index 5.00E-09 3.77 22344219 | |
| 5 96101944 rs27524-A 5:96101944 Psoriasis 3.00E-11 1.13 20953190 | |
| 5 96118866 rs17482078-T 5:96118866 Behcet's disease 5.00E-11 4.56 23291587 | |
| 5 96118866 rs17482078-T 5:96118866 Behcet's disease 4.00E-08 3.08 23291587 | |
| 5 96124330 rs30187-T 5:96124330 Ankylosing spondylitis 2.00E-27 NR 21743469 | |
| 5 96129512 rs27434-A 5:96129512 Ankylosing spondylitis 5.00E-12 1.19 20062062 | |
| 5 96244549 rs2549794-C 5:96244549 Crohn's disease 1.00E-10 1.05 21102463 | |
| 5 96252803 rs1363907-A 5:96252803 Inflammatory bowel disease 6.00E-13 1.07 23128233 | |
| 5 96290647 rs7705093-T 5:96290647 Birdshot chorioretinopathy 2.00E-09 2.2 24957906 | |
| 5 97969453 rs467650-? x rs7153749-? 5:97969453 Venous thromboembolism (gene x gene interaction) 1.00E-08 1.49 23509962 | |
| 5 101769726 rs6878284-C 5:101769726 Schizophrenia 9.00E-09 1.09 23974872 | |
| 5 101946798 rs7705924-G 5:101946798 Crohn's disease 2.00E-08 1.48 22412388 | |
| 5 102596720 rs26232-C 5:102596720 Rheumatoid arthritis 4.00E-08 1.14 20453842 | |
| 5 102608924 rs2561477-G 5:102608924 Rheumatoid arthritis 2.00E-11 1.11 24390342 | |
| 5 102608924 rs2561477-G 5:102608924 Rheumatoid arthritis 1.00E-10 1.09 24390342 | |
| 5 102725095 rs9327881-? 5:102725095 Amyotrophic lateral sclerosis (sporadic) 5.00E-09 NR 24529757 | |
| 5 104954328 rs10479334-? 5:104954328 Personality dimensions 2.00E-09 NR 21368711 | |
| 5 107915736 rs10447248-A 5:107915736 Adiponectin levels 5.00E-08 NR 21700879 | |
| 5 108113344 rs13177718-T 5:108113344 Height 3.00E-08 0.04 20881960 | |
| 5 108502493 rs7710527-? x rs10278194-? 5:108502493 Age-related hearing impairment (interaction) 6.00E-09 NR 24939585 | |
| 5 108948937 rs367615-? 5:108948937 Colorectal cancer 4.00E-08 1.35 23300701 | |
| 5 109221026 rs112724034-? 5:109221026 Alzheimer's disease (cognitive decline) 9.00E-13 0.31 23535033 | |
| 5 110146446 rs17513503-G 5:110146446 IgE grass sensitization 1.00E-08 1.39 22036096 | |
| 5 110190052 rs10056340-G 5:110190052 Allergic sensitization 5.00E-14 1.2 23817571 | |
| 5 110401872 rs1837253-C 5:110401872 Asthma 1.00E-16 1.17 21804548 | |
| 5 110401872 rs1837253-? 5:110401872 Asthma 1.00E-14 NR 21804549 | |
| 5 110401872 rs1837253-C 5:110401872 Asthma and hay fever 1.00E-09 1.17 24388013 | |
| 5 110405675 rs3806932-? 5:110405675 Eosinophilic esophagitis (pediatric) 3.00E-09 1.85 20208534 | |
| 5 110467499 rs1438673-C 5:110467499 Self-reported allergy 2.00E-20 0.11 23817569 | |
| 5 110467499 rs1438673-C 5:110467499 Asthma and hay fever 3.00E-11 1.16 24388013 | |
| 5 113030164 rs4621553-? 5:113030164 Sudden cardiac arrest 4.00E-08 1.4 21658281 | |
| 5 113798986 rs17136627-A 5:113798986 Coronary arterial lesions in patients with Kawasaki disease 2.00E-08 12.6 23677057 | |
| 5 115759490 rs26595-T 5:115759490 Wegener's granulomatosis 2.00E-08 1.35 23740775 | |
| 5 121887537 rs4836045-? x rs12449554-? 5:121887537 Age-related hearing impairment (interaction) 4.00E-09 NR 24939585 | |
| 5 122531347 rs17470137-A 5:122531347 Aortic root size 1.00E-11 0.03 19584346 | |
| 5 122657199 rs1582931-A 5:122657199 Height 2.00E-10 0.02 20881960 | |
| 5 122855416 rs4530754-G 5:122855416 LDL cholesterol 4.00E-12 0.03 24097068 | |
| 5 122855416 rs4530754-G 5:122855416 "Cholesterol, total" 2.00E-09 0.02 24097068 | |
| 5 124332103 rs4836133-A 5:124332103 Body mass index 2.00E-09 0.07 20935630 | |
| 5 125918148 rs13182402-G 5:125918148 Osteoporosis 2.00E-09 2.25 20072603 | |
| 5 130017287 rs4836519-T 5:130017287 Inflammatory bowel disease 4.00E-10 1.07 23128233 | |
| 5 131402738 rs3091338-T 5:131402738 Crohn's disease 4.00E-08 1.23 22412388 | |
| 5 131430118 rs657075-A 5:131430118 Rheumatoid arthritis 3.00E-10 1.12 22446963 | |
| 5 131590534 rs7727544-T 5:131590534 Blood metabolite levels 7.00E-16 0.02 24816252 | |
| 5 131633355 rs419291-T 5:131633355 Blood metabolite levels 3.00E-18 0.01 24816252 | |
| 5 131652529 rs11950562-A 5:131652529 Blood metabolite levels 2.00E-41 0.04 24816252 | |
| 5 131652529 rs11950562-A 5:131652529 Blood metabolite levels 7.00E-11 0.03 24816252 | |
| 5 131660431 rs273914-A 5:131660431 Blood metabolite levels 3.00E-11 0.02 24816252 | |
| 5 131661156 rs273913-T 5:131661156 Blood metabolite levels 1.00E-25 0.03 24816252 | |
| 5 131665378 rs272889-A 5:131665378 Blood metabolite ratios 3.00E-51 0.04 24816252 | |
| 5 131665378 rs272889-A 5:131665378 Metabolic traits 7.00E-16 0.08 21886157 | |
| 5 131677997 rs272869-A 5:131677997 Blood metabolite levels 1.00E-11 0.02 24816252 | |
| 5 131686146 rs10058074-A 5:131686146 Height 4.00E-12 1.15 23563607 | |
| 5 131699867 rs274546-A 5:131699867 Height 7.00E-16 0.03 20881960 | |
| 5 131714409 rs274567-T 5:131714409 Blood metabolite levels 3.00E-12 0.02 24816252 | |
| 5 131741696 rs2405522-A 5:131741696 Blood metabolite levels 4.00E-29 0.13 24816252 | |
| 5 131744574 rs1016988-G 5:131744574 Fibrinogen 1.00E-12 6.84 20031577 | |
| 5 131756058 rs11242111-A 5:131756058 Fibrinogen 2.00E-21 0.02 23969696 | |
| 5 131769174 rs2106854-T 5:131769174 Fibrinogen 2.00E-48 0.02 23969696 | |
| 5 131770805 rs2188962-T 5:131770805 Inflammatory bowel disease 1.00E-52 1.16 23128233 | |
| 5 131770805 rs2188962-T 5:131770805 Crohn's disease 2.00E-18 1.25 18587394 | |
| 5 131784393 rs12521868-T 5:131784393 Crohn's disease 1.00E-20 1.23 21102463 | |
| 5 131801726 rs2522056-A 5:131801726 Fibrinogen 1.00E-15 0.06 20031576 | |
| 5 131819921 rs2070729-A 5:131819921 Platelet counts 1.00E-10 2.39 22139419 | |
| 5 131839618 rs4705952-G 5:131839618 C-reactive protein 1.00E-08 0.04 21300955 | |
| 5 131862977 rs4143832-C 5:131862977 Eosinophil counts 1.00E-10 7.1 19198610 | |
| 5 131973177 rs2040704-? 5:131973177 IgE levels 4.00E-08 13.9 18846228 | |
| 5 131995843 rs1295686-A 5:131995843 Atopic dermatitis 2.00E-17 1.38 23886662 | |
| 5 131995964 rs20541-A 5:131995964 IgE levels 3.00E-18 0.08 22075330 | |
| 5 131995964 rs20541-G 5:131995964 Psoriasis 5.00E-15 1.27 19169254 | |
| 5 131995964 rs20541-? 5:131995964 Hodgkin's lymphoma 1.00E-08 1.47 22286212 | |
| 5 131998413 rs2069757-A 5:131998413 Hodgkin's lymphoma 2.00E-11 1.59 24920014 | |
| 5 132049027 rs2897442-C 5:132049027 Atopic dermatitis 4.00E-08 1.11 22197932 | |
| 5 133849177 rs13187289-G 5:133849177 Menarche (age at onset) 2.00E-10 3 21102462 | |
| 5 134356705 rs526896-T 5:134356705 Height 2.00E-13 0.03 20881960 | |
| 5 134356705 rs526896-T 5:134356705 Height 9.00E-10 1.15 23563607 | |
| 5 134366200 rs3805663-T 5:134366200 Testicular germ cell tumor 2.00E-08 1.25 23666240 | |
| 5 134443606 rs254560-A 5:134443606 Ulcerative colitis 1.00E-09 1.07 21297633 | |
| 5 134443606 rs254560-A 5:134443606 Ulcerative colitis 3.00E-09 1.06 23128233 | |
| 5 134499092 rs647161-A 5:134499092 Colorectal cancer 2.00E-14 1.15 24836286 | |
| 5 134499092 rs647161-A 5:134499092 Colorectal cancer 1.00E-10 1.11 23263487 | |
| 5 134499092 rs647161-A 5:134499092 Colorectal cancer 4.00E-10 1.17 23263487 | |
| 5 137707315 rs757647-A 5:137707315 Menarche (age at onset) 5.00E-08 2.4 21102462 | |
| 5 138314106 rs2882667-? x rs449303-? 5:138314106 Age-related hearing impairment (interaction) 8.00E-09 NR 24939585 | |
| 5 138850905 rs13181561-G 5:138850905 Immune reponse to smallpox (secreted IFN-alpha) 3.00E-14 NR 22610502 | |
| 5 141479065 rs11167764-C 5:141479065 Crohn's disease 2.00E-09 1.06 21102463 | |
| 5 141513204 rs6863411-T 5:141513204 Inflammatory bowel disease 4.00E-14 1.09 23128233 | |
| 5 141681788 rs4624820-A 5:141681788 Testicular germ cell tumor 3.00E-31 1.52 23666240 | |
| 5 141681788 rs4624820-? 5:141681788 Testicular germ cell cancer 1.00E-14 1.47 20543847 | |
| 5 141681788 rs4624820-A 5:141681788 Testicular germ cell tumor 3.00E-13 1.37 19483681 | |
| 5 141681788 rs4624820-G 5:141681788 Testicular germ cell tumor 8.00E-10 1.64 23666239 | |
| 5 145038831 rs10515552-? 5:145038831 Vitamin B12 levels 4.00E-08 43.93 22367966 | |
| 5 147842353 rs11168048-? 5:147842353 Pulmonary function (interaction) 5.00E-17 NR 23284291 | |
| 5 147842353 rs11168048-T 5:147842353 Pulmonary function 1.00E-11 0.4 20010835 | |
| 5 147845815 rs3995090-C 5:147845815 Pulmonary function 4.00E-09 0.07 20010834 | |
| 5 147856333 rs7733088-? 5:147856333 Airflow obstruction 4.00E-09 1.23 22837378 | |
| 5 148904092 rs10058728-T 5:148904092 Esophageal cancer 5.00E-09 2.04 21642993 | |
| 5 150223387 rs13361189-? 5:150223387 Crohn's disease 2.00E-10 1.38 17554261 | |
| 5 150258867 rs11747270-G 5:150258867 Crohn's disease 3.00E-16 1.33 18587394 | |
| 5 150270420 rs7714584-G 5:150270420 Crohn's disease 8.00E-19 1.37 21102463 | |
| 5 150277909 rs11741861-G 5:150277909 Inflammatory bowel disease 3.00E-37 1.25 23128233 | |
| 5 150440097 rs2233287-A 5:150440097 Systemic sclerosis 5.00E-09 1.31 21750679 | |
| 5 150450236 rs4958881-G 5:150450236 Myasthenia gravis 3.00E-10 1.73 23055271 | |
| 5 150458146 rs10036748-A 5:150458146 Systemic lupus erythematosus 2.00E-09 1.23 19838193 | |
| 5 150461049 rs960709-? 5:150461049 Systemic lupus erythematosus and Systemic sclerosis 2.00E-08 1.21 23740937 | |
| 5 150473674 rs999556-? 5:150473674 Myopia (pathological) 1.00E-15 NR 23049088 | |
| 5 150478318 rs17728338-A 5:150478318 Psoriasis 1.00E-20 1.59 19169254 | |
| 5 150746034 rs10463316-A 5:150746034 Metabolite levels (Pyroglutamine) 2.00E-10 0.14 23934736 | |
| 5 152540354 rs2910032-C 5:152540354 Schizophrenia 4.00E-08 1.08 23974872 | |
| 5 152610222 rs727809-? x rs10751106-? 5:152610222 Age-related hearing impairment (interaction) 6.00E-09 NR 24939585 | |
| 5 152654479 rs17504622-T 5:152654479 Schizophrenia 3.00E-09 1.24 23974872 | |
| 5 153057548 rs12189362-? 5:153057548 Sudden cardiac arrest 3.00E-10 1.5 21658281 | |
| 5 153543466 rs7708584-A 5:153543466 Body mass index 5.00E-14 0.02 23583978 | |
| 5 153837106 rs148763909-? 5:153837106 Alzheimer's disease (cognitive decline) 1.00E-08 0.15 23535033 | |
| 5 156390297 rs6882076-T 5:156390297 "Cholesterol, total" 5.00E-41 0.05 24097068 | |
| 5 156390297 rs6882076-T 5:156390297 LDL cholesterol 3.00E-31 0.05 24097068 | |
| 5 156390297 rs6882076-T 5:156390297 "Cholesterol, total" 7.00E-28 1.98 20686565 | |
| 5 156390297 rs6882076-T 5:156390297 LDL cholesterol 2.00E-22 1.67 20686565 | |
| 5 156390297 rs6882076-T 5:156390297 Triglycerides 2.00E-15 0.03 24097068 | |
| 5 156390297 rs6882076-G 5:156390297 Triglycerides 4.00E-12 2.63 20686565 | |
| 5 156398169 rs1501908-G 5:156398169 LDL cholesterol 1.00E-11 0.07 19060906 | |
| 5 156932376 rs2277027-? 5:156932376 Pulmonary function (interaction) 2.00E-11 NR 23284291 | |
| 5 156932376 rs2277027-A 5:156932376 Pulmonary function 1.00E-10 0.38 20010835 | |
| 5 157804457 rs9313772-T 5:157804457 Blood pressure 1.00E-11 0.34 21909110 | |
| 5 157820602 rs2149954-T 5:157820602 Longevity (90 years and older) 2.00E-08 1.1 24688116 | |
| 5 157845402 rs11953630-T 5:157845402 Diastolic blood pressure 4.00E-13 0.28 21909115 | |
| 5 157845402 rs11953630-T 5:157845402 Systolic blood pressure 3.00E-11 0.41 21909115 | |
| 5 157962085 rs1878935-? x rs4077020-? 5:157962085 Age-related hearing impairment (interaction) 9.00E-09 NR 24939585 | |
| 5 158244083 rs1432679-C 5:158244083 Breast cancer 2.00E-14 1.07 23535729 | |
| 5 158604963 rs10076782-A 5:158604963 Mean platelet volume 4.00E-08 0.01 22139419 | |
| 5 158717789 rs2082412-G 5:158717789 Psoriasis 2.00E-28 1.44 19169254 | |
| 5 158750769 rs3213094-A 5:158750769 Psoriasis 3.00E-26 1.28 19169255 | |
| 5 158750769 rs3213094-? 5:158750769 Psoriasis 5.00E-11 1.39 20953190 | |
| 5 158759900 rs2546890-A 5:158759900 Psoriasis 1.00E-20 1.54 20953188 | |
| 5 158759900 rs2546890-A 5:158759900 Multiple sclerosis 1.00E-11 1.11 21833088 | |
| 5 158787385 rs6556412-A 5:158787385 Crohn's disease 5.00E-14 1.18 21102463 | |
| 5 158814533 rs10045431-C 5:158814533 Crohn's disease 4.00E-13 1.11 18587394 | |
| 5 158818745 rs6556416-C 5:158818745 Ankylosing spondylitis 2.00E-08 NR 21743469 | |
| 5 158826792 rs6871626-A 5:158826792 Inflammatory bowel disease 1.00E-42 1.18 23128233 | |
| 5 158826792 rs6871626-A 5:158826792 Ulcerative colitis 1.00E-21 1.17 21297633 | |
| 5 158829527 rs12188300-T 5:158829527 Psoriatic arthritis 7.00E-17 1.7 20953186 | |
| 5 159007778 rs10065906-C 5:159007778 Major depressive disorder 5.00E-08 1.47 23377640 | |
| 5 168256240 rs4282339-A 5:168256240 Height 7.00E-16 0.04 20881960 | |
| 5 170059227 rs11960314-? x rs2160166-? 5:170059227 Age-related hearing impairment (interaction) 4.00E-09 NR 24939585 | |
| 5 171015623 rs6892884-? 5:171015623 Height 4.00E-08 NR 20881960 | |
| 5 171151231 rs10516089-? x rs11072930-? 5:171151231 Venous thromboembolism (gene x gene interaction) 4.00E-09 1.59 23509962 | |
| 5 171181237 rs153750-G 5:171181237 Height 3.00E-10 1.16 23563607 | |
| 5 171203438 rs12153391-A 5:171203438 Height 4.00E-12 0.03 20881960 | |
| 5 172480336 rs251253-C 5:172480336 PR interval 9.00E-13 1.49 20062060 | |
| 5 172595308 rs29784-T 5:172595308 Infantile hypertrophic pyloric stenosis 8.00E-18 1.36 23989729 | |
| 5 172595308 rs29784-A 5:172595308 Infantile hypertrophic pyloric stenosis 1.00E-15 1.42 22306654 | |
| 5 172664163 rs6882776-G 5:172664163 Heart rate 2.00E-12 0.3 23583979 | |
| 5 172939426 rs6869841-A 5:172939426 Prostate cancer 5.00E-08 1.07 23535732 | |
| 5 172984114 rs889014-T 5:172984114 Height 9.00E-16 0.03 20881960 | |
| 5 173279842 rs359457-T 5:173279842 Crohn's disease 3.00E-12 1.08 21102463 | |
| 5 173337853 rs17695092-T 5:173337853 Crohn's disease 5.00E-09 1.1 23128233 | |
| 5 173362458 rs6861681-A 5:173362458 Waist-hip ratio 2.00E-09 0.02 20935629 | |
| 5 174974576 rs10476160-? x rs1707420-? 5:174974576 Venous thromboembolism (gene x gene interaction) 9.00E-09 1.61 23509962 | |
| 5 176378574 rs365132-T 5:176378574 Menopause (age at onset) 9.00E-32 0.29 22267201 | |
| 5 176378574 rs365132-T 5:176378574 Menarche and menopause (age at onset) 8.00E-14 0.39 19448621 | |
| 5 176517326 rs422421-T 5:176517326 Height 1.00E-12 0.03 20881960 | |
| 5 176794191 rs12654812-A 5:176794191 Inflammatory bowel disease 2.00E-08 1.07 23128233 | |
| 5 176798306 rs11746443-? 5:176798306 Nephrolithiasis 9.00E-12 1.19 22396660 | |
| 5 176817636 rs6420094-G 5:176817636 Chronic kidney disease 1.00E-14 0.01 20383146 | |
| 5 176841339 rs2545801-C 5:176841339 Activated partial thromboplastin time 6.00E-88 1.68 22703881 | |
| 5 176841339 rs2545801-? 5:176841339 Metabolite levels 9.00E-11 0.12 22286219 | |
| 5 176842474 rs2731672-T 5:176842474 Circulating vasoactive peptide levels 1.00E-67 4.61 23381795 | |
| 5 176842474 rs2731672-A 5:176842474 Activated partial thromboplastin time 2.00E-30 0.45 20303064 | |
| 5 176842474 rs2731672-T 5:176842474 Blood metabolite ratios 6.00E-26 0.18 24816252 | |
| 5 176842474 rs2731672-T 5:176842474 Circulating vasoactive peptide levels 6.00E-24 0.02 23381795 | |
| 5 176842474 rs2731672-? 5:176842474 Metabolite levels 3.00E-14 NR 22916037 | |
| 5 179135815 rs6893300-C 5:179135815 Resting heart rate 9.00E-09 NR 24680774 | |
| 5 179168097 rs17617068-T 5:179168097 Resting heart rate 1.00E-08 NR 24680774 | |
| 5 179731014 rs6879260-T 5:179731014 Height 2.00E-09 0.02 20881960 | |
| 6 221146 rs9501753-? 6:221146 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) 1.00E-08 NR 24554482 | |
| 6 396321 rs12203592-T 6:396321 Black vs. blond hair color 7.00E-127 0.35 18483556 | |
| 6 396321 rs12203592-T 6:396321 Freckling 2.00E-91 1.61 20585627 | |
| 6 396321 rs12203592-C 6:396321 Hair color 1.00E-28 0.35 23548203 | |
| 6 396321 rs12203592-T 6:396321 Hair color 2.00E-28 0.59 20585627 | |
| 6 396321 rs12203592-T 6:396321 Black vs. red hair color 9.00E-28 0.31 18483556 | |
| 6 396321 rs12203592-C 6:396321 Tanning 3.00E-23 0.35 23548203 | |
| 6 396321 rs12203592-T 6:396321 Eye color 2.00E-15 0.42 20585627 | |
| 6 396321 rs12203592-? 6:396321 Progressive supranuclear palsy 6.00E-15 1.48 21685912 | |
| 6 396321 rs12203592-T 6:396321 Non-melanoma skin cancer 7.00E-14 0.21 23548203 | |
| 6 411064 rs872071-G 6:411064 Chronic lymphocytic leukemia 2.00E-20 1.54 18758461 | |
| 6 411064 rs872071-G 6:411064 Chronic lymphocytic leukemia 6.00E-20 1.33 23770605 | |
| 6 411064 rs872071-G 6:411064 Chronic lymphocytic leukemia 3.00E-16 1.39 24292274 | |
| 6 411064 rs872071-G 6:411064 Chronic lymphocytic leukemia 8.00E-14 1.47 22700719 | |
| 6 426155 rs9378815-C 6:426155 Rheumatoid arthritis 2.00E-10 1.09 24390342 | |
| 6 466033 rs1540771-A 6:466033 Freckles 4.00E-18 1.4 17952075 | |
| 6 471136 rs12202284-A 6:471136 Non-melanoma skin cancer 5.00E-08 0.15 23548203 | |
| 6 475489 rs12210050-T 6:475489 Tanning 5.00E-14 0.22 19340012 | |
| 6 475489 rs12210050-T 6:475489 Basal cell carcinoma 1.00E-09 1.24 21700618 | |
| 6 1318878 rs11242675-T 6:1318878 Breast cancer 7.00E-09 1.06 23535729 | |
| 6 2912277 rs318497-? x rs7019259-? 6:2912277 Venous thromboembolism (gene x gene interaction) 5.00E-09 2.33 23509962 | |
| 6 3433318 rs17309827-T 6:3433318 Crohn's disease 7.00E-09 1.1 21102463 | |
| 6 4146198 rs9392556-T 6:4146198 Blood metabolite levels 4.00E-38 0.04 24816252 | |
| 6 5071492 rs9392653-T x rs7780976-C 6:5071492 Venous thromboembolism (gene x gene interaction) 2.00E-09 1.74 23509962 | |
| 6 6318126 rs3024321-A 6:6318126 End-stage coagulation 8.00E-142 0.89 23381943 | |
| 6 6318795 rs5985-C 6:6318795 End-stage coagulation 3.00E-186 1.08 23381943 | |
| 6 6331936 rs1318606-T 6:6331936 End-stage coagulation 4.00E-17 0.27 23381943 | |
| 6 6337506 rs11243081-C 6:6337506 End-stage coagulation 5.00E-18 0.3 23381943 | |
| 6 6341287 rs17142067-A 6:6341287 End-stage coagulation 1.00E-17 0.3 23381943 | |
| 6 6743149 rs1294421-G 6:6743149 Waist-hip ratio 2.00E-10 1.16 23563607 | |
| 6 7102084 rs675209-T 6:7102084 Urate levels 1.00E-23 0.06 23263486 | |
| 6 7102084 rs675209-T 6:7102084 Urate levels 1.00E-09 4.39 20884846 | |
| 6 7217517 rs6931262-T 6:7217517 Waist-hip ratio 3.00E-08 0.06 23966867 | |
| 6 7258617 rs9502570-A 6:7258617 Type 2 diabetes 1.00E-09 1.06 24509480 | |
| 6 7563232 rs2076295-G 6:7563232 Interstitial lung disease 1.00E-19 1.43 23583980 | |
| 6 7695973 rs1885486-A 6:7695973 Height 5.00E-17 1.18 23563607 | |
| 6 7720059 rs12198986-A 6:7720059 Height 2.00E-11 6.8 18391951 | |
| 6 7725760 rs3812163-A 6:7725760 Height 1.00E-23 0.04 20881960 | |
| 6 7801112 rs6923462-T 6:7801112 Forced vital capacity 6.00E-13 30.88 24929828 | |
| 6 10892499 rs9366664-? x rs1600646-? 6:10892499 Age-related hearing impairment (interaction) 1.00E-09 NR 24939585 | |
| 6 10897488 rs2153157-A 6:10897488 Menopause (age at onset) 8.00E-12 0.17 22267201 | |
| 6 10897488 rs2153157-T 6:10897488 Menarche and menopause (age at onset) 5.00E-08 0.29 19448621 | |
| 6 10960158 rs6918936-C 6:10960158 Phospholipid levels (plasma) 3.00E-08 0.03 21829377 | |
| 6 10969141 rs4713103-T 6:10969141 Phospholipid levels (plasma) 3.00E-36 0.04 21829377 | |
| 6 10969141 rs4713103-T 6:10969141 Phospholipid levels (plasma) 8.00E-14 0.11 21829377 | |
| 6 10982359 rs17606561-? 6:10982359 Phospholipid levels (plasma) 1.00E-11 0 22359512 | |
| 6 10982973 rs3734398-T 6:10982973 Phospholipid levels (plasma) 1.00E-43 0.04 21829377 | |
| 6 10995015 rs2236212-C 6:10995015 Phospholipid levels (plasma) 1.00E-15 0.11 21829377 | |
| 6 11008622 rs3798713-C 6:11008622 Phospholipid levels (plasma) 2.00E-12 0.04 21829377 | |
| 6 11040423 rs3798722-? 6:11040423 Metabolite levels 4.00E-09 NR 22916037 | |
| 6 11042909 rs9393903-A 6:11042909 Metabolic traits 2.00E-14 0.06 21886157 | |
| 6 11072322 rs9393915-T 6:11072322 Blood metabolite ratios 1.00E-22 0.04 24816252 | |
| 6 11074347 rs4711171-T 6:11074347 Phospholipid levels (plasma) 5.00E-13 0.01 21829377 | |
| 6 11076026 rs1321535-T 6:11076026 Phospholipid levels (plasma) 1.00E-38 0.04 21829377 | |
| 6 11076026 rs1321535-T 6:11076026 Phospholipid levels (plasma) 5.00E-11 0.04 21829377 | |
| 6 11084554 rs4713169-C 6:11084554 Blood metabolite levels 3.00E-14 0.03 24816252 | |
| 6 11730082 rs2294426-? 6:11730082 Orofacial clefts (interaction) 4.00E-08 NR 21618603 | |
| 6 12296255 rs5370-T 6:12296255 Circulating vasoactive peptide levels 1.00E-27 2.96 23381795 | |
| 6 12901441 rs9369640-C 6:12901441 Coronary artery disease 3.00E-11 1.1 24262325 | |
| 6 12903435 rs4714955-? 6:12903435 Coronary artery disease or large artery stroke 2.00E-11 NR 24262325 | |
| 6 12903435 rs4714955-? 6:12903435 Coronary artery disease or ischemic stroke 4.00E-11 NR 24262325 | |
| 6 12903957 rs9349379-? 6:12903957 Coronary heart disease 9.00E-26 NR 21846871 | |
| 6 12903957 rs9349379-? 6:12903957 Coronary heart disease 9.00E-26 NR 21378988 | |
| 6 12903957 rs9349379-A 6:12903957 Coronary artery calcification 4.00E-22 0.2 22144573 | |
| 6 12903957 rs9349379-G 6:12903957 Coronary heart disease 6.00E-12 1.19 22745674 | |
| 6 12903957 rs9349379-? 6:12903957 Migraine without aura 3.00E-10 1.16 23793025 | |
| 6 12903957 rs9349379-G 6:12903957 Coronary heart disease 8.00E-10 1.34 22745674 | |
| 6 12903957 rs9349379-G 6:12903957 Coronary heart disease 2.00E-09 1.15 22751097 | |
| 6 12903957 rs9349379-? 6:12903957 Migraine 3.00E-08 1.16 22683712 | |
| 6 12903957 rs9349379-? 6:12903957 Migraine 5.00E-08 1.08 23793025 | |
| 6 12927544 rs12526453-C 6:12927544 Coronary heart disease 1.00E-09 1.1 21378990 | |
| 6 12927544 rs12526453-C 6:12927544 Myocardial infarction (early onset) 1.00E-09 1.12 19198609 | |
| 6 13722523 rs204247-G 6:13722523 Breast cancer 8.00E-09 1.05 23535729 | |
| 6 14096658 rs12529514-C 6:14096658 Rheumatoid arthritis 2.00E-08 1.14 22446963 | |
| 6 14719496 rs17119-A 6:14719496 Inflammatory bowel disease 3.00E-11 1.07 23128233 | |
| 6 16127407 rs3757354-T 6:16127407 LDL cholesterol 2.00E-17 0.04 24097068 | |
| 6 16127407 rs3757354-T 6:16127407 "Cholesterol, total" 2.00E-15 0.04 24097068 | |
| 6 16127407 rs3757354-T 6:16127407 LDL cholesterol 1.00E-11 1.43 20686565 | |
| 6 16127407 rs3757354-T 6:16127407 "Cholesterol, total" 3.00E-09 1.46 20686565 | |
| 6 16197194 rs2142672-C 6:16197194 LDL cholesterol 2.00E-08 0.01 20864672 | |
| 6 16288192 rs6459467-A 6:16288192 Blood metabolite levels 2.00E-16 0.02 24816252 | |
| 6 19785588 rs7739264-T 6:19785588 Endometriosis 4.00E-10 1.17 23104006 | |
| 6 19841493 rs1047014-T 6:19841493 Height 2.00E-13 0.03 20881960 | |
| 6 20641336 rs9348440-A 6:20641336 Glycemic traits 3.00E-19 0.25 23575436 | |
| 6 20657564 rs4712523-G 6:20657564 Type 2 diabetes 7.00E-20 1.27 19401414 | |
| 6 20657564 rs4712523-G 6:20657564 Type 2 diabetes and other traits 2.00E-12 1.2 19734900 | |
| 6 20657865 rs4712524-G 6:20657865 Type 2 diabetes 3.00E-10 1.22 18711366 | |
| 6 20661034 rs10946398-C 6:20661034 Type 2 diabetes 1.00E-08 1.16 17463249 | |
| 6 20661250 rs7754840-C 6:20661250 Diabetes (gestational) 7.00E-16 1.52 22233651 | |
| 6 20661250 rs7754840-C 6:20661250 Type 2 diabetes 2.00E-13 1.18 23945395 | |
| 6 20661250 rs7754840-C 6:20661250 Type 2 diabetes 4.00E-11 1.12 17463246 | |
| 6 20661250 rs7754840-C 6:20661250 Type 2 diabetes 4.00E-11 1.12 17463248 | |
| 6 20661250 rs7754840-C 6:20661250 Type 2 diabetes 7.00E-10 1.35 22961080 | |
| 6 20665946 rs7772603-C 6:20665946 Glycated hemoglobin levels 4.00E-08 0.06 24647736 | |
| 6 20679709 rs7756992-G 6:20679709 Type 2 diabetes 2.00E-26 1.2 24509480 | |
| 6 20679709 rs7756992-G 6:20679709 Type 2 diabetes 8.00E-09 1.2 17460697 | |
| 6 20685486 rs9356744-T 6:20685486 Body mass index 5.00E-13 0.04 24861553 | |
| 6 20685486 rs9356744-T 6:20685486 Body mass index 2.00E-11 3.39 22344219 | |
| 6 20686573 rs7766070-A 6:20686573 Type 2 diabetes 6.00E-11 1.21 22693455 | |
| 6 20686573 rs7766070-A 6:20686573 Type 2 diabetes 7.00E-10 1.26 22693455 | |
| 6 20688121 rs10440833-A 6:20688121 Type 2 diabetes 2.00E-22 1.25 20581827 | |
| 6 20694884 rs2206734-C 6:20694884 Body mass index 1.00E-11 0.04 22344221 | |
| 6 20703952 rs6931514-G 6:20703952 Birth weight 2.00E-18 0.05 23202124 | |
| 6 20703952 rs6931514-G 6:20703952 Type 2 diabetes 1.00E-11 1.25 18372903 | |
| 6 20725423 rs7747752-C 6:20725423 Glycated hemoglobin levels 1.00E-11 0.05 22290723 | |
| 6 20728731 rs6908425-C 6:20728731 Crohn's disease 9.00E-10 1.21 18587394 | |
| 6 20728731 rs6908425-C 6:20728731 Crohn's disease 1.00E-08 1.17 21102463 | |
| 6 20812588 rs9358372-G 6:20812588 Inflammatory bowel disease 9.00E-14 1.09 23128233 | |
| 6 21384613 rs9466056-A 6:21384613 Bone mineral density 3.00E-13 0.04 22504420 | |
| 6 21430728 rs12663356-C 6:21430728 Crohn's disease 4.00E-12 1.1 23128233 | |
| 6 22125964 rs4712653-C 6:22125964 Neuroblastoma 8.00E-17 1.4 21124317 | |
| 6 22131929 rs9295536-A 6:22131929 Neuroblastoma 8.00E-16 1.36 22941191 | |
| 6 22140004 rs6939340-G 6:22140004 Neuroblastoma 9.00E-15 1.37 18463370 | |
| 6 23437676 rs7771911-A 6:23437676 Immune reponse to smallpox (secreted IL-12p40) 2.00E-12 NR 22610502 | |
| 6 24441746 rs9467160-A 6:24441746 Liver enzyme levels 1.00E-11 0.03 18940312 | |
| 6 24480295 rs6911965-C 6:24480295 Hematological and biochemical traits 2.00E-11 0.24 20139978 | |
| 6 24491475 rs1883415-C 6:24491475 Liver enzyme levels (alkaline phosphatase) 6.00E-26 3.1 22001757 | |
| 6 25533534 rs12526480-T 6:25533534 Mean platelet volume 9.00E-09 4.39 22423221 | |
| 6 25548288 rs441460-G 6:25548288 Platelet counts 9.00E-18 3.08 22139419 | |
| 6 25607571 rs742132-A 6:25607571 Uric acid levels 9.00E-09 0.05 19503597 | |
| 6 25776949 rs11754288-A 6:25776949 Blood metabolite levels 2.00E-12 0.04 24816252 | |
| 6 25776949 rs11754288-A 6:25776949 Cardiovascular disease risk factors 4.00E-09 0.08 21943158 | |
| 6 25794431 rs2762353-A 6:25794431 Blood metabolite levels 3.00E-13 0.03 24816252 | |
| 6 25813150 rs1165196-G 6:25813150 Urate levels 5.00E-25 6.21 20884846 | |
| 6 25818588 rs1185567-A 6:25818588 Blood metabolite ratios 1.00E-26 0.03 24816252 | |
| 6 25821616 rs1165151-T 6:25821616 Urate levels 7.00E-70 0.09 23263486 | |
| 6 25821770 rs17342717-T 6:25821770 Iron status biomarkers 9.00E-10 0.09 21149283 | |
| 6 25821770 rs17342717-C 6:25821770 Iron levels 5.00E-09 36.5 21208937 | |
| 6 25821770 rs17342717-T 6:25821770 Red blood cell traits 5.00E-08 0.38 20927387 | |
| 6 25823444 rs1183201-A 6:25823444 Uric acid levels 3.00E-14 0.06 19503597 | |
| 6 25842951 rs1408272-G 6:25842951 Red blood cell traits 5.00E-67 0.03 23222517 | |
| 6 25842951 rs1408272-G 6:25842951 Mean corpuscular hemoglobin 4.00E-39 0.02 19862010 | |
| 6 25842951 rs1408272-T 6:25842951 Hematology traits 1.00E-11 0.32 19853236 | |
| 6 25842951 rs1408272-T 6:25842951 Iron status biomarkers 9.00E-09 0.04 21149283 | |
| 6 25869371 rs548987-C 6:25869371 Homocysteine levels 1.00E-08 0.06 23824729 | |
| 6 25870542 rs1165205-? 6:25870542 Urate levels 4.00E-29 0.09 18834626 | |
| 6 26091179 rs1799945-G 6:26091179 Diastolic blood pressure 2.00E-15 0.46 21909115 | |
| 6 26091179 rs1799945-G 6:26091179 Systolic blood pressure 8.00E-12 0.63 21909115 | |
| 6 26091179 rs1799945-G 6:26091179 Hypertension 2.00E-10 0.1 21909115 | |
| 6 26091179 rs1799945-C 6:26091179 Iron levels 3.00E-09 4.95 21208937 | |
| 6 26093141 rs1800562-A 6:26093141 Mean corpuscular volume 1.00E-46 0.01 19862010 | |
| 6 26093141 rs1800562-A 6:26093141 Alcohol consumption (transferrin glycosylation) 2.00E-32 0.63 21665994 | |
| 6 26093141 rs1800562-A 6:26093141 Hematological parameters 1.00E-23 1.41 19820697 | |
| 6 26093141 rs1800562-G 6:26093141 Glycated hemoglobin levels 3.00E-20 0.06 20858683 | |
| 6 26093141 rs1800562-A 6:26093141 Hemoglobin 6.00E-19 0.16 19862010 | |
| 6 26093141 rs1800562-? 6:26093141 Hepcidin levels 3.00E-15 0.61 21785125 | |
| 6 26093141 rs1800562-? 6:26093141 Iron status biomarkers 4.00E-15 NR 19084217 | |
| 6 26093141 rs1800562-A 6:26093141 LDL cholesterol 8.00E-14 0.06 24097068 | |
| 6 26093141 rs1800562-A 6:26093141 "Cholesterol, total" 2.00E-12 0.06 24097068 | |
| 6 26093141 rs1800562-A 6:26093141 Cardiovascular disease risk factors 5.00E-12 0.18 21943158 | |
| 6 26093141 rs1800562-? 6:26093141 Iron status biomarkers 4.00E-11 0.66 19084217 | |
| 6 26093141 rs1800562-? 6:26093141 Hepcidin levels 5.00E-11 0.51 21785125 | |
| 6 26093141 rs1800562-? 6:26093141 Iron status biomarkers 1.00E-10 0.68 19084217 | |
| 6 26093141 rs1800562-A 6:26093141 Iron status biomarkers 6.00E-10 44.27 21483845 | |
| 6 26093141 rs1800562-A 6:26093141 LDL cholesterol 6.00E-10 2.22 20686565 | |
| 6 26093141 rs1800562-A 6:26093141 Hematocrit 2.00E-09 0.31 19862010 | |
| 6 26093141 rs1800562-A 6:26093141 Red blood cell traits 3.00E-09 0.49 20927387 | |
| 6 26093141 rs1800562-A 6:26093141 Red blood cell traits 3.00E-09 0.49 20927387 | |
| 6 26093141 rs1800562-? 6:26093141 Hepcidin levels 4.00E-09 0.44 21785125 | |
| 6 26093141 rs1800562-A 6:26093141 Mean corpuscular hemoglobin 7.00E-09 0.36 23263863 | |
| 6 26093141 rs1800562-A 6:26093141 "Cholesterol, total" 2.00E-08 2.16 20686565 | |
| 6 26093141 rs1800562-A 6:26093141 Iron status biomarkers 2.00E-08 0.22 19820699 | |
| 6 26093141 rs1800562-A 6:26093141 Iron status biomarkers 3.00E-08 35.36 21483845 | |
| 6 26107463 rs198846-G 6:26107463 Blood pressure 2.00E-12 0.48 21909110 | |
| 6 26107463 rs198846-A 6:26107463 Hemoglobin 1.00E-08 NR 19820698 | |
| 6 26200677 rs806794-A 6:26200677 Height 1.00E-39 0.05 20881960 | |
| 6 26200677 rs806794-A 6:26200677 Height 1.00E-25 1.26 23563607 | |
| 6 26233387 rs10946808-G 6:26233387 Height 4.00E-17 0.36 18391950 | |
| 6 26233387 rs10946808-? 6:26233387 Height 6.00E-12 0.07 19343178 | |
| 6 26233387 rs10946808-A 6:26233387 Height 6.00E-10 5.6 18391951 | |
| 6 26510564 rs1056667-T 6:26510564 Educational attainment 2.00E-08 0.09 23722424 | |
| 6 27037080 rs13194491-? 6:27037080 Iron status biomarkers 1.00E-08 NR 19084217 | |
| 6 27143883 rs13194053-T 6:27143883 Schizophrenia 1.00E-08 1.22 19571811 | |
| 6 27143883 rs13194053-T 6:27143883 Schizophrenia 1.00E-08 1.28 19571809 | |
| 6 27248931 rs6932590-T 6:27248931 Schizophrenia 1.00E-12 1.16 19571808 | |
| 6 27411729 rs76439045-? 6:27411729 PR interval in Tripanosoma cruzi seropositivity 5.00E-08 NR 24324551 | |
| 6 27560587 rs10946940-A 6:27560587 Systemic lupus erythematosus 8.00E-09 1.45 24871463 | |
| 6 27710165 rs17693963-? 6:27710165 Schizophrenia or bipolar disorder 3.00E-11 NR 24280982 | |
| 6 27710165 rs17693963-? 6:27710165 Schizophrenia 3.00E-11 1.24 22688191 | |
| 6 27710165 rs17693963-? 6:27710165 "Schizophrenia, schizoaffective disorder or bipolar disorder" 2.00E-09 NR 24166486 | |
| 6 27710165 rs17693963-? 6:27710165 Schizophrenia or bipolar disorder 3.00E-09 NR 24280982 | |
| 6 28227604 rs1635-? 6:28227604 Schizophrenia 7.00E-12 1.28 22037552 | |
| 6 28322296 rs6903823-G 6:28322296 Pulmonary function 2.00E-10 0.04 21946350 | |
| 6 28776117 rs4324798-A 6:28776117 Lung adenocarcinoma 2.00E-08 1.16 19836008 | |
| 6 29084232 rs3129109-T 6:29084232 Height 2.00E-17 0.03 20881960 | |
| 6 29356331 rs9257809-A 6:29356331 Barrett's esophagus 4.00E-09 1.21 22961001 | |
| 6 29434414 rs4713226-A 6:29434414 Immune reponse to smallpox (secreted IFN-alpha) 2.00E-08 NR 22610502 | |
| 6 29611431 rs29232-A 6:29611431 Nasopharyngeal carcinoma 9.00E-17 1.67 19664746 | |
| 6 29670261 rs3129055-G 6:29670261 Nasopharyngeal carcinoma 7.00E-11 1.51 19664746 | |
| 6 29705659 rs2523393-A 6:29705659 Multiple sclerosis 1.00E-17 1.28 19525953 | |
| 6 29723161 rs9258260-T 6:29723161 Crohn's disease 2.00E-10 1.45 22412388 | |
| 6 29789171 rs1610677-? 6:29789171 Rheumatoid arthritis 4.00E-15 1.32 21653640 | |
| 6 29828660 rs2523822-? 6:29828660 Drug-induced liver injury (amoxicillin-clavulanate) 2.00E-10 2.3 21570397 | |
| 6 29849619 rs2523809-T 6:29849619 IgE levels 4.00E-08 0.06 22075330 | |
| 6 29906691 rs2860580-? 6:29906691 Nasopharyngeal carcinoma 5.00E-67 1.72 20512145 | |
| 6 29918099 rs2517713-A 6:29918099 Nasopharyngeal carcinoma 4.00E-20 1.88 19664746 | |
| 6 29920332 rs9260489-G 6:29920332 Beta-2 microglubulin plasma levels 2.00E-22 0.04 23417110 | |
| 6 29920332 rs9260489-T 6:29920332 Multiple sclerosis 1.00E-11 1.21 22190364 | |
| 6 29923838 rs2571391-C 6:29923838 IgE levels 1.00E-15 0.06 22075330 | |
| 6 29935250 rs3893464-G 6:29935250 Graves' disease 2.00E-20 1.53 21900946 | |
| 6 29941943 rs2523946-C 6:29941943 IgA nephropathy 2.00E-11 1.21 22197929 | |
| 6 29942083 rs3823355-T 6:29942083 Vitiligo 9.00E-23 1.5 20410501 | |
| 6 29970589 rs7758512-? 6:29970589 HIV-1 control 2.00E-08 NR 20041166 | |
| 6 29973925 rs4313034-T 6:29973925 Graves' disease 2.00E-15 1.67 21900946 | |
| 6 30017071 rs6917603-? 6:30017071 Lipid metabolism phenotypes 3.00E-29 0.24 22286219 | |
| 6 30032522 rs8321-? 6:30032522 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 8.00E-09 1.08 23453885 | |
| 6 30075864 rs2023472-A 6:30075864 Beta-2 microglubulin plasma levels 3.00E-15 0.03 23417110 | |
| 6 30165273 rs2523722-G 6:30165273 Schizophrenia 1.00E-16 1.25 22883433 | |
| 6 30174131 rs2021722-? 6:30174131 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 2.00E-12 NR 23453885 | |
| 6 30174131 rs2021722-C 6:30174131 Schizophrenia 2.00E-12 1.15 21926974 | |
| 6 30537606 rs3132613-C 6:30537606 Graves' disease 1.00E-13 1.43 21900946 | |
| 6 30774357 rs3130783-A 6:30774357 Age-related macular degeneration 2.00E-11 1.16 23455636 | |
| 6 30876152 rs1052693-G 6:30876152 Complement C3 and C4 levels 3.00E-48 0.1 23028341 | |
| 6 31002616 rs4248154-C 6:31002616 Graves' disease 1.00E-13 1.38 21900946 | |
| 6 31018407 rs2517532-G 6:31018407 Hypothyroidism 1.00E-08 1.16 22493691 | |
| 6 31024808 rs9262632-G 6:31024808 HIV-1 control 1.00E-08 3.1 21051598 | |
| 6 31030122 rs2517510-T 6:31030122 White blood cell count 4.00E-13 0.01 21738480 | |
| 6 31058178 rs4947296-C 6:31058178 Graves' disease 4.00E-51 1.77 21841780 | |
| 6 31058178 rs4947296-? 6:31058178 Behcet's disease 1.00E-11 2.57 23001997 | |
| 6 31058340 rs3130544-A 6:31058340 Myasthenia gravis 2.00E-90 5.64 23055271 | |
| 6 31074030 rs6457327-C 6:31074030 Follicular lymphoma 5.00E-11 1.69 19620980 | |
| 6 31097301 rs3130559-T 6:31097301 Chronic obstructive pulmonary disease-related biomarkers 8.00E-09 NR 23144326 | |
| 6 31099577 rs4959053-? 6:31099577 Behcet's disease 2.00E-20 4.38 23001997 | |
| 6 31106268 rs3130573-G 6:31106268 Systemic sclerosis 6.00E-10 1.25 21750679 | |
| 6 31107187 rs1265093-A 6:31107187 Chronic obstructive pulmonary disease-related biomarkers 6.00E-09 NR 23144326 | |
| 6 31107258 rs2285803-A 6:31107258 Multiple myeloma 1.00E-10 1.19 23955597 | |
| 6 31111356 rs9263739-T 6:31111356 Ulcerative colitis 4.00E-67 2.73 19915573 | |
| 6 31118019 rs1265112-G 6:31118019 Nevirapine-induced rash 1.00E-08 4.36 21810746 | |
| 6 31118511 rs130067-G 6:31118511 Prostate cancer 3.00E-08 1.05 21743467 | |
| 6 31130593 rs1419881-? 6:31130593 Chronic hepatitis B infection 1.00E-18 1.37 23760081 | |
| 6 31136453 rs3130501-G 6:31136453 Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) 2.00E-08 1.74 21801394 | |
| 6 31136714 rs3132524-G 6:31136714 Type 2 diabetes 4.00E-09 1.07 24509480 | |
| 6 31143582 rs3131018-C 6:31143582 HIV-1 control 4.00E-16 2.1 21051598 | |
| 6 31184196 rs3869109-G 6:31184196 Coronary heart disease 1.00E-09 1.14 22319020 | |
| 6 31197514 rs3130941-C 6:31197514 IgE levels 1.00E-10 0.1 24324648 | |
| 6 31221668 rs3095254-C 6:31221668 White blood cell types 6.00E-11 0.07 21738478 | |
| 6 31232111 rs3130542-A 6:31232111 Hepatitis B 9.00E-14 1.33 24162738 | |
| 6 31238318 rs9264638-A 6:31238318 Beta-2 microglubulin plasma levels 2.00E-23 0.04 23417110 | |
| 6 31240431 rs2074488-T 6:31240431 Chronic obstructive pulmonary disease-related biomarkers 2.00E-10 NR 23144326 | |
| 6 31241109 rs13191343-T 6:31241109 Psoriatic arthritis 2.00E-72 2.37 20953186 | |
| 6 31242174 rs2524079-A 6:31242174 White blood cell count 1.00E-11 0.01 21738480 | |
| 6 31252396 rs2524054-A 6:31252396 CD4:CD8 lymphocyte ratio 2.00E-28 0.37 20045101 | |
| 6 31252396 rs2524054-A 6:31252396 CD4:CD8 lymphocyte ratio 6.00E-21 0.31 20045101 | |
| 6 31252925 rs12191877-T 6:31252925 Psoriasis 1.00E-100 2.64 19169254 | |
| 6 31252925 rs12191877-? 6:31252925 Psoriasis 4.00E-32 2.79 20953188 | |
| 6 31258837 rs9468925-? 6:31258837 Vitiligo 2.00E-33 1.35 20526339 | |
| 6 31263751 rs2894207-? 6:31263751 Nasopharyngeal carcinoma 3.00E-33 1.64 20512145 | |
| 6 31265490 rs2247056-T 6:31265490 Triglycerides 2.00E-15 2.99 20686565 | |
| 6 31265490 rs2247056-T 6:31265490 Height 4.00E-12 1.18 23563607 | |
| 6 31272321 rs9368677-G 6:31272321 Atopic dermatitis 1.00E-17 1.36 23042114 | |
| 6 31274380 rs9264942-C 6:31274380 HIV-1 control 3.00E-35 2.9 21051598 | |
| 6 31274380 rs9264942-C 6:31274380 HIV-1 control 6.00E-32 5.3 20041166 | |
| 6 31274380 rs9264942-C 6:31274380 Crohn's disease 5.00E-28 1.15 23128233 | |
| 6 31274380 rs9264942-? 6:31274380 HIV-1 control 6.00E-12 NR 20041166 | |
| 6 31274555 rs10484554-? 6:31274555 Psoriasis 4.00E-214 4.66 20953190 | |
| 6 31274555 rs10484554-T 6:31274555 Psoriasis 2.00E-39 2.8 18369459 | |
| 6 31312326 rs3134792-? 6:31312326 Psoriasis 1.00E-09 NR 18364390 | |
| 6 31322367 rs3819299-G 6:31322367 Platelet counts 9.00E-10 5.05 22139419 | |
| 6 31322559 rs2523608-G 6:31322559 HIV-1 control 9.00E-20 2.6 21051598 | |
| 6 31322559 rs2523608-A 6:31322559 Beta-2 microglubulin plasma levels 9.00E-09 0.02 23417110 | |
| 6 31327064 rs2523590-C 6:31327064 HIV-1 control 2.00E-13 2.4 21051598 | |
| 6 31327701 rs9378249-? 6:31327701 Bipolar disorder 1.00E-08 NR 21254220 | |
| 6 31336100 rs7743761-? 6:31336100 Ankylosing spondylitis 5.00E-304 NR 20062062 | |
| 6 31336418 rs9266406-? 6:31336418 Behcet's disease 2.00E-10 2.29 23001997 | |
| 6 31346822 rs9266629-C 6:31346822 Chronic obstructive pulmonary disease-related biomarkers 4.00E-10 NR 23144326 | |
| 6 31350704 rs1521-T 6:31350704 Graves' disease 2.00E-65 1.92 21841780 | |
| 6 31352113 rs9266772-C 6:31352113 Self-reported allergy 3.00E-12 0.1 23817569 | |
| 6 31353329 rs2596565-? 6:31353329 Rheumatoid arthritis (ACPA-negative) 9.00E-09 1.4 24532677 | |
| 6 31354182 rs6932730-T 6:31354182 Allergic sensitization 4.00E-08 1.14 23817571 | |
| 6 31354560 rs13437082-? 6:31354560 Height 5.00E-08 0.07 19343178 | |
| 6 31362310 rs16899524-C 6:31362310 Beta-2 microglubulin plasma levels 1.00E-08 0.04 23417110 | |
| 6 31365787 rs4349859-A 6:31365787 Ankylosing spondylitis 1.00E-200 NR 21743469 | |
| 6 31366595 rs2596542-A 6:31366595 Hepatocellular carcinoma 4.00E-13 1.39 21499248 | |
| 6 31379931 rs1063635-? 6:31379931 Rheumatoid arthritis 1.00E-17 1.35 21653640 | |
| 6 31380529 rs2256183-A 6:31380529 Height 8.00E-29 0.04 20881960 | |
| 6 31390410 rs2516448-? 6:31390410 Cervical cancer 4.00E-18 1.42 23482656 | |
| 6 31391401 rs4418214-C 6:31391401 HIV-1 control 1.00E-34 4.4 21051598 | |
| 6 31391401 rs4418214-C 6:31391401 HIV-1 susceptibility 4.00E-11 1.52 23935489 | |
| 6 31405617 rs2596466-C 6:31405617 Beta-2 microglubulin plasma levels 2.00E-12 0.05 23417110 | |
| 6 31407828 rs9469003-C 6:31407828 Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) 2.00E-09 1.73 21801394 | |
| 6 31431691 rs2255221-T 6:31431691 HIV-1 control 4.00E-14 2.7 21051598 | |
| 6 31431780 rs2395029-G 6:31431780 HIV-1 control 5.00E-35 5.8 20041166 | |
| 6 31431780 rs2395029-? 6:31431780 Drug-induced liver injury (flucloxacillin) 9.00E-33 45 19483685 | |
| 6 31431780 rs2395029-C 6:31431780 Psoriasis 2.00E-26 4.1 18369459 | |
| 6 31431780 rs2395029-G 6:31431780 HIV-1 control 1.00E-25 5.3 21051598 | |
| 6 31431780 rs2395029-G 6:31431780 AIDS progression 3.00E-19 3.47 19115949 | |
| 6 31431780 rs2395029-? 6:31431780 HIV-1 control 1.00E-11 NR 20041166 | |
| 6 31440669 rs3828890-G 6:31440669 Renal function-related traits (eGRFcrea) 1.00E-09 0.01 22797727 | |
| 6 31440669 rs3828890-G 6:31440669 Renal function-related traits (sCR) 3.00E-09 0.01 22797727 | |
| 6 31446796 rs2248462-? 6:31446796 Hodgkin's lymphoma 7.00E-16 1.64 22286212 | |
| 6 31448862 rs3749946-A 6:31448862 Ulcerative colitis 2.00E-15 1.97 24837172 | |
| 6 31448976 rs3099844-? 6:31448976 Neonatal lupus 5.00E-10 3.34 20662065 | |
| 6 31448976 rs3099844-A 6:31448976 Metabolic syndrome 2.00E-08 0.15 22399527 | |
| 6 31475486 rs3132468-? 6:31475486 Dengue shock syndrome 4.00E-11 1.34 22001756 | |
| 6 31481299 rs2516399-A 6:31481299 White blood cell types 2.00E-12 0.11 21738478 | |
| 6 31505480 rs2734583-? 6:31505480 Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) 2.00E-08 66.8 21912425 | |
| 6 31542308 rs1799964-C 6:31542308 Crohn's disease 4.00E-11 1.19 21102463 | |
| 6 31557791 rs11575839-A 6:31557791 Complement C3 and C4 levels 1.00E-54 0.23 23028341 | |
| 6 31568469 rs2857595-G 6:31568469 Pulmonary function 2.00E-10 0.04 21946350 | |
| 6 31572956 rs2844479-A 6:31572956 Height 3.00E-10 1.14 23563607 | |
| 6 31572956 rs2844479-T 6:31572956 Weight 2.00E-08 3.58 19079260 | |
| 6 31595882 rs1046080-A 6:31595882 Blood metabolite ratios 1.00E-14 0.03 24816252 | |
| 6 31602967 rs1046089-A 6:31602967 Menopause (age at onset) 2.00E-16 0.21 22267201 | |
| 6 31602967 rs1046089-A 6:31602967 Menopause (age at onset) 4.00E-11 0.19 23307926 | |
| 6 31616366 rs805303-G 6:31616366 Systolic blood pressure 2.00E-11 0.38 21909115 | |
| 6 31616366 rs805303-G 6:31616366 Diastolic blood pressure 3.00E-11 0.23 21909115 | |
| 6 31616366 rs805303-G 6:31616366 Hypertension 1.00E-10 0.05 21909115 | |
| 6 31620520 rs3117582-C 6:31620520 Lung adenocarcinoma 5.00E-12 1.22 19836008 | |
| 6 31620520 rs3117582-? 6:31620520 Lung cancer 4.00E-10 1.24 19654303 | |
| 6 31620520 rs3117582-C 6:31620520 Lung cancer 5.00E-10 1.24 18978787 | |
| 6 31622606 rs805297-A 6:31622606 Rheumatoid arthritis 3.00E-10 1.56 21844665 | |
| 6 31721033 rs3131379-A 6:31721033 Systemic lupus erythematosus 2.00E-52 2.36 18204446 | |
| 6 31778529 rs2075799-T 6:31778529 Complement C3 and C4 levels 6.00E-97 0.17 23028341 | |
| 6 31802541 rs9368699-? 6:31802541 HIV-1 control 5.00E-08 NR 20041166 | |
| 6 31837066 rs11966200-A 6:31837066 Vitiligo 1.00E-48 1.9 20526339 | |
| 6 31851234 rs652888-? 6:31851234 Chronic hepatitis B infection 7.00E-13 1.38 23760081 | |
| 6 31870326 rs558702-A 6:31870326 Systemic lupus erythematosus 8.00E-21 2.28 24871463 | |
| 6 31870856 rs9267665-? 6:31870856 Hepatitis B vaccine response 1.00E-17 2.05 21764829 | |
| 6 31903804 rs9332739-? 6:31903804 Age-related macular degeneration 2.00E-23 2.17 21665990 | |
| 6 31903804 rs9332739-? 6:31903804 Age-related macular degeneration (CNV) 2.00E-08 2.08 22705344 | |
| 6 31906010 rs9380272-A 6:31906010 Age-related macular degeneration 2.00E-08 4.31 20385819 | |
| 6 31914180 rs641153-? 6:31914180 Age-related macular degeneration 6.00E-31 1.85 21665990 | |
| 6 31914180 rs641153-? 6:31914180 Age-related macular degeneration 2.00E-20 NR 20385826 | |
| 6 31914180 rs641153-? 6:31914180 Age-related macular degeneration (CNV) 1.00E-17 2.22 22705344 | |
| 6 31914180 rs641153-? 6:31914180 Age-related macular degeneration (GA) 2.00E-09 2.13 22705344 | |
| 6 31916951 rs541862-T 6:31916951 Age-related macular degeneration 9.00E-17 1.89 22694956 | |
| 6 31919917 rs522162-? 6:31919917 Age-related macular degeneration 2.00E-10 2.33 23577725 | |
| 6 31930351 rs2734331-A 6:31930351 Blood metabolite levels 7.00E-13 0.07 24816252 | |
| 6 31930462 rs429608-G 6:31930462 Age-related macular degeneration 4.00E-89 1.74 23455636 | |
| 6 31930462 rs429608-G 6:31930462 Age-related macular degeneration 3.00E-21 2.16 20385819 | |
| 6 31930462 rs429608-? 6:31930462 Age-related macular degeneration 5.00E-15 1.85 20861866 | |
| 6 31940897 rs389884-C 6:31940897 Hematology traits 2.00E-08 0.03 23263863 | |
| 6 32019746 rs2857009-G 6:32019746 Complement C3 and C4 levels 1.00E-22 0.08 23028341 | |
| 6 32050067 rs185819-T 6:32050067 Height 3.00E-08 5.2 18391951 | |
| 6 32050758 rs1150754-A 6:32050758 Systemic lupus erythematosus 6.00E-29 2.21 21408207 | |
| 6 32074804 rs12153855-T 6:32074804 Atopic dermatitis 3.00E-14 1.58 23886662 | |
| 6 32074804 rs12153855-C 6:32074804 Age-related macular degeneration 1.00E-09 1.44 22694956 | |
| 6 32079567 rs17207986-G 6:32079567 Ulcerative colitis 1.00E-16 3.95 20848476 | |
| 6 32109979 rs204999-A 6:32109979 Serum total protein level 4.00E-11 0.03 23022100 | |
| 6 32109979 rs204999-A 6:32109979 Serum total protein level 3.00E-09 0.03 23022100 | |
| 6 32114515 rs9296009-T 6:32114515 IgG glycosylation 4.00E-08 0.21 23382691 | |
| 6 32136547 rs1061808-? 6:32136547 Phospholipid levels (plasma) 8.00E-10 0.9 22359512 | |
| 6 32151443 rs2070600-? 6:32151443 Pulmonary function (interaction) 1.00E-21 NR 23284291 | |
| 6 32151443 rs2070600-T 6:32151443 Pulmonary function 3.00E-15 0.09 20010834 | |
| 6 32151443 rs2070600-T 6:32151443 Pulmonary function 3.00E-14 1 20010835 | |
| 6 32155581 rs204993-A 6:32155581 Asthma 2.00E-15 1.17 21804548 | |
| 6 32158319 rs176095-T 6:32158319 Atopic dermatitis 8.00E-20 1.4 23042114 | |
| 6 32165444 rs2071278-G 6:32165444 Complement C3 and C4 levels 4.00E-72 0.13 23028341 | |
| 6 32171683 rs2071277-C 6:32171683 Age-related macular degeneration 2.00E-11 1.3 22694956 | |
| 6 32172993 rs3131296-G 6:32172993 Schizophrenia 2.00E-10 1.19 19571808 | |
| 6 32184345 rs404860-A 6:32184345 Asthma 4.00E-23 1.21 21804548 | |
| 6 32190406 rs443198-? 6:32190406 Systemic sclerosis 9.00E-21 1.82 21779181 | |
| 6 32190620 rs3134931-T 6:32190620 Circulating myeloperoxidase levels (serum) 1.00E-08 0.05 23620142 | |
| 6 32192331 rs3096702-A 6:32192331 Prostate cancer 5.00E-09 1.07 23535732 | |
| 6 32205045 rs549182-A 6:32205045 Ulcerative colitis 8.00E-10 1.59 24837172 | |
| 6 32208324 rs424232-C 6:32208324 Celiac disease 5.00E-21 NR 23936387 | |
| 6 32218843 rs3115573-? 6:32218843 Nephropathy 1.00E-09 1.62 20595679 | |
| 6 32218989 rs9296015-? 6:32218989 Rheumatoid arthritis 2.00E-38 NR 21505073 | |
| 6 32218989 rs9296015-? 6:32218989 Systemic sclerosis 1.00E-08 1.85 21779181 | |
| 6 32257566 rs926070-A 6:32257566 Chronic lymphocytic leukemia 4.00E-08 1.27 24292274 | |
| 6 32282854 rs6910071-G 6:32282854 Rheumatoid arthritis 1.00E-299 2.88 20453842 | |
| 6 32282854 rs6910071-? 6:32282854 Rheumatoid arthritis 2.00E-124 2.3 24449572 | |
| 6 32305979 rs3129900-? 6:32305979 Lumiracoxib-related liver injury 7.00E-25 7.5 20639878 | |
| 6 32308908 rs9469099-G 6:32308908 Atopic dermatitis 5.00E-19 1.61 23042114 | |
| 6 32315727 rs910049-A 6:32315727 Hepatitis C induced liver cirrhosis 9.00E-11 1.46 23321320 | |
| 6 32321554 rs2395148-? 6:32321554 Arthritis (juvenile idiopathic) 2.00E-10 5.37 18576341 | |
| 6 32336187 rs3129934-T 6:32336187 Multiple sclerosis 7.00E-16 2.34 22457343 | |
| 6 32336187 rs3129934-T 6:32336187 Multiple sclerosis 9.00E-11 3.3 18941528 | |
| 6 32337630 rs2273017-A 6:32337630 Graves' disease 2.00E-22 1.53 21900946 | |
| 6 32338695 rs3129943-T 6:32338695 Asthma 3.00E-15 1.17 21804548 | |
| 6 32341353 rs9268402-G 6:32341353 Coronary heart disease 3.00E-15 1.16 22751097 | |
| 6 32345283 rs7758128-A 6:32345283 Vitiligo 8.00E-11 NR 21326295 | |
| 6 32358513 rs3117098-G 6:32358513 Asthma 5.00E-12 1.16 21804548 | |
| 6 32363816 rs2076530-? 6:32363816 Sarcoidosis 3.00E-11 NR 22936702 | |
| 6 32368087 rs3817963-G 6:32368087 Lung adenocarcinoma 3.00E-10 1.18 22797724 | |
| 6 32368087 rs3817963-? 6:32368087 Multiple sclerosis (OCB status) 6.00E-10 1.61 23472185 | |
| 6 32368087 rs3817963-A 6:32368087 Hepatitis C induced liver cirrhosis 1.00E-08 1.3 23321320 | |
| 6 32373232 rs10947261-T 6:32373232 Crohn's disease 3.00E-12 1.36 23850713 | |
| 6 32373312 rs10947262-T 6:32373312 Knee osteoarthritis 5.00E-09 1.31 20305777 | |
| 6 32373698 rs3806156-T 6:32373698 Vitiligo 7.00E-19 1.42 20410501 | |
| 6 32376788 rs3763317-C 6:32376788 Complement C3 and C4 levels 9.00E-66 0.12 23028341 | |
| 6 32379489 rs9268516-T 6:32379489 Asthma 1.00E-08 1.15 23028483 | |
| 6 32379736 rs9405098-A 6:32379736 Hepatitis C induced liver cirrhosis 1.00E-10 1.37 23321320 | |
| 6 32387809 rs2395163-? 6:32387809 Parkinson's disease 3.00E-11 1.24 22451204 | |
| 6 32389648 rs3135363-? 6:32389648 Hepatitis B vaccine response 7.00E-22 1.53 21764829 | |
| 6 32389648 rs3135363-C 6:32389648 Hepatitis C induced liver cirrhosis 1.00E-10 1.37 23321320 | |
| 6 32401079 rs3129860-A 6:32401079 Hepatitis C induced liver cirrhosis 1.00E-09 1.36 23321320 | |
| 6 32401217 rs3135338-A 6:32401217 Multiple sclerosis 2.00E-25 3.43 20159113 | |
| 6 32406342 rs3129871-? 6:32406342 Multiple sclerosis (OCB status) 1.00E-16 1.98 23472185 | |
| 6 32406342 rs3129871-? 6:32406342 Multiple sclerosis (OCB status) 6.00E-15 1.72 23472185 | |
| 6 32408527 rs9268645-? 6:32408527 Type 1 diabetes 1.00E-100 NR 19430480 | |
| 6 32409530 rs3129882-? 6:32409530 Systemic sclerosis 2.00E-27 2.17 21779181 | |
| 6 32409530 rs3129882-G 6:32409530 Parkinson's disease 2.00E-10 1.26 20711177 | |
| 6 32409530 rs3129882-G 6:32409530 Parkinson's disease 5.00E-10 1.38 24511991 | |
| 6 32409530 rs3129882-G 6:32409530 Parkinson's disease 3.00E-08 1.31 24511991 | |
| 6 32412435 rs3177928-A 6:32412435 "Cholesterol, total" 1.00E-21 0.05 24097068 | |
| 6 32412435 rs3177928-A 6:32412435 "Cholesterol, total" 4.00E-19 2.31 20686565 | |
| 6 32412435 rs3177928-A 6:32412435 LDL cholesterol 3.00E-17 0.05 24097068 | |
| 6 32412435 rs3177928-A 6:32412435 LDL cholesterol 2.00E-15 1.83 20686565 | |
| 6 32413051 rs3135388-A 6:32413051 Multiple sclerosis 4.00E-225 2.75 19525953 | |
| 6 32413051 rs3135388-A 6:32413051 Multiple sclerosis 9.00E-81 1.99 17660530 | |
| 6 32413545 rs3129889-G 6:32413545 Multiple sclerosis 1.00E-206 2.97 22190364 | |
| 6 32414273 rs3129890-T 6:32414273 Asthma 5.00E-13 1.15 21804548 | |
| 6 32428285 rs6903608-G 6:32428285 Hodgkin's lymphoma 3.00E-50 1.7 21037568 | |
| 6 32428285 rs6903608-C 6:32428285 Hodgkin's lymphoma 7.00E-31 1.64 24920014 | |
| 6 32428285 rs6903608-G 6:32428285 Hodgkin's lymphoma 5.00E-27 1.62 24149102 | |
| 6 32428772 rs9268839-G 6:32428772 Rheumatoid arthritis 1.00E-250 2.47 24390342 | |
| 6 32428772 rs9268839-G 6:32428772 Rheumatoid arthritis 1.00E-250 2.28 24390342 | |
| 6 32428772 rs9268839-G 6:32428772 Rheumatoid arthritis 2.00E-145 1.9 24390342 | |
| 6 32429643 rs9268853-C 6:32429643 Rheumatoid arthritis 5.00E-109 2.4 21653640 | |
| 6 32429643 rs9268853-T 6:32429643 Ulcerative colitis 1.00E-55 1.4 21297633 | |
| 6 32429643 rs9268853-C 6:32429643 Lymphoma 2.00E-10 1.56 23349640 | |
| 6 32429719 rs9268856-C 6:32429719 Frontotemporal dementia 6.00E-09 1.24 24943344 | |
| 6 32431147 rs9268877-? 6:32431147 Ulcerative colitis 4.00E-23 NR 19915572 | |
| 6 32431147 rs9268877-T 6:32431147 Ulcerative colitis 6.00E-18 1.45 18836448 | |
| 6 32431962 rs114002140-A 6:32431962 Schizophrenia 9.00E-14 1.67 23974872 | |
| 6 32432835 rs9268923-C 6:32432835 Ulcerative colitis 4.00E-15 1.45 20228798 | |
| 6 32433167 rs2395185-? 6:32433167 Hodgkin's lymphoma 4.00E-31 1.82 22286212 | |
| 6 32433167 rs2395185-G 6:32433167 Ulcerative colitis 5.00E-22 1.92 19915573 | |
| 6 32433167 rs2395185-? 6:32433167 Ulcerative colitis 1.00E-16 1.52 19122664 | |
| 6 32433167 rs2395185-T 6:32433167 Lung cancer 1.00E-08 1.17 23143601 | |
| 6 32448599 rs7748270-T 6:32448599 Rheumatoid arthritis 1.00E-16 2.01 24782177 | |
| 6 32448599 rs7748270-T 6:32448599 Rheumatoid arthritis 4.00E-13 1.74 24782177 | |
| 6 32501144 rs2157337-? 6:32501144 Rheumatoid arthritis 9.00E-52 NR 21156761 | |
| 6 32520907 rs3828840-? 6:32520907 Multiple sclerosis (OCB status) 5.00E-15 1.94 23472185 | |
| 6 32569691 rs477515-T 6:32569691 Hepatitis B vaccine response 3.00E-19 2.05 24282030 | |
| 6 32569691 rs477515-T 6:32569691 Epstein-Barr virus immune response (EBNA-1) 3.00E-13 0.28 23326239 | |
| 6 32569691 rs477515-? 6:32569691 Inflammatory bowel disease 1.00E-08 1.38 18758464 | |
| 6 32573471 rs9270965-? 6:32573471 Narcolepsy (onset before 2009 H1N1 influenza pandemic) 5.00E-12 1.72 24204295 | |
| 6 32573991 rs9270984-T 6:32573991 Systemic lupus erythematosus 5.00E-24 1.73 23273568 | |
| 6 32574171 rs615672-? 6:32574171 Rheumatoid arthritis 8.00E-27 NR 17554300 | |
| 6 32576478 rs9271100-? 6:32576478 Systemic lupus erythematosus 1.00E-12 1.9 19838193 | |
| 6 32576795 rs9271117-? 6:32576795 Narcolepsy (onset before 2009 H1N1 influenza pandemic) 6.00E-14 1.75 24204295 | |
| 6 32577380 rs660895-? 6:32577380 Rheumatoid arthritis 1.00E-108 3.62 17804836 | |
| 6 32577380 rs660895-G 6:32577380 IgA nephropathy 4.00E-20 1.34 22197929 | |
| 6 32578082 rs674313-T 6:32578082 Chronic lymphocytic leukemia 7.00E-09 1.69 21131588 | |
| 6 32578530 rs9271192-C 6:32578530 Alzheimer's disease (late onset) 3.00E-12 1.11 24162737 | |
| 6 32581889 rs4530903-T 6:32581889 Lymphoma 3.00E-12 1.93 23349640 | |
| 6 32581889 rs4530903-T 6:32581889 Lymphoma 2.00E-08 1.37 23349640 | |
| 6 32586854 rs9271366-G 6:32586854 Multiple sclerosis 7.00E-184 2.78 19525955 | |
| 6 32586854 rs9271366-C 6:32586854 Inflammatory bowel disease 2.00E-70 4.44 21699788 | |
| 6 32586854 rs9271366-? 6:32586854 Immunoglobulin A 3.00E-33 7.69 20694011 | |
| 6 32586854 rs9271366-C 6:32586854 Inflammatory bowel disease 3.00E-31 2.41 21699788 | |
| 6 32586854 rs9271366-G 6:32586854 Ulcerative colitis 1.00E-18 2.1 23511034 | |
| 6 32586854 rs9271366-G 6:32586854 Multiple sclerosis 4.00E-17 2.62 20598377 | |
| 6 32586854 rs9271366-A 6:32586854 Crohn's disease 5.00E-12 1.66 23850713 | |
| 6 32586854 rs9271366-T 6:32586854 Inflammatory bowel disease 8.00E-11 1.79 21699788 | |
| 6 32590925 rs3129763-? 6:32590925 Systemic sclerosis 1.00E-11 1.65 21779181 | |
| 6 32590953 rs9271588-T 6:32590953 Sj��gren's syndrome 9.00E-37 1.75 24097066 | |
| 6 32592200 rs9271640-? 6:32592200 Multiple sclerosis (OCB status) 2.00E-20 2.37 23472185 | |
| 6 32592737 rs28421666-? 6:32592737 Nasopharyngeal carcinoma 2.00E-18 1.49 20512145 | |
| 6 32595223 rs9271858-G 6:32595223 Leishmaniasis (visceral) 3.00E-17 1.41 23291585 | |
| 6 32599999 rs9272105-A 6:32599999 Hepatocellular carcinoma 5.00E-22 1.28 22807686 | |
| 6 32599999 rs9272105-A 6:32599999 Response to interferon beta therapy 4.00E-10 0.26 21502966 | |
| 6 32600803 rs9272143-? 6:32600803 Cervical cancer 3.00E-22 1.49 23482656 | |
| 6 32602269 rs9272219-? 6:32602269 Rheumatoid arthritis 1.00E-45 1.92 21653640 | |
| 6 32603007 rs2040406-G 6:32603007 Multiple sclerosis 1.00E-20 2.05 20453840 | |
| 6 32604372 rs9272346-G 6:32604372 Type 1 diabetes 5.00E-134 5.49 17554300 | |
| 6 32604372 rs9272346-G 6:32604372 Type 1 diabetes 6.00E-129 NR 18978792 | |
| 6 32604372 rs9272346-? 6:32604372 Asthma 2.00E-08 NR 23181788 | |
| 6 32605884 rs2187668-? 6:32605884 Nephropathy (idiopathic membranous) 8.00E-93 4.32 21323541 | |
| 6 32605884 rs2187668-? 6:32605884 Autoimmune hepatitis type-1 2.00E-78 2.9 24768677 | |
| 6 32605884 rs2187668-A 6:32605884 Celiac disease 1.00E-50 6.23 20190752 | |
| 6 32605884 rs2187668-A 6:32605884 Immunoglobulin A 2.00E-33 2.53 20694011 | |
| 6 32605884 rs2187668-A 6:32605884 Systemic lupus erythematosus 6.00E-28 2.23 21408207 | |
| 6 32605884 rs2187668-A 6:32605884 Systemic lupus erythematosus 3.00E-21 NR 18204098 | |
| 6 32605884 rs2187668-A 6:32605884 Celiac disease 1.00E-19 7.04 17558408 | |
| 6 32612397 rs6927022-A 6:32612397 Ulcerative colitis 5.00E-133 1.44 23128233 | |
| 6 32625869 rs9273349-C 6:32625869 Asthma 7.00E-14 1.18 20860503 | |
| 6 32626130 rs7744020-A 6:32626130 Narcolepsy (age of onset) 8.00E-09 1.9 24204295 | |
| 6 32626311 rs6906021-C 6:32626311 Self-reported allergy 7.00E-15 0.09 23817569 | |
| 6 32626311 rs6906021-C 6:32626311 Allergic sensitization 2.00E-12 1.15 23817571 | |
| 6 32626601 rs9273373-G 6:32626601 Asthma and hay fever 4.00E-14 1.24 24388013 | |
| 6 32628428 rs2854275-T 6:32628428 Epstein-Barr virus immune response (EBNA-1) 2.00E-10 0.45 23326239 | |
| 6 32632832 rs9274407-? 6:32632832 Drug-induced liver injury (amoxicillin-clavulanate) 5.00E-14 3.1 21570397 | |
| 6 32633713 rs9274477-G 6:32633713 Narcolepsy (age of onset) 2.00E-08 1.82 24204295 | |
| 6 32651540 rs17212223-T 6:32651540 Narcolepsy (age of onset) 3.00E-08 1.95 24204295 | |
| 6 32657578 rs7774434-C 6:32657578 Primary biliary cirrhosis 4.00E-34 1.6 21399635 | |
| 6 32657578 rs7774434-C 6:32657578 Primary biliary cirrhosis 3.00E-26 1.75 20639880 | |
| 6 32658079 rs7775228-A 6:32658079 Asthma 5.00E-15 1.17 21804548 | |
| 6 32658079 rs7775228-C 6:32658079 IgE grass sensitization 2.00E-09 1.33 22036096 | |
| 6 32663631 rs3129720-? 6:32663631 Multiple sclerosis (OCB status) 5.00E-15 1.91 23472185 | |
| 6 32663851 rs6457617-T 6:32663851 Rheumatoid arthritis 5.00E-75 2.36 17554300 | |
| 6 32663851 rs6457617-T 6:32663851 Systemic sclerosis 2.00E-37 1.61 21750679 | |
| 6 32663851 rs6457617-T 6:32663851 Graves' disease 7.00E-33 1.4 21841780 | |
| 6 32663851 rs6457617-? 6:32663851 Systemic sclerosis 4.00E-17 1.37 20383147 | |
| 6 32663851 rs6457617-? 6:32663851 Rheumatoid arthritis 1.00E-09 NR 18668548 | |
| 6 32663999 rs6457620-? 6:32663999 Rheumatoid arthritis 4.00E-186 2.55 18794853 | |
| 6 32663999 rs6457620-C 6:32663999 Height 2.00E-16 0.03 20881960 | |
| 6 32664458 rs2647012-G 6:32664458 Follicular lymphoma 2.00E-21 1.56 21533074 | |
| 6 32664960 rs9357152-G 6:32664960 HPV seropositivity 1.00E-14 NR 21896673 | |
| 6 32665420 rs10484561-G 6:32665420 Follicular lymphoma 1.00E-29 1.95 20639881 | |
| 6 32666295 rs9275319-A 6:32666295 Hepatocellular carcinoma (hepatitis B virus related) 3.00E-17 1.49 23242368 | |
| 6 32667910 rs2647044-A 6:32667910 Type 1 diabetes 1.00E-16 8.3 17632545 | |
| 6 32668100 rs2647045-? 6:32668100 Lymphoma 4.00E-10 1.69 23349640 | |
| 6 32669156 rs9275390-? 6:32669156 Systemic sclerosis 3.00E-54 2.38 21779181 | |
| 6 32669955 rs9275406-T 6:32669955 Rheumatoid arthritis 3.00E-12 2.1 23918589 | |
| 6 32670255 rs2856718-A 6:32670255 Hepatitis B 4.00E-37 1.56 21750111 | |
| 6 32670255 rs2856718-? 6:32670255 Chronic hepatitis B infection 2.00E-24 1.6 23760081 | |
| 6 32671103 rs13192471-G 6:32671103 Rheumatoid arthritis 2.00E-58 1.97 20453841 | |
| 6 32671248 rs1794275-A 6:32671248 IgA nephropathy 3.00E-13 1.3 22197929 | |
| 6 32675470 rs12525220-A 6:32675470 Rheumatoid arthritis 7.00E-14 3.02 24782177 | |
| 6 32675470 rs12525220-A 6:32675470 Rheumatoid arthritis 2.00E-13 2.87 24782177 | |
| 6 32675470 rs12525220-A 6:32675470 Rheumatoid arthritis 3.00E-12 2.61 24782177 | |
| 6 32677912 rs9275563-? 6:32677912 Multiple sclerosis (OCB status) 6.00E-11 1.75 23472185 | |
| 6 32678597 rs4273729 6:32678597 Chronic hepatitis C infection 5.00E-17 1.59 23420232 | |
| 6 32678999 rs9275572-G 6:32678999 Alopecia areata 1.00E-35 2.21 20596022 | |
| 6 32678999 rs9275572-T 6:32678999 Chronic hepatitis C infection 4.00E-16 1.27 24376798 | |
| 6 32678999 rs9275572-A 6:32678999 Systemic lupus erythematosus 5.00E-16 1.74 24871463 | |
| 6 32678999 rs9275572-A 6:32678999 Hepatocellular carcinoma 6.00E-09 1.3 21499248 | |
| 6 32680576 rs7764819-T 6:32680576 Pulmonary function (interaction) 4.00E-09 0 23284291 | |
| 6 32680576 rs7764819-T 6:32680576 Pulmonary function (interaction) 4.00E-09 0 23284291 | |
| 6 32680928 rs7765379-G 6:32680928 Crohn's disease 9.00E-59 1.93 23266558 | |
| 6 32680928 rs7765379-? 6:32680928 Rheumatoid arthritis 5.00E-23 2.51 21452313 | |
| 6 32681277 rs2858331-G 6:32681277 IgE levels 1.00E-08 0.04 22075330 | |
| 6 32681631 rs9275596-? 6:32681631 Nephropathy 2.00E-26 1.59 21399633 | |
| 6 32687973 rs9275698-T 6:32687973 Asthma 5.00E-12 1.18 21804548 | |
| 6 32700083 rs2858884-A 6:32700083 Narcolepsy 3.00E-08 1.79 20711174 | |
| 6 32707295 rs9276370-T 6:32707295 Chronic hepatitis B infection 2.00E-12 1.95 24940741 | |
| 6 32725193 rs2301271-T 6:32725193 Systemic lupus erythematosus 2.00E-12 1.47 21408207 | |
| 6 32726803 rs1049110-C 6:32726803 IgG glycosylation 2.00E-08 0.19 23382691 | |
| 6 32726803 rs1049110-C 6:32726803 IgG glycosylation 4.00E-08 0.19 23382691 | |
| 6 32730012 rs7453920-G 6:32730012 Hepatitis B 5.00E-37 1.89 24162738 | |
| 6 32730012 rs7453920-G 6:32730012 Hepatitis B 6.00E-28 1.81 21750111 | |
| 6 32730012 rs7453920-? 6:32730012 Chronic hepatitis B infection 7.00E-26 2 23760081 | |
| 6 32730012 rs7453920-G 6:32730012 Chronic hepatitis B infection 7.00E-15 2.31 24940741 | |
| 6 32730086 rs2051549-? 6:32730086 Systemic lupus erythematosus 3.00E-22 NR 23053960 | |
| 6 32736695 rs9276606-T 6:32736695 Complement C3 and C4 levels 3.00E-22 0.09 23028341 | |
| 6 32741868 rs2621416-G 6:32741868 Lymphoma 2.00E-09 1.57 23349640 | |
| 6 32763514 rs2857151-G 6:32763514 Kawasaki disease 5.00E-11 1.47 22446962 | |
| 6 32804070 rs241428-G 6:32804070 Complement C3 and C4 levels 9.00E-83 0.23 23028341 | |
| 6 32809848 rs9357155-? 6:32809848 Nephropathy 2.00E-12 1.41 21399633 | |
| 6 32852647 rs2187689-C 6:32852647 Disc degeneration (lumbar) 3.00E-08 0.23 22993228 | |
| 6 32961361 rs9500927-T 6:32961361 Asthma 4.00E-09 1.13 21804548 | |
| 6 32975014 rs399604-C 6:32975014 Platelet counts 1.00E-10 2.35 22139419 | |
| 6 33033022 rs3077-G 6:33033022 Hepatitis B 2.00E-61 1.87 21750111 | |
| 6 33033022 rs3077-C 6:33033022 Hepatitis B (viral clearance) 4.00E-45 1.82 22737229 | |
| 6 33033022 rs3077-? 6:33033022 Chronic hepatitis B infection 5.00E-39 1.89 23760081 | |
| 6 33033022 rs3077-C 6:33033022 Hepatitis B (viral clearance) 1.00E-09 1.67 22737229 | |
| 6 33042880 rs987870-? 6:33042880 Systemic sclerosis 2.00E-20 2.09 21779181 | |
| 6 33042880 rs987870-C 6:33042880 Asthma 2.00E-10 1.4 21814517 | |
| 6 33054861 rs9277535-G 6:33054861 Hepatitis B 3.00E-54 1.77 21750111 | |
| 6 33054861 rs9277535-? 6:33054861 Chronic hepatitis B infection 4.00E-40 1.89 23760081 | |
| 6 33054861 rs9277535-G 6:33054861 Hepatitis B 6.00E-39 1.75 19349983 | |
| 6 33054861 rs9277535-G 6:33054861 Hepatitis B (viral clearance) 2.00E-21 1.64 22737229 | |
| 6 33054861 rs9277535-G 6:33054861 Hepatitis B (viral clearance) 2.00E-17 1.52 22737229 | |
| 6 33054861 rs9277535-G 6:33054861 Chronic hepatitis B infection 5.00E-14 1.59 24940741 | |
| 6 33054861 rs9277535-? 6:33054861 Hepatitis B vaccine response 3.00E-12 1.39 21764829 | |
| 6 33055538 rs9277554-C 6:33055538 Wegener's granulomatosis 2.00E-50 4.17 23740775 | |
| 6 33060118 rs2281388-T 6:33060118 Graves' disease 2.00E-65 1.64 21841780 | |
| 6 33069893 rs3117242-? 6:33069893 Antineutrophil cytoplasmic antibody-associated vasculitis 1.00E-71 3.67 22808956 | |
| 6 33072172 rs4282438-? 6:33072172 Cervical cancer 5.00E-27 1.35 23817570 | |
| 6 33072172 rs4282438-G 6:33072172 Sj��gren's syndrome 9.00E-25 1.58 24097066 | |
| 6 33086448 rs1883414-? 6:33086448 Nephropathy 5.00E-09 1.28 21399633 | |
| 6 33104175 rs9366816-C 6:33104175 Chronic hepatitis B infection 3.00E-10 1.43 24940741 | |
| 6 33143948 rs2254287-G 6:33143948 LDL cholesterol 5.00E-08 1.91 18193043 | |
| 6 33204274 rs9277952-? 6:33204274 Cervical cancer 2.00E-09 1.18 23817570 | |
| 6 33540209 rs210134-G 6:33540209 Platelet counts 7.00E-36 4.96 22139419 | |
| 6 33540209 rs210134-G 6:33540209 Mean platelet volume 2.00E-15 6.16 22423221 | |
| 6 33540209 rs210134-A 6:33540209 Platelet counts 2.00E-08 8.92 23263863 | |
| 6 33541719 rs513349-A 6:33541719 Platelet counts 2.00E-12 7.75 23263863 | |
| 6 33542538 rs210138-G 6:33542538 Testicular germ cell tumor 2.00E-24 1.44 23666240 | |
| 6 33542538 rs210138-G 6:33542538 Testicular germ cell tumor 1.00E-13 1.5 19483681 | |
| 6 33546837 rs210142-C 6:33546837 Chronic lymphocytic leukemia 9.00E-16 1.4 22700719 | |
| 6 33546837 rs210142-C 6:33546837 Chronic lymphocytic leukemia 5.00E-08 1.22 23770605 | |
| 6 33548394 rs5745568-T 6:33548394 Platelet counts 7.00E-11 0.09 20139978 | |
| 6 33618162 rs9394159-T 6:33618162 Graves' disease 4.00E-12 1.36 21900946 | |
| 6 33659046 rs4711336-? 6:33659046 Height 3.00E-08 NR 20881960 | |
| 6 33706479 rs9469578-T 6:33706479 Phosphorus levels 1.00E-11 0.06 20558539 | |
| 6 33764033 rs751728-T 6:33764033 Crohn's disease 1.00E-08 1.32 23850713 | |
| 6 33817929 rs4713693-T 6:33817929 Graves' disease 7.00E-13 1.4 21900946 | |
| 6 34036446 rs1906953-A 6:34036446 Osteosarcoma 8.00E-09 1.57 23727862 | |
| 6 34165721 rs7742369-G 6:34165721 Height 1.00E-13 0.11 20189936 | |
| 6 34194866 rs1759645-C 6:34194866 Height 5.00E-15 1.29 23563607 | |
| 6 34195011 rs1776897-? 6:34195011 Height 8.00E-11 0.12 19343178 | |
| 6 34195011 rs1776897-C 6:34195011 Height 1.00E-08 8.8 18391951 | |
| 6 34199092 rs2780226-T 6:34199092 Height 8.00E-28 0.08 20881960 | |
| 6 34214322 rs1150781-C 6:34214322 Height 2.00E-08 0.05 21998595 | |
| 6 34238514 rs6918981-G 6:34238514 Height 2.00E-08 0.55 19893584 | |
| 6 34238514 rs6918981-G 6:34238514 Height 3.00E-08 0.4 19396169 | |
| 6 34302869 rs206936-G 6:34302869 Body mass index 3.00E-08 0.06 20935630 | |
| 6 34546560 rs2814982-T 6:34546560 "Cholesterol, total" 4.00E-15 0.04 24097068 | |
| 6 34546560 rs2814982-T 6:34546560 "Cholesterol, total" 5.00E-11 1.86 20686565 | |
| 6 34552797 rs2814944-A 6:34552797 HDL cholesterol 4.00E-09 0.49 20686565 | |
| 6 34581636 rs2744971-G 6:34581636 Height 8.00E-13 1.26 23563607 | |
| 6 34618893 rs2814993-A 6:34618893 Height 4.00E-12 0.09 18391952 | |
| 6 34683635 rs6938239-? 6:34683635 Height 6.00E-12 NR 20881960 | |
| 6 34823187 rs3734266-G 6:34823187 Systemic lupus erythematosus 1.00E-12 1.56 23273568 | |
| 6 34845449 rs4646949-? 6:34845449 Fasting insulin-related traits (interaction with BMI) 4.00E-08 NR 22581228 | |
| 6 35005084 rs13210323-A 6:35005084 Height 8.00E-12 1.17 23563607 | |
| 6 35034800 rs17609940-G 6:35034800 Coronary heart disease 1.00E-08 1.07 21378990 | |
| 6 35341850 rs9470004-T 6:35341850 Height 1.00E-11 0.08 21998595 | |
| 6 35402785 rs4713858-G 6:35402785 Height 4.00E-08 6.8 18391951 | |
| 6 35402805 rs6457821-A 6:35402805 Height 2.00E-12 0.1 20881960 | |
| 6 36618821 rs1321313-C 6:36618821 Electrocardiographic conduction measures 5.00E-25 0.81 23463857 | |
| 6 36622900 rs1321311-? 6:36622900 Colorectal cancer 1.00E-10 1.1 22634755 | |
| 6 36622900 rs1321311-T 6:36622900 Electrocardiographic traits 3.00E-10 6.52 20062063 | |
| 6 36623379 rs9470361-A 6:36623379 QRS duration 3.00E-27 0.87 21076409 | |
| 6 38106844 rs9470794-C 6:38106844 Type 2 diabetes 2.00E-10 1.12 22158537 | |
| 6 38365841 rs9296249-T 6:38365841 Restless legs syndrome 4.00E-18 1.67 17637780 | |
| 6 38365873 rs9357271-T 6:38365873 Restless legs syndrome 8.00E-22 1.47 21779176 | |
| 6 38440970 rs3923809-A 6:38440970 Restless legs syndrome 1.00E-17 1.9 17634447 | |
| 6 39250837 rs2758886-A 6:39250837 "Cholesterol, total" 3.00E-08 0.02 24097068 | |
| 6 39284050 rs1535500-T 6:39284050 Type 2 diabetes 2.00E-08 1.08 22158537 | |
| 6 40536128 rs2494938-A 6:40536128 "Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)" 1.00E-12 1.15 23103227 | |
| 6 40536128 rs2494938-A 6:40536128 "Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)" 5.00E-09 1.18 23103227 | |
| 6 40603057 rs4301303-? x rs10444487-? 6:40603057 Age-related hearing impairment (interaction) 7.00E-09 NR 24939585 | |
| 6 40802261 rs10484761-G 6:40802261 Esophageal cancer 7.00E-12 1.33 21642993 | |
| 6 41127972 rs7748513-G 6:41127972 C-reactive protein 1.00E-10 NR 22939635 | |
| 6 41129252 rs75932628-T 6:41129252 Alzheimer's disease 2.00E-12 2.9 23150908 | |
| 6 41336101 rs6922617-A 6:41336101 Alzheimer's disease biomarkers 4.00E-08 0.09 23562540 | |
| 6 41905275 rs3218097-A 6:41905275 Mean corpuscular volume 4.00E-27 0.16 20139978 | |
| 6 41905275 rs3218097-A 6:41905275 Mean corpuscular hemoglobin 2.00E-20 0.14 20139978 | |
| 6 41905275 rs3218097-T 6:41905275 Red blood cell count 1.00E-10 0.1 20139978 | |
| 6 41914378 rs9349204-G 6:41914378 Red blood cell traits 2.00E-40 0.37 23222517 | |
| 6 41925159 rs9349205-A 6:41925159 Mean corpuscular volume 1.00E-31 0.01 19862010 | |
| 6 41925159 rs9349205-A 6:41925159 Mean corpuscular hemoglobin 8.00E-20 0.01 19862010 | |
| 6 41925290 rs11970772-T 6:41925290 Hematological parameters 7.00E-19 0.58 19820697 | |
| 6 42925803 rs9296404-T 6:42925803 Plasma homocysteine levels (post-methionine load test) 2.00E-63 0.36 24651765 | |
| 6 43757896 rs998584-A 6:43757896 Triglycerides 3.00E-15 0.49 24097068 | |
| 6 43757896 rs998584-A 6:43757896 HDL cholesterol 2.00E-11 0.03 24097068 | |
| 6 43757896 rs998584-C 6:43757896 Adiponectin levels 3.00E-08 0.03 22479202 | |
| 6 43764551 rs1358980-T 6:43764551 Sexual dimorphism in anthropometric traits 2.00E-11 NR 23754948 | |
| 6 43795968 rs943072-G 6:43795968 Ulcerative colitis 2.00E-10 1.15 21297633 | |
| 6 43804571 rs729761-T 6:43804571 Urate levels 8.00E-16 0.05 23263486 | |
| 6 43806609 rs881858-G 6:43806609 Chronic kidney disease 9.00E-14 1.08 20383146 | |
| 6 43811762 rs9472138-T 6:43811762 Thyroid hormone levels 7.00E-16 0.08 23408906 | |
| 6 43811762 rs9472138-T 6:43811762 Thyroid hormone levels 6.00E-12 0.09 23408906 | |
| 6 43826627 rs943080-T 6:43826627 Age-related macular degeneration 9.00E-16 1.15 23455636 | |
| 6 43828582 rs4711751-T 6:43828582 Age-related macular degeneration 9.00E-09 1.15 21665990 | |
| 6 43897727 rs9472155-T 6:43897727 Vascular endothelial growth factor levels 2.00E-26 NR 21757650 | |
| 6 43904780 rs11755845-T 6:43904780 Thyroid hormone levels 2.00E-10 0.07 23408906 | |
| 6 44232920 rs2233434-G 6:44232920 Rheumatoid arthritis 6.00E-19 1.19 22446963 | |
| 6 44232920 rs2233434-G 6:44232920 Rheumatoid arthritis 1.00E-15 1.2 23028356 | |
| 6 44233921 rs2233424-T 6:44233921 Rheumatoid arthritis 1.00E-19 1.26 24390342 | |
| 6 44233921 rs2233424-T 6:44233921 Rheumatoid arthritis 2.00E-13 1.24 24390342 | |
| 6 44233921 rs2233424-T 6:44233921 Rheumatoid arthritis 3.00E-08 1.33 24390342 | |
| 6 44594159 rs556621-A 6:44594159 Stroke (ischemic) 5.00E-08 1.21 22941190 | |
| 6 44639184 rs11755164-T 6:44639184 Bone mineral density 6.00E-11 0.04 22504420 | |
| 6 44946506 rs9472414-A 6:44946506 Height 2.00E-09 0.03 20881960 | |
| 6 45244415 rs10948222-C 6:45244415 Height 5.00E-11 1.15 23563607 | |
| 6 46675025 rs7756935-A 6:46675025 Lipoprotein-associated phospholipase A2 activity and mass 1.00E-10 0.03 22003152 | |
| 6 46682079 rs1362931-A 6:46682079 Lipoprotein-associated phospholipase A2 activity and mass 3.00E-19 0.02 23118302 | |
| 6 46684222 rs1805017-T 6:46684222 Lipoprotein-associated phospholipase A2 activity and mass 2.00E-23 0.04 22003152 | |
| 6 46684222 rs1805017-T 6:46684222 Lipoprotein-associated phospholipase A2 activity and mass 6.00E-14 11.1 20442857 | |
| 6 47453378 rs9349407-C 6:47453378 Alzheimer's disease (late onset) 9.00E-09 1.11 21460841 | |
| 6 47487762 rs10948363-G 6:47487762 Alzheimer's disease (late onset) 5.00E-11 1.1 24162737 | |
| 6 49382193 rs9369898-A 6:49382193 Homocysteine levels 2.00E-10 0.04 23824729 | |
| 6 49409487 rs9473555-? 6:49409487 Folate pathway vitamin levels 5.00E-08 0.04 19744961 | |
| 6 50798526 rs2206277-T 6:50798526 Obesity 5.00E-22 1.12 23563607 | |
| 6 50798526 rs2206277-T 6:50798526 Obesity 7.00E-16 1.07 23563607 | |
| 6 50803050 rs987237-G 6:50803050 Body mass index 3.00E-20 0.13 20935630 | |
| 6 50803050 rs987237-G 6:50803050 Body mass index 2.00E-11 1.2 23563607 | |
| 6 50803050 rs987237-G 6:50803050 Adiposity 2.00E-11 0.04 19557161 | |
| 6 50836279 rs734597-A 6:50836279 Obesity (extreme) 3.00E-08 NR 21935397 | |
| 6 50845490 rs2207139-G 6:50845490 Obesity 3.00E-19 1.2 23563607 | |
| 6 52101739 rs763780-G 6:52101739 Response to gemcitabine in pancreatic cancer 3.00E-08 3.3 22142827 | |
| 6 53924697 rs9296736-T 6:53924697 Liver enzyme levels (gamma-glutamyl transferase) 3.00E-09 3 22001757 | |
| 6 70182710 rs78536982-T 6:70182710 Triglycerides 7.00E-09 1.38 24886709 | |
| 6 71289189 rs1048886-G 6:71289189 Type 2 diabetes 3.00E-08 1.54 21490949 | |
| 6 72193707 rs9351814-? 6:72193707 Coronary artery disease or ischemic stroke 5.00E-08 NR 24262325 | |
| 6 73643289 rs7744813-C 6:73643289 Refractive error 4.00E-09 0.11 23396134 | |
| 6 76265642 rs9360921-T 6:76265642 Height 3.00E-13 0.04 20881960 | |
| 6 79556166 rs16890334-C 6:79556166 Blood pressure measurement (high sodium and potassium intervention) 1.00E-10 5.38 24165912 | |
| 6 79556166 rs16890334-C 6:79556166 Blood pressure measurement (high sodium intervention) 4.00E-09 5.43 24165912 | |
| 6 80845989 rs2322633-T 6:80845989 Height 3.00E-09 1.12 23563607 | |
| 6 81800362 rs310405-A 6:81800362 Height 2.00E-13 0.03 20881960 | |
| 6 81800362 rs310405-A 6:81800362 Height 1.00E-10 1.14 23563607 | |
| 6 82193109 rs17530068-G 6:82193109 Breast cancer 8.00E-09 1.05 23535729 | |
| 6 82794594 rs1538138-T 6:82794594 Corneal structure 1.00E-12 0.07 23291589 | |
| 6 86117129 rs494562-G 6:86117129 Metabolic traits 7.00E-13 0.3 21886157 | |
| 6 86117129 rs494562-A 6:86117129 Blood metabolite levels 1.00E-12 0.12 24816252 | |
| 6 87867063 rs1925690-? 6:87867063 MRI atrophy measures 3.00E-08 0 21116278 | |
| 6 89732101 rs12201676-? 6:89732101 Bipolar disorder and schizophrenia 4.00E-08 1.31 20889312 | |
| 6 89879168 rs7775554-A 6:89879168 Blood metabolite levels 1.00E-15 0.02 24816252 | |
| 6 90657783 rs404256-C 6:90657783 IgG glycosylation 7.00E-09 0.21 23382691 | |
| 6 90880035 rs2474619-? 6:90880035 Celiac disease 2.00E-08 1.28 24999842 | |
| 6 90880393 rs10944479-A 6:90880393 Thyroid peroxidase antibody positivity 4.00E-08 1.25 24586183 | |
| 6 90926612 rs10806425-A 6:90926612 Celiac disease 4.00E-10 1.13 20190752 | |
| 6 90957463 rs3757247-A 6:90957463 Vitiligo 3.00E-08 1.2 22561518 | |
| 6 90958231 rs11755527-G 6:90958231 Type 1 diabetes 5.00E-12 1.13 18978792 | |
| 6 90958231 rs11755527-G 6:90958231 Type 1 diabetes autoantibodies 3.00E-08 1.1 21829393 | |
| 6 90958231 rs11755527-? 6:90958231 Type 1 diabetes 5.00E-08 NR 19430480 | |
| 6 90973159 rs1847472-C 6:90973159 Inflammatory bowel disease 2.00E-10 1.06 23128233 | |
| 6 90973159 rs1847472-G 6:90973159 Crohn's disease 5.00E-09 1.07 21102463 | |
| 6 90996769 rs12212193-G 6:90996769 Multiple sclerosis 4.00E-08 1.09 21833088 | |
| 6 95156418 rs2224003-? 6:95156418 Brain connectivity 1.00E-09 NR 23471985 | |
| 6 95156454 rs10485022-? 6:95156454 Brain connectivity 5.00E-09 NR 23471985 | |
| 6 97065212 rs11759769-A 6:97065212 Migraine without aura 2.00E-12 1.18 23793025 | |
| 6 97065212 rs11759769-A 6:97065212 Migraine 1.00E-11 1.1 23793025 | |
| 6 98576223 rs12202969-A 6:98576223 Bipolar disorder 1.00E-08 1.12 24618891 | |
| 6 98584733 rs9320913-A 6:98584733 Educational attainment 4.00E-10 0.1 23722424 | |
| 6 98990489 rs6904416-C 6:98990489 C-reactive protein and white blood cell count 9.00E-10 0.18 22788528 | |
| 6 100208438 rs4840086-G 6:100208438 Menarche (age at onset) 2.00E-08 2.1 21102462 | |
| 6 105180785 rs4336470-C 6:105180785 Neuroblastoma 3.00E-11 1.26 22941191 | |
| 6 105367616 rs9391253-T 6:105367616 Height 5.00E-12 1.16 23563607 | |
| 6 105378954 rs7759938-C 6:105378954 Menarche (age at onset) 5.00E-60 6.4 21102462 | |
| 6 105378954 rs7759938-T 6:105378954 Height 8.00E-31 0.05 20881960 | |
| 6 105378954 rs7759938-C 6:105378954 Pubertal anthropometrics 4.00E-09 0.11 23449627 | |
| 6 105378954 rs7759938-C 6:105378954 Menarche (age at onset) 7.00E-09 0.09 19448620 | |
| 6 105400837 rs314280-T 6:105400837 Menarche (age at onset) 2.00E-14 1.2 19448622 | |
| 6 105406274 rs17065417-A 6:105406274 Neuroblastoma 1.00E-08 1.38 22941191 | |
| 6 105407662 rs314277-A 6:105407662 Menarche and menopause (age at onset) 3.00E-13 0.16 19448621 | |
| 6 105407662 rs314277-A 6:105407662 Height 1.00E-08 0.41 18391950 | |
| 6 105407999 rs314276-C 6:105407999 Menarche (age at onset) 4.00E-16 0.14 19448623 | |
| 6 105407999 rs314276-C 6:105407999 Puberty onset 2.00E-08 0.08 24770850 | |
| 6 106188818 rs6568401-C 6:106188818 Primary tooth development (time to first tooth eruption) 2.00E-10 0.19 23704328 | |
| 6 106435025 rs6568421-G 6:106435025 Inflammatory bowel disease 8.00E-20 1.11 23128233 | |
| 6 106435025 rs6568421-G 6:106435025 Crohn's disease 4.00E-08 1.13 21102463 | |
| 6 106435269 rs7746082-C 6:106435269 Crohn's disease 2.00E-10 1.17 18587394 | |
| 6 106522027 rs6911490-T 6:106522027 Ulcerative colitis 1.00E-08 1.08 21297633 | |
| 6 106568034 rs548234-G 6:106568034 Systemic lupus erythematosus 5.00E-12 1.25 19838193 | |
| 6 106667535 rs9372120-G 6:106667535 Rheumatoid arthritis 8.00E-10 1.11 24390342 | |
| 6 106667535 rs9372120-G 6:106667535 Rheumatoid arthritis 4.00E-08 1.1 24390342 | |
| 6 108017671 rs12525668-? 6:108017671 Myopia (pathological) 8.00E-11 NR 23049088 | |
| 6 109268050 rs2798641-T 6:109268050 Pulmonary function 8.00E-09 0.04 21946350 | |
| 6 109285189 rs2273669-G 6:109285189 Prostate cancer 8.00E-09 1.07 23535732 | |
| 6 109608497 rs9386791-C 6:109608497 Red blood cell traits 1.00E-08 0.23 23446634 | |
| 6 109616420 rs9374080-C 6:109616420 Mean corpuscular volume 4.00E-10 0 19862010 | |
| 6 109626965 rs1008084-G 6:109626965 Red blood cell traits 6.00E-26 0.01 23222517 | |
| 6 109634828 rs11966072-G 6:109634828 Red blood cell count 7.00E-09 0.11 20139978 | |
| 6 109634828 rs11966072-G 6:109634828 Mean corpuscular hemoglobin 1.00E-08 0.11 20139978 | |
| 6 109634828 rs11966072-G 6:109634828 Mean corpuscular volume 3.00E-08 0.11 20139978 | |
| 6 109783941 rs1046943-A 6:109783941 Height 3.00E-08 0.02 20881960 | |
| 6 111424015 rs9400467-T 6:111424015 Blood metabolite levels 7.00E-14 0.01 24816252 | |
| 6 111554822 rs6901004-C 6:111554822 Blood metabolite levels 1.00E-11 0.01 24816252 | |
| 6 111673714 rs240993-A 6:111673714 Psoriasis 5.00E-20 1.25 20953190 | |
| 6 111747083 rs7760535-G 6:111747083 Metabolic traits 1.00E-12 0.04 21886157 | |
| 6 111794409 rs6900341-? 6:111794409 Metabolite levels 4.00E-15 0.13 22286219 | |
| 6 111848191 rs3851228-T 6:111848191 Inflammatory bowel disease 1.00E-13 1.15 23128233 | |
| 6 111913262 rs33980500-T 6:111913262 Psoriatic arthritis 1.00E-20 1.95 20953186 | |
| 6 111913262 rs33980500-T 6:111913262 Psoriasis 1.00E-16 NR 20953188 | |
| 6 112122226 rs2148710-T 6:112122226 Anger 3.00E-08 0.22 24489884 | |
| 6 114622214 rs7770227-? x rs10230573-? 6:114622214 Age-related hearing impairment (interaction) 5.00E-09 NR 24939585 | |
| 6 116312893 rs9488822-T 6:116312893 "Cholesterol, total" 2.00E-10 1.18 20686565 | |
| 6 116312893 rs9488822-T 6:116312893 "Cholesterol, total" 1.00E-09 0.03 24097068 | |
| 6 116312893 rs9488822-T 6:116312893 LDL cholesterol 3.00E-09 0.89 20686565 | |
| 6 116387134 rs1999930-? 6:116387134 Age-related macular degeneration 1.00E-08 1.15 21665990 | |
| 6 116443735 rs3812111-T 6:116443735 Age-related macular degeneration 2.00E-08 1.1 23455636 | |
| 6 117114025 rs6901250-A 6:117114025 C-reactive protein 5.00E-08 0.04 21300955 | |
| 6 117210052 rs339331-T 6:117210052 Prostate cancer 2.00E-12 1.22 20676098 | |
| 6 117522156 rs961764-C 6:117522156 Height 1.00E-11 0.02 20881960 | |
| 6 117786180 rs9387478-C 6:117786180 Lung cancer 4.00E-10 1.18 23143601 | |
| 6 117871836 rs9285425-G 6:117871836 Height 2.00E-08 1.14 23563607 | |
| 6 118574061 rs281868-G 6:118574061 Resting heart rate 4.00E-10 6.3 20639392 | |
| 6 118578043 rs89107-G 6:118578043 Cardiac structure and function 1.00E-09 0.03 19584346 | |
| 6 118653204 rs12210810-C 6:118653204 QT interval 2.00E-17 3.13 19305409 | |
| 6 118667522 rs11153730-C 6:118667522 QT interval 2.00E-29 0.09 19587794 | |
| 6 118667522 rs11153730-T 6:118667522 Heart rate 8.00E-21 0.38 23583979 | |
| 6 118680374 rs11970286-T 6:118680374 QT interval 2.00E-24 1.64 19305409 | |
| 6 118962740 rs6906287-C 6:118962740 Electrocardiographic conduction measures 6.00E-16 0.54 23463857 | |
| 6 118993632 rs11756438-A 6:118993632 QT interval 5.00E-22 1.4 19305408 | |
| 6 121730722 rs17083533-A 6:121730722 Heart rate 1.00E-08 0.74 23583979 | |
| 6 121781390 rs11154027-C 6:121781390 Heart rate 7.00E-12 0.32 23583979 | |
| 6 122114451 rs9320841-? 6:122114451 Resting heart rate 5.00E-15 13 23183192 | |
| 6 122131485 rs1015451-C 6:122131485 Heart rate 1.00E-33 0.71 23583979 | |
| 6 122146034 rs9398652-A 6:122146034 Resting heart rate 4.00E-15 12.6 20639392 | |
| 6 122158270 rs12110693-A 6:122158270 Biomedical quantitative traits 2.00E-09 0.66 19396169 | |
| 6 126090377 rs9388451-C 6:126090377 Brugada syndrome 5.00E-17 1.58 23872634 | |
| 6 126698719 rs9388489-G 6:126698719 Type 1 diabetes 4.00E-13 1.17 19430480 | |
| 6 126767600 rs1361108-T 6:126767600 Menarche (age at onset) 2.00E-08 2.1 21102462 | |
| 6 126820561 rs2130604-T 6:126820561 "Bone mineral density (paediatric, skull)" 3.00E-11 0.11 24945404 | |
| 6 126820561 rs2130604-T 6:126820561 "Bone mineral density (paediatric, skull)" 4.00E-11 0.13 24945404 | |
| 6 126851160 rs1490384-T 6:126851160 Height 4.00E-21 0.03 20881960 | |
| 6 126851160 rs1490384-T 6:126851160 Height 1.00E-16 1.18 23563607 | |
| 6 126964510 rs4273712-G 6:126964510 Intracranial volume 2.00E-13 12.5 22504418 | |
| 6 126966308 rs4549631-C 6:126966308 Height 5.00E-13 0.06 18391952 | |
| 6 126986996 rs1262476-G 6:126986996 "Bone mineral density (paediatric, upper limb)" 3.00E-09 0.1 24945404 | |
| 6 126986996 rs1262476-G 6:126986996 "Bone mineral density (paediatric, upper limb)" 4.00E-08 0.1 24945404 | |
| 6 127115454 rs13209747-T 6:127115454 Blood pressure 2.00E-11 0.56 23972371 | |
| 6 127115454 rs13209747-T 6:127115454 Blood pressure 3.00E-10 0.85 23972371 | |
| 6 127167072 rs13204965-A 6:127167072 Bone mineral density 8.00E-12 0.04 22504420 | |
| 6 127167072 rs13204965-C 6:127167072 Bone mineral density 3.00E-08 0.07 21533022 | |
| 6 127436064 rs1936800-T 6:127436064 Renal function-related traits (BUN) 1.00E-11 0.01 22797727 | |
| 6 127436064 rs1936800-C 6:127436064 HDL cholesterol 3.00E-10 0.02 24097068 | |
| 6 127436064 rs1936800-C 6:127436064 Triglycerides 3.00E-08 0.02 24097068 | |
| 6 127456122 rs9491697-G 6:127456122 Crohn's disease 4.00E-10 1.08 23128233 | |
| 6 127468274 rs7741021-C 6:127468274 Bone properties (heel) 9.00E-21 0.06 24430505 | |
| 6 127468274 rs7741021-C 6:127468274 Bone properties (heel) 1.00E-19 0.06 24430505 | |
| 6 127468274 rs7741021-? 6:127468274 Bone properties (heel) 4.00E-08 NR 24430505 | |
| 6 127493611 rs6569474-A 6:127493611 Metabolite levels 1.00E-08 0.01 21909109 | |
| 6 127509157 rs7745274-A 6:127509157 Waist-hip ratio 9.00E-10 1.15 23563607 | |
| 6 127600630 rs2180341-G 6:127600630 Breast cancer 3.00E-08 1.41 18326623 | |
| 6 128245765 rs13204742-T 6:128245765 Crohn's disease 8.00E-15 1.17 23128233 | |
| 6 128278798 rs802734-G 6:128278798 Celiac disease 3.00E-14 1.17 20190752 | |
| 6 128278798 rs802734-A 6:128278798 Multiple sclerosis 6.00E-09 1.1 21833088 | |
| 6 129820038 rs12193446-A 6:129820038 Axial length 1.00E-08 0.12 24144296 | |
| 6 129834629 rs12205363-C 6:129834629 Refractive error 2.00E-12 0.24 23396134 | |
| 6 130345835 rs1415701-G 6:130345835 Height 5.00E-13 1.19 23563607 | |
| 6 130349119 rs6569648-T 6:130349119 Height 1.00E-21 0.04 20881960 | |
| 6 130761957 rs3813359-? x rs9924528-? 6:130761957 Age-related hearing impairment (interaction) 7.00E-10 NR 24939585 | |
| 6 131757247 rs9375813-A 6:131757247 C-reactive protein levels 3.00E-08 0.17 24763700 | |
| 6 133315804 rs271170-T 6:133315804 Bone mineral density 3.00E-12 0.11 23437003 | |
| 6 133350936 rs3012465-G 6:133350936 "Bone mineral density (paediatric, skull)" 8.00E-17 0.13 24945404 | |
| 6 133350936 rs3012465-G 6:133350936 "Bone mineral density (paediatric, skull)" 2.00E-12 0.12 24945404 | |
| 6 134214525 rs12190287-C 6:134214525 Coronary heart disease 1.00E-12 1.08 21378990 | |
| 6 134214525 rs12190287-G 6:134214525 Coronary artery disease 2.00E-09 1.11 24262325 | |
| 6 134214525 rs12190287-? 6:134214525 Coronary artery disease or ischemic stroke 2.00E-08 NR 24262325 | |
| 6 134214525 rs12190287-? 6:134214525 Coronary artery disease or large artery stroke 2.00E-08 NR 24262325 | |
| 6 134773554 rs9321453-T 6:134773554 Urate levels 1.00E-09 0.14 21768215 | |
| 6 135411228 rs9376090-C 6:135411228 "Cholesterol, total" 3.00E-09 0.03 24097068 | |
| 6 135415004 rs7745098-G 6:135415004 Hodgkin's lymphoma 3.00E-09 1.21 24149102 | |
| 6 135418635 rs7775698-T 6:135418635 Mean corpuscular hemoglobin 3.00E-66 0.21 20139978 | |
| 6 135418635 rs7775698-T 6:135418635 Mean corpuscular volume 3.00E-56 0.19 20139978 | |
| 6 135418635 rs7775698-T 6:135418635 Red blood cell count 7.00E-48 0.18 20139978 | |
| 6 135418635 rs7775698-C 6:135418635 Hematology traits 8.00E-18 0.19 19853236 | |
| 6 135418635 rs7775698-T 6:135418635 Red blood cell traits 1.00E-15 0.38 20927387 | |
| 6 135418635 rs7775698-T 6:135418635 Red blood cell traits 1.00E-14 0.09 20927387 | |
| 6 135418635 rs7775698-T 6:135418635 Platelet counts 3.00E-14 0.09 20139978 | |
| 6 135418635 rs7775698-T 6:135418635 Mean corpuscular hemoglobin 4.00E-13 0.25 23263863 | |
| 6 135418635 rs7775698-C 6:135418635 Hematology traits 5.00E-13 0.19 19853236 | |
| 6 135418635 rs7775698-T 6:135418635 Mean corpuscular hemoglobin concentration 6.00E-12 0.09 20139978 | |
| 6 135418635 rs7775698-T 6:135418635 Hematological and biochemical traits 1.00E-10 0.08 20139978 | |
| 6 135418635 rs7775698-T 6:135418635 Mean corpuscular volume 2.00E-09 0.54 23263863 | |
| 6 135418916 rs7776054-G 6:135418916 Mean corpuscular hemoglobin 7.00E-69 0.01 19862010 | |
| 6 135419018 rs9399137-C 6:135419018 Platelet counts 5.00E-47 5.9 22139419 | |
| 6 135419018 rs9399137-? 6:135419018 F-cell distribution 3.00E-36 15.8 17767159 | |
| 6 135419018 rs9399137-T 6:135419018 Mean corpuscular hemoglobin 4.00E-15 0.25 23263863 | |
| 6 135419018 rs9399137-T 6:135419018 Glycated hemoglobin levels 9.00E-15 0.07 24647736 | |
| 6 135419018 rs9399137-T 6:135419018 Mean corpuscular volume 1.00E-11 0.55 23263863 | |
| 6 135419018 rs9399137-T 6:135419018 Platelet counts 8.00E-10 5.51 24026423 | |
| 6 135419018 rs9399137-T 6:135419018 Hematology traits 1.00E-09 0.16 19853236 | |
| 6 135419018 rs9399137-C 6:135419018 HbA2 levels 5.00E-09 NR 23043469 | |
| 6 135423209 rs9373124-C 6:135423209 Other erythrocyte phenotypes 7.00E-14 0 19862010 | |
| 6 135423209 rs9373124-T 6:135423209 White blood cell types 1.00E-10 0.08 21738478 | |
| 6 135426573 rs4895441-G 6:135426573 Mean corpuscular volume 7.00E-86 0.01 19862010 | |
| 6 135426573 rs4895441-G 6:135426573 White blood cell count 2.00E-09 0.07 20139978 | |
| 6 135427144 rs9376092-? 6:135427144 Beta thalassemia/hemoglobin E disease 2.00E-11 2.91 20183929 | |
| 6 135427159 rs9389269-T 6:135427159 Red blood cell traits 3.00E-19 0.6 23222517 | |
| 6 135427817 rs9402686-A 6:135427817 Hematological parameters 7.00E-42 0.82 19820697 | |
| 6 135432552 rs9494145-C 6:135432552 Red blood cell traits 3.00E-15 0.98 20927387 | |
| 6 135432552 rs9494145-T 6:135432552 Mean platelet volume 3.00E-09 8.19 22423221 | |
| 6 135435501 rs9483788-G 6:135435501 Other erythrocyte phenotypes 1.00E-47 0 19862010 | |
| 6 135435501 rs9483788-C 6:135435501 Hematocrit 3.00E-15 0.22 19862010 | |
| 6 135452152 rs6569992-A 6:135452152 Red blood cell traits 6.00E-09 0.07 20927387 | |
| 6 135452152 rs6569992-A 6:135452152 Red blood cell traits 1.00E-08 0.3 20927387 | |
| 6 135452152 rs6569992-A 6:135452152 Red blood cell traits 3.00E-08 0.75 20927387 | |
| 6 135739355 rs11154801-A 6:135739355 Multiple sclerosis 1.00E-13 1.13 21833088 | |
| 6 136001003 rs9389316-A 6:136001003 Immune reponse to smallpox (secreted IL-2) 7.00E-13 NR 22610502 | |
| 6 136133659 rs947583-C 6:136133659 Phosphorus levels 3.00E-12 0.04 20558539 | |
| 6 136368005 rs11154851-? 6:136368005 Alzheimer's disease (cognitive decline) 1.00E-08 0.25 23535033 | |
| 6 137452908 rs17066096-G 6:137452908 Multiple sclerosis 6.00E-13 1.14 21833088 | |
| 6 137967214 rs13192841-A 6:137967214 Multiple sclerosis 1.00E-08 1.1 21833088 | |
| 6 137973068 rs2327832-G 6:137973068 Celiac disease 4.00E-19 1.23 20190752 | |
| 6 138002637 rs10499194-C 6:138002637 Rheumatoid arthritis 1.00E-09 1.33 17982456 | |
| 6 138006504 rs6920220-A 6:138006504 Inflammatory bowel disease 1.00E-21 1.1 23128233 | |
| 6 138006504 rs6920220-A 6:138006504 Ulcerative colitis 8.00E-17 1.14 21297633 | |
| 6 138006504 rs6920220-A 6:138006504 Rheumatoid arthritis 9.00E-13 1.22 20453842 | |
| 6 138006504 rs6920220-? 6:138006504 Rheumatoid arthritis 2.00E-09 1.24 18794853 | |
| 6 138006504 rs6920220-? 6:138006504 Rheumatoid arthritis 3.00E-08 1.23 24449572 | |
| 6 138006504 rs6920220-? 6:138006504 Rheumatoid arthritis 3.00E-08 1.23 24449572 | |
| 6 138132516 rs10499197-? 6:138132516 Systemic lupus erythematosus and Systemic sclerosis 2.00E-09 1.64 23740937 | |
| 6 138195723 rs5029939-? 6:138195723 Systemic lupus erythematosus 3.00E-12 2.28 19165918 | |
| 6 138195723 rs5029939-G 6:138195723 Sj��gren's syndrome 8.00E-09 1.67 24097066 | |
| 6 138196066 rs2230926-C 6:138196066 Systemic lupus erythematosus 1.00E-17 1.72 19838193 | |
| 6 138196066 rs2230926-G 6:138196066 Systemic lupus erythematosus 1.00E-13 2.71 23273568 | |
| 6 138199417 rs610604-G 6:138199417 Psoriasis 9.00E-12 1.19 19169254 | |
| 6 138227364 rs7752903-G 6:138227364 Rheumatoid arthritis 2.00E-29 1.38 24390342 | |
| 6 138227364 rs7752903-G 6:138227364 Rheumatoid arthritis 2.00E-20 1.41 24390342 | |
| 6 138227364 rs7752903-G 6:138227364 Rheumatoid arthritis 7.00E-11 1.34 24390342 | |
| 6 139829666 rs605066-C 6:139829666 HDL cholesterol 3.00E-08 0.03 24097068 | |
| 6 139829666 rs605066-C 6:139829666 HDL cholesterol 3.00E-08 0.39 20686565 | |
| 6 139834012 rs632057-G 6:139834012 Mean corpuscular hemoglobin 1.00E-09 0.08 20139978 | |
| 6 139834012 rs632057-G 6:139834012 Mean corpuscular volume 1.00E-09 0.08 20139978 | |
| 6 139835689 rs668459-T 6:139835689 Mean corpuscular hemoglobin 9.00E-09 0.14 23263863 | |
| 6 139835689 rs668459-T 6:139835689 Mean corpuscular volume 4.00E-08 0.34 23263863 | |
| 6 139838419 rs628751-C 6:139838419 Mean corpuscular hemoglobin 1.00E-17 0 19862010 | |
| 6 139839423 rs643381-A 6:139839423 Mean corpuscular volume 5.00E-25 0 19862010 | |
| 6 139844429 rs590856-G 6:139844429 Red blood cell traits 5.00E-36 0.31 23222517 | |
| 6 142548099 rs225717-C 6:142548099 Retinal vascular caliber 1.00E-16 1.9 21060863 | |
| 6 142655801 rs7741741-T 6:142655801 Height 1.00E-20 1.24 23563607 | |
| 6 142679572 rs6570507-? 6:142679572 Scoliosis 1.00E-14 1.27 23666238 | |
| 6 142679572 rs6570507-? 6:142679572 Scoliosis 4.00E-12 1.26 23666238 | |
| 6 142679572 rs6570507-? 6:142679572 Height 4.00E-11 0.08 19343178 | |
| 6 142703877 rs4896582-A 6:142703877 Height 2.00E-18 0.38 18391950 | |
| 6 142750516 rs3817928-? 6:142750516 Pulmonary function (interaction) 3.00E-12 NR 23284291 | |
| 6 142750516 rs3817928-A 6:142750516 Pulmonary function 1.00E-09 0.42 20010835 | |
| 6 142767633 rs3748069-A 6:142767633 Height 5.00E-14 6.5 18391951 | |
| 6 142797289 rs7763064-A 6:142797289 Height 1.00E-33 0.05 20881960 | |
| 6 143898894 rs12199775-A 6:143898894 Inflammatory bowel disease 2.00E-08 1.13 23128233 | |
| 6 146918950 rs2275606-A 6:146918950 Leprosy 4.00E-14 1.3 22019778 | |
| 6 147680359 rs9390459-A 6:147680359 Coagulation factor levels 1.00E-22 4.8 20231535 | |
| 6 147703299 rs9399599-T 6:147703299 Plasma plasminogen activator levels 3.00E-14 0.03 24578379 | |
| 6 147971574 rs1302019-? 6:147971574 Myopia (pathological) 2.00E-23 NR 23049088 | |
| 6 148521292 rs9497965-T 6:148521292 Thyroid hormone levels 2.00E-08 0.05 23408906 | |
| 6 148521292 rs9497965-T 6:148521292 Thyroid hormone levels 3.00E-08 0.07 23408906 | |
| 6 149329267 rs2500535-A 6:149329267 Response to antidepressants 4.00E-08 27 20360315 | |
| 6 149608874 rs9485372-G 6:149608874 Breast cancer 4.00E-12 1.11 22383897 | |
| 6 149834574 rs9373594-T 6:149834574 Rheumatoid arthritis 3.00E-09 1.09 24390342 | |
| 6 149834574 rs9373594-T 6:149834574 Rheumatoid arthritis 5.00E-08 1.11 24390342 | |
| 6 150358012 rs9479482-A 6:150358012 Alopecia areata 4.00E-19 1.65 20596022 | |
| 6 151004770 rs17080102-C 6:151004770 Blood pressure 2.00E-11 0.74 23972371 | |
| 6 151004770 rs17080102-C 6:151004770 Blood pressure 5.00E-08 1.02 23972371 | |
| 6 151207078 rs11754661-A 6:151207078 Alzheimer's disease (late onset) 2.00E-10 2.1 20885792 | |
| 6 151252985 rs6922269-A 6:151252985 Coronary heart disease 3.00E-08 1.23 17634449 | |
| 6 151895456 rs6909279-G 6:151895456 Bone mineral density 1.00E-09 0.09 23437003 | |
| 6 151898506 rs1871859-? 6:151898506 Bone mineral density 9.00E-13 NR 24249740 | |
| 6 151901409 rs4870044-T 6:151901409 Bone mineral density (spine) 2.00E-11 0.11 18445777 | |
| 6 151901802 rs4869739-T 6:151901802 Bone properties (heel) 3.00E-18 0.07 24430505 | |
| 6 151907748 rs4869742-T 6:151907748 Bone mineral density 4.00E-35 0.08 22504420 | |
| 6 151914113 rs3757318-A 6:151914113 Breast cancer 2.00E-21 1.16 23535729 | |
| 6 151933175 rs1038304-G 6:151933175 Bone mineral density (spine) 4.00E-11 0.1 18445777 | |
| 6 151933175 rs1038304-G 6:151933175 Bone mineral density (hip) 4.00E-10 0.08 19079262 | |
| 6 151933175 rs1038304-G 6:151933175 Bone mineral density (hip) 5.00E-09 0.08 18445777 | |
| 6 151936677 rs6929137-A 6:151936677 Bone mineral density (spine) 2.00E-10 0.1 19079262 | |
| 6 151948366 rs2046210-A 6:151948366 Breast cancer 5.00E-16 1.15 23535733 | |
| 6 151948366 rs2046210-A 6:151948366 Breast cancer 2.00E-15 1.29 19219042 | |
| 6 151948366 rs2046210-C 6:151948366 Breast Cancer in BRCA1 mutation carriers 5.00E-09 1.28 23544013 | |
| 6 151957714 rs12173570-T 6:151957714 Breast size 6.00E-11 0.17 22747683 | |
| 6 151987357 rs9383938-T 6:151987357 Breast cancer 2.00E-10 1.28 22976474 | |
| 6 152008780 rs3020331-T 6:152008780 Bone properties (heel) 7.00E-15 0.07 24430505 | |
| 6 152008780 rs3020331-T 6:152008780 Bone properties (heel) 3.00E-09 0.06 24430505 | |
| 6 152009638 rs2941740-G 6:152009638 Bone mineral density (hip) 2.00E-10 0.07 19801982 | |
| 6 152059563 rs2982552-G 6:152059563 Bone properties (heel) 2.00E-10 0.05 24430505 | |
| 6 152068364 rs1999805-C 6:152068364 Bone mineral density (spine) 2.00E-08 0.09 18445777 | |
| 6 152090707 rs2504063-A 6:152090707 Bone mineral density (spine) 6.00E-11 0.08 19801982 | |
| 6 152110943 rs543650-T 6:152110943 Height 1.00E-17 0.03 20881960 | |
| 6 152285687 rs2982694-? 6:152285687 Sudden cardiac arrest 7.00E-10 1.43 21658281 | |
| 6 152358179 rs2982712-C 6:152358179 Height 4.00E-10 1.17 23563607 | |
| 6 152790573 rs9371601-? 6:152790573 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 4.00E-09 NR 23453885 | |
| 6 153441079 rs1933488-A 6:153441079 Prostate cancer 4.00E-18 1.12 23535732 | |
| 6 154478440 rs2236256-C 6:154478440 Chronic lymphocytic leukemia 2.00E-10 1.23 24292274 | |
| 6 156913012 rs2817461-? 6:156913012 Sensory disturbances after bilateral sagittal split ramus osteotomy 4.00E-08 NR 23834954 | |
| 6 158929442 rs9456307-A 6:158929442 Height 2.00E-09 0.05 20881960 | |
| 6 159465977 rs1738074-A 6:159465977 Celiac disease 3.00E-15 1.16 20190752 | |
| 6 159465977 rs1738074-G 6:159465977 Multiple sclerosis 7.00E-15 1.13 21833088 | |
| 6 159472295 rs212402-? 6:159472295 Celiac disease 8.00E-09 1.31 24999842 | |
| 6 159490436 rs212388-C 6:159490436 Crohn's disease 3.00E-14 1.11 23128233 | |
| 6 159490436 rs212388-G 6:159490436 Crohn's disease 2.00E-11 1.1 21102463 | |
| 6 159490436 rs212388-C 6:159490436 Crohn's disease and celiac disease 2.00E-10 NR 21298027 | |
| 6 159506600 rs2451258-T 6:159506600 Rheumatoid arthritis 3.00E-11 1.1 24390342 | |
| 6 159506600 rs2451258-T 6:159506600 Rheumatoid arthritis 2.00E-10 1.1 24390342 | |
| 6 160564476 rs662138-C 6:160564476 Blood metabolite levels 5.00E-49 0.08 24816252 | |
| 6 160564476 rs662138-G 6:160564476 Metabolic traits 7.00E-25 0.16 21886157 | |
| 6 160564476 rs662138-C 6:160564476 Blood metabolite levels 9.00E-25 0.06 24816252 | |
| 6 160564476 rs662138-C 6:160564476 Blood metabolite levels 1.00E-22 0.03 24816252 | |
| 6 160564476 rs662138-C 6:160564476 Blood metabolite levels 3.00E-14 0.02 24816252 | |
| 6 160578860 rs1564348-C 6:160578860 "Cholesterol, total" 3.00E-23 0.05 24097068 | |
| 6 160578860 rs1564348-C 6:160578860 LDL cholesterol 3.00E-21 0.05 24097068 | |
| 6 160578860 rs1564348-C 6:160578860 LDL cholesterol 2.00E-17 1.95 20686565 | |
| 6 160578860 rs1564348-C 6:160578860 "Cholesterol, total" 1.00E-16 2.18 20686565 | |
| 6 160581374 rs651164-G 6:160581374 Prostate cancer 2.00E-10 1.15 21743057 | |
| 6 160581374 rs651164-? 6:160581374 Prostate cancer 2.00E-09 NR 19767753 | |
| 6 160668389 rs2279463-G 6:160668389 Chronic kidney disease 6.00E-12 0.01 20383146 | |
| 6 160669081 rs316020-A 6:160669081 Blood metabolite ratios 3.00E-286 0.18 24816252 | |
| 6 160670282 rs316019-A 6:160670282 Blood metabolite levels 2.00E-259 0.18 24816252 | |
| 6 160681393 rs3127573-G 6:160681393 Creatinine levels 7.00E-10 1.1 20383145 | |
| 6 160741622 rs3120139-A 6:160741622 Lp (a) levels 4.00E-09 0.32 21900290 | |
| 6 160833664 rs9364554-T 6:160833664 Prostate cancer 6.00E-10 1.17 18264097 | |
| 6 160840252 rs7758229-T 6:160840252 Colorectal cancer 8.00E-09 1.28 21242260 | |
| 6 160910517 rs12214416-A 6:160910517 Lp (a) levels 5.00E-08 0.5 21900290 | |
| 6 160960359 rs6919346-? 6:160960359 Lp (a) levels 4.00E-11 0.66 19124843 | |
| 6 160961137 rs3798220-C 6:160961137 Coronary heart disease 3.00E-11 1.51 21378990 | |
| 6 161010118 rs10455872-G 6:161010118 Lp (a) levels 5.00E-39 1.28 21900290 | |
| 6 161010118 rs10455872-G 6:161010118 Lipoprotein-associated phospholipase A2 activity change in response to statin therapy 2.00E-16 4.8 23118302 | |
| 6 161010118 rs10455872-? 6:161010118 Response to statin therapy (LDL-C) 5.00E-15 6.8 22331829 | |
| 6 161010118 rs10455872-? 6:161010118 Coronary artery disease or large artery stroke 9.00E-14 NR 24262325 | |
| 6 161010118 rs10455872-? 6:161010118 Coronary artery disease or ischemic stroke 2.00E-12 NR 24262325 | |
| 6 161010118 rs10455872-G 6:161010118 Aortic-valve calcification 3.00E-11 2.05 23388002 | |
| 6 161010118 rs10455872-A 6:161010118 Response to statin therapy 1.00E-09 0.28 22368281 | |
| 6 161018174 rs7770628-? 6:161018174 Protein quantitative trait loci 4.00E-10 NR 18464913 | |
| 6 161089817 rs1084651-A 6:161089817 HDL cholesterol 3.00E-08 0.56 20686565 | |
| 6 161137990 rs783147-A 6:161137990 Lp (a) levels 3.00E-17 0.3 21900290 | |
| 6 162161619 rs926849-C 6:162161619 Disc degeneration (lumbar) 3.00E-08 0.13 22993228 | |
| 6 166046483 rs753760-C 6:166046483 Thyroid hormone levels 1.00E-24 0.1 23408906 | |
| 6 166046483 rs753760-C 6:166046483 Thyroid hormone levels 6.00E-20 0.13 23408906 | |
| 6 166046483 rs753760-C 6:166046483 Thyroid hormone levels 5.00E-09 0.08 23408906 | |
| 6 166155457 rs1039002-? 6:166155457 Bipolar disorder 2.00E-08 NR 22205951 | |
| 6 167360389 rs2236313-T 6:167360389 Vitiligo 1.00E-16 1.2 20526339 | |
| 6 167371110 rs2149085-T 6:167371110 Crohn's disease 8.00E-12 1.34 23850713 | |
| 6 167373547 rs1819333-T 6:167373547 Inflammatory bowel disease 7.00E-21 1.08 23128233 | |
| 6 167383075 rs9355610-G 6:167383075 Graves' disease 7.00E-10 1.19 21841780 | |
| 6 167406633 rs415890-C 6:167406633 Crohn's disease 3.00E-12 1.17 21102463 | |
| 6 167437988 rs2301436-T 6:167437988 Crohn's disease 1.00E-12 1.21 18587394 | |
| 6 167532793 rs3093024-T 6:167532793 Rheumatoid arthritis 8.00E-19 1.19 20453841 | |
| 6 167533062 rs1854853-A 6:167533062 Rheumatoid arthritis 7.00E-15 1.42 24782177 | |
| 6 167533062 rs1854853-A 6:167533062 Rheumatoid arthritis 2.00E-10 1.26 24782177 | |
| 6 167534290 rs3093023-A 6:167534290 Rheumatoid arthritis 2.00E-11 1.13 20453842 | |
| 6 167534290 rs3093023-A 6:167534290 Rheumatoid arthritis 4.00E-09 1.15 24782177 | |
| 6 167540842 rs1571878-C 6:167540842 Rheumatoid arthritis 5.00E-35 1.17 24390342 | |
| 6 167540842 rs1571878-C 6:167540842 Rheumatoid arthritis 1.00E-22 1.28 24390342 | |
| 6 167540842 rs1571878-C 6:167540842 Rheumatoid arthritis 2.00E-18 1.13 24390342 | |
| 6 167548547 rs62436827-G 6:167548547 Triglycerides 7.00E-09 1.49 24886709 | |
| 6 170379025 rs924043-? 6:170379025 Type 1 diabetes 8.00E-09 1.35 21980299 | |
| 7 1083777 rs1997243-G 7:1083777 "Cholesterol, total" 3.00E-10 0.03 24097068 | |
| 7 1273845 rs10275044-T 7:1273845 Renal function-related traits (BUN) 4.00E-09 0.01 22797727 | |
| 7 1285195 rs10277115-T 7:1285195 Renal function-related traits (sCR) 5.00E-11 0.01 22797727 | |
| 7 1285195 rs10277115-T 7:1285195 Renal function-related traits (eGRFcrea) 1.00E-10 0.01 22797727 | |
| 7 1920826 rs10275045-? 7:1920826 Schizophrenia or bipolar disorder 2.00E-09 NR 24280982 | |
| 7 1968953 rs12699477-C 7:1968953 Testicular germ cell tumor 6.00E-09 1.21 23666239 | |
| 7 2004421 rs12666575-? 7:2004421 Schizophrenia 2.00E-09 1.12 22688191 | |
| 7 2017445 rs6461049-T 7:2017445 Schizophrenia 6.00E-13 1.11 23974872 | |
| 7 2036669 rs4721295-? 7:2036669 "Schizophrenia, schizoaffective disorder or bipolar disorder" 6.00E-10 NR 24166486 | |
| 7 2759795 rs798554-C 7:2759795 Height 4.00E-23 1.24 23563607 | |
| 7 2763102 rs798544-G 7:2763102 Height 7.00E-15 5.9 18391951 | |
| 7 2789880 rs798502-A 7:2789880 Ulcerative colitis 6.00E-17 1.13 23128233 | |
| 7 2789880 rs798502-A 7:2789880 Ulcerative colitis 3.00E-15 1.13 21297633 | |
| 7 2801803 rs798489-T 7:2801803 Height 2.00E-33 0.05 20881960 | |
| 7 2869985 rs1182188-? 7:2869985 Height 3.00E-09 0.07 19343178 | |
| 7 3128789 rs4722404-G 7:3128789 Atopic dermatitis 8.00E-09 1.18 23042114 | |
| 7 6449272 rs702485-G 7:6449272 HDL cholesterol 6.00E-12 0.02 24097068 | |
| 7 8152067 rs59072263-G 7:8152067 Intraocular pressure 1.00E-08 0.45 23836780 | |
| 7 15064309 rs2191349-T 7:15064309 Fasting glucose-related traits 3.00E-44 NR 20081858 | |
| 7 15064309 rs2191349-? 7:15064309 Fasting glucose-related traits (interaction with BMI) 3.00E-21 NR 22581228 | |
| 7 15064309 rs2191349-T 7:15064309 Fasting glucose-related traits 3.00E-17 NR 20081858 | |
| 7 15064984 rs6947830-A 7:15064984 Metabolic syndrome 1.00E-13 0.1 22399527 | |
| 7 16707861 rs58370486-? 7:16707861 Alzheimer's disease (cognitive decline) 6.00E-11 0.36 23535033 | |
| 7 17284577 rs4410790-T 7:17284577 Caffeine consumption 2.00E-19 0.15 21490707 | |
| 7 17287106 rs6968554-A 7:17287106 Blood metabolite levels 9.00E-14 0.06 24816252 | |
| 7 17287269 rs6968865-T 7:17287269 Coffee consumption 2.00E-11 0.26 21357676 | |
| 7 17309279 rs12670403-C 7:17309279 Metabolic traits 5.00E-15 0.29 21886157 | |
| 7 17919258 rs4142995-T 7:17919258 HDL cholesterol 9.00E-12 0.03 24097068 | |
| 7 17997612 rs10226084-T 7:17997612 Fibrinogen 5.00E-10 0.01 23969696 | |
| 7 18504508 rs213273-? 7:18504508 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) 2.00E-08 NR 24554482 | |
| 7 18877874 rs2073963-G 7:18877874 Male-pattern baldness 1.00E-12 1.29 22693459 | |
| 7 19031935 rs11984041-A 7:19031935 Stroke 2.00E-11 1.42 22306652 | |
| 7 19049388 rs2107595-A 7:19049388 Stroke (ischemic) 2.00E-16 1.39 23041239 | |
| 7 19049388 rs2107595-? 7:19049388 Coronary artery disease or large artery stroke 3.00E-12 NR 24262325 | |
| 7 19049388 rs2107595-A 7:19049388 Large artery stroke 3.00E-12 1.39 24262325 | |
| 7 19616522 rs4470914-T 7:19616522 Height 9.00E-10 0.03 20881960 | |
| 7 20994491 rs12155172-A 7:20994491 Prostate cancer 5.00E-13 1.11 23535732 | |
| 7 21584088 rs2285947-A 7:21584088 "Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)" 1.00E-16 1.17 23103227 | |
| 7 21584088 rs2285947-A 7:21584088 "Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)" 2.00E-08 1.17 23103227 | |
| 7 21607352 rs12670798-C 7:21607352 "Cholesterol, total" 1.00E-16 0.04 24097068 | |
| 7 21607352 rs12670798-C 7:21607352 LDL cholesterol 5.00E-14 0.03 24097068 | |
| 7 21607352 rs12670798-T 7:21607352 "Cholesterol, total" 7.00E-10 1.7 20686565 | |
| 7 21607352 rs12670798-C 7:21607352 LDL cholesterol 7.00E-10 1.26 20686565 | |
| 7 21607352 rs12670798-G 7:21607352 LDL cholesterol 6.00E-09 0.09 19060911 | |
| 7 21938240 rs4487645-C 7:21938240 Multiple myeloma 3.00E-14 1.38 22120009 | |
| 7 21938240 rs4487645-C 7:21938240 Multiple myeloma (hyperdiploidy) 1.00E-09 1.43 23502783 | |
| 7 22732839 rs2097677-A 7:22732839 C-reactive protein 4.00E-11 0.1 21196492 | |
| 7 22856606 rs2286503-T 7:22856606 Fibrinogen 7.00E-09 0.01 23969696 | |
| 7 23482685 rs6957923-G 7:23482685 Height 5.00E-10 1.14 23563607 | |
| 7 23502974 rs12534093-A 7:23502974 Height 2.00E-14 0.03 20881960 | |
| 7 25871109 rs1055144-T 7:25871109 Waist-hip ratio 1.00E-24 0.04 20935629 | |
| 7 25901639 rs12700667-A 7:25901639 Endometriosis 1.00E-09 1.2 21151130 | |
| 7 25901639 rs12700667-A 7:25901639 Endometriosis 4.00E-09 1.18 23104006 | |
| 7 25950545 rs10261878-C 7:25950545 Body mass index 1.00E-10 0.03 23583978 | |
| 7 25991826 rs4722551-C 7:25991826 LDL cholesterol 4.00E-14 0.04 24097068 | |
| 7 25991826 rs4722551-C 7:25991826 Triglycerides 9.00E-11 0.02 24097068 | |
| 7 25991826 rs4722551-C 7:25991826 "Cholesterol, total" 7.00E-09 0.03 24097068 | |
| 7 26891665 rs7804356-? 7:26891665 Type 1 diabetes 5.00E-09 1.14 19430480 | |
| 7 26892440 rs10486483-A 7:26892440 Crohn's disease 3.00E-08 1.09 23128233 | |
| 7 27231762 rs4722672-C 7:27231762 Ulcerative colitis 2.00E-08 1.09 23128233 | |
| 7 27335561 rs11564024-C 7:27335561 Immune reponse to smallpox (secreted IL-1beta) 3.00E-08 NR 22610502 | |
| 7 27337867 rs17428471-T 7:27337867 Blood pressure 2.00E-12 1.2 23972371 | |
| 7 27337867 rs17428471-T 7:27337867 Blood pressure 2.00E-09 0.61 23972371 | |
| 7 28174986 rs67250450-T 7:28174986 Rheumatoid arthritis 3.00E-09 1.11 24390342 | |
| 7 28174986 rs67250450-T 7:28174986 Rheumatoid arthritis 4.00E-09 1.1 24390342 | |
| 7 28180556 rs864745-T 7:28180556 Type 2 diabetes 5.00E-14 1.1 18372903 | |
| 7 28180556 rs864745-T 7:28180556 Crohn's disease 4.00E-09 1.09 23128233 | |
| 7 28185091 rs849141-? 7:28185091 Height 3.00E-11 0.08 19343178 | |
| 7 28189083 rs1029534-T 7:28189083 Height 8.00E-14 1.18 23563607 | |
| 7 28189411 rs1635852-A 7:28189411 Height 9.00E-10 0.25 18952825 | |
| 7 28189411 rs1635852-? 7:28189411 Systemic lupus erythematosus and Systemic sclerosis 2.00E-08 1.14 23740937 | |
| 7 28189946 rs1708299-A 7:28189946 Height 6.00E-25 0.04 20881960 | |
| 7 28196222 rs849134-A 7:28196222 Type 2 diabetes 3.00E-09 1.13 20581827 | |
| 7 28196413 rs849135-G 7:28196413 Type 2 diabetes 2.00E-09 1.12 24509480 | |
| 7 30937178 rs1000597-? 7:30937178 Nephrolithiasis 2.00E-14 1.22 22396660 | |
| 7 33256039 rs10262453-A 7:33256039 Sagittal craniosynostosis 6.00E-20 4.17 23160099 | |
| 7 35554788 rs343064-A 7:35554788 Non-alcoholic fatty liver disease histology (other) 3.00E-08 1.31 20708005 | |
| 7 37374510 rs6974491-A 7:37374510 Primary biliary cirrhosis 4.00E-08 1.25 21399635 | |
| 7 37436854 rs11984075-G 7:37436854 Celiac disease and Rheumatoid arthritis 5.00E-08 NR 21383967 | |
| 7 37841534 rs2718058-A 7:37841534 Alzheimer's disease (late onset) 5.00E-09 1.08 24162737 | |
| 7 37938422 rs10226308-A 7:37938422 Bone mineral density 6.00E-13 0.06 22504420 | |
| 7 37989095 rs16879765-A 7:37989095 Dupuytren's disease 6.00E-39 1.98 21732829 | |
| 7 38004406 rs1668357-? 7:38004406 Myopia (pathological) 4.00E-08 NR 23049088 | |
| 7 38128326 rs6959212-T 7:38128326 Bone mineral density 4.00E-38 0.07 22504420 | |
| 7 38128326 rs6959212-T 7:38128326 Height 2.00E-09 0.02 20881960 | |
| 7 38136277 rs1524058-T 7:38136277 Bone mineral density (spine) 1.00E-09 0.07 19801982 | |
| 7 40466200 rs4379368-T 7:40466200 Migraine 1.00E-09 1.11 23793025 | |
| 7 41470093 rs1079866-G 7:41470093 Menarche (age at onset) 6.00E-14 3.9 21102462 | |
| 7 44223721 rs730497-A 7:44223721 Glycated hemoglobin levels 6.00E-12 0.03 19096518 | |
| 7 44229068 rs1799884-T 7:44229068 Glycated hemoglobin levels 2.00E-22 0.12 24647736 | |
| 7 44229068 rs1799884-T 7:44229068 Glycated hemoglobin levels 1.00E-20 0.04 20858683 | |
| 7 44229068 rs1799884-A 7:44229068 Metabolite levels 2.00E-19 0.06 21909109 | |
| 7 44229068 rs1799884-A 7:44229068 Glycemic traits 5.00E-18 0.06 23575436 | |
| 7 44229068 rs1799884-A 7:44229068 Glycemic traits 3.00E-10 0.16 23575436 | |
| 7 44229068 rs1799884-A 7:44229068 Glycemic traits 3.00E-09 0.21 23575436 | |
| 7 44231216 rs3757840-A 7:44231216 Metabolic syndrome 4.00E-13 0.1 22399527 | |
| 7 44235668 rs4607517-A 7:44235668 Fasting glucose-related traits 7.00E-92 NR 20081858 | |
| 7 44235668 rs4607517-? 7:44235668 Fasting glucose-related traits (interaction with BMI) 8.00E-56 NR 22581228 | |
| 7 44235668 rs4607517-A 7:44235668 Fasting plasma glucose 1.00E-25 0.06 19060907 | |
| 7 44235668 rs4607517-A 7:44235668 Fasting glucose-related traits 2.00E-16 NR 20081858 | |
| 7 44259871 rs1127065-G 7:44259871 Metabolic syndrome 9.00E-11 0.08 22399527 | |
| 7 44276651 rs3757837-C 7:44276651 Osteoarthritis (hip) 8.00E-10 1.27 23989986 | |
| 7 44579180 rs2072183-C 7:44579180 LDL cholesterol 7.00E-16 0.04 24097068 | |
| 7 44579180 rs2072183-C 7:44579180 "Cholesterol, total" 4.00E-15 0.04 24097068 | |
| 7 44579180 rs2072183-C 7:44579180 "Cholesterol, total" 3.00E-11 2.01 20686565 | |
| 7 44579180 rs2072183-A 7:44579180 LDL cholesterol 4.00E-11 1.17 20686565 | |
| 7 46008110 rs11977526-A 7:46008110 Insulin-like growth factors 3.00E-101 NR 21216879 | |
| 7 46620145 rs7784776-G 7:46620145 QRS duration 1.00E-09 0.39 21076409 | |
| 7 46753553 rs700752-G 7:46753553 Insulin-like growth factors 4.00E-21 NR 21216879 | |
| 7 46753553 rs700752-G 7:46753553 Insulin-like growth factors 5.00E-09 NR 21216879 | |
| 7 50269672 rs1456893-A 7:50269672 Crohn's disease 5.00E-09 1.2 18587394 | |
| 7 50304461 rs1456896-T 7:50304461 Inflammatory bowel disease 7.00E-15 1.09 23128233 | |
| 7 50304461 rs1456896-T 7:50304461 Crohn's disease 1.00E-08 1.14 21102463 | |
| 7 50305863 rs4917014-A 7:50305863 Systemic lupus erythematosus 3.00E-23 1.39 19838193 | |
| 7 50305863 rs4917014-G 7:50305863 HDL cholesterol 1.00E-08 0.02 24097068 | |
| 7 50335232 rs4917017-G 7:50335232 IgG glycosylation 1.00E-08 0.2 23382691 | |
| 7 50350267 rs6583437-G 7:50350267 IgG glycosylation 7.00E-10 0.2 23382691 | |
| 7 50350267 rs6583437-G 7:50350267 IgG glycosylation 1.00E-09 0.19 23382691 | |
| 7 50350267 rs6583437-G 7:50350267 IgG glycosylation 2.00E-09 0.19 23382691 | |
| 7 50350267 rs6583437-G 7:50350267 IgG glycosylation 5.00E-09 0.19 23382691 | |
| 7 50350267 rs6583437-G 7:50350267 IgG glycosylation 1.00E-08 0.18 23382691 | |
| 7 50350267 rs6583437-G 7:50350267 IgG glycosylation 3.00E-08 0.18 23382691 | |
| 7 50350267 rs6583437-G 7:50350267 IgG glycosylation 4.00E-08 0.17 23382691 | |
| 7 50355207 rs6421315-C 7:50355207 IgG glycosylation 2.00E-13 0.24 23382691 | |
| 7 50355207 rs6421315-C 7:50355207 IgG glycosylation 8.00E-12 0.22 23382691 | |
| 7 50355207 rs6421315-C 7:50355207 IgG glycosylation 7.00E-11 0.21 23382691 | |
| 7 50355207 rs6421315-C 7:50355207 IgG glycosylation 8.00E-09 0.19 23382691 | |
| 7 50355207 rs6421315-C 7:50355207 IgG glycosylation 1.00E-08 0.18 23382691 | |
| 7 50428428 rs12718597-A 7:50428428 Mean corpuscular volume 5.00E-13 0 19862010 | |
| 7 50428445 rs12718598-T 7:50428445 Red blood cell traits 2.00E-13 0.2 23222517 | |
| 7 50466304 rs11978267-G 7:50466304 Acute lymphoblastic leukemia (childhood) 8.00E-11 1.69 19684603 | |
| 7 50469981 rs11980379-? 7:50469981 Acute lymphoblastic leukemia (B-cell precursor) 3.00E-33 NR 23996088 | |
| 7 50470604 rs4132601-C 7:50470604 Acute lymphoblastic leukemia (childhood) 1.00E-19 1.69 19684604 | |
| 7 50473251 rs6964969-C 7:50473251 Acute lymphoblastic leukemia (childhood) 2.00E-29 1.67 23512250 | |
| 7 50610379 rs7809234-A 7:50610379 Blood metabolite ratios 6.00E-14 0.05 24816252 | |
| 7 51027194 rs4948088-? 7:51027194 Type 1 diabetes 4.00E-08 1.3 19430480 | |
| 7 52006415 rs406001-? 7:52006415 Post-traumatic stress disorder (asjusted for relatedness) 2.00E-08 NR 23726511 | |
| 7 52006415 rs406001-? 7:52006415 Post-traumatic stress disorder (asjusted for relatedness) 3.00E-08 NR 23726511 | |
| 7 56079094 rs4947534-T 7:56079094 Blood metabolite levels 2.00E-14 0.02 24816252 | |
| 7 56097265 rs4948102-? 7:56097265 Plasma homocysteine levels (post-methionine load test) 1.00E-16 NR 24651765 | |
| 7 65271197 rs17711722-T 7:65271197 Calcium levels 8.00E-09 0.02 24068962 | |
| 7 65326821 rs11763147-A 7:65326821 Corneal structure 4.00E-09 0.07 23291589 | |
| 7 66421446 rs4718428-T 7:66421446 Corneal structure 3.00E-10 0.05 23291589 | |
| 7 68050413 rs1403155-A 7:68050413 Immune reponse to smallpox (secreted IL-2) 2.00E-08 NR 22610502 | |
| 7 68611960 rs6945541-C 7:68611960 Male-pattern baldness 2.00E-09 1.27 22693459 | |
| 7 69806023 rs6943555-A 7:69806023 Alcohol consumption 4.00E-08 0.01 21471458 | |
| 7 72129667 rs13238203-T 7:72129667 Triglycerides 1.00E-09 7.91 20686565 | |
| 7 72856269 rs2240466-G 7:72856269 Triglycerides 1.00E-12 0.14 19060911 | |
| 7 72856430 rs1178979-A 7:72856430 Triglycerides 2.00E-12 0.05 20864672 | |
| 7 72857049 rs1178977-A 7:72857049 Urate levels 1.00E-12 0.05 23263486 | |
| 7 72864869 rs714052-G 7:72864869 Triglycerides 3.00E-15 0.16 19060906 | |
| 7 72904810 rs17145713-T 7:72904810 Protein C levels 3.00E-08 0.06 20802025 | |
| 7 72971231 rs13233571-C 7:72971231 C-reactive protein 4.00E-09 0.05 21300955 | |
| 7 72977898 rs12539316-C 7:72977898 Gamma glutamyl transpeptidase 6.00E-10 0.01 21909109 | |
| 7 72982874 rs17145738-T 7:72982874 Triglycerides 9.00E-99 0.12 24097068 | |
| 7 72982874 rs17145738-G 7:72982874 Triglycerides 9.00E-59 7.91 20686565 | |
| 7 72982874 rs17145738-T 7:72982874 Triglycerides 7.00E-22 0.14 18193044 | |
| 7 72982874 rs17145738-T 7:72982874 HDL cholesterol 5.00E-13 0.04 24097068 | |
| 7 72982874 rs17145738-C 7:72982874 Triglycerides 2.00E-12 8.21 18193043 | |
| 7 72982874 rs17145738-T 7:72982874 HDL cholesterol 1.00E-09 0.57 20686565 | |
| 7 72987354 rs2286276-T 7:72987354 Triglycerides 1.00E-15 0.07 21909109 | |
| 7 73010442 rs13247874-? 7:73010442 Lipid metabolism phenotypes 8.00E-14 0.16 22286219 | |
| 7 73017005 rs13226650-A 7:73017005 Metabolic syndrome 2.00E-11 0.12 22399527 | |
| 7 73020337 rs3812316-C 7:73020337 Triglycerides 1.00E-10 10.5 18193046 | |
| 7 73026378 rs17145750-C 7:73026378 Liver enzyme levels (gamma-glutamyl transferase) 3.00E-09 4.5 22001757 | |
| 7 74126034 rs117026326-T 7:74126034 Sj��gren's syndrome 1.00E-53 2.2 24097066 | |
| 7 75173180 rs1167796-G 7:75173180 Systemic lupus erythematosus 2.00E-08 1.2 19838193 | |
| 7 77416439 rs6465825-C 7:77416439 Chronic kidney disease 2.00E-09 0.01 20383146 | |
| 7 80236014 rs13236689-T 7:80236014 Mean platelet volume 3.00E-09 4.18 22423221 | |
| 7 80340622 rs2366858-C 7:80340622 HDL cholesterol 6.00E-10 0.03 23726366 | |
| 7 83656800 rs10235789-C 7:83656800 Iris characteristics 7.00E-11 0.12 21835309 | |
| 7 89977760 rs42648-A 7:89977760 Homocysteine levels 2.00E-08 0.04 23824729 | |
| 7 92236829 rs4272-G 7:92236829 Rheumatoid arthritis 5.00E-09 1.1 24390342 | |
| 7 92236829 rs4272-G 7:92236829 Rheumatoid arthritis 1.00E-08 1.1 24390342 | |
| 7 92248076 rs42235-T 7:92248076 Height 8.00E-47 0.06 20881960 | |
| 7 92248076 rs42235-T 7:92248076 Height 1.00E-28 1.28 23563607 | |
| 7 92264410 rs2282978-C 7:92264410 Height 8.00E-23 0.09 18391952 | |
| 7 92264410 rs2282978-? 7:92264410 Height 1.00E-08 0.06 19343178 | |
| 7 92264410 rs2282978-C 7:92264410 Height 1.00E-08 5.8 18391951 | |
| 7 92408370 rs445-C 7:92408370 White blood cell types 7.00E-10 0.08 21738478 | |
| 7 92408370 rs445-T 7:92408370 White blood cell count 2.00E-08 0.07 20139978 | |
| 7 93549596 rs180242-T 7:93549596 Heart rate 7.00E-12 0.32 23583979 | |
| 7 94061404 rs115744676-? 7:94061404 PR interval in Tripanosoma cruzi seropositivity 7.00E-09 NR 24324551 | |
| 7 94938257 rs2057681-G 7:94938257 Paraoxonase activity 1.00E-303 NR 22982463 | |
| 7 94938257 rs2057681-G 7:94938257 Metabolite levels 7.00E-15 NR 23281178 | |
| 7 94954696 rs854572-C 7:94954696 Paraoxonase activity 5.00E-116 NR 22982463 | |
| 7 95600368 rs13231718-C 7:95600368 Immune reponse to smallpox (secreted IL-10) 5.00E-09 NR 22610502 | |
| 7 96117918 rs4729260-G 7:96117918 Bone mineral density (spine) 2.00E-10 0.08 19801982 | |
| 7 96119481 rs10429035-? 7:96119481 Bone mineral density 4.00E-12 NR 24249740 | |
| 7 96120675 rs4727338-C 7:96120675 Bone mineral density 8.00E-48 0.08 22504420 | |
| 7 96133531 rs7781370-T 7:96133531 Bone mineral density (hip) 5.00E-12 0.08 19801982 | |
| 7 97816327 rs6465657-C 7:97816327 Prostate cancer 1.00E-09 1.12 18264097 | |
| 7 97816327 rs6465657-? 7:97816327 Prostate cancer 2.00E-08 NR 19767753 | |
| 7 97993362 rs3779195-A 7:97993362 Sex hormone-binding globulin levels 3.00E-08 0.03 22829776 | |
| 7 98759117 rs9297145-C 7:98759117 Inflammatory bowel disease 8.00E-12 1.08 23128233 | |
| 7 98760504 rs7809799-G 7:98760504 Ulcerative colitis 9.00E-11 1.56 20228798 | |
| 7 98957880 rs740160-T 7:98957880 Dehydroepiandrosterone sulphate levels 2.00E-16 0.15 21533175 | |
| 7 99115677 rs12533251-A 7:99115677 Blood metabolite levels 2.00E-11 0.06 24816252 | |
| 7 99118801 rs11761528-T 7:99118801 Dehydroepiandrosterone sulphate levels 3.00E-36 0.16 21533175 | |
| 7 99141373 rs10278040-A 7:99141373 Blood metabolite levels 9.00E-113 0.36 24816252 | |
| 7 99141373 rs10278040-A 7:99141373 Blood metabolite levels 1.00E-29 0.19 24816252 | |
| 7 99163951 rs11974702-A 7:99163951 Blood metabolite levels 3.00E-75 0.18 24816252 | |
| 7 99184778 rs7809615-T 7:99184778 Blood metabolite ratios 8.00E-139 0.25 24816252 | |
| 7 99240179 rs10242455-A 7:99240179 Blood metabolite levels 2.00E-109 0.22 24816252 | |
| 7 99489571 rs17277546-A 7:99489571 Metabolic traits 9.00E-40 0.48 21886157 | |
| 7 99489571 rs17277546-A 7:99489571 Dehydroepiandrosterone sulphate levels 2.00E-11 0.11 21533175 | |
| 7 99593346 rs4727443-C 7:99593346 Interstitial lung disease 1.00E-08 1.3 23583980 | |
| 7 100004446 rs1476679-T 7:100004446 Alzheimer's disease (late onset) 6.00E-10 1.1 24162737 | |
| 7 100015457 rs13222543-T 7:100015457 Blood metabolite ratios 4.00E-104 0.49 24816252 | |
| 7 100015457 rs13222543-T 7:100015457 Blood metabolite levels 7.00E-74 0.48 24816252 | |
| 7 100015457 rs13222543-T 7:100015457 Blood metabolite levels 3.00E-47 0.35 24816252 | |
| 7 100015457 rs13222543-T 7:100015457 Blood metabolite levels 1.00E-20 0.26 24816252 | |
| 7 100214015 rs7786877-G 7:100214015 Mean corpuscular volume 3.00E-11 0 19862010 | |
| 7 100235970 rs7385804-C 7:100235970 Hematocrit 4.00E-10 0.15 19862010 | |
| 7 100235970 rs7385804-C 7:100235970 Hematological parameters 5.00E-10 0.01 19820697 | |
| 7 100240296 rs2075672-A 7:100240296 Red blood cell traits 2.00E-20 0.02 23222517 | |
| 7 100315517 rs1734907-A 7:100315517 Inflammatory bowel disease 2.00E-13 1.11 23128233 | |
| 7 100345106 rs2075671-A 7:100345106 Other erythrocyte phenotypes 1.00E-09 0 19862010 | |
| 7 100453208 rs314370-C 7:100453208 Resting heart rate 6.00E-10 7.6 20639392 | |
| 7 100458093 rs7801190-C 7:100458093 Coronary heart disease 3.00E-08 1.31 21347282 | |
| 7 100486754 rs12666989-C 7:100486754 Resting heart rate 2.00E-08 7 20639392 | |
| 7 100497131 rs13245899-G 7:100497131 Heart rate 8.00E-27 0.45 23583979 | |
| 7 100512119 rs6976053-? 7:100512119 Plasminogen activator inhibitor type 1 levels (PAI-1) 6.00E-13 0.05 22990020 | |
| 7 100769538 rs2227631-? 7:100769538 Plasminogen activator inhibitor type 1 levels (PAI-1) 3.00E-24 0.07 22990020 | |
| 7 101115994 rs17135437-A 7:101115994 Response to citalopram treatment 3.00E-08 NR 22760553 | |
| 7 102519031 rs17135875-C 7:102519031 Blood pressure measurement (cold pressor test) 4.00E-09 3.44 24165912 | |
| 7 103527369 rs3914132-? 7:103527369 Otosclerosis 2.00E-08 1.54 19230858 | |
| 7 105658451 rs6967330-A 7:105658451 "Asthma (childhood, severe)" 3.00E-14 1.26 24241537 | |
| 7 106359216 rs342275-C 7:106359216 Platelet counts 6.00E-25 3.74 22139419 | |
| 7 106372219 rs342293-G 7:106372219 Mean platelet volume 7.00E-57 0.02 22139419 | |
| 7 106372219 rs342293-G 7:106372219 Mean platelet volume 2.00E-33 0.02 19820697 | |
| 7 106372219 rs342293-G 7:106372219 Mean platelet volume 1.00E-24 0.02 19221038 | |
| 7 106372219 rs342293-C 7:106372219 Mean platelet volume 5.00E-22 0.15 24026423 | |
| 7 106372219 rs342293-C 7:106372219 Mean platelet volume 2.00E-08 4.05 22423221 | |
| 7 106372903 rs342296-G 7:106372903 Mean platelet volume 1.00E-11 0.16 22423221 | |
| 7 106409452 rs17398575-A 7:106409452 Carotid intima media thickness 2.00E-12 0.16 21909108 | |
| 7 106411858 rs17477177-T 7:106411858 Blood pressure 2.00E-13 0.42 21909110 | |
| 7 107244545 rs10953541-C 7:107244545 Coronary heart disease 3.00E-08 1.08 21378988 | |
| 7 107480315 rs4380874-T 7:107480315 Ulcerative colitis 2.00E-26 1.14 23128233 | |
| 7 107492789 rs4510766-A 7:107492789 Ulcerative colitis 2.00E-16 1.2 21297633 | |
| 7 107495434 rs886774-G 7:107495434 Ulcerative colitis 3.00E-08 1.11 19915572 | |
| 7 107592198 rs2072209-G 7:107592198 IgG glycosylation 1.00E-08 0.37 23382691 | |
| 7 107782200 rs382140-A 7:107782200 Coffee consumption 4.00E-09 0.08 21876539 | |
| 7 107973297 rs6975557-? 7:107973297 Femoral neck bone geometry and menarche (age at onset) 5.00E-08 NR 23593202 | |
| 7 111527560 rs10255299-G 7:111527560 C-reactive protein and white blood cell count 7.00E-11 0.24 22788528 | |
| 7 116162729 rs4236601-A 7:116162729 Glaucoma (primary open-angle) 2.00E-11 1.27 20835238 | |
| 7 116186241 rs3807989-A 7:116186241 PR interval 4.00E-28 2.3 20062060 | |
| 7 116186241 rs3807989-A 7:116186241 Electrocardiographic traits 7.00E-13 6.4 20062063 | |
| 7 116186241 rs3807989-G 7:116186241 Atrial fibrillation 4.00E-12 1.11 22544366 | |
| 7 116186241 rs3807989-A 7:116186241 PR segment 5.00E-12 1.4 24850809 | |
| 7 116191301 rs11773845-A 7:116191301 PR interval 4.00E-12 2.29 23139255 | |
| 7 116358044 rs38855-G 7:116358044 Triglycerides 2.00E-08 0.02 24097068 | |
| 7 116892846 rs38904-T 7:116892846 Inflammatory bowel disease 1.00E-08 1.05 23128233 | |
| 7 116917118 rs4730775-? 7:116917118 Dupuytren's disease 3.00E-08 1.2 21732829 | |
| 7 119606632 rs17142462-A 7:119606632 Immune reponse to smallpox (secreted IL-12p40) 3.00E-09 NR 22610502 | |
| 7 120747308 rs13223036-T 7:120747308 "Bone mineral density (paediatric, skull)" 2.00E-28 0.17 24945404 | |
| 7 120747308 rs13223036-T 7:120747308 "Bone mineral density (paediatric, skull)" 3.00E-22 0.17 24945404 | |
| 7 120758899 rs798943-G 7:120758899 "Bone mineral density (paediatric, upper limb)" 1.00E-37 0.2 24945404 | |
| 7 120758899 rs798943-G 7:120758899 "Bone mineral density (paediatric, upper limb)" 3.00E-32 0.2 24945404 | |
| 7 120785064 rs13245690-A 7:120785064 Bone mineral density 2.00E-11 0.05 22504420 | |
| 7 120903815 rs4609139-T 7:120903815 Bone mineral density 1.00E-10 0.08 22792070 | |
| 7 120962164 rs2908007-G 7:120962164 Bone properties (heel) 2.00E-59 0.15 24430505 | |
| 7 120962164 rs2908007-G 7:120962164 Bone properties (heel) 4.00E-35 0.14 24430505 | |
| 7 120962164 rs2908007-G 7:120962164 Bone properties (heel) 1.00E-09 0.14 24430505 | |
| 7 120969769 rs2908004-G 7:120969769 Bone mineral density 1.00E-15 0.16 22792071 | |
| 7 120969769 rs2908004-A 7:120969769 "Bone mineral density (paediatric, lower limb)" 3.00E-11 0.1 24945404 | |
| 7 120969769 rs2908004-A 7:120969769 "Bone mineral density (paediatric, lower limb)" 1.00E-09 0.1 24945404 | |
| 7 120974765 rs3801387-A 7:120974765 Bone mineral density 3.00E-51 0.09 22504420 | |
| 7 120979089 rs2707466-C 7:120979089 Cortical thickness 2.00E-10 0.11 22792071 | |
| 7 120983343 rs10242100-? 7:120983343 Bone mineral density 2.00E-10 NR 24249740 | |
| 7 121018579 rs917727-T 7:121018579 Bone mineral density 1.00E-27 0.15 22792070 | |
| 7 121033121 rs7776725-C 7:121033121 "Bone mineral density (paediatric, total body less head)" 6.00E-20 0.16 24945404 | |
| 7 121033121 rs7776725-C 7:121033121 "Bone mineral density (paediatric, total body less head)" 2.00E-15 0.16 24945404 | |
| 7 121033121 rs7776725-C 7:121033121 Biomedical quantitative traits 1.00E-11 NR 19396169 | |
| 7 123411223 rs4731120-C 7:123411223 Platelet counts 3.00E-12 4.14 22139419 | |
| 7 124462661 rs17246404-C 7:124462661 Chronic lymphocytic leukemia 3.00E-08 1.22 24292274 | |
| 7 127164958 rs6467136-G 7:127164958 Type 2 diabetes 5.00E-11 1.11 22158537 | |
| 7 127246903 rs10229583-G 7:127246903 Type 2 diabetes 2.00E-10 1.14 23532257 | |
| 7 127862802 rs791595-A 7:127862802 Type 2 diabetes 3.00E-13 1.17 23945395 | |
| 7 128415195 rs1799922-T 7:128415195 Primary tooth development (number of teeth) 4.00E-09 0.14 23704328 | |
| 7 128568960 rs729302-A 7:128568960 Systemic lupus erythematosus 1.00E-09 1.47 23273568 | |
| 7 128568960 rs729302-A 7:128568960 Systemic lupus erythematosus 4.00E-08 1.29 23053960 | |
| 7 128573967 rs4728142-A 7:128573967 Systemic lupus erythematosus 8.00E-19 1.43 19838193 | |
| 7 128573967 rs4728142-A 7:128573967 Ulcerative colitis 4.00E-14 1.1 23128233 | |
| 7 128573967 rs4728142-A 7:128573967 Systemic lupus erythematosus 7.00E-10 1.45 24871463 | |
| 7 128573967 rs4728142-A 7:128573967 Ulcerative colitis 2.00E-08 1.07 21297633 | |
| 7 128594183 rs10488631-C 7:128594183 Systemic lupus erythematosus 7.00E-18 1.92 21408207 | |
| 7 128594183 rs10488631-C 7:128594183 Systemic lupus erythematosus 2.00E-13 1.83 24871463 | |
| 7 128594183 rs10488631-C 7:128594183 Systemic sclerosis 2.00E-13 1.5 20383147 | |
| 7 128594183 rs10488631-C 7:128594183 Systemic lupus erythematosus 2.00E-11 NR 18204098 | |
| 7 128594183 rs10488631-C 7:128594183 Rheumatoid arthritis 4.00E-11 1.19 20453842 | |
| 7 128594183 rs10488631-? 7:128594183 Systemic sclerosis 2.00E-10 1.5 21779181 | |
| 7 128594183 rs10488631-C 7:128594183 Primary biliary cirrhosis 3.00E-10 1.63 20639880 | |
| 7 128594183 rs10488631-? 7:128594183 Systemic sclerosis 1.00E-09 1.61 21779181 | |
| 7 128617466 rs12531711-G 7:128617466 Primary biliary cirrhosis 9.00E-17 1.58 21399635 | |
| 7 128617466 rs12531711-A 7:128617466 Systemic lupus erythematosus 6.00E-13 1.59 23053960 | |
| 7 128617466 rs12531711-G 7:128617466 Systemic lupus erythematosus 6.00E-09 1.58 21408207 | |
| 7 128695983 rs13239597-? 7:128695983 Systemic lupus erythematosus and Systemic sclerosis 1.00E-29 1.66 23740937 | |
| 7 128717906 rs12537284-A 7:128717906 Systemic lupus erythematosus 4.00E-19 1.54 18204446 | |
| 7 129004847 rs11766298-T 7:129004847 Response to fenofibrate 4.00E-09 4.41 22890011 | |
| 7 129663496 rs11556924-C 7:129663496 Coronary heart disease 9.00E-18 1.09 21378990 | |
| 7 129663496 rs11556924-T 7:129663496 Coronary artery disease 3.00E-10 1.1 24262325 | |
| 7 129663496 rs11556924-? 7:129663496 Coronary artery disease or large artery stroke 8.00E-10 NR 24262325 | |
| 7 129663496 rs11556924-? 7:129663496 Coronary artery disease or ischemic stroke 9.00E-10 NR 24262325 | |
| 7 130003487 rs17164851-? x rs2162234-? 7:130003487 Age-related hearing impairment (interaction) 2.00E-09 NR 24939585 | |
| 7 130433384 rs4731702-T 7:130433384 HDL cholesterol 5.00E-17 0.03 24097068 | |
| 7 130433384 rs4731702-T 7:130433384 HDL cholesterol 1.00E-15 0.59 20686565 | |
| 7 130466854 rs972283-G 7:130466854 Type 2 diabetes 2.00E-10 1.07 20581827 | |
| 7 130585553 rs157935-T 7:130585553 Basal cell carcinoma 9.00E-11 1.23 24403052 | |
| 7 132030011 rs1364505-A x rs1204660-A 7:132030011 Venous thromboembolism (gene x gene interaction) 2.00E-09 1.8 23509962 | |
| 7 134785741 rs17231212-G 7:134785741 Immune reponse to smallpox (secreted IL-10) 2.00E-08 NR 22610502 | |
| 7 135293128 rs4294134-G 7:135293128 Paget's disease 8.00E-10 1.45 21623375 | |
| 7 135329978 rs12530845-? 7:135329978 Red blood cell traits 3.00E-08 NR 23222517 | |
| 7 136642634 rs2350782-C 7:136642634 Heart rate 1.00E-12 0.51 23583979 | |
| 7 137788492 rs6980334-A 7:137788492 Blood metabolite ratios 4.00E-20 0.04 24816252 | |
| 7 137799569 rs2035647-A 7:137799569 Blood metabolite levels 2.00E-17 0.03 24816252 | |
| 7 140195463 rs12534545-? x rs11641717-? 7:140195463 Age-related hearing impairment (interaction) 5.00E-09 NR 24939585 | |
| 7 141672604 rs10246939-? 7:141672604 Bitter taste perception 2.00E-62 0.39 23966204 | |
| 7 141673345 rs713598-? 7:141673345 Bitter taste response 2.00E-104 NR 20675712 | |
| 7 141801007 rs3800993-T 7:141801007 Blood metabolite levels 2.00E-15 0.03 24816252 | |
| 7 142274852 rs2854536-? 7:142274852 Narcolepsy 4.00E-08 1.28 24204295 | |
| 7 142456928 rs10273639-C 7:142456928 Pancreatitis 2.00E-14 1.36 23143602 | |
| 7 143109139 rs11767557-? 7:143109139 Alzheimer's disease (late onset) 6.00E-10 1.11 21460841 | |
| 7 143110762 rs11771145-G 7:143110762 Alzheimer's disease (late onset) 1.00E-13 1.11 24162737 | |
| 7 144074929 rs720475-G 7:144074929 Breast cancer 7.00E-11 1.06 23535729 | |
| 7 148650634 rs822552-C 7:148650634 Height 3.00E-08 0.03 20881960 | |
| 7 149203662 rs855913-A 7:149203662 Amyotrophic lateral sclerosis 4.00E-08 1.08 19451621 | |
| 7 149289464 rs354033-G 7:149289464 Multiple sclerosis 5.00E-09 1.11 21833088 | |
| 7 150512172 rs10231759-C 7:150512172 Height 4.00E-09 1.15 23563607 | |
| 7 150517022 rs2110001-C 7:150517022 Height 3.00E-13 0.03 20881960 | |
| 7 150529449 rs17173637-C 7:150529449 HDL cholesterol 2.00E-08 0.04 24097068 | |
| 7 150543721 rs1005390-T 7:150543721 Blood metabolite ratios 3.00E-16 0.04 24816252 | |
| 7 150543721 rs1005390-T 7:150543721 Blood metabolite levels 3.00E-14 0.03 24816252 | |
| 7 150622162 rs2968864-C 7:150622162 QT interval 8.00E-16 1.4 19305408 | |
| 7 150623137 rs2968863-T 7:150623137 QT interval 2.00E-15 1.35 19305409 | |
| 7 150637863 rs4725982-T 7:150637863 QT interval 5.00E-16 1.58 19305408 | |
| 7 150667210 rs3807375-T 7:150667210 Electrocardiographic traits 5.00E-11 11.95 20062063 | |
| 7 150915071 rs1122979-G 7:150915071 IgG glycosylation 2.00E-10 0.31 23382691 | |
| 7 150915071 rs1122979-G 7:150915071 IgG glycosylation 6.00E-10 0.3 23382691 | |
| 7 150915071 rs1122979-G 7:150915071 IgG glycosylation 1.00E-09 0.3 23382691 | |
| 7 150915071 rs1122979-G 7:150915071 IgG glycosylation 2.00E-09 0.29 23382691 | |
| 7 150919829 rs7812088-A 7:150919829 Bone mineral density 7.00E-09 0.05 22504420 | |
| 7 151406005 rs10480300-C 7:151406005 Red blood cell traits 8.00E-15 0.05 23222517 | |
| 7 151406005 rs10480300-T 7:151406005 Urate levels 4.00E-09 0.04 23263486 | |
| 7 151407801 rs7805747-A 7:151407801 Chronic kidney disease 4.00E-12 1.18 20383146 | |
| 7 151415041 rs10224002-G 7:151415041 Hemoglobin 3.00E-15 0.07 19862010 | |
| 7 151415041 rs10224002-G 7:151415041 Hematocrit 6.00E-15 0.2 19862010 | |
| 7 152924893 rs2710201-? x rs3780293-? 7:152924893 Venous thromboembolism (gene x gene interaction) 3.00E-09 2.5 23509962 | |
| 7 154210798 rs10260404-C 7:154210798 Amyotrophic lateral sclerosis 5.00E-08 1.3 18084291 | |
| 7 157387441 rs10274279-? 7:157387441 Myopia (pathological) 4.00E-11 NR 23049088 | |
| 7 158846929 rs2730260-C 7:158846929 Myopia (pathological) 9.00E-14 1.33 23406873 | |
| 8 1373720 rs28680850-A 8:1373720 Triglycerides 7.00E-09 1.26 24886709 | |
| 8 4022811 rs2407308-? x rs2036534-? 8:4022811 Age-related hearing impairment (interaction) 1.00E-08 NR 24939585 | |
| 8 4180844 rs10503253-A 8:4180844 Schizophrenia 2.00E-08 1.16 21926974 | |
| 8 4180844 rs10503253-? 8:4180844 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 4.00E-08 NR 23453885 | |
| 8 4238139 rs6558872-? 8:4238139 "Schizophrenia, schizoaffective disorder or bipolar disorder" 5.00E-08 NR 24166486 | |
| 8 6323278 rs2916733-C 8:6323278 Epirubicin-induced leukopenia 2.00E-09 2.74 21799462 | |
| 8 6822785 rs2738048-A 8:6822785 IgA nephropathy 3.00E-14 1.27 22197929 | |
| 8 9178268 rs6984305-A 8:9178268 Liver enzyme levels (alkaline phosphatase) 2.00E-10 2.7 22001757 | |
| 8 9183358 rs9987289-A 8:9183358 HDL cholesterol 2.00E-41 0.08 24097068 | |
| 8 9183358 rs9987289-A 8:9183358 "Cholesterol, total" 2.00E-36 0.08 24097068 | |
| 8 9183358 rs9987289-A 8:9183358 HDL cholesterol 6.00E-25 1.21 20686565 | |
| 8 9183358 rs9987289-A 8:9183358 LDL cholesterol 9.00E-24 0.07 24097068 | |
| 8 9183358 rs9987289-T 8:9183358 "Cholesterol, total" 9.00E-24 3.14 20686565 | |
| 8 9183358 rs9987289-T 8:9183358 LDL cholesterol 7.00E-15 2.22 20686565 | |
| 8 9183358 rs9987289-A 8:9183358 C-reactive protein 3.00E-13 0.07 21300955 | |
| 8 9183358 rs9987289-A 8:9183358 HDL Cholesterol - Triglycerides (HDLC-TG) 1.00E-08 0.25 21386085 | |
| 8 9183358 rs9987289-A 8:9183358 Metabolic syndrome (bivariate traits) 4.00E-08 0.24 21386085 | |
| 8 9183596 rs4841132-G 8:9183596 Glycemic traits (pregnancy) 5.00E-15 0.03 23903356 | |
| 8 9183596 rs4841132-G 8:9183596 Glycemic traits (pregnancy) 3.00E-13 0.01 23903356 | |
| 8 9183596 rs4841132-? 8:9183596 Fasting insulin-related traits (interaction with BMI) 2.00E-10 NR 22581228 | |
| 8 9183596 rs4841132-? 8:9183596 Metabolite levels 2.00E-09 NR 22916037 | |
| 8 9183596 rs4841132-? 8:9183596 Fasting glucose-related traits (interaction with BMI) 8.00E-09 NR 22581228 | |
| 8 9184691 rs6601299-T 8:9184691 Coronary heart disease 1.00E-08 0.14 21347282 | |
| 8 9185146 rs2126259-A 8:9185146 LDL cholesterol 7.00E-12 0.02 20864672 | |
| 8 9187242 rs1461729-T 8:9187242 HDL cholesterol 7.00E-09 0.04 23726366 | |
| 8 9860080 rs7826222-G 8:9860080 Adiposity 9.00E-09 0.04 19557161 | |
| 8 10671272 rs6601530-G 8:10671272 Carotid intima media thickness 2.00E-08 0.01 21909108 | |
| 8 10683929 rs11776767-C 8:10683929 Triglycerides 3.00E-11 0.02 24097068 | |
| 8 10683929 rs11776767-C 8:10683929 Triglycerides 1.00E-08 2.01 20686565 | |
| 8 11045161 rs7819412-G 8:11045161 Triglycerides 3.00E-08 0.04 19060906 | |
| 8 11340181 rs7812879-G 8:11340181 Systemic lupus erythematosus 2.00E-24 1.45 19838193 | |
| 8 11341880 rs2736337-C 8:11341880 Rheumatoid arthritis 3.00E-13 1.11 24390342 | |
| 8 11343680 rs2254546-G 8:11343680 Kawasaki disease 8.00E-21 1.85 22446962 | |
| 8 11343680 rs2254546-G 8:11343680 Systemic lupus erythematosus 2.00E-13 1.49 23273568 | |
| 8 11343973 rs2736340-T 8:11343973 Kawasaki disease 9.00E-10 1.54 22446961 | |
| 8 11343973 rs2736340-A 8:11343973 Rheumatoid arthritis 6.00E-09 1.19 19503088 | |
| 8 11343973 rs2736340-? 8:11343973 Systemic lupus erythematosus and Systemic sclerosis 1.00E-08 1.22 23740937 | |
| 8 11349186 rs13277113-A 8:11349186 Systemic lupus erythematosus 1.00E-10 1.39 18204098 | |
| 8 11349186 rs13277113-A 8:11349186 Systemic lupus erythematosus 2.00E-10 1.39 23053960 | |
| 8 11352541 rs2618476-? 8:11352541 Systemic lupus erythematosus 2.00E-08 1.29 19165918 | |
| 8 12979400 rs12541254-A x rs305009-A 8:12979400 Venous thromboembolism (gene x gene interaction) 3.00E-09 1.65 23509962 | |
| 8 13058674 rs2016444-G 8:13058674 Fractional exhaled nitric oxide (childhood) 1.00E-12 0.29 24315451 | |
| 8 15532585 rs4831760-? 8:15532585 Pulmonary function decline 5.00E-08 0.22 22424883 | |
| 8 17205577 rs4921542-? 8:17205577 Creutzfeldt-Jakob disease (variant) 2.00E-08 3.25 22137330 | |
| 8 18259366 rs721399-T 8:18259366 Blood metabolite levels 4.00E-58 0.03 24816252 | |
| 8 18272377 rs4921913-T 8:18272377 Blood metabolite ratios 3.00E-47 0.04 24816252 | |
| 8 18272438 rs4921914-T 8:18272438 Blood metabolite levels 1.00E-60 0.09 24816252 | |
| 8 18272438 rs4921914-T 8:18272438 Urinary metabolites (H-NMR features) 4.00E-32 0.51 24586186 | |
| 8 18272438 rs4921914-C 8:18272438 Urinary metabolites 1.00E-28 NR 21572414 | |
| 8 18272881 rs1495741-A 8:18272881 Blood metabolite levels 1.00E-27 0.06 24816252 | |
| 8 18272881 rs1495741-G 8:18272881 Triglycerides 4.00E-14 2.97 20686565 | |
| 8 18272881 rs1495741-G 8:18272881 Triglycerides 3.00E-12 0.04 24097068 | |
| 8 18272881 rs1495741-? 8:18272881 Bladder cancer 4.00E-11 1.15 20972438 | |
| 8 18272881 rs1495741-A 8:18272881 Bladder cancer 2.00E-10 1.14 24163127 | |
| 8 18272881 rs1495741-G 8:18272881 "Cholesterol, total" 2.00E-09 1.07 20686565 | |
| 8 18272881 rs1495741-G 8:18272881 "Cholesterol, total" 3.00E-08 0.03 24097068 | |
| 8 18273300 rs1495743-G 8:18273300 Metabolic traits 2.00E-40 0.26 21886157 | |
| 8 19813529 rs268-G 8:19813529 Metabolic syndrome 2.00E-12 0.38 22399527 | |
| 8 19816238 rs295-A 8:19816238 Metabolic syndrome 2.00E-09 0.17 21386085 | |
| 8 19816934 rs301-C 8:19816934 Metabolic syndrome (bivariate traits) 3.00E-11 0.22 21386085 | |
| 8 19819328 rs325-T 8:19819328 HDL cholesterol 8.00E-26 0.05 20864672 | |
| 8 19819439 rs326-A 8:19819439 Triglycerides 5.00E-12 6.6 18193046 | |
| 8 19819439 rs326-T 8:19819439 HDL cholesterol 1.00E-08 0.02 23726366 | |
| 8 19819439 rs326-T 8:19819439 Triglycerides 1.00E-08 0.04 23726366 | |
| 8 19819724 rs328-G 8:19819724 Triglycerides 2.00E-28 0.19 18193044 | |
| 8 19819724 rs328-G 8:19819724 HDL cholesterol 9.00E-23 0.17 18193044 | |
| 8 19819724 rs328-G 8:19819724 Lipid traits 2.00E-14 0.04 24386095 | |
| 8 19819724 rs328-G 8:19819724 Lipid traits 3.00E-10 0.07 24386095 | |
| 8 19819724 rs328-? 8:19819724 Triglycerides 1.00E-09 NR 22171074 | |
| 8 19820405 rs331-? 8:19820405 Lipid metabolism phenotypes 1.00E-17 1.46 19936222 | |
| 8 19820405 rs331-? 8:19820405 Lipid metabolism phenotypes 1.00E-14 1.21 19936222 | |
| 8 19820405 rs331-? 8:19820405 Lipid metabolism phenotypes 3.00E-14 1.51 19936222 | |
| 8 19820405 rs331-? 8:19820405 Lipid metabolism phenotypes 1.00E-11 1.26 19936222 | |
| 8 19824492 rs13702-A 8:19824492 HDL Cholesterol - Triglycerides (HDLC-TG) 1.00E-16 0.29 21386085 | |
| 8 19824563 rs1059611-? 8:19824563 Lipid metabolism phenotypes 1.00E-20 2.88 19936222 | |
| 8 19824563 rs1059611-? 8:19824563 Lipid metabolism phenotypes 2.00E-17 0.07 19936222 | |
| 8 19824667 rs15285-A 8:19824667 Triglycerides-Blood Pressure (TG-BP) 1.00E-10 0.27 21386085 | |
| 8 19826373 rs2197089-C 8:19826373 Metabolic syndrome (bivariate traits) 2.00E-09 0.18 21386085 | |
| 8 19827848 rs10105606-C 8:19827848 Triglycerides 4.00E-26 0.07 20864672 | |
| 8 19830921 rs10096633-G 8:19830921 Triglycerides 2.00E-18 0.17 19060911 | |
| 8 19830921 rs10096633-T 8:19830921 Triglycerides 9.00E-14 0.17 20139978 | |
| 8 19830921 rs10096633-A 8:19830921 Metabolic traits 5.00E-08 0.12 19060910 | |
| 8 19832646 rs17482753-T 8:19832646 HDL cholesterol 3.00E-11 2.02 20031538 | |
| 8 19832646 rs17482753-T 8:19832646 Lipid traits 6.00E-10 -0.24 24023261 | |
| 8 19844222 rs12678919-G 8:19844222 Triglycerides 2.00E-199 0.17 24097068 | |
| 8 19844222 rs12678919-G 8:19844222 HDL cholesterol 1.00E-149 0.16 24097068 | |
| 8 19844222 rs12678919-G 8:19844222 Triglycerides 2.00E-115 13.64 20686565 | |
| 8 19844222 rs12678919-G 8:19844222 HDL cholesterol 1.00E-97 2.25 20686565 | |
| 8 19844222 rs12678919-G 8:19844222 Triglycerides 2.00E-41 0.25 19060906 | |
| 8 19844222 rs12678919-G 8:19844222 HDL cholesterol 2.00E-34 0.23 19060906 | |
| 8 19844222 rs12678919-? 8:19844222 Metabolite levels 9.00E-13 NR 22916037 | |
| 8 19845376 rs7841189-C 8:19845376 Metabolic syndrome 1.00E-14 0.18 22399527 | |
| 8 19847690 rs10503669-T 8:19847690 HDL cholesterol 8.00E-43 0.04 21909109 | |
| 8 19847690 rs10503669-T 8:19847690 Triglycerides 7.00E-39 0.09 21909109 | |
| 8 19847690 rs10503669-C 8:19847690 Triglycerides 4.00E-22 11.57 18193043 | |
| 8 19847690 rs10503669-A 8:19847690 HDL cholesterol 4.00E-19 2.09 18193043 | |
| 8 19848080 rs17410962-G 8:19848080 Triglycerides 7.00E-09 0.11 23726366 | |
| 8 19849757 rs17091905-A 8:19849757 Cardiovascular disease risk factors 5.00E-15 0.17 21943158 | |
| 8 19849757 rs17091905-A 8:19849757 Cardiovascular disease risk factors 6.00E-12 0.15 21943158 | |
| 8 19860460 rs79236614-? 8:19860460 Triglycerides 7.00E-09 1.89 24886709 | |
| 8 19865175 rs2083637-G 8:19865175 HDL cholesterol 6.00E-18 0.11 19060911 | |
| 8 19865175 rs2083637-G 8:19865175 Metabolic syndrome 2.00E-10 0.04 20694148 | |
| 8 19868386 rs1441756-G 8:19868386 Metabolic syndrome (bivariate traits) 3.00E-08 0.18 21386085 | |
| 8 19912370 rs115849089-? 8:19912370 Lipid metabolism phenotypes 4.00E-15 0.22 22286219 | |
| 8 19928582 rs9644568-? 8:19928582 Hypertriglyceridemia 4.00E-11 2 23505323 | |
| 8 21820813 rs7843479-A 8:21820813 Mean corpuscular volume 3.00E-08 0.07 20139978 | |
| 8 23082971 rs13278062-T 8:23082971 Age-related macular degeneration 3.00E-15 1.15 23455636 | |
| 8 23082971 rs13278062-T 8:23082971 Age-related macular degeneration 1.00E-12 1.37 21909106 | |
| 8 23526463 rs1512268-? 8:23526463 Prostate cancer 3.00E-30 1.18 19767753 | |
| 8 23526463 rs1512268-? 8:23526463 Prostate cancer 4.00E-11 NR 20676098 | |
| 8 23751151 rs10109414-T 8:23751151 Chronic kidney disease 1.00E-08 NR 20383146 | |
| 8 23777006 rs17786744-A 8:23777006 Urate levels 1.00E-08 0.03 23263486 | |
| 8 24116304 rs1013209-T 8:24116304 Height 2.00E-09 0.03 20881960 | |
| 8 25892142 rs11135910-A 8:25892142 Prostate cancer 8.00E-11 1.11 23535732 | |
| 8 26206077 rs1594829-C 8:26206077 Height 4.00E-08 1.15 23563607 | |
| 8 26714874 rs13278849-A 8:26714874 Blood metabolite levels 3.00E-11 0.01 24816252 | |
| 8 27195121 rs28834970-C 8:27195121 Alzheimer's disease (late onset) 7.00E-14 1.1 24162737 | |
| 8 27464519 rs11136000-? 8:27464519 Alzheimer's disease 9.00E-10 1.16 19734902 | |
| 8 27467686 rs9331896-T 8:27467686 Alzheimer's disease (late onset) 3.00E-25 1.16 24162737 | |
| 8 27487790 rs569214-? 8:27487790 Alzheimer's disease 4.00E-08 1.14 21627779 | |
| 8 29360305 rs10091038-A 8:29360305 Response to statin therapy 3.00E-08 NR 20339536 | |
| 8 29509616 rs9693444-A 8:29509616 Breast cancer 9.00E-14 1.07 23535729 | |
| 8 32411216 rs16879552-G 8:32411216 Hirschsprung's disease 2.00E-08 1.68 19196962 | |
| 8 32416274 rs7825175-A 8:32416274 Thyroid hormone levels 3.00E-09 0.07 23408906 | |
| 8 32416274 rs7825175-A 8:32416274 Thyroid hormone levels 2.00E-08 0.08 23408906 | |
| 8 32432369 rs2439302-G 8:32432369 Thyroid cancer 2.00E-09 1.36 22267200 | |
| 8 33665680 rs10503951-? 8:33665680 Immune response to smallpox vaccine (IL-6) 3.00E-09 NR 22542470 | |
| 8 36846109 rs7816345-T 8:36846109 Breast size 2.00E-14 0.15 22747683 | |
| 8 37977732 rs2517388-G 8:37977732 Menopause (age at onset) 9.00E-15 0.26 22267201 | |
| 8 38031345 rs16887244-? 8:38031345 Schizophrenia 1.00E-10 1.19 22037555 | |
| 8 39823145 rs2160860-A 8:39823145 Blood metabolite levels 7.00E-11 0.01 24816252 | |
| 8 40484239 rs2722425-? 8:40484239 Fasting plasma glucose 2.00E-08 NR 17903298 | |
| 8 40726394 rs7829127-G 8:40726394 Refractive error 4.00E-10 0.12 23396134 | |
| 8 41519462 rs515071-? 8:41519462 Type 2 diabetes 1.00E-08 1.18 22456796 | |
| 8 41549194 rs6474359-T 8:41549194 Glycated hemoglobin levels 1.00E-08 0.06 20858683 | |
| 8 41630405 rs4737009-A 8:41630405 Glycated hemoglobin levels 1.00E-15 0.08 24647736 | |
| 8 41630405 rs4737009-A 8:41630405 Glycated hemoglobin levels 6.00E-12 0.03 20858683 | |
| 8 42044965 rs2020921-G 8:42044965 Plasma plasminogen activator levels 2.00E-08 0.07 24578379 | |
| 8 42205080 rs3136739-A 8:42205080 Plasma plasminogen activator levels 1.00E-09 0.06 24578379 | |
| 8 42546711 rs1451240-? 8:42546711 Nicotine dependence 7.00E-16 NR 22524403 | |
| 8 42550498 rs6474412-T 8:42550498 Smoking behavior 1.00E-08 0.29 20418888 | |
| 8 49884817 rs17641971-T 8:49884817 Blood metabolite levels 3.00E-22 0.03 24816252 | |
| 8 50024944 rs10504073-T 8:50024944 Blood metabolite ratios 3.00E-32 0.03 24816252 | |
| 8 52757093 rs10504130-A x rs2847351-G 8:52757093 Venous thromboembolism (gene x gene interaction) 4.00E-09 1.88 23509962 | |
| 8 52887541 rs1015213-A 8:52887541 Glaucoma (primary open-angle) 3.00E-09 1.5 22922875 | |
| 8 55327091 rs10958409-A 8:55327091 Intracranial aneurysm 1.00E-10 1.36 18997786 | |
| 8 55421614 rs10102164-A 8:55421614 LDL cholesterol 4.00E-11 0.03 24097068 | |
| 8 55421614 rs10102164-A 8:55421614 "Cholesterol, total" 5.00E-11 0.03 24097068 | |
| 8 55437524 rs9298506-A 8:55437524 Intracranial aneurysm 1.00E-12 1.28 20364137 | |
| 8 55437524 rs9298506-A 8:55437524 Intracranial aneurysm 2.00E-09 1.35 18997786 | |
| 8 56358274 rs2622590-A 8:56358274 Serum thyroid-stimulating hormone levels 2.00E-10 0.03 24852370 | |
| 8 56599548 rs4737395-? 8:56599548 Myopia (pathological) 5.00E-09 NR 23049088 | |
| 8 57095808 rs10958476-? 8:57095808 Height 1.00E-09 NR 20881960 | |
| 8 57100149 rs7833986-A 8:57100149 Height 8.00E-10 0.12 20189936 | |
| 8 57100791 rs13273123-G 8:57100791 Height 1.00E-09 0.71 19396169 | |
| 8 57194163 rs7460090-T 8:57194163 Height 8.00E-27 0.06 20881960 | |
| 8 57209246 rs4075154-A 8:57209246 Height 3.00E-09 1.29 23563607 | |
| 8 59388565 rs2081687-A 8:59388565 "Cholesterol, total" 9.00E-13 1.26 20686565 | |
| 8 59388565 rs2081687-T 8:59388565 "Cholesterol, total" 9.00E-12 0.04 24097068 | |
| 8 59388565 rs2081687-A 8:59388565 LDL cholesterol 4.00E-09 0.95 20686565 | |
| 8 60179086 rs7837791-T 8:60179086 Refractive error 4.00E-12 0.11 23396134 | |
| 8 67360725 rs1030420-T 8:67360725 Blood metabolite levels 1.00E-11 0.02 24816252 | |
| 8 67381268 rs10112574-A 8:67381268 Blood metabolite ratios 3.00E-14 0.03 24816252 | |
| 8 69992380 rs2912522-? 8:69992380 Dupuytren's disease 2.00E-13 1.39 21732829 | |
| 8 70976505 rs7010162-G 8:70976505 Testicular germ cell tumor 5.00E-08 1.22 23666240 | |
| 8 71386904 rs10091374-A 8:71386904 Cardiac Troponin-T levels 9.00E-09 0.04 23247143 | |
| 8 74007347 rs12677663-T 8:74007347 Crohn's disease 2.00E-08 1.15 22412388 | |
| 8 76230301 rs6472903-T 8:76230301 Breast cancer 2.00E-17 1.1 23535729 | |
| 8 76417937 rs2943559-G 8:76417937 Breast cancer 6.00E-15 1.13 23535729 | |
| 8 76478768 rs2941484-T 8:76478768 Urate levels 4.00E-17 0.04 23263486 | |
| 8 76615663 rs4735692-A 8:76615663 Obesity 4.00E-10 1.04 23563607 | |
| 8 76615663 rs4735692-A 8:76615663 Obesity 2.00E-09 1.06 23563607 | |
| 8 78093837 rs7821178-A 8:78093837 Menarche (age at onset) 3.00E-09 2.4 21102462 | |
| 8 78160179 rs7846385-C 8:78160179 Height 5.00E-08 5 18391951 | |
| 8 78178485 rs6473015-A 8:78178485 Height 7.00E-13 0.03 20881960 | |
| 8 81095395 rs998731-T 8:81095395 Rheumatoid arthritis 7.00E-09 1.09 24390342 | |
| 8 81095395 rs998731-T 8:81095395 Rheumatoid arthritis 2.00E-08 1.08 24390342 | |
| 8 81291879 rs7009110-T 8:81291879 Asthma and hay fever 4.00E-09 1.14 24388013 | |
| 8 81461974 rs440837-A 8:81461974 Sex hormone-binding globulin levels 3.00E-09 0.03 22829776 | |
| 8 82151747 rs12216812-? 8:82151747 Myopia (pathological) 3.00E-09 NR 23049088 | |
| 8 82653644 rs11782652-A 8:82653644 Ovarian cancer 7.00E-10 1.24 23535730 | |
| 8 82653644 rs11782652-A 8:82653644 Ovarian cancer 6.00E-09 1.19 23535730 | |
| 8 86268313 rs1532423-A 8:86268313 Blood trace element (Zn levels) 6.00E-12 0.18 23720494 | |
| 8 86467538 rs10102392-? x rs11238734-? 8:86467538 Age-related hearing impairment (interaction) 7.00E-09 NR 24939585 | |
| 8 88868340 rs12543318-C 8:88868340 Orofacial clefts 2.00E-08 1.27 22863734 | |
| 8 89547932 rs10504861-? 8:89547932 Migraine without aura 1.00E-08 1.16 23793025 | |
| 8 89592083 rs11995572-T 8:89592083 Schizophrenia 3.00E-08 1.12 23974872 | |
| 8 89760311 rs7004633-? 8:89760311 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 3.00E-08 NR 23453885 | |
| 8 90778513 rs42490-G 8:90778513 Leprosy 1.00E-16 1.32 20018961 | |
| 8 90823687 rs40457-A 8:90823687 Leprosy 1.00E-12 1.3 20018961 | |
| 8 90875918 rs7015630-T 8:90875918 Crohn's disease 1.00E-08 1.08 23128233 | |
| 8 94222945 rs278541-C 8:94222945 IgG glycosylation 4.00E-08 0.8 23382691 | |
| 8 94222945 rs278541-C 8:94222945 IgG glycosylation 4.00E-08 0.81 23382691 | |
| 8 95960511 rs896854-T 8:95960511 Type 2 diabetes 1.00E-09 1.06 20581827 | |
| 8 98166913 rs1835740-A 8:98166913 Migraine 2.00E-11 1.18 20802479 | |
| 8 98282189 rs1864729-? 8:98282189 Estradiol plasma levels (breast cancer) 3.00E-08 1.59 23518928 | |
| 8 101024505 rs7006527-? 8:101024505 Basal cell carcinoma 9.00E-13 1.3 24403052 | |
| 8 101024505 rs7006527-? 8:101024505 Basal cell carcinoma 9.00E-10 1.3 24403052 | |
| 8 102463602 rs678347-G 8:102463602 Rheumatoid arthritis 7.00E-09 1.1 24390342 | |
| 8 102463602 rs678347-G 8:102463602 Rheumatoid arthritis 2.00E-08 1.08 24390342 | |
| 8 103578874 rs2511714-G 8:103578874 Chronic lymphocytic leukemia 5.00E-08 1.19 23770605 | |
| 8 105359432 rs2458413-A 8:105359432 Paget's disease 7.00E-17 1.4 21623375 | |
| 8 105958020 rs284489-? 8:105958020 Glaucoma (primary open-angle) 9.00E-10 1.61 22570617 | |
| 8 106581528 rs6993770-T 8:106581528 Vascular endothelial growth factor levels 5.00E-23 NR 21757650 | |
| 8 106581528 rs6993770-A 8:106581528 Platelet counts 4.00E-17 3.67 22139419 | |
| 8 109228008 rs611744-? 8:109228008 Dupuytren's disease 8.00E-15 1.33 21732829 | |
| 8 110115676 rs7832552-T 8:110115676 Body mass (lean) 4.00E-10 0.1 19268274 | |
| 8 116599199 rs2293889-T 8:116599199 HDL cholesterol 4.00E-17 0.03 24097068 | |
| 8 116599199 rs2293889-T 8:116599199 HDL cholesterol 6.00E-11 0.44 20686565 | |
| 8 116648565 rs2737229-C 8:116648565 "Cholesterol, total" 2.00E-08 1.11 20686565 | |
| 8 117574515 rs140355816-G 8:117574515 Colorectal cancer 2.00E-08 1.59 24737748 | |
| 8 117630683 rs16892766-A 8:117630683 Colorectal cancer 3.00E-18 1.27 18372905 | |
| 8 117647788 rs6469656-A 8:117647788 Colorectal cancer 5.00E-08 1.09 24836286 | |
| 8 118025645 rs3019885-G 8:118025645 Asthma 5.00E-13 1.34 21814517 | |
| 8 118184783 rs13266634-C 8:118184783 Type 2 diabetes 2.00E-14 1.22 19401414 | |
| 8 118184783 rs13266634-A 8:118184783 Glycated hemoglobin levels 5.00E-08 0.02 19096518 | |
| 8 118184783 rs13266634-C 8:118184783 Type 2 diabetes 5.00E-08 1.12 17463246 | |
| 8 118184783 rs13266634-C 8:118184783 Type 2 diabetes 5.00E-08 1.12 17463248 | |
| 8 118184783 rs13266634-C 8:118184783 Type 2 diabetes 5.00E-08 1.12 17463249 | |
| 8 118185025 rs3802177-G 8:118185025 Type 2 diabetes 2.00E-18 1.16 24509480 | |
| 8 118185025 rs3802177-G 8:118185025 Type 2 diabetes 1.00E-08 1.15 20581827 | |
| 8 118185025 rs3802177-G 8:118185025 Type 2 diabetes 4.00E-08 1.23 22693455 | |
| 8 118185733 rs11558471-? 8:118185733 Fasting glucose-related traits (interaction with BMI) 3.00E-20 NR 22581228 | |
| 8 118185733 rs11558471-A 8:118185733 Proinsulin levels 3.00E-18 NR 21873549 | |
| 8 118185733 rs11558471-A 8:118185733 Fasting glucose-related traits 3.00E-11 NR 20081858 | |
| 8 119923873 rs4355801-A 8:119923873 Bone mineral density 8.00E-10 0.09 18455228 | |
| 8 119976542 rs7839059-A 8:119976542 Bone mineral density 1.00E-10 0.1 23437003 | |
| 8 119977792 rs2062375-G 8:119977792 Osteoporosis-related phenotypes 3.00E-11 0.14 20548944 | |
| 8 120007420 rs2062377-A 8:120007420 Bone mineral density 3.00E-39 0.08 22504420 | |
| 8 120007420 rs2062377-T 8:120007420 Bone mineral density (spine) 4.00E-16 0.09 19801982 | |
| 8 120012700 rs11995824-G 8:120012700 Bone mineral density (hip) 7.00E-09 0.07 19801982 | |
| 8 120013276 rs4424296-? 8:120013276 Bone mineral density 9.00E-14 NR 24249740 | |
| 8 120044829 rs6469804-A 8:120044829 Bone mineral density (spine) 7.00E-15 0.12 18445777 | |
| 8 120052238 rs6993813-C 8:120052238 Bone mineral density (hip) 3.00E-11 0.09 18445777 | |
| 8 120063542 rs2450083-T 8:120063542 "Bone mineral density (paediatric, skull)" 2.00E-11 0.1 24945404 | |
| 8 120063542 rs2450083-T 8:120063542 "Bone mineral density (paediatric, skull)" 3.00E-08 0.1 24945404 | |
| 8 120435812 rs2071518-T 8:120435812 Blood pressure 4.00E-09 0.31 21909110 | |
| 8 121562418 rs4455882-A 8:121562418 Myopia (pathological) 2.00E-11 1.32 23406873 | |
| 8 121610438 rs6469937-A 8:121610438 Myopia (severe) 2.00E-09 1.27 23933737 | |
| 8 123408091 rs11781551-A 8:123408091 Carotid intima media thickness 2.00E-11 0.01 21909108 | |
| 8 123973068 rs10108684-? 8:123973068 Immune response to smallpox vaccine (IL-6) 1.00E-08 NR 22542470 | |
| 8 126477978 rs2001945-C 8:126477978 Triglycerides 1.00E-20 0.04 21909109 | |
| 8 126479315 rs6982636-? 8:126479315 Lipid metabolism phenotypes 7.00E-12 1.95 19936222 | |
| 8 126479315 rs6982636-? 8:126479315 Lipid metabolism phenotypes 1.00E-09 0.03 19936222 | |
| 8 126481475 rs2980879-T 8:126481475 Adiponectin levels 1.00E-09 0.03 22479202 | |
| 8 126481475 rs2980879-T 8:126481475 Adiponectin levels 7.00E-09 0.03 22479202 | |
| 8 126482077 rs2954021-A 8:126482077 Liver enzyme levels (alkaline phosphatase) 2.00E-13 1.4 22001757 | |
| 8 126482077 rs2954021-A 8:126482077 Liver enzyme levels (alanine transaminase) 5.00E-09 1.6 22001757 | |
| 8 126484526 rs2954026-G 8:126484526 HDL Cholesterol - Triglycerides (HDLC-TG) 8.00E-09 0.16 21386085 | |
| 8 126486409 rs17321515-G 8:126486409 Triglycerides 4.00E-17 0.08 18193044 | |
| 8 126486409 rs17321515-A 8:126486409 Triglycerides 7.00E-13 6.42 18193043 | |
| 8 126490972 rs2954029-T 8:126490972 Triglycerides 1.00E-107 0.08 24097068 | |
| 8 126490972 rs2954029-T 8:126490972 "Cholesterol, total" 2.00E-65 0.06 24097068 | |
| 8 126490972 rs2954029-T 8:126490972 Triglycerides 3.00E-55 5.64 20686565 | |
| 8 126490972 rs2954029-T 8:126490972 LDL cholesterol 2.00E-50 0.06 24097068 | |
| 8 126490972 rs2954029-A 8:126490972 "Cholesterol, total" 5.00E-36 2.3 20686565 | |
| 8 126490972 rs2954029-T 8:126490972 HDL cholesterol 3.00E-29 0.04 24097068 | |
| 8 126490972 rs2954029-A 8:126490972 LDL cholesterol 3.00E-29 1.84 20686565 | |
| 8 126490972 rs2954029-T 8:126490972 Triglycerides 3.00E-19 0.11 19060906 | |
| 8 126490972 rs2954029-T 8:126490972 HDL cholesterol 6.00E-19 0.61 20686565 | |
| 8 126490972 rs2954029-T 8:126490972 Triglycerides 2.00E-11 0.04 20864672 | |
| 8 126493746 rs2954033-A 8:126493746 Triglycerides-Blood Pressure (TG-BP) 9.00E-09 0.17 21386085 | |
| 8 126504726 rs6987702-G 8:126504726 "Cholesterol, total" 3.00E-09 0.07 19060911 | |
| 8 126523523 rs4360309-T 8:126523523 Triglycerides 7.00E-09 1.35 24886709 | |
| 8 126534671 rs921720-G 8:126534671 Inflammatory bowel disease 8.00E-20 1.08 23128233 | |
| 8 126537570 rs4871611-A 8:126537570 Crohn's disease 2.00E-12 1.17 21102463 | |
| 8 126540051 rs1551398-A 8:126540051 Crohn's disease 5.00E-09 1.08 18587394 | |
| 8 128093297 rs1016343-T 8:128093297 Prostate cancer 4.00E-10 1.31 21743057 | |
| 8 128103937 rs1456315-? 8:128103937 Prostate cancer 2.00E-29 NR 20676098 | |
| 8 128103937 rs1456315-? 8:128103937 Prostate cancer 1.00E-12 NR 23023329 | |
| 8 128104343 rs13254738-C 8:128104343 Prostate cancer 4.00E-10 1.59 22923026 | |
| 8 128106880 rs6983561-C 8:128106880 Prostate cancer 4.00E-13 1.87 22923026 | |
| 8 128124916 rs16901979-A 8:128124916 Prostate cancer 3.00E-14 1.8 19767754 | |
| 8 128124916 rs16901979-A 8:128124916 Prostate cancer 1.00E-12 1.79 17401366 | |
| 8 128125195 rs10505483-T 8:128125195 Prostate cancer 7.00E-15 1.73 22923026 | |
| 8 128320346 rs16902094-G 8:128320346 Prostate cancer 6.00E-15 1.21 19767754 | |
| 8 128323181 rs445114-T 8:128323181 Prostate cancer 5.00E-10 1.14 19767754 | |
| 8 128355618 rs13281615-G 8:128355618 Breast cancer 1.00E-27 1.09 23535729 | |
| 8 128355618 rs13281615-C 8:128355618 Breast cancer 5.00E-12 1.08 17529967 | |
| 8 128387852 rs1562430-A 8:128387852 Breast cancer 3.00E-11 1.16 21263130 | |
| 8 128388025 rs2392780-? 8:128388025 Breast cancer (early onset) 1.00E-08 1.15 24493630 | |
| 8 128407443 rs10505477-T 8:128407443 Colorectal cancer 8.00E-13 1.2 24737748 | |
| 8 128407443 rs10505477-A 8:128407443 Colorectal cancer 3.00E-11 1.17 17618283 | |
| 8 128407443 rs10505477-A 8:128407443 Prostate cancer (early onset) 9.00E-09 1.39 24740154 | |
| 8 128413305 rs6983267-G 8:128413305 Prostate cancer 4.00E-15 0.29 24753544 | |
| 8 128413305 rs6983267-G 8:128413305 Colorectal cancer 1.00E-14 1.27 17618284 | |
| 8 128413305 rs6983267-G 8:128413305 Colorectal cancer 5.00E-14 1.14 24836286 | |
| 8 128413305 rs6983267-G 8:128413305 Prostate cancer 9.00E-13 1.42 18264097 | |
| 8 128413305 rs6983267-G 8:128413305 Prostate cancer 9.00E-13 1.26 17401363 | |
| 8 128413305 rs6983267-G 8:128413305 Prostate cancer 7.00E-12 1.28 18264096 | |
| 8 128413305 rs6983267-G 8:128413305 Colorectal cancer 1.00E-11 1.13 23266556 | |
| 8 128413305 rs6983267-? 8:128413305 Colorectal cancer 7.00E-11 1.24 18372905 | |
| 8 128413305 rs6983267-G 8:128413305 Prostate cancer (early onset) 1.00E-08 1.36 24740154 | |
| 8 128413305 rs6983267-G 8:128413305 Colorectal cancer 2.00E-08 1.18 21242260 | |
| 8 128424792 rs7014346-A 8:128424792 Colorectal cancer 9.00E-26 1.19 18372901 | |
| 8 128485038 rs1447295-A 8:128485038 Prostate cancer 2.00E-19 1.58 19767754 | |
| 8 128485038 rs1447295-A 8:128485038 Prostate cancer 6.00E-18 0.51 24753544 | |
| 8 128485038 rs1447295-A 8:128485038 Prostate cancer 6.00E-18 1.6 17401366 | |
| 8 128485038 rs1447295-A 8:128485038 Prostate cancer 2.00E-14 1.43 17401363 | |
| 8 128517573 rs4242382-A 8:128517573 Prostate cancer 3.00E-19 1.66 18264096 | |
| 8 128518554 rs4242384-? 8:128518554 Prostate cancer 2.00E-24 NR 19767753 | |
| 8 128518554 rs4242384-C 8:128518554 Prostate cancer 3.00E-16 1.56 21743057 | |
| 8 128518554 rs4242384-C 8:128518554 Prostate cancer 3.00E-16 1.88 18264097 | |
| 8 128539360 rs7837688-? 8:128539360 Prostate cancer 1.00E-25 NR 20676098 | |
| 8 128718068 rs9642880-T 8:128718068 Bladder cancer 4.00E-38 1.24 24163127 | |
| 8 128718068 rs9642880-T 8:128718068 Bladder cancer 2.00E-18 1.21 20972438 | |
| 8 128718068 rs9642880-T 8:128718068 Urinary bladder cancer 7.00E-12 1.21 20348956 | |
| 8 128718068 rs9642880-T 8:128718068 Urinary bladder cancer 9.00E-12 1.22 18794855 | |
| 8 128815029 rs4410871-T 8:128815029 Allergic sensitization 5.00E-10 1.14 23817571 | |
| 8 128815029 rs4410871-G 8:128815029 Multiple sclerosis 8.00E-09 1.11 21833088 | |
| 8 129192271 rs2019960-G 8:129192271 Hodgkin's lymphoma 1.00E-13 1.33 21037568 | |
| 8 129192271 rs2019960-G 8:129192271 Hodgkin's lymphoma 6.00E-10 1.37 24149102 | |
| 8 129192271 rs2019960-G 8:129192271 Multiple sclerosis 5.00E-09 1.12 21833088 | |
| 8 129194641 rs11780156-T 8:129194641 Breast cancer 3.00E-11 1.07 23535729 | |
| 8 129264589 rs9792269-? 8:129264589 Celiac disease 3.00E-09 1.14 20190752 | |
| 8 129316014 rs975730-? 8:129316014 Celiac disease and Rheumatoid arthritis 2.00E-08 NR 21383967 | |
| 8 129542100 rs1516971-T 8:129542100 Rheumatoid arthritis 3.00E-11 1.16 24390342 | |
| 8 129542100 rs1516971-T 8:129542100 Rheumatoid arthritis 1.00E-10 1.15 24390342 | |
| 8 129543949 rs10088218-? 8:129543949 Ovarian cancer 1.00E-17 1.29 23535730 | |
| 8 129543949 rs10088218-? 8:129543949 Ovarian cancer 3.00E-12 1.18 23535730 | |
| 8 129543949 rs10088218-G 8:129543949 Ovarian cancer 3.00E-09 1.19 20852632 | |
| 8 129567181 rs6651252-T 8:129567181 Crohn's disease 4.00E-18 1.23 21102463 | |
| 8 129567181 rs6651252-T 8:129567181 Crohn's disease 1.00E-16 1.19 23128233 | |
| 8 129946154 rs987525-A 8:129946154 Orofacial clefts 5.00E-35 1.92 22863734 | |
| 8 129946154 rs987525-A 8:129946154 Orofacial clefts 1.00E-26 NR 22863734 | |
| 8 129946154 rs987525-A 8:129946154 Orofacial clefts 3.00E-24 2.57 19270707 | |
| 8 129946154 rs987525-A 8:129946154 Cleft lip 4.00E-16 1.78 20436469 | |
| 8 129946154 rs987525-A 8:129946154 Orofacial clefts 2.00E-11 NR 22863734 | |
| 8 130491752 rs891835-G 8:130491752 Glioma 8.00E-11 1.24 19578367 | |
| 8 130572110 rs10956483-C 8:130572110 White blood cell types 2.00E-10 0.07 21738478 | |
| 8 130613614 rs10098310-A 8:130613614 White blood cell count 3.00E-20 0.03 21738480 | |
| 8 130624105 rs1991866-G 8:130624105 Inflammatory bowel disease 2.00E-09 1.05 23128233 | |
| 8 130685457 rs4295627-? 8:130685457 Glioma 5.00E-21 1.4 21531791 | |
| 8 130685457 rs4295627-G 8:130685457 Glioma 2.00E-18 1.36 19578367 | |
| 8 130725665 rs6470764-T 8:130725665 Height 2.00E-28 0.05 20881960 | |
| 8 133929917 rs853308-G 8:133929917 Vitiligo 2.00E-08 1.2 22561518 | |
| 8 134145512 rs2294025-T 8:134145512 Graves' disease 8.00E-09 1.16 23612905 | |
| 8 135637337 rs12680655-C 8:135637337 Height 2.00E-14 0.03 20881960 | |
| 8 142104944 rs4961252-G 8:142104944 Response to interferon beta therapy 3.00E-08 0.23 21502966 | |
| 8 143312933 rs4129585-A 8:143312933 Schizophrenia 2.00E-10 1.09 23974872 | |
| 8 143761931 rs2294008-C 8:143761931 Duodenal ulcer 2.00E-33 1.41 22387998 | |
| 8 143761931 rs2294008-T 8:143761931 Bladder cancer 3.00E-15 1.13 24163127 | |
| 8 143761931 rs2294008-T 8:143761931 Bladder cancer 4.00E-11 1.13 20972438 | |
| 8 143761931 rs2294008-T 8:143761931 Bladder cancer 2.00E-10 1.15 19648920 | |
| 8 144565905 rs380904-A x rs8086028-A 8:144565905 Venous thromboembolism (gene x gene interaction) 5.00E-10 1.67 23509962 | |
| 8 145005561 rs6995402-C 8:145005561 Platelet counts 5.00E-10 2.3 22139419 | |
| 8 145021167 rs7464572-C 8:145021167 Fibrinogen 1.00E-09 0.01 23969696 | |
| 8 145043543 rs11136341-G 8:145043543 LDL cholesterol 4.00E-13 1.4 20686565 | |
| 8 145043543 rs11136341-G 8:145043543 LDL cholesterol 7.00E-12 0.05 24097068 | |
| 8 145043543 rs11136341-G 8:145043543 "Cholesterol, total" 9.00E-10 1.34 20686565 | |
| 8 145043543 rs11136341-G 8:145043543 "Cholesterol, total" 6.00E-09 0.04 24097068 | |
| 8 145139522 rs6558295-G 8:145139522 Metabolic traits 2.00E-59 0.12 21886157 | |
| 8 145145687 rs7822232-A 8:145145687 Blood metabolite levels 5.00E-15 0.03 24816252 | |
| 8 145155408 rs12550729-T 8:145155408 Blood metabolite levels 6.00E-110 0.06 24816252 | |
| 9 331490 rs10813766-T 9:331490 Mean platelet volume 4.00E-12 0.01 22139419 | |
| 9 845516 rs7040024-A 9:845516 Testicular cancer 1.00E-11 1.7 21551455 | |
| 9 863635 rs755383-T 9:863635 Testicular germ cell tumor 2.00E-26 1.38 23666240 | |
| 9 863635 rs755383-T 9:863635 Testicular germ cell cancer 1.00E-23 1.37 20543847 | |
| 9 863635 rs755383-T 9:863635 Testicular cancer 9.00E-10 1.5 21551455 | |
| 9 1202371 rs10809650-? 9:1202371 Dupuytren's disease 6.00E-09 1.25 21732829 | |
| 9 2640759 rs3780181-G 9:2640759 "Cholesterol, total" 7.00E-10 0.04 24097068 | |
| 9 2640759 rs3780181-G 9:2640759 LDL cholesterol 2.00E-09 0.04 24097068 | |
| 9 2691186 rs10738760-A 9:2691186 Vascular endothelial growth factor levels 1.00E-39 NR 21757650 | |
| 9 3929424 rs514716-G 9:3929424 Alzheimer's disease biomarkers 3.00E-09 0.07 23562540 | |
| 9 3929424 rs514716-G 9:3929424 Alzheimer's disease biomarkers 1.00E-08 0.07 23562540 | |
| 9 4267209 rs1571583-A 9:4267209 Thyroid hormone levels 3.00E-08 0.06 23408906 | |
| 9 4287466 rs7041847-A 9:4287466 Type 2 diabetes 2.00E-14 1.1 22158537 | |
| 9 4289050 rs7034200-A 9:4289050 Fasting glucose-related traits 1.00E-13 NR 20081858 | |
| 9 4289050 rs7034200-A 9:4289050 Fasting glucose-related traits 1.00E-12 NR 20081858 | |
| 9 4291747 rs7020673-? 9:4291747 Type 1 diabetes 5.00E-12 1.14 19430480 | |
| 9 4293150 rs10814916-C 9:4293150 Type 2 diabetes 6.00E-12 1.11 22961080 | |
| 9 4744743 rs409801-C 9:4744743 Platelet counts 3.00E-49 5.59 22139419 | |
| 9 4763176 rs385893-C 9:4763176 Hematological parameters 9.00E-17 6.26 19820697 | |
| 9 4763176 rs385893-C 9:4763176 Platelet counts 3.00E-13 5.93 20139978 | |
| 9 4763176 rs385893-T 9:4763176 Platelet counts 3.00E-13 0.1 20139978 | |
| 9 4792339 rs423955-A 9:4792339 Platelet counts 1.00E-09 4.94 24026423 | |
| 9 4814948 rs13300663-C 9:4814948 Platelet counts 1.00E-29 5.59 22139419 | |
| 9 4844265 rs2236496-C 9:4844265 Red blood cell traits 1.00E-19 0.28 23222517 | |
| 9 4844265 rs2236496-C 9:4844265 Mean corpuscular volume 3.00E-14 0.09 20139978 | |
| 9 4844265 rs2236496-C 9:4844265 Mean corpuscular hemoglobin 6.00E-11 0.08 20139978 | |
| 9 4856877 rs10758658-A 9:4856877 Mean corpuscular volume 3.00E-20 0 19862010 | |
| 9 4856877 rs10758658-A 9:4856877 Mean corpuscular hemoglobin 2.00E-14 0 19862010 | |
| 9 4981602 rs10758669-C 9:4981602 Inflammatory bowel disease 8.00E-45 1.17 23128233 | |
| 9 4981602 rs10758669-C 9:4981602 Ulcerative colitis 2.00E-25 1.17 21297633 | |
| 9 4981602 rs10758669-C 9:4981602 Crohn's disease 1.00E-13 1.18 21102463 | |
| 9 4981602 rs10758669-C 9:4981602 Crohn's disease 3.00E-09 1.12 18587394 | |
| 9 5070831 rs10974944-? 9:5070831 Myeloproliferative neoplasms 4.00E-20 3.1 19287384 | |
| 9 5893861 rs2150702-G 9:5893861 Multiple sclerosis 3.00E-08 1.16 22190364 | |
| 9 6172380 rs7032572-G 9:6172380 Self-reported allergy 2.00E-09 0.11 23817569 | |
| 9 6175855 rs72699186-T 9:6175855 Asthma and hay fever 2.00E-09 1.26 24388013 | |
| 9 6190076 rs1342326-C 9:6190076 Asthma 9.00E-10 1.2 20860503 | |
| 9 6193455 rs2381416-? 9:6193455 Asthma 2.00E-12 NR 21804549 | |
| 9 6213387 rs928413-G 9:6213387 "Asthma (childhood, severe)" 9.00E-13 1.24 24241537 | |
| 9 8045606 rs2146180-G 9:8045606 Personality dimensions 3.00E-08 0.06 23903073 | |
| 9 8695233 rs16928280-? 9:8695233 Immune response to measles-mumps-rubella vaccine 3.00E-10 NR 24811271 | |
| 9 8846955 rs1975197-A 9:8846955 Restless legs syndrome 3.00E-10 1.29 21779176 | |
| 9 8846955 rs1975197-T 9:8846955 Restless legs syndrome 6.00E-09 1.31 18660810 | |
| 9 8879118 rs17584499-T 9:8879118 Type 2 diabetes 9.00E-10 1.57 20174558 | |
| 9 9261737 rs4626664-A 9:9261737 Restless legs syndrome 6.00E-10 1.44 18660810 | |
| 9 12396731 rs13289810-? 9:12396731 Hair color 1.00E-19 NR 22556244 | |
| 9 12521826 rs16929097-? 9:12521826 Asthma (childhood onset) 8.00E-09 NR 23829686 | |
| 9 12672097 rs1408799-C 9:12672097 Blue vs. green eyes 6.00E-17 1.4 18488028 | |
| 9 13557491 rs1324183-A 9:13557491 Corneal structure 8.00E-09 0.05 23291589 | |
| 9 15289578 rs471364-C 9:15289578 HDL cholesterol 3.00E-10 0.08 19060906 | |
| 9 15296034 rs643531-C 9:15296034 HDL cholesterol 7.00E-09 0.01 20864672 | |
| 9 15305378 rs581080-G 9:15305378 HDL cholesterol 1.00E-19 0.04 24097068 | |
| 9 15305378 rs581080-G 9:15305378 "Cholesterol, total" 1.00E-13 0.04 24097068 | |
| 9 15305378 rs581080-C 9:15305378 HDL cholesterol 1.00E-13 0.72 20686565 | |
| 9 15305378 rs581080-G 9:15305378 "Cholesterol, total" 3.00E-09 1.57 20686565 | |
| 9 16368732 rs7864648-T 9:16368732 Height 2.00E-08 0.02 20881960 | |
| 9 16864521 rs2153271-C 9:16864521 Freckling 4.00E-10 0.4 20585627 | |
| 9 16915021 rs3814113-? 9:16915021 Ovarian cancer 4.00E-32 1.28 23535730 | |
| 9 16915021 rs3814113-? 9:16915021 Ovarian cancer 4.00E-29 1.21 23535730 | |
| 9 16915021 rs3814113-T 9:16915021 Ovarian cancer 5.00E-19 1.22 19648919 | |
| 9 16915021 rs3814113-A 9:16915021 Ovarian cancer in BRCA1 mutation carriers 6.00E-11 1.3 23544013 | |
| 9 21747803 rs4636294-A 9:21747803 Cutaneous nevi 3.00E-15 0.2 19578365 | |
| 9 21816528 rs7023329-? 9:21816528 Melanoma 7.00E-09 1.2 21983787 | |
| 9 21984661 rs3731217-? 9:21984661 Acute lymphoblastic leukemia (B-cell precursor) 2.00E-08 NR 23996088 | |
| 9 21986847 rs3731211-A 9:21986847 Platelet counts 6.00E-14 3.28 22139419 | |
| 9 22003367 rs1063192-G 9:22003367 Vertical cup-disc ratio 4.00E-15 0.01 20548946 | |
| 9 22003367 rs1063192-T 9:22003367 Glaucoma (primary open-angle) 5.00E-11 1.33 22419738 | |
| 9 22019129 rs523096-A 9:22019129 Glaucoma 5.00E-11 2.13 22792221 | |
| 9 22031005 rs7865618-A 9:22031005 Coronary heart disease 2.00E-27 1.18 21606135 | |
| 9 22031005 rs7865618-A 9:22031005 Glaucoma (primary open-angle) 9.00E-11 1.78 22428042 | |
| 9 22033366 rs2157719-? 9:22033366 Glaucoma (primary open-angle) 2.00E-18 1.45 22570617 | |
| 9 22033366 rs2157719-? 9:22033366 Glioma 5.00E-16 1.26 21531791 | |
| 9 22033366 rs2157719-? 9:22033366 Glaucoma (primary open-angle) 1.00E-12 1.72 22570617 | |
| 9 22034719 rs2151280-G 9:22034719 Basal cell carcinoma 3.00E-10 1.2 24403052 | |
| 9 22043926 rs1412829-C 9:22043926 Glioma (high-grade) 2.00E-10 1.42 19578366 | |
| 9 22062134 rs1011970-T 9:22062134 Breast cancer 3.00E-08 1.09 20453838 | |
| 9 22068652 rs4977756-G 9:22068652 Glioma 7.00E-15 1.24 19578367 | |
| 9 22068652 rs4977756-A 9:22068652 Glaucoma 1.00E-14 1.39 21532571 | |
| 9 22068652 rs4977756-G 9:22068652 Glioma 1.00E-08 1.28 22886559 | |
| 9 22072264 rs10757269-G 9:22072264 Ankle-brachial index 9.00E-09 0 22199011 | |
| 9 22081850 rs6475606-T 9:22081850 Intracranial aneurysm 4.00E-08 1.35 22961961 | |
| 9 22083404 rs1333040-T 9:22083404 Intracranial aneurysm 2.00E-22 1.32 20364137 | |
| 9 22083404 rs1333040-T 9:22083404 Intracranial aneurysm 1.00E-10 1.29 18997786 | |
| 9 22084310 rs1537370-T 9:22084310 Coronary artery calcification 2.00E-11 0.53 23561647 | |
| 9 22096055 rs10757274-G 9:22096055 Coronary heart disease 8.00E-45 1.37 22751097 | |
| 9 22098574 rs4977574-G 9:22098574 Myocardial infarction (early onset) 3.00E-44 1.29 19198609 | |
| 9 22098574 rs4977574-G 9:22098574 Coronary heart disease 2.00E-25 1.2 21378988 | |
| 9 22098574 rs4977574-G 9:22098574 Coronary heart disease 1.00E-22 1.29 21378990 | |
| 9 22103813 rs1333042-? 9:22103813 Coronary heart disease 1.00E-09 1.3 23364394 | |
| 9 22115105 rs10965235-C 9:22115105 Endometriosis 6.00E-12 1.44 20601957 | |
| 9 22115286 rs944797-C 9:22115286 Coronary heart disease 6.00E-16 1.25 21971053 | |
| 9 22115959 rs2383207-G 9:22115959 Abdominal aortic aneurysm 2.00E-08 1.27 20622881 | |
| 9 22124477 rs10757278-G 9:22124477 Myocardial infarction 1.00E-20 1.28 17478679 | |
| 9 22125503 rs1333049-? 9:22125503 Coronary artery disease or large artery stroke 1.00E-59 NR 24262325 | |
| 9 22125503 rs1333049-C 9:22125503 Coronary heart disease 7.00E-58 1.27 21606135 | |
| 9 22125503 rs1333049-? 9:22125503 Coronary artery disease or ischemic stroke 1.00E-56 NR 24262325 | |
| 9 22125503 rs1333049-C 9:22125503 Coronary artery disease 3.00E-56 1.24 24262325 | |
| 9 22125503 rs1333049-C 9:22125503 Coronary artery calcification 3.00E-24 0.2 22144573 | |
| 9 22125503 rs1333049-C 9:22125503 Coronary heart disease 3.00E-19 1.36 17634449 | |
| 9 22125503 rs1333049-C 9:22125503 Coronary heart disease 1.00E-13 1.47 17554300 | |
| 9 22132076 rs2383208-A 9:22132076 Type 2 diabetes 2.00E-29 1.34 19401414 | |
| 9 22132076 rs2383208-A 9:22132076 Type 2 diabetes 3.00E-17 1.22 22961080 | |
| 9 22133284 rs10965250-G 9:22133284 Type 2 diabetes 1.00E-10 1.2 20581827 | |
| 9 22134094 rs10811661-T 9:22134094 Type 2 diabetes 1.00E-27 1.18 24509480 | |
| 9 22134094 rs10811661-T 9:22134094 Type 2 diabetes 1.00E-18 1.23 23945395 | |
| 9 22134094 rs10811661-T 9:22134094 Type 2 diabetes 8.00E-15 1.2 17463248 | |
| 9 22134094 rs10811661-T 9:22134094 Type 2 diabetes 5.00E-08 1.2 17463246 | |
| 9 22136489 rs1333051-A 9:22136489 Type 2 diabetes 6.00E-10 1.22 21573907 | |
| 9 22137685 rs7018475-? 9:22137685 Type 2 diabetes 3.00E-08 1.35 22293688 | |
| 9 22169700 rs1537377-C 9:22169700 Endometriosis 2.00E-09 1.15 23104006 | |
| 9 22206987 rs1679013-C 9:22206987 Chronic lymphocytic leukemia 1.00E-08 1.19 23770605 | |
| 9 25192573 rs181881383-? 9:25192573 Ejection fraction in Tripanosoma cruzi seropositivity 2.00E-08 NR 24324551 | |
| 9 27536397 rs2814707-? 9:27536397 Amyotrophic lateral sclerosis 7.00E-09 1.22 19734901 | |
| 9 27543281 rs3849942-A 9:27543281 Amyotrophic lateral sclerosis 9.00E-11 2.16 20801718 | |
| 9 27543281 rs3849942-? 9:27543281 Amyotrophic lateral sclerosis (sporadic) 1.00E-08 NR 24256812 | |
| 9 27543281 rs3849942-? 9:27543281 Amyotrophic lateral sclerosis 1.00E-08 1.23 19734901 | |
| 9 28414339 rs10968576-G 9:28414339 Body mass index 3.00E-13 0.11 20935630 | |
| 9 28414339 rs10968576-G 9:28414339 Obesity 3.00E-08 1.07 23563607 | |
| 9 28425515 rs1412239-G 9:28425515 Obesity 2.00E-10 1.11 23563607 | |
| 9 30879675 rs10813374-? 9:30879675 Immune response to measles-mumps-rubella vaccine 3.00E-08 NR 24811271 | |
| 9 33124872 rs12342831-C 9:33124872 IgG glycosylation 3.00E-11 0.24 23382691 | |
| 9 33124872 rs12342831-C 9:33124872 IgG glycosylation 3.00E-11 0.24 23382691 | |
| 9 33124872 rs12342831-C 9:33124872 IgG glycosylation 1.00E-10 0.23 23382691 | |
| 9 33124872 rs12342831-C 9:33124872 IgG glycosylation 3.00E-10 0.22 23382691 | |
| 9 33124872 rs12342831-T 9:33124872 IgG glycosylation 5.00E-08 0.05 23382691 | |
| 9 33128021 rs10813951-G 9:33128021 IgG glycosylation 5.00E-10 0.22 23382691 | |
| 9 33128021 rs10813951-G 9:33128021 IgG glycosylation 1.00E-09 0.22 23382691 | |
| 9 33139453 rs3780486-C 9:33139453 IgG glycosylation 5.00E-11 0.23 23382691 | |
| 9 33139453 rs3780486-C 9:33139453 IgG glycosylation 9.00E-11 0.23 23382691 | |
| 9 33153527 rs10813957-G 9:33153527 IgG glycosylation 2.00E-09 0.22 23382691 | |
| 9 33153527 rs10813957-G 9:33153527 IgG glycosylation 3.00E-09 0.21 23382691 | |
| 9 33153527 rs10813957-G 9:33153527 IgG glycosylation 5.00E-08 0.2 23382691 | |
| 9 34710260 rs2812378-G 9:34710260 Rheumatoid arthritis 3.00E-08 1.12 18794853 | |
| 9 34710338 rs11574914-A 9:34710338 Rheumatoid arthritis 2.00E-15 1.13 24390342 | |
| 9 34710338 rs11574914-A 9:34710338 Rheumatoid arthritis 3.00E-15 1.12 24390342 | |
| 9 34743681 rs951005-A 9:34743681 Rheumatoid arthritis 4.00E-10 1.19 20453842 | |
| 9 36099399 rs4878639-C 9:36099399 IgG glycosylation 4.00E-08 0.2 23382691 | |
| 9 36969205 rs16933812-? 9:36969205 Obesity and blood pressure 9.00E-09 NR 22013104 | |
| 9 71434707 rs4744712-A 9:71434707 Chronic kidney disease 8.00E-14 0.01 20383146 | |
| 9 71766593 rs11145465-A 9:71766593 Refractive error 7.00E-09 0.12 23396134 | |
| 9 72998332 rs11142387-C 9:72998332 Body mass index 1.00E-09 0.04 22344221 | |
| 9 72998332 rs11142387-C 9:72998332 Body mass index 3.00E-08 0.03 24861553 | |
| 9 77149837 rs7042950-G 9:77149837 Refractive error 4.00E-08 0.1 23396134 | |
| 9 77499796 rs11144134-T 9:77499796 Magnesium levels 8.00E-15 0.01 20700443 | |
| 9 78542286 rs11144688-G 9:78542286 Height 4.00E-16 1.48 23563607 | |
| 9 78542286 rs11144688-A 9:78542286 Height 1.00E-11 0.05 20881960 | |
| 9 80044056 rs2296781-? x rs10819087-? 9:80044056 Age-related hearing impairment (interaction) 5.00E-09 NR 24939585 | |
| 9 81905590 rs17791513-A 9:81905590 Type 2 diabetes 3.00E-08 1.21 24509480 | |
| 9 81952128 rs13292136-C 9:81952128 Type 2 diabetes 3.00E-08 1.11 20581827 | |
| 9 86552205 rs7853377-A 9:86552205 Height 5.00E-08 0.02 20881960 | |
| 9 87770927 rs12340987-A 9:87770927 Birth weight 1.00E-08 0.13 24950379 | |
| 9 89116628 rs8181166-C 9:89116628 Height 3.00E-12 0.03 20881960 | |
| 9 90835726 rs2778031-T 9:90835726 Height 9.00E-13 0.03 20881960 | |
| 9 93636664 rs290227-G 9:93636664 Vascular dementia 7.00E-11 2.2 23480133 | |
| 9 93928416 rs4743820-T 9:93928416 Inflammatory bowel disease 4.00E-09 1.06 23128233 | |
| 9 95429120 rs9969804-A 9:95429120 Height 8.00E-17 0.03 20881960 | |
| 9 96716028 rs11789015-A 9:96716028 Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined) 1.00E-09 1.2 24121790 | |
| 9 96893945 rs1257763-A 9:96893945 Height 1.00E-09 0.07 20881960 | |
| 9 97713459 rs10821415-A 9:97713459 Atrial fibrillation 4.00E-11 1.11 22544366 | |
| 9 97741336 rs3802457-G 9:97741336 Polycystic ovary syndrome 5.00E-14 1.3 22885925 | |
| 9 98231008 rs16909898-? 9:98231008 Pulmonary function (interaction) 8.00E-12 NR 23284291 | |
| 9 98256235 rs473902-T 9:98256235 Height 2.00E-17 0.07 20881960 | |
| 9 98259703 rs10512248-G 9:98259703 Height 4.00E-11 0.05 18391952 | |
| 9 99161512 rs2025151-G 9:99161512 Height 2.00E-12 1.22 23563607 | |
| 9 100546600 rs925489-T 9:100546600 Hypothyroidism 2.00E-19 1.28 22493691 | |
| 9 100546600 rs925489-C 9:100546600 Serum thyroid-stimulating hormone levels 1.00E-13 0.06 24852370 | |
| 9 100549013 rs7850258-? 9:100549013 Hypothyroidism 4.00E-09 1.23 21981779 | |
| 9 100550028 rs1443438-A 9:100550028 Obesity-related traits 1.00E-09 0.04 23251661 | |
| 9 100556109 rs965513-A 9:100556109 Thyroid cancer 2.00E-27 1.75 19198613 | |
| 9 100556109 rs965513-A 9:100556109 "Thyroid cancer (Papillary, radiation-related)" 5.00E-12 1.65 20350937 | |
| 9 100556109 rs965513-A 9:100556109 Thyroid cancer 3.00E-10 1.78 23894154 | |
| 9 100591463 rs7045138-T 9:100591463 Thyroid hormone levels 2.00E-11 0.1 23408906 | |
| 9 101123336 rs10986018-? 9:101123336 Folate pathway vitamin levels 2.00E-08 0.06 19744961 | |
| 9 101908365 rs334353-T 9:101908365 Age-related macular degeneration 3.00E-11 1.13 23455636 | |
| 9 104223233 rs10819937-C 9:104223233 Liver enzyme levels (alkaline phosphatase) 1.00E-09 2.5 22001757 | |
| 9 107589134 rs4149310-? 9:107589134 Metabolite levels 2.00E-10 NR 22916037 | |
| 9 107620835 rs9282541-A 9:107620835 HDL cholesterol 6.00E-26 0.37 23505323 | |
| 9 107647220 rs4149268-C 9:107647220 HDL cholesterol 1.00E-10 0.82 18193043 | |
| 9 107647655 rs3890182-A 9:107647655 HDL cholesterol 3.00E-10 0.1 18193044 | |
| 9 107653426 rs12686004-T 9:107653426 HDL cholesterol 2.00E-18 0.02 21909109 | |
| 9 107657070 rs3905000-G 9:107657070 HDL cholesterol 9.00E-13 0.11 19060911 | |
| 9 107664301 rs1883025-T 9:107664301 HDL cholesterol 2.00E-65 0.07 24097068 | |
| 9 107664301 rs1883025-T 9:107664301 "Cholesterol, total" 6.00E-53 0.07 24097068 | |
| 9 107664301 rs1883025-T 9:107664301 HDL cholesterol 2.00E-33 0.94 20686565 | |
| 9 107664301 rs1883025-T 9:107664301 "Cholesterol, total" 3.00E-27 2.24 20686565 | |
| 9 107664301 rs1883025-T 9:107664301 Metabolic syndrome 6.00E-10 0.1 22399527 | |
| 9 107664301 rs1883025-T 9:107664301 HDL cholesterol 1.00E-09 0.08 19060906 | |
| 9 107665739 rs2575876-? 9:107665739 Lipid metabolism phenotypes 2.00E-11 0.14 22286219 | |
| 9 108936674 rs7861820-C 9:108936674 Menarche and menopause (age at onset) 3.00E-09 0.09 19448621 | |
| 9 108967088 rs2090409-A 9:108967088 Menarche (age at onset) 2.00E-33 4.7 21102462 | |
| 9 108967088 rs2090409-A 9:108967088 Menarche (age at onset) 2.00E-09 0.1 19448620 | |
| 9 109599046 rs7027110-A 9:109599046 Height 2.00E-13 0.03 20881960 | |
| 9 109632353 rs4743034-A 9:109632353 Height 2.00E-08 5.3 18391951 | |
| 9 110156300 rs817826-C 9:110156300 Prostate cancer 5.00E-14 1.41 23023329 | |
| 9 110306115 rs10759243-A 9:110306115 Breast cancer 1.00E-08 1.06 23535729 | |
| 9 110888478 rs865686-T 9:110888478 Breast cancer 1.00E-34 1.12 23535729 | |
| 9 110888478 rs865686-T 9:110888478 Breast cancer 2.00E-10 1.12 21263130 | |
| 9 113662681 rs1007000-T 9:113662681 Corneal structure 5.00E-12 0.07 23291589 | |
| 9 113807082 rs1468758-T 9:113807082 Height 1.00E-09 0.03 20881960 | |
| 9 113915905 rs10980800-T 9:113915905 White blood cell count 2.00E-22 0.04 21738480 | |
| 9 114293634 rs10980926-A 9:114293634 Menarche (age at onset) 4.00E-11 2.5 21102462 | |
| 9 114301585 rs10441737-T 9:114301585 Menarche (age at onset) 4.00E-15 2.78 23599027 | |
| 9 115550363 rs787274-? x rs11250795-? 9:115550363 Age-related hearing impairment (interaction) 7.00E-10 NR 24939585 | |
| 9 116991071 rs7868992-G 9:116991071 Tourette syndrome 3.00E-08 1.29 22889924 | |
| 9 117083803 rs150611042-A 9:117083803 Thrombin generation potential phenotypes 7.00E-15 0.35 24357727 | |
| 9 117088064 rs10982156-T 9:117088064 End-stage coagulation 2.00E-10 0.46 23381943 | |
| 9 117240906 rs79509430-A 9:117240906 Obesity-related traits 2.00E-08 0.06 23251661 | |
| 9 117545666 rs6478106-T 9:117545666 Crohn's disease 5.00E-46 1.73 23266558 | |
| 9 117549327 rs7853287-A 9:117549327 Serum IgA levels 3.00E-10 0.12 24676358 | |
| 9 117552885 rs3810936-C 9:117552885 Crohn's disease 1.00E-15 1.21 21102463 | |
| 9 117553249 rs4246905-C 9:117553249 Inflammatory bowel disease 3.00E-32 1.14 23128233 | |
| 9 117553249 rs4246905-C 9:117553249 Ulcerative colitis 6.00E-12 1.1 21297633 | |
| 9 117558703 rs6478108-A 9:117558703 Leprosy 3.00E-21 1.37 20018961 | |
| 9 117566440 rs4263839-G 9:117566440 Crohn's disease 3.00E-10 1.22 18587394 | |
| 9 117567013 rs4979462-T 9:117567013 Primary biliary cirrhosis 3.00E-14 1.56 23000144 | |
| 9 117568766 rs6478109-? 9:117568766 Inflammatory bowel disease 3.00E-08 1.36 18758464 | |
| 9 117592638 rs2006996-C 9:117592638 Inflammatory bowel disease 4.00E-16 1.75 21699788 | |
| 9 117592638 rs2006996-T 9:117592638 Inflammatory bowel disease 4.00E-13 1.67 21699788 | |
| 9 119122342 rs751543-T 9:119122342 Height 7.00E-10 0.03 20881960 | |
| 9 119252629 rs6478241-A 9:119252629 Migraine - clinic-based 1.00E-09 1.16 23793025 | |
| 9 119252629 rs6478241-A 9:119252629 Migraine 4.00E-08 1.16 22683712 | |
| 9 120287708 rs2771051-? x rs827637-? 9:120287708 Venous thromboembolism (gene x gene interaction) 4.00E-09 1.49 23509962 | |
| 9 120292334 rs1985317-? x rs827637-? 9:120292334 Venous thromboembolism (gene x gene interaction) 1.00E-09 1.52 23509962 | |
| 9 121359286 rs11789399-? 9:121359286 Bipolar disorder and schizophrenia 6.00E-09 1.29 20889312 | |
| 9 123162666 rs12379034-C 9:123162666 Rheumatoid arthritis 1.00E-16 1.49 24782177 | |
| 9 123162666 rs12379034-C 9:123162666 Rheumatoid arthritis 1.00E-12 1.34 24782177 | |
| 9 123636121 rs10985070-C 9:123636121 Rheumatoid arthritis 5.00E-11 1.08 24390342 | |
| 9 123636121 rs10985070-C 9:123636121 Rheumatoid arthritis 4.00E-09 1.09 24390342 | |
| 9 123640500 rs1953126-T 9:123640500 Celiac disease and Rheumatoid arthritis 4.00E-11 NR 21383967 | |
| 9 123651301 rs2072438-T 9:123651301 Rheumatoid arthritis 3.00E-09 1.14 24782177 | |
| 9 123652898 rs881375-? 9:123652898 Rheumatoid arthritis 4.00E-08 NR 19503088 | |
| 9 123690239 rs3761847-G 9:123690239 Rheumatoid arthritis 4.00E-14 1.32 17804836 | |
| 9 123914874 rs9408926-A 9:123914874 Immune reponse to smallpox (secreted IFN-alpha) 4.00E-08 NR 22610502 | |
| 9 123951917 rs9408928-G 9:123951917 Immune reponse to smallpox (secreted IFN-alpha) 4.00E-09 NR 22610502 | |
| 9 124422403 rs7025486-A 9:124422403 Abdominal aortic aneurysm 5.00E-10 1.21 20622881 | |
| 9 126154354 rs872863-? 9:126154354 Myopia (pathological) 2.00E-11 NR 23049088 | |
| 9 126446778 rs10818854-A 9:126446778 Polycystic ovary syndrome 9.00E-18 1.51 21151128 | |
| 9 126525212 rs2479106-G 9:126525212 Polycystic ovary syndrome 8.00E-19 1.34 21151128 | |
| 9 126525212 rs2479106-G 9:126525212 Polycystic ovary syndrome 5.00E-10 1.35 22885925 | |
| 9 126783847 rs2075064-T 9:126783847 Waist circumference 2.00E-08 0.07 23966867 | |
| 9 131572027 rs15676-A 9:131572027 Blood metabolite levels 1.00E-12 0.02 24816252 | |
| 9 131874641 rs7849270-A 9:131874641 Blood metabolite ratios 3.00E-21 0.03 24816252 | |
| 9 131888116 rs10988217-A 9:131888116 Blood metabolite levels 1.00E-18 0.02 24816252 | |
| 9 133464084 rs7466269-A 9:133464084 Height 3.00E-17 0.03 20881960 | |
| 9 133464084 rs7466269-A 9:133464084 Height 2.00E-10 1.14 23563607 | |
| 9 133464084 rs7466269-A 9:133464084 "Bone mineral density (paediatric, lower limb)" 2.00E-08 0.09 24945404 | |
| 9 133464084 rs7466269-A 9:133464084 "Bone mineral density (paediatric, total body less head)" 3.00E-08 0.08 24945404 | |
| 9 133478827 rs7851693-C 9:133478827 Bone mineral density 3.00E-22 0.05 22504420 | |
| 9 136131188 rs8176749-T 9:136131188 Tumor biomarkers 7.00E-105 0.21 23300138 | |
| 9 136131188 rs8176749-C 9:136131188 Urinary metabolites (H-NMR features) 4.00E-12 0.48 24586186 | |
| 9 136131322 rs8176746-T 9:136131322 Mean corpuscular hemoglobin concentration 4.00E-08 0.08 20139978 | |
| 9 136131415 rs8176743-C 9:136131415 End-stage coagulation 2.00E-17 0.58 23381943 | |
| 9 136131461 rs8176741-? 9:136131461 Elevated serum carcinoembryonic antigen levels 2.00E-24 NR 24941225 | |
| 9 136132754 rs8176722-A 9:136132754 Malaria 9.00E-10 1.28 23717212 | |
| 9 136132873 rs8176720-C 9:136132873 Serum alkaline phosphatase levels 3.00E-21 0.04 24094242 | |
| 9 136132908 rs8176719-G 9:136132908 Malaria 4.00E-21 1.48 22895189 | |
| 9 136132908 rs8176719-G 9:136132908 Venous thromboembolism 6.00E-12 1.47 22672568 | |
| 9 136135552 rs8176704-A 9:136135552 Coagulation factor levels 4.00E-34 0.34 23267103 | |
| 9 136137065 rs687621-A 9:136137065 Activated partial thromboplastin time 9.00E-100 0.82 22703881 | |
| 9 136137065 rs687621-G 9:136137065 Venous thromboembolism 2.00E-52 1.55 23650146 | |
| 9 136137106 rs687289-T 9:136137106 Coagulation factor levels 1.00E-128 0.33 23267103 | |
| 9 136137106 rs687289-G 9:136137106 Urinary metabolites (H-NMR features) 1.00E-12 0.27 24586186 | |
| 9 136137106 rs687289-G 9:136137106 Urinary metabolites (H-NMR features) 2.00E-12 0.27 24586186 | |
| 9 136139265 rs657152-T 9:136139265 Liver enzyme levels 2.00E-30 0.05 18940312 | |
| 9 136139265 rs657152-C 9:136139265 Urinary metabolites (H-NMR features) 1.00E-19 0.34 24586186 | |
| 9 136139265 rs657152-T 9:136139265 Phytosterol levels 9.00E-13 8 20529992 | |
| 9 136139265 rs657152-A 9:136139265 Thyroid hormone levels 4.00E-10 0.06 23408906 | |
| 9 136139265 rs657152-A 9:136139265 Obesity-related traits 2.00E-08 0.04 23251661 | |
| 9 136139265 rs657152-T 9:136139265 Serum alkaline phosphatase levels 4.00E-08 0.06 24094242 | |
| 9 136141870 rs2519093-A 9:136141870 Venous thromboembolism 8.00E-16 1.69 22672568 | |
| 9 136142217 rs644234-G 9:136142217 Protein biomarker 4.00E-47 0.07 23056639 | |
| 9 136142355 rs643434-G 9:136142355 End-stage coagulation 1.00E-49 0.51 23381943 | |
| 9 136142355 rs643434-A 9:136142355 Inflammatory biomarkers 9.00E-25 NR 22291609 | |
| 9 136143442 rs612169-G 9:136143442 Metabolic traits 9.00E-40 0.2 21886157 | |
| 9 136149229 rs505922-T 9:136149229 End-stage coagulation 5.00E-57 0.56 23381943 | |
| 9 136149229 rs505922-? 9:136149229 Protein quantitative trait loci 7.00E-40 NR 18464913 | |
| 9 136149229 rs505922-C 9:136149229 Venous thromboembolism 1.00E-34 1.92 21980494 | |
| 9 136149229 rs505922-C 9:136149229 Venous thromboembolism 4.00E-15 1.81 19278955 | |
| 9 136149229 rs505922-T 9:136149229 Duodenal ulcer 1.00E-10 1.32 22387998 | |
| 9 136149229 rs505922-? 9:136149229 Graves' disease 2.00E-10 1.14 23612905 | |
| 9 136149229 rs505922-C 9:136149229 Pancreatic cancer 5.00E-08 1.2 19648918 | |
| 9 136149399 rs507666-A 9:136149399 Soluble ICAM-1 3.00E-91 17.3 21533024 | |
| 9 136149399 rs507666-G 9:136149399 Soluble ICAM-1 5.00E-29 17.73 18604267 | |
| 9 136149399 rs507666-A 9:136149399 Lipid traits 2.00E-11 0.07 24386095 | |
| 9 136149399 rs507666-A 9:136149399 Lipid traits 4.00E-11 0.02 24386095 | |
| 9 136153875 rs651007-T 9:136153875 E-selectin levels 2.00E-82 9.71 20147318 | |
| 9 136153875 rs651007-A 9:136153875 Serum alkaline phosphatase levels 1.00E-56 0.08 24094242 | |
| 9 136153875 rs651007-C 9:136153875 End-stage coagulation 2.00E-25 0.46 23381943 | |
| 9 136153875 rs651007-T 9:136153875 Blood metabolite levels 6.00E-20 0.07 24816252 | |
| 9 136153875 rs651007-A 9:136153875 Metabolite levels 6.00E-09 2.28 21909109 | |
| 9 136154168 rs579459-T 9:136154168 Liver enzyme levels (alkaline phosphatase) 3.00E-123 8.8 22001757 | |
| 9 136154168 rs579459-T 9:136154168 Soluble levels of adhesion molecules 2.00E-41 14 20167578 | |
| 9 136154168 rs579459-T 9:136154168 Urinary metabolites (H-NMR features) 2.00E-32 0.53 24586186 | |
| 9 136154168 rs579459-C 9:136154168 Soluble E-selectin levels 1.00E-29 NR 19729612 | |
| 9 136154168 rs579459-T 9:136154168 Blood metabolite ratios 1.00E-28 0.12 24816252 | |
| 9 136154168 rs579459-T 9:136154168 Urinary metabolites (H-NMR features) 1.00E-28 0.49 24586186 | |
| 9 136154168 rs579459-T 9:136154168 Red blood cell traits 9.00E-18 0.02 23222517 | |
| 9 136154168 rs579459-C 9:136154168 Coronary heart disease 4.00E-14 1.1 21378990 | |
| 9 136154168 rs579459-? 9:136154168 Coronary artery disease or ischemic stroke 2.00E-09 NR 24262325 | |
| 9 136154168 rs579459-? 9:136154168 Coronary artery disease or large artery stroke 3.00E-08 NR 24262325 | |
| 9 136154433 rs649129-T 9:136154433 Blood metabolite ratios 9.00E-37 0.09 24816252 | |
| 9 136154433 rs649129-T 9:136154433 Soluble levels of adhesion molecules 1.00E-15 3.95 20167578 | |
| 9 136154867 rs495828-T 9:136154867 Hematological and biochemical traits 4.00E-59 0.31 20139978 | |
| 9 136154867 rs495828-T 9:136154867 Blood metabolite ratios 6.00E-34 0.09 24816252 | |
| 9 136154867 rs495828-T 9:136154867 Venous thromboembolism 3.00E-16 1.65 22672568 | |
| 9 136154867 rs495828-T 9:136154867 Red blood cell count 3.00E-12 0.09 20139978 | |
| 9 136154867 rs495828-T 9:136154867 Hematological and biochemical traits 1.00E-11 0.09 20139978 | |
| 9 136154867 rs495828-T 9:136154867 Hematological and biochemical traits 6.00E-10 0.08 20139978 | |
| 9 136154867 rs495828-A 9:136154867 Angiotensin-converting enzyme activity 3.00E-08 4.9 20066004 | |
| 9 136155000 rs9411489-T 9:136155000 LDL cholesterol 2.00E-41 0.08 24097068 | |
| 9 136155000 rs9411489-T 9:136155000 "Cholesterol, total" 3.00E-35 0.07 24097068 | |
| 9 136155000 rs635634-T 9:136155000 LDL cholesterol 8.00E-22 2.05 20686565 | |
| 9 136155000 rs635634-T 9:136155000 "Cholesterol, total" 9.00E-21 2.3 20686565 | |
| 9 136155359 rs7030248-? 9:136155359 Elevated serum carcinoembryonic antigen levels 4.00E-15 NR 24941225 | |
| 9 136166346 rs7025162-A 9:136166346 Serum alkaline phosphatase levels 3.00E-27 0.05 24094242 | |
| 9 136187163 rs493014-G x rs886090-A 9:136187163 Venous thromboembolism (gene x gene interaction) 6.00E-11 1.64 23509962 | |
| 9 136323754 rs4962153-A 9:136323754 Liver enzyme levels 8.00E-21 0.06 18940312 | |
| 9 136478355 rs3025343-G 9:136478355 Smoking behavior 4.00E-08 1.12 20418890 | |
| 9 136925663 rs11789898-T 9:136925663 Platelet counts 2.00E-10 3.01 22139419 | |
| 9 137436314 rs3118515-A 9:137436314 Central corneal thickness 8.00E-10 0.23 23493294 | |
| 9 137440212 rs3132306-T 9:137440212 Central corneal thickness 3.00E-10 0.15 22814818 | |
| 9 137440528 rs1536482-A 9:137440528 Corneal structure 3.00E-22 0.12 23291589 | |
| 9 137568051 rs7044529-T 9:137568051 Corneal structure 5.00E-12 0.13 23291589 | |
| 9 137568051 rs7044529-A 9:137568051 Central corneal thickness 5.00E-08 0.13 20719862 | |
| 9 138529722 rs1537415-G 9:138529722 Periodontitis 6.00E-09 1.59 19897590 | |
| 9 139089679 rs7860634-A 9:139089679 Thyroid hormone levels 2.00E-14 0.1 23408906 | |
| 9 139089679 rs7860634-A 9:139089679 Thyroid hormone levels 2.00E-08 0.11 23408906 | |
| 9 139089679 rs7860634-A 9:139089679 Thyroid hormone levels 5.00E-08 0.1 23408906 | |
| 9 139111870 rs7849585-T 9:139111870 Height 5.00E-14 0.03 20881960 | |
| 9 139121740 rs12338076-C 9:139121740 Height 2.00E-08 0.06 20189936 | |
| 9 139252148 rs11787792-A 9:139252148 Type 2 diabetes 2.00E-10 1.15 23945395 | |
| 9 139265596 rs34971035-? 9:139265596 Monocyte chemoattractant protein-1 5.00E-08 NR 23017229 | |
| 9 139266405 rs10781499-A 9:139266405 Inflammatory bowel disease 4.00E-56 1.19 23128233 | |
| 9 139266405 rs10781499-A 9:139266405 Ulcerative colitis 3.00E-19 1.12 21297633 | |
| 9 139266496 rs4077515-T 9:139266496 Crohn's disease 1.00E-36 1.18 21102463 | |
| 9 139266496 rs4077515-C 9:139266496 Ulcerative colitis 5.00E-08 1.14 20228799 | |
| 9 139860264 rs11145951-T 9:139860264 Corneal structure 6.00E-12 0.09 23291589 | |
| 9 139862633 rs57024841-A 9:139862633 Beta-trace protein levels 1.00E-23 0.05 23328707 | |
| 10 318076 rs12246027-A 10:318076 Blood metabolite levels 1.00E-10 0.01 24816252 | |
| 10 771532 rs877282-? 10:771532 Uric acid levels 5.00E-08 NR 23703922 | |
| 10 1156165 rs10794720-T 10:1156165 Chronic kidney disease 1.00E-08 0.01 20383146 | |
| 10 2789594 rs9329300-? 10:2789594 Amyotrophic lateral sclerosis (sporadic) 2.00E-09 3.1 24529757 | |
| 10 5138036 rs2518049-A 10:5138036 Metabolic traits 7.00E-13 0.07 21886157 | |
| 10 5254847 rs1832007-G 10:5254847 Triglycerides 2.00E-12 0.03 24097068 | |
| 10 5256272 rs17134585-T 10:5256272 Blood metabolite ratios 3.00E-38 0.04 24816252 | |
| 10 6037726 rs7911500-? 10:6037726 Inflammatory biomarkers 5.00E-09 NR 22228203 | |
| 10 6081230 rs12722515-C 10:6081230 Inflammatory bowel disease 4.00E-10 1.1 23128233 | |
| 10 6094697 rs61839660-? 10:6094697 Type 1 diabetes 5.00E-09 1.6 22293688 | |
| 10 6097283 rs12722495-A 10:6097283 Type 1 diabetes autoantibodies 1.00E-38 1.61 21829393 | |
| 10 6098824 rs706779-A 10:6098824 Vitiligo 3.00E-09 1.27 20410501 | |
| 10 6098949 rs706778-T 10:6098949 Rheumatoid arthritis 5.00E-15 1.12 24390342 | |
| 10 6098949 rs706778-T 10:6098949 Rheumatoid arthritis 5.00E-14 1.1 24390342 | |
| 10 6098949 rs706778-T 10:6098949 Rheumatoid arthritis 1.00E-11 1.14 20453842 | |
| 10 6101713 rs3118470-G 10:6101713 Alopecia areata 2.00E-12 1.41 20596022 | |
| 10 6101713 rs3118470-G 10:6101713 Multiple sclerosis 3.00E-11 1.12 21833088 | |
| 10 6102012 rs12722489-C 10:6102012 Crohn's disease 3.00E-09 1.11 21102463 | |
| 10 6102012 rs12722489-C 10:6102012 Multiple sclerosis 3.00E-08 1.25 17660530 | |
| 10 6102012 rs12722489-C 10:6102012 Multiple sclerosis 4.00E-08 1.23 22190364 | |
| 10 6103762 rs12722486-? 10:6103762 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) 2.00E-09 38.2 24554482 | |
| 10 6110829 rs7090512-G 10:6110829 Multiple sclerosis 5.00E-20 1.19 21833088 | |
| 10 6123495 rs12251307-? 10:6123495 Type 1 diabetes 1.00E-13 NR 19430480 | |
| 10 6315794 rs7077335-? 10:6315794 Myopia (pathological) 2.00E-12 NR 23049088 | |
| 10 6390450 rs947474-A 10:6390450 Rheumatoid arthritis 3.00E-10 1.12 24390342 | |
| 10 6390450 rs947474-A 10:6390450 Rheumatoid arthritis 4.00E-10 1.11 24390342 | |
| 10 6390450 rs947474-G 10:6390450 Type 1 diabetes 4.00E-09 1.1 18978792 | |
| 10 6606541 rs4748153-? 10:6606541 Immune response to smallpox vaccine (IL-6) 3.00E-08 NR 22542470 | |
| 10 8089136 rs4143094-T 10:8089136 Colorectal cancer (diet interaction) 9.00E-09 1.17 24743840 | |
| 10 8093034 rs501764-C 10:8093034 Hodgkin's lymphoma 4.00E-10 1.39 24149102 | |
| 10 8104208 rs3824662-T 10:8104208 Acute lymphoblastic leukemia (B-cell precursor) 9.00E-12 1.31 23996088 | |
| 10 8104722 rs3824660-C 10:8104722 Rheumatoid arthritis 3.00E-09 1.1 24390342 | |
| 10 8104722 rs3824660-C 10:8104722 Rheumatoid arthritis 2.00E-08 1.08 24390342 | |
| 10 8701219 rs10795668-G 10:8701219 Colorectal cancer 5.00E-15 1.15 24836286 | |
| 10 8701219 rs10795668-A 10:8701219 Colorectal cancer 3.00E-13 1.12 18372905 | |
| 10 8739580 rs11255841-T 10:8739580 Colorectal cancer 7.00E-11 1.19 24737748 | |
| 10 8972018 rs10508372-C 10:8972018 Asthma 2.00E-15 1.16 21804548 | |
| 10 9049253 rs12413578-C 10:9049253 Rheumatoid arthritis 5.00E-08 1.2 24390342 | |
| 10 9053132 rs962993-T 10:9053132 Self-reported allergy 2.00E-08 0.07 23817569 | |
| 10 9328651 rs10491003-T 10:9328651 Calcium levels 5.00E-09 0.03 24068962 | |
| 10 9363877 rs12247397-G 10:9363877 Immune reponse to smallpox (secreted IL-1beta) 3.00E-09 NR 22610502 | |
| 10 12277992 rs7068966-T 10:12277992 Pulmonary function 6.00E-13 0.03 21946350 | |
| 10 12277992 rs7068966-T 10:12277992 Pulmonary function 3.00E-12 0.03 21946350 | |
| 10 12277992 rs7068966-? 10:12277992 Pulmonary function (interaction) 2.00E-11 NR 23284291 | |
| 10 12307894 rs11257655-T 10:12307894 Type 2 diabetes 3.00E-09 1.06 24509480 | |
| 10 12307894 rs11257655-T 10:12307894 Type 2 diabetes 7.00E-09 1.15 22961080 | |
| 10 12314997 rs10906115-A 10:12314997 Type 2 diabetes 1.00E-08 1.13 20862305 | |
| 10 12328010 rs12779790-G 10:12328010 Type 2 diabetes 1.00E-10 1.11 18372903 | |
| 10 12918764 rs7909670-T 10:12918764 Height 3.00E-09 0.02 20881960 | |
| 10 13155726 rs1561570-T 10:13155726 Paget's disease 4.00E-38 1.67 21623375 | |
| 10 13155726 rs1561570-? 10:13155726 Paget's disease 6.00E-13 1.54 20436471 | |
| 10 16919052 rs1801239-T 10:16919052 Urinary albumin excretion 1.00E-11 0.08 21355061 | |
| 10 17156151 rs1801222-A 10:17156151 Homocysteine levels 8.00E-10 0.05 23824729 | |
| 10 17156151 rs1801222-? 10:17156151 Folate pathway vitamin levels 3.00E-09 0.05 19744961 | |
| 10 17223244 rs12780845-A 10:17223244 Homocysteine levels 8.00E-10 0.05 23824729 | |
| 10 17260290 rs10904908-G 10:17260290 "Cholesterol, total" 3.00E-11 0.03 24097068 | |
| 10 18419972 rs4373814-G 10:18419972 Systolic blood pressure 5.00E-11 0.37 21909115 | |
| 10 18419972 rs4373814-G 10:18419972 Diastolic blood pressure 4.00E-10 0.22 21909115 | |
| 10 18442482 rs10740993-C 10:18442482 Primary tooth development (number of teeth) 2.00E-09 0.14 23704328 | |
| 10 18708798 rs11014166-A 10:18708798 Diastolic blood pressure 1.00E-08 0.37 19430479 | |
| 10 18727959 rs12258967-G 10:18727959 Blood pressure 2.00E-16 0.43 21909110 | |
| 10 18734528 rs17691888-G 10:18734528 Schizophrenia 1.00E-10 1.16 23974872 | |
| 10 20593087 rs12219125-T 10:20593087 Diabetic retinopathy 9.00E-09 NR 21310492 | |
| 10 21830104 rs11012732-A 10:21830104 Meningioma 2.00E-14 1.46 21804547 | |
| 10 21915619 rs1243180-T 10:21915619 Ovarian cancer 2.00E-08 1.1 23535730 | |
| 10 22032942 rs7072776-A 10:22032942 Breast cancer 4.00E-14 1.07 23535729 | |
| 10 22315843 rs11814448-C 10:22315843 Breast cancer 9.00E-16 1.26 23535729 | |
| 10 22839628 rs10828317-T 10:22839628 Acute lymphoblastic leukemia (B-cell precursor) 2.00E-09 1.23 23996088 | |
| 10 25918879 rs12775535-? 10:25918879 Immune response to smallpox vaccine (IL-6) 4.00E-09 NR 22542470 | |
| 10 28025771 rs10508727-? 10:28025771 Immune response to smallpox vaccine (IL-6) 1.00E-10 NR 22542470 | |
| 10 28479942 rs3905706-T 10:28479942 Bone mineral density 2.00E-16 0.05 22504420 | |
| 10 30316072 rs3739998-C 10:30316072 Coronary heart disease 1.00E-11 1.15 21088011 | |
| 10 30335122 rs2505083-C 10:30335122 Coronary heart disease 4.00E-08 1.07 21378988 | |
| 10 30728101 rs1042058-C 10:30728101 Inflammatory bowel disease 6.00E-11 1.08 23128233 | |
| 10 30912030 rs399593-? 10:30912030 Dental caries 9.00E-09 NR 23064961 | |
| 10 31415106 rs793108-T 10:31415106 Rheumatoid arthritis 1.00E-09 1.08 24390342 | |
| 10 35287650 rs17582416-G 10:35287650 Crohn's disease 2.00E-09 1.16 18587394 | |
| 10 35295431 rs11010067-G 10:35295431 Inflammatory bowel disease 2.00E-25 1.12 23128233 | |
| 10 35535695 rs12242110-G 10:35535695 Crohn's disease 1.00E-09 1.15 21102463 | |
| 10 35554054 rs12261843-G 10:35554054 Ulcerative colitis 7.00E-10 1.07 21297633 | |
| 10 37508450 rs1148259-? 10:37508450 Metabolite levels 3.00E-09 NR 19043545 | |
| 10 38258842 rs2749592-? x rs1373221-? 10:38258842 Age-related hearing impairment (interaction) 4.00E-09 NR 24939585 | |
| 10 43612609 rs2742234-T 10:43612609 Hirschsprung's disease 4.00E-18 NR 19196962 | |
| 10 43755754 rs28461806-G 10:43755754 Obesity-related traits 5.00E-08 0.05 23251661 | |
| 10 44775824 rs1746048-C 10:44775824 Coronary heart disease 3.00E-10 1.09 21378990 | |
| 10 44775824 rs1746048-C 10:44775824 Myocardial infarction (early onset) 7.00E-09 1.17 19198609 | |
| 10 44864168 rs266095-? 10:44864168 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) 8.00E-09 56.3 24554482 | |
| 10 45955064 rs2279434-T 10:45955064 Mean corpuscular hemoglobin 4.00E-12 0.13 20139978 | |
| 10 45955064 rs2279434-T 10:45955064 Mean corpuscular volume 3.00E-11 0.12 20139978 | |
| 10 45958881 rs2291429-A 10:45958881 Blood metabolite levels 9.00E-11 0.02 24816252 | |
| 10 45966422 rs901683-A 10:45966422 Red blood cell traits 2.00E-16 0.36 23222517 | |
| 10 46013277 rs970548-C 10:46013277 HDL cholesterol 2.00E-10 0.03 24097068 | |
| 10 46013277 rs970548-C 10:46013277 "Cholesterol, total" 8.00E-09 0.03 24097068 | |
| 10 46024729 rs11239550-G 10:46024729 Mean corpuscular volume 1.00E-10 0 19862010 | |
| 10 48388226 rs11204213-T 10:48388226 Corneal curvature 1.00E-13 0.29 24963161 | |
| 10 49699957 rs4838605-C 10:49699957 Diabetic retinopathy 2.00E-09 NR 21310492 | |
| 10 50025396 rs7097397-G 10:50025396 Systemic lupus erythematosus 8.00E-12 1.3 20169177 | |
| 10 50042951 rs877819-A 10:50042951 Systemic lupus erythematosus 8.00E-09 1.46 23273568 | |
| 10 50097819 rs2671692-A 10:50097819 Rheumatoid arthritis 3.00E-09 1.07 24390342 | |
| 10 50119054 rs1913517-A 10:50119054 Systemic lupus erythematosus 7.00E-12 1.24 19838193 | |
| 10 51524969 rs3123078-? 10:51524969 Prostate cancer 1.00E-19 NR 19767753 | |
| 10 51549494 rs10993994-T 10:51549494 Prostate cancer 9.00E-29 1.25 18264097 | |
| 10 51549494 rs10993994-T 10:51549494 Prostate cancer 3.00E-26 0.4 24753544 | |
| 10 51549494 rs10993994-T 10:51549494 Prostate-specific antigen levels 5.00E-17 0.12 23269536 | |
| 10 51549494 rs10993994-T 10:51549494 Serum prostate-specific antigen levels 7.00E-13 9.2 21160077 | |
| 10 51549494 rs10993994-T 10:51549494 Prostate cancer 7.00E-13 1.16 18264096 | |
| 10 51549494 rs10993994-T 10:51549494 PCA3 expression level 1.00E-09 1.25 23555189 | |
| 10 51549494 rs10993994-? 10:51549494 Prostate cancer 3.00E-08 NR 20676098 | |
| 10 51593352 rs7085433-A 10:51593352 Mean corpuscular hemoglobin 6.00E-10 0.1 20139978 | |
| 10 51593352 rs7085433-A 10:51593352 Mean corpuscular volume 7.00E-09 0.1 20139978 | |
| 10 52646093 rs10821905-A 10:52646093 Urate levels 7.00E-17 0.06 23263486 | |
| 10 53770239 rs1903989-? x rs4767920-? 10:53770239 Age-related hearing impairment (interaction) 1.00E-09 NR 24939585 | |
| 10 54223977 rs1733724-A 10:54223977 QRS duration 3.00E-08 0.49 21076409 | |
| 10 54427825 rs1373004-T 10:54427825 Bone mineral density 2.00E-12 0.06 22504420 | |
| 10 54439728 rs7902708-G 10:54439728 Bone properties (heel) 5.00E-15 0.09 24430505 | |
| 10 54439728 rs7902708-G 10:54439728 Bone properties (heel) 1.00E-08 0.07 24430505 | |
| 10 55384743 rs12256830-? 10:55384743 Immune response to smallpox vaccine (IL-6) 2.00E-10 NR 22542470 | |
| 10 59913151 rs1819658-C 10:59913151 Crohn's disease 9.00E-17 1.19 21102463 | |
| 10 59997926 rs2790216-G 10:59997926 Inflammatory bowel disease 8.00E-09 1.07 23128233 | |
| 10 60265404 rs7084402-G 10:60265404 Refractive error 2.00E-13 0.11 23396134 | |
| 10 61380482 rs10826334-G 10:61380482 Systolic blood pressure (alcohol consumption interaction) 1.00E-08 0.24 24376456 | |
| 10 61380482 rs10826334-G 10:61380482 Systolic blood pressure (alcohol consumption interaction) 4.00E-08 0.86 24376456 | |
| 10 61413353 rs12356193-A 10:61413353 Blood metabolite levels 4.00E-63 0.03 24816252 | |
| 10 61413353 rs12356193-A 10:61413353 Blood metabolite levels 2.00E-33 0.03 24816252 | |
| 10 61413353 rs12356193-A 10:61413353 Blood metabolite levels 8.00E-20 0.02 24816252 | |
| 10 61413353 rs12356193-A 10:61413353 Uric acid levels 1.00E-08 0.08 19503597 | |
| 10 61449564 rs7094971-G 10:61449564 Metabolic traits 3.00E-14 0.05 21886157 | |
| 10 61467182 rs1171617-T 10:61467182 Blood metabolite levels 2.00E-14 0.04 24816252 | |
| 10 61469090 rs1171615-T 10:61469090 Blood metabolite ratios 2.00E-95 0.08 24816252 | |
| 10 61469090 rs1171615-T 10:61469090 Blood metabolite levels 3.00E-34 0.05 24816252 | |
| 10 61469090 rs1171615-T 10:61469090 Blood metabolite levels 4.00E-11 0.03 24816252 | |
| 10 61469538 rs1171614-T 10:61469538 Urate levels 2.00E-28 0.08 23263486 | |
| 10 61469538 rs1171614-T 10:61469538 Blood metabolite levels 3.00E-23 0.03 24816252 | |
| 10 61469538 rs1171614-T 10:61469538 Blood metabolite levels 7.00E-14 0.04 24816252 | |
| 10 62179812 rs10994336-T 10:62179812 Bipolar disorder 9.00E-09 1.45 18711365 | |
| 10 62185494 rs4948418-T 10:62185494 Bipolar disorder 4.00E-10 NR 22182935 | |
| 10 62222107 rs10994359-C 10:62222107 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 3.00E-09 1.08 23453885 | |
| 10 62279124 rs10994397-? 10:62279124 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 7.00E-09 NR 23453885 | |
| 10 62322034 rs10994415-C 10:62322034 Bipolar disorder 7.00E-11 1.27 24618891 | |
| 10 63467553 rs4590817-G 10:63467553 Blood pressure 2.00E-18 0.58 21909110 | |
| 10 63524591 rs1530440-T 10:63524591 Diastolic blood pressure 1.00E-09 0.39 19430483 | |
| 10 63721176 rs7090445-? 10:63721176 Acute lymphoblastic leukemia (B-cell precursor) 5.00E-54 NR 23996088 | |
| 10 63723577 rs10821936-C 10:63723577 Acute lymphoblastic leukemia (childhood) 6.00E-46 1.86 23512250 | |
| 10 63723577 rs10821936-C 10:63723577 Acute lymphoblastic leukemia (childhood) 1.00E-15 1.91 19684603 | |
| 10 63752159 rs7089424-C 10:63752159 Acute lymphoblastic leukemia (childhood) 7.00E-19 1.65 19684604 | |
| 10 63779871 rs71508903-T 10:63779871 Rheumatoid arthritis 5.00E-22 1.16 24390342 | |
| 10 63779871 rs71508903-T 10:63779871 Rheumatoid arthritis 3.00E-15 1.15 24390342 | |
| 10 63779871 rs71508903-T 10:63779871 Rheumatoid arthritis 1.00E-08 1.18 24390342 | |
| 10 63785089 rs10821944-G 10:63785089 Rheumatoid arthritis 6.00E-18 1.16 22446963 | |
| 10 63805617 rs4948496-C 10:63805617 Systemic lupus erythematosus 5.00E-11 1.18 23273568 | |
| 10 63830286 rs7090871-T 10:63830286 Corneal structure 6.00E-10 0.06 23291589 | |
| 10 63958112 rs3125734-T 10:63958112 Rheumatoid arthritis 5.00E-09 1.2 23028356 | |
| 10 64036881 rs6479800-C 10:64036881 Rheumatoid arthritis 4.00E-08 1.11 24390342 | |
| 10 64187564 rs7089814-C 10:64187564 Breast size 3.00E-09 0.1 22747683 | |
| 10 64251977 rs10822013-T 10:64251977 Breast cancer 6.00E-09 1.12 21908515 | |
| 10 64278682 rs10995190-G 10:64278682 Breast cancer 1.00E-36 1.16 23535729 | |
| 10 64278682 rs10995190-G 10:64278682 Breast cancer 5.00E-15 1.16 20453838 | |
| 10 64278682 rs10995190-A 10:64278682 Mammographic density 1.00E-09 0.18 21278746 | |
| 10 64391375 rs10995245-A 10:64391375 Narcolepsy 1.00E-11 1.23 24204295 | |
| 10 64398466 rs10995251-C 10:64398466 Atopic dermatitis 6.00E-20 1.28 23042114 | |
| 10 64415184 rs7076156-G 10:64415184 Crohn's disease 7.00E-09 1.19 22412388 | |
| 10 64438486 rs10995271-C 10:64438486 Crohn's disease 4.00E-20 1.25 18587394 | |
| 10 64445564 rs10761659-G 10:64445564 Inflammatory bowel disease 6.00E-46 1.17 23128233 | |
| 10 64445564 rs10761659-G 10:64445564 Crohn's disease 4.00E-22 1.23 21102463 | |
| 10 64470675 rs224136-? 10:64470675 Crohn's disease 1.00E-10 1.67 17435756 | |
| 10 64580575 rs224278-C 10:64580575 Ewing sarcoma 4.00E-17 1.66 22327514 | |
| 10 65027610 rs10761731-T 10:65027610 Platelet counts 2.00E-24 3.85 22139419 | |
| 10 65027610 rs10761731-T 10:65027610 Triglycerides 3.00E-12 2.38 20686565 | |
| 10 65027610 rs10761731-T 10:65027610 Triglycerides 8.00E-12 0.03 24097068 | |
| 10 65050659 rs7075195-A 10:65050659 Mean platelet volume 2.00E-44 0.01 22139419 | |
| 10 65050659 rs7075195-A 10:65050659 Mean platelet volume 3.00E-18 0.13 24026423 | |
| 10 65101207 rs10740118-C 10:65101207 Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid) 8.00E-09 0.25 24823311 | |
| 10 65104500 rs7896518-A 10:65104500 Mean platelet volume 2.00E-12 5.18 22423221 | |
| 10 65121565 rs12355784-A 10:65121565 Liver enzyme levels 5.00E-10 0.03 18940312 | |
| 10 65133156 rs2393967-A 10:65133156 Mean platelet volume 3.00E-21 0.01 19820697 | |
| 10 65133822 rs7923609-G 10:65133822 Liver enzyme levels (alkaline phosphatase) 6.00E-23 2.2 22001757 | |
| 10 65138910 rs7910927-T 10:65138910 Sex hormone-binding globulin levels 6.00E-35 0.05 22829776 | |
| 10 65138910 rs7910927-T 10:65138910 Sex hormone-binding globulin levels 1.00E-25 0.05 22829776 | |
| 10 65138910 rs7910927-T 10:65138910 Sex hormone-binding globulin levels 2.00E-13 0.05 22829776 | |
| 10 65162153 rs7896783-A 10:65162153 Fibrinogen 9.00E-22 0.01 23969696 | |
| 10 65261184 rs2893923-T 10:65261184 Platelet aggregation 5.00E-08 NR 20526338 | |
| 10 65274927 rs10761779-G 10:65274927 Liver enzyme levels 7.00E-10 0.03 18940312 | |
| 10 65337153 rs10822184-T 10:65337153 Androgen levels 1.00E-08 0.06 22936694 | |
| 10 67966574 rs12251332-C 10:67966574 Metabolite levels (Pyroglutamine) 5.00E-08 0.17 23934736 | |
| 10 69991853 rs7916697-A 10:69991853 Optic disc parameters 2.00E-15 0.09 21307088 | |
| 10 70000881 rs1900004-T 10:70000881 Optic disc parameters 3.00E-35 0.07 20548946 | |
| 10 70000881 rs1900004-T 10:70000881 Vertical cup-disc ratio 2.00E-08 0.01 20548946 | |
| 10 70011838 rs3858145-A 10:70011838 Optic nerve measurement (disc area) 3.00E-10 0.3 20395239 | |
| 10 70019371 rs12571093-G 10:70019371 Optic nerve measurement (disc area) 2.00E-10 0.31 20395239 | |
| 10 70931474 rs1802295-A 10:70931474 Type 2 diabetes 4.00E-08 1.08 21874001 | |
| 10 70939801 rs10998624-A 10:70939801 Immune reponse to smallpox (secreted IL-1beta) 1.00E-09 NR 22610502 | |
| 10 70982941 rs4746822-T 10:70982941 Glycemic traits (pregnancy) 1.00E-22 0.28 23903356 | |
| 10 71093392 rs16926246-C 10:71093392 Glycated hemoglobin levels 3.00E-54 0.09 20858683 | |
| 10 71093392 rs16926246-T 10:71093392 Hematocrit 1.00E-13 0.33 19862010 | |
| 10 71093392 rs16926246-T 10:71093392 Hemoglobin 2.00E-11 0.11 19862010 | |
| 10 71099888 rs10159477-A 10:71099888 Red blood cell traits 4.00E-20 0.09 23222517 | |
| 10 71099913 rs7072268-A 10:71099913 Glycated hemoglobin levels 2.00E-25 0.05 19096518 | |
| 10 71218094 rs12776158-? x rs695567-? 10:71218094 Age-related hearing impairment (interaction) 6.00E-09 NR 24939585 | |
| 10 72114378 rs4747011-? 10:72114378 Brain connectivity 9.00E-10 NR 23471985 | |
| 10 73135919 rs1417210-? 10:73135919 Vitiligo 2.00E-08 1.14 22951725 | |
| 10 73778267 rs1245582-? 10:73778267 Disc degeneration (lumbar) 4.00E-08 1.2 24216480 | |
| 10 75421208 rs10824026-A 10:75421208 Atrial fibrillation 4.00E-09 1.15 22544366 | |
| 10 75673101 rs2227564-C 10:75673101 Inflammatory bowel disease 7.00E-10 1.08 23128233 | |
| 10 76295789 rs7924176-G 10:76295789 Permanent tooth development 6.00E-18 0.11 21931568 | |
| 10 76295789 rs7924176-A 10:76295789 Primary tooth development (number of teeth) 8.00E-16 0.19 23704328 | |
| 10 76295789 rs7924176-A 10:76295789 Primary tooth development (time to first tooth eruption) 2.00E-08 0.17 23704328 | |
| 10 78315224 rs11001819-G 10:78315224 Pulmonary function 3.00E-12 0.03 21946350 | |
| 10 78315224 rs11001819-? 10:78315224 Pulmonary function (interaction) 5.00E-08 NR 23284291 | |
| 10 78646536 rs2116830-G 10:78646536 Obesity 3.00E-10 1.26 21708048 | |
| 10 79401316 rs7071206-T 10:79401316 Bone mineral density 5.00E-19 0.06 22504420 | |
| 10 79680434 rs754466-T 10:79680434 Liver enzyme levels (gamma-glutamyl transferase) 6.00E-10 3.5 22001757 | |
| 10 80819132 rs704017-G 10:80819132 Colorectal cancer 2.00E-08 1.1 24836286 | |
| 10 80841148 rs704010-T 10:80841148 Breast cancer 7.00E-22 1.08 23535729 | |
| 10 80841148 rs704010-A 10:80841148 Breast cancer 4.00E-09 1.07 20453838 | |
| 10 80925577 rs7916441-? 10:80925577 Height 6.00E-10 NR 20881960 | |
| 10 80931481 rs780151-G 10:80931481 Height 2.00E-09 1.13 23563607 | |
| 10 80942631 rs12571751-A 10:80942631 Type 2 diabetes 2.00E-10 1.09 24509480 | |
| 10 81032532 rs1250546-A 10:81032532 Inflammatory bowel disease 3.00E-18 1.1 23128233 | |
| 10 81032885 rs1250544-G 10:81032885 Crohn's disease and psoriasis 7.00E-14 1.16 22482804 | |
| 10 81058027 rs1250552-? 10:81058027 Celiac disease 9.00E-10 1.12 20190752 | |
| 10 81060317 rs1250550-G 10:81060317 Crohn's disease 1.00E-30 1.19 21102463 | |
| 10 81060317 rs1250550-A 10:81060317 Multiple sclerosis 6.00E-09 1.1 21833088 | |
| 10 81060317 rs1250550-? 10:81060317 Inflammatory bowel disease (early onset) 6.00E-09 1.16 19915574 | |
| 10 81121696 rs2145998-A 10:81121696 Height 4.00E-13 0.03 20881960 | |
| 10 81694950 rs1923539-A 10:81694950 Chronic obstructive pulmonary disease-related biomarkers 5.00E-09 NR 23144326 | |
| 10 81705433 rs7078012-T 10:81705433 Chronic obstructive pulmonary disease-related biomarkers 5.00E-09 NR 23144326 | |
| 10 81706973 rs726288-T 10:81706973 Rheumatoid arthritis 9.00E-09 1.22 24390342 | |
| 10 81735981 rs3923564-G 10:81735981 Chronic obstructive pulmonary disease-related biomarkers 2.00E-27 NR 23144326 | |
| 10 81788104 rs12220777-C 10:81788104 Chronic obstructive pulmonary disease-related biomarkers 7.00E-11 NR 23144326 | |
| 10 81847914 rs728616-T 10:81847914 Chronic obstructive pulmonary disease-related biomarkers 2.00E-12 NR 23144326 | |
| 10 81882370 rs3851050-C 10:81882370 Chronic obstructive pulmonary disease-related biomarkers 1.00E-11 NR 23144326 | |
| 10 81933748 rs6585424-G 10:81933748 Chronic obstructive pulmonary disease-related biomarkers 1.00E-10 NR 23144326 | |
| 10 82254047 rs6586030-G 10:82254047 Inflammatory bowel disease 9.00E-16 1.12 23128233 | |
| 10 83566686 rs9787485-T 10:83566686 Homeostasis model assessment of insulin resistance (interaction) 4.00E-08 NR 24204828 | |
| 10 83566686 rs9787485-T 10:83566686 Fasting insulin (interaction) 5.00E-08 NR 24204828 | |
| 10 90023033 rs10509540-? 10:90023033 Type 1 diabetes 1.00E-28 1.33 19430480 | |
| 10 90749963 rs1800682-A 10:90749963 Chronic lymphocytic leukemia 2.00E-08 1.25 24292274 | |
| 10 90759724 rs4406737-G 10:90759724 Chronic lymphocytic leukemia 1.00E-14 1.27 23770605 | |
| 10 91002927 rs1412444-T 10:91002927 Coronary heart disease 3.00E-13 1.09 21378988 | |
| 10 91002927 rs1412444-T 10:91002927 Coronary heart disease 4.00E-08 1.1 21606135 | |
| 10 92592956 rs12249377-? 10:92592956 White matter microstructure (global fractional anisotropy) 3.00E-10 NR 24736177 | |
| 10 93348120 rs1329650-T 10:93348120 Smoking behavior 6.00E-10 0.37 20418890 | |
| 10 94436851 rs7911264-C 10:94436851 Inflammatory bowel disease 3.00E-08 1.07 23128233 | |
| 10 94462882 rs1111875-C 10:94462882 Type 2 diabetes 3.00E-19 1.15 24509480 | |
| 10 94462882 rs1111875-C 10:94462882 Type 2 diabetes 7.00E-12 1.21 19401414 | |
| 10 94462882 rs1111875-C 10:94462882 Type 2 diabetes 6.00E-10 1.13 17463246 | |
| 10 94462882 rs1111875-C 10:94462882 Type 2 diabetes 6.00E-10 1.13 17463248 | |
| 10 94462882 rs1111875-C 10:94462882 Type 2 diabetes 2.00E-08 1.14 23945395 | |
| 10 94465559 rs5015480-C 10:94465559 Type 2 diabetes 1.00E-15 1.18 20581827 | |
| 10 94465559 rs5015480-C 10:94465559 Type 2 diabetes 2.00E-09 1.18 22693455 | |
| 10 94481917 rs7923837-G 10:94481917 Multiple sclerosis 5.00E-09 1.1 21833088 | |
| 10 94485211 rs2497306-C 10:94485211 Dehydroepiandrosterone sulphate levels 5.00E-09 0.04 21533175 | |
| 10 94839642 rs2068888-A 10:94839642 Triglycerides 2.00E-11 0.02 24097068 | |
| 10 94839642 rs2068888-A 10:94839642 Triglycerides 2.00E-08 2.28 20686565 | |
| 10 94924324 rs10882165-T 10:94924324 Refractive error 1.00E-11 0.11 23396134 | |
| 10 95348182 rs10882272-C 10:95348182 Retinol levels 7.00E-15 0.03 21878437 | |
| 10 95895177 rs9663362-G 10:95895177 Blood pressure 5.00E-09 0.27 21909110 | |
| 10 95895940 rs932764-G 10:95895940 Systolic blood pressure 7.00E-16 0.48 21909115 | |
| 10 95895940 rs932764-G 10:95895940 Hypertension 9.00E-09 0.06 21909115 | |
| 10 96013705 rs9419788-? 10:96013705 Personality dimensions 4.00E-08 NR 21368711 | |
| 10 96058298 rs3765524-? 10:96058298 Dengue shock syndrome 3.00E-10 1.25 22001756 | |
| 10 96058298 rs3765524-T 10:96058298 Esophageal cancer and gastric cancer 2.00E-09 1.35 20729852 | |
| 10 96066341 rs2274223-G 10:96066341 Esophageal cancer 4.00E-20 1.34 21642993 | |
| 10 96070375 rs3781264-C 10:96070375 Esophageal cancer and gastric cancer 4.00E-09 1.36 20729852 | |
| 10 96405329 rs12772169-? 10:96405329 Acenocoumarol maintenance dosage 8.00E-12 NR 19578179 | |
| 10 96405502 rs12777823-? 10:96405502 Response to clopidogrel therapy 2.00E-13 NR 19706858 | |
| 10 96405502 rs12777823-? 10:96405502 Warfarin maintenance dose 5.00E-12 NR 23755828 | |
| 10 96522365 rs4986894-T 10:96522365 Blood metabolite levels 6.00E-12 0.04 24816252 | |
| 10 96665937 rs1853207-T 10:96665937 Blood metabolite levels 1.00E-12 0.11 24816252 | |
| 10 96681846 rs1074145-? 10:96681846 Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) 2.00E-16 NR 24528284 | |
| 10 96681846 rs1074145-? 10:96681846 Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) 4.00E-09 NR 24528284 | |
| 10 96702047 rs1799853-? 10:96702047 Warfarin maintenance dose 1.00E-31 0.54 19300499 | |
| 10 96707202 rs4086116-? 10:96707202 Warfarin maintenance dose 6.00E-12 NR 18535201 | |
| 10 96734676 rs1934963-T 10:96734676 Blood metabolite levels 9.00E-65 0.03 24816252 | |
| 10 96741053 rs1057910-? 10:96741053 Warfarin maintenance dose 3.00E-79 1.11 19300499 | |
| 10 96751270 rs2185570-C 10:96751270 Dehydroepiandrosterone sulphate levels 2.00E-08 0.06 21533175 | |
| 10 96788561 rs1934955-A 10:96788561 Blood metabolite levels 3.00E-16 0.03 24816252 | |
| 10 96828323 rs2071426-T 10:96828323 Blood metabolite levels 4.00E-14 0.05 24816252 | |
| 10 96828323 rs2071426-T 10:96828323 Blood metabolite levels 7.00E-14 0.06 24816252 | |
| 10 97395962 rs56322409-T 10:97395962 Blood metabolite levels 8.00E-11 0.01 24816252 | |
| 10 99359739 rs2297644-? 10:99359739 Metabolite levels 1.00E-12 0.15 22286219 | |
| 10 100127551 rs17109512 10:100127551 Aspartate aminotransferase 3.00E-14 NR 21900944 | |
| 10 100147060 rs4345897-G 10:100147060 Metabolite levels 2.00E-91 NR 23281178 | |
| 10 100147060 rs4345897-A 10:100147060 Urinary metabolites (H-NMR features) 2.00E-19 0.34 24586186 | |
| 10 100147060 rs4345897-A 10:100147060 Urinary metabolites (H-NMR features) 4.00E-12 0.27 24586186 | |
| 10 100148176 rs2147896-A 10:100148176 Urinary metabolites (H-NMR features) 3.00E-164 0.85 24586186 | |
| 10 100148176 rs2147896-A 10:100148176 Urinary metabolites (H-NMR features) 2.00E-55 0.57 24586186 | |
| 10 100148176 rs2147896-A 10:100148176 Urinary metabolites (H-NMR features) 8.00E-30 0.42 24586186 | |
| 10 100148176 rs2147896-A 10:100148176 Urinary metabolites (H-NMR features) 6.00E-19 0.36 24586186 | |
| 10 100156853 rs7072216-C 10:100156853 Metabolite levels 8.00E-15 1.19 21931564 | |
| 10 100159136 rs4488133-A 10:100159136 Blood metabolite levels 1.00E-48 0.1 24816252 | |
| 10 100165997 rs17455577-C 10:100165997 Urinary metabolites (H-NMR features) 3.00E-22 0.45 24586186 | |
| 10 100855702 rs12570188-? 10:100855702 Asthma (childhood onset) 5.00E-08 NR 23829686 | |
| 10 101282200 rs11190134-G 10:101282200 Red blood cell traits 1.00E-10 0.01 23222517 | |
| 10 101284237 rs4409764-T 10:101284237 Inflammatory bowel disease 1.00E-54 1.18 23128233 | |
| 10 101284237 rs4409764-T 10:101284237 Crohn's disease 2.00E-20 1.22 21102463 | |
| 10 101287764 rs10883365-? 10:101287764 Crohn's disease 4.00E-10 1.18 17554261 | |
| 10 101290301 rs6584283-T 10:101290301 Ulcerative colitis 8.00E-21 1.21 21297633 | |
| 10 101291593 rs11190140-T 10:101291593 Crohn's disease 3.00E-16 1.2 18587394 | |
| 10 101291593 rs11190140-T 10:101291593 Ulcerative colitis 1.00E-08 1.2 20228799 | |
| 10 101345366 rs1035209-T 10:101345366 Colorectal cancer 5.00E-11 1.12 24737748 | |
| 10 101795361 rs10883437-T 10:101795361 Liver enzyme levels (alanine transaminase) 4.00E-09 2.3 22001757 | |
| 10 101805442 rs11599750-T 10:101805442 Height 2.00E-13 0.03 20881960 | |
| 10 101813802 rs7084921-T 10:101813802 Bone mineral density 9.00E-10 0.03 22504420 | |
| 10 101823543 rs4462272-? x rs563748-? 10:101823543 Age-related hearing impairment (interaction) 8.00E-09 NR 24939585 | |
| 10 101861435 rs11597390-A 10:101861435 Liver enzyme levels 2.00E-08 0.04 18940312 | |
| 10 102075479 rs603424-A 10:102075479 Blood metabolite ratios 1.00E-115 0.05 24816252 | |
| 10 102075479 rs603424-A 10:102075479 Metabolic traits 3.00E-57 0.12 21886157 | |
| 10 102075479 rs603424-A 10:102075479 Blood metabolite levels 6.00E-21 0.02 24816252 | |
| 10 102075479 rs603424-A 10:102075479 Blood metabolite levels 7.00E-16 0.04 24816252 | |
| 10 102075479 rs603424-A 10:102075479 Palmitoleic acid (16:1n-7) plasma levels 6.00E-15 0.03 23362303 | |
| 10 102075479 rs603424-A 10:102075479 Blood metabolite levels 1.00E-14 0.04 24816252 | |
| 10 102075479 rs603424-A 10:102075479 Blood metabolite levels 2.00E-14 0.03 24816252 | |
| 10 102075479 rs603424-? 10:102075479 Phospholipid levels (plasma) 6.00E-14 1.4 22359512 | |
| 10 102075479 rs603424-G 10:102075479 Serum metabolite levels 1.00E-11 0.11 24625756 | |
| 10 102302457 rs11190604-A 10:102302457 Palmitoleic acid (16:1n-7) plasma levels 6.00E-09 0.02 23362303 | |
| 10 102979207 rs11190870-? 10:102979207 Scoliosis 1.00E-19 1.56 22019779 | |
| 10 104414221 rs3850699-A 10:104414221 Prostate cancer 5.00E-10 1.1 23535732 | |
| 10 104594507 rs1004467-A 10:104594507 Systolic blood pressure 1.00E-10 1.05 19430479 | |
| 10 104623578 rs9527-? 10:104623578 Arsenic metabolism 3.00E-09 NR 22383894 | |
| 10 104628873 rs7085104-A 10:104628873 Schizophrenia 4.00E-13 1.11 23974872 | |
| 10 104629011 rs12416687-T 10:104629011 Blood pressure 4.00E-09 0.59 24954895 | |
| 10 104660004 rs11191454-? 10:104660004 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 1.00E-08 1.13 23453885 | |
| 10 104698978 rs4919694-? 10:104698978 Arsenic metabolism 3.00E-08 NR 22383894 | |
| 10 104719096 rs12413409-G 10:104719096 Coronary heart disease 1.00E-09 1.12 21378990 | |
| 10 104719096 rs12413409-G 10:104719096 Intracranial aneurysm 1.00E-09 1.29 20364137 | |
| 10 104719096 rs12413409-? 10:104719096 Coronary artery disease or large artery stroke 2.00E-08 NR 24262325 | |
| 10 104775908 rs7914558-? 10:104775908 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 2.00E-09 NR 23453885 | |
| 10 104775908 rs7914558-G 10:104775908 Schizophrenia 2.00E-08 1.22 21926974 | |
| 10 104846178 rs11191548-T 10:104846178 Systolic blood pressure 7.00E-26 1.1 21909115 | |
| 10 104846178 rs11191548-T 10:104846178 Systolic blood pressure 7.00E-24 1.16 19430483 | |
| 10 104846178 rs11191548-T 10:104846178 Blood pressure 4.00E-17 1.18 21572416 | |
| 10 104846178 rs11191548-T 10:104846178 Blood pressure 7.00E-12 0.58 21572416 | |
| 10 104846178 rs11191548-T 10:104846178 Blood pressure 8.00E-11 0.53 21909110 | |
| 10 104906211 rs11191580-? 10:104906211 Schizophrenia 2.00E-09 1.23 22688191 | |
| 10 104906211 rs11191580-? 10:104906211 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 1.00E-08 NR 23453885 | |
| 10 104906211 rs11191580-T 10:104906211 Schizophrenia 3.00E-08 1.2 21926974 | |
| 10 104906211 rs11191580-C 10:104906211 Body mass index 4.00E-08 0.03 24861553 | |
| 10 104939215 rs11191593-T 10:104939215 Blood pressure 1.00E-15 0.66 21909110 | |
| 10 105672842 rs11191865-A 10:105672842 Interstitial lung disease 2.00E-08 1.25 23583980 | |
| 10 105675946 rs9419958-T 10:105675946 Telomere length 9.00E-11 0.08 23001564 | |
| 10 105676465 rs9420907-A 10:105676465 Telomere length 7.00E-11 0.07 23535734 | |
| 10 105677897 rs4387287-A 10:105677897 Telomere length 2.00E-11 0.1 20421499 | |
| 10 105714399 rs7913069-A 10:105714399 Uterine fibroids 9.00E-14 1.47 21460842 | |
| 10 105846074 rs1320448-? 10:105846074 Cardiac hypertrophy 2.00E-08 NR 21348951 | |
| 10 107516352 rs17119461-? 10:107516352 Melanoma 7.00E-12 8.4 21706340 | |
| 10 110435038 rs4244274-? x rs7155714-? 10:110435038 Age-related hearing impairment (interaction) 4.00E-09 NR 24939585 | |
| 10 111735750 rs17095355-T 10:111735750 Biliary atresia 7.00E-09 1.77 20460270 | |
| 10 112186148 rs11195128-T 10:112186148 Crohn's disease 2.00E-10 1.42 23850713 | |
| 10 112909105 rs869244-A 10:112909105 Platelet aggregation 3.00E-12 NR 20526338 | |
| 10 113042093 rs10885122-G 10:113042093 Fasting glucose-related traits 3.00E-16 NR 20081858 | |
| 10 113933886 rs2255141-A 10:113933886 "Cholesterol, total" 7.00E-16 0.03 24097068 | |
| 10 113933886 rs2255141-A 10:113933886 LDL cholesterol 1.00E-13 0.03 24097068 | |
| 10 113933886 rs2255141-A 10:113933886 "Cholesterol, total" 2.00E-10 1.14 20686565 | |
| 10 113933886 rs2255141-A 10:113933886 LDL cholesterol 2.00E-09 1.08 20686565 | |
| 10 114498476 rs7086803-A 10:114498476 Lung cancer 4.00E-18 1.28 23143601 | |
| 10 114726843 rs11196172-A 10:114726843 Colorectal cancer 1.00E-12 1.14 24836286 | |
| 10 114754088 rs7901695-C 10:114754088 Type 2 diabetes 1.00E-48 1.37 17463249 | |
| 10 114756041 rs4506565-T 10:114756041 Type 2 diabetes 5.00E-12 1.36 17554300 | |
| 10 114756041 rs4506565-T 10:114756041 Fasting glucose-related traits 1.00E-08 NR 20081858 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 8.00E-75 1.4 24509480 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 9.00E-75 1.19 23300278 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 2.00E-51 1.4 20581827 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 2.00E-40 1.58 22693455 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 2.00E-38 1.15 23300278 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 1.00E-35 1.51 23209189 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 3.00E-35 1.15 23300278 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 2.00E-34 1.65 17293876 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 2.00E-31 1.38 17463246 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes and other traits 1.00E-30 1.48 19734900 | |
| 10 114758349 rs7903146-? 10:114758349 Type 2 diabetes 9.00E-30 1.49 19056611 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 3.00E-23 1.37 18372903 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 6.00E-22 1.3 23300278 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 4.00E-21 1.26 22693455 | |
| 10 114758349 rs7903146-T 10:114758349 Proinsulin levels 2.00E-20 NR 21873549 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 3.00E-19 1.44 23300278 | |
| 10 114758349 rs7903146-? 10:114758349 Type 2 diabetes 6.00E-16 1.31 19056611 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 2.00E-15 1.48 23945395 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 2.00E-15 1.46 22101970 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 1.00E-14 1.37 24390345 | |
| 10 114758349 rs7903146-? 10:114758349 Fasting glucose-related traits (interaction with BMI) 2.00E-14 NR 22581228 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 8.00E-12 1.54 19401414 | |
| 10 114758349 rs7903146-? 10:114758349 Type 2 diabetes 2.00E-10 1.38 17460697 | |
| 10 114758349 rs7903146-T 10:114758349 Type 2 diabetes 1.00E-08 1.34 17463248 | |
| 10 114758349 rs7903146-A 10:114758349 Type 2 diabetes 5.00E-08 1.71 17668382 | |
| 10 114773927 rs7904519-G 10:114773927 Breast cancer 3.00E-08 1.06 23535729 | |
| 10 114880551 rs12772424-? 10:114880551 Bipolar disorder (body mass index interaction) 3.00E-08 NR 24322204 | |
| 10 115235114 rs1472750-? 10:115235114 Myopia (pathological) 5.00E-09 NR 23049088 | |
| 10 115481018 rs3814231-G 10:115481018 Vitiligo 4.00E-08 1.23 22561518 | |
| 10 115781527 rs2782980-T 10:115781527 Blood pressure 2.00E-09 0.34 21909110 | |
| 10 115805056 rs1801253-G 10:115805056 Birth weight 4.00E-09 0.04 23202124 | |
| 10 118397971 rs10885997-? 10:118397971 Phospholipid levels (plasma) 8.00E-09 0.8 22359512 | |
| 10 118827560 rs7078160-A 10:118827560 Orofacial clefts 4.00E-11 1.38 22863734 | |
| 10 118827560 rs7078160-A 10:118827560 Orofacial clefts 6.00E-10 NR 22863734 | |
| 10 118827560 rs7078160-A 10:118827560 Orofacial clefts 2.00E-08 1.36 20023658 | |
| 10 119533757 rs7088969-T 10:119533757 Homeostasis model assessment of beta-cell function (interaction) 3.00E-08 NR 24204828 | |
| 10 120278944 rs12413624-T 10:120278944 Pancreatic cancer 5.00E-11 1.23 22158540 | |
| 10 121149403 rs10886471-C 10:121149403 Type 2 diabetes 7.00E-09 1.12 22961080 | |
| 10 121429633 rs2234962-? 10:121429633 Dilated cardiomyopathy 4.00E-12 1.52 21459883 | |
| 10 122945086 rs3943077-A 10:122945086 Adiponectin levels 3.00E-14 0.07 24105470 | |
| 10 123032519 rs11199874-? 10:123032519 Prostate cancer 3.00E-10 NR 22130093 | |
| 10 123033549 rs10788160-A 10:123033549 Serum prostate-specific antigen levels 5.00E-15 10.2 21160077 | |
| 10 123093901 rs11199914-C 10:123093901 Breast cancer 2.00E-08 1.05 23535729 | |
| 10 123337335 rs2981579-A 10:123337335 Breast cancer 2.00E-170 1.27 23535729 | |
| 10 123337335 rs2981579-A 10:123337335 Breast cancer 4.00E-31 1.43 20453838 | |
| 10 123337335 rs2981579-T 10:123337335 Breast cancer 2.00E-10 1.17 19330030 | |
| 10 123340311 rs2981578-C 10:123340311 Breast cancer 1.00E-12 1.23 24143190 | |
| 10 123346116 rs2981575-? 10:123346116 Breast cancer in BRCA2 mutation carriers 1.00E-08 1.28 21060860 | |
| 10 123346190 rs1219648-? 10:123346190 Breast cancer 1.00E-30 1.31 21263130 | |
| 10 123346190 rs1219648-G 10:123346190 Breast cancer 2.00E-13 1.32 20872241 | |
| 10 123346190 rs1219648-G 10:123346190 Breast cancer 1.00E-10 1.2 17529973 | |
| 10 123348662 rs2912774-? 10:123348662 Breast cancer (early onset) 3.00E-27 1.29 24493630 | |
| 10 123352317 rs2981582-A 10:123352317 Breast cancer 2.00E-76 1.26 17529967 | |
| 10 124214448 rs10490924-T 10:124214448 Age-related macular degeneration (CNV) 2.00E-138 3.67 22705344 | |
| 10 124214448 rs10490924-? 10:124214448 Age-related macular degeneration 5.00E-119 NR 20385826 | |
| 10 124214448 rs10490924-T 10:124214448 Age-related macular degeneration 3.00E-72 3 22694956 | |
| 10 124214448 rs10490924-T 10:124214448 Age-related macular degeneration 1.00E-60 2.75 20861866 | |
| 10 124214448 rs10490924-T 10:124214448 Age-related macular degeneration (GA) 7.00E-47 2.52 22705344 | |
| 10 124214448 rs10490924-A 10:124214448 Age-related macular degeneration 8.00E-27 2.28 23577725 | |
| 10 124214448 rs10490924-T 10:124214448 Age-related macular degeneration (CNV vs. GA) 7.00E-14 1.38 22705344 | |
| 10 124215315 rs3750848-C 10:124215315 Age-related macular degeneration (extreme sampling) 3.00E-29 3.12 23577725 | |
| 10 124219275 rs3793917-G 10:124219275 Age-related macular degeneration 4.00E-60 3.4 20385819 | |
| 10 124219275 rs3793917-? 10:124219275 Age-related macular degeneration 1.00E-25 1.39 23326517 | |
| 10 124219275 rs3793917-? 10:124219275 Age-related macular degeneration 4.00E-24 1.45 23326517 | |
| 10 124220544 rs11200638-A 10:124220544 Age-related macular degeneration (wet) 8.00E-12 1.6 17053108 | |
| 10 125222037 rs2282015-G x rs13050454-A 10:125222037 Venous thromboembolism (gene x gene interaction) 8.00E-10 1.5 23509962 | |
| 10 126426148 rs2629540-? 10:126426148 Cocaine dependence 4.00E-08 NR 23958962 | |
| 10 128777390 rs9733352-C 10:128777390 Apolipoprotein Levels 4.00E-08 0.06 23031429 | |
| 10 131426022 rs477692-? 10:131426022 Response to temozolomide 1.00E-08 NR 23047291 | |
| 10 132747887 rs10829848-T 10:132747887 Insulin-related traits 3.00E-08 0.3 22791750 | |
| 10 133172119 rs10734105-G 10:133172119 Crohn's disease 3.00E-08 1.27 22412388 | |
| 10 135197336 rs11101730-A 10:135197336 Blood metabolite levels 3.00E-13 0.06 24816252 | |
| 11 202856 rs11602954-G 11:202856 Mean platelet volume 1.00E-14 0.01 19820697 | |
| 11 202856 rs11602954-G 11:202856 Platelet counts 5.00E-12 6.46 24026423 | |
| 11 203788 rs2280543-G 11:203788 Uterine fibroids 4.00E-12 1.39 21460842 | |
| 11 243268 rs505404-G 11:243268 Platelet counts 7.00E-25 4.66 22139419 | |
| 11 270715 rs17655730-T 11:270715 Mean platelet volume 2.00E-15 0.01 22139419 | |
| 11 589564 rs4963128-? 11:589564 Systemic lupus erythematosus 3.00E-10 1.28 18204446 | |
| 11 1093945 rs7934606-T 11:1093945 Interstitial lung disease 7.00E-34 1.52 23583980 | |
| 11 1241221 rs35705950-T 11:1241221 Idiopathic pulmonary fibrosis 2.00E-50 2.43 24429156 | |
| 11 1325829 rs5743890-A 11:1325829 Idiopathic pulmonary fibrosis 3.00E-11 1.64 24429156 | |
| 11 1874072 rs907611-A 11:1874072 Ulcerative colitis 1.00E-10 1.08 21297633 | |
| 11 1874072 rs907611-A 11:1874072 Inflammatory bowel disease 3.00E-10 1.07 23128233 | |
| 11 1874072 rs907611-A 11:1874072 Bladder cancer 4.00E-08 1.15 24163127 | |
| 11 1909006 rs3817198-C 11:1909006 Breast cancer 2.00E-11 1.07 23535729 | |
| 11 1909006 rs3817198-C 11:1909006 Breast cancer 3.00E-09 1.07 17529967 | |
| 11 2024544 rs4930103-A 11:2024544 DNA methylation (parent-of-origin) 5.00E-16 NR 23725790 | |
| 11 2024544 rs4930103-G 11:2024544 DNA methylation (variation) 1.00E-14 NR 23725790 | |
| 11 2170143 rs1004446-G 11:2170143 Type 1 diabetes autoantibodies 3.00E-23 1.4 21829393 | |
| 11 2170143 rs1004446-C 11:2170143 Type 1 diabetes 4.00E-09 1.61 17632545 | |
| 11 2182224 rs689-? 11:2182224 Type 1 diabetes autoantibodies 5.00E-196 NR 21829393 | |
| 11 2213166 rs7111341-? 11:2213166 Type 1 diabetes 4.00E-48 NR 19430480 | |
| 11 2228952 rs7126629-C 11:2228952 Prostate cancer (early onset) 2.00E-08 1.44 24740154 | |
| 11 2233574 rs7127900-? 11:2233574 Prostate cancer 3.00E-33 1.22 19767753 | |
| 11 2311152 rs7944004-T 11:2311152 Chronic lymphocytic leukemia 2.00E-10 1.2 23770605 | |
| 11 2484803 rs2074238-T 11:2484803 QT interval 3.00E-17 7.88 19305408 | |
| 11 2489342 rs12296050-T 11:2489342 QT interval 3.00E-17 1.44 19305409 | |
| 11 2489342 rs12296050-T 11:2489342 Electrocardiographic traits 8.00E-11 13.16 20062063 | |
| 11 2502319 rs12576239-T 11:2502319 QT interval 1.00E-15 1.75 19305408 | |
| 11 2691471 rs231362-G 11:2691471 Type 2 diabetes 3.00E-13 1.08 20581827 | |
| 11 2810731 rs2237886-T 11:2810731 Height 2.00E-13 0.05 20881960 | |
| 11 2831541 rs8181588-A 11:2831541 Type 2 diabetes 5.00E-09 1.3 24101674 | |
| 11 2839751 rs2237892-C 11:2839751 Type 2 diabetes 2.00E-42 1.4 18711367 | |
| 11 2839751 rs2237892-C 11:2839751 Type 2 diabetes 4.00E-29 1.3 23945395 | |
| 11 2839751 rs2237892-C 11:2839751 Type 2 diabetes 1.00E-26 1.33 19401414 | |
| 11 2839751 rs2237892-T 11:2839751 Body mass index 9.00E-13 0.03 24861553 | |
| 11 2844216 rs163182-C 11:2844216 Type 2 diabetes 2.00E-17 1.28 21799836 | |
| 11 2847069 rs163184-G 11:2847069 Type 2 diabetes 2.00E-14 1.09 24509480 | |
| 11 2857194 rs2237895-C 11:2857194 Type 2 diabetes 1.00E-09 1.29 20174558 | |
| 11 2858546 rs2237897-C 11:2858546 Type 2 diabetes 1.00E-16 1.33 18711366 | |
| 11 2858546 rs2237897-C 11:2858546 Type 2 diabetes 9.00E-15 1.31 24390345 | |
| 11 3029089 rs7481584-A 11:3029089 Calcium levels 1.00E-10 0.02 24068962 | |
| 11 4790575 rs12788102-A 11:4790575 Malaria 2.00E-16 2.15 23717212 | |
| 11 5029703 rs2445284-G 11:5029703 Sickle cell anemia (haemolysis) 1.00E-29 0.82 23406172 | |
| 11 5225447 rs7950726-A 11:5225447 HbA2 levels 1.00E-11 NR 23043469 | |
| 11 5225635 rs11036238-? 11:5225635 Malaria 4.00E-11 1.59 19465909 | |
| 11 5230907 rs7120391-C 11:5230907 Red blood cell traits 5.00E-09 0.3 23696099 | |
| 11 5264146 rs2071348-? 11:5264146 Beta thalassemia/hemoglobin E disease 3.00E-15 4.05 20183929 | |
| 11 5303063 rs2213169-T 11:5303063 Mean corpuscular hemoglobin concentration 1.00E-13 0.22 23263863 | |
| 11 5303063 rs2213169-T 11:5303063 Hematology traits 5.00E-11 0.45 23263863 | |
| 11 5306509 rs4910742-A 11:5306509 Fetal hemoglobin levels 1.00E-21 0.58 18245381 | |
| 11 5306509 rs4910742-G 11:5306509 Inflammatory biomarkers 2.00E-09 NR 22291609 | |
| 11 5373251 rs5006884-A 11:5373251 Fetal hemoglobin levels 3.00E-08 0.16 20018918 | |
| 11 5471746 rs7948471-A 11:5471746 Sickle cell anemia (haemolysis) 3.00E-10 0.26 23406172 | |
| 11 5518156 rs372091-C 11:5518156 Malaria 6.00E-14 2.17 22895189 | |
| 11 7367095 rs10769780-? 11:7367095 Phospholipid levels (plasma) 3.00E-08 0.8 22359512 | |
| 11 7968359 rs878860-G 11:7968359 Atopic dermatitis 2.00E-22 1.31 23042114 | |
| 11 8252853 rs110419-A 11:8252853 Neuroblastoma 5.00E-16 1.34 21124317 | |
| 11 8252853 rs110419-A 11:8252853 Neuroblastoma 1.00E-13 1.32 22941191 | |
| 11 8604593 rs4929949-C 11:8604593 Body mass index 3.00E-09 0.06 20935630 | |
| 11 8639200 rs4929923-T 11:8639200 Menarche (age at onset) 1.00E-08 2.3 21102462 | |
| 11 8662516 rs11042023-C 11:8662516 Obesity 1.00E-11 1.07 23563607 | |
| 11 10350538 rs7129220-G 11:10350538 Systolic blood pressure 3.00E-12 0.62 21909115 | |
| 11 10368119 rs2957692-G 11:10368119 Circulating vasoactive peptide levels 1.00E-12 0.02 23381795 | |
| 11 10388782 rs2923084-G 11:10388782 HDL cholesterol 5.00E-08 0.03 24097068 | |
| 11 10388782 rs2923084-G 11:10388782 HDL cholesterol 5.00E-08 0.41 20686565 | |
| 11 10390581 rs6484218-A 11:10390581 "Schizophrenia, bipolar disorder and depression (combined)" 4.00E-08 NR 20713499 | |
| 11 12698040 rs7926971-A 11:12698040 Height 4.00E-10 0.02 20881960 | |
| 11 13293905 rs900145-C 11:13293905 Menarche (age at onset) 2.00E-08 2.3 21102462 | |
| 11 13361524 rs6486122-? 11:13361524 Plasminogen activator inhibitor type 1 levels (PAI-1) 2.00E-10 0.05 22990020 | |
| 11 14021639 rs2618516-T 11:14021639 Brain connectivity 6.00E-10 0 23471985 | |
| 11 14224346 rs11023139-? 11:14224346 Alzheimer's disease (cognitive decline) 7.00E-11 0.31 23535033 | |
| 11 14914878 rs10741657-? 11:14914878 Vitamin D insufficiency 3.00E-20 NR 20541252 | |
| 11 15694462 rs7117858-G 11:15694462 Bone mineral density (hip) 6.00E-10 0.09 19801982 | |
| 11 15710084 rs7108738-T 11:15710084 Bone mineral density 1.00E-32 0.08 22504420 | |
| 11 15710084 rs7108738-? 11:15710084 Bone mineral density 1.00E-15 NR 24249740 | |
| 11 16250183 rs1401454-T 11:16250183 Blood pressure 5.00E-10 0.45 23972371 | |
| 11 16902268 rs381815-T 11:16902268 Systolic blood pressure 2.00E-09 0.65 19430479 | |
| 11 16902268 rs381815-T 11:16902268 Blood pressure 3.00E-08 0.3 21909110 | |
| 11 17008605 rs11024102-G 11:17008605 Glaucoma (primary open-angle) 5.00E-12 1.22 22922875 | |
| 11 17160148 rs4356203-? 11:17160148 Schizophrenia or bipolar disorder 6.00E-09 NR 24280982 | |
| 11 17316029 rs1330-T 11:17316029 Height 5.00E-09 0.02 20881960 | |
| 11 17408630 rs5215-C 11:17408630 Type 2 diabetes 3.00E-11 1.08 24509480 | |
| 11 17408630 rs5215-C 11:17408630 Type 2 diabetes 5.00E-11 1.14 17463249 | |
| 11 17409572 rs5219-T 11:17409572 Type 2 diabetes 7.00E-11 1.14 17463248 | |
| 11 17409572 rs5219-? 11:17409572 Type 2 diabetes 1.00E-09 1.25 19056611 | |
| 11 18285774 rs4638289-A 11:18285774 Amyloid A serum levels 3.00E-53 0.31 21124955 | |
| 11 18323517 rs4353250-T 11:18323517 Amyloid A serum levels 2.00E-51 0.27 21124955 | |
| 11 18325146 rs2403254-T 11:18325146 Blood metabolite levels 1.00E-30 0.04 24816252 | |
| 11 18325146 rs2403254-T 11:18325146 Metabolic traits 1.00E-20 0.11 21886157 | |
| 11 18357270 rs4150581-A 11:18357270 Blood metabolite ratios 2.00E-37 0.04 24816252 | |
| 11 18370898 rs4150642-G 11:18370898 Amyloid A serum levels 3.00E-111 0.36 21124955 | |
| 11 18419806 rs2896526-G 11:18419806 Amyloid A serum levels 4.00E-22 0.22 21124955 | |
| 11 18632984 rs10128711-T 11:18632984 "Cholesterol, total" 1.00E-11 0.03 24097068 | |
| 11 18632984 rs10128711-T 11:18632984 "Cholesterol, total" 3.00E-08 1.06 20686565 | |
| 11 21565079 rs12279250-C 11:21565079 Thiazide-induced adverse metabolic effects in hypertensive patients 7.00E-09 28.2 23400010 | |
| 11 22105030 rs11026407-C 11:22105030 Plasma thyroid-stimulating hormone levels 2.00E-08 0.13 24722205 | |
| 11 27505677 rs10835187-C 11:27505677 "Bone mineral density (paediatric, skull)" 2.00E-17 0.13 24945404 | |
| 11 27505677 rs10835187-C 11:27505677 "Bone mineral density (paediatric, skull)" 3.00E-13 0.12 24945404 | |
| 11 27505677 rs10835187-T 11:27505677 Bone mineral density 5.00E-08 0.03 22504420 | |
| 11 27563382 rs988712-G 11:27563382 Obesity 5.00E-17 1.36 21708048 | |
| 11 27667202 rs925946-T 11:27667202 Body mass index 9.00E-10 3.85 19079260 | |
| 11 27667202 rs925946-T 11:27667202 Weight 4.00E-09 3.8 19079260 | |
| 11 27679916 rs6265-G 11:27679916 Body mass index 5.00E-10 4.58 19079260 | |
| 11 27679916 rs6265-C 11:27679916 Smoking behavior 2.00E-08 1.06 20418890 | |
| 11 27684517 rs11030104-A 11:27684517 Body mass index 2.00E-20 0.05 24861553 | |
| 11 27725986 rs10767664-A 11:27725986 Body mass index 5.00E-26 0.19 20935630 | |
| 11 27728539 rs2030323-C 11:27728539 Obesity 3.00E-22 1.12 23563607 | |
| 11 27728539 rs2030323-C 11:27728539 Obesity 5.00E-17 1.07 23563607 | |
| 11 27728539 rs2030323-C 11:27728539 Body mass index 4.00E-16 0.05 22344221 | |
| 11 27728539 rs2030323-C 11:27728539 Obesity 6.00E-11 1.13 23563607 | |
| 11 27728539 rs2030323-C 11:27728539 Body mass index 6.00E-10 1.18 23563607 | |
| 11 30382899 rs12294104-T 11:30382899 Menopause (age at onset) 1.00E-11 0.23 22267201 | |
| 11 30749090 rs963837-T 11:30749090 Renal function-related traits (eGRFcrea) 1.00E-09 0 22797727 | |
| 11 30749090 rs963837-T 11:30749090 Renal function-related traits (sCR) 3.00E-09 0 22797727 | |
| 11 30760335 rs3925584-? 11:30760335 Chronic kidney disease 8.00E-18 0.01 22479191 | |
| 11 30760335 rs3925584-C 11:30760335 Magnesium levels 5.00E-16 0.01 20700443 | |
| 11 30768678 rs10767873-C 11:30768678 Renal function-related traits (BUN) 5.00E-16 0.01 22797727 | |
| 11 30951674 rs163879-T 11:30951674 Bone mineral density 2.00E-11 0.04 22504420 | |
| 11 31210771 rs16921914-A 11:31210771 Bone mineral density (spine) 2.00E-09 0.08 19801982 | |
| 11 32364187 rs2057178-? 11:32364187 Tuberculosis 1.00E-12 NR 24057671 | |
| 11 32364187 rs2057178-? 11:32364187 Tuberculosis 3.00E-11 1.1 22306650 | |
| 11 34555191 rs836132-C 11:34555191 β2-Glycoprotein I (β2-GPI) plasma levels 5.00E-08 0.65 23279374 | |
| 11 34805849 rs7929679-G 11:34805849 Chronic obstructive pulmonary disease-related biomarkers 7.00E-09 NR 23144326 | |
| 11 34834204 rs12793173-C 11:34834204 Cystic fibrosis severity 1.00E-09 NR 21602797 | |
| 11 35280852 rs10768122-G 11:35280852 Vitiligo 2.00E-09 1.22 22561518 | |
| 11 43648368 rs4237643-T 11:43648368 Forced vital capacity 4.00E-08 16.67 24929828 | |
| 11 43728330 rs11037575-C 11:43728330 Neuroblastoma 5.00E-08 1.23 22941191 | |
| 11 44843134 rs11038167-? 11:44843134 Schizophrenia 1.00E-11 1.29 22037552 | |
| 11 45227567 rs17723470-T 11:45227567 Thyroid hormone levels 9.00E-11 0.07 23408906 | |
| 11 45250732 rs2863171-C 11:45250732 Forced vital capacity 9.00E-10 23.92 24929828 | |
| 11 45873091 rs11605924-? 11:45873091 Fasting glucose-related traits (interaction with BMI) 4.00E-15 NR 22581228 | |
| 11 45873091 rs11605924-A 11:45873091 Fasting glucose-related traits 1.00E-14 NR 20081858 | |
| 11 46722221 rs7932354-T 11:46722221 Bone mineral density 5.00E-18 0.05 22504420 | |
| 11 46722221 rs7932354-T 11:46722221 Bone mineral density (hip) 4.00E-09 0.07 19801982 | |
| 11 46743247 rs3136441-C 11:46743247 HDL cholesterol 7.00E-29 0.05 24097068 | |
| 11 46743247 rs3136441-C 11:46743247 HDL cholesterol 7.00E-29 0.05 24097068 | |
| 11 46743247 rs3136441-C 11:46743247 HDL cholesterol 3.00E-18 0.78 20686565 | |
| 11 47176005 rs747650-G 11:47176005 Acne (severe) 4.00E-09 1.24 24399259 | |
| 11 47275064 rs10838681-G 11:47275064 Metabolic syndrome 1.00E-09 0.08 22399527 | |
| 11 47286290 rs7120118-G 11:47286290 HDL cholesterol 4.00E-08 0.04 19060910 | |
| 11 47293799 rs10501320-G 11:47293799 Proinsulin levels 1.00E-88 NR 21873549 | |
| 11 47312892 rs10838687-T 11:47312892 Proinsulin levels 7.00E-12 NR 21873549 | |
| 11 47336320 rs7944584-A 11:47336320 Fasting glucose-related traits 2.00E-18 NR 20081858 | |
| 11 47336320 rs7944584-? 11:47336320 Fasting glucose-related traits (interaction with BMI) 4.00E-12 NR 22581228 | |
| 11 47373425 rs2856656-C 11:47373425 Thrombin generation potential phenotypes 5.00E-22 0.19 24357727 | |
| 11 47441513 rs10838708-G 11:47441513 Height 2.00E-09 1.15 23563607 | |
| 11 47557871 rs10838725-C 11:47557871 Alzheimer's disease (late onset) 1.00E-08 1.08 24162737 | |
| 11 47650993 rs3817334-T 11:47650993 Body mass index 2.00E-12 0.06 20935630 | |
| 11 47663049 rs10838738-G 11:47663049 Body mass index 5.00E-09 0.07 19079261 | |
| 11 48064194 rs138315285-A 11:48064194 Thrombin generation potential phenotypes 6.00E-11 35.81 24357727 | |
| 11 48091303 rs10838798-T 11:48091303 Height 7.00E-12 1.16 23563607 | |
| 11 48098280 rs10838801-A 11:48098280 Height 4.00E-12 0.03 20881960 | |
| 11 48333360 rs1483121-? 11:48333360 Fasting glucose-related traits (interaction with BMI) 2.00E-08 NR 22581228 | |
| 11 48518893 rs7395662-G 11:48518893 HDL cholesterol 6.00E-11 0.07 19060911 | |
| 11 49559172 rs1814175-T 11:49559172 Height 2.00E-08 0.02 20881960 | |
| 11 51414216 rs5017948-A 11:51414216 Height 3.00E-08 0.03 20881960 | |
| 11 51512088 rs11246602-C 11:51512088 HDL cholesterol 2.00E-10 0.03 24097068 | |
| 11 55862091 rs2945816-? 11:55862091 Phospholipid levels (plasma) 2.00E-08 0.8 22359512 | |
| 11 56175671 rs1945213-? 11:56175671 Acute lymphoblastic leukemia (childhood) 3.00E-08 1.3 22076464 | |
| 11 56175671 rs1945213-? 11:56175671 Acute lymphoblastic leukemia (childhood) 4.00E-08 NR 22076464 | |
| 11 57203009 rs11229030-C 11:57203009 Crohn's disease 8.00E-09 1.15 22412388 | |
| 11 58060192 rs12289961-T 11:58060192 Lymphoma 4.00E-08 1.29 23349640 | |
| 11 58339124 rs10896794-T 11:58339124 Inflammatory bowel disease 7.00E-10 1.08 23128233 | |
| 11 58472799 rs2507838-A 11:58472799 Body mass (lean) 2.00E-08 NR 23108985 | |
| 11 59224144 rs7943953-? 11:59224144 Odorant perception (β-ionone) 1.00E-31 14.75 23910658 | |
| 11 59633493 rs526934-? 11:59633493 Folate pathway vitamin levels 2.00E-10 0.05 19744961 | |
| 11 59837192 rs2298585-? 11:59837192 Vitamin B12 levels 3.00E-15 71.8 22367966 | |
| 11 59923508 rs983392-A 11:59923508 Alzheimer's disease (late onset) 6.00E-16 1.11 24162737 | |
| 11 59939307 rs610932-? 11:59939307 Alzheimer's disease 2.00E-14 1.11 21460840 | |
| 11 59940599 rs1019670-A 11:59940599 Fibrinogen 4.00E-09 0.01 23969696 | |
| 11 59997666 rs600550-T 11:59997666 Lipoprotein-associated phospholipase A2 activity and mass 2.00E-11 0.01 23118302 | |
| 11 60023087 rs1562990-? 11:60023087 Alzheimer's disease 4.00E-11 1.14 21627779 | |
| 11 60034429 rs4938933-? 11:60034429 Alzheimer's disease (late onset) 8.00E-12 1.12 21460841 | |
| 11 60760612 rs17824933-G 11:60760612 Multiple sclerosis 4.00E-09 1.18 19525953 | |
| 11 60776209 rs11230563-C 11:60776209 Inflammatory bowel disease 9.00E-13 1.09 23128233 | |
| 11 60793651 rs4939490-? 11:60793651 Multiple sclerosis 1.00E-09 1.3 21244703 | |
| 11 60832282 rs650258-G 11:60832282 Multiple sclerosis 2.00E-11 1.12 21833088 | |
| 11 61417472 rs1692120-A 11:61417472 Phospholipid levels (plasma) 1.00E-08 0.01 21829377 | |
| 11 61490486 rs198426-T 11:61490486 Phospholipid levels (plasma) 3.00E-09 0.02 21829377 | |
| 11 61551356 rs174535-T 11:61551356 Phospholipid levels (plasma) 1.00E-151 0.07 21829377 | |
| 11 61551356 rs174535-T 11:61551356 Blood metabolite levels 2.00E-94 0.06 24816252 | |
| 11 61551356 rs174535-T 11:61551356 Phospholipid levels (plasma) 6.00E-58 0.08 21829377 | |
| 11 61551356 rs174535-T 11:61551356 Blood metabolite levels 3.00E-36 0.04 24816252 | |
| 11 61551927 rs174536-A 11:61551927 Phospholipid levels (plasma) 1.00E-63 0.02 21829377 | |
| 11 61557803 rs102275-? 11:61557803 Metabolite levels 4.00E-264 NR 22916037 | |
| 11 61557803 rs102275-? 11:61557803 Phospholipid levels (plasma) 1.00E-203 0 22359512 | |
| 11 61557803 rs102275-T 11:61557803 Phospholipid levels (plasma) 8.00E-153 0.07 21829377 | |
| 11 61557803 rs102275-C 11:61557803 Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid) 7.00E-147 2.49 24823311 | |
| 11 61557803 rs102275-T 11:61557803 Phospholipid levels (plasma) 7.00E-64 0.02 21829377 | |
| 11 61557803 rs102275-C 11:61557803 Oleic acid (18:1n-9) plasma levels 2.00E-32 0.23 23362303 | |
| 11 61557803 rs102275-C 11:61557803 Stearic acid (18:0) plasma levels 1.00E-20 0.18 23362303 | |
| 11 61557803 rs102275-T 11:61557803 Palmitoleic acid (16:1n-7) plasma levels 7.00E-13 0.02 23362303 | |
| 11 61557803 rs102275-C 11:61557803 Crohn's disease 2.00E-11 1.08 21102463 | |
| 11 61560081 rs174538-A 11:61560081 Phospholipid levels (plasma) 5.00E-58 0.08 21829377 | |
| 11 61560081 rs174538-A 11:61560081 Blood metabolite levels 9.00E-14 0.03 24816252 | |
| 11 61564299 rs4246215-T 11:61564299 Phospholipid levels (plasma) 1.00E-139 0.07 21829377 | |
| 11 61564299 rs4246215-T 11:61564299 Phospholipid levels (plasma) 9.00E-60 0.02 21829377 | |
| 11 61564299 rs4246215-T 11:61564299 Phospholipid levels (plasma) 6.00E-55 0.08 21829377 | |
| 11 61564299 rs4246215-T 11:61564299 Inflammatory bowel disease 2.00E-15 1.08 23128233 | |
| 11 61564299 rs4246215-T 11:61564299 Platelet counts 3.00E-10 2.45 22139419 | |
| 11 61565908 rs174541-T 11:61565908 Metabolite levels 3.00E-09 0.28 23378610 | |
| 11 61569830 rs174546-T 11:61569830 LDL cholesterol 2.00E-39 0.05 24097068 | |
| 11 61569830 rs174546-T 11:61569830 Triglycerides 7.00E-38 0.05 24097068 | |
| 11 61569830 rs174546-T 11:61569830 "Cholesterol, total" 3.00E-37 0.05 24097068 | |
| 11 61569830 rs174546-T 11:61569830 HDL cholesterol 8.00E-28 0.04 24097068 | |
| 11 61569830 rs174546-T 11:61569830 Triglycerides 5.00E-24 3.82 20686565 | |
| 11 61569830 rs174546-C 11:61569830 "Cholesterol, total" 2.00E-22 1.78 20686565 | |
| 11 61569830 rs174546-T 11:61569830 LDL cholesterol 1.00E-21 1.71 20686565 | |
| 11 61570783 rs174547-? 11:61570783 Lipid metabolism phenotypes 8.00E-262 0.57 22286219 | |
| 11 61570783 rs174547-C 11:61570783 Metabolite levels 7.00E-179 36.3 20037589 | |
| 11 61570783 rs174547-T 11:61570783 Phospholipid levels (plasma) 4.00E-154 0.07 21829377 | |
| 11 61570783 rs174547-C 11:61570783 Metabolic traits 9.00E-116 0.18 21886157 | |
| 11 61570783 rs174547-T 11:61570783 Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid) 2.00E-72 0.02 24823311 | |
| 11 61570783 rs174547-T 11:61570783 Phospholipid levels (plasma) 3.00E-64 0.02 21829377 | |
| 11 61570783 rs174547-C 11:61570783 Triglycerides 2.00E-14 0.06 19060906 | |
| 11 61570783 rs174547-C 11:61570783 HDL cholesterol 2.00E-12 0.09 19060906 | |
| 11 61570783 rs174547-C 11:61570783 Resting heart rate 2.00E-09 6.2 20639392 | |
| 11 61571348 rs174548-C 11:61571348 Blood metabolite levels 1.00E-84 0.05 24816252 | |
| 11 61571348 rs174548-G 11:61571348 Triglycerides 5.00E-14 0.03 20864672 | |
| 11 61571348 rs174548-G 11:61571348 HDL cholesterol 1.00E-12 0.01 20864672 | |
| 11 61571348 rs174548-G 11:61571348 Hematology traits 4.00E-08 0.02 23303382 | |
| 11 61571348 rs174548-? 11:61571348 Metabolite levels 5.00E-08 NR 19043545 | |
| 11 61571382 rs174549-G 11:61571382 Metabolite levels 2.00E-30 NR 23281178 | |
| 11 61571382 rs174549-A 11:61571382 Heart rate 1.00E-22 0.36 23583979 | |
| 11 61571478 rs174550-T 11:61571478 Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid) 4.00E-274 1.47 24823311 | |
| 11 61571478 rs174550-T 11:61571478 Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid) 4.00E-140 0.05 24823311 | |
| 11 61571478 rs174550-T 11:61571478 Phospholipid levels (plasma) 1.00E-57 0.08 21829377 | |
| 11 61571478 rs174550-T 11:61571478 Blood metabolite levels 7.00E-24 0.04 24816252 | |
| 11 61571478 rs174550-T 11:61571478 Fasting glucose-related traits 2.00E-15 NR 20081858 | |
| 11 61571478 rs174550-T 11:61571478 Fasting glucose-related traits 5.00E-13 NR 20081858 | |
| 11 61571478 rs174550-? 11:61571478 Fasting glucose-related traits (interaction with BMI) 2.00E-09 NR 22581228 | |
| 11 61579760 rs174555-T 11:61579760 Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid) 5.00E-168 0.39 24823311 | |
| 11 61580635 rs174556-T 11:61580635 Blood metabolite levels 2.00E-22 0.04 24816252 | |
| 11 61595564 rs968567-T 11:61595564 Blood metabolite levels 2.00E-21 0.03 24816252 | |
| 11 61595564 rs968567-T 11:61595564 Blood metabolite levels 3.00E-19 0.04 24816252 | |
| 11 61595564 rs968567-C 11:61595564 Rheumatoid arthritis 2.00E-08 1.12 24390342 | |
| 11 61597212 rs174570-G 11:61597212 LDL cholesterol 4.00E-13 0.11 19060911 | |
| 11 61597212 rs174570-G 11:61597212 "Cholesterol, total" 2.00E-10 0.09 19060911 | |
| 11 61597972 rs1535-A 11:61597972 Phospholipid levels (plasma) 3.00E-152 0.07 21829377 | |
| 11 61597972 rs1535-A 11:61597972 Phospholipid levels (plasma) 3.00E-63 0.02 21829377 | |
| 11 61600342 rs174574-A 11:61600342 Phospholipid levels (plasma) 4.00E-55 0.08 21829377 | |
| 11 61603237 rs2727270-T 11:61603237 Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid) 3.00E-21 0.69 24823311 | |
| 11 61603358 rs2727271-A 11:61603358 Blood metabolite levels 3.00E-11 0.06 24816252 | |
| 11 61604814 rs174577-A 11:61604814 P wave duration 3.00E-08 0.74 24850809 | |
| 11 61605499 rs174578-A 11:61605499 Blood metabolite levels 6.00E-42 0.04 24816252 | |
| 11 61605499 rs174578-A 11:61605499 Blood metabolite levels 3.00E-24 0.03 24816252 | |
| 11 61623140 rs174601-T 11:61623140 Blood metabolite levels 8.00E-16 0.03 24816252 | |
| 11 61623140 rs174601-T 11:61623140 Liver enzyme levels (alkaline phosphatase) 3.00E-09 1.7 22001757 | |
| 11 61639573 rs174448-A 11:61639573 Phospholipid levels (plasma) 3.00E-60 0.05 21829377 | |
| 11 61639573 rs174448-A 11:61639573 Phospholipid levels (plasma) 7.00E-28 0.05 21829377 | |
| 11 61639573 rs174448-A 11:61639573 Phospholipid levels (plasma) 4.00E-25 0.01 21829377 | |
| 11 61655305 rs1000778-A 11:61655305 Sphingolipid levels 7.00E-13 0.62 19798445 | |
| 11 61663691 rs174468-A 11:61663691 Phospholipid levels (plasma) 3.00E-35 0.04 21829377 | |
| 11 61663691 rs174468-A 11:61663691 Phospholipid levels (plasma) 2.00E-17 0.05 21829377 | |
| 11 61663691 rs174468-A 11:61663691 Phospholipid levels (plasma) 1.00E-12 0.01 21829377 | |
| 11 61678754 rs174479-? 11:61678754 Sphingolipid levels 2.00E-14 0 22359512 | |
| 11 61711475 rs2521572-T 11:61711475 Phospholipid levels (plasma) 2.00E-09 0.05 21829377 | |
| 11 61722645 rs1109748-A 11:61722645 Phospholipid levels (plasma) 5.00E-09 0.05 21829377 | |
| 11 61795586 rs11230874-T 11:61795586 Phospholipid levels (plasma) 2.00E-08 0.07 21829377 | |
| 11 62103420 rs2463822-T 11:62103420 Chronic obstructive pulmonary disease-related biomarkers 1.00E-10 NR 23144326 | |
| 11 62186542 rs3741240-A 11:62186542 Chronic obstructive pulmonary disease-related biomarkers 1.00E-26 NR 23144326 | |
| 11 62197427 rs2077224-A 11:62197427 Chronic obstructive pulmonary disease-related biomarkers 2.00E-14 NR 23144326 | |
| 11 62199817 rs17157266-C 11:62199817 Chronic obstructive pulmonary disease-related biomarkers 1.00E-09 NR 23144326 | |
| 11 64048912 rs477895-T 11:64048912 Mean platelet volume 5.00E-08 4.19 22423221 | |
| 11 64097233 rs694739-A 11:64097233 Crohn's disease 6.00E-10 1.1 21102463 | |
| 11 64107477 rs479777-? 11:64107477 Sarcoidosis 3.00E-18 1.18 22837380 | |
| 11 64129722 rs538147-G 11:64129722 Primary biliary cirrhosis 2.00E-10 1.23 21399635 | |
| 11 64150370 rs559928-C 11:64150370 Inflammatory bowel disease 4.00E-11 1.1 23128233 | |
| 11 64331462 rs17300741-A 11:64331462 Uric acid levels 7.00E-14 0.06 19503597 | |
| 11 64334114 rs2078267-T 11:64334114 Urate levels 9.00E-38 0.07 23263486 | |
| 11 64334114 rs2078267-C 11:64334114 Urate levels 2.00E-26 6.8 20884846 | |
| 11 64357072 rs505802-T 11:64357072 Uric acid levels 2.00E-09 0.06 19503597 | |
| 11 64359221 rs12800450-T 11:64359221 Urate levels 3.00E-16 1.19 21768215 | |
| 11 64440920 rs506338-C 11:64440920 Urate levels 2.00E-31 0.23 20139978 | |
| 11 64464085 rs504915-T 11:64464085 Renal function-related traits (urea) 3.00E-63 0.23 22797727 | |
| 11 64478063 rs478607-A 11:64478063 Urate levels 4.00E-11 0.05 23263486 | |
| 11 64546391 rs606458-T 11:64546391 Urate levels 6.00E-11 0.18 21768215 | |
| 11 64557054 rs493573-A 11:64557054 Urate levels 2.00E-17 0.8 21768215 | |
| 11 65143892 rs34400381-A 11:65143892 Serum dimethylarginine levels (symmetric) 2.00E-10 0.36 24159190 | |
| 11 65249145 rs17146964-G 11:65249145 Vertical cup-disc ratio 4.00E-09 0.01 20548946 | |
| 11 65336819 rs3782089-T 11:65336819 Height 4.00E-13 0.06 20881960 | |
| 11 65391317 rs12801636-A 11:65391317 HDL cholesterol 3.00E-08 0.02 24097068 | |
| 11 65494260 rs478304-T 11:65494260 Acne (severe) 3.00E-11 1.2 24927181 | |
| 11 65551957 rs479844-G 11:65551957 Atopic dermatitis 1.00E-13 1.14 22197932 | |
| 11 65560620 rs642803-T 11:65560620 Urate levels 3.00E-13 0.04 23263486 | |
| 11 65583066 rs3903072-G 11:65583066 Breast cancer 9.00E-12 1.05 23535729 | |
| 11 65656564 rs2231884-T 11:65656564 Inflammatory bowel disease 3.00E-10 1.08 23128233 | |
| 11 65895166 rs564343-A 11:65895166 Obesity (early onset extreme) 2.00E-09 1.22 23563609 | |
| 11 66826160 rs7112925-T 11:66826160 Height 9.00E-10 0.02 20881960 | |
| 11 67421341 rs12288023-C 11:67421341 Serum metabolite levels 9.00E-16 0.27 24625756 | |
| 11 67931761 rs4930561-G 11:67931761 IgG glycosylation 9.00E-10 0.19 23382691 | |
| 11 67931761 rs4930561-G 11:67931761 IgG glycosylation 1.00E-08 0.17 23382691 | |
| 11 68192346 rs599083-G 11:68192346 Bone mineral density (spine) 5.00E-08 0.07 19801982 | |
| 11 68195104 rs525592-? 11:68195104 Bone mineral density 3.00E-11 NR 24249740 | |
| 11 68201295 rs3736228-T 11:68201295 Bone mineral density 2.00E-26 0.08 22504420 | |
| 11 68201295 rs3736228-T 11:68201295 Bone mineral density 6.00E-12 0.13 18455228 | |
| 11 68263370 rs12272917-T 11:68263370 "Bone mineral density (paediatric, skull)" 1.00E-10 0.11 24945404 | |
| 11 68263370 rs12272917-T 11:68263370 "Bone mineral density (paediatric, skull)" 2.00E-10 0.12 24945404 | |
| 11 68562328 rs17610395-? 11:68562328 Lipid metabolism phenotypes 8.00E-12 0.17 22286219 | |
| 11 68846399 rs35264875-T 11:68846399 Blond vs. brown hair color 4.00E-30 2.49 18488028 | |
| 11 68978580 rs11228565-A 11:68978580 Prostate cancer 7.00E-12 1.23 19767754 | |
| 11 68994497 rs7931342-G 11:68994497 Prostate cancer 2.00E-12 1.19 18264097 | |
| 11 68994667 rs10896449-G 11:68994667 Prostate cancer 2.00E-09 1.1 18264096 | |
| 11 68995958 rs7130881-? 11:68995958 Prostate cancer 8.00E-13 NR 19767753 | |
| 11 68995958 rs7130881-G 11:68995958 Prostate cancer 9.00E-09 1.31 21743057 | |
| 11 69239741 rs7105934-? 11:69239741 Renal cell carcinoma 8.00E-14 1.45 21131975 | |
| 11 69307695 rs537626-? 11:69307695 Breast cancer (early onset) 2.00E-15 1.29 24493630 | |
| 11 69328764 rs614367-T 11:69328764 Breast cancer 2.00E-63 1.21 23535729 | |
| 11 69328764 rs614367-T 11:69328764 Breast cancer 3.00E-15 1.15 20453838 | |
| 11 69328764 rs614367-? 11:69328764 Breast cancer (early onset) 1.00E-08 1.34 24493630 | |
| 11 69462910 rs603965-G 11:69462910 Multiple myeloma (IgH translocation) 2.00E-11 1.95 23502783 | |
| 11 69462910 rs603965-G 11:69462910 Multiple myeloma (IgH translocation) 8.00E-11 1.82 23502783 | |
| 11 71167449 rs12785878-? 11:71167449 Vitamin D insufficiency 2.00E-27 NR 20541252 | |
| 11 72373496 rs3781913-T 11:72373496 Rheumatoid arthritis 6.00E-10 1.12 22446963 | |
| 11 72432985 rs11603334-A 11:72432985 Proinsulin levels 3.00E-102 NR 21873549 | |
| 11 72432985 rs11603334-? 11:72432985 Fasting glucose-related traits (interaction with BMI) 2.00E-14 NR 22581228 | |
| 11 72433098 rs1552224-A 11:72433098 Type 2 diabetes 1.00E-22 1.14 20581827 | |
| 11 72863697 rs11235667-G 11:72863697 Crohn's disease 7.00E-09 1.46 23850713 | |
| 11 74345550 rs3824999-? 11:74345550 Colorectal cancer 4.00E-10 1.08 22634755 | |
| 11 75276178 rs606452-C 11:75276178 Height 2.00E-09 0.04 22021425 | |
| 11 75282052 rs634552-T 11:75282052 Height 4.00E-13 0.04 20881960 | |
| 11 75455021 rs499974-A 11:75455021 HDL cholesterol 1.00E-08 0.03 24097068 | |
| 11 75909619 rs4944092-G 11:75909619 PR interval 3.00E-08 1.19 20062060 | |
| 11 76270683 rs7130588-G 11:76270683 Atopic dermatitis 4.00E-13 1.29 23886662 | |
| 11 76270683 rs7130588-G 11:76270683 Asthma 2.00E-08 1.09 21907864 | |
| 11 76299194 rs2155219-T 11:76299194 Inflammatory bowel disease 4.00E-36 1.15 23128233 | |
| 11 76299194 rs2155219-T 11:76299194 Self-reported allergy 2.00E-19 0.11 23817569 | |
| 11 76299194 rs2155219-T 11:76299194 Allergic sensitization 1.00E-18 1.18 23817571 | |
| 11 76299194 rs2155219-T 11:76299194 Ulcerative colitis 5.00E-16 1.13 21297633 | |
| 11 76299194 rs2155219-T 11:76299194 IgE grass sensitization 1.00E-08 1.22 22036096 | |
| 11 76299194 rs2155219-T 11:76299194 Allergic rhinitis 4.00E-08 1.17 22036096 | |
| 11 76301316 rs7927894-A 11:76301316 Atopic dermatitis 8.00E-10 1.22 19349984 | |
| 11 76301316 rs7927894-T 11:76301316 Crohn's disease 1.00E-09 1.16 18587394 | |
| 11 76301375 rs7927997-T 11:76301375 Crohn's disease 6.00E-13 1.17 21102463 | |
| 11 78091150 rs2373115-G 11:78091150 Alzheimer's disease (late onset) 1.00E-10 4.06 17553421 | |
| 11 78095373 rs10899489-A 11:78095373 Menarche (age at onset) 8.00E-09 3.1 21102462 | |
| 11 79077193 rs12576775-? 11:79077193 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 4.00E-08 NR 23453885 | |
| 11 79077193 rs12576775-G 11:79077193 Bipolar disorder 4.00E-08 1.14 21926972 | |
| 11 79083620 rs12290811-A 11:79083620 Bipolar disorder 1.00E-09 1.19 24618891 | |
| 11 83620787 rs790356-G 11:83620787 Wilms tumor 4.00E-15 1.28 22544364 | |
| 11 85017476 rs17148090-? 11:85017476 Phospholipid levels (plasma) 4.00E-08 0.7 22359512 | |
| 11 85677471 rs17817600-? 11:85677471 Alzheimer's disease 2.00E-08 1.33 22832961 | |
| 11 85787824 rs536841-? 11:85787824 Alzheimer's disease 3.00E-09 1.16 21627779 | |
| 11 85800279 rs561655-? 11:85800279 Alzheimer's disease (late onset) 7.00E-11 1.15 21460841 | |
| 11 85867875 rs10792832-G 11:85867875 Alzheimer's disease (late onset) 9.00E-26 1.15 24162737 | |
| 11 85868640 rs3851179-? 11:85868640 Alzheimer's disease 1.00E-09 1.16 19734902 | |
| 11 86853997 rs597319-G 11:86853997 Bone properties (heel) 5.00E-26 0.07 24430505 | |
| 11 86853997 rs597319-G 11:86853997 Bone properties (heel) 8.00E-14 0.06 24430505 | |
| 11 87125438 rs6592362-A 11:87125438 Inflammatory bowel disease 2.00E-08 1.08 23128233 | |
| 11 88557991 rs10831496-G 11:88557991 Tanning 5.00E-09 0.14 19340012 | |
| 11 88911696 rs1042602-C 11:88911696 Freckles 2.00E-11 1.32 17952075 | |
| 11 88911696 rs1042602-C 11:88911696 Skin pigmentation 4.00E-10 4.36 17999355 | |
| 11 89005253 rs1847134-A 11:89005253 Eye color 1.00E-15 1.58 20585627 | |
| 11 89011046 rs1393350-G 11:89011046 Vitiligo 2.00E-18 1.53 20410501 | |
| 11 89011046 rs1393350-A 11:89011046 Melanoma 2.00E-14 1.29 19578364 | |
| 11 89011046 rs1393350-A 11:89011046 Melanoma 2.00E-13 1.3 21983787 | |
| 11 89011046 rs1393350-A 11:89011046 Tanning 2.00E-13 0.19 19340012 | |
| 11 89011046 rs1393350-A 11:89011046 Blue vs. green eyes 3.00E-12 1.52 17952075 | |
| 11 89011046 rs1393350-A 11:89011046 Eye color 3.00E-09 0.28 20585627 | |
| 11 89017961 rs1126809-G 11:89017961 Tanning 5.00E-21 0.12 23548203 | |
| 11 89017961 rs1126809-G 11:89017961 Sunburns 2.00E-08 0.6 23548203 | |
| 11 89148372 rs7130284-T 11:89148372 Homocysteine levels 2.00E-20 0.12 23824729 | |
| 11 89201627 rs957140-A 11:89201627 Homocysteine levels 2.00E-08 0.05 23824729 | |
| 11 89875437 rs11018874-G 11:89875437 White blood cell types 2.00E-09 0.08 21738478 | |
| 11 92651002 rs7950811-A 11:92651002 Conduct disorder (symptom count) 1.00E-08 0.16 20585324 | |
| 11 92673828 rs1387153-T 11:92673828 Fasting plasma glucose 2.00E-36 0.07 19060909 | |
| 11 92673828 rs1387153-T 11:92673828 Type 2 diabetes 8.00E-15 1.09 20581827 | |
| 11 92673828 rs1387153-T 11:92673828 Glycated hemoglobin levels 4.00E-11 0.03 20858683 | |
| 11 92673828 rs1387153-C 11:92673828 Metabolic syndrome (bivariate traits) 2.00E-09 0.21 21386085 | |
| 11 92673828 rs1387153-C 11:92673828 Metabolic syndrome (bivariate traits) 8.00E-09 0.19 21386085 | |
| 11 92681013 rs10830956-C 11:92681013 Metabolic syndrome (bivariate traits) 5.00E-11 0.2 21386085 | |
| 11 92690032 rs7936247-T 11:92690032 Glycemic traits (pregnancy) 3.00E-16 0.22 23903356 | |
| 11 92690032 rs7936247-T 11:92690032 Glycemic traits (pregnancy) 2.00E-12 0 23903356 | |
| 11 92691532 rs2166706-G 11:92691532 Fasting plasma glucose 2.00E-09 0.07 19651812 | |
| 11 92698427 rs10830962-C 11:92698427 Metabolite levels 1.00E-16 0.04 21909109 | |
| 11 92698427 rs10830962-G 11:92698427 Metabolic syndrome 5.00E-16 0.12 22399527 | |
| 11 92698427 rs10830962-G 11:92698427 Diabetes (gestational) 2.00E-13 1.45 22233651 | |
| 11 92698427 rs10830962-C 11:92698427 Glycemic traits 5.00E-13 0.04 23575436 | |
| 11 92698427 rs10830962-C 11:92698427 Glycemic traits 3.00E-12 0.19 23575436 | |
| 11 92708710 rs10830963-G 11:92708710 Fasting glucose-related traits 6.00E-175 NR 20081858 | |
| 11 92708710 rs10830963-? 11:92708710 Fasting glucose-related traits (interaction with BMI) 4.00E-105 NR 22581228 | |
| 11 92708710 rs10830963-G 11:92708710 Fasting plasma glucose 3.00E-50 0.07 19060907 | |
| 11 92708710 rs10830963-G 11:92708710 Fasting glucose-related traits 3.00E-43 NR 20081858 | |
| 11 92708710 rs10830963-G 11:92708710 Fasting plasma glucose 1.00E-12 1.38 22508271 | |
| 11 92708710 rs10830963-? 11:92708710 Metabolite levels 3.00E-11 0.14 22286219 | |
| 11 92708710 rs10830963-G 11:92708710 Obesity-related traits 4.00E-08 0.05 23251661 | |
| 11 92784203 rs7931462-G 11:92784203 DNA methylation (parent-of-origin) 2.00E-09 NR 23725790 | |
| 11 92792100 rs7120482-? 11:92792100 Adverse response to radiation therapy 5.00E-08 3.1 23719583 | |
| 11 95311422 rs4409785-C 11:95311422 Vitiligo 2.00E-13 1.34 22561518 | |
| 11 95311422 rs4409785-C 11:95311422 Rheumatoid arthritis 1.00E-11 1.12 24390342 | |
| 11 95311422 rs4409785-C 11:95311422 Rheumatoid arthritis 4.00E-09 1.12 24390342 | |
| 11 95866700 rs10765792-? 11:95866700 Sudden cardiac arrest 8.00E-13 1.54 21658281 | |
| 11 95995448 rs11021504-A 11:95995448 Height 8.00E-09 0.08 23456168 | |
| 11 96023427 rs483905-A 11:96023427 Ulcerative colitis 1.00E-08 1.06 23128233 | |
| 11 100173537 rs11223581-G 11:100173537 Immune reponse to smallpox (secreted IL-2) 9.00E-09 NR 22610502 | |
| 11 100593538 rs633185-G 11:100593538 Systolic blood pressure 1.00E-17 0.57 21909115 | |
| 11 100593538 rs633185-G 11:100593538 Diastolic blood pressure 2.00E-15 0.33 21909115 | |
| 11 100593538 rs633185-G 11:100593538 Hypertension 5.00E-11 0.07 21909115 | |
| 11 100593538 rs633185-G 11:100593538 Blood pressure 7.00E-10 0.33 21909110 | |
| 11 102070639 rs1894116-G 11:102070639 Polycystic ovary syndrome 1.00E-22 1.27 22885925 | |
| 11 102401661 rs11568818-A 11:102401661 Prostate cancer 2.00E-11 1.1 23535732 | |
| 11 102691482 rs11225434-C 11:102691482 Matrix metalloproteinase levels 9.00E-29 0.39 20031604 | |
| 11 102695108 rs495366-A 11:102695108 Matrix metalloproteinase levels 6.00E-34 0.44 20031604 | |
| 11 102720945 rs626750-G 11:102720945 Chronic obstructive pulmonary disease (severe) 3.00E-09 NR 24621683 | |
| 11 103660567 rs974819-T 11:103660567 Coronary heart disease 2.00E-09 1.07 21378988 | |
| 11 104334239 rs11226373-G 11:104334239 Matrix metalloproteinase levels 2.00E-18 0.44 20031604 | |
| 11 105556598 rs11601239-C 11:105556598 Refractive error 6.00E-09 0.1 23396134 | |
| 11 108175462 rs1801516-? 11:108175462 Melanoma 3.00E-09 1.19 21983787 | |
| 11 108283161 rs11212617-A 11:108283161 Response to metformin 3.00E-09 NR 21845381 | |
| 11 108283161 rs11212617-C 11:108283161 Response to metformin in type 2 diabetes (glycemic) 3.00E-09 1.35 21186350 | |
| 11 110913240 rs4938174-A 11:110913240 Corneal structure 4.00E-09 0.06 23291589 | |
| 11 111171709 rs3802842-C 11:111171709 Colorectal cancer 6.00E-10 1.11 18372901 | |
| 11 111275133 rs4938534-A 11:111275133 Primary biliary cirrhosis 2.00E-08 1.39 23000144 | |
| 11 112023827 rs1834481-G 11:112023827 Interleukin-18 levels 1.00E-08 NR 20150558 | |
| 11 112051169 rs2115763-T 11:112051169 Interleukin-18 levels 4.00E-09 NR 20150558 | |
| 11 112064431 rs7105056-A 11:112064431 Immune reponse to smallpox (secreted IL-12p40) 1.00E-08 NR 22610502 | |
| 11 112085316 rs2250417-T 11:112085316 Inflammatory biomarkers 2.00E-32 0.1 24182552 | |
| 11 112085316 rs2250417-? 11:112085316 Protein quantitative trait loci 7.00E-13 NR 18464913 | |
| 11 112991618 rs1436109-? 11:112991618 Cardiac muscle measurement 4.00E-09 NR 21212386 | |
| 11 114386830 rs561722-C 11:114386830 Ulcerative colitis 5.00E-17 1.12 23128233 | |
| 11 114431956 rs678170-A 11:114431956 Ulcerative colitis 5.00E-14 1.09 21297633 | |
| 11 116584987 rs4938303-T 11:116584987 Triglycerides 4.00E-21 0.07 20864672 | |
| 11 116586283 rs7350481-G 11:116586283 Triglycerides 1.00E-49 0.24 20139978 | |
| 11 116586283 rs7350481-T 11:116586283 Hematological and biochemical traits 9.00E-10 0.12 20139978 | |
| 11 116603724 rs12272004-C 11:116603724 LDL cholesterol 5.00E-13 0.18 19060911 | |
| 11 116603724 rs12272004-C 11:116603724 Triglycerides 5.00E-13 0.18 19060911 | |
| 11 116603724 rs12272004-A 11:116603724 Carotenoid and tocopherol levels 8.00E-10 0.07 19185284 | |
| 11 116607437 rs1558861-C 11:116607437 Triglycerides 2.00E-26 17 18193046 | |
| 11 116617240 rs11216126-C 11:116617240 HDL cholesterol 3.00E-34 0.03 21909109 | |
| 11 116619073 rs28927680-G 11:116619073 Triglycerides 2.00E-17 0.26 18193044 | |
| 11 116626258 rs11825181-A 11:116626258 Blood metabolite levels 3.00E-11 0.08 24816252 | |
| 11 116626258 rs11825181-A 11:116626258 Triglycerides-Blood Pressure (TG-BP) 3.00E-09 0.32 21386085 | |
| 11 116633862 rs11820589-A 11:116633862 Metabolic syndrome (bivariate traits) 6.00E-09 0.32 21386085 | |
| 11 116639104 rs10790162-A 11:116639104 Waist Circumference - Triglycerides (WC-TG) 7.00E-16 0.39 21386085 | |
| 11 116639104 rs10790162-A 11:116639104 HDL Cholesterol - Triglycerides (HDLC-TG) 3.00E-15 0.38 21386085 | |
| 11 116639104 rs10790162-A 11:116639104 Metabolic syndrome 5.00E-09 0.25 21386085 | |
| 11 116647607 rs2160669-? 11:116647607 Triglycerides 3.00E-128 NR 24097068 | |
| 11 116648917 rs964184-G 11:116648917 Triglycerides 7.00E-240 16.95 20686565 | |
| 11 116648917 rs964184-C 11:116648917 Triglycerides 7.00E-224 0.23 24097068 | |
| 11 116648917 rs964184-G 11:116648917 Triglycerides 4.00E-62 0.3 19060906 | |
| 11 116648917 rs964184-G 11:116648917 "Cholesterol, total" 6.00E-57 4.68 20686565 | |
| 11 116648917 rs964184-C 11:116648917 "Cholesterol, total" 3.00E-55 0.12 24097068 | |
| 11 116648917 rs964184-C 11:116648917 HDL cholesterol 6.00E-48 0.11 24097068 | |
| 11 116648917 rs964184-G 11:116648917 HDL cholesterol 5.00E-47 1.5 20686565 | |
| 11 116648917 rs964184-? 11:116648917 Hypertriglyceridemia 5.00E-35 1.77 23505323 | |
| 11 116648917 rs964184-G 11:116648917 Triglycerides 4.00E-33 0.16 23726366 | |
| 11 116648917 rs964184-G 11:116648917 Triglycerides 6.00E-33 1.89 24886709 | |
| 11 116648917 rs964184-G 11:116648917 Metabolic syndrome 3.00E-31 0.23 22399527 | |
| 11 116648917 rs964184-G 11:116648917 LDL cholesterol 1.00E-26 2.85 20686565 | |
| 11 116648917 rs964184-C 11:116648917 LDL cholesterol 2.00E-26 0.09 24097068 | |
| 11 116648917 rs964184-G 11:116648917 Hypertriglyceridemia 5.00E-24 3.28 20657596 | |
| 11 116648917 rs964184-? 11:116648917 Metabolite levels 8.00E-20 NR 22916037 | |
| 11 116648917 rs964184-G 11:116648917 Coronary heart disease 1.00E-17 1.13 21378990 | |
| 11 116648917 rs964184-C 11:116648917 Blood metabolite levels 8.00E-15 0.03 24816252 | |
| 11 116648917 rs964184-G 11:116648917 HDL cholesterol 1.00E-12 0.17 19060906 | |
| 11 116648917 rs964184-G 11:116648917 HDL cholesterol 3.00E-12 0.05 23726366 | |
| 11 116648917 rs964184-G 11:116648917 Response to Vitamin E supplementation 3.00E-12 0.07 22437554 | |
| 11 116648917 rs964184-G 11:116648917 Vitamin E levels 8.00E-12 0.04 21729881 | |
| 11 116648917 rs964184-G 11:116648917 HDL cholesterol 2.00E-11 0.03 20864672 | |
| 11 116648917 rs964184-C 11:116648917 Lipoprotein-associated phospholipase A2 activity and mass 8.00E-11 0.03 22003152 | |
| 11 116648917 rs964184-? 11:116648917 Phospholipid levels (plasma) 2.00E-10 1 22359512 | |
| 11 116648917 rs964184-? 11:116648917 Coronary artery disease or large artery stroke 9.00E-10 NR 24262325 | |
| 11 116649135 rs11823543-A 11:116649135 Triglycerides-Blood Pressure (TG-BP) 3.00E-09 0.35 21386085 | |
| 11 116652207 rs12286037-T 11:116652207 Triglycerides 1.00E-26 25.82 18193043 | |
| 11 116652207 rs12286037-C 11:116652207 Metabolic syndrome (bivariate traits) 1.00E-08 0.32 21386085 | |
| 11 116652207 rs12286037-T 11:116652207 Lipoprotein-associated phospholipase A2 activity and mass 4.00E-08 6.4 20442857 | |
| 11 116652423 rs6589566-C 11:116652423 Triglycerides 5.00E-14 0.21 23726366 | |
| 11 116652423 rs6589566-G 11:116652423 LDL cholesterol 3.00E-11 NR 18179892 | |
| 11 116653296 rs2075290-C 11:116653296 Waist Circumference - Triglycerides (WC-TG) 1.00E-16 0.41 21386085 | |
| 11 116653296 rs2075290-C 11:116653296 HDL Cholesterol - Triglycerides (HDLC-TG) 2.00E-14 0.39 21386085 | |
| 11 116653296 rs2075290-C 11:116653296 Metabolic syndrome 2.00E-09 0.26 21386085 | |
| 11 116654435 rs603446-T 11:116654435 Triglycerides 2.00E-86 0.09 21909109 | |
| 11 116657561 rs3741298-G 11:116657561 Obesity-related traits 3.00E-08 0.04 23251661 | |
| 11 116660686 rs2266788-A 11:116660686 Waist Circumference - Triglycerides (WC-TG) 2.00E-16 0.41 21386085 | |
| 11 116660686 rs2266788-C 11:116660686 HDL Cholesterol - Triglycerides (HDLC-TG) 5.00E-13 0.39 21386085 | |
| 11 116660686 rs2266788-C 11:116660686 Metabolic syndrome 2.00E-09 0.26 21386085 | |
| 11 116660686 rs2266788-C 11:116660686 Triglycerides-Blood Pressure (TG-BP) 4.00E-08 0.37 21386085 | |
| 11 116662579 rs651821-C 11:116662579 Lipid traits 2.00E-59 0.17 24386095 | |
| 11 116662579 rs651821-? 11:116662579 Triglycerides 9.00E-26 NR 22171074 | |
| 11 116662579 rs651821-? 11:116662579 Lipid metabolism phenotypes 8.00E-20 0.27 22286219 | |
| 11 116663707 rs662799-A 11:116663707 Lipid traits 6.00E-24 0.14 24023260 | |
| 11 116684028 rs7396835-T 11:116684028 Quantitative traits 1.00E-09 0.23 19197348 | |
| 11 116706047 rs12721025-A 11:116706047 Infantile hypertrophic pyloric stenosis 2.00E-10 1.59 23989729 | |
| 11 116722041 rs10047462-T 11:116722041 Iron status biomarkers 4.00E-25 0.04 21149283 | |
| 11 116732512 rs2075292-G 11:116732512 Triglycerides 5.00E-08 8.7 18193046 | |
| 11 116807343 rs139961185-A 11:116807343 Triglycerides 7.00E-09 1.44 24886709 | |
| 11 116884789 rs11216230-A 11:116884789 HDL cholesterol 3.00E-10 0.22 24886709 | |
| 11 117037361 rs7112513-? 11:117037361 Protein quantitative trait loci 6.00E-09 NR 18464913 | |
| 11 117075566 rs508487-T 11:117075566 Cardiovascular disease risk factors 2.00E-10 0.24 21943158 | |
| 11 117091609 rs236918-C 11:117091609 Iron status biomarkers 1.00E-27 0.04 21149283 | |
| 11 117531731 rs10892151-A 11:117531731 Triglycerides 3.00E-29 NR 19074352 | |
| 11 118477367 rs498872-? 11:118477367 Glioma 5.00E-11 1.22 21531791 | |
| 11 118477367 rs498872-T 11:118477367 Glioma 1.00E-08 1.18 19578367 | |
| 11 118486067 rs11603023-T 11:118486067 "Cholesterol, total" 1.00E-08 0.02 24097068 | |
| 11 118549582 rs507080-A 11:118549582 Serum metabolite levels 3.00E-30 0.51 24625756 | |
| 11 118573519 rs4639966-G 11:118573519 Systemic lupus erythematosus 1.00E-16 1.29 19838193 | |
| 11 118574675 rs494459-T 11:118574675 Height 2.00E-08 0.02 20881960 | |
| 11 118611781 rs10892279-? 11:118611781 Celiac disease and Rheumatoid arthritis 1.00E-12 NR 21383967 | |
| 11 118698537 rs638893-C 11:118698537 Vitiligo 2.00E-09 1.22 22951725 | |
| 11 118729391 rs10790268-G 11:118729391 Rheumatoid arthritis 1.00E-17 1.17 24390342 | |
| 11 118729391 rs10790268-G 11:118729391 Rheumatoid arthritis 1.00E-15 1.14 24390342 | |
| 11 118743772 rs6421571-C 11:118743772 Primary biliary cirrhosis 3.00E-12 1.37 21399635 | |
| 11 118754353 rs630923-C 11:118754353 Inflammatory bowel disease 7.00E-09 1.07 23128233 | |
| 11 119099906 rs4938642-C 11:119099906 Platelet counts 8.00E-11 4.73 22139419 | |
| 11 121435587 rs11218343-T 11:121435587 Alzheimer's disease (late onset) 1.00E-14 1.3 24162737 | |
| 11 121435587 rs11218343-? 11:121435587 Alzheimer's disease (late onset) 2.00E-09 1.23 23565137 | |
| 11 121797897 rs1219414-? 11:121797897 Rheumatoid arthritis 5.00E-58 NR 21156761 | |
| 11 122522375 rs7941030-C 11:122522375 HDL cholesterol 1.00E-14 0.03 24097068 | |
| 11 122522375 rs7941030-C 11:122522375 "Cholesterol, total" 2.00E-14 0.03 24097068 | |
| 11 122522375 rs7941030-C 11:122522375 "Cholesterol, total" 2.00E-10 0.97 20686565 | |
| 11 122522375 rs7941030-G 11:122522375 HDL cholesterol 3.00E-08 0.31 20686565 | |
| 11 122870683 rs6589964-A 11:122870683 Menarche (age at onset) 2.00E-12 2.7 21102462 | |
| 11 123361397 rs735665-A 11:123361397 Chronic lymphocytic leukemia 4.00E-39 1.62 23770605 | |
| 11 123361397 rs735665-A 11:123361397 Chronic lymphocytic leukemia 4.00E-24 1.64 24292274 | |
| 11 123361397 rs735665-A 11:123361397 Chronic lymphocytic leukemia 3.00E-12 1.52 22700719 | |
| 11 123361397 rs735665-A 11:123361397 Chronic lymphocytic leukemia 4.00E-12 1.45 18758461 | |
| 11 123361397 rs735665-T 11:123361397 Follicular lymphoma 4.00E-09 1.81 20639881 | |
| 11 124539273 rs12282107-C 11:124539273 Serum metabolite levels 5.00E-14 0.29 24625756 | |
| 11 124606285 rs12807809-T 11:124606285 Schizophrenia 2.00E-09 1.15 19571808 | |
| 11 125826702 rs4937076-A 11:125826702 Primary tooth development (time to first tooth eruption) 4.00E-08 0.15 23704328 | |
| 11 126243952 rs11220462-A 11:126243952 LDL cholesterol 7.00E-21 0.06 24097068 | |
| 11 126243952 rs11220462-A 11:126243952 LDL cholesterol 1.00E-15 1.95 20686565 | |
| 11 126243952 rs11220462-A 11:126243952 "Cholesterol, total" 6.00E-15 0.05 24097068 | |
| 11 126243952 rs11220462-T 11:126243952 "Cholesterol, total" 2.00E-11 2.01 20686565 | |
| 11 126283785 rs2236653-T 11:126283785 Liver enzyme levels (alkaline phosphatase) 2.00E-09 1.5 22001757 | |
| 11 127761666 rs7927044-A 11:127761666 Asthma (childhood onset) 7.00E-09 0.16 22560479 | |
| 11 128311059 rs6590330-A 11:128311059 Systemic lupus erythematosus 2.00E-25 1.37 19838193 | |
| 11 128311059 rs6590330-A 11:128311059 Systemic lupus erythematosus 3.00E-08 1.51 23273568 | |
| 11 128328959 rs1128334-A 11:128328959 Systemic lupus erythematosus 2.00E-11 1.29 20169177 | |
| 11 128380974 rs11221332-A 11:128380974 Celiac disease 5.00E-16 1.21 20190752 | |
| 11 128496952 rs73013527-C 11:128496952 Rheumatoid arthritis 1.00E-10 1.09 24390342 | |
| 11 128582557 rs665440-? 11:128582557 Myopia (pathological) 2.00E-08 NR 23049088 | |
| 11 128586155 rs654723-A 11:128586155 Height 4.00E-11 0.03 20881960 | |
| 11 129461171 rs11820646-C 11:129461171 Breast cancer 1.00E-09 1.05 23535729 | |
| 11 130273230 rs11222084-T 11:130273230 Blood pressure 2.00E-11 0.34 21909110 | |
| 11 130817579 rs7940866-T 11:130817579 Schizophrenia 2.00E-09 1.09 23974872 | |
| 11 133392294 rs7117082-? 11:133392294 Amyotrophic lateral sclerosis (sporadic) 8.00E-09 2.79 24529757 | |
| 12 320920 rs499368-A 12:320920 Blood metabolite levels 8.00E-13 0.02 24816252 | |
| 12 320920 rs499368-A 12:320920 Metabolite levels 2.00E-10 0.36 23378610 | |
| 12 335922 rs555044-A 12:335922 Serum metabolite levels 1.00E-12 0.07 24625756 | |
| 12 349298 rs10774021-C 12:349298 Chronic kidney disease 1.00E-09 1.05 20383146 | |
| 12 351467 rs11613331-A 12:351467 Blood metabolite levels 2.00E-25 0.04 24816252 | |
| 12 355842 rs7969761-T 12:355842 Blood metabolite ratios 1.00E-27 0.05 24816252 | |
| 12 783484 rs12425791-A 12:783484 Stroke 1.00E-09 1.29 19369658 | |
| 12 1638171 rs2887571-A 12:1638171 Bone mineral density 6.00E-12 0.04 22504420 | |
| 12 2345295 rs1006737-? 12:2345295 Schizophrenia or bipolar disorder 6.00E-13 NR 24280982 | |
| 12 2345295 rs1006737-A 12:2345295 Schizophrenia 5.00E-12 1.1 23974872 | |
| 12 2345295 rs1006737-? 12:2345295 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 5.00E-09 1.07 23453885 | |
| 12 2345295 rs1006737-A 12:2345295 Bipolar disorder and major depressive disorder (combined) 3.00E-08 1.18 20351715 | |
| 12 2419896 rs4765913-A 12:2419896 Bipolar disorder 2.00E-08 1.14 21926972 | |
| 12 2523355 rs7312105-G 12:2523355 Red blood cell traits 3.00E-09 0.1 23222517 | |
| 12 4332478 rs10849023-C 12:4332478 Red blood cell traits 8.00E-12 0.01 23222517 | |
| 12 4333919 rs11611647-C 12:4333919 Red blood cell count 6.00E-09 0.07 20139978 | |
| 12 4368352 rs10774214-T 12:4368352 Colorectal cancer 1.00E-10 1.14 24836286 | |
| 12 4368352 rs10774214-T 12:4368352 Colorectal cancer 5.00E-10 1.17 23263487 | |
| 12 4368352 rs10774214-T 12:4368352 Colorectal cancer 3.00E-08 1.09 23263487 | |
| 12 4606168 rs2970818-A 12:4606168 Phosphorus levels 4.00E-09 0.05 20558539 | |
| 12 5797101 rs12579350-? 12:5797101 Panic disorder 4.00E-09 NR 19165232 | |
| 12 6153534 rs1063856-A 12:6153534 Coagulation factor levels 5.00E-16 0.12 23267103 | |
| 12 6289219 rs1558324-A 12:6289219 Mean platelet volume 2.00E-21 0.01 22139419 | |
| 12 6291093 rs7342306-G 12:6291093 Platelet counts 4.00E-11 2.53 22139419 | |
| 12 6385727 rs10849432-T 12:6385727 Colorectal cancer 6.00E-10 1.14 24836286 | |
| 12 6440009 rs1800693-G 12:6440009 Multiple sclerosis 4.00E-14 1.12 21833088 | |
| 12 6440009 rs1800693-C 12:6440009 Multiple sclerosis 2.00E-11 1.2 19525953 | |
| 12 6440009 rs1800693-C 12:6440009 Primary biliary cirrhosis 2.00E-09 1.22 21399635 | |
| 12 6502742 rs11616188-A 12:6502742 Ankylosing spondylitis 4.00E-12 NR 21743469 | |
| 12 7334813 rs7973719-C 12:7334813 IgG glycosylation 4.00E-08 0.18 23382691 | |
| 12 7691134 rs7136716-G 12:7691134 Hematological and biochemical traits 3.00E-26 0.17 20139978 | |
| 12 9082581 rs4883201-G 12:9082581 "Cholesterol, total" 2.00E-09 0.04 24097068 | |
| 12 9833628 rs3764021-C 12:9833628 Type 1 diabetes 5.00E-08 1.57 17554300 | |
| 12 9876091 rs10466829-A 12:9876091 Multiple sclerosis 1.00E-08 1.09 21833088 | |
| 12 9910164 rs4763879-A 12:9910164 Type 1 diabetes 2.00E-11 1.09 19430480 | |
| 12 10560957 rs2617170-T 12:10560957 Behcet's disease 1.00E-09 1.28 23291587 | |
| 12 11279092 rs1031391-? 12:11279092 Bitter taste perception 2.00E-19 0.23 23966204 | |
| 12 11855773 rs2856321-A 12:11855773 Height 5.00E-15 0.03 20881960 | |
| 12 11855773 rs2856321-G 12:11855773 Height 3.00E-11 1.14 23563607 | |
| 12 12657513 rs11612508-G 12:12657513 Inflammatory bowel disease 1.00E-08 1.06 23128233 | |
| 12 12773521 rs12822507-A 12:12773521 Systemic lupus erythematosus 2.00E-08 1.16 23273568 | |
| 12 12834894 rs10845606-C 12:12834894 Systemic lupus erythematosus 4.00E-17 1.27 23273568 | |
| 12 12870695 rs34330-C 12:12870695 Systemic lupus erythematosus 5.00E-12 1.19 23273568 | |
| 12 13872044 rs2268118-A 12:13872044 Immune reponse to smallpox (secreted IL-2) 1.00E-08 NR 22610502 | |
| 12 14413931 rs12422552-C 12:14413931 Breast cancer 4.00E-08 1.05 23535729 | |
| 12 14587301 rs3213764-G 12:14587301 Prostate-specific antigen levels 2.00E-09 0.05 23359319 | |
| 12 14653867 rs2900333-C 12:14653867 Testicular germ cell tumor 1.00E-13 1.32 23666240 | |
| 12 14653867 rs2900333-C 12:14653867 Testicular germ cell cancer 6.00E-10 1.27 20543847 | |
| 12 15735442 rs2300290-? 12:15735442 Cognitive function 1.00E-08 1.1 22126837 | |
| 12 20230639 rs10770612-G 12:20230639 Aortic root size 2.00E-08 0.03 19584346 | |
| 12 20473758 rs7134375-A 12:20473758 HDL cholesterol 1.00E-08 0.02 24097068 | |
| 12 20473758 rs7134375-A 12:20473758 HDL cholesterol 4.00E-08 0.4 20686565 | |
| 12 20498036 rs7955516-C 12:20498036 Adiponectin levels 4.00E-08 0.02 22479202 | |
| 12 20857467 rs10770705-A 12:20857467 Height 8.00E-18 0.03 20881960 | |
| 12 21017875 rs2417940-? 12:21017875 Bilirubin levels 7.00E-19 0.06 23371916 | |
| 12 21017875 rs2417940-? 12:21017875 Bilirubin levels 2.00E-17 0.05 20639394 | |
| 12 21017875 rs2417940-? 12:21017875 Bilirubin levels 2.00E-16 0.07 23371916 | |
| 12 21017875 rs2417940-? 12:21017875 Bilirubin levels 5.00E-13 0.06 23371916 | |
| 12 21074122 rs2117032-C 12:21074122 Bilirubin levels 3.00E-14 0.13 19419973 | |
| 12 21331549 rs4149056-T 12:21331549 Blood metabolite levels 1.00E-73 0.12 24816252 | |
| 12 21331549 rs4149056-T 12:21331549 Blood metabolite levels 9.00E-44 0.08 24816252 | |
| 12 21331549 rs4149056-T 12:21331549 Blood metabolite levels 3.00E-32 0.09 24816252 | |
| 12 21331549 rs4149056-T 12:21331549 Blood metabolite levels 1.00E-18 0.05 24816252 | |
| 12 21331549 rs4149056-T 12:21331549 Blood metabolite levels 3.00E-18 0.03 24816252 | |
| 12 21331549 rs4149056-C 12:21331549 Bilirubin levels 7.00E-13 0.05 19414484 | |
| 12 21331549 rs4149056-C 12:21331549 Response to statin therapy 2.00E-09 4.5 18650507 | |
| 12 21331549 rs4149056-T 12:21331549 Sex hormone-binding globulin levels 2.00E-08 0.03 22829776 | |
| 12 21352315 rs1871395-A 12:21352315 Blood metabolite levels 1.00E-89 0.11 24816252 | |
| 12 21352315 rs1871395-A 12:21352315 Blood metabolite levels 2.00E-52 0.09 24816252 | |
| 12 21352315 rs1871395-A 12:21352315 Blood metabolite levels 4.00E-31 0.04 24816252 | |
| 12 21352541 rs12317268-A 12:21352541 Blood metabolite levels 2.00E-67 0.14 24816252 | |
| 12 21352541 rs12317268-A 12:21352541 Blood metabolite levels 4.00E-60 0.1 24816252 | |
| 12 21352541 rs12317268-A 12:21352541 Blood metabolite levels 2.00E-45 0.05 24816252 | |
| 12 21368722 rs4363657-? 12:21368722 Bilirubin levels 5.00E-08 0.06 21646302 | |
| 12 21377559 rs4149080-C 12:21377559 Methotrexate clearance (acute lymphoblastic leukemia) 6.00E-21 12 23233662 | |
| 12 21378021 rs4149081-A 12:21378021 Metabolic traits 3.00E-22 0.21 21886157 | |
| 12 21382619 rs11045879-C 12:21382619 Metabolite levels 5.00E-15 NR 23281178 | |
| 12 21382619 rs11045879-T 12:21382619 Methotrexate phramacokinetics (acute lymphoblastic leukemia) 8.00E-11 1.8 19901119 | |
| 12 21388621 rs12829704-A 12:21388621 Blood metabolite levels 9.00E-21 0.04 24816252 | |
| 12 21993478 rs704178-G 12:21993478 Hippocampal sclerosis of aging 1.00E-09 2.13 24770881 | |
| 12 24184544 rs10842262-? 12:24184544 Non-obstructive azoospermia 2.00E-09 1.23 22197933 | |
| 12 24770878 rs17287293-A 12:24770878 Heart rate 3.00E-20 0.44 23583979 | |
| 12 24770878 rs17287293-G 12:24770878 Resting heart rate 2.00E-10 8.6 20639392 | |
| 12 24788339 rs11047543-A 12:24788339 PR interval 3.00E-13 2.09 20062060 | |
| 12 26453283 rs718314-? 12:26453283 Renal cell carcinoma 9.00E-10 1.19 22010048 | |
| 12 27984190 rs4420311-G 12:27984190 "Bone mineral density (paediatric, lower limb)" 3.00E-08 0.09 24945404 | |
| 12 27984190 rs4420311-G 12:27984190 "Bone mineral density (paediatric, total body less head)" 4.00E-08 0.09 24945404 | |
| 12 28017159 rs7953528-A 12:28017159 Bone mineral density 2.00E-12 0.05 22504420 | |
| 12 28017522 rs258415-? 12:28017522 White matter microstructure (global fractional anisotropy) 8.00E-10 NR 24736177 | |
| 12 28155080 rs10771399-A 12:28155080 Breast cancer 8.00E-31 1.16 23535729 | |
| 12 28155080 rs10771399-T 12:28155080 Breast cancer 2.00E-12 1.2 23535733 | |
| 12 28155080 rs10771399-G 12:28155080 "Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)" 2.00E-08 1.39 24325915 | |
| 12 28156081 rs12371778-G 12:28156081 Breast size 1.00E-08 0.16 22747683 | |
| 12 28534415 rs2638953-C 12:28534415 Height 7.00E-17 0.03 20881960 | |
| 12 28569714 rs10843164-T 12:28569714 Height 6.00E-12 1.16 23563607 | |
| 12 29435480 rs2015599-A 12:29435480 Mean platelet volume 6.00E-16 0.01 22139419 | |
| 12 33576990 rs7980799-A 12:33576990 Heart rate 6.00E-24 0.38 23583979 | |
| 12 39106731 rs826838-C 12:39106731 Heart rate 4.00E-09 0.23 23583979 | |
| 12 40428561 rs1994090-? 12:40428561 Parkinson's disease 3.00E-08 1.39 19915576 | |
| 12 40601940 rs11175593-T 12:40601940 Crohn's disease 3.00E-10 1.54 18587394 | |
| 12 40620808 rs1491942-? 12:40620808 Parkinson's disease 6.00E-15 1.17 22438815 | |
| 12 40620808 rs1491942-G 12:40620808 Parkinson's disease 6.00E-14 1.27 21292315 | |
| 12 40734202 rs34637584-A 12:40734202 Parkinson's disease 2.00E-28 9.62 21738487 | |
| 12 40757328 rs34778348-? 12:40757328 Parkinson's disease 3.00E-21 2.23 22438815 | |
| 12 40792300 rs11564258-A 12:40792300 Inflammatory bowel disease 6.00E-29 1.33 23128233 | |
| 12 40792300 rs11564258-A 12:40792300 Crohn's disease 6.00E-21 1.74 21102463 | |
| 12 41365640 rs1442190-? 12:41365640 Parkinson's disease 2.00E-27 3.72 24842889 | |
| 12 41721430 rs1880887-? 12:41721430 Protein quantitative trait loci 1.00E-10 NR 18464913 | |
| 12 44153826 rs4251424-A 12:44153826 Immune reponse to smallpox (secreted TNF-alpha) 2.00E-08 NR 22610502 | |
| 12 45774908 rs17095830-G 12:45774908 Ankylosing spondylitis 2.00E-08 1.29 22138694 | |
| 12 48208368 rs11168249-C 12:48208368 Inflammatory bowel disease 8.00E-09 1.05 23128233 | |
| 12 49474605 rs12821008-T 12:49474605 Bone mineral density 1.00E-15 0.05 22504420 | |
| 12 49676010 rs10875943-C 12:49676010 Prostate cancer 7.00E-12 1.07 21743467 | |
| 12 50226467 rs10875976-A 12:50226467 Obesity 2.00E-10 1.04 23563607 | |
| 12 50247468 rs7138803-A 12:50247468 Obesity 1.00E-20 1.09 23563607 | |
| 12 50247468 rs7138803-A 12:50247468 Body mass index 2.00E-17 0.12 20935630 | |
| 12 50247468 rs7138803-A 12:50247468 Obesity 1.00E-16 1.14 23563607 | |
| 12 50247468 rs7138803-A 12:50247468 Body mass index 2.00E-09 1.13 23563607 | |
| 12 50573433 rs34245511-C 12:50573433 Colorectal cancer 3.00E-08 1.14 24737748 | |
| 12 51134741 rs7968440-A 12:51134741 Fibrinogen 3.00E-08 0.01 23969696 | |
| 12 51155663 rs11169552-C 12:51155663 Colorectal cancer 2.00E-10 1.09 20972440 | |
| 12 52251272 rs7976059-T 12:52251272 Urate levels 2.00E-09 0.03 23263486 | |
| 12 53273904 rs902774-A 12:53273904 Prostate cancer 5.00E-09 1.17 21743057 | |
| 12 53727955 rs2016266-A 12:53727955 Bone mineral density 3.00E-20 0.05 22504420 | |
| 12 53727955 rs2016266-G 12:53727955 Bone mineral density (spine) 1.00E-08 0.07 19801982 | |
| 12 54417576 rs736825-C 12:54417576 Bone mineral density 8.00E-16 0.05 22504420 | |
| 12 54687232 rs10506328-C 12:54687232 Mean platelet volume 2.00E-09 0.09 24026423 | |
| 12 54712308 rs10876550-G 12:54712308 Mean platelet volume 2.00E-14 0.01 22139419 | |
| 12 54736470 rs4326844-A 12:54736470 Platelet counts 5.00E-08 8.68 23263863 | |
| 12 56114769 rs3138144-C 12:56114769 Refractive error 4.00E-12 0.12 23396134 | |
| 12 56364321 rs2069408-C 12:56364321 Asthma 1.00E-10 1.15 21804548 | |
| 12 56390636 rs705702-G 12:56390636 Polycystic ovary syndrome 9.00E-26 1.27 22885925 | |
| 12 56394954 rs773125-A 12:56394954 Rheumatoid arthritis 1.00E-10 1.09 24390342 | |
| 12 56394954 rs773125-A 12:56394954 Rheumatoid arthritis 2.00E-08 1.09 24390342 | |
| 12 56401085 rs10876864-G 12:56401085 Vitiligo 8.00E-12 1.18 22951725 | |
| 12 56412487 rs1701704-T 12:56412487 Type 1 diabetes autoantibodies 5.00E-18 1.25 21829393 | |
| 12 56412487 rs1701704-G 12:56412487 Asthma 2.00E-13 1.19 21804548 | |
| 12 56412487 rs1701704-C 12:56412487 Type 1 diabetes 9.00E-10 1.25 18198356 | |
| 12 56412487 rs1701704-C 12:56412487 Alopecia areata 3.00E-08 1.34 20596022 | |
| 12 56416928 rs2456973-C 12:56416928 Vitiligo 3.00E-14 1.29 22561518 | |
| 12 56470625 rs11171739-C 12:56470625 Type 1 diabetes 1.00E-11 1.34 17554300 | |
| 12 56482180 rs2292239-T 12:56482180 Type 1 diabetes autoantibodies 3.00E-27 1.3 21829393 | |
| 12 56482180 rs2292239-? 12:56482180 Type 1 diabetes 2.00E-25 NR 19430480 | |
| 12 56482180 rs2292239-A 12:56482180 Type 1 diabetes 2.00E-20 1.28 17554260 | |
| 12 56482180 rs2292239-A 12:56482180 Type 1 diabetes 3.00E-16 NR 18978792 | |
| 12 56680745 rs3816804-C 12:56680745 Height 3.00E-09 0.12 23456168 | |
| 12 56737973 rs2066808-A 12:56737973 Psoriasis 1.00E-09 1.34 19169254 | |
| 12 56740682 rs2066807-C 12:56740682 Height 1.00E-13 0.05 20881960 | |
| 12 56828056 rs11171846-A 12:56828056 Immune reponse to smallpox (secreted IFN-alpha) 6.00E-10 NR 22610502 | |
| 12 56863770 rs2657880-? 12:56863770 Metabolite levels 7.00E-30 NR 22916037 | |
| 12 56865056 rs2638315-? 12:56865056 Metabolite levels 2.00E-35 0.29 22286219 | |
| 12 56865338 rs2657879-A 12:56865338 Blood metabolite levels 6.00E-19 0.02 24816252 | |
| 12 56865338 rs2657879-A 12:56865338 Blood metabolite levels 6.00E-18 0.02 24816252 | |
| 12 56865338 rs2657879-G 12:56865338 Metabolic traits 3.00E-17 0.04 21886157 | |
| 12 56912864 rs2694917-T 12:56912864 Blood metabolite ratios 2.00E-29 0.02 24816252 | |
| 12 57023284 rs941207-G 12:57023284 Platelet counts 2.00E-10 2.75 22139419 | |
| 12 57055291 rs2950390-C 12:57055291 Mean platelet volume 7.00E-14 0.01 22139419 | |
| 12 57146069 rs2277339-G 12:57146069 Menopause (age at onset) 2.00E-19 0.38 22267201 | |
| 12 57489709 rs1059513-T 12:57489709 Allergic sensitization 1.00E-14 1.3 23817571 | |
| 12 57489709 rs1059513-C 12:57489709 IgE levels 2.00E-12 0.12 22075330 | |
| 12 57527283 rs11172113-? 12:57527283 Migraine 4.00E-19 1.11 23793025 | |
| 12 57527283 rs11172113-? 12:57527283 Migraine without aura 1.00E-10 1.15 23793025 | |
| 12 57527283 rs11172113-T 12:57527283 Migraine 4.00E-09 1.11 21666692 | |
| 12 57527283 rs11172113-T 12:57527283 Pulmonary function 1.00E-08 0.03 21946350 | |
| 12 57527283 rs11172113-? 12:57527283 Migraine 3.00E-08 1.16 22683712 | |
| 12 57534470 rs1466535-C 12:57534470 Abdominal aortic aneurysm 5.00E-10 1.15 22055160 | |
| 12 57792580 rs11613352-T 12:57792580 Triglycerides 9.00E-14 0.03 24097068 | |
| 12 57792580 rs11613352-T 12:57792580 HDL cholesterol 2.00E-13 0.03 24097068 | |
| 12 57792580 rs11613352-T 12:57792580 Triglycerides 4.00E-10 2.7 20686565 | |
| 12 57792580 rs11613352-T 12:57792580 HDL cholesterol 2.00E-08 0.46 20686565 | |
| 12 57809456 rs1106766-T 12:57809456 Urate levels 2.00E-11 5.16 20884846 | |
| 12 57844049 rs3741414-T 12:57844049 Urate levels 2.00E-25 0.07 23263486 | |
| 12 58133256 rs12368653-A 12:58133256 Multiple sclerosis 2.00E-09 1.1 21833088 | |
| 12 58162739 rs703842-A 12:58162739 Multiple sclerosis 5.00E-11 1.23 19525955 | |
| 12 65534624 rs6581612-C 12:65534624 Hippocampal volume 7.00E-11 63.3 22504421 | |
| 12 65718299 rs17178006-G 12:65718299 Hippocampal volume 5.00E-11 123.8 22504421 | |
| 12 65762058 rs12229918-C 12:65762058 Primary tooth development (time to first tooth eruption) 7.00E-14 0.22 23704328 | |
| 12 65762058 rs12229918-C 12:65762058 Primary tooth development (number of teeth) 2.00E-09 0.15 23704328 | |
| 12 65783378 rs10506525-C 12:65783378 Primary tooth development (time to first tooth eruption) 6.00E-09 0.46 20195514 | |
| 12 66174894 rs1531343-C 12:66174894 Type 2 diabetes 4.00E-09 1.1 20581827 | |
| 12 66212318 rs2261181-T 12:66212318 Type 2 diabetes 4.00E-08 1.16 24509480 | |
| 12 66224461 rs2272046-A 12:66224461 Polycystic ovary syndrome 2.00E-21 1.43 22885925 | |
| 12 66227257 rs7979673-T 12:66227257 Height 7.00E-10 0.06 21998595 | |
| 12 66338202 rs17101923-G 12:66338202 Primary tooth development (time to first tooth eruption) 6.00E-11 0.21 23704328 | |
| 12 66338202 rs17101923-G 12:66338202 Primary tooth development (number of teeth) 1.00E-10 0.18 23704328 | |
| 12 66343810 rs10784502-C 12:66343810 Brain structure 1.00E-12 NR 22504417 | |
| 12 66351826 rs1351394-T 12:66351826 Height 2.00E-65 0.06 20881960 | |
| 12 66351826 rs1351394-T 12:66351826 Height 7.00E-32 1.26 23563607 | |
| 12 66358347 rs1042725-T 12:66358347 Height 3.00E-20 0.48 18391950 | |
| 12 66358347 rs1042725-T 12:66358347 Birth weight 1.00E-19 0.05 23202124 | |
| 12 66358347 rs1042725-C 12:66358347 Height 3.00E-18 0.05 18391952 | |
| 12 66358347 rs1042725-C 12:66358347 Height 6.00E-16 0.4 17767157 | |
| 12 66358347 rs1042725-T 12:66358347 Head circumference (infant) 3.00E-10 0.07 22504419 | |
| 12 66359752 rs8756-C 12:66359752 Height 2.00E-16 6.6 18391951 | |
| 12 66359752 rs8756-? 12:66359752 Height 5.00E-14 0.08 19343178 | |
| 12 66364509 rs12424086-C 12:66364509 Permanent tooth development 2.00E-12 0.11 21931568 | |
| 12 66371880 rs7968682-T 12:66371880 Height 4.00E-10 0.04 22021425 | |
| 12 66394664 rs4026608-C 12:66394664 Aortic root size 2.00E-09 0.03 19584346 | |
| 12 68500075 rs7134599-A 12:68500075 Inflammatory bowel disease 9.00E-32 1.1 23128233 | |
| 12 68500075 rs7134599-A 12:68500075 Ulcerative colitis 1.00E-16 1.19 21297633 | |
| 12 68504592 rs1558744-A 12:68504592 Ulcerative colitis 3.00E-12 1.35 19122664 | |
| 12 68504592 rs1558744-A 12:68504592 Ulcerative colitis 4.00E-12 1.16 20228799 | |
| 12 68779413 rs416350-? 12:68779413 Temperament (bipolar disorder) 4.00E-08 2.1 22365631 | |
| 12 68961584 rs12313946-C 12:68961584 White blood cell count 3.00E-08 0.07 20139978 | |
| 12 69771073 rs315122-G x rs884483-C 12:69771073 Venous thromboembolism (gene x gene interaction) 1.00E-09 2.05 23509962 | |
| 12 69827658 rs10748128-T 12:69827658 Height 2.00E-20 0.04 20881960 | |
| 12 69827658 rs10748128-T 12:69827658 Height 7.00E-15 1.19 23563607 | |
| 12 70954464 rs17108344-? 12:70954464 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) 3.00E-08 25.3 24554482 | |
| 12 71249996 rs12229663-G 12:71249996 Refractive error 5.00E-09 0.1 23396134 | |
| 12 71663102 rs7961581-C 12:71663102 Type 2 diabetes 1.00E-09 1.09 18372903 | |
| 12 76220618 rs7307780-? 12:76220618 Sudden cardiac arrest 5.00E-15 1.45 21658281 | |
| 12 77899510 rs17788937-? 12:77899510 Myopia (pathological) 4.00E-15 NR 23049088 | |
| 12 84564068 rs1545843-A 12:84564068 Major depressive disorder 1.00E-09 1.4 21521612 | |
| 12 88829294 rs11104870-C 12:88829294 Red blood cell traits 6.00E-11 0.01 23222517 | |
| 12 88890671 rs995030-G 12:88890671 Testicular germ cell tumor 2.00E-50 2.26 23666240 | |
| 12 88890671 rs995030-G 12:88890671 Testicular germ cell tumor 1.00E-31 2.55 19483681 | |
| 12 88890671 rs1508595-G 12:88890671 Testicular germ cell tumor 3.00E-30 2.69 19483681 | |
| 12 88890671 rs995030-A 12:88890671 Testicular germ cell tumor 3.00E-13 2.33 23666239 | |
| 12 88953561 rs3782181-? 12:88953561 Testicular germ cell cancer 2.00E-26 2.22 20543847 | |
| 12 88953959 rs4474514-A 12:88953959 Testicular cancer 6.00E-15 3.07 19483682 | |
| 12 89328335 rs12821256-C 12:89328335 Blond vs. brown hair color 4.00E-30 2.32 17952075 | |
| 12 89328335 rs12821256-C 12:89328335 Hair color 7.00E-19 0.18 23548203 | |
| 12 89941549 rs4842666-T 12:89941549 Blood pressure 4.00E-08 0.71 24954895 | |
| 12 90008959 rs2681472-A 12:90008959 Hypertension 2.00E-11 0.15 19430479 | |
| 12 90008959 rs2681472-A 12:90008959 Diastolic blood pressure 1.00E-09 0.5 19430479 | |
| 12 90013089 rs2681492-T 12:90013089 Systolic blood pressure 4.00E-11 0.85 19430479 | |
| 12 90060586 rs17249754-G 12:90060586 Blood pressure 8.00E-20 1.17 21572416 | |
| 12 90060586 rs17249754-G 12:90060586 Blood pressure 1.00E-17 0.56 21909110 | |
| 12 90060586 rs17249754-A 12:90060586 Blood pressure 7.00E-15 0.8 24001895 | |
| 12 90060586 rs17249754-G 12:90060586 Blood pressure 2.00E-13 0.58 21572416 | |
| 12 90060586 rs17249754-G 12:90060586 Blood pressure 6.00E-10 0.39 21909110 | |
| 12 90081188 rs7136259-T 12:90081188 Coronary heart disease 6.00E-10 1.11 22751097 | |
| 12 90305779 rs7965584-G 12:90305779 Magnesium levels 1.00E-16 0.07 20700443 | |
| 12 93978504 rs11107116-T 12:93978504 Height 1.00E-34 0.05 20881960 | |
| 12 93978504 rs11107116-G 12:93978504 Height 6.00E-10 0.04 18391952 | |
| 12 93980088 rs10492321-A 12:93980088 Height 7.00E-11 1.26 23563607 | |
| 12 94120339 rs10859563-? 12:94120339 Height 3.00E-12 NR 20881960 | |
| 12 94235165 rs61144803-? 12:94235165 Alzheimer's disease (cognitive decline) 5.00E-08 0.16 23535033 | |
| 12 95711876 rs10859871-C 12:95711876 Endometriosis 5.00E-13 1.2 23104006 | |
| 12 96027759 rs17356907-A 12:96027759 Breast cancer 2.00E-22 1.1 23535729 | |
| 12 96271428 rs1036429-T 12:96271428 Pulmonary function 2.00E-11 0.04 21946350 | |
| 12 96817422 rs2028385-G x rs2038227-C 12:96817422 Venous thromboembolism (gene x gene interaction) 9.00E-09 1.69 23509962 | |
| 12 96858362 rs12423247-? 12:96858362 Phospholipid levels (plasma) 3.00E-08 0.8 22359512 | |
| 12 97901270 rs11109072-A 12:97901270 Obesity (early onset extreme) 4.00E-09 1.67 23563609 | |
| 12 100820085 rs12296850-A 12:100820085 Squamous cell carcinoma 1.00E-10 1.28 23341777 | |
| 12 101742180 rs57083693-C 12:101742180 Alcohol dependence (age at onset) 4.00E-08 1.35 24962325 | |
| 12 102321935 rs4622329-A 12:102321935 Systemic lupus erythematosus 9.00E-12 1.19 23273568 | |
| 12 102373788 rs7971536-A 12:102373788 Height 8.00E-14 0.03 20881960 | |
| 12 102799598 rs5742692-G 12:102799598 Height 4.00E-08 0.07 20189936 | |
| 12 102875569 rs35767-G 12:102875569 Fasting glucose-related traits 2.00E-09 NR 20081858 | |
| 12 102875569 rs35767-G 12:102875569 Fasting insulin-related traits 2.00E-09 NR 20081858 | |
| 12 102875569 rs35767-G 12:102875569 Fasting glucose-related traits 3.00E-08 NR 20081858 | |
| 12 102875569 rs35767-G 12:102875569 Fasting insulin-related traits 3.00E-08 NR 20081858 | |
| 12 102912558 rs35747-? 12:102912558 Fasting insulin-related traits (interaction with BMI) 1.00E-09 NR 22581228 | |
| 12 103257876 rs1498694-A 12:103257876 Blood metabolite levels 7.00E-11 0.01 24816252 | |
| 12 103483094 rs10745954-A 12:103483094 C-reactive protein 2.00E-11 0.04 21300955 | |
| 12 103495151 rs10778213-G 12:103495151 C-reactive protein 1.00E-10 0.12 18439548 | |
| 12 104445742 rs1564892-A 12:104445742 Corneal structure 2.00E-10 0.08 23291589 | |
| 12 107149422 rs2067615-A 12:107149422 Heart rate 2.00E-09 0.28 23583979 | |
| 12 107367225 rs1053051-T 12:107367225 Bone mineral density 1.00E-09 0.03 22504420 | |
| 12 109895168 rs2338104-C 12:109895168 HDL cholesterol 1.00E-10 0.07 19060906 | |
| 12 109895168 rs2338104-G 12:109895168 HDL cholesterol 3.00E-08 0.48 18193043 | |
| 12 110000193 rs7134594-C 12:110000193 HDL cholesterol 7.00E-15 0.44 20686565 | |
| 12 110000193 rs7134594-C 12:110000193 HDL cholesterol 2.00E-13 0.04 24097068 | |
| 12 111333622 rs10849915-G 12:111333622 Alcohol consumption 1.00E-23 0.55 21270382 | |
| 12 111340243 rs10774610-? 12:111340243 Drinking behavior 9.00E-120 3.33 21372407 | |
| 12 111350655 rs3782889-C 12:111350655 Coronary heart disease 4.00E-14 1.26 23364394 | |
| 12 111414461 rs12229654-G 12:111414461 Gamma glutamyl transpeptidase 9.00E-58 0.01 21909109 | |
| 12 111414461 rs12229654-G 12:111414461 Alcohol consumption 4.00E-35 0.79 21270382 | |
| 12 111414461 rs12229654-G 12:111414461 HDL cholesterol 3.00E-23 0.03 21909109 | |
| 12 111414461 rs12229654-G 12:111414461 Glycemic traits 9.00E-13 0.28 23575436 | |
| 12 111414461 rs12229654-T 12:111414461 Body mass index 5.00E-09 0.03 24861553 | |
| 12 111708458 rs1265564-? 12:111708458 Type 1 diabetes 1.00E-16 1.45 22293688 | |
| 12 111833788 rs10774624-G 12:111833788 Rheumatoid arthritis 7.00E-09 1.09 24390342 | |
| 12 111884608 rs3184504-T 12:111884608 Type 1 diabetes autoantibodies 2.00E-38 1.3 21829393 | |
| 12 111884608 rs3184504-? 12:111884608 Type 1 diabetes 3.00E-27 NR 19430480 | |
| 12 111884608 rs3184504-T 12:111884608 Platelet counts 1.00E-26 3.99 22139419 | |
| 12 111884608 rs3184504-T 12:111884608 Diastolic blood pressure 4.00E-25 0.45 21909115 | |
| 12 111884608 rs3184504-T 12:111884608 Red blood cell traits 4.00E-19 0.05 23222517 | |
| 12 111884608 rs3184504-T 12:111884608 Eosinophil counts 7.00E-19 7.6 19198610 | |
| 12 111884608 rs3184504-T 12:111884608 Blood metabolite levels 6.00E-18 0.02 24816252 | |
| 12 111884608 rs3184504-T 12:111884608 Diastolic blood pressure 3.00E-14 0.48 19430479 | |
| 12 111884608 rs3184504-T 12:111884608 Hypothyroidism 3.00E-12 1.2 22493691 | |
| 12 111884608 rs3184504-C 12:111884608 Platelet counts 5.00E-11 5.33 24026423 | |
| 12 111884608 rs3184504-T 12:111884608 Systolic blood pressure 5.00E-09 0.58 19430479 | |
| 12 111884608 rs3184504-C 12:111884608 Beta-2 microglubulin plasma levels 3.00E-08 0.02 23417110 | |
| 12 111887659 rs739496-A 12:111887659 Platelet counts 5.00E-19 0.14 20139978 | |
| 12 111904371 rs4766578-T 12:111904371 Vitiligo 4.00E-18 1.32 22561518 | |
| 12 111910219 rs10774625-A 12:111910219 Retinal vascular caliber 2.00E-13 1.5 21060863 | |
| 12 112007756 rs653178-G 12:112007756 Celiac disease 7.00E-21 1.2 20190752 | |
| 12 112007756 rs653178-T 12:112007756 Blood pressure 7.00E-20 0.43 21909110 | |
| 12 112007756 rs653178-C 12:112007756 Celiac disease and Rheumatoid arthritis 3.00E-19 NR 21383967 | |
| 12 112007756 rs653178-T 12:112007756 Diastolic blood pressure 3.00E-18 0.46 19430483 | |
| 12 112007756 rs653178-T 12:112007756 Urate levels 7.00E-12 0.04 23263486 | |
| 12 112007756 rs653178-T 12:112007756 Chronic kidney disease 4.00E-11 0.01 20383146 | |
| 12 112007756 rs653178-C 12:112007756 Thyroid peroxidase antibody positivity 1.00E-09 1.14 24586183 | |
| 12 112072424 rs11065987-G 12:112072424 "Cholesterol, total" 2.00E-16 0.03 24097068 | |
| 12 112072424 rs11065987-? 12:112072424 Coronary artery disease or ischemic stroke 4.00E-14 NR 24262325 | |
| 12 112072424 rs11065987-G 12:112072424 Hematocrit 1.00E-12 0.17 19862010 | |
| 12 112072424 rs11065987-G 12:112072424 "Cholesterol, total" 7.00E-12 0.96 20686565 | |
| 12 112072424 rs11065987-G 12:112072424 LDL cholesterol 1.00E-11 0.03 24097068 | |
| 12 112072424 rs11065987-A 12:112072424 Hemoglobin 1.00E-11 0.06 19862010 | |
| 12 112072424 rs11065987-G 12:112072424 Tetralogy of Fallot 8.00E-11 1.34 23297363 | |
| 12 112072424 rs11065987-? 12:112072424 Coronary artery disease or large artery stroke 3.00E-10 NR 24262325 | |
| 12 112072424 rs11065987-G 12:112072424 LDL cholesterol 2.00E-09 0.97 20686565 | |
| 12 112110489 rs3782886-A 12:112110489 Myocardial infarction 1.00E-14 1.46 24916648 | |
| 12 112110489 rs3782886-G 12:112110489 Hematological and biochemical traits 5.00E-09 0.08 20139978 | |
| 12 112168009 rs11066015-A 12:112168009 Esophageal cancer 7.00E-21 1.38 21642993 | |
| 12 112168009 rs11066015-A 12:112168009 Coronary heart disease 5.00E-11 1.41 23364394 | |
| 12 112190438 rs6490294-A 12:112190438 Mean platelet volume 5.00E-09 4.38 22423221 | |
| 12 112241766 rs671-? 12:112241766 Drinking behavior 4.00E-211 6.25 21372407 | |
| 12 112241766 rs671-A 12:112241766 Coronary heart disease 2.00E-34 1.43 21971053 | |
| 12 112241766 rs671-? 12:112241766 Response to alcohol consumption (flushing response) 5.00E-26 1.81 24277619 | |
| 12 112241766 rs671-A 12:112241766 Esophageal cancer 3.00E-24 1.67 19698717 | |
| 12 112241766 rs671-? 12:112241766 Alcohol consumption (maxi-drinks) 1.00E-16 0.16 24277619 | |
| 12 112241766 rs671-G 12:112241766 Body mass index 3.00E-11 0.04 24861553 | |
| 12 112241766 rs671-A 12:112241766 Renal function-related traits (sCR) 3.00E-10 0 22797727 | |
| 12 112241766 rs671-A 12:112241766 Mean corpuscular hemoglobin concentration 7.00E-10 0.08 20139978 | |
| 12 112241766 rs671-A 12:112241766 Hematological and biochemical traits 5.00E-09 0.12 20139978 | |
| 12 112241766 rs671-? 12:112241766 Alcohol dependence 5.00E-08 0.88 24277619 | |
| 12 112486818 rs17696736-G 12:112486818 Type 1 diabetes 6.00E-18 NR 18978792 | |
| 12 112486818 rs17696736-G 12:112486818 Type 1 diabetes 2.00E-16 1.22 17554260 | |
| 12 112486818 rs17696736-G 12:112486818 Type 1 diabetes 2.00E-14 1.34 17554300 | |
| 12 112521448 rs4767364-A 12:112521448 Upper aerodigestive tract cancers 2.00E-08 1.13 21437268 | |
| 12 112645401 rs2074356-T 12:112645401 Gamma glutamyl transpeptidase 3.00E-126 0.02 21909109 | |
| 12 112645401 rs2074356-T 12:112645401 Alcohol consumption 9.00E-59 1.06 21270382 | |
| 12 112645401 rs2074356-T 12:112645401 HDL cholesterol 7.00E-37 0.04 21909109 | |
| 12 112645401 rs2074356-T 12:112645401 Esophageal cancer 2.00E-31 1.56 21642993 | |
| 12 112645401 rs2074356-T 12:112645401 Glycemic traits 1.00E-16 0.32 23575436 | |
| 12 112645401 rs2074356-T 12:112645401 Glycemic traits 6.00E-14 0.06 23575436 | |
| 12 112645401 rs2074356-T 12:112645401 Biomedical quantitative traits 8.00E-12 0.01 19396169 | |
| 12 112645401 rs2074356-A 12:112645401 Renal function-related traits (BUN) 2.00E-09 0.01 22797727 | |
| 12 112645401 rs2074356-T 12:112645401 Glycemic traits 6.00E-09 0.17 23575436 | |
| 12 112817783 rs11066280-T 12:112817783 Drinking behavior 3.00E-215 3.33 23364009 | |
| 12 112817783 rs11066280-A 12:112817783 Metabolite levels 3.00E-63 0 21909109 | |
| 12 112817783 rs11066280-T 12:112817783 Blood pressure 1.00E-35 1.01 21572416 | |
| 12 112817783 rs11066280-T 12:112817783 Blood pressure 8.00E-31 1.56 21572416 | |
| 12 112817783 rs11066280-A 12:112817783 Metabolite levels 8.00E-22 0 21909109 | |
| 12 112817783 rs11066280-A 12:112817783 Esophageal cancer 2.00E-15 1.3 21642993 | |
| 12 112817783 rs11066280-A 12:112817783 Coronary heart disease 2.00E-11 1.19 22751097 | |
| 12 112871372 rs11066301-G 12:112871372 Hematological parameters 8.00E-12 4.65 19820697 | |
| 12 113100994 rs17824620-C 12:113100994 Platelet counts 1.00E-08 2.46 22139419 | |
| 12 113365621 rs11066453-G 12:113365621 Gamma glutamyl transpeptidase 6.00E-44 0.01 21909109 | |
| 12 113365621 rs11066453-G 12:113365621 Glycemic traits 5.00E-09 0.24 23575436 | |
| 12 113409176 rs2072134-A 12:113409176 Alcohol consumption 6.00E-17 0.61 21270382 | |
| 12 113607502 rs2384207-? 12:113607502 Response to fenofibrate (adiponectin levels) 5.00E-08 0.06 23149075 | |
| 12 114685571 rs1270884-A 12:114685571 Prostate cancer 7.00E-11 1.07 23535732 | |
| 12 114793240 rs883079-C 12:114793240 QRS duration 1.00E-10 0.49 21076409 | |
| 12 114795443 rs3825214-G 12:114795443 Electrocardiographic traits 3.00E-13 7.35 20062063 | |
| 12 114795443 rs3825214-G 12:114795443 Electrocardiographic traits 3.00E-12 7.36 20062063 | |
| 12 114802138 rs1895585-A 12:114802138 PR interval 1.00E-19 3.19 23139255 | |
| 12 114868138 rs1265507-? 12:114868138 Mammographic density 1.00E-08 NR 22532574 | |
| 12 115094260 rs11067228-A 12:115094260 Serum prostate-specific antigen levels 2.00E-11 8.3 21160077 | |
| 12 115346424 rs1896312-C 12:115346424 PR interval 3.00E-17 1.95 20062060 | |
| 12 115352731 rs2384550-A 12:115352731 Diastolic blood pressure 4.00E-08 0.35 19430479 | |
| 12 115381740 rs10850409-A 12:115381740 PR segment 8.00E-13 1.65 24850809 | |
| 12 115552437 rs35444-A 12:115552437 Blood pressure 1.00E-10 0.5 21572416 | |
| 12 115836522 rs1292011-A 12:115836522 Breast cancer 9.00E-22 1.09 23535729 | |
| 12 117327592 rs7294919-C 12:117327592 Brain structure 7.00E-16 47.58 22504417 | |
| 12 117327592 rs7294919-T 12:117327592 Hippocampal volume 3.00E-11 107.8 22504421 | |
| 12 119387918 rs1997111-T 12:119387918 Cerebrospinal T-tau levels 1.00E-08 NR 20932310 | |
| 12 119619997 rs78852656-? 12:119619997 PR interval in Tripanosoma cruzi seropositivity 4.00E-08 NR 24324551 | |
| 12 121160615 rs2066938-G 12:121160615 Metabolic traits 4.00E-305 0.61 21886157 | |
| 12 121175524 rs2014355-T 12:121175524 Metabolite levels 5.00E-96 21.5 20037589 | |
| 12 121177272 rs3916-G 12:121177272 Urinary metabolites (H-NMR features) 2.00E-22 0.4 24586186 | |
| 12 121388962 rs2650000-A 12:121388962 Metabolic traits 3.00E-11 0.4 19060910 | |
| 12 121388962 rs2650000-A 12:121388962 LDL cholesterol 2.00E-08 0.07 19060906 | |
| 12 121402932 rs7305618-T 12:121402932 C-reactive protein 1.00E-08 0.27 21647738 | |
| 12 121402932 rs7305618-C 12:121402932 Type 2 diabetes 2.00E-08 1.14 21573907 | |
| 12 121403724 rs7953249-G 12:121403724 N-glycan levels 2.00E-08 0.17 21203500 | |
| 12 121405126 rs2251468-A 12:121405126 Homocysteine levels 1.00E-12 0.05 23824729 | |
| 12 121416650 rs1169288-C 12:121416650 LDL cholesterol 6.00E-21 0.04 24097068 | |
| 12 121416650 rs1169288-G 12:121416650 Gamma gluatamyl transferase levels 2.00E-18 0.13 22010049 | |
| 12 121416650 rs1169288-C 12:121416650 "Cholesterol, total" 4.00E-17 0.03 24097068 | |
| 12 121416650 rs1169288-C 12:121416650 LDL cholesterol 1.00E-15 1.42 20686565 | |
| 12 121416650 rs1169288-C 12:121416650 "Cholesterol, total" 1.00E-14 1.45 20686565 | |
| 12 121420260 rs7979473-A 12:121420260 C-reactive protein 1.00E-10 0.12 22939635 | |
| 12 121420807 rs1183910-G 12:121420807 C-reactive protein 2.00E-124 0.15 21300955 | |
| 12 121420807 rs1183910-T 12:121420807 C-reactive protein 1.00E-30 13.8 19567438 | |
| 12 121420807 rs1183910-G 12:121420807 C-reactive protein 4.00E-12 0.05 23844046 | |
| 12 121423956 rs2393791-G 12:121423956 Gamma glutamyl transpeptidase 7.00E-30 0.01 21909109 | |
| 12 121423956 rs2393791-G 12:121423956 C-reactive protein levels 3.00E-10 0.12 24763700 | |
| 12 121423956 rs2393791-C 12:121423956 C-reactive protein and white blood cell count 3.00E-09 0.05 22788528 | |
| 12 121424861 rs7310409-G 12:121424861 Liver enzyme levels (gamma-glutamyl transferase) 7.00E-45 6.8 22001757 | |
| 12 121424861 rs7310409-A 12:121424861 C-reactive protein 7.00E-17 0.15 18439548 | |
| 12 121424861 rs7310409-G 12:121424861 C-reactive protein 3.00E-08 0.07 21196492 | |
| 12 121435587 rs2259816-T 12:121435587 C-reactive protein 3.00E-10 0.14 22939635 | |
| 12 121438844 rs735396-G 12:121438844 N-glycan levels 4.00E-08 0.17 21203500 | |
| 12 121439433 rs1169310-A 12:121439433 C-reactive protein 2.00E-08 0.13 18439552 | |
| 12 121442670 rs1169313-C 12:121442670 Liver enzyme levels 2.00E-10 0.01 18940312 | |
| 12 121460686 rs7957197-T 12:121460686 Type 2 diabetes 2.00E-08 1.07 20581827 | |
| 12 121471337 rs3213545-A 12:121471337 Cardiovascular disease risk factors 4.00E-15 0.12 21943158 | |
| 12 122342964 rs7314056-C 12:122342964 Urinary metabolites (H-NMR features) 4.00E-16 0.44 24586186 | |
| 12 122365583 rs7961894-T 12:122365583 Mean platelet volume 1.00E-103 0.03 22139419 | |
| 12 122365583 rs7961894-A 12:122365583 Mean platelet volume 7.00E-48 0.03 19110211 | |
| 12 122365583 rs7961894-T 12:122365583 Mean platelet volume 3.00E-44 0.03 19820697 | |
| 12 122365583 rs7961894-T 12:122365583 Mean platelet volume 6.00E-38 0.31 24026423 | |
| 12 122365583 rs7961894-C 12:122365583 Platelet counts 1.00E-10 3.92 22139419 | |
| 12 122395777 rs830124-A 12:122395777 Urinary metabolites 1.00E-46 NR 21572414 | |
| 12 122397476 rs493519-T 12:122397476 Blood metabolite levels 1.00E-18 0.04 24816252 | |
| 12 122625992 rs7953704-A 12:122625992 Urate levels 3.00E-08 0.03 23263486 | |
| 12 123296294 rs12817488-T 12:123296294 Parkinson's disease 3.00E-13 1.14 21292315 | |
| 12 123640853 rs1727313-C 12:123640853 Type 2 diabetes 1.00E-08 1.06 24509480 | |
| 12 123731423 rs11532322-A 12:123731423 Schizophrenia 2.00E-08 1.09 23974872 | |
| 12 123796238 rs4759375-T 12:123796238 HDL cholesterol 8.00E-09 0.86 20686565 | |
| 12 123796238 rs4759375-T 12:123796238 HDL cholesterol 3.00E-08 0.06 24097068 | |
| 12 123822711 rs7980687-A 12:123822711 Head circumference (infant) 8.00E-09 0.07 22504419 | |
| 12 123823546 rs11830103-A 12:123823546 Height 4.00E-15 0.04 20881960 | |
| 12 124203832 rs6488898-G 12:124203832 Adiponectin levels 3.00E-10 0.05 22479202 | |
| 12 124460167 rs4765127-T 12:124460167 HDL cholesterol 3.00E-10 0.44 20686565 | |
| 12 124460167 rs4765127-T 12:124460167 HDL cholesterol 8.00E-10 0.03 24097068 | |
| 12 124460167 rs4765127-G 12:124460167 Triglycerides 1.00E-08 2.42 20686565 | |
| 12 124460167 rs4765127-T 12:124460167 Triglycerides 2.00E-08 0.03 24097068 | |
| 12 125261593 rs838880-C 12:125261593 HDL cholesterol 6.00E-32 0.05 24097068 | |
| 12 125261593 rs838880-C 12:125261593 HDL cholesterol 3.00E-14 0.61 20686565 | |
| 12 125307053 rs11057830-A 12:125307053 Vitamin E levels 8.00E-09 0.03 21729881 | |
| 12 125312425 rs10846744-C 12:125312425 Lipoprotein-associated phospholipase A2 activity and mass 1.00E-08 4.6 20442857 | |
| 12 125316743 rs11057841-T 12:125316743 Lipoprotein-associated phospholipase A2 activity and mass 6.00E-14 0.03 23118302 | |
| 12 125320850 rs4765623-? 12:125320850 Renal cell carcinoma 3.00E-08 1.15 21131975 | |
| 12 129300694 rs1385374-A 12:129300694 Systemic lupus erythematosus 2.00E-11 1.26 19838193 | |
| 12 131291101 rs7301826-C 12:131291101 Plasma plasminogen activator levels 1.00E-09 0.03 24578379 | |
| 12 131456449 rs11061269-? 12:131456449 Amyotrophic lateral sclerosis (sporadic) 8.00E-10 3.78 24529757 | |
| 12 131576191 rs1569019-? 12:131576191 Height 5.00E-08 0.95 19729412 | |
| 12 131621762 rs885389-A 12:131621762 RR interval (heart rate) 4.00E-08 0.17 20031603 | |
| 13 19311241 rs9552416-? 13:19311241 Fasting insulin-related traits (interaction with BMI) 3.00E-24 NR 22581228 | |
| 13 21300909 rs2253017-T 13:21300909 PR segment 2.00E-08 1.58 24850809 | |
| 13 22131897 rs2798269-T 13:22131897 PR segment 3.00E-10 1.38 24850809 | |
| 13 23228691 rs1034200-A 13:23228691 Corneal structure 4.00E-09 0.1 23291589 | |
| 13 23228691 rs1034200-C 13:23228691 Central corneal thickness 4.00E-09 0.14 20719862 | |
| 13 23294033 rs4373767-C 13:23294033 Myopia (pathological) 3.00E-10 0.16 22685421 | |
| 13 23864657 rs9552911-G 13:23864657 Type 2 diabetes 2.00E-08 1.49 23300278 | |
| 13 24127210 rs1572072-? 13:24127210 Nasopharyngeal carcinoma 1.00E-08 1.19 20512145 | |
| 13 24205195 rs9510787-G 13:24205195 Nasopharyngeal carcinoma 2.00E-09 1.2 20512145 | |
| 13 24293859 rs753955-G 13:24293859 Lung cancer 2.00E-12 1.18 21725308 | |
| 13 24432467 rs9318086-A 13:24432467 Myopia (pathological) 2.00E-16 1.32 21640322 | |
| 13 27531267 rs17085007-C 13:27531267 Inflammatory bowel disease 3.00E-19 1.11 23128233 | |
| 13 27531267 rs17085007-C 13:27531267 Ulcerative colitis 1.00E-16 1.16 21297633 | |
| 13 28020180 rs4771122-G 13:28020180 Body mass index 9.00E-10 0.09 20935630 | |
| 13 28491198 rs2293941-? 13:28491198 Fasting glucose-related traits (interaction with BMI) 5.00E-10 NR 22581228 | |
| 13 31819325 rs9542236-C 13:31819325 Age-related macular degeneration 2.00E-08 1.1 23455636 | |
| 13 32953388 rs4942486-T 13:32953388 LDL cholesterol 2.00E-11 0.02 24097068 | |
| 13 32972626 rs11571833-T 13:32972626 Lung cancer 5.00E-20 2.47 24880342 | |
| 13 32972626 rs11571833-T 13:32972626 Lung cancer 2.00E-19 1.83 24880342 | |
| 13 32972626 rs11571833-T 13:32972626 Breast cancer 5.00E-08 1.26 23535729 | |
| 13 33147052 rs718444-T 13:33147052 Height 2.00E-10 1.14 23563607 | |
| 13 33147548 rs7332115-T 13:33147548 Height 6.00E-10 0.02 20881960 | |
| 13 33693837 rs9315204-T 13:33693837 Intracranial aneurysm 3.00E-09 1.2 20364137 | |
| 13 34606186 rs2321744-? x rs6497540-? 13:34606186 Venous thromboembolism (gene x gene interaction) 1.00E-09 2.04 23509962 | |
| 13 36652617 rs1926320-C 13:36652617 Vertical cup-disc ratio 1.00E-08 0.01 20548946 | |
| 13 40118068 rs9315702-A 13:40118068 Hippocampal atrophy 2.00E-08 NR 22745009 | |
| 13 40368069 rs9603616-C 13:40368069 Rheumatoid arthritis 2.00E-12 1.1 24390342 | |
| 13 40368069 rs9603616-C 13:40368069 Rheumatoid arthritis 3.00E-11 1.11 24390342 | |
| 13 41013977 rs941823-C 13:41013977 Inflammatory bowel disease 2.00E-14 1.07 23128233 | |
| 13 41013977 rs941823-C 13:41013977 Ulcerative colitis 4.00E-12 1.12 21297633 | |
| 13 41109429 rs2755237-A 13:41109429 Central corneal thickness 1.00E-08 0.17 20719862 | |
| 13 41110884 rs2721051-T 13:41110884 Corneal structure 4.00E-14 0.17 23291589 | |
| 13 41110884 rs2721051-G 13:41110884 Central corneal thickness 5.00E-10 0.24 20485516 | |
| 13 41558110 rs7329174-G 13:41558110 Crohn's disease 8.00E-09 1.27 23266558 | |
| 13 41558110 rs7329174-G 13:41558110 Systemic lupus erythematosus 1.00E-08 1.26 21044949 | |
| 13 42559076 rs7336933-A 13:42559076 Calcium levels 9.00E-10 0.02 24068962 | |
| 13 42653437 rs1012053-A 13:42653437 Bipolar disorder 2.00E-08 1.59 17486107 | |
| 13 42754522 rs4142110-? 13:42754522 Nephrolithiasis 5.00E-09 1.14 22396660 | |
| 13 42951449 rs9533090-T 13:42951449 Bone mineral density 5.00E-68 0.1 22504420 | |
| 13 42951449 rs9533090-T 13:42951449 Bone mineral density (spine) 5.00E-25 0.12 19801982 | |
| 13 42952145 rs9594738-T 13:42952145 Bone mineral density (hip) 2.00E-08 0.1 18445777 | |
| 13 42965694 rs8001611-? 13:42965694 Bone mineral density 2.00E-12 1.21 23644456 | |
| 13 42969049 rs9533095-? 13:42969049 Bone mineral density 2.00E-15 NR 24249740 | |
| 13 43032593 rs9594759-T 13:43032593 Bone mineral density (spine) 2.00E-21 0.17 18445777 | |
| 13 43032593 rs9594759-T 13:43032593 Bone mineral density (spine) 2.00E-17 0.12 19079262 | |
| 13 43052880 rs2062305-G 13:43052880 Crohn's disease 5.00E-10 1.1 21102463 | |
| 13 43116133 rs1021188-C 13:43116133 Bone mineral density 2.00E-14 3.89 21124946 | |
| 13 43116133 rs1021188-C 13:43116133 Bone mineral density 4.00E-14 0.15 23437003 | |
| 13 43128577 rs9525638-C 13:43128577 "Bone mineral density (paediatric, upper limb)" 3.00E-09 0.09 24945404 | |
| 13 43128577 rs9525638-T 13:43128577 Cortical thickness 4.00E-09 0.09 22792071 | |
| 13 43128577 rs9525638-C 13:43128577 "Bone mineral density (paediatric, upper limb)" 2.00E-08 0.09 24945404 | |
| 13 43143029 rs17536328-T 13:43143029 "Bone mineral density (paediatric, total body less head)" 8.00E-09 0.09 24945404 | |
| 13 43770474 rs9533425-G 13:43770474 End-stage coagulation 2.00E-09 0.31 23381943 | |
| 13 44457925 rs3764147-G 13:44457925 Leprosy 4.00E-54 1.68 20018961 | |
| 13 44457925 rs3764147-G 13:44457925 Crohn's disease 2.00E-21 1.16 23128233 | |
| 13 44457925 rs3764147-G 13:44457925 Crohn's disease 2.00E-13 1.25 18587394 | |
| 13 44457925 rs3764147-G 13:44457925 Crohn's disease 1.00E-10 1.17 21102463 | |
| 13 45900267 rs7323755-? 13:45900267 Myopia (pathological) 2.00E-13 NR 23049088 | |
| 13 47238717 rs9590974-A 13:47238717 PR segment 2.00E-08 1.19 24850809 | |
| 13 48162558 rs2478333-A 13:48162558 QT interval 4.00E-08 0.17 20031603 | |
| 13 50563447 rs9596219-T 13:50563447 Height 1.00E-09 1.16 23563607 | |
| 13 51105334 rs3118905-A 13:51105334 Height 1.00E-45 0.06 20881960 | |
| 13 51106788 rs3118906-G 13:51106788 Height 2.00E-24 1.26 23563607 | |
| 13 51111355 rs3116602-G 13:51111355 Height 7.00E-09 0.04 18391952 | |
| 13 51116901 rs3118914-? 13:51116901 Height 4.00E-10 0.08 19343178 | |
| 13 51390598 rs9316505-A 13:51390598 Primary tooth development (number of teeth) 3.00E-08 0.13 23704328 | |
| 13 54064981 rs9568856-? 13:54064981 Obesity 2.00E-09 1.22 22484627 | |
| 13 54107352 rs9568867-A 13:54107352 Obesity 2.00E-09 1.15 23563607 | |
| 13 61113739 rs4886238-A 13:61113739 Menopause (age at onset) 1.00E-10 0.17 22267201 | |
| 13 61513669 rs7337573-? 13:61513669 Phospholipid levels (plasma) 2.00E-08 0.8 22359512 | |
| 13 72347696 rs626277-C 13:72347696 Chronic kidney disease 3.00E-11 0.01 20383146 | |
| 13 73559982 rs8002688-T 13:73559982 Blood pressure measurement (low sodium intervention) 2.00E-09 2.04 24165912 | |
| 13 73728139 rs9600079-T 13:73728139 Prostate cancer 3.00E-09 1.18 20676098 | |
| 13 73741149 rs11838472-? 13:73741149 Myopia (pathological) 3.00E-17 NR 23049088 | |
| 13 73908846 rs9573163-G 13:73908846 Pancreatic cancer 5.00E-13 1.26 22158540 | |
| 13 73916628 rs9543325-C 13:73916628 Pancreatic cancer 3.00E-11 1.26 20101243 | |
| 13 74520186 rs1886512-A 13:74520186 QRS duration 1.00E-08 0.4 21076409 | |
| 13 74742322 rs12429889-? 13:74742322 Sudden cardiac arrest 5.00E-20 1.64 21658281 | |
| 13 75128114 rs17718828-? 13:75128114 Phospholipid levels (plasma) 1.00E-08 0.8 22359512 | |
| 13 76326282 rs539514-? 13:76326282 Type 1 diabetes 6.00E-11 1.43 21980299 | |
| 13 78381146 rs975739-G 13:78381146 Hair color 2.00E-14 0.08 23548203 | |
| 13 79025787 rs9318552-T 13:79025787 Diastolic blood pressure (alcohol consumption interaction) 5.00E-08 0.39 24376456 | |
| 13 79410574 rs11838918-C 13:79410574 Conduct disorder (symptom count) 1.00E-08 0.28 20585324 | |
| 13 80692811 rs8001641-A 13:80692811 Orofacial clefts 9.00E-11 1.35 22863734 | |
| 13 80692811 rs8001641-A 13:80692811 Orofacial clefts 3.00E-10 1.31 22863734 | |
| 13 80717156 rs1359790-G 13:80717156 Type 2 diabetes 6.00E-09 1.15 20862305 | |
| 13 85177888 rs2197609-? x rs1547553-? 13:85177888 Age-related hearing impairment (interaction) 2.00E-09 NR 24939585 | |
| 13 85348247 rs4424809-? x rs1547553-? 13:85348247 Age-related hearing impairment (interaction) 1.00E-09 NR 24939585 | |
| 13 92024574 rs7319045-A 13:92024574 Height 1.00E-11 0.03 20881960 | |
| 13 92988323 rs7982677-A 13:92988323 Tetralogy of Fallot 3.00E-09 1.29 23297363 | |
| 13 94408506 rs7995215-? 13:94408506 Attention deficit hyperactivity disorder 1.00E-08 NR 18839057 | |
| 13 95898207 rs4148441-G 13:95898207 Platelet counts 7.00E-12 4.12 22139419 | |
| 13 95922765 rs8002180-T 13:95922765 Blood metabolite levels 8.00E-23 0.02 24816252 | |
| 13 95971016 rs9302065-A 13:95971016 Blood metabolite levels 1.00E-19 0.02 24816252 | |
| 13 96951433 rs2038823-C 13:96951433 Diabetic retinopathy 5.00E-11 NR 21310492 | |
| 13 97017548 rs7989336-A 13:97017548 Obesity 1.00E-08 1.1 23563607 | |
| 13 99385990 rs9582259-C 13:99385990 Immune reponse to smallpox (secreted IL-1beta) 3.00E-08 NR 22610502 | |
| 13 99956622 rs9557195-T 13:99956622 Inflammatory bowel disease 2.00E-14 1.11 23128233 | |
| 13 100041738 rs7335046-G 13:100041738 Basal cell carcinoma 3.00E-08 1.26 21700618 | |
| 13 100518634 rs41281112-? 13:100518634 Vitamin B12 levels 9.00E-10 83.6 22367966 | |
| 13 100818092 rs2184971-G 13:100818092 Refractive error 2.00E-08 0.09 23396134 | |
| 13 102965003 rs1336708-? x rs1423386-? 13:102965003 Venous thromboembolism (gene x gene interaction) 5.00E-09 1.72 23509962 | |
| 13 105039146 rs17450420-? 13:105039146 Esophageal cancer (alcohol interaction) 5.00E-08 1.7 22960999 | |
| 13 106096812 rs11618212-? 13:106096812 Myopia (pathological) 5.00E-12 NR 23049088 | |
| 13 109473946 rs17393344-? 13:109473946 Alzheimer's disease (cognitive decline) 2.00E-08 0.26 23535033 | |
| 13 110818598 rs3742207-C 13:110818598 Arterial stiffness 5.00E-08 21 20031579 | |
| 13 110929162 rs494558-G 13:110929162 Obesity-related traits 5.00E-08 0.05 23251661 | |
| 13 110960712 rs4773144-G 13:110960712 Coronary heart disease 4.00E-09 1.07 21378990 | |
| 13 112221297 rs7333181-A 13:112221297 Menopause (age at onset) 3.00E-08 0.52 19448619 | |
| 13 113331868 rs7998202-G 13:113331868 Glycated hemoglobin levels 5.00E-09 0.03 20858683 | |
| 13 113536627 rs1278769-G 13:113536627 Interstitial lung disease 7.00E-09 1.27 23583980 | |
| 13 113694509 rs11842874-A 13:113694509 Osteoarthritis 2.00E-08 1.17 21871595 | |
| 13 113752831 rs10665-A 13:113752831 End-stage coagulation 2.00E-47 0.85 23381943 | |
| 13 113753164 rs2181540-T 13:113753164 End-stage coagulation 1.00E-46 0.83 23381943 | |
| 13 113756540 rs555212-G 13:113756540 End-stage coagulation 1.00E-15 0.37 23381943 | |
| 13 113760034 rs561241-C 13:113760034 Prothrombin time 4.00E-56 0.04 22703881 | |
| 13 113760034 rs561241-? 13:113760034 Factor VII 5.00E-16 NR 17903294 | |
| 13 113772707 rs6041-G 13:113772707 End-stage coagulation 2.00E-45 0.88 23381943 | |
| 13 113793849 rs3211770-G 13:113793849 End-stage coagulation 3.00E-19 0.53 23381943 | |
| 13 114012898 rs7317038-C 13:114012898 Mean platelet volume 8.00E-12 0.01 22139419 | |
| 14 23002684 rs1154155-G 14:23002684 Narcolepsy 5.00E-49 1.64 24204295 | |
| 14 23002684 rs1154155-C 14:23002684 Narcolepsy 3.00E-22 1.69 19412176 | |
| 14 23464482 rs997154-G 14:23464482 Primary tooth development (number of teeth) 3.00E-08 0.15 23704328 | |
| 14 23585333 rs4982731-C 14:23585333 Acute lymphoblastic leukemia (childhood) 9.00E-12 1.36 23512250 | |
| 14 23589057 rs2239633-? 14:23589057 Acute lymphoblastic leukemia (B-cell precursor) 1.00E-16 NR 23996088 | |
| 14 23861811 rs365990-G 14:23861811 Heart rate 5.00E-45 0.56 23583979 | |
| 14 23861811 rs365990-G 14:23861811 Electrocardiographic traits 9.00E-11 5.25 20062063 | |
| 14 23865885 rs452036-A 14:23865885 Resting heart rate 4.00E-14 7.8 20639392 | |
| 14 23977010 rs223116-A 14:23977010 Resting heart rate 3.00E-08 7.4 20639392 | |
| 14 24771285 rs4280164-G 14:24771285 Parent of origin effect on language impairment (paternal) 4.00E-08 3.87 24571439 | |
| 14 24830850 rs1950500-T 14:24830850 Height 2.00E-18 0.03 20881960 | |
| 14 24830850 rs1950500-T 14:24830850 Height 1.00E-11 1.16 23563607 | |
| 14 24883887 rs8017377-A 14:24883887 LDL cholesterol 3.00E-15 0.03 24097068 | |
| 14 24883887 rs8017377-T 14:24883887 LDL cholesterol 4.00E-11 1.17 20686565 | |
| 14 25102160 rs8192917-G 14:25102160 Vitiligo 3.00E-08 1.28 20410501 | |
| 14 25503799 rs10147992-G 14:25503799 White blood cell types 1.00E-08 0.06 21738478 | |
| 14 28728111 rs6576132-A 14:28728111 Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry) 5.00E-08 0 24825563 | |
| 14 30515112 rs11847697-T 14:30515112 Body mass index 6.00E-11 0.17 20935630 | |
| 14 35682172 rs12586317-T 14:35682172 Psoriasis 2.00E-08 1.15 20953189 | |
| 14 35832666 rs8016947-C 14:35832666 Psoriasis 2.00E-11 1.19 20953190 | |
| 14 36574018 rs1537424-T 14:36574018 Thyroid hormone levels 1.00E-08 0.05 23408906 | |
| 14 36649246 rs944289-T 14:36649246 Thyroid cancer 2.00E-09 1.37 19198613 | |
| 14 36738361 rs116909374-T 14:36738361 Thyroid cancer 5.00E-11 2.09 22267200 | |
| 14 37132769 rs2236007-G 14:37132769 Breast cancer 2.00E-13 1.08 23535729 | |
| 14 38077148 rs1998359-G 14:38077148 Self-reported allergy 5.00E-08 0.08 23817569 | |
| 14 38683261 rs11622412-T 14:38683261 Metabolite levels (5-HIAA/ MHPG Ratio) 5.00E-08 0.32 23319000 | |
| 14 51403531 rs7142143-C 14:51403531 Acute lymphoblastic leukemia (childhood) 7.00E-09 3.61 23007406 | |
| 14 53372330 rs8008270-G 14:53372330 Prostate cancer 2.00E-14 1.12 23535732 | |
| 14 53400629 rs17125944-C 14:53400629 Alzheimer's disease (late onset) 8.00E-09 1.14 24162737 | |
| 14 54410919 rs4444235-C 14:54410919 Colorectal cancer 8.00E-10 1.11 19011631 | |
| 14 54417522 rs17563-G 14:54417522 Primary tooth development (time to first tooth eruption) 9.00E-17 0.24 23704328 | |
| 14 55614636 rs2274273-A 14:55614636 Protein biomarker 2.00E-188 0.19 23056639 | |
| 14 60903757 rs1254319-A 14:60903757 Refractive error 1.00E-08 0.09 23396134 | |
| 14 60957279 rs2093210-T 14:60957279 Height 6.00E-17 0.03 20881960 | |
| 14 60957279 rs2093210-C 14:60957279 Height 8.00E-13 1.16 23563607 | |
| 14 61072875 rs10483727-T 14:61072875 Vertical cup-disc ratio 1.00E-11 0.01 20548946 | |
| 14 61072875 rs10483727-A 14:61072875 Glaucoma (primary open-angle) 4.00E-11 1.32 22570617 | |
| 14 61308337 rs6573333-A 14:61308337 Immune reponse to smallpox (secreted IFN-alpha) 3.00E-10 NR 22610502 | |
| 14 61908111 rs1957894-T 14:61908111 Obesity (early onset extreme) 3.00E-10 1.5 23563609 | |
| 14 61940675 rs3783782-A 14:61940675 Rheumatoid arthritis 2.00E-09 1.14 24390342 | |
| 14 61940675 rs3783782-A 14:61940675 Rheumatoid arthritis 4.00E-09 1.14 24390342 | |
| 14 64232386 rs17101394-? 14:64232386 Sphingolipid levels 3.00E-57 0 22359512 | |
| 14 64234243 rs4902243-A 14:64234243 Blood metabolite levels 3.00E-37 0.04 24816252 | |
| 14 64235556 rs7157785-T 14:64235556 Blood metabolite ratios 1.00E-133 0.07 24816252 | |
| 14 64235556 rs7157785-T 14:64235556 Blood metabolite levels 7.00E-87 0.07 24816252 | |
| 14 64235556 rs7157785-A 14:64235556 Sphingolipid levels 9.00E-66 0 19798445 | |
| 14 64680848 rs1152591-A 14:64680848 Atrial fibrillation 6.00E-13 1.13 22544366 | |
| 14 65475540 rs4466998-A 14:65475540 Mean corpuscular volume 5.00E-08 0 19862010 | |
| 14 65502239 rs7155454-A 14:65502239 Red blood cell traits 2.00E-12 0 23222517 | |
| 14 65758642 rs7159888-A 14:65758642 N-glycan levels 3.00E-18 0.26 21203500 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 1.00E-22 0.31 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 3.00E-21 0.3 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 8.00E-20 0.29 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 2.00E-19 0.29 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 3.00E-17 0.27 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 5.00E-15 0.25 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 3.00E-14 0.24 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 7.00E-14 0.24 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 2.00E-13 0.23 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 2.00E-13 0.23 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 1.00E-10 0.2 23382691 | |
| 14 65775695 rs11847263-G 14:65775695 IgG glycosylation 3.00E-08 0.17 23382691 | |
| 14 65914867 rs10483776-G 14:65914867 N-glycan levels 1.00E-08 0.22 21203500 | |
| 14 67939483 rs17104363-G 14:67939483 Obesity-related traits 5.00E-08 0.04 23251661 | |
| 14 67975822 rs1077989-? 14:67975822 Phospholipid levels (plasma) 9.00E-18 0 22359512 | |
| 14 68520906 rs8022206-G 14:68520906 Platelet counts 2.00E-10 3.2 22139419 | |
| 14 68660428 rs2588809-T 14:68660428 Breast cancer 1.00E-10 1.08 23535729 | |
| 14 68699594 rs1314913-? 14:68699594 Breast cancer (male) 3.00E-13 1.57 23001122 | |
| 14 68753593 rs911263-T 14:68753593 Primary biliary cirrhosis 2.00E-11 1.29 21399635 | |
| 14 68760141 rs1950897-T 14:68760141 Rheumatoid arthritis 8.00E-11 1.1 24390342 | |
| 14 68760141 rs1950897-T 14:68760141 Rheumatoid arthritis 5.00E-08 1.09 24390342 | |
| 14 68785077 rs8017304-A 14:68785077 Age-related macular degeneration 9.00E-11 1.11 23455636 | |
| 14 68788924 rs1956529-T 14:68788924 Primary tooth development (number of teeth) 3.00E-08 0.51 20195514 | |
| 14 68813115 rs1570106-T 14:68813115 Height 8.00E-09 0.03 20881960 | |
| 14 69034682 rs999737-C 14:69034682 Breast cancer 3.00E-19 1.09 23535729 | |
| 14 69126744 rs7141529-G 14:69126744 Prostate cancer 3.00E-10 1.09 23535732 | |
| 14 69210199 rs4902642-G 14:69210199 Crohn's disease 2.00E-10 1.07 21102463 | |
| 14 69254191 rs4902647-G 14:69254191 Multiple sclerosis 9.00E-12 1.11 21833088 | |
| 14 69263599 rs1465788-? 14:69263599 Type 1 diabetes 2.00E-12 1.16 19430480 | |
| 14 69273905 rs194749-C 14:69273905 Inflammatory bowel disease 3.00E-10 1.08 23128233 | |
| 14 69314059 rs434943-A 14:69314059 Fibrinogen 1.00E-08 0.01 23969696 | |
| 14 69318262 rs8003722-? x rs229353-? 14:69318262 Age-related hearing impairment (interaction) 8.00E-09 NR 24939585 | |
| 14 70347348 rs11158820-? 14:70347348 Digit length ratio 2.00E-11 NR 23263445 | |
| 14 70365924 rs11627546-C 14:70365924 Red blood cell traits 1.00E-09 0.16 23222517 | |
| 14 70456699 rs227425-G 14:70456699 Bone mineral density 4.00E-13 2.2 24249740 | |
| 14 70502050 rs17175227-G 14:70502050 Tuberculosis 9.00E-09 7.14 24057671 | |
| 14 73081068 rs2526932-G 14:73081068 C-reactive protein and white blood cell count 6.00E-13 0.28 22788528 | |
| 14 73972535 rs2041073-T 14:73972535 Blood metabolite levels 3.00E-13 0.02 24816252 | |
| 14 73976934 rs8018967-T 14:73976934 Blood metabolite ratios 6.00E-19 0.03 24816252 | |
| 14 74990746 rs862034-A 14:74990746 Height 7.00E-14 0.03 20881960 | |
| 14 75701221 rs4899554-C 14:75701221 Inflammatory bowel disease 3.00E-08 1.08 23128233 | |
| 14 76005557 rs2300603-A 14:76005557 Multiple sclerosis 2.00E-08 1.11 21833088 | |
| 14 78786077 rs11624704-? 14:78786077 Obesity 3.00E-09 NR 21552555 | |
| 14 79899454 rs7141420-T 14:79899454 Obesity 1.00E-17 1.08 23563607 | |
| 14 79903376 rs2370983-A 14:79903376 Obesity 3.00E-09 1.04 23563607 | |
| 14 79936964 rs10150332-C 14:79936964 Body mass index 3.00E-11 0.13 20935630 | |
| 14 79945162 rs10146997-G 14:79945162 Waist circumference 5.00E-08 0.65 19557197 | |
| 14 81451229 rs12101261-T 14:81451229 Graves' disease 7.00E-24 1.35 21841780 | |
| 14 85809911 rs17796783-T 14:85809911 Heart rate 3.00E-13 0.33 23583979 | |
| 14 87506248 rs11624056-? 14:87506248 Sudden cardiac arrest 3.00E-08 1.43 21658281 | |
| 14 88472595 rs8005161-T 14:88472595 Crohn's disease 4.00E-18 1.23 21102463 | |
| 14 88472595 rs8005161-T 14:88472595 Inflammatory bowel disease 2.00E-14 1.15 23128233 | |
| 14 88487689 rs2119704-C 14:88487689 Multiple sclerosis 2.00E-10 1.22 21833088 | |
| 14 91442779 rs1286083-T 14:91442779 Bone mineral density 2.00E-15 0.05 22504420 | |
| 14 91841069 rs941764-G 14:91841069 Breast cancer 4.00E-10 1.06 23535729 | |
| 14 92427222 rs7153027-A 14:92427222 Height 1.00E-10 5.7 18391951 | |
| 14 92459958 rs8007661-T 14:92459958 Height 6.00E-10 0.42 18391950 | |
| 14 92485881 rs7155279-T 14:92485881 Height 1.00E-10 0.02 20881960 | |
| 14 92763391 rs4900109-G 14:92763391 Iris characteristics 8.00E-21 0.17 21835309 | |
| 14 92773663 rs12896399-T 14:92773663 Blond vs. brown hair color 1.00E-48 2.56 17952075 | |
| 14 92773663 rs12896399-T 14:92773663 Blue vs. green eyes 4.00E-38 2.06 17952075 | |
| 14 92773663 rs12896399-G 14:92773663 Hair color 2.00E-36 0.16 23548203 | |
| 14 92773663 rs12896399-G 14:92773663 Eye color 2.00E-23 1.73 20585627 | |
| 14 92773663 rs12896399-G 14:92773663 Black vs. blond hair color 8.00E-21 0.18 18483556 | |
| 14 92773663 rs12896399-T 14:92773663 Eye color 1.00E-16 0.34 20585627 | |
| 14 92773663 rs12896399-T 14:92773663 Hair color 5.00E-13 0.31 20585627 | |
| 14 92773663 rs12896399-G 14:92773663 Eye color 4.00E-11 0.33 23548203 | |
| 14 92926952 rs10498633-G 14:92926952 Alzheimer's disease (late onset) 6.00E-09 1.1 24162737 | |
| 14 93103309 rs10498635-C 14:93103309 Paget's disease 3.00E-11 1.44 21623375 | |
| 14 93115410 rs754388-C 14:93115410 "Bone mineral density (paediatric, lower limb)" 1.00E-10 0.13 24945404 | |
| 14 93115410 rs754388-C 14:93115410 "Bone mineral density (paediatric, lower limb)" 2.00E-09 0.14 24945404 | |
| 14 93115410 rs754388-C 14:93115410 "Bone mineral density (paediatric, total body less head)" 3.00E-09 0.12 24945404 | |
| 14 93115410 rs754388-C 14:93115410 Chronic obstructive pulmonary disease (moderate to severe) 5.00E-09 NR 24621683 | |
| 14 93115410 rs754388-C 14:93115410 "Bone mineral density (paediatric, total body less head)" 5.00E-08 0.12 24945404 | |
| 14 93501026 rs8006385-G 14:93501026 Platelet counts 1.00E-10 3.59 22139419 | |
| 14 93595591 rs11624776-A 14:93595591 Thyroid hormone levels 2.00E-09 0.06 23408906 | |
| 14 94844843 rs1303-? 14:94844843 Metabolite levels 5.00E-48 NR 22916037 | |
| 14 94863636 rs7151526-? 14:94863636 Antineutrophil cytoplasmic antibody-associated vasculitis 2.00E-09 1.69 22808956 | |
| 14 95012384 rs11160190-G 14:95012384 Vaspin levels 4.00E-41 0.04 22907691 | |
| 14 95720678 rs8014194-A 14:95720678 Response to statin therapy 2.00E-08 NR 20339536 | |
| 14 95764564 rs115102486-? 14:95764564 Alzheimer's disease (cognitive decline) 2.00E-08 0.31 23535033 | |
| 14 98488007 rs1456988-? 14:98488007 Graves' disease 5.00E-09 1.12 23612905 | |
| 14 98498951 rs4900384-G 14:98498951 Type 1 diabetes 4.00E-09 1.09 19430480 | |
| 14 98588321 rs7152623-? 14:98588321 Aortic stiffness 3.00E-15 0.08 22068335 | |
| 14 100133942 rs2895811-C 14:100133942 Coronary heart disease 1.00E-10 1.07 21378990 | |
| 14 101032217 rs6575793-C 14:101032217 Menarche (age at onset) 1.00E-08 2.3 21102462 | |
| 14 101159416 rs7149242-G 14:101159416 Platelet counts 3.00E-08 2.14 22139419 | |
| 14 101306045 rs941576-A 14:101306045 Type 1 diabetes 1.00E-10 1.11 19966805 | |
| 14 103040087 rs11628318-A 14:103040087 Platelet counts 2.00E-10 2.57 22139419 | |
| 14 103563195 rs8017161-A 14:103563195 Primary biliary cirrhosis 3.00E-13 1.22 21399635 | |
| 14 103566785 rs2297067-T 14:103566785 Platelet counts 2.00E-10 3.54 22139419 | |
| 14 103572815 rs944002-G 14:103572815 Liver enzyme levels (gamma-glutamyl transferase) 6.00E-29 6.3 22001757 | |
| 14 103572815 rs944002-G 14:103572815 Gamma gluatamyl transferase levels 5.00E-13 0.13 22010049 | |
| 14 103572815 rs944002-A 14:103572815 Mean platelet volume 5.00E-11 0.01 22139419 | |
| 14 103822762 rs17616316-G 14:103822762 Red blood cell traits 8.00E-11 0.01 23222517 | |
| 14 103883633 rs11623869-T 14:103883633 Bone mineral density 5.00E-16 0.04 22504420 | |
| 14 104357638 rs4144027-T 14:104357638 Blood metabolite levels 1.00E-11 0.01 24816252 | |
| 14 105277209 rs4983559-G 14:105277209 HDL cholesterol 1.00E-08 0.02 24097068 | |
| 14 105391005 rs2841277-T 14:105391005 Rheumatoid arthritis 2.00E-14 1.15 22446963 | |
| 14 105392837 rs2582532-C 14:105392837 Rheumatoid arthritis 5.00E-08 1.18 24390342 | |
| 14 105729792 rs3000073-G 14:105729792 Mean platelet volume 3.00E-11 0.01 22139419 | |
| 14 106232585 rs10136766-A 14:106232585 IgG levels 8.00E-16 0.23 23225573 | |
| 15 25894658 rs6576443-A 15:25894658 Immune reponse to smallpox (secreted IFN-alpha) 6.00E-09 NR 22610502 | |
| 15 26277545 rs4906844-? 15:26277545 Cortical thickness 1.00E-08 0.07 21810643 | |
| 15 28335820 rs11855019-G 15:28335820 Black vs. blond hair color 2.00E-24 0.28 18483556 | |
| 15 28335820 rs11855019-G 15:28335820 Black vs. red hair color 6.00E-20 0.29 18483556 | |
| 15 28356859 rs1129038-C 15:28356859 Vitiligo 4.00E-08 1.22 22561518 | |
| 15 28365618 rs12913832-A 15:28365618 Eye color 1.00E-300 2.49 20585627 | |
| 15 28365618 rs12913832-? 15:28365618 Eye color traits 1.00E-300 NR 20463881 | |
| 15 28365618 rs12913832-A 15:28365618 Eye color 1.00E-177 2.82 23548203 | |
| 15 28365618 rs12913832-G 15:28365618 Hair color 1.00E-167 0.39 23548203 | |
| 15 28365618 rs12913832-G 15:28365618 Eye color 1.00E-158 2.84 23548203 | |
| 15 28365618 rs12913832-A 15:28365618 Black vs. blond hair color 4.00E-103 0.44 18483556 | |
| 15 28365618 rs12913832-A 15:28365618 Hair color 9.00E-88 0.97 20585627 | |
| 15 28365618 rs12913832-A 15:28365618 Black vs. red hair color 1.00E-77 0.44 18483556 | |
| 15 28365618 rs12913832-A 15:28365618 Eye color 3.00E-52 8.43 20585627 | |
| 15 28365618 rs12913832-G 15:28365618 Tanning 1.00E-22 0.14 23548203 | |
| 15 28513364 rs916977-? 15:28513364 Iris color 1.00E-43 NR 18252221 | |
| 15 28530182 rs1667394-A 15:28530182 Blue vs. brown eyes 1.00E-241 29.43 17952075 | |
| 15 28530182 rs1667394-A 15:28530182 Blue vs. green eyes 2.00E-53 6.74 17952075 | |
| 15 28530182 rs1667394-A 15:28530182 Blond vs. brown hair color 6.00E-35 4.94 17952075 | |
| 15 28530182 rs1667394-C 15:28530182 Eye color 2.00E-20 0.35 23118974 | |
| 15 29006093 rs8033165-T 15:29006093 Black vs. red hair color 2.00E-12 0.15 18483556 | |
| 15 29006093 rs8033165-T 15:29006093 Black vs. blond hair color 5.00E-11 0.12 18483556 | |
| 15 30173885 rs785422-T 15:30173885 Corneal structure 3.00E-11 0.14 23291589 | |
| 15 32927476 rs8037818-G 15:32927476 Obesity-related traits 5.00E-08 0.04 23251661 | |
| 15 32994756 rs4779584-? 15:32994756 Colorectal cancer 2.00E-08 1.18 21761138 | |
| 15 33012502 rs73376930-G 15:33012502 Colorectal cancer 1.00E-11 1.25 24737748 | |
| 15 33905410 rs2229116-G 15:33905410 Carotid atherosclerosis in HIV infection 3.00E-08 NR 20009918 | |
| 15 34989626 rs11073058-T 15:34989626 Axial length 4.00E-11 0.07 24144296 | |
| 15 35005886 rs524952-A 15:35005886 Refractive error 1.00E-15 0.16 23396134 | |
| 15 35006073 rs634990-C 15:35006073 Refractive error 2.00E-14 0.23 20835239 | |
| 15 37349802 rs1568679-? 15:37349802 Response to antipsychotic treatment 1.00E-08 NR 20195266 | |
| 15 38764843 rs11073328-T 15:38764843 Systemic lupus erythematosus 1.00E-14 1.94 24871463 | |
| 15 38822905 rs7403531-T 15:38822905 Type 2 diabetes 4.00E-09 1.1 22961080 | |
| 15 38834033 rs8032939-C 15:38834033 Rheumatoid arthritis 2.00E-18 1.13 24390342 | |
| 15 38834033 rs8032939-C 15:38834033 Rheumatoid arthritis 3.00E-14 1.13 24390342 | |
| 15 38899190 rs16967103-C 15:38899190 Crohn's disease 4.00E-09 1.09 23128233 | |
| 15 40339494 rs4924410-A 15:40339494 Ewing sarcoma 7.00E-09 1.46 22327514 | |
| 15 40360741 rs7181230-G 15:40360741 Dehydroepiandrosterone sulphate levels 5.00E-11 0.05 21533175 | |
| 15 40700022 rs10518693-T 15:40700022 Metabolic traits 1.00E-13 0.09 21886157 | |
| 15 40703211 rs9635324-A 15:40703211 Blood metabolite ratios 9.00E-43 0.04 24816252 | |
| 15 40703211 rs9635324-A 15:40703211 Blood metabolite levels 2.00E-35 0.03 24816252 | |
| 15 40717302 rs2034650-A 15:40717302 Interstitial lung disease 1.00E-11 1.3 23583980 | |
| 15 41563950 rs28374715-A 15:41563950 Ulcerative colitis 2.00E-08 1.08 23128233 | |
| 15 42683787 rs2412710-A 15:42683787 Triglycerides 2.00E-11 0.1 24097068 | |
| 15 42683787 rs2412710-A 15:42683787 Triglycerides 2.00E-08 7 20686565 | |
| 15 43836478 rs2251844-C 15:43836478 Tumor biomarkers 1.00E-14 0.09 23300138 | |
| 15 44219607 rs16948098-A 15:44219607 Serum albumin level 2.00E-08 0.02 23022100 | |
| 15 44245931 rs2929282-T 15:44245931 Triglycerides 2.00E-11 5.13 20686565 | |
| 15 44245931 rs2929282-T 15:44245931 Triglycerides 2.00E-09 0.07 24097068 | |
| 15 45641225 rs2453533-? 15:45641225 Chronic kidney disease 5.00E-22 NR 20383146 | |
| 15 45652703 rs1153858-C 15:45652703 Homoarginine levels 1.00E-45 0.27 24047826 | |
| 15 45686091 rs2433610-T 15:45686091 Serum metabolite levels 9.00E-12 0.09 24625756 | |
| 15 45698793 rs2467853-G 15:45698793 Renal function and chronic kidney disease 6.00E-14 0.01 19430482 | |
| 15 45719187 rs17536527-C 15:45719187 Glomerular filtration rate 8.00E-10 1.13 23535967 | |
| 15 46639808 rs4775302-? 15:46639808 Prostate cancer 4.00E-08 NR 22130093 | |
| 15 48392165 rs1834640-G 15:48392165 Skin pigmentation 1.00E-50 12.5 17999355 | |
| 15 48914775 rs1036476-? 15:48914775 Thoracic aortic aneurysms and dissections 6.00E-13 1.9 21909107 | |
| 15 49735297 rs4338740-C 15:49735297 Thyroid volume 3.00E-13 1.45 21565293 | |
| 15 49735297 rs4338740-T 15:49735297 Thyroid volume 1.00E-12 0.07 21565293 | |
| 15 49746364 rs10519227-A 15:49746364 Thyroid hormone levels 1.00E-11 0.07 23408906 | |
| 15 49746364 rs10519227-A 15:49746364 Thyroid hormone levels 6.00E-10 0.1 23408906 | |
| 15 50477138 rs1365505-T 15:50477138 Blood metabolite ratios 4.00E-14 0.03 24816252 | |
| 15 51048602 rs12915708-C 15:51048602 Fibrinogen 7.00E-10 0.01 23969696 | |
| 15 51516055 rs2899472-A 15:51516055 Cerebrospinal AB1-42 levels 2.00E-09 NR 20932310 | |
| 15 51524292 rs2414095-A 15:51524292 Hormone measurements 7.00E-31 0.08 24049095 | |
| 15 51524292 rs2414095-A 15:51524292 Follicule stimulating hormone 2.00E-16 0.11 24049095 | |
| 15 51530495 rs16964211-A 15:51530495 Height 2.00E-09 0.05 20881960 | |
| 15 51573533 rs3751599-G 15:51573533 Height 5.00E-10 0.19 23456168 | |
| 15 51617708 rs2445762-C 15:51617708 Hormone measurements 8.00E-28 0.11 24049095 | |
| 15 53279378 rs719714-? 15:53279378 Cognitive function 4.00E-08 9.45 22126837 | |
| 15 53907948 rs17730281-G 15:53907948 Renal function-related traits (BUN) 3.00E-11 0.01 22797727 | |
| 15 53940307 rs10518733-C 15:53940307 Hematological and biochemical traits 2.00E-08 0.07 20139978 | |
| 15 53942928 rs17730436-T 15:53942928 Renal function-related traits (sCR) 1.00E-13 0.01 22797727 | |
| 15 53942928 rs17730436-T 15:53942928 Renal function-related traits (eGRFcrea) 6.00E-13 0.01 22797727 | |
| 15 53946593 rs491567-C 15:53946593 Chronic kidney disease 3.00E-13 0.01 20383146 | |
| 15 56194877 rs8032158-C 15:56194877 Keloid 6.00E-13 1.51 20711176 | |
| 15 56210929 rs17819300-? 15:56210929 Brain connectivity 1.00E-10 NR 23471985 | |
| 15 58471979 rs16939881-? 15:58471979 Metabolite levels 3.00E-27 NR 22916037 | |
| 15 58674695 rs4775041-C 15:58674695 HDL cholesterol 3.00E-20 1.38 18193043 | |
| 15 58674695 rs4775041-C 15:58674695 Triglycerides 2.00E-08 3.62 18193043 | |
| 15 58678512 rs10468017-? 15:58678512 Phospholipid levels (plasma) 7.00E-43 0 22359512 | |
| 15 58678512 rs10468017-T 15:58678512 HDL cholesterol 8.00E-23 0.1 19060906 | |
| 15 58678512 rs10468017-T 15:58678512 Blood metabolite levels 3.00E-12 0.02 24816252 | |
| 15 58678512 rs10468017-T 15:58678512 Cardiovascular disease risk factors 3.00E-12 0.1 21943158 | |
| 15 58678512 rs10468017-? 15:58678512 Age-related macular degeneration 3.00E-12 1.19 21665990 | |
| 15 58678512 rs10468017-? 15:58678512 Age-related macular degeneration 1.00E-08 1.22 20385826 | |
| 15 58680643 rs35853021-? 15:58680643 Lipid metabolism phenotypes 7.00E-76 0.31 22286219 | |
| 15 58680954 rs2043085-A 15:58680954 Metabolic syndrome (bivariate traits) 1.00E-08 0.17 21386085 | |
| 15 58680954 rs2043085-T 15:58680954 Lipid traits 2.00E-08 0.01 24386095 | |
| 15 58683366 rs1532085-A 15:58683366 HDL cholesterol 1.00E-188 0.11 24097068 | |
| 15 58683366 rs1532085-? 15:58683366 Metabolite levels 9.00E-104 NR 22916037 | |
| 15 58683366 rs1532085-A 15:58683366 HDL cholesterol 3.00E-96 1.45 20686565 | |
| 15 58683366 rs1532085-A 15:58683366 "Cholesterol, total" 7.00E-47 0.05 24097068 | |
| 15 58683366 rs1532085-G 15:58683366 HDL cholesterol 1.00E-35 0.13 19060911 | |
| 15 58683366 rs1532085-G 15:58683366 Metabolic syndrome 5.00E-24 0.13 22399527 | |
| 15 58683366 rs1532085-A 15:58683366 "Cholesterol, total" 9.00E-20 1.54 20686565 | |
| 15 58683366 rs1532085-? 15:58683366 Lipid metabolism phenotypes 1.00E-19 0.11 19936222 | |
| 15 58683366 rs1532085-A 15:58683366 Triglycerides 2.00E-18 0.03 24097068 | |
| 15 58683366 rs1532085-? 15:58683366 Lipid metabolism phenotypes 4.00E-16 0.11 19936222 | |
| 15 58683366 rs1532085-? 15:58683366 Lipid metabolism phenotypes 9.00E-15 1.42 19936222 | |
| 15 58683366 rs1532085-G 15:58683366 Triglycerides 2.00E-13 2.99 20686565 | |
| 15 58683366 rs1532085-G 15:58683366 Red blood cell traits 7.00E-11 0.03 23222517 | |
| 15 58683366 rs1532085-A 15:58683366 HDL cholesterol 2.00E-10 0.05 19060910 | |
| 15 58687880 rs493258-C 15:58687880 Age-related macular degeneration 2.00E-08 1.16 20385826 | |
| 15 58688467 rs920915-C 15:58688467 Age-related macular degeneration 3.00E-11 1.13 23455636 | |
| 15 58694020 rs16940212-T 15:58694020 HDL cholesterol 1.00E-24 0.02 21909109 | |
| 15 58723426 rs1077835-A 15:58723426 HDL cholesterol 2.00E-14 0.17 23505323 | |
| 15 58723479 rs1077834-T 15:58723479 Hematological and biochemical traits 1.00E-14 0.14 20139978 | |
| 15 58723675 rs1800588-T 15:58723675 HDL cholesterol 2.00E-32 0.14 18193044 | |
| 15 58723939 rs2070895-A 15:58723939 Blood metabolite levels 1.00E-18 0.03 24816252 | |
| 15 58726744 rs261334-G 15:58726744 HDL cholesterol 5.00E-22 0.03 20864672 | |
| 15 58730498 rs588136-? 15:58730498 Lipid traits 2.00E-12 0.05 24023260 | |
| 15 58730498 rs588136-T 15:58730498 Blood metabolite levels 8.00E-12 0.03 24816252 | |
| 15 58731153 rs261342-C 15:58731153 Metabolite levels 9.00E-13 NR 23281178 | |
| 15 59487930 rs2306786-? 15:59487930 Metabolite levels 1.00E-10 NR 22916037 | |
| 15 60878030 rs340005-G 15:60878030 Gamma gluatamyl transferase levels 2.00E-08 0.08 22010049 | |
| 15 60883281 rs339969-A 15:60883281 Liver enzyme levels (gamma-glutamyl transferase) 7.00E-20 4.5 22001757 | |
| 15 60894965 rs340029-T 15:60894965 C-reactive protein 4.00E-09 0.03 21300955 | |
| 15 62380259 rs7178424-T 15:62380259 Height 6.00E-09 0.02 20881960 | |
| 15 62383155 rs4502156-T 15:62383155 Proinsulin levels 4.00E-20 NR 21873549 | |
| 15 62396389 rs7172432-? 15:62396389 Type 2 diabetes 9.00E-14 1.11 20818381 | |
| 15 62396942 rs7173964-? 15:62396942 Fasting glucose-related traits (interaction with BMI) 6.00E-12 NR 22581228 | |
| 15 62433962 rs11071657-A 15:62433962 Fasting glucose-related traits 4.00E-08 NR 20081858 | |
| 15 63333724 rs3809566-G 15:63333724 Platelet counts 4.00E-10 2.44 22139419 | |
| 15 63341996 rs11071720-T 15:63341996 Mean platelet volume 2.00E-08 0.01 19820697 | |
| 15 63396867 rs2652834-A 15:63396867 HDL cholesterol 4.00E-11 0.03 24097068 | |
| 15 63396867 rs2652834-A 15:63396867 HDL cholesterol 9.00E-09 0.39 20686565 | |
| 15 63422772 rs2652822-C 15:63422772 Metabolic traits 7.00E-27 0.09 21886157 | |
| 15 63423739 rs1472631-A 15:63423739 Blood metabolite levels 2.00E-88 0.04 24816252 | |
| 15 63737925 rs10519210-? 15:63737925 Heart failure 1.00E-08 1.53 20445134 | |
| 15 65183801 rs1719271-G 15:65183801 Platelet counts 1.00E-11 3.41 22139419 | |
| 15 66051345 rs6494537-C 15:66051345 Mean corpuscular hemoglobin 3.00E-09 0.08 20139978 | |
| 15 66070693 rs2572207-C 15:66070693 Red blood cell traits 3.00E-09 0.15 23222517 | |
| 15 67442596 rs17293632-T 15:67442596 Crohn's disease 3.00E-19 1.12 21102463 | |
| 15 67442596 rs17293632-T 15:67442596 Inflammatory bowel disease 6.00E-16 1.07 23128233 | |
| 15 67446785 rs744910-G 15:67446785 Asthma 4.00E-09 1.12 20860503 | |
| 15 67450305 rs17228058-G 15:67450305 Self-reported allergy 1.00E-08 0.08 23817569 | |
| 15 67467507 rs12913547-T 15:67467507 Corneal structure 5.00E-10 0.08 23291589 | |
| 15 67468285 rs17294280-G 15:67468285 Asthma and hay fever 4.00E-09 1.18 24388013 | |
| 15 68036852 rs12593813-G 15:68036852 Restless legs syndrome 1.00E-22 1.41 21779176 | |
| 15 68036852 rs12593813-G 15:68036852 Restless legs syndrome 1.00E-15 1.5 17637780 | |
| 15 68043057 rs8028313-C 15:68043057 Obesity 6.00E-13 1.08 23563607 | |
| 15 68043057 rs8028313-C 15:68043057 Obesity 1.00E-11 1.06 23563607 | |
| 15 68080886 rs4776970-A 15:68080886 Body mass index 2.00E-09 2.55 22344219 | |
| 15 68086838 rs2241423-G 15:68086838 Body mass index 1.00E-18 0.13 20935630 | |
| 15 69059084 rs8030672-A 15:69059084 Esophageal cancer 1.00E-11 1.56 21642993 | |
| 15 69991417 rs8026898-A 15:69991417 Rheumatoid arthritis 4.00E-19 1.15 24390342 | |
| 15 69991417 rs8026898-A 15:69991417 Rheumatoid arthritis 6.00E-18 1.15 24390342 | |
| 15 70018990 rs7176508-A 15:70018990 Chronic lymphocytic leukemia 8.00E-18 1.42 24292274 | |
| 15 70018990 rs7176508-A 15:70018990 Chronic lymphocytic leukemia 1.00E-17 1.32 23770605 | |
| 15 70018990 rs7176508-A 15:70018990 Chronic lymphocytic leukemia 5.00E-12 1.37 18758461 | |
| 15 70018990 rs7176508-A 15:70018990 Chronic lymphocytic leukemia 3.00E-11 1.42 22700719 | |
| 15 70048157 rs10152591-A 15:70048157 Height 3.00E-10 0.04 20881960 | |
| 15 71109147 rs1549318-T 15:71109147 Proinsulin levels 2.00E-10 NR 21873549 | |
| 15 71645120 rs12899618-? 15:71645120 Pulmonary function (interaction) 4.00E-21 NR 23284291 | |
| 15 71645120 rs12899618-G 15:71645120 Pulmonary function 7.00E-15 0.09 20010834 | |
| 15 71696886 rs12441227-? 15:71696886 Pulmonary function 3.00E-09 NR 23932459 | |
| 15 72161403 rs12902421-T 15:72161403 Height 3.00E-08 0.06 20881960 | |
| 15 73652174 rs7164883-G 15:73652174 Atrial fibrillation 3.00E-17 1.19 22544366 | |
| 15 73665506 rs4489968-T 15:73665506 Heart rate 4.00E-20 0.51 23583979 | |
| 15 73978337 rs8038465-T 15:73978337 Liver enzyme levels (gamma-glutamyl transferase) 1.00E-09 2.4 22001757 | |
| 15 74176557 rs16958445-G 15:74176557 Exfoliation glaucoma or exfoliation syndrome 2.00E-16 5.18 24938310 | |
| 15 74219582 rs3825942-G 15:74219582 Glaucoma (exfoliation) 3.00E-21 20.1 17690259 | |
| 15 74226765 rs4337252-C 15:74226765 Height 7.00E-09 1.14 23563607 | |
| 15 74229195 rs893818-T 15:74229195 Exfoliation glaucoma or exfoliation syndrome 3.00E-84 20.94 24938310 | |
| 15 74241506 rs750460-? 15:74241506 Height 4.00E-12 NR 20881960 | |
| 15 74305966 rs8039584-? 15:74305966 Myopia (pathological) 5.00E-08 NR 23049088 | |
| 15 74336633 rs5742915-T 15:74336633 Height 1.00E-15 0.03 20881960 | |
| 15 74336633 rs5742915-C 15:74336633 Paget's disease 2.00E-14 1.34 21623375 | |
| 15 75019449 rs2470893-T 15:75019449 Caffeine consumption 5.00E-14 0.12 21490707 | |
| 15 75019449 rs2470893-T 15:75019449 Coffee consumption 2.00E-11 0.07 21876539 | |
| 15 75027880 rs2472297-T 15:75027880 Coffee consumption 5.00E-14 0.31 21357676 | |
| 15 75077367 rs1378942-C 15:75077367 Diastolic blood pressure 3.00E-26 0.42 21909115 | |
| 15 75077367 rs1378942-C 15:75077367 Diastolic blood pressure 1.00E-23 0.43 19430483 | |
| 15 75077367 rs1378942-C 15:75077367 Systolic blood pressure 6.00E-23 0.61 21909115 | |
| 15 75077367 rs1378942-C 15:75077367 Blood pressure 2.00E-15 0.39 21909110 | |
| 15 75125645 rs6495122-A 15:75125645 Diastolic blood pressure 2.00E-10 0.4 19430479 | |
| 15 75125645 rs6495122-A 15:75125645 Coffee consumption 7.00E-09 0.05 21876539 | |
| 15 75334184 rs2120019-C 15:75334184 Blood trace element (Zn levels) 2.00E-18 0.29 23720494 | |
| 15 75424593 rs7172677-? 15:75424593 Systemic lupus erythematosus and Systemic sclerosis 3.00E-08 1.21 23740937 | |
| 15 76158983 rs1394125-A 15:76158983 Chronic kidney disease 3.00E-17 0.01 20383146 | |
| 15 76158983 rs1394125-A 15:76158983 Urate levels 3.00E-13 0.04 23263486 | |
| 15 76293971 rs11072566-A 15:76293971 Red blood cell traits 3.00E-10 0.03 23222517 | |
| 15 77030792 rs2404602-A 15:77030792 Blood metabolite levels 4.00E-13 0.03 24816252 | |
| 15 77747190 rs7178572-G 15:77747190 Type 2 diabetes 2.00E-11 1.08 24509480 | |
| 15 77747190 rs7178572-G 15:77747190 Type 2 diabetes 7.00E-11 1.09 21874001 | |
| 15 77747190 rs7178572-G 15:77747190 Type 2 diabetes 1.00E-08 1.11 22693455 | |
| 15 77963887 rs9652490-G 15:77963887 Essential tremor 1.00E-09 1.55 19182806 | |
| 15 78789488 rs13180-? 15:78789488 Chronic obstructive pulmonary disease 2.00E-08 1.3 20173748 | |
| 15 78806023 rs8034191-? 15:78806023 Lung cancer 3.00E-26 1.29 19654303 | |
| 15 78806023 rs8034191-C 15:78806023 Lung cancer 5.00E-20 1.3 18385738 | |
| 15 78806023 rs8034191-G 15:78806023 Lung cancer 3.00E-18 1.3 18385676 | |
| 15 78806023 rs8034191-C 15:78806023 Chronic obstructive pulmonary disease 1.00E-10 1.4 19300482 | |
| 15 78806023 rs8034191-G 15:78806023 Lung cancer 1.00E-08 1.38 18780872 | |
| 15 78816057 rs8031948-T 15:78816057 Airflow obstruction 3.00E-09 1.22 22837378 | |
| 15 78833223 rs12901682-? 15:78833223 Response to tocilizumab in rheumatoid arthritis 4.00E-08 135.02 22491018 | |
| 15 78851615 rs2036527-A 15:78851615 Smoking behavior 2.00E-08 0.04 22832964 | |
| 15 78894339 rs1051730-G 15:78894339 Smoking behavior 3.00E-73 1.02 20418890 | |
| 15 78894339 rs1051730-A 15:78894339 Smoking behavior 2.00E-69 0.8 20418888 | |
| 15 78894339 rs1051730-G 15:78894339 Smoking behavior 2.00E-66 0.08 20418889 | |
| 15 78894339 rs1051730-T 15:78894339 Lung adenocarcinoma 2.00E-51 1.31 19836008 | |
| 15 78894339 rs1051730-T 15:78894339 Nicotine dependence 6.00E-20 0.1 18385739 | |
| 15 78894339 rs1051730-A 15:78894339 Lung cancer 1.00E-15 1.35 18978790 | |
| 15 78898723 rs12914385-T 15:78898723 Chronic obstructive pulmonary disease (severe) 3.00E-16 1.39 24621683 | |
| 15 78898723 rs12914385-T 15:78898723 Chronic obstructive pulmonary disease (moderate to severe) 6.00E-14 1.28 24621683 | |
| 15 78908032 rs8042374-? 15:78908032 Lung cancer 8.00E-12 NR 18978787 | |
| 15 79019578 rs899997-? 15:79019578 Coronary artery disease or large artery stroke 2.00E-08 NR 24262325 | |
| 15 79029723 rs2219939-? 15:79029723 Coronary artery disease or ischemic stroke 2.00E-09 NR 24262325 | |
| 15 79080234 rs1994016-C 15:79080234 Coronary heart disease 5.00E-13 1.19 21239051 | |
| 15 79089111 rs3825807-A 15:79089111 Coronary heart disease 1.00E-12 1.08 21378990 | |
| 15 79111093 rs4380028-C 15:79111093 Coronary heart disease 4.00E-09 1.07 21378988 | |
| 15 79235446 rs3825932-T 15:79235446 Type 1 diabetes 3.00E-15 1.16 18978792 | |
| 15 79372875 rs4778879-G 15:79372875 Refractive error 4.00E-11 0.1 23396134 | |
| 15 79451869 rs939658-G 15:79451869 Refractive error 2.00E-09 0.15 20835236 | |
| 15 80432222 rs11634397-G 15:80432222 Type 2 diabetes 2.00E-09 1.06 20581827 | |
| 15 84568158 rs10906982-A 15:84568158 Height 2.00E-08 0.05 18391952 | |
| 15 84580156 rs11259933-A 15:84580156 Height 1.00E-19 1.19 23563607 | |
| 15 84580582 rs11259936-A 15:84580582 Height 2.00E-35 0.04 20881960 | |
| 15 84582124 rs4842838-? 15:84582124 Height 3.00E-08 0.06 19343178 | |
| 15 85825567 rs6496932-A 15:85825567 Corneal structure 7.00E-13 0.11 23291589 | |
| 15 85825567 rs6496932-C 15:85825567 Central corneal thickness 1.00E-08 0.13 20719862 | |
| 15 87191977 rs2469184-A 15:87191977 Activated partial thromboplastin time 4.00E-08 0.16 22703881 | |
| 15 89119104 rs17776563-A 15:89119104 Thyroid hormone levels 3.00E-10 0.06 23408906 | |
| 15 89388905 rs16942341-T 15:89388905 Height 4.00E-27 0.13 20881960 | |
| 15 89395626 rs2280470-A 15:89395626 Height 1.00E-15 1.18 23563607 | |
| 15 89395626 rs2280470-? 15:89395626 Height 1.00E-14 NR 20881960 | |
| 15 89398105 rs2351491-T 15:89398105 Height 2.00E-09 0.06 21998595 | |
| 15 89863928 rs2307449-G 15:89863928 Menopause (age at onset) 4.00E-13 0.18 22267201 | |
| 15 90089276 rs8038108-C 15:90089276 Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry) 5.00E-09 0.01 24825563 | |
| 15 90345335 rs2007084-A 15:90345335 Blood metabolite levels 2.00E-12 0.07 24816252 | |
| 15 90374257 rs2028299-C 15:90374257 Type 2 diabetes 2.00E-11 1.1 21874001 | |
| 15 91172901 rs7495132-C 15:91172901 Inflammatory bowel disease 9.00E-11 1.13 23128233 | |
| 15 91437388 rs2521501-T 15:91437388 Systolic blood pressure 5.00E-19 0.65 21909115 | |
| 15 91437388 rs2521501-T 15:91437388 Diastolic blood pressure 2.00E-15 0.36 21909115 | |
| 15 91437388 rs2521501-T 15:91437388 Blood pressure 3.00E-08 0.34 21909110 | |
| 15 91521337 rs8042680-A 15:91521337 Type 2 diabetes 2.00E-10 1.07 20581827 | |
| 15 94141833 rs12437854-G 15:94141833 Type 1 diabetes nephropathy 2.00E-09 1.8 23028342 | |
| 15 95270467 rs7173947-C 15:95270467 Hematological and biochemical traits 3.00E-08 0.11 20139978 | |
| 15 96708291 rs8023580-T 15:96708291 Sex hormone-binding globulin levels 8.00E-12 0.03 22829776 | |
| 15 97607681 rs8023715-A 15:97607681 Systemic lupus erythematosus 1.00E-08 1.81 24871463 | |
| 15 99194896 rs2871865-C 15:99194896 Height 3.00E-21 0.06 20881960 | |
| 15 99271135 rs6598541-A 15:99271135 Urate levels 5.00E-15 0.04 23263486 | |
| 15 100758385 rs4965593-C 15:100758385 Height 7.00E-10 1.15 23563607 | |
| 15 100759614 rs4965598-T 15:100759614 Height 4.00E-13 0.03 20881960 | |
| 15 100786271 rs4533267-A 15:100786271 Height 3.00E-08 5.6 18391951 | |
| 15 101558562 rs930847-T 15:101558562 Corneal structure 6.00E-19 0.11 23291589 | |
| 15 101781934 rs752092-A 15:101781934 Corneal structure 2.00E-09 0.08 23291589 | |
| 15 101865472 rs7182874-T 15:101865472 Relative hand skill in reading disability 9.00E-09 0.37 24068947 | |
| 15 101875123 rs11855415-A 15:101875123 Handedness in dyslexia 2.00E-08 0.35 21051773 | |
| 16 163598 rs11248850-G 16:163598 Red blood cell traits 6.00E-23 0.01 23222517 | |
| 16 184390 rs7203560-G 16:184390 Mean corpuscular hemoglobin 5.00E-62 1.26 23263863 | |
| 16 184390 rs7203560-G 16:184390 Mean corpuscular volume 8.00E-43 2.56 23263863 | |
| 16 184390 rs7203560-G 16:184390 Mean corpuscular hemoglobin concentration 1.00E-33 0.53 23263863 | |
| 16 184390 rs7203560-G 16:184390 Hematology traits 2.00E-23 0.15 23263863 | |
| 16 184390 rs7203560-C 16:184390 Sickle cell anemia (haemolysis) 2.00E-09 0.44 23406172 | |
| 16 184390 rs7203560-G 16:184390 Hematology traits 2.00E-08 0.2 23263863 | |
| 16 225653 rs2858942-A 16:225653 Mean corpuscular hemoglobin 3.00E-09 0.07 20139978 | |
| 16 240280 rs1211375-A 16:240280 Mean corpuscular hemoglobin 3.00E-17 0.21 23263863 | |
| 16 240280 rs1211375-A 16:240280 Mean corpuscular volume 1.00E-16 0.53 23263863 | |
| 16 240280 rs1211375-A 16:240280 Hematology traits 7.00E-14 0.04 23263863 | |
| 16 298588 rs13339636-G 16:298588 Red blood cell traits 2.00E-34 0.68 23446634 | |
| 16 304803 rs7189020-T 16:304803 Mean corpuscular volume 2.00E-12 0 19862010 | |
| 16 309155 rs1122794-A 16:309155 Mean corpuscular hemoglobin 3.00E-10 0 19862010 | |
| 16 309155 rs1122794-A 16:309155 Red blood cell traits 1.00E-08 0.16 23446634 | |
| 16 310380 rs13335629-A 16:310380 Red blood cell traits 9.00E-48 0.33 23446634 | |
| 16 310380 rs13335629-A 16:310380 Red blood cell traits 7.00E-24 0.17 23446634 | |
| 16 310380 rs13335629-A 16:310380 Red blood cell traits 3.00E-23 0.19 23446634 | |
| 16 310380 rs13335629-A 16:310380 Red blood cell traits 4.00E-22 0.65 23446634 | |
| 16 314780 rs9924561-T 16:314780 Red blood cell traits 8.00E-36 1.56 23696099 | |
| 16 314780 rs9924561-T 16:314780 Red blood cell traits 5.00E-29 3.57 23696099 | |
| 16 314780 rs9924561-T 16:314780 Red blood cell traits 9.00E-17 0.47 23696099 | |
| 16 375782 rs9921222-T 16:375782 Bone mineral density 1.00E-16 0.04 22504420 | |
| 16 580124 rs2266928-A 16:580124 Mean corpuscular hemoglobin concentration 3.00E-11 0.12 23263863 | |
| 16 792190 rs11648796-A 16:792190 Height 1.00E-13 0.03 20881960 | |
| 16 1532463 rs13336428-A 16:1532463 Bone mineral density 1.00E-16 0.04 22504420 | |
| 16 1837406 rs2235649-T 16:1837406 Blood metabolite levels 2.00E-11 0.02 24816252 | |
| 16 1838836 rs1065656-G 16:1838836 Insulin-like growth factors 1.00E-11 NR 21216879 | |
| 16 2249376 rs26868-A 16:2249376 Height 9.00E-17 0.03 20881960 | |
| 16 4013467 rs2531995-T 16:4013467 Obesity 4.00E-08 1.07 23563607 | |
| 16 5585852 rs870288-? 16:5585852 Phospholipid levels (plasma) 1.00E-08 0.8 22359512 | |
| 16 7459347 rs10500355-? 16:7459347 Refractive error 4.00E-09 0.11 23474815 | |
| 16 7459683 rs17648524-C 16:7459683 Refractive error 6.00E-10 0.12 23396134 | |
| 16 9862556 rs11866328-G 16:9862556 Hepatitis B 2.00E-08 1.68 22004137 | |
| 16 11177801 rs7200786-A 16:11177801 Multiple sclerosis 9.00E-17 1.15 21833088 | |
| 16 11179873 rs12708716-A 16:11179873 Type 1 diabetes 3.00E-18 1.23 17554260 | |
| 16 11179873 rs12708716-? 16:11179873 Type 1 diabetes 2.00E-16 NR 19430480 | |
| 16 11179873 rs12708716-G 16:11179873 Type 1 diabetes autoantibodies 5.00E-14 1.2 21829393 | |
| 16 11179873 rs12708716-G 16:11179873 Type 1 diabetes 7.00E-13 NR 18978792 | |
| 16 11187783 rs12924729-G 16:11187783 Primary biliary cirrhosis 3.00E-12 1.29 21399635 | |
| 16 11228712 rs62026376-C 16:11228712 Asthma and hay fever 1.00E-08 1.17 24388013 | |
| 16 11238783 rs2903692-G 16:11238783 Type 1 diabetes 7.00E-11 1.54 17632545 | |
| 16 11347858 rs4780355-T 16:11347858 Crohn's disease and psoriasis 1.00E-13 1.16 22482804 | |
| 16 11373320 rs529866-C 16:11373320 Inflammatory bowel disease 2.00E-16 1.12 23128233 | |
| 16 11403893 rs12928822-? 16:11403893 Celiac disease 3.00E-08 1.16 20190752 | |
| 16 11691753 rs8049607-T 16:11691753 QT interval 5.00E-15 1.23 19305408 | |
| 16 11691753 rs8049607-T 16:11691753 QT interval 6.00E-15 1.25 19305409 | |
| 16 11839326 rs4780401-T 16:11839326 Rheumatoid arthritis 9.00E-09 1.09 24390342 | |
| 16 11839326 rs4780401-T 16:11839326 Rheumatoid arthritis 4.00E-08 1.07 24390342 | |
| 16 12016919 rs10852344-C 16:12016919 Menopause (age at onset) 1.00E-11 0.17 22267201 | |
| 16 12016919 rs10852344-T 16:12016919 Menopause (age at onset) 5.00E-08 0.16 23307926 | |
| 16 14388305 rs1659127-A 16:14388305 Height 1.00E-11 0.03 20881960 | |
| 16 14388305 rs1659127-A 16:14388305 Menarche (age at onset) 4.00E-09 2.4 21102462 | |
| 16 14395432 rs246185-T 16:14395432 Puberty onset (genital enlargement) 9.00E-09 0.14 24770850 | |
| 16 15129459 rs4985155-A 16:15129459 Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid) 2.00E-67 0.22 24823311 | |
| 16 15129459 rs4985155-A 16:15129459 Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid) 2.00E-12 0.01 24823311 | |
| 16 15129459 rs4985155-A 16:15129459 Bone mineral density 2.00E-10 0.03 22504420 | |
| 16 15129940 rs3198697-T 16:15129940 Triglycerides 2.00E-08 0.02 24097068 | |
| 16 15129970 rs7200543-G 16:15129970 Metabolic traits 5.00E-16 0.07 21886157 | |
| 16 15130351 rs1741-C 16:15130351 Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid) 2.00E-10 0.2 24823311 | |
| 16 15130594 rs6498540-A 16:15130594 Blood metabolite levels 3.00E-11 0.02 24816252 | |
| 16 15132108 rs2740-A 16:15132108 Blood metabolite ratios 5.00E-32 0.02 24816252 | |
| 16 15140211 rs4500751-? 16:15140211 Phospholipid levels (plasma) 6.00E-23 0 22359512 | |
| 16 15148646 rs11075253-? 16:15148646 Lipid metabolism phenotypes 5.00E-15 0.14 22286219 | |
| 16 15150833 rs2280018-A 16:15150833 Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid) 5.00E-25 0.16 24823311 | |
| 16 15150833 rs2280018-A 16:15150833 Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid) 4.00E-14 0.38 24823311 | |
| 16 16123459 rs924135-A 16:16123459 Blood metabolite levels 2.00E-19 0.02 24816252 | |
| 16 16127235 rs2062541-A 16:16127235 Blood metabolite ratios 1.00E-25 0.02 24816252 | |
| 16 16127235 rs2062541-A 16:16127235 Blood metabolite levels 6.00E-13 0.02 24816252 | |
| 16 16128742 rs246234-C 16:16128742 Blood metabolite levels 3.00E-14 0.02 24816252 | |
| 16 19933600 rs12444979-C 16:19933600 Body mass index 3.00E-21 0.17 20935630 | |
| 16 19935073 rs12446554-G 16:19935073 Obesity 4.00E-12 1.07 23563607 | |
| 16 19935389 rs12446632-G 16:19935389 Obesity 2.00E-10 1.09 23563607 | |
| 16 19944363 rs11639988-A 16:19944363 Obesity 4.00E-09 1.15 23563607 | |
| 16 20257867 rs12597579-C 16:20257867 Body mass index 1.00E-08 4.09 22344219 | |
| 16 20364588 rs4293393-T 16:20364588 Chronic kidney disease and serum creatinine levels 4.00E-10 1.25 20686651 | |
| 16 20365654 rs13333226-A 16:20365654 Hypertension 4.00E-11 1.15 21082022 | |
| 16 20367690 rs12917707-T 16:20367690 Urinary uromodulin levels 8.00E-73 0.32 24578125 | |
| 16 20367690 rs12917707-T 16:20367690 Chronic kidney disease 1.00E-20 NR 20383146 | |
| 16 20367690 rs12917707-T 16:20367690 Renal function and chronic kidney disease 5.00E-16 0.02 19430482 | |
| 16 20367690 rs12917707-G 16:20367690 Renal function and chronic kidney disease 2.00E-12 1.25 19430482 | |
| 16 20371588 rs4494548-A 16:20371588 Urinary uromodulin levels 4.00E-15 0.17 24578125 | |
| 16 20400839 rs11864909-C 16:20400839 Renal function-related traits (sCR) 1.00E-10 0.01 22797727 | |
| 16 20400839 rs11864909-C 16:20400839 Renal function-related traits (eGRFcrea) 4.00E-10 0.01 22797727 | |
| 16 20408377 rs12446492-A 16:20408377 Urinary uromodulin levels 6.00E-27 0.15 24578125 | |
| 16 20449616 rs11647589-A 16:20449616 Blood metabolite levels 3.00E-11 0.03 24816252 | |
| 16 20477474 rs6497490-T 16:20477474 Blood metabolite levels 5.00E-27 0.08 24816252 | |
| 16 20491058 rs1394678-T 16:20491058 Blood metabolite levels 2.00E-20 0.04 24816252 | |
| 16 20555259 rs7499271-A 16:20555259 Serum metabolite levels 6.00E-11 0.25 24625756 | |
| 16 23634026 rs420259-? 16:23634026 Bipolar disorder 9.00E-09 NR 21254220 | |
| 16 23864590 rs7404095-C 16:23864590 Inflammatory bowel disease 1.00E-09 1.06 23128233 | |
| 16 24675589 rs8045064-? 16:24675589 Alzheimer's disease (cognitive decline) 4.00E-08 0.21 23535033 | |
| 16 24931798 rs4788439-T 16:24931798 Blood metabolite levels 7.00E-13 0.03 24816252 | |
| 16 25002350 rs4787294-A 16:25002350 Blood metabolite levels 1.00E-20 0.08 24816252 | |
| 16 28490517 rs151181-G 16:28490517 Crohn's disease 2.00E-11 1.07 21102463 | |
| 16 28517709 rs26528-C 16:28517709 Inflammatory bowel disease 1.00E-21 1.1 23128233 | |
| 16 28539848 rs4788084-G 16:28539848 Type 1 diabetes 3.00E-13 1.09 19430480 | |
| 16 28539848 rs4788084-C 16:28539848 Type 1 diabetes autoantibodies 1.00E-08 1.15 21829393 | |
| 16 28837515 rs8049439-G 16:28837515 Inflammatory bowel disease (early onset) 2.00E-09 1.14 19915574 | |
| 16 28883241 rs7498665-G 16:28883241 Obesity 3.00E-13 1.07 23563607 | |
| 16 28883241 rs7498665-G 16:28883241 Obesity 5.00E-12 1.05 23563607 | |
| 16 28883241 rs7498665-G 16:28883241 Body mass index 5.00E-11 0.15 19079261 | |
| 16 28883241 rs7498665-G 16:28883241 Body mass index 3.00E-10 3.63 19079260 | |
| 16 28883241 rs7498665-G 16:28883241 Weight 1.00E-09 3.69 19079260 | |
| 16 28885659 rs7359397-T 16:28885659 Body mass index 2.00E-20 0.15 20935630 | |
| 16 28921809 rs7184597-T 16:28921809 Obesity 7.00E-09 1.1 23563607 | |
| 16 29967434 rs4788196-G 16:29967434 Pubertal anthropometrics 9.00E-11 0.07 23449627 | |
| 16 30482494 rs11150589-T 16:30482494 Ulcerative colitis 6.00E-10 1.09 23128233 | |
| 16 30642867 rs7197475-A 16:30642867 Systemic lupus erythematosus 3.00E-08 1.31 19838193 | |
| 16 30918487 rs11649653-G 16:30918487 Triglycerides 3.00E-08 2.13 20686565 | |
| 16 30942625 rs10782001-G 16:30942625 Psoriasis 9.00E-10 1.16 20953189 | |
| 16 31048079 rs10871454-? 16:31048079 Warfarin maintenance dose 5.00E-34 NR 18535201 | |
| 16 31107689 rs9923231-T 16:31107689 Warfarin maintenance dose 3.00E-181 0.97 19300499 | |
| 16 31107689 rs9923231-? 16:31107689 Warfarin maintenance dose 9.00E-31 NR 20833655 | |
| 16 31313253 rs9888739-T 16:31313253 Systemic lupus erythematosus 2.00E-23 1.62 18204446 | |
| 16 31313253 rs9888739-T 16:31313253 Systemic lupus erythematosus 1.00E-15 1.8 21408207 | |
| 16 31313253 rs9888739-T 16:31313253 Systemic lupus erythematosus 4.00E-11 1.64 24871463 | |
| 16 31326706 rs11860650-? 16:31326706 Systemic lupus erythematosus and Systemic sclerosis 1.00E-10 1.32 23740937 | |
| 16 31368874 rs11574637-C 16:31368874 Systemic lupus erythematosus 3.00E-11 1.33 18204098 | |
| 16 50103734 rs4785204-T 16:50103734 Esophageal cancer (squamous cell) 2.00E-20 1.24 22960999 | |
| 16 50142944 rs8046148-G 16:50142944 Testicular germ cell tumor 4.00E-09 1.32 23666240 | |
| 16 50719103 rs9302752-G 16:50719103 Leprosy 4.00E-40 1.59 20018961 | |
| 16 50739582 rs17221417-G 16:50739582 Crohn's disease 4.00E-11 1.29 17554300 | |
| 16 50756774 rs5743289-? 16:50756774 Crohn's disease 6.00E-17 NR 17804789 | |
| 16 50756774 rs5743289-T 16:50756774 Inflammatory bowel disease 4.00E-10 1.46 18758464 | |
| 16 50756881 rs2076756-G 16:50756881 Crohn's disease 4.00E-69 1.53 21102463 | |
| 16 50756881 rs2076756-G 16:50756881 Crohn's disease 1.00E-37 1.66 22412388 | |
| 16 50756881 rs2076756-? 16:50756881 Crohn's disease 1.00E-21 1.71 17684544 | |
| 16 50756881 rs2076756-? 16:50756881 Crohn's disease 7.00E-14 NR 17435756 | |
| 16 50756881 rs2076756-G 16:50756881 Crohn's disease 3.00E-10 1.46 22936669 | |
| 16 50756881 rs2076756-? 16:50756881 Inflammatory bowel disease 5.00E-10 NR 17068223 | |
| 16 50763778 rs2066847-T 16:50763778 Crohn's disease 6.00E-209 3.1 23128233 | |
| 16 50763778 rs2066847-C 16:50763778 Crohn's disease 3.00E-24 3.99 18587394 | |
| 16 50763778 rs2066847-? 16:50763778 Crohn's disease 2.00E-15 1.62 20570966 | |
| 16 50854418 rs16948876-A 16:50854418 Leprosy 2.00E-10 1.56 22019778 | |
| 16 50986308 rs1564981-A 16:50986308 Bone mineral density 2.00E-10 0.04 22504420 | |
| 16 51021803 rs1566045-T 16:51021803 Bone mineral density 2.00E-22 0.06 22504420 | |
| 16 51158710 rs10521222-C 16:51158710 C-reactive protein 9.00E-13 0.1 21300955 | |
| 16 51458290 rs1362756-C 16:51458290 Optic disc parameters 5.00E-09 0.03 20548946 | |
| 16 51609947 rs2030114-A 16:51609947 Blood pressure measurement (high sodium and potassium intervention) 7.00E-13 3.14 24165912 | |
| 16 52347819 rs4784165-G 16:52347819 Polycystic ovary syndrome 4.00E-11 1.15 22885925 | |
| 16 52575907 rs4784223-? 16:52575907 Breast cancer (early onset) 6.00E-21 1.27 24493630 | |
| 16 52586341 rs3803662-A 16:52586341 Breast cancer 2.00E-114 1.24 23535729 | |
| 16 52586341 rs3803662-T 16:52586341 Breast cancer 1.00E-36 1.2 17529967 | |
| 16 52586341 rs3803662-T 16:52586341 Breast cancer 6.00E-19 1.28 17529974 | |
| 16 52586341 rs3803662-A 16:52586341 Breast cancer 3.00E-15 1.3 20453838 | |
| 16 52586341 rs3803662-? 16:52586341 Breast cancer (male) 4.00E-15 1.5 23001122 | |
| 16 52586341 rs3803662-T 16:52586341 Breast cancer 6.00E-13 1.14 23535733 | |
| 16 52586341 rs3803662-T 16:52586341 Breast cancer 3.00E-11 1.21 24143190 | |
| 16 52586341 rs3803662-T 16:52586341 Breast cancer 1.00E-09 1.16 19330030 | |
| 16 52599188 rs4784227-T 16:52599188 Breast cancer 1.00E-28 1.24 20585626 | |
| 16 52624738 rs3104767-G 16:52624738 Restless legs syndrome 9.00E-19 1.35 21779176 | |
| 16 52635000 rs12922061-T 16:52635000 Breast cancer 4.00E-10 1.23 24143190 | |
| 16 52635164 rs3112612-T 16:52635164 Breast cancer 4.00E-10 1.15 21263130 | |
| 16 53192331 rs7204230-T 16:53192331 Fibrinogen 1.00E-10 0.01 23969696 | |
| 16 53639438 rs3213758-A 16:53639438 Vitiligo (non-segmental) 6.00E-11 2.77 23678272 | |
| 16 53769677 rs6499640-A 16:53769677 Weight 6.00E-14 5.5 19079260 | |
| 16 53769677 rs6499640-A 16:53769677 Body mass index 4.00E-13 5.25 19079260 | |
| 16 53800754 rs9940128-A 16:53800754 Body mass index 4.00E-23 0.08 23669352 | |
| 16 53800754 rs9940128-A 16:53800754 Metabolic syndrome 2.00E-09 0.09 22399527 | |
| 16 53800954 rs1421085-C 16:53800954 Obesity 6.00E-39 1.45 23563607 | |
| 16 53800954 rs1421085-C 16:53800954 Obesity 1.00E-28 1.39 19151714 | |
| 16 53800954 rs1421085-C 16:53800954 Obesity (early onset extreme) 3.00E-28 1.44 23563609 | |
| 16 53800954 rs1421085-C 16:53800954 Dietary macronutrient intake 1.00E-09 0.1 23636237 | |
| 16 53803574 rs1558902-A 16:53803574 Body mass index 5.00E-120 0.39 20935630 | |
| 16 53803574 rs1558902-A 16:53803574 Obesity 2.00E-81 1.14 23563607 | |
| 16 53803574 rs1558902-A 16:53803574 Body mass index 7.00E-27 0.08 24861553 | |
| 16 53803574 rs1558902-A 16:53803574 Obesity (early onset extreme) 5.00E-19 1.37 20421936 | |
| 16 53803574 rs1558902-? 16:53803574 Waist circumference 5.00E-19 NR 19557197 | |
| 16 53809247 rs1121980-A 16:53809247 HDL cholesterol 7.00E-09 0.02 24097068 | |
| 16 53809247 rs1121980-A 16:53809247 Triglycerides 3.00E-08 0.02 24097068 | |
| 16 53809247 rs1121980-? 16:53809247 Body mass index 4.00E-08 0.06 18454148 | |
| 16 53811788 rs62033400-G 16:53811788 Body mass index 2.00E-14 0.08 24064335 | |
| 16 53813367 rs17817449-T 16:53813367 Breast cancer 6.00E-14 1.08 23535729 | |
| 16 53813367 rs17817449-? 16:53813367 Obesity 2.00E-12 NR 21552555 | |
| 16 53813450 rs8043757-T 16:53813450 Obesity 5.00E-110 1.23 23563607 | |
| 16 53816275 rs8050136-A 16:53816275 Body mass index 1.00E-47 8.04 19079260 | |
| 16 53816275 rs8050136-A 16:53816275 Weight 5.00E-36 7.05 19079260 | |
| 16 53816275 rs8050136-C 16:53816275 Adiposity 3.00E-26 0.06 21706003 | |
| 16 53816275 rs8050136-? 16:53816275 Type 2 diabetes 2.00E-17 1.3 19056611 | |
| 16 53816275 rs8050136-A 16:53816275 Type 2 diabetes 7.00E-14 1.23 17463249 | |
| 16 53816275 rs8050136-A 16:53816275 Type 2 diabetes 1.00E-12 1.17 17463248 | |
| 16 53816275 rs8050136-A 16:53816275 Body mass in chronic obstructive pulmonary disease 4.00E-08 NR 21037115 | |
| 16 53819169 rs9936385-C 16:53819169 Type 2 diabetes 1.00E-12 1.13 24509480 | |
| 16 53819893 rs11075990-G 16:53819893 Body mass index 2.00E-51 1.35 23563607 | |
| 16 53820527 rs9939609-A 16:53820527 Body mass index 4.00E-51 0.33 19079261 | |
| 16 53820527 rs9939609-A 16:53820527 Type 2 diabetes 1.00E-20 1.25 22693455 | |
| 16 53820527 rs9939609-A 16:53820527 Body mass index 2.00E-20 0.36 17434869 | |
| 16 53820527 rs9939609-A 16:53820527 Menarche (age at onset) 3.00E-08 2.1 21102462 | |
| 16 53821615 rs7202116-G 16:53821615 Body mass index 2.00E-10 0.04 22982992 | |
| 16 53822651 rs7185735-G 16:53822651 Obesity 1.00E-79 1.33 23563607 | |
| 16 53825488 rs9941349-T 16:53825488 Obesity (extreme) 6.00E-12 1.48 19553259 | |
| 16 53828066 rs17817964-T 16:53828066 Body mass index 1.00E-10 0.07 23583978 | |
| 16 53830465 rs9930506-A 16:53830465 Obesity-related traits 3.00E-08 0.16 17658951 | |
| 16 53842908 rs12149832-A 16:53842908 Body mass index 5.00E-22 0.07 22344221 | |
| 16 53845487 rs11642841-A 16:53845487 Type 2 diabetes 3.00E-08 1.13 20581827 | |
| 16 53855291 rs11075995-? 16:53855291 Breast cancer 4.00E-08 1.11 23535733 | |
| 16 54114824 rs16953002-A 16:54114824 Melanoma 4.00E-12 1.16 23455637 | |
| 16 54489793 rs2388639-? 16:54489793 Asthma (corticosteroid response) 9.00E-09 0.88 24486069 | |
| 16 55604128 rs6499766-A 16:55604128 Thyroid hormone levels 5.00E-08 0.1 23408906 | |
| 16 56985139 rs9989419-G 16:56985139 HDL cholesterol 1.00E-32 0.04 20864672 | |
| 16 56985139 rs9989419-G 16:56985139 HDL cholesterol 3.00E-31 1.72 18193043 | |
| 16 56985139 rs9989419-A 16:56985139 HDL cholesterol 9.00E-27 2.66 20031538 | |
| 16 56985139 rs9989419-A 16:56985139 Lipid traits 5.00E-11 6.57 24023261 | |
| 16 56988044 rs173539-T 16:56988044 HDL cholesterol 4.00E-75 0.25 19060906 | |
| 16 56988044 rs173539-? 16:56988044 Metabolite levels 3.00E-70 NR 22916037 | |
| 16 56988044 rs173539-T 16:56988044 Cardiovascular disease risk factors 3.00E-65 0.26 21943158 | |
| 16 56988044 rs173539-C 16:56988044 Metabolic syndrome (bivariate traits) 1.00E-16 0.29 21386085 | |
| 16 56988044 rs173539-C 16:56988044 HDL Cholesterol - Triglycerides (HDLC-TG) 5.00E-16 0.26 21386085 | |
| 16 56988044 rs173539-C 16:56988044 Metabolic syndrome 9.00E-09 0.16 21386085 | |
| 16 56989590 rs247616-T 16:56989590 Cardiovascular disease risk factors 1.00E-23 2.99 20838585 | |
| 16 56989590 rs247616-T 16:56989590 Blood metabolite levels 1.00E-11 0.01 24816252 | |
| 16 56989590 rs247616-T 16:56989590 Lipoprotein-associated phospholipase A2 activity and mass 3.00E-08 0.02 22003152 | |
| 16 56990716 rs247617-C 16:56990716 Metabolic syndrome 9.00E-60 0.25 22399527 | |
| 16 56990716 rs247617-A 16:56990716 HDL cholesterol 1.00E-44 0.06 23726366 | |
| 16 56990716 rs247617-C 16:56990716 HDL cholesterol 3.00E-16 0.05 23726366 | |
| 16 56993324 rs3764261-A 16:56993324 HDL cholesterol 2.00E-57 3.47 18193043 | |
| 16 56993324 rs3764261-A 16:56993324 Metabolic syndrome 1.00E-48 0.07 20694148 | |
| 16 56993324 rs3764261-? 16:56993324 Lipid metabolism phenotypes 1.00E-36 0.22 22286219 | |
| 16 56993324 rs3764261-A 16:56993324 LDL cholesterol 2.00E-34 0.05 24097068 | |
| 16 56993324 rs3764261-A 16:56993324 "Cholesterol, total" 4.00E-31 0.05 24097068 | |
| 16 56993324 rs3764261-A 16:56993324 Hematological and biochemical traits 5.00E-29 0.25 20139978 | |
| 16 56993324 rs3764261-A 16:56993324 HDL cholesterol 7.00E-29 0.09 19060910 | |
| 16 56993324 rs3764261-? 16:56993324 Waist circumference and related phenotypes 1.00E-27 NR 18454146 | |
| 16 56993324 rs3764261-T 16:56993324 Lipid traits 2.00E-25 0.06 24386095 | |
| 16 56993324 rs3764261-A 16:56993324 Triglycerides 2.00E-25 0.04 24097068 | |
| 16 56993324 rs3764261-T 16:56993324 Lipoprotein-associated phospholipase A2 activity and mass 7.00E-21 0.02 23118302 | |
| 16 56993324 rs3764261-A 16:56993324 "Cholesterol, total" 7.00E-14 1.67 20686565 | |
| 16 56993324 rs3764261-G 16:56993324 Metabolic syndrome (bivariate traits) 3.00E-13 0.29 21386085 | |
| 16 56993324 rs3764261-T 16:56993324 LDL cholesterol 9.00E-13 1.45 20686565 | |
| 16 56993324 rs3764261-A 16:56993324 Triglycerides 1.00E-12 2.88 20686565 | |
| 16 56993324 rs3764261-A 16:56993324 HDL cholesterol 3.00E-12 6.2 19359809 | |
| 16 56993324 rs3764261-A 16:56993324 Age-related macular degeneration 7.00E-09 1.15 21665990 | |
| 16 56995236 rs1800775-? 16:56995236 Lipid metabolism phenotypes 3.00E-93 3.1 19936222 | |
| 16 56995236 rs1800775-A 16:56995236 HDL cholesterol 4.00E-93 3.09 20031564 | |
| 16 56995236 rs1800775-? 16:56995236 Lipid metabolism phenotypes 5.00E-87 0.73 19936222 | |
| 16 56995236 rs1800775-? 16:56995236 Lipid metabolism phenotypes 1.00E-81 2.66 19936222 | |
| 16 56995236 rs1800775-? 16:56995236 Lipid metabolism phenotypes 8.00E-78 0.09 19936222 | |
| 16 56995236 rs1800775-C 16:56995236 HDL cholesterol 1.00E-73 0.18 18193044 | |
| 16 56995236 rs1800775-? 16:56995236 Lipid metabolism phenotypes 2.00E-59 0.7 19936222 | |
| 16 56995236 rs1800775-? 16:56995236 Lipid metabolism phenotypes 1.00E-53 0.08 19936222 | |
| 16 56995236 rs1800775-C 16:56995236 Triglycerides 3.00E-13 2.1 17463246 | |
| 16 56995236 rs1800775-A 16:56995236 Blood metabolite levels 1.00E-11 0.01 24816252 | |
| 16 56995236 rs1800775-A 16:56995236 Lipid traits 3.00E-09 0.04 24023260 | |
| 16 56997233 rs1864163-G 16:56997233 HDL cholesterol 7.00E-39 4.12 18193043 | |
| 16 56997233 rs1864163-? 16:56997233 Lipid metabolism phenotypes 3.00E-25 27.87 19936222 | |
| 16 56997233 rs1864163-? 16:56997233 Lipid metabolism phenotypes 7.00E-22 30.38 19936222 | |
| 16 56997233 rs1864163-G 16:56997233 Age-related macular degeneration 7.00E-16 1.22 23455636 | |
| 16 57000938 rs118146573-A 16:57000938 "Cholesterol, total" 4.00E-10 0.2 24886709 | |
| 16 57002732 rs9939224-G 16:57002732 Metabolic syndrome (bivariate traits) 7.00E-12 0.31 21386085 | |
| 16 57005479 rs1532624-C 16:57005479 HDL cholesterol 9.00E-94 0.21 19060911 | |
| 16 57005479 rs1532624-? 16:57005479 Lipid metabolism phenotypes 1.00E-66 3.09 19936222 | |
| 16 57005479 rs1532624-? 16:57005479 Lipid metabolism phenotypes 3.00E-55 2.61 19936222 | |
| 16 57005479 rs1532624-? 16:57005479 Lipid metabolism phenotypes 1.00E-39 3.92 19936222 | |
| 16 57005479 rs1532624-A 16:57005479 HDL cholesterol 1.00E-24 0.23 23505323 | |
| 16 57005479 rs1532624-? 16:57005479 Cholesterol 3.00E-20 9.99 20066028 | |
| 16 57006590 rs7499892-? 16:57006590 Lipid metabolism phenotypes 1.00E-20 0.76 19936222 | |
| 16 57006590 rs7499892-? 16:57006590 Lipid metabolism phenotypes 2.00E-14 0.74 19936222 | |
| 16 57012379 rs12708980-C 16:57012379 HDL cholesterol 2.00E-28 0.04 21909109 | |
| 16 57015091 rs5880-C 16:57015091 HDL cholesterol 2.00E-16 0.29 24886709 | |
| 16 58075282 rs12447804-? 16:58075282 Pulmonary function (interaction) 4.00E-08 NR 23284291 | |
| 16 58075282 rs12447804-T 16:58075282 Pulmonary function 4.00E-08 0.04 21946350 | |
| 16 58209274 rs74019828-A 16:58209274 Telomere length 5.00E-08 0.38 24795349 | |
| 16 58567238 rs37062-G 16:58567238 QT interval 3.00E-25 1.75 19305408 | |
| 16 58622178 rs7188697-A 16:58622178 QT interval 7.00E-25 1.66 19305409 | |
| 16 58776314 rs4784054-A 16:58776314 Blood metabolite levels 2.00E-21 0.04 24816252 | |
| 16 58829790 rs12709013-T 16:58829790 Blood metabolite ratios 3.00E-24 0.03 24816252 | |
| 16 60314656 rs9932186-? 16:60314656 Phospholipid levels (plasma) 3.00E-08 0.8 22359512 | |
| 16 60733603 rs17822114-? 16:60733603 Myopia (pathological) 3.00E-18 NR 23049088 | |
| 16 62100211 rs8050940-? 16:62100211 Myopia (pathological) 1.00E-26 NR 23049088 | |
| 16 66158736 rs8050896-T 16:66158736 Response to antipsychotic treatment 4.00E-08 NR 23241943 | |
| 16 67225501 rs3729639-T 16:67225501 Coronary heart disease 2.00E-11 0.09 21347282 | |
| 16 67902070 rs2271293-G 16:67902070 HDL cholesterol 8.00E-16 0.13 19060911 | |
| 16 67902070 rs2271293-A 16:67902070 HDL cholesterol 9.00E-13 0.07 19060906 | |
| 16 67911517 rs8060686-T 16:67911517 Metabolic syndrome 2.00E-10 0.11 22399527 | |
| 16 67928042 rs16942887-A 16:67928042 HDL cholesterol 8.00E-54 0.08 24097068 | |
| 16 67928042 rs16942887-A 16:67928042 HDL cholesterol 8.00E-33 1.27 20686565 | |
| 16 68013471 rs255049-G 16:68013471 HDL cholesterol 3.00E-08 0.05 19060910 | |
| 16 68304392 rs8056893-A 16:68304392 Blood metabolite ratios 3.00E-39 0.04 24816252 | |
| 16 68304392 rs8056893-A 16:68304392 Blood metabolite levels 2.00E-30 0.03 24816252 | |
| 16 68326200 rs6499165-A 16:68326200 Metabolic traits 1.00E-18 0.11 21886157 | |
| 16 68331890 rs2863979-A 16:68331890 Blood metabolite levels 1.00E-17 0.01 24816252 | |
| 16 68591230 rs1728785-G 16:68591230 Ulcerative colitis 3.00E-08 1.17 19915572 | |
| 16 68591230 rs1728785-C 16:68591230 Ulcerative colitis 4.00E-08 1.08 23128233 | |
| 16 68674788 rs6499188-A 16:68674788 Ulcerative colitis 4.00E-08 1.14 21297633 | |
| 16 68820946 rs9929218-G 16:68820946 Colorectal cancer 1.00E-08 1.1 19011631 | |
| 16 69563890 rs7193778-T 16:69563890 Urate levels 8.00E-10 0.05 23263486 | |
| 16 69588572 rs1364063-C 16:69588572 Menarche (age at onset) 2.00E-08 2.1 21102462 | |
| 16 71634811 rs4788815-? 16:71634811 Metabolite levels 2.00E-17 0.15 22286219 | |
| 16 71634811 rs4788815-? 16:71634811 Metabolite levels 4.00E-13 NR 22916037 | |
| 16 72108093 rs2000999-A 16:72108093 Haptoglobin levels 8.00E-59 0.14 22403646 | |
| 16 72108093 rs2000999-A 16:72108093 LDL cholesterol 4.00E-41 0.07 24097068 | |
| 16 72108093 rs2000999-A 16:72108093 "Cholesterol, total" 7.00E-41 0.06 24097068 | |
| 16 72108093 rs2000999-A 16:72108093 "Cholesterol, total" 3.00E-24 2.34 20686565 | |
| 16 72108093 rs2000999-A 16:72108093 LDL cholesterol 2.00E-22 2 20686565 | |
| 16 72114002 rs217181-? 16:72114002 Metabolite levels 1.00E-36 NR 22916037 | |
| 16 72220373 rs7186908-C 16:72220373 Liver enzyme levels (alkaline phosphatase) 5.00E-09 2 22001757 | |
| 16 72756101 rs10500569-? 16:72756101 Metabolite levels 7.00E-12 NR 22916037 | |
| 16 73029160 rs7193343-T 16:73029160 Atrial fibrillation 1.00E-10 1.21 19597491 | |
| 16 73051620 rs2106261-T 16:73051620 Atrial fibrillation 3.00E-16 1.24 22544366 | |
| 16 73051620 rs2106261-T 16:73051620 Atrial fibrillation 2.00E-15 1.25 19597492 | |
| 16 73068678 rs879324-A 16:73068678 Stroke (ischemic) 2.00E-08 1.25 23041239 | |
| 16 74670458 rs4888262-C 16:74670458 Testicular germ cell tumor 5.00E-12 1.26 23666239 | |
| 16 75247245 rs7202877-G 16:75247245 Type 1 diabetes 3.00E-15 1.28 19430480 | |
| 16 75390316 rs2865531-T 16:75390316 Pulmonary function 2.00E-11 0.03 21946350 | |
| 16 75390316 rs2865531-? 16:75390316 Pulmonary function (interaction) 2.00E-08 NR 23284291 | |
| 16 76566157 rs4485401-? 16:76566157 Sphingolipid levels 2.00E-08 0.8 22359512 | |
| 16 77427769 rs11864477-C 16:77427769 Bone mineral density 2.00E-08 1 19249006 | |
| 16 78187138 rs1079572-G 16:78187138 Forced vital capacity 1.00E-08 16.26 24929828 | |
| 16 79645989 rs889472-C 16:79645989 Renal function-related traits (urea) 1.00E-09 0.07 22797727 | |
| 16 79682751 rs1424233-A 16:79682751 Obesity 4.00E-13 1.12 19151714 | |
| 16 79734987 rs7188445-A 16:79734987 Urate levels 2.00E-09 0.03 23263486 | |
| 16 79744548 rs17767419-T 16:79744548 Thyroid volume 9.00E-15 0.07 21565293 | |
| 16 79749276 rs3813579-A 16:79749276 Thyroid volume 4.00E-10 1.32 21565293 | |
| 16 79749353 rs3813582-T 16:79749353 Thyroid hormone levels 8.00E-18 0.08 23408906 | |
| 16 79749353 rs3813582-T 16:79749353 Thyroid hormone levels 6.00E-17 0.12 23408906 | |
| 16 79749353 rs3813582-T 16:79749353 Thyroid function 6.00E-10 0.07 22494929 | |
| 16 80497601 rs4581712-A 16:80497601 Liver enzyme levels (gamma-glutamyl transferase) 3.00E-09 3.2 22001757 | |
| 16 80650805 rs13329835-G 16:80650805 Breast cancer 2.00E-16 1.08 23535729 | |
| 16 81264597 rs6564851-G 16:81264597 Carotenoid and tocopherol levels 2.00E-24 0.15 19185284 | |
| 16 81534790 rs2925979-T 16:81534790 Adiponectin levels 3.00E-21 0.04 22479202 | |
| 16 81534790 rs2925979-T 16:81534790 HDL cholesterol 1.00E-19 0.04 24097068 | |
| 16 81534790 rs2925979-T 16:81534790 HDL cholesterol 2.00E-11 0.45 20686565 | |
| 16 81534790 rs2925979-T 16:81534790 Adiponectin levels 2.00E-10 0.08 24105470 | |
| 16 82519228 rs1991867-? 16:82519228 White matter microstructure (global fractional anisotropy) 2.00E-09 NR 24736177 | |
| 16 82650717 rs3865188-? 16:82650717 Adiponectin levels 3.00E-83 0.09 20887962 | |
| 16 82650717 rs3865188-T 16:82650717 Adiponectin levels 4.00E-30 0.11 20876611 | |
| 16 82662268 rs4783244-T 16:82662268 Adiponectin levels 7.00E-165 0.33 24105470 | |
| 16 82662268 rs4783244-T 16:82662268 Adiponectin levels 6.00E-17 0.35 21771975 | |
| 16 82663288 rs12051272-T 16:82663288 Adiponectin levels 6.00E-48 0.26 22479202 | |
| 16 82663288 rs12051272-? 16:82663288 Adiponectin levels 5.00E-40 NR 22065538 | |
| 16 82663288 rs12051272-T 16:82663288 Adiponectin levels 1.00E-14 0.26 22479202 | |
| 16 83712435 rs3784943-? 16:83712435 Response to amphetamines 5.00E-08 NR 22952603 | |
| 16 83764204 rs3096277-? 16:83764204 Blood pressure 1.00E-09 NR 17903302 | |
| 16 84423034 rs8048576-A 16:84423034 Chronic obstructive pulmonary disease-related biomarkers 9.00E-13 NR 23144326 | |
| 16 84578241 rs371915-? 16:84578241 Eosinophilic esophagitis (pediatric) 2.00E-08 1.9 20208534 | |
| 16 85944439 rs391525-? 16:85944439 Chronic lymphocytic leukemia 3.00E-09 1.56 21131588 | |
| 16 85946450 rs424971-G 16:85946450 Monocyte count 3.00E-16 0.22 23314186 | |
| 16 85955671 rs1044873-C 16:85955671 Chronic lymphocytic leukemia 1.00E-09 1.29 24292274 | |
| 16 85973028 rs12711490-? 16:85973028 Systemic lupus erythematosus and Systemic sclerosis 3.00E-10 1.28 23740937 | |
| 16 85991705 rs11642873-? 16:85991705 Systemic sclerosis 2.00E-12 1.33 21779181 | |
| 16 86009740 rs16940186-G 16:86009740 Ulcerative colitis 4.00E-10 1.56 23511034 | |
| 16 86011033 rs13333054-A 16:86011033 Multiple sclerosis 1.00E-08 1.11 21833088 | |
| 16 86011337 rs10521318-C 16:86011337 Inflammatory bowel disease 1.00E-09 1.16 23128233 | |
| 16 86014241 rs16940202-C 16:86014241 Ulcerative colitis 6.00E-19 1.15 21297633 | |
| 16 86014241 rs16940202-C 16:86014241 Ulcerative colitis 3.00E-09 1.52 23511034 | |
| 16 86017663 rs17445836-G 16:86017663 Multiple sclerosis 4.00E-09 1.25 19525953 | |
| 16 86019087 rs13330176-A 16:86019087 Rheumatoid arthritis 1.00E-12 1.12 24390342 | |
| 16 86019087 rs13330176-A 16:86019087 Rheumatoid arthritis 9.00E-09 1.12 24390342 | |
| 16 86019271 rs11117432-G 16:86019271 Primary biliary cirrhosis 5.00E-11 1.31 21399635 | |
| 16 86403118 rs9936833-C 16:86403118 Barrett's esophagus 3.00E-10 1.14 22961001 | |
| 16 86710660 rs10048146-A 16:86710660 Bone mineral density 1.00E-14 0.05 22504420 | |
| 16 86710660 rs10048146-G 16:86710660 Bone mineral density (spine) 2.00E-08 0.09 19801982 | |
| 16 86714715 rs71390846-? 16:86714715 Bone mineral density 2.00E-10 NR 24249740 | |
| 16 87878822 rs8051149-A 16:87878822 Blood metabolite levels 9.00E-26 0.03 24816252 | |
| 16 88298124 rs12447690-G 16:88298124 Central corneal thickness 6.00E-22 0.16 20719862 | |
| 16 88298124 rs12447690-C 16:88298124 Central corneal thickness 9.00E-11 0.16 20485516 | |
| 16 88331640 rs9938149-A 16:88331640 Corneal structure 2.00E-49 0.17 23291589 | |
| 16 88331640 rs9938149-A 16:88331640 Central corneal thickness 1.00E-12 0.16 22814818 | |
| 16 88777242 rs8052560-A 16:88777242 Height 3.00E-08 0.03 20881960 | |
| 16 88840462 rs10445033-G 16:88840462 Red blood cell traits 2.00E-22 0.02 23222517 | |
| 16 88844932 rs9933309-C 16:88844932 Glycated hemoglobin levels 1.00E-08 0.07 24647736 | |
| 16 88853729 rs837763-C 16:88853729 Mean corpuscular hemoglobin concentration 4.00E-13 0.09 20139978 | |
| 16 89708096 rs154657-A 16:89708096 Homocysteine levels 2.00E-43 0.1 23824729 | |
| 16 89755903 rs258322-A 16:89755903 Melanoma 3.00E-27 1.7 21983787 | |
| 16 89755903 rs258322-A 16:89755903 Melanoma 3.00E-27 1.67 19578364 | |
| 16 89755903 rs258322-T 16:89755903 Black vs. red hair color 2.00E-23 0.36 18483556 | |
| 16 89755903 rs258322-A 16:89755903 Melanoma 2.00E-09 1.5 24980573 | |
| 16 89818089 rs9926296-A 16:89818089 Vitiligo 2.00E-13 1.27 22561518 | |
| 16 89818732 rs12931267-G 16:89818732 Hair color 5.00E-87 0.56 20585627 | |
| 16 89818732 rs12931267-G 16:89818732 Freckling 8.00E-62 1.88 20585627 | |
| 16 89818732 rs12931267-G 16:89818732 Hair color 3.00E-10 0.56 20585627 | |
| 16 89859753 rs12921383-T 16:89859753 Homocysteine levels 8.00E-11 0.09 23824729 | |
| 16 89986117 rs1805007-T 16:89986117 Red vs non-red hair color 2.00E-142 12.47 17952075 | |
| 16 89986117 rs1805007-T 16:89986117 Freckles 1.00E-96 4.37 17952075 | |
| 16 89986117 rs1805007-C 16:89986117 Tanning 1.00E-65 0.39 23548203 | |
| 16 89986117 rs1805007-T 16:89986117 Skin sensitivity to sun 2.00E-55 2.94 17952075 | |
| 16 89986117 rs1805007-C 16:89986117 Sunburns 2.00E-19 1.66 23548203 | |
| 16 89986117 rs1805007-T 16:89986117 Basal cell carcinoma 4.00E-17 1.55 21700618 | |
| 16 89986117 rs1805007-T 16:89986117 Blond vs. brown hair color 2.00E-13 2.34 17952075 | |
| 16 89986117 rs1805007-C 16:89986117 Non-melanoma skin cancer 3.00E-10 0.34 23548203 | |
| 16 89986117 rs1805007-C 16:89986117 Hair color 3.00E-09 0.16 23548203 | |
| 16 90066936 rs4785763-A 16:90066936 Melanoma 6.00E-22 1.36 19578364 | |
| 16 90084561 rs11648785-T 16:90084561 Tanning 3.00E-09 0.14 19340012 | |
| 17 618965 rs684232-G 17:618965 Prostate cancer 5.00E-15 1.1 23535732 | |
| 17 800593 rs12603526-C 17:800593 Colorectal cancer 3.00E-08 1.1 24836286 | |
| 17 1618363 rs11078597-C 17:1618363 Serum albumin level 1.00E-14 0.02 23022100 | |
| 17 1618363 rs11078597-C 17:1618363 Serum albumin level 7.00E-13 0.02 23022100 | |
| 17 2068932 rs4790881-A 17:2068932 Bone mineral density 1.00E-18 0.05 22504420 | |
| 17 2125605 rs1231206-A 17:2125605 Coronary heart disease 9.00E-10 1.07 21378990 | |
| 17 2126504 rs216172-C 17:2126504 Coronary heart disease 1.00E-09 1.07 21378990 | |
| 17 2143460 rs10852932-T 17:2143460 Aortic root size 2.00E-11 0.03 19584346 | |
| 17 2171637 rs17761864-A 17:2171637 Esophageal cancer (squamous cell) 2.00E-11 1.21 22960999 | |
| 17 2216258 rs391300-G 17:2216258 Type 2 diabetes 3.00E-09 1.28 20174558 | |
| 17 2262703 rs4790333-T 17:2262703 Proinsulin levels 3.00E-09 NR 21873549 | |
| 17 3393068 rs923375-? 17:3393068 Myopia (pathological) 4.00E-16 NR 23049088 | |
| 17 4683035 rs12051548-? 17:4683035 Metabolite levels 1.00E-11 NR 22916037 | |
| 17 4683035 rs12051548-? 17:4683035 Sphingolipid levels 1.00E-09 0 22359512 | |
| 17 4824625 rs12602901-C 17:4824625 Blood metabolite levels 1.00E-26 0.04 24816252 | |
| 17 4836381 rs6065-T 17:4836381 Platelet counts 2.00E-12 0.12 20139978 | |
| 17 4836381 rs6065-T 17:4836381 Platelet counts 3.00E-11 4.19 22139419 | |
| 17 5272580 rs72634030-A 17:5272580 Rheumatoid arthritis 2.00E-09 1.12 24390342 | |
| 17 6595930 rs170149-A 17:6595930 Blood metabolite levels 1.00E-13 0.03 24816252 | |
| 17 6683878 rs1509123-T 17:6683878 Blood metabolite levels 5.00E-09 0.03 24816252 | |
| 17 6915401 rs2271316-C 17:6915401 Blood metabolite levels 2.00E-23 0.11 24816252 | |
| 17 6940393 rs312457-G 17:6940393 Type 2 diabetes 8.00E-13 1.2 23945395 | |
| 17 6945087 rs75493593-? 17:6945087 Type 2 diabetes 5.00E-15 1.25 24390345 | |
| 17 7091650 rs314253-C 17:7091650 Liver enzyme levels (alkaline phosphatase) 8.00E-12 2.1 22001757 | |
| 17 7091650 rs314253-C 17:7091650 "Cholesterol, total" 3.00E-10 0.02 24097068 | |
| 17 7091650 rs314253-C 17:7091650 LDL cholesterol 3.00E-10 0.02 24097068 | |
| 17 7142851 rs117616209-? 17:7142851 Metabolite levels 3.00E-14 0.51 22286219 | |
| 17 7462555 rs11552708-G 17:7462555 IgM levels 4.00E-09 NR 23118916 | |
| 17 7462969 rs3803800-A 17:7462969 Non-albumin protein levels 7.00E-15 0.1 22558069 | |
| 17 7462969 rs3803800-A 17:7462969 IgA nephropathy 9.00E-11 1.21 22197929 | |
| 17 7487108 rs2075230-G 17:7487108 Hormone measurements 5.00E-19 0.09 24049095 | |
| 17 7487108 rs2075230-G 17:7487108 Hormone measurements 1.00E-08 0.28 24049095 | |
| 17 7491177 rs4227-G 17:7491177 IgA nephropathy 4.00E-10 1.23 22197929 | |
| 17 7521915 rs12150660-T 17:7521915 Sex hormone-binding globulin levels 2.00E-106 0.1 22829776 | |
| 17 7521915 rs12150660-T 17:7521915 Sex hormone-binding globulin levels 4.00E-80 0.11 22829776 | |
| 17 7521915 rs12150660-T 17:7521915 Sex hormone-binding globulin levels 2.00E-55 0.08 22829776 | |
| 17 7521915 rs12150660-T 17:7521915 Testosterone levels 1.00E-41 31.8 21998597 | |
| 17 7521915 rs12150660-T 17:7521915 Sex hormone-binding globulin levels 6.00E-30 0.09 22829776 | |
| 17 7534678 rs6258-T 17:7534678 Sex hormone-binding globulin levels 3.00E-46 0.27 22829776 | |
| 17 7534678 rs6258-T 17:7534678 Testosterone levels 2.00E-22 82.3 21998597 | |
| 17 7537792 rs727428-T 17:7537792 Sex hormone-binding globulin levels 2.00E-16 0.13 22675492 | |
| 17 7537792 rs727428-T 17:7537792 Androgen levels 1.00E-12 0.07 22936694 | |
| 17 7537792 rs727428-T 17:7537792 Androgen levels 1.00E-11 0.1 22936694 | |
| 17 7545721 rs1641537-T 17:7545721 Sex hormone-binding globulin levels 1.00E-24 0.06 22829776 | |
| 17 7552123 rs72829446-T 17:7552123 Androgen levels 9.00E-10 0.16 22936694 | |
| 17 7571752 rs78378222-G 17:7571752 Basal cell carcinoma 4.00E-22 2.24 24403052 | |
| 17 7571752 rs78378222-C 17:7571752 Basal cell carcinoma 2.00E-20 2.16 21946351 | |
| 17 7578115 rs1625895-T 17:7578115 Sex hormone-binding globulin levels 2.00E-21 0.12 22829776 | |
| 17 8136092 rs3027234-T 17:8136092 Telomere length 2.00E-08 0.06 23001564 | |
| 17 10033679 rs11656696-A 17:10033679 Intraocular pressure 1.00E-08 0.19 22570627 | |
| 17 11407901 rs2969180-A 17:11407901 Refractive error 7.00E-11 0.1 23396134 | |
| 17 14294021 rs3848445-? 17:14294021 Protein quantitative trait loci 8.00E-09 NR 18464913 | |
| 17 14561016 rs12940030-T 17:14561016 Corneal structure 7.00E-10 0.08 23291589 | |
| 17 16845167 rs4792800-G 17:16845167 IgG levels 1.00E-12 NR 22673310 | |
| 17 16848750 rs4561508-T 17:16848750 Hematology traits 8.00E-24 0.03 23303382 | |
| 17 16848750 rs4561508-T 17:16848750 Serum total protein level 2.00E-18 0.04 23022100 | |
| 17 16848750 rs4561508-T 17:16848750 Serum total protein level 2.00E-11 0.05 23022100 | |
| 17 16848750 rs4561508-T 17:16848750 Serum total protein level 1.00E-09 0.04 23022100 | |
| 17 16849139 rs4273077-G 17:16849139 Hematological and biochemical traits 3.00E-10 0.09 20139978 | |
| 17 16849139 rs4273077-G 17:16849139 Multiple myeloma 8.00E-09 1.26 23955597 | |
| 17 16863638 rs4985726-G 17:16863638 Non-albumin protein levels 7.00E-24 0.14 22558069 | |
| 17 16863638 rs4985726-G 17:16863638 Non-albumin protein levels 1.00E-14 0.11 22558069 | |
| 17 17543722 rs12936587-? 17:17543722 Coronary artery disease or large artery stroke 2.00E-10 NR 24262325 | |
| 17 17543722 rs12936587-G 17:17543722 Coronary heart disease 4.00E-10 1.07 21378990 | |
| 17 17544704 rs12449964-? 17:17544704 Coronary artery disease or ischemic stroke 2.00E-08 NR 24262325 | |
| 17 19804247 rs397969-C 17:19804247 Platelet counts 2.00E-09 2.13 22139419 | |
| 17 21284223 rs4640244-A 17:21284223 Height 2.00E-08 0.02 20881960 | |
| 17 25541278 rs4795519-C 17:25541278 Chronic myeloid leukemia 1.00E-12 1.85 21540461 | |
| 17 25843643 rs2945412-A 17:25843643 Crohn's disease 9.00E-17 1.14 23128233 | |
| 17 26092037 rs944722-C 17:26092037 Fractional exhaled nitric oxide (childhood) 1.00E-09 0.07 24315451 | |
| 17 26106675 rs4795067-G 17:26106675 Psoriasis 4.00E-11 1.19 20953189 | |
| 17 26206414 rs3751972-C 17:26206414 Fractional exhaled nitric oxide (childhood) 2.00E-10 0.09 24315451 | |
| 17 26206414 rs3751972-C 17:26206414 Fractional exhaled nitric oxide (childhood) 7.00E-09 0.1 24315451 | |
| 17 26610252 rs34517613-T 17:26610252 Amyotrophic lateral sclerosis (sporadic) 9.00E-09 1.2 24256812 | |
| 17 27675226 rs11653144-T 17:27675226 Mean platelet volume 4.00E-08 0.13 22423221 | |
| 17 27703349 rs2138852-C 17:27703349 Mean platelet volume 7.00E-28 0.02 19110211 | |
| 17 27703349 rs2138852-T 17:27703349 Mean platelet volume 1.00E-22 0.02 19820697 | |
| 17 27714587 rs8076739-T 17:27714587 Mean platelet volume 5.00E-38 0.01 22139419 | |
| 17 27769598 rs9900280-G 17:27769598 Mean platelet volume 1.00E-10 0.1 24026423 | |
| 17 27814496 rs559972-T 17:27814496 Platelet counts 3.00E-18 3.26 22139419 | |
| 17 27917771 rs3110496-A 17:27917771 Height 7.00E-09 0.02 20881960 | |
| 17 29164023 rs3764419-A 17:29164023 Height 2.00E-21 0.04 20881960 | |
| 17 29164023 rs3764419-C 17:29164023 Height 9.00E-14 1.16 23563607 | |
| 17 29247715 rs3760318-C 17:29247715 Height 2.00E-09 6 18391951 | |
| 17 29333516 rs17826255-? 17:29333516 Myopia (pathological) 8.00E-09 NR 23049088 | |
| 17 30343282 rs17780086-A 17:30343282 Height 3.00E-08 0.03 20881960 | |
| 17 31078272 rs17183295-T 17:31078272 Refractive error 1.00E-10 0.13 23396134 | |
| 17 32593665 rs3091315-A 17:32593665 Crohn's disease 2.00E-13 1.2 21102463 | |
| 17 32593974 rs3091316-G 17:32593974 Inflammatory bowel disease 1.00E-26 1.12 23128233 | |
| 17 32593974 rs3091316-G 17:32593974 Crohn's disease 4.00E-08 1.14 22412388 | |
| 17 33324382 rs2074518-T 17:33324382 QT interval 6.00E-12 1.05 19305408 | |
| 17 33884804 rs10512472-C 17:33884804 Platelet counts 2.00E-14 3.64 22139419 | |
| 17 33944055 rs16971217-C 17:33944055 Mean platelet volume 4.00E-12 0.01 22139419 | |
| 17 34819191 rs4796217-? 17:34819191 Protein quantitative trait loci 4.00E-21 NR 18464913 | |
| 17 36096515 rs757210-G 17:36096515 Ovarian cancer 8.00E-10 1.12 23535730 | |
| 17 36098040 rs4430796-A 17:36098040 Prostate cancer 1.00E-11 1.22 17603485 | |
| 17 36098040 rs4430796-G 17:36098040 Type 2 diabetes 2.00E-11 1.19 22961080 | |
| 17 36098040 rs4430796-A 17:36098040 Serum prostate-specific antigen levels 6.00E-11 9.4 21160077 | |
| 17 36098040 rs4430796-A 17:36098040 Endometrial cancer 7.00E-10 1.19 21499250 | |
| 17 36098040 rs4430796-G 17:36098040 Type 2 diabetes 9.00E-10 1.13 24509480 | |
| 17 36098040 rs4430796-A 17:36098040 Prostate cancer 1.00E-09 1.18 18264096 | |
| 17 36101156 rs7501939-? 17:36101156 Prostate cancer 3.00E-18 NR 19767753 | |
| 17 36101156 rs7501939-? 17:36101156 Prostate cancer 1.00E-12 NR 20676098 | |
| 17 36101156 rs7501939-C 17:36101156 Prostate cancer 9.00E-12 1.41 18264097 | |
| 17 36922196 rs1043515-A 17:36922196 Height 3.00E-10 0.02 20881960 | |
| 17 37740161 rs1877030-C 17:37740161 Rheumatoid arthritis 2.00E-08 1.09 24390342 | |
| 17 37813856 rs11869286-G 17:37813856 HDL cholesterol 3.00E-17 0.03 24097068 | |
| 17 37813856 rs11869286-C 17:37813856 HDL cholesterol 3.00E-14 0.51 20686565 | |
| 17 37912377 rs12946510-T 17:37912377 Inflammatory bowel disease 4.00E-38 1.16 23128233 | |
| 17 37976469 rs9303277-T 17:37976469 Primary biliary cirrhosis 2.00E-09 1.38 20639880 | |
| 17 37976469 rs9303277-T 17:37976469 Primary biliary cirrhosis 4.00E-09 1.44 23000144 | |
| 17 38040763 rs2872507-A 17:38040763 Ulcerative colitis 5.00E-11 1.15 21297633 | |
| 17 38040763 rs2872507-A 17:38040763 Crohn's disease 2.00E-09 1.14 21102463 | |
| 17 38040763 rs2872507-A 17:38040763 Crohn's disease 5.00E-09 1.12 18587394 | |
| 17 38051348 rs8067378-G 17:38051348 Cervical cancer 9.00E-10 1.19 23817570 | |
| 17 38057197 rs8069176-A 17:38057197 Fractional exhaled nitric oxide (childhood) 2.00E-08 0.07 24315451 | |
| 17 38062196 rs2305480-G 17:38062196 "Asthma (childhood, severe)" 6.00E-23 1.32 24241537 | |
| 17 38062196 rs2305480-A 17:38062196 Ulcerative colitis 3.00E-08 1.15 20228799 | |
| 17 38064405 rs11078927-? 17:38064405 Asthma 2.00E-16 NR 21804549 | |
| 17 38066240 rs2290400-? 17:38066240 Type 1 diabetes 6.00E-13 1.15 19430480 | |
| 17 38069949 rs7216389-T 17:38069949 Asthma 9.00E-11 1.45 17611496 | |
| 17 38074031 rs9303280-T 17:38074031 Self-reported allergy 9.00E-09 0.07 23817569 | |
| 17 38089344 rs4794820-? 17:38089344 Asthma 1.00E-08 1.33 22561531 | |
| 17 38110689 rs17609240-G 17:38110689 Hematological parameters 9.00E-09 0.02 19820697 | |
| 17 38121993 rs3894194-A 17:38121993 "Asthma (childhood, severe)" 3.00E-21 1.59 24241537 | |
| 17 38121993 rs3894194-A 17:38121993 Asthma 5.00E-09 1.17 20860503 | |
| 17 38122680 rs7212938-G 17:38122680 Asthma and hay fever 4.00E-10 1.16 24388013 | |
| 17 38128648 rs3859192-? 17:38128648 White blood cell count 2.00E-12 0.14 22037903 | |
| 17 38143548 rs4065321-T 17:38143548 White blood cell count 3.00E-14 0.09 20139978 | |
| 17 38156712 rs4794822-T 17:38156712 White blood cell count 9.00E-35 0.02 21738480 | |
| 17 38156712 rs4794822-T 17:38156712 White blood cell types 4.00E-16 0.09 21738478 | |
| 17 38156712 rs4794822-C 17:38156712 Neutrophil count 6.00E-10 0.1 20172861 | |
| 17 38166879 rs8078723-T 17:38166879 White blood cell count 2.00E-31 0.04 21738480 | |
| 17 38166879 rs8078723-C 17:38166879 C-reactive protein and white blood cell count 3.00E-09 0.16 22788528 | |
| 17 38599172 rs584438-C 17:38599172 Height 5.00E-12 1.18 23563607 | |
| 17 38770286 rs7221109-? 17:38770286 Type 1 diabetes 1.00E-09 1.05 19430480 | |
| 17 39897264 rs6503659-A 17:39897264 Esophageal cancer (squamous cell) 3.00E-16 1.27 22960999 | |
| 17 39953961 rs191392302-? 17:39953961 PR interval in Tripanosoma cruzi seropositivity 3.00E-08 NR 24324551 | |
| 17 40481529 rs2293152-C 17:40481529 Multiple sclerosis 4.00E-08 1.22 22190364 | |
| 17 40507980 rs9891119-A 17:40507980 Crohn's disease 2.00E-15 1.37 23266558 | |
| 17 40507980 rs9891119-C 17:40507980 Multiple sclerosis 2.00E-10 1.11 21833088 | |
| 17 40514201 rs744166-A 17:40514201 Crohn's disease 7.00E-12 1.18 18587394 | |
| 17 40514201 rs744166-G 17:40514201 Multiple sclerosis 3.00E-10 1.15 20159113 | |
| 17 40527544 rs12942547-A 17:40527544 Inflammatory bowel disease 6.00E-22 1.1 23128233 | |
| 17 40570772 rs11871801-A 17:40570772 Crohn's disease 3.00E-08 1.15 21102463 | |
| 17 41798824 rs4792909-T 17:41798824 Bone mineral density 2.00E-11 0.04 22504420 | |
| 17 41807331 rs1513670-A 17:41807331 Bone mineral density (hip) 2.00E-08 0.08 19079262 | |
| 17 41878166 rs8077889-C 17:41878166 Triglycerides 1.00E-08 0.03 24097068 | |
| 17 42193185 rs228769-G 17:42193185 Bone mineral density (hip) 2.00E-08 0.08 19801982 | |
| 17 42225547 rs227584-A 17:42225547 Bone mineral density 3.00E-24 0.06 22504420 | |
| 17 42241929 rs12602486-G 17:42241929 Glycated hemoglobin levels 1.00E-24 0.36 24244560 | |
| 17 42442344 rs708382-T 17:42442344 Platelet counts 2.00E-08 2.44 22139419 | |
| 17 43208121 rs12946454-T 17:43208121 Systolic blood pressure 1.00E-08 0.57 19430483 | |
| 17 43216281 rs4986172-T 17:43216281 Height 2.00E-16 0.03 20881960 | |
| 17 43516402 rs17631303-G 17:43516402 Ovarian cancer in BRCA1 mutation carriers 1.00E-08 1.27 23544013 | |
| 17 43516402 rs17631303-? 17:43516402 Ovarian cancer in BRCA1 mutation carriers 1.00E-08 NR 23544013 | |
| 17 43714850 rs2942168-G 17:43714850 Parkinson's disease 1.00E-28 1.27 21292315 | |
| 17 43719143 rs393152-A 17:43719143 Parkinson's disease 2.00E-16 1.3 19915575 | |
| 17 43805194 rs9303521-T 17:43805194 Bone mineral density (spine) 1.00E-08 0.07 19801982 | |
| 17 43923683 rs12185268-A 17:43923683 Parkinson's disease 3.00E-14 1.3 21738487 | |
| 17 43924219 rs12373124-T 17:43924219 Male-pattern baldness 5.00E-10 1.33 22693459 | |
| 17 43925297 rs17690703-C 17:43925297 Idiopathic pulmonary fibrosis 6.00E-09 1.43 24429156 | |
| 17 43977827 rs1864325-T 17:43977827 Bone mineral density 5.00E-11 0.04 22504420 | |
| 17 44019712 rs242557-? 17:44019712 Progressive supranuclear palsy 9.00E-18 1.43 21685912 | |
| 17 44056767 rs1981997-G 17:44056767 Interstitial lung disease 9.00E-14 1.41 23583980 | |
| 17 44081064 rs8070723-? 17:44081064 Progressive supranuclear palsy 2.00E-118 5.11 21685912 | |
| 17 44081064 rs8070723-? 17:44081064 Parkinson's disease 7.00E-12 1.3 21044948 | |
| 17 44187257 rs9303525-G 17:44187257 Intracranial volume 8.00E-15 14.9 22504418 | |
| 17 44187492 rs17577094-? 17:44187492 Parkinson's disease 8.00E-09 1.56 24842889 | |
| 17 44788310 rs183211-A 17:44788310 Ovarian cancer in BRCA1 mutation carriers 3.00E-08 1.25 23544013 | |
| 17 44788310 rs183211-? 17:44788310 Ovarian cancer in BRCA1 mutation carriers 3.00E-08 NR 23544013 | |
| 17 44828931 rs199533-C 17:44828931 Parkinson's disease 1.00E-14 1.28 19915575 | |
| 17 44856641 rs199515-? 17:44856641 Parkinson's disease 3.00E-17 1.32 22451204 | |
| 17 45013271 rs17608766-T 17:45013271 Blood pressure 6.00E-15 0.53 21909110 | |
| 17 45013271 rs17608766-T 17:45013271 Systolic blood pressure 1.00E-10 0.56 21909115 | |
| 17 45013271 rs17608766-C 17:45013271 QRS duration 5.00E-10 0.53 21076409 | |
| 17 45425115 rs7206971-T 17:45425115 LDL cholesterol 4.00E-09 0.87 20686565 | |
| 17 45425115 rs7206971-A 17:45425115 "Cholesterol, total" 1.00E-08 1.01 20686565 | |
| 17 45768836 rs8070463-C 17:45768836 Ankylosing spondylitis 5.00E-08 NR 21743469 | |
| 17 46123004 rs72823592-G 17:46123004 Epilepsy (generalized) 9.00E-09 1.3 22949513 | |
| 17 46411500 rs9303542-? 17:46411500 Ovarian cancer 3.00E-10 1.14 23535730 | |
| 17 46411500 rs9303542-? 17:46411500 Ovarian cancer 6.00E-09 1.12 23535730 | |
| 17 46669430 rs9299-? 17:46669430 Obesity 4.00E-09 1.14 22484627 | |
| 17 46988597 rs46522-T 17:46988597 Coronary heart disease 2.00E-08 1.06 21378990 | |
| 17 47080431 rs1994969-T 17:47080431 Primary tooth development (number of teeth) 7.00E-16 0.19 23704328 | |
| 17 47080431 rs1994969-T 17:47080431 Primary tooth development (time to first tooth eruption) 2.00E-14 0.03 23704328 | |
| 17 47084711 rs9674544-G 17:47084711 Primary tooth development (number of teeth) 2.00E-08 0.27 20195514 | |
| 17 47345186 rs11650494-A 17:47345186 Prostate cancer 2.00E-09 1.15 23535732 | |
| 17 47390014 rs2072153-C 17:47390014 Height 4.00E-08 0.02 20881960 | |
| 17 47436749 rs7210100-? 17:47436749 Prostate cancer 3.00E-13 1.51 21602798 | |
| 17 47440466 rs16948048-G 17:47440466 Diastolic blood pressure 5.00E-09 0.31 19430483 | |
| 17 47445751 rs2411984-A 17:47445751 Sex hormone-binding globulin levels 4.00E-14 0.03 22829776 | |
| 17 47445751 rs2411984-A 17:47445751 Sex hormone-binding globulin levels 2.00E-10 0.03 22829776 | |
| 17 47566312 rs16948200-A 17:47566312 Immune reponse to smallpox (secreted IL-2) 2.00E-08 NR 22610502 | |
| 17 48692082 rs117964204-? 17:48692082 Alzheimer's disease (cognitive decline) 1.00E-09 0.28 23535033 | |
| 17 49244747 rs4605213-C 17:49244747 Height 3.00E-08 0.02 20881960 | |
| 17 49613785 rs9635759-A 17:49613785 Menarche (age at onset) 7.00E-13 3 21102462 | |
| 17 53056471 rs6504950-G 17:53056471 Breast cancer 2.00E-13 1.06 23535729 | |
| 17 53364788 rs7224610-A 17:53364788 Urate levels 5.00E-17 0.04 23263486 | |
| 17 53757787 rs1549519-T 17:53757787 Height 6.00E-09 0.05 22021425 | |
| 17 54773238 rs227731-C 17:54773238 Orofacial clefts 1.00E-08 1.38 20023658 | |
| 17 54773238 rs227731-C 17:54773238 Orofacial clefts 2.00E-08 1.23 22863734 | |
| 17 54778817 rs227724-A 17:54778817 Height 7.00E-15 0.03 20881960 | |
| 17 54839759 rs1401796-? 17:54839759 Height 2.00E-08 NR 20881960 | |
| 17 56369849 rs12940923-A 17:56369849 Circulating myeloperoxidase levels (plasma) 4.00E-09 0.07 23620142 | |
| 17 56632543 rs9905704-T 17:56632543 Testicular germ cell tumor 4.00E-13 1.27 23666239 | |
| 17 56632543 rs9905704-T 17:56632543 Testicular germ cell tumor 3.00E-09 1.21 23666240 | |
| 17 56709058 rs412000-C 17:56709058 Primary tooth development (time to first tooth eruption) 2.00E-09 0.16 23704328 | |
| 17 57287454 rs6503905-A 17:57287454 Circulating myeloperoxidase levels (plasma) 3.00E-12 0.06 23620142 | |
| 17 57850251 rs11650106-C 17:57850251 Lipoprotein-associated phospholipase A2 activity and mass 3.00E-09 0.01 23118302 | |
| 17 57963537 rs1292053-G 17:57963537 Inflammatory bowel disease 9.00E-13 1.08 23128233 | |
| 17 59239221 rs11868441-G 17:59239221 Renal function-related traits (BUN) 2.00E-09 0.01 22797727 | |
| 17 59286644 rs8068952-G 17:59286644 Vertical cup-disc ratio 3.00E-08 0.01 20548946 | |
| 17 59292436 rs72832584-? 17:59292436 Alzheimer's disease (cognitive decline) 1.00E-11 0.3 23535033 | |
| 17 59456589 rs9895661-C 17:59456589 Chronic kidney disease 1.00E-15 0.01 20383146 | |
| 17 59456589 rs9895661-C 17:59456589 Renal function-related traits (eGRFcrea) 5.00E-11 0.01 22797727 | |
| 17 59456589 rs9895661-C 17:59456589 Renal function-related traits (sCR) 7.00E-11 0 22797727 | |
| 17 59465697 rs2079742-T 17:59465697 Urate levels 1.00E-08 0.04 23263486 | |
| 17 59483766 rs8068318-G 17:59483766 Creatinine levels 3.00E-10 0.8 20383145 | |
| 17 59496649 rs2079795-T 17:59496649 Height 2.00E-24 0.04 20881960 | |
| 17 59496649 rs2079795-T 17:59496649 Height 1.00E-18 1.2 23563607 | |
| 17 59880646 rs34289250-C 17:59880646 Ovarian cancer 6.00E-13 7.95 21964575 | |
| 17 61563458 rs4329-G 17:61563458 Metabolic traits 8.00E-20 0.13 21886157 | |
| 17 61566031 rs4343-A 17:61566031 Blood metabolite ratios 1.00E-37 0.06 24816252 | |
| 17 61566031 rs4343-G 17:61566031 Angiotensin-converting enzyme activity 3.00E-25 16.2 20066004 | |
| 17 61566031 rs4343-G 17:61566031 Serum metabolite levels 9.00E-25 0.22 24625756 | |
| 17 61566031 rs4343-A 17:61566031 Serum metabolite levels 1.00E-18 0.35 24625756 | |
| 17 61566031 rs4343-G 17:61566031 Serum metabolite levels 8.00E-14 0.21 24625756 | |
| 17 61569732 rs4351-A 17:61569732 Blood metabolite levels 4.00E-22 0.06 24816252 | |
| 17 61569732 rs4351-A 17:61569732 Blood metabolite levels 1.00E-19 0.05 24816252 | |
| 17 61569732 rs4351-A 17:61569732 Blood metabolite levels 3.00E-17 0.05 24816252 | |
| 17 61569732 rs4351-A 17:61569732 Blood metabolite levels 1.00E-14 0.04 24816252 | |
| 17 61569732 rs4351-A 17:61569732 Metabolite levels 9.00E-13 NR 23281178 | |
| 17 61573761 rs4362-T 17:61573761 Blood metabolite levels 1.00E-21 0.06 24816252 | |
| 17 61763031 rs11658329-G 17:61763031 Height 5.00E-10 0.05 22021425 | |
| 17 61763031 rs11658329-C 17:61763031 Height 6.00E-10 0.05 21998595 | |
| 17 61966465 rs2665838-C 17:61966465 Height 5.00E-25 0.04 20881960 | |
| 17 61977248 rs2854160-T 17:61977248 Height 5.00E-08 0.05 21998595 | |
| 17 61978548 rs2941551-G 17:61978548 Height 3.00E-14 1.19 23563607 | |
| 17 62007498 rs2070776-? 17:62007498 Height 9.00E-09 NR 20881960 | |
| 17 62998023 rs10853057-? 17:62998023 White matter microstructure (global fractional anisotropy) 3.00E-10 NR 24736177 | |
| 17 64210580 rs1801689-C 17:64210580 LDL cholesterol 1.00E-11 0.1 24097068 | |
| 17 64779430 rs3889237-C 17:64779430 Height 3.00E-08 0.06 22021425 | |
| 17 65898809 rs7216064-A 17:65898809 Lung adenocarcinoma 7.00E-11 1.2 22797724 | |
| 17 66382209 rs11655081-? 17:66382209 Musician's dystonia 4.00E-09 4.33 24375517 | |
| 17 66875294 rs4148008-G 17:66875294 HDL cholesterol 1.00E-12 0.03 24097068 | |
| 17 66875294 rs4148008-G 17:66875294 HDL cholesterol 2.00E-10 0.42 20686565 | |
| 17 68090207 rs11867479-T 17:68090207 Height 2.00E-10 0.03 20881960 | |
| 17 68185586 rs8080944-A 17:68185586 Primary tooth development (time to first tooth eruption) 8.00E-34 0.34 23704328 | |
| 17 68185586 rs8080944-A 17:68185586 Primary tooth development (number of teeth) 2.00E-19 0.22 23704328 | |
| 17 68190826 rs8079702-G 17:68190826 Primary tooth development (time to first tooth eruption) 4.00E-22 1.62 20195514 | |
| 17 68190826 rs8079702-G 17:68190826 Primary tooth development (number of teeth) 1.00E-14 1.15 20195514 | |
| 17 68259446 rs623011-A 17:68259446 Thyrotoxic hypokalemic periodic paralysis 4.00E-12 5.47 22399142 | |
| 17 68326338 rs312691-C 17:68326338 Thyrotoxic hypokalemic periodic paralysis 8.00E-14 3.2 22863731 | |
| 17 68494992 rs17779747-T 17:68494992 QT interval 6.00E-12 1.02 19305409 | |
| 17 68521861 rs7219669-T 17:68521861 Cardiac repolarization 6.00E-14 1.7 22342860 | |
| 17 68644189 rs17718586-? 17:68644189 Sudden cardiac arrest 2.00E-08 1.53 21658281 | |
| 17 68718734 rs4793501-C 17:68718734 Refractive error 3.00E-08 0.08 23396134 | |
| 17 68976415 rs6501431-T 17:68976415 Forced vital capacity 3.00E-09 23.05 24929828 | |
| 17 69108753 rs1859962-? 17:69108753 Prostate cancer 2.00E-16 NR 19767753 | |
| 17 69108753 rs1859962-G 17:69108753 Prostate cancer 3.00E-11 1.27 21743057 | |
| 17 69108753 rs1859962-G 17:69108753 Prostate cancer 3.00E-10 1.2 17603485 | |
| 17 69118636 rs4793529-T 17:69118636 Prostate cancer 2.00E-13 0.28 24753544 | |
| 17 69125606 rs11654749-T 17:69125606 Pulmonary function (interaction) 1.00E-08 0.02 23284291 | |
| 17 69236998 rs12946942-T 17:69236998 Adolescent idiopathic scoliosis (severe) 6.00E-12 2.21 24023777 | |
| 17 69949016 rs7217932-A 17:69949016 Bone mineral density 2.00E-11 0.03 22504420 | |
| 17 70098161 rs9913711-C 17:70098161 Liver enzyme levels (gamma-glutamyl transferase) 1.00E-09 2.4 22001757 | |
| 17 70127536 rs9915657-T 17:70127536 Thyroid hormone levels 8.00E-13 0.06 23408906 | |
| 17 70641698 rs7210086-A 17:70641698 Ulcerative colitis 2.00E-09 1.11 23128233 | |
| 17 72699833 rs10512597-A 17:72699833 Fibrinogen 8.00E-11 6.45 20031577 | |
| 17 72699833 rs10512597-T 17:72699833 Fibrinogen 1.00E-08 0.01 23969696 | |
| 17 73872948 rs1055129-G 17:73872948 White matter hyperintensity burden 3.00E-11 NR 21681796 | |
| 17 73888672 rs3744028-C 17:73888672 White matter hyperintensity burden 4.00E-15 NR 21681796 | |
| 17 74733403 rs3744061-G 17:74733403 Retinal arteriolar caliber 2.00E-10 0.86 23776548 | |
| 17 74988444 rs7221059-C 17:74988444 Pulmonary emphysema 3.00E-08 0.33 24383474 | |
| 17 76403984 rs4129767-G 17:76403984 HDL cholesterol 2.00E-11 0.02 24097068 | |
| 17 76403984 rs4129767-G 17:76403984 HDL cholesterol 5.00E-09 0.4 20686565 | |
| 17 76439361 rs72925845-? 17:76439361 Triglycerides 7.00E-09 1.64 24886709 | |
| 17 78348494 rs6565681-A 17:78348494 Moyamoya disease 2.00E-08 4.82 21048783 | |
| 17 78591111 rs7503807-A 17:78591111 Obesity 2.00E-08 1.04 23563607 | |
| 17 79235788 rs7224668-C 17:79235788 IgG glycosylation 3.00E-08 0.17 23382691 | |
| 17 79596811 rs9894429-T 17:79596811 Eye color traits 9.00E-14 0.12 20463881 | |
| 17 80086395 rs4625783-T 17:80086395 Blood metabolite levels 4.00E-13 0.02 24816252 | |
| 17 80685426 rs1046875-A 17:80685426 Glycated hemoglobin levels 4.00E-17 0.08 24647736 | |
| 17 80685533 rs1046896-T 17:80685533 Glycated hemoglobin levels 2.00E-26 0.04 20858683 | |
| 18 1977713 rs6505987-? 18:1977713 PR interval in Tripanosoma cruzi seropositivity 3.00E-08 NR 24324551 | |
| 18 2946291 rs643507-C 18:2946291 Body mass index (asthmatics) 8.00E-09 NR 23517042 | |
| 18 2967845 rs8087073-? 18:2967845 PR interval in Tripanosoma cruzi seropositivity 1.00E-09 NR 24324551 | |
| 18 6939947 rs597503-? 18:6939947 Sudden cardiac arrest 2.00E-08 1.45 21658281 | |
| 18 7068462 rs8090011-G 18:7068462 Type 2 diabetes 8.00E-09 1.13 22693455 | |
| 18 12606463 rs9959145-? 18:12606463 Immune response to smallpox vaccine (IL-6) 3.00E-08 NR 22542470 | |
| 18 12779947 rs2542151-G 18:12779947 Crohn's disease 5.00E-17 1.35 18587394 | |
| 18 12779947 rs2542151-C 18:12779947 Type 1 diabetes 1.00E-14 1.3 17554260 | |
| 18 12779947 rs2542151-G 18:12779947 Type 1 diabetes autoantibodies 4.00E-13 1.3 21829393 | |
| 18 12779947 rs2542151-? 18:12779947 Crohn's disease 3.00E-08 1.15 17554261 | |
| 18 12797694 rs2847297-G 18:12797694 Rheumatoid arthritis 2.00E-08 1.1 22446963 | |
| 18 12809340 rs1893217-G 18:12809340 Inflammatory bowel disease 3.00E-26 1.17 23128233 | |
| 18 12809340 rs1893217-? 18:12809340 Type 1 diabetes 4.00E-15 NR 19430480 | |
| 18 12809340 rs1893217-G 18:12809340 Crohn's disease 1.00E-14 1.25 21102463 | |
| 18 12809340 rs1893217-G 18:12809340 Celiac disease and Rheumatoid arthritis 5.00E-12 NR 21383967 | |
| 18 12809340 rs1893217-G 18:12809340 Celiac disease 3.00E-10 1.17 20190752 | |
| 18 12821593 rs2847281-C 18:12821593 Esophageal cancer (squamous cell) 2.00E-11 1.2 22960999 | |
| 18 12821593 rs2847281-A 18:12821593 C-reactive protein 2.00E-08 0.03 21300955 | |
| 18 12881361 rs8083786-G 18:12881361 Rheumatoid arthritis 6.00E-18 1.14 24390342 | |
| 18 12881361 rs8083786-G 18:12881361 Rheumatoid arthritis 2.00E-11 1.18 24390342 | |
| 18 12881361 rs8083786-G 18:12881361 Rheumatoid arthritis 8.00E-09 1.12 24390342 | |
| 18 13708574 rs4796995-A 18:13708574 Bone mineral density 5.00E-08 0.03 22504420 | |
| 18 19261413 rs11662721-? 18:19261413 Phospholipid levels (plasma) 1.00E-08 0 22359512 | |
| 18 20190795 rs4331426-G 18:20190795 Tuberculosis 7.00E-09 1.19 20694014 | |
| 18 20190795 rs4331426-? 18:20190795 Tuberculosis 2.00E-08 NR 24057671 | |
| 18 20223695 rs11661542-C 18:20223695 Intracranial aneurysm 1.00E-12 1.22 20364137 | |
| 18 20720973 rs11082304-T 18:20720973 Height 5.00E-15 1.18 23563607 | |
| 18 20720973 rs11082304-G 18:20720973 Platelet counts 5.00E-11 2.48 22139419 | |
| 18 20724328 rs4800148-A 18:20724328 Height 4.00E-09 6.4 18391951 | |
| 18 20727611 rs4800452-T 18:20727611 Height 4.00E-30 0.05 20881960 | |
| 18 20879217 rs9949617-? 18:20879217 Hypertriglyceridemia 2.00E-08 1.28 23505323 | |
| 18 24156425 rs16942421-? 18:24156425 Sudden cardiac arrest 8.00E-10 1.68 21658281 | |
| 18 24337424 rs527616-G 18:24337424 Breast cancer 2.00E-10 1.05 23535729 | |
| 18 24570667 rs1436904-T 18:24570667 Breast cancer 3.00E-08 1.04 23535729 | |
| 18 29187279 rs1667255-C 18:29187279 Retinol levels 6.00E-14 0.03 21878437 | |
| 18 33694120 rs1050631-T 18:33694120 Esophageal squamous cell cancer (length of survival) 4.00E-08 1.3 23644492 | |
| 18 40673380 rs12456492-? 18:40673380 Parkinson's disease 2.00E-10 1.19 22451204 | |
| 18 42800148 rs10502861-C 18:42800148 Male-pattern baldness 3.00E-09 1.28 22693459 | |
| 18 43187130 rs7227483-G 18:43187130 Renal function-related traits (BUN) 7.00E-18 0.01 22797727 | |
| 18 43202404 rs7232775-C 18:43202404 Metabolite levels 8.00E-14 0.01 21909109 | |
| 18 43231622 rs4890568-G 18:43231622 Hematological and biochemical traits 2.00E-10 0.09 20139978 | |
| 18 43309911 rs17674580-T 18:43309911 Bladder cancer 8.00E-11 1.17 21750109 | |
| 18 43316966 rs7238033-? 18:43316966 Bladder cancer 9.00E-09 1.2 21824976 | |
| 18 44752238 rs1398217-G 18:44752238 Menarche (age at onset) 2.00E-13 2.7 21102462 | |
| 18 45865597 rs11082671-G 18:45865597 Height 2.00E-08 0.11 23456168 | |
| 18 46395022 rs7240004-A 18:46395022 Inflammatory bowel disease 1.00E-09 1.06 23128233 | |
| 18 46450976 rs7229639-A 18:46450976 Colorectal cancer 3.00E-11 1.22 24448986 | |
| 18 46450976 rs7229639-A 18:46450976 Colorectal cancer 2.00E-08 1.2 24836286 | |
| 18 46453463 rs4939827-T 18:46453463 Colorectal cancer 8.00E-28 1.2 18372901 | |
| 18 46453463 rs4939827-T 18:46453463 Colorectal cancer 1.00E-12 1.16 17934461 | |
| 18 46453463 rs4939827-? 18:46453463 Colorectal cancer 2.00E-10 1.12 23266556 | |
| 18 46587654 rs1787200-A 18:46587654 Height 1.00E-10 0.05 21998595 | |
| 18 46587654 rs1787200-T 18:46587654 Height 7.00E-10 0.04 22021425 | |
| 18 46959500 rs9967417-C 18:46959500 Height 9.00E-25 0.04 20881960 | |
| 18 46959500 rs9967417-G 18:46959500 Height 5.00E-09 1.13 23563607 | |
| 18 47159090 rs7240405-A 18:47159090 HDL cholesterol 5.00E-10 2.27 20031538 | |
| 18 47160814 rs7228085-? 18:47160814 Lipid metabolism phenotypes 7.00E-11 0.11 22286219 | |
| 18 47160953 rs7241918-G 18:47160953 HDL cholesterol 3.00E-49 1.31 20686565 | |
| 18 47160953 rs7241918-G 18:47160953 HDL cholesterol 1.00E-44 0.09 24097068 | |
| 18 47160953 rs7241918-A 18:47160953 "Cholesterol, total" 2.00E-19 1.94 20686565 | |
| 18 47160953 rs7241918-G 18:47160953 "Cholesterol, total" 4.00E-18 0.06 24097068 | |
| 18 47167214 rs4939883-? 18:47167214 Lipid metabolism phenotypes 7.00E-16 1.51 19936222 | |
| 18 47167214 rs4939883-T 18:47167214 HDL cholesterol 7.00E-15 0.14 19060906 | |
| 18 47167214 rs4939883-? 18:47167214 Lipid metabolism phenotypes 6.00E-14 2.53 19936222 | |
| 18 47167214 rs4939883-? 18:47167214 Lipid metabolism phenotypes 5.00E-13 1.59 19936222 | |
| 18 47167214 rs4939883-? 18:47167214 Lipid metabolism phenotypes 2.00E-11 2.62 19936222 | |
| 18 47167214 rs4939883-G 18:47167214 "Cholesterol, total" 2.00E-11 0.07 19060911 | |
| 18 47167214 rs4939883-G 18:47167214 HDL cholesterol 2.00E-11 0.1 19060911 | |
| 18 47167214 rs4939883-? 18:47167214 Lipid metabolism phenotypes 4.00E-10 0.31 19936222 | |
| 18 47167214 rs4939883-? 18:47167214 Lipid metabolism phenotypes 1.00E-09 1.24 19936222 | |
| 18 47167214 rs4939883-? 18:47167214 Lipid metabolism phenotypes 1.00E-09 0.35 19936222 | |
| 18 47167214 rs4939883-? 18:47167214 Lipid metabolism phenotypes 2.00E-08 1.33 19936222 | |
| 18 47172283 rs2187375-A 18:47172283 Blood metabolite levels 3.00E-17 0.02 24816252 | |
| 18 47181668 rs2156552-T 18:47181668 HDL cholesterol 2.00E-12 0.03 20864672 | |
| 18 47181668 rs2156552-T 18:47181668 HDL cholesterol 6.00E-12 1.2 18193043 | |
| 18 48713040 rs8096445-A 18:48713040 Immune response to smallpox vaccine (IL-6) 9.00E-09 NR 22610502 | |
| 18 52752017 rs12966547-? 18:52752017 "Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)" 3.00E-10 NR 23453885 | |
| 18 52752017 rs12966547-G 18:52752017 Schizophrenia 3.00E-08 1.4 21926974 | |
| 18 52752700 rs4801131-C 18:52752700 Schizophrenia 1.00E-08 1.08 23974872 | |
| 18 52949657 rs1261117-T 18:52949657 Schizophrenia 3.00E-10 1.6 23894747 | |
| 18 53155002 rs9960767-C 18:53155002 Schizophrenia 4.00E-09 1.23 19571808 | |
| 18 53207207 rs1452787-A 18:53207207 Sclerosing cholangitis and ulcerative colitis (combined) 3.00E-08 1.33 22821403 | |
| 18 53210302 rs613872-G 18:53210302 Fuchs's corneal dystrophy 1.00E-18 5.47 20825314 | |
| 18 55322502 rs12968116-C 18:55322502 Liver enzyme levels (gamma-glutamyl transferase) 9.00E-10 4.8 22001757 | |
| 18 56084054 rs4503880-T 18:56084054 Liver enzyme levels (gamma-glutamyl transferase) 3.00E-12 3.6 22001757 | |
| 18 56384192 rs7238078-A 18:56384192 Multiple sclerosis 3.00E-09 1.12 21833088 | |
| 18 57503378 rs8093763-A 18:57503378 Bleomycin sensitivity 3.00E-08 0.18 21106707 | |
| 18 57622287 rs4368253-C 18:57622287 Chronic lymphocytic leukemia 3.00E-08 1.19 23770605 | |
| 18 57734857 rs723486-T 18:57734857 Body mass index 4.00E-17 0.08 23669352 | |
| 18 57828637 rs2331841-A 18:57828637 Body mass index 2.00E-11 0.05 22344221 | |
| 18 57829135 rs6567160-C 18:57829135 Body mass index 8.00E-19 0.09 24064335 | |
| 18 57829135 rs6567160-C 18:57829135 Fat body mass 3.00E-11 0.09 24064335 | |
| 18 57839769 rs571312-A 18:57839769 Body mass index 6.00E-42 0.23 20935630 | |
| 18 57841589 rs591166-A 18:57841589 Body mass index 7.00E-14 0.05 24861553 | |
| 18 57849023 rs12967135-A 18:57849023 HDL cholesterol 7.00E-09 0.42 20686565 | |
| 18 57849023 rs12967135-A 18:57849023 HDL cholesterol 4.00E-08 0.03 24097068 | |
| 18 57850422 rs538656-T 18:57850422 Obesity 2.00E-36 1.15 23563607 | |
| 18 57851097 rs17782313-C 18:57851097 Body mass index 5.00E-18 0.2 19079261 | |
| 18 57851097 rs17782313-C 18:57851097 Body mass index 3.00E-15 0.05 18454148 | |
| 18 57851097 rs17782313-C 18:57851097 Obesity 5.00E-15 1.22 19151714 | |
| 18 57851097 rs17782313-T 18:57851097 Height 4.00E-11 0.03 20881960 | |
| 18 57851763 rs10871777-G 18:57851763 Obesity 2.00E-27 1.1 23563607 | |
| 18 57852587 rs476828-C 18:57852587 Obesity (early onset extreme) 9.00E-14 1.33 23563609 | |
| 18 57852948 rs11152213-C 18:57852948 Obesity 3.00E-22 1.19 23563607 | |
| 18 57858829 rs8089364-C 18:57858829 Body mass index 4.00E-21 1.24 23563607 | |
| 18 57882787 rs489693-? 18:57882787 Antipsychotic drug-induced weight gain 6.00E-12 NR 22566560 | |
| 18 57884750 rs12970134-A 18:57884750 Weight 5.00E-13 4.66 19079260 | |
| 18 57884750 rs12970134-A 18:57884750 Body mass index 1.00E-12 4.38 19079260 | |
| 18 57884750 rs12970134-A 18:57884750 Waist circumference and related phenotypes 2.00E-09 0.88 18454146 | |
| 18 57884750 rs12970134-A 18:57884750 Type 2 diabetes 3.00E-08 1.08 24509480 | |
| 18 60054857 rs884205-A 18:60054857 Bone mineral density 2.00E-17 0.05 22504420 | |
| 18 60054857 rs884205-A 18:60054857 Bone mineral density (spine) 9.00E-09 0.08 19801982 | |
| 18 60054857 rs884205-C 18:60054857 "Bone mineral density (paediatric, skull)" 2.00E-08 0.1 24945404 | |
| 18 60060735 rs2957128-A 18:60060735 Paget's disease 2.00E-11 1.46 20436471 | |
| 18 60082093 rs3018362-A 18:60082093 Paget's disease 8.00E-21 1.45 21623375 | |
| 18 60082093 rs3018362-A 18:60082093 Paget's disease 5.00E-13 1.52 20436471 | |
| 18 60126112 rs694419-T 18:60126112 Serum albumin level 4.00E-09 0.01 23022100 | |
| 18 60126112 rs694419-T 18:60126112 Serum albumin level 1.00E-08 0.01 23022100 | |
| 18 60793549 rs4987855-G 18:60793549 Chronic lymphocytic leukemia 3.00E-12 1.47 23770605 | |
| 18 60793921 rs4987852-? 18:60793921 Chronic lymphocytic leukemia 8.00E-11 1.41 23770605 | |
| 18 67516845 rs893001-C 18:67516845 Mean platelet volume 1.00E-10 0.01 19820697 | |
| 18 67530439 rs727088-G 18:67530439 Inflammatory bowel disease 5.00E-09 1.08 23128233 | |
| 18 67531642 rs763361-C 18:67531642 Type 1 diabetes autoantibodies 1.00E-09 1.12 21829393 | |
| 18 67531642 rs763361-A 18:67531642 Type 1 diabetes 1.00E-08 1.16 17554260 | |
| 18 67536496 rs12969657-T 18:67536496 Mean platelet volume 3.00E-11 0.01 22139419 | |
| 18 67544046 rs2469434-C 18:67544046 Rheumatoid arthritis 9.00E-10 1.07 24390342 | |
| 18 67544046 rs2469434-C 18:67544046 Rheumatoid arthritis 1.00E-08 1.11 24390342 | |
| 18 69439073 rs17085106-? 18:69439073 Orofacial clefts 4.00E-08 4.07 19656524 | |
| 18 70150939 rs2217560-G 18:70150939 Pulmonary arterial hypertension (without BMPR2 mutations) 7.00E-10 1.97 23502781 | |
| 18 71167752 rs7240777-A 18:71167752 Thyroid hormone levels 3.00E-08 0.08 23408906 | |
| 18 71788676 rs9945428-? x rs4823535-? 18:71788676 Venous thromboembolism (gene x gene interaction) 7.00E-09 1.61 23509962 | |
| 18 73462854 rs1943199-? 18:73462854 Rheumatoid arthritis (ACPA-negative) 2.00E-08 1.94 24532677 | |
| 18 74182975 rs6565887-G 18:74182975 Renal transplant outcome 4.00E-08 0.29 23432519 | |
| 18 76773973 rs7241993-G 18:76773973 Prostate cancer 2.00E-09 1.09 23535732 | |
| 18 77624479 rs62103177-? 18:77624479 Opioid sensitivity 4.00E-10 NR 24143882 | |
| 19 1046520 rs3764650-? 19:1046520 Alzheimer's disease 5.00E-17 1.23 21460840 | |
| 19 1050420 rs115550680-G 19:1050420 Alzheimer's disease (late onset) 2.00E-09 1.79 23571587 | |
| 19 1063443 rs4147929-A 19:1063443 Alzheimer's disease (late onset) 1.00E-15 1.15 24162737 | |
| 19 1124031 rs2024092-A 19:1124031 Crohn's disease 8.00E-22 1.16 23128233 | |
| 19 1124835 rs740495-G 19:1124835 Crohn's disease 8.00E-12 1.16 21102463 | |
| 19 1650134 rs1860661-? 19:1650134 Hodgkin's lymphoma 4.00E-10 1.23 24920014 | |
| 19 2160529 rs3803915-C 19:2160529 Myocardial infarction 4.00E-09 1.12 24916648 | |
| 19 2170954 rs12986413-T 19:2170954 Height 3.00E-08 0.31 18391950 | |
| 19 2176403 rs11880992-A 19:2176403 Height 2.00E-12 1.15 23563607 | |
| 19 2177193 rs12982744-C 19:2177193 Height 3.00E-16 0.03 20881960 | |
| 19 2177193 rs12982744-G 19:2177193 Osteoarthritis 1.00E-11 0.09 22566624 | |
| 19 3428834 rs7507204-C 19:3428834 Height 4.00E-16 0.04 20881960 | |
| 19 3797100 rs12104221-A 19:3797100 Obesity-related traits 3.00E-08 0.05 23251661 | |
| 19 4717672 rs12610495-G 19:4717672 Interstitial lung disease 2.00E-12 1.29 23583980 | |
| 19 5834212 rs17271883-G 19:5834212 Tumor biomarkers 5.00E-132 0.28 23300138 | |
| 19 5839746 rs3760776-T 19:5839746 Tumor biomarkers 2.00E-56 0.17 23300138 | |
| 19 5839746 rs3760776-A 19:5839746 N-glycan levels 4.00E-17 0.41 21203500 | |
| 19 5839746 rs3760776-? 19:5839746 Vitamin B12 levels 4.00E-13 49.78 22367966 | |
| 19 5839746 rs3760776-A 19:5839746 N-glycan levels 1.00E-12 0.34 21203500 | |
| 19 5839746 rs3760776-A 19:5839746 N-glycan levels 3.00E-12 0.34 21203500 | |
| 19 5839746 rs3760776-A 19:5839746 N-glycan levels 9.00E-10 0.3 21203500 | |
| 19 5841356 rs3760775-T 19:5841356 Tumor biomarkers 3.00E-290 0.48 23300138 | |
| 19 5841356 rs3760775-T 19:5841356 Tumor biomarkers 1.00E-35 0.07 23300138 | |
| 19 5841356 rs3760775-? 19:5841356 Elevated serum carcinoembryonic antigen levels 8.00E-19 NR 24941225 | |
| 19 5851801 rs2306969-? 19:5851801 Elevated serum carcinoembryonic antigen levels 3.00E-08 NR 24941225 | |
| 19 6668972 rs1077667-G 19:6668972 Multiple sclerosis 9.00E-14 1.16 21833088 | |
| 19 6690771 rs3745567-T 19:6690771 Complement C3 and C4 levels 2.00E-09 0.09 23028341 | |
| 19 6718387 rs2230199-C 19:6718387 Age-related macular degeneration 1.00E-41 1.42 23455636 | |
| 19 6718387 rs2230199-C 19:6718387 Age-related macular degeneration 5.00E-29 1.53 21665990 | |
| 19 6718387 rs2230199-C 19:6718387 Age-related macular degeneration (GA) 5.00E-13 1.83 22705344 | |
| 19 6718387 rs2230199-C 19:6718387 Age-related macular degeneration (CNV) 1.00E-12 1.61 22705344 | |
| 19 6718387 rs2230199-C 19:6718387 Age-related macular degeneration 1.00E-10 1.74 20385819 | |
| 19 6718387 rs2230199-C 19:6718387 Age-related macular degeneration 1.00E-08 1.44 20861866 | |
| 19 6718387 rs2230199-? 19:6718387 Age-related macular degeneration 2.00E-08 NR 20385826 | |
| 19 7166109 rs2059807-G 19:7166109 Polycystic ovary syndrome 1.00E-08 1.14 22885925 | |
| 19 7184762 rs891088-A 19:7184762 Height 2.00E-12 0.03 20881960 | |
| 19 7223848 rs4804416-T 19:7223848 Thyroid hormone levels 3.00E-10 0.06 23408906 | |
| 19 7224431 rs7248104-A 19:7224431 Triglycerides 5.00E-10 0.02 24097068 | |
| 19 8271721 rs7258249-? 19:8271721 Sphingolipid levels 1.00E-34 0 22359512 | |
| 19 8271721 rs7258249-G 19:8271721 Sphingolipid levels 2.00E-27 0 19798445 | |
| 19 8433196 rs7255436-C 19:8433196 HDL cholesterol 2.00E-08 0.03 24097068 | |
| 19 8433196 rs7255436-C 19:8433196 HDL cholesterol 3.00E-08 0.45 20686565 | |
| 19 8469738 rs2967605-T 19:8469738 HDL cholesterol 1.00E-08 0.12 19060906 | |
| 19 8644031 rs4072910-C 19:8644031 Height 4.00E-13 0.03 20881960 | |
| 19 8789381 rs2164983-A 19:8789381 Atopic dermatitis 7.00E-09 1.16 22197932 | |
| 19 10394792 rs1799969-A 19:10394792 Soluble ICAM-1 1.00E-120 24.9 21533024 | |
| 19 10394792 rs1799969-A 19:10394792 Soluble ICAM-1 4.00E-47 28.19 18604267 | |
| 19 10395683 rs5498-G 19:10395683 Soluble ICAM-1 6.00E-89 13.8 21533024 | |
| 19 10395683 rs5498-A 19:10395683 Soluble ICAM-1 5.00E-25 13.22 18604267 | |
| 19 10397238 rs281437-? 19:10397238 Soluble ICAM-1 3.00E-10 10.1 18604267 | |
| 19 10397403 rs3093030-T 19:10397403 Soluble levels of adhesion molecules 4.00E-23 4.15 20167578 | |
| 19 10463118 rs34536443-G 19:10463118 Rheumatoid arthritis 5.00E-16 1.46 24390342 | |
| 19 10469975 rs12720356-G 19:10469975 Crohn's disease 1.00E-12 1.12 21102463 | |
| 19 10469975 rs12720356-A 19:10469975 Psoriasis 4.00E-11 1.4 20953190 | |
| 19 10472933 rs280519-A 19:10472933 Psoriasis 4.00E-09 1.13 20953190 | |
| 19 10475652 rs2304256-? 19:10475652 Type 1 diabetes autoantibodies 1.00E-10 NR 21829393 | |
| 19 10475652 rs2304256-C 19:10475652 Type 1 diabetes 4.00E-09 1.16 19966805 | |
| 19 10512911 rs11879191-G 19:10512911 Inflammatory bowel disease 2.00E-18 1.14 23128233 | |
| 19 11092139 rs11669133-A 19:11092139 Coronary heart disease 1.00E-08 0.17 21347282 | |
| 19 11163601 rs1122608-? 19:11163601 Coronary artery disease or ischemic stroke 3.00E-12 NR 24262325 | |
| 19 11163601 rs1122608-? 19:11163601 Coronary artery disease or large artery stroke 2.00E-11 NR 24262325 | |
| 19 11163601 rs1122608-T 19:11163601 Coronary artery disease 3.00E-11 1.14 24262325 | |
| 19 11163601 rs1122608-G 19:11163601 Coronary heart disease 1.00E-09 1.14 21378990 | |
| 19 11163601 rs1122608-G 19:11163601 Myocardial infarction (early onset) 2.00E-09 1.15 19198609 | |
| 19 11188153 rs55791371-? 19:11188153 Lipid metabolism phenotypes 8.00E-17 0.26 22286219 | |
| 19 11200008 rs17249141-T 19:11200008 LDL cholesterol 2.00E-17 32.93 23726366 | |
| 19 11202306 rs6511720-T 19:11202306 LDL cholesterol 4.00E-262 0.22 24097068 | |
| 19 11202306 rs6511720-T 19:11202306 "Cholesterol, total" 5.00E-202 0.19 24097068 | |
| 19 11202306 rs6511720-T 19:11202306 LDL cholesterol 4.00E-117 6.99 20686565 | |
| 19 11202306 rs6511720-? 19:11202306 LDL cholesterol 3.00E-115 NR 24097068 | |
| 19 11202306 rs6511720-T 19:11202306 "Cholesterol, total" 7.00E-97 7.09 20686565 | |
| 19 11202306 rs6511720-T 19:11202306 LDL cholesterol 2.00E-51 0.26 18193044 | |
| 19 11202306 rs6511720-? 19:11202306 Lipid metabolism phenotypes 2.00E-31 6.53 19936222 | |
| 19 11202306 rs6511720-T 19:11202306 LDL cholesterol 2.00E-26 0.26 19060906 | |
| 19 11202306 rs6511720-G 19:11202306 LDL cholesterol 4.00E-26 9.17 18193043 | |
| 19 11202306 rs6511720-? 19:11202306 Lipid metabolism phenotypes 1.00E-25 6.89 19936222 | |
| 19 11202306 rs6511720-? 19:11202306 Lipid metabolism phenotypes 5.00E-25 4.52 19936222 | |
| 19 11202306 rs6511720-? 19:11202306 Lipid metabolism phenotypes 3.00E-18 4.49 19936222 | |
| 19 11202306 rs6511720-T 19:11202306 Lipoprotein-associated phospholipase A2 activity and mass 3.00E-11 0.05 22003152 | |
| 19 11202306 rs6511720-T 19:11202306 Cardiovascular disease risk factors 5.00E-11 0.15 21943158 | |
| 19 11202306 rs6511720-? 19:11202306 Abdominal aortic aneurysm 2.00E-10 1.32 24046328 | |
| 19 11202306 rs6511720-? 19:11202306 Metabolite levels 4.00E-09 NR 22916037 | |
| 19 11210912 rs2228671-G 19:11210912 "Cholesterol, total" 9.00E-24 0.16 19060911 | |
| 19 11210912 rs2228671-G 19:11210912 LDL cholesterol 4.00E-14 0.14 19060911 | |
| 19 11227326 rs2738446-C 19:11227326 Metabolite levels 2.00E-12 2.95 21909109 | |
| 19 11342703 rs12979813-T 19:11342703 HDL cholesterol 2.00E-09 0.02 23726366 | |
| 19 11347493 rs737337-C 19:11347493 HDL cholesterol 5.00E-17 0.06 24097068 | |
| 19 11347493 rs737337-C 19:11347493 HDL cholesterol 3.00E-09 0.64 20686565 | |
| 19 11350488 rs2278426-? 19:11350488 HDL cholesterol 3.00E-09 0.14 23505323 | |
| 19 12752425 rs10411619-T 19:12752425 Pulmonary emphysema 1.00E-09 0.18 24383474 | |
| 19 12932269 rs7255045-A 19:12932269 Mean corpuscular volume 2.00E-12 0 19862010 | |
| 19 13001547 rs11085824-G 19:13001547 Mean corpuscular hemoglobin 1.00E-11 0 19862010 | |
| 19 13010520 rs8012-A 19:13010520 Blood metabolite levels 6.00E-45 0.04 24816252 | |
| 19 13024250 rs741702-A 19:13024250 Red blood cell traits 8.00E-20 0.01 23222517 | |
| 19 15990431 rs2108622-T 19:15990431 Metabolite levels 9.00E-24 NR 23281178 | |
| 19 15990431 rs2108622-T 19:15990431 Vitamin E levels 1.00E-10 0.03 21729881 | |
| 19 15990431 rs2108622-? 19:15990431 Acenocoumarol maintenance dosage 3.00E-10 NR 19578179 | |
| 19 15990431 rs2108622-? 19:15990431 Warfarin maintenance dose 3.00E-10 0.21 19300499 | |
| 19 15990431 rs2108622-T 19:15990431 Warfarin maintenance dose 3.00E-08 NR 20833655 | |
| 19 16185559 rs8109288-A 19:16185559 Mean platelet volume 1.00E-11 0.03 22139419 | |
| 19 16185559 rs8109288-G 19:16185559 Platelet counts 3.00E-10 11.95 22139419 | |
| 19 16185559 rs8109288-G 19:16185559 Mean platelet volume 5.00E-10 8.72 22423221 | |
| 19 16185559 rs8109288-G 19:16185559 Mean platelet volume 3.00E-09 0.26 22423221 | |
| 19 16548375 rs10411936-A 19:16548375 White blood cell count 3.00E-12 0.02 21738480 | |
| 19 17232499 rs11667918-C 19:17232499 Glycated hemoglobin levels 9.00E-12 0.06 24647736 | |
| 19 17283303 rs2279008-T 19:17283303 Height 3.00E-08 0.03 20881960 | |
| 19 17389704 rs8170-? 19:17389704 Ovarian cancer 3.00E-14 1.19 23535730 | |
| 19 17389704 rs8170-G 19:17389704 Breast Cancer in BRCA1 mutation carriers 4.00E-13 1.19 23544013 | |
| 19 17389704 rs8170-A 19:17389704 Breast cancer 9.00E-13 1.15 23535733 | |
| 19 17389704 rs8170-A 19:17389704 Breast cancer 2.00E-09 1.26 20852631 | |
| 19 17392894 rs8100241-G 19:17392894 Breast cancer 4.00E-08 1.14 22976474 | |
| 19 17394124 rs2363956-C 19:17394124 "Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)" 2.00E-08 1.22 24325915 | |
| 19 17434093 rs77331626-G 19:17434093 Rheumatoid arthritis 7.00E-24 1.21 24390342 | |
| 19 17752689 rs12608932-? 19:17752689 Amyotrophic lateral sclerosis 3.00E-14 1.25 19734901 | |
| 19 17752689 rs12608932-C 19:17752689 Amyotrophic lateral sclerosis 5.00E-08 1.37 22959728 | |
| 19 17902334 rs265548-C 19:17902334 Tumor biomarkers 1.00E-13 0.07 23300138 | |
| 19 18304700 rs874628-A 19:18304700 Multiple sclerosis 1.00E-08 1.11 21833088 | |
| 19 18571141 rs4808801-A 19:18571141 Breast cancer 5.00E-15 1.08 23535729 | |
| 19 18618867 rs4808136-A 19:18618867 Blood metabolite levels 5.00E-14 0.01 24816252 | |
| 19 18803172 rs10419226-A 19:18803172 Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined) 4.00E-10 1.18 24121790 | |
| 19 18817903 rs10423674-A 19:18817903 Menarche (age at onset) 6.00E-09 2.3 21102462 | |
| 19 19361735 rs1064395-A 19:19361735 Bipolar disorder 2.00E-09 1.17 21353194 | |
| 19 19407718 rs10401969-C 19:19407718 "Cholesterol, total" 4.00E-77 0.14 24097068 | |
| 19 19407718 rs10401969-C 19:19407718 Triglycerides 1.00E-69 0.12 24097068 | |
| 19 19407718 rs10401969-C 19:19407718 LDL cholesterol 3.00E-54 0.12 24097068 | |
| 19 19407718 rs10401969-C 19:19407718 "Cholesterol, total" 3.00E-38 4.74 20686565 | |
| 19 19407718 rs10401969-C 19:19407718 Triglycerides 2.00E-29 7.83 20686565 | |
| 19 19407718 rs10401969-C 19:19407718 LDL cholesterol 7.00E-22 3.11 20686565 | |
| 19 19407718 rs10401969-T 19:19407718 LDL cholesterol 1.00E-11 0.05 20864672 | |
| 19 19407718 rs10401969-C 19:19407718 LDL cholesterol 2.00E-08 0.05 19060906 | |
| 19 19473445 rs2905424-T 19:19473445 Schizophrenia 3.00E-09 1.09 23974872 | |
| 19 19658472 rs16996148-G 19:19658472 LDL cholesterol 3.00E-09 3.32 18193043 | |
| 19 19658472 rs16996148-G 19:19658472 Triglycerides 3.00E-09 6.1 18193043 | |
| 19 19658472 rs16996148-T 19:19658472 Triglycerides 4.00E-09 0.1 18193044 | |
| 19 19658472 rs16996148-T 19:19658472 LDL cholesterol 3.00E-08 0.1 18193044 | |
| 19 19662220 rs17216525-T 19:19662220 Triglycerides 4.00E-11 0.11 19060906 | |
| 19 19789528 rs2304130-G 19:19789528 "Cholesterol, total" 2.00E-15 0.15 19060911 | |
| 19 19789528 rs2304130-? 19:19789528 Sphingolipid levels 6.00E-09 0.8 22359512 | |
| 19 19789528 rs2304130-G 19:19789528 Triglycerides 4.00E-08 0.07 20864672 | |
| 19 21666210 rs2562456-? 19:21666210 Pain 2.00E-10 NR 19207018 | |
| 19 22359440 rs412658-T 19:22359440 Telomere length 1.00E-08 0.05 23001564 | |
| 19 30296853 rs8102137-C 19:30296853 Bladder cancer 1.00E-11 1.13 24163127 | |
| 19 30296853 rs8102137-C 19:30296853 Bladder cancer 2.00E-11 1.13 20972438 | |
| 19 30990700 rs3786800-? 19:30990700 Myopia (pathological) 3.00E-12 NR 23049088 | |
| 19 33181484 rs3892630-T 19:33181484 Red blood cell traits 1.00E-10 0.18 23222517 | |
| 19 33356891 rs12460876-C 19:33356891 Chronic kidney disease 3.00E-15 0.01 20383146 | |
| 19 33364628 rs8101881-T 19:33364628 Urinary metabolites (H-NMR features) 1.00E-33 0.45 24586186 | |
| 19 33364628 rs8101881-T 19:33364628 Urinary metabolites (H-NMR features) 1.00E-33 0.45 24586186 | |
| 19 33364628 rs8101881-T 19:33364628 Urinary metabolites (H-NMR features) 2.00E-33 0.44 24586186 | |
| 19 33364628 rs8101881-C 19:33364628 Urinary metabolites 6.00E-27 NR 21572414 | |
| 19 33364628 rs8101881-T 19:33364628 Blood metabolite levels 1.00E-16 0.03 24816252 | |
| 19 33453659 rs4805834-A 19:33453659 Creatinine levels 5.00E-11 1 20383145 | |
| 19 33532300 rs10411210-C 19:33532300 Colorectal cancer 5.00E-09 1.15 19011631 | |
| 19 33599127 rs10416218-T 19:33599127 Bone mineral density 7.00E-11 0.04 22504420 | |
| 19 33605300 rs10416265-G 19:33605300 Bone properties (heel) 2.00E-13 0.06 24430505 | |
| 19 33605300 rs10416265-G 19:33605300 Bone properties (heel) 4.00E-12 0.06 24430505 | |
| 19 33731551 rs17694108-A 19:33731551 Inflammatory bowel disease 6.00E-15 1.1 23128233 | |
| 19 33750314 rs10500264-? 19:33750314 Inflammatory bowel disease (early onset) 4.00E-10 1.21 19915574 | |
| 19 33757062 rs736289-T 19:33757062 Crohn's disease 9.00E-09 1.06 21102463 | |
| 19 33889000 rs889140-A 19:33889000 Adiponectin levels 4.00E-12 0.08 24105470 | |
| 19 33893008 rs3786897-A 19:33893008 Type 2 diabetes 1.00E-08 1.1 22158537 | |
| 19 33899065 rs731839-G 19:33899065 Adiponectin levels 8.00E-12 0.03 22479202 | |
| 19 33899065 rs731839-G 19:33899065 HDL cholesterol 3.00E-09 0.02 24097068 | |
| 19 33899065 rs731839-G 19:33899065 Triglycerides 3.00E-09 0.02 24097068 | |
| 19 33906123 rs4805885-T 19:33906123 Adiponectin levels 2.00E-08 0.03 22479202 | |
| 19 34309532 rs29941-C 19:34309532 Body mass index 7.00E-12 4.18 19079260 | |
| 19 34309532 rs29941-G 19:34309532 Body mass index 3.00E-09 0.06 20935630 | |
| 19 34309532 rs29941-C 19:34309532 Weight 5.00E-09 3.73 19079260 | |
| 19 34322137 rs11084753-G 19:34322137 Body mass index 2.00E-08 0.06 19079261 | |
| 19 35555190 rs4806073-C 19:35555190 Serum albumin level 4.00E-18 0.03 23022100 | |
| 19 35555190 rs4806073-C 19:35555190 Serum albumin level 3.00E-15 0.03 23022100 | |
| 19 35559474 rs11671010-? 19:35559474 Serum albumin level 2.00E-13 NR 23022100 | |
| 19 38735613 rs8102476-C 19:38735613 Prostate cancer 2.00E-11 1.12 19767754 | |
| 19 39731783 rs12980275-? 19:39731783 Lipid levels in hepatitis C treatment 5.00E-17 NR 22497812 | |
| 19 39738787 rs12979860-? 19:39738787 Chronic hepatitis C infection 2.00E-30 2.2 23420232 | |
| 19 39738787 rs12979860-C 19:39738787 Response to hepatitis C treatment 1.00E-28 2 19684573 | |
| 19 39743165 rs8099917-G 19:39743165 Response to hepatitis C treatment 3.00E-32 27.1 19749757 | |
| 19 39743165 rs8099917-G 19:39743165 Response to hepatitis C treatment 1.00E-20 3 21228123 | |
| 19 39743165 rs8099917-G 19:39743165 Chronic hepatitis C infection 6.00E-09 2.31 20060832 | |
| 19 39743165 rs8099917-G 19:39743165 Response to hepatitis C treatment 9.00E-09 1.98 19749758 | |
| 19 41224204 rs28493229-? 19:41224204 Kawasaki disease 2.00E-12 1.52 22081228 | |
| 19 41281016 rs2233152-A 19:41281016 Kawasaki disease 4.00E-10 1.52 22446962 | |
| 19 41302706 rs7937-? 19:41302706 Chronic obstructive pulmonary disease 3.00E-09 1.37 22080838 | |
| 19 41310571 rs3733829-G 19:41310571 Smoking behavior 1.00E-08 0.33 20418890 | |
| 19 41358624 rs4105144-C 19:41358624 Smoking behavior 2.00E-12 0.39 20418888 | |
| 19 41363765 rs8102683-? 19:41363765 Smoking behavior 4.00E-42 2.76 23049750 | |
| 19 41937095 rs17318596-A 19:41937095 Height 5.00E-16 0.03 20881960 | |
| 19 41985587 rs11672691-G 19:41985587 Prostate cancer 1.00E-08 1.11 23065704 | |
| 19 44286513 rs3760982-A 19:44286513 Breast cancer 2.00E-10 1.06 23535729 | |
| 19 44888276 rs4142248-? 19:44888276 Myopia (pathological) 3.00E-15 NR 23049088 | |
| 19 45247627 rs4803750-? 19:45247627 Lipid metabolism phenotypes 3.00E-51 8.5 19936222 | |
| 19 45247627 rs4803750-? 19:45247627 Lipid metabolism phenotypes 1.00E-37 9.28 19936222 | |
| 19 45247627 rs4803750-? 19:45247627 Lipid metabolism phenotypes 1.00E-27 9.28 19936222 | |
| 19 45376284 rs519113-G 19:45376284 Alzheimer's disease (late onset) 5.00E-39 2.09 23565137 | |
| 19 45376284 rs519113-C 19:45376284 HDL cholesterol 8.00E-11 0.02 21909109 | |
| 19 45382034 rs6859-A 19:45382034 Alzheimer's disease 6.00E-14 NR 18823527 | |
| 19 45392254 rs6857-T 19:45392254 Alzheimer's disease biomarkers 1.00E-10 NR 23419831 | |
| 19 45392254 rs6857-? 19:45392254 Alzheimer's disease (age of onset) 2.00E-10 NR 22005931 | |
| 19 45395266 rs157580-? 19:45395266 Alzheimer's disease 8.00E-89 1.69 21627779 | |
| 19 45395266 rs157580-? 19:45395266 Alzheimer's disease 1.00E-40 NR 19125160 | |
| 19 45395266 rs157580-G 19:45395266 LDL cholesterol 2.00E-19 0.11 19060911 | |
| 19 45395266 rs157580-G 19:45395266 LDL cholesterol 5.00E-08 0.11 19060910 | |
| 19 45395619 rs2075650-G 19:45395619 Alzheimer's disease 1.00E-295 2.53 20460622 | |
| 19 45395619 rs2075650-? 19:45395619 Alzheimer's disease 2.00E-157 2.53 19734902 | |
| 19 45395619 rs2075650-G 19:45395619 Alzheimer's disease 9.00E-116 4.48 24755620 | |
| 19 45395619 rs2075650-G 19:45395619 Alzheimer's disease (late onset) 5.00E-36 2.94 20885792 | |
| 19 45395619 rs2075650-G 19:45395619 C-reactive protein 2.00E-21 0.12 23844046 | |
| 19 45395619 rs2075650-G 19:45395619 "Cholesterol, total" 3.00E-19 0.14 19060911 | |
| 19 45395619 rs2075650-? 19:45395619 Longevity 3.00E-17 1.41 21418511 | |
| 19 45395619 rs2075650-? 19:45395619 Alzheimer's disease 2.00E-16 NR 19734903 | |
| 19 45395619 rs2075650-G 19:45395619 Cardiovascular disease risk factors 2.00E-14 0.15 21943158 | |
| 19 45395619 rs2075650-? 19:45395619 Alzheimer's disease 4.00E-13 NR 24770881 | |
| 19 45395619 rs2075650-? 19:45395619 Alzheimer's disease 3.00E-11 NR 20061627 | |
| 19 45395619 rs2075650-G 19:45395619 Cognitive decline 2.00E-08 0.2 23207651 | |
| 19 45395619 rs2075650-G 19:45395619 Cardiovascular disease risk factors 4.00E-08 0.12 21943158 | |
| 19 45396219 rs157582-T 19:45396219 Metabolic syndrome 1.00E-08 0.1 22399527 | |
| 19 45396665 rs59007384-T 19:45396665 Alzheimer's disease biomarkers 7.00E-09 NR 23419831 | |
| 19 45403216 rs115881343-? 19:45403216 Cognitive decline (age-related) 4.00E-09 0.04 24468470 | |
| 19 45403412 rs1160985-C 19:45403412 LDL cholesterol 2.00E-21 6.77 23726366 | |
| 19 45403412 rs1160985-T 19:45403412 Lipid traits 4.00E-13 0.13 24386095 | |
| 19 45403412 rs1160985-C 19:45403412 C-reactive protein 4.00E-13 0.13 22939635 | |
| 19 45410002 rs769449-? 19:45410002 C-reactive protein 9.00E-21 0.26 18439548 | |
| 19 45410002 rs769449-? 19:45410002 Cognitive decline (age-related) 5.00E-19 0.03 24468470 | |
| 19 45410002 rs769449-A 19:45410002 Alzheimer's disease biomarkers 2.00E-18 0.09 23562540 | |
| 19 45410002 rs769449-A 19:45410002 Alzheimer's disease biomarkers 2.00E-16 0.08 23562540 | |
| 19 45411941 rs429358-C 19:45411941 Alzheimer's disease biomarkers 5.00E-14 NR 23419831 | |
| 19 45412079 rs7412-? 19:45412079 Lipid metabolism phenotypes 3.00E-58 0.75 22286219 | |
| 19 45412079 rs7412-T 19:45412079 Lipid traits 3.00E-53 0.48 24023260 | |
| 19 45412079 rs7412-? 19:45412079 Response to statin therapy (LDL-C) 2.00E-47 6.2 22331829 | |
| 19 45412079 rs7412-T 19:45412079 Lipid traits 2.00E-30 0.09 24023260 | |
| 19 45412079 rs7412-? 19:45412079 LDL cholesterol 2.00E-09 12.3 23067351 | |
| 19 45414451 rs439401-T 19:45414451 Triglycerides 1.00E-30 5.5 20686565 | |
| 19 45414451 rs439401-G 19:45414451 Triglycerides 2.00E-09 0.09 19060911 | |
| 19 45414451 rs439401-C 19:45414451 HDL Cholesterol - Triglycerides (HDLC-TG) 1.00E-08 0.24 21386085 | |
| 19 45415640 rs445925-T 19:45415640 Lipoprotein-associated phospholipase A2 activity and mass 1.00E-56 0.07 23118302 | |
| 19 45415640 rs445925-? 19:45415640 Metabolite levels 6.00E-42 NR 22916037 | |
| 19 45415640 rs445925-A 19:45415640 Blood metabolite ratios 5.00E-23 0.09 24816252 | |
| 19 45415640 rs445925-G 19:45415640 Cardiovascular disease risk factors 9.00E-19 11.96 20838585 | |
| 19 45415640 rs445925-G 19:45415640 Apolipoprotein Levels 2.00E-14 0.15 23031429 | |
| 19 45415640 rs445925-G 19:45415640 Apolipoprotein Levels 4.00E-11 0.23 23031429 | |
| 19 45415640 rs445925-A 19:45415640 Carotid intima media thickness 2.00E-08 0.02 21909108 | |
| 19 45422587 rs12721054-G 19:45422587 Triglycerides 3.00E-19 0.1 23726366 | |
| 19 45422846 rs56131196-A 19:45422846 Alzheimer's disease biomarkers 4.00E-12 NR 23419831 | |
| 19 45422946 rs4420638-G 19:45422946 LDL cholesterol 2.00E-178 0.23 24097068 | |
| 19 45422946 rs4420638-G 19:45422946 "Cholesterol, total" 1.00E-149 0.2 24097068 | |
| 19 45422946 rs4420638-? 19:45422946 Alzheimer's disease 8.00E-149 3.45 22832961 | |
| 19 45422946 rs4420638-G 19:45422946 LDL cholesterol 9.00E-147 7.14 20686565 | |
| 19 45422946 rs4420638-A 19:45422946 C-reactive protein 9.00E-139 0.24 21300955 | |
| 19 45422946 rs4420638-G 19:45422946 "Cholesterol, total" 5.00E-111 6.83 20686565 | |
| 19 45422946 rs4420638-G 19:45422946 LDL cholesterol 1.00E-60 0.19 18193044 | |
| 19 45422946 rs4420638-? 19:45422946 Alzheimer's disease 2.00E-44 NR 17998437 | |
| 19 45422946 rs4420638-G 19:45422946 LDL cholesterol 3.00E-43 6.61 18193043 | |
| 19 45422946 rs4420638-G 19:45422946 LDL cholesterol 2.00E-40 0.06 20864672 | |
| 19 45422946 rs4420638-? 19:45422946 Alzheimer's disease 1.00E-39 NR 17975299 | |
| 19 45422946 rs4420638-? 19:45422946 Alzheimer's disease (late onset) 1.00E-39 4.01 17474819 | |
| 19 45422946 rs4420638-? 19:45422946 Longevity (90 years and older) 3.00E-36 1.39 24688116 | |
| 19 45422946 rs4420638-A 19:45422946 Lipoprotein-associated phospholipase A2 activity and mass 5.00E-30 0.05 22003152 | |
| 19 45422946 rs4420638-? 19:45422946 Cognitive decline 4.00E-27 NR 22054870 | |
| 19 45422946 rs4420638-G 19:45422946 LDL cholesterol 4.00E-27 0.29 19060906 | |
| 19 45422946 rs4420638-G 19:45422946 C-reactive protein 5.00E-27 21.8 19567438 | |
| 19 45422946 rs4420638-? 19:45422946 Longevity (85 years and older) 2.00E-26 1.22 24688116 | |
| 19 45422946 rs4420638-G 19:45422946 Lipoprotein-associated phospholipase A2 activity and mass 6.00E-24 8 20442857 | |
| 19 45422946 rs4420638-G 19:45422946 HDL cholesterol 2.00E-21 0.07 24097068 | |
| 19 45422946 rs4420638-G 19:45422946 HDL cholesterol 4.00E-21 1.06 20686565 | |
| 19 45422946 rs4420638-G 19:45422946 LDL cholesterol 1.00E-20 0.06 18262040 | |
| 19 45422946 rs4420638-A 19:45422946 Age-related macular degeneration 2.00E-20 1.3 23455636 | |
| 19 45422946 rs4420638-? 19:45422946 Longevity 2.00E-16 NR 21740922 | |
| 19 45422946 rs4420638-G 19:45422946 Lipid traits 1.00E-14 0.25 24023261 | |
| 19 45422946 rs4420638-G 19:45422946 Triglycerides 3.00E-13 2.4 17463246 | |
| 19 45422946 rs4420638-? 19:45422946 Alzheimer's disease (age of onset) 1.00E-12 NR 22005931 | |
| 19 45432557 rs7259004-? 19:45432557 Sphingolipid levels 5.00E-10 0 22359512 | |
| 19 45740771 rs17356664-C 19:45740771 Platelet counts 4.00E-10 2.6 22139419 | |
| 19 46172278 rs11671664-G 19:46172278 Body mass index 6.00E-14 4.22 22344219 | |
| 19 46172278 rs11671664-G 19:46172278 Body mass index 7.00E-14 0.05 22344221 | |
| 19 46172278 rs11671664-G 19:46172278 Body mass index 3.00E-12 0.04 24861553 | |
| 19 46181392 rs1800437-G 19:46181392 Obesity 3.00E-14 1.1 23563607 | |
| 19 46182304 rs10423928-T 19:46182304 Obesity 4.00E-13 1.16 23563607 | |
| 19 46182304 rs10423928-A 19:46182304 Two-hour glucose challenge 3.00E-12 0.09 20081857 | |
| 19 46202172 rs2287019-C 19:46202172 Body mass index 2.00E-16 0.15 20935630 | |
| 19 46849806 rs4802307-G 19:46849806 Crohn's disease 2.00E-10 1.1 23128233 | |
| 19 47123783 rs1126510-G 19:47123783 Ulcerative colitis 2.00E-09 1.08 23128233 | |
| 19 47207654 rs11083846-A 19:47207654 Chronic lymphocytic leukemia 4.00E-09 1.35 18758461 | |
| 19 47208481 rs425105-? 19:47208481 Type 1 diabetes 3.00E-11 1.16 19430480 | |
| 19 47569003 rs3810291-A 19:47569003 Body mass index 2.00E-12 0.09 20935630 | |
| 19 48365523 rs296396-T 19:48365523 Blood metabolite levels 1.00E-92 0.18 24816252 | |
| 19 48365523 rs296396-T 19:48365523 Blood metabolite levels 1.00E-12 0.05 24816252 | |
| 19 48371102 rs296381-T 19:48371102 Blood metabolite levels 5.00E-143 0.16 24816252 | |
| 19 48371102 rs296381-T 19:48371102 Blood metabolite levels 1.00E-10 0.05 24816252 | |
| 19 48372195 rs182420-T 19:48372195 Blood metabolite levels 6.00E-12 0.05 24816252 | |
| 19 48385057 rs2547231-A 19:48385057 Blood metabolite ratios 3.00E-191 0.14 24816252 | |
| 19 48385057 rs2547231-A 19:48385057 Blood metabolite levels 3.00E-22 0.08 24816252 | |
| 19 48385057 rs2547231-A 19:48385057 Blood metabolite levels 4.00E-16 0.06 24816252 | |
| 19 48385057 rs2547231-A 19:48385057 Blood metabolite levels 3.00E-11 0.04 24816252 | |
| 19 48401893 rs2637125-A 19:48401893 Dehydroepiandrosterone sulphate levels 3.00E-19 0.09 21533175 | |
| 19 49095278 rs3786749-? 19:49095278 Elevated serum carcinoembryonic antigen levels 1.00E-10 NR 24941225 | |
| 19 49117104 rs433852-? 19:49117104 Elevated serum carcinoembryonic antigen levels 5.00E-08 NR 24941225 | |
| 19 49118371 rs2292342-? 19:49118371 Elevated serum carcinoembryonic antigen levels 7.00E-12 NR 24941225 | |
| 19 49136651 rs12608544-? 19:49136651 Elevated serum carcinoembryonic antigen levels 2.00E-12 NR 24941225 | |
| 19 49144790 rs11880333-? 19:49144790 Elevated serum carcinoembryonic antigen levels 5.00E-12 NR 24941225 | |
| 19 49152955 rs8111500-? 19:49152955 Elevated serum carcinoembryonic antigen levels 4.00E-09 NR 24941225 | |
| 19 49206172 rs516246-T 19:49206172 Crohn's disease 1.00E-15 1.11 23128233 | |
| 19 49206172 rs516246-T 19:49206172 Liver enzyme levels (gamma-glutamyl transferase) 8.00E-10 2.3 22001757 | |
| 19 49206417 rs492602-G 19:49206417 Vitamin B12 levels 5.00E-17 0.09 18776911 | |
| 19 49206417 rs492602-G 19:49206417 "Cholesterol, total" 1.00E-16 0.03 24097068 | |
| 19 49206417 rs492602-G 19:49206417 "Cholesterol, total" 2.00E-10 1.27 20686565 | |
| 19 49206603 rs281377-T 19:49206603 Liver enzyme levels (alkaline phosphatase) 1.00E-15 1.8 22001757 | |
| 19 49206631 rs1047781-T 19:49206631 Tumor biomarkers 6.00E-209 0.24 23300138 | |
| 19 49206631 rs1047781-T 19:49206631 Tumor biomarkers 8.00E-176 0.44 23300138 | |
| 19 49206631 rs1047781-? 19:49206631 Elevated serum carcinoembryonic antigen levels 1.00E-56 NR 24941225 | |
| 19 49206631 rs1047781-? 19:49206631 Vitamin B12 levels 4.00E-36 70.21 22367966 | |
| 19 49206674 rs601338-A 19:49206674 Blood metabolite ratios 2.00E-20 0.06 24816252 | |
| 19 49206674 rs601338-A 19:49206674 Blood metabolite levels 3.00E-11 0.04 24816252 | |
| 19 49206985 rs602662-A 19:49206985 Folate pathway vitamin levels 3.00E-20 49.77 19303062 | |
| 19 49206985 rs602662-? 19:49206985 Folate pathway vitamin levels 2.00E-15 0.07 19744961 | |
| 19 49208865 rs504963-A 19:49208865 Crohn's disease 2.00E-08 NR 20570966 | |
| 19 49209010 rs503279-C 19:49209010 Metabolic traits 4.00E-20 0.13 21886157 | |
| 19 49209010 rs503279-T 19:49209010 Blood metabolite ratios 1.00E-13 0.05 24816252 | |
| 19 49214274 rs281379-A 19:49214274 Crohn's disease 7.00E-12 1.07 21102463 | |
| 19 49214274 rs281379-G 19:49214274 Pubertal anthropometrics 5.00E-08 0.07 23449627 | |
| 19 49228272 rs2287921-C 19:49228272 Urinary metabolites (H-NMR features) 3.00E-36 0.48 24586186 | |
| 19 49228272 rs2287921-T 19:49228272 Retinal vascular caliber 2.00E-25 2.1 21060863 | |
| 19 49228272 rs2287921-C 19:49228272 Urinary metabolites (H-NMR features) 7.00E-19 0.37 24586186 | |
| 19 49228272 rs2287921-C 19:49228272 Urinary metabolites (H-NMR features) 1.00E-12 0.3 24586186 | |
| 19 49233406 rs281408-C 19:49233406 Urinary metabolites (H-NMR features) 4.00E-32 0.42 24586186 | |
| 19 49248730 rs838145-G 19:49248730 Dietary macronutrient intake 4.00E-10 0.22 23636237 | |
| 19 49254504 rs2071699-? 19:49254504 Elevated serum carcinoembryonic antigen levels 3.00E-10 NR 24941225 | |
| 19 49259529 rs838133-A 19:49259529 Homocysteine levels 7.00E-09 0.04 23824729 | |
| 19 49259529 rs838133-A 19:49259529 Dietary macronutrient intake 8.00E-09 0.11 23372041 | |
| 19 49497155 rs3764618-G 19:49497155 Follicule stimulating hormone 4.00E-08 NR 24049095 | |
| 19 49869051 rs2303759-C 19:49869051 Multiple sclerosis 5.00E-09 1.11 21833088 | |
| 19 50000009 rs2280401-A 19:50000009 Metabolite levels 9.00E-13 0.03 21909109 | |
| 19 50000009 rs2280401-A 19:50000009 Serum albumin level 6.00E-09 0.01 23022100 | |
| 19 50000009 rs2280401-A 19:50000009 Hematological and biochemical traits 3.00E-08 0.11 20139978 | |
| 19 50926742 rs3745516-A 19:50926742 Primary biliary cirrhosis 2.00E-13 1.38 21399635 | |
| 19 50926742 rs3745516-A 19:50926742 Primary biliary cirrhosis 8.00E-11 1.46 20639880 | |
| 19 51349090 rs266849-A 19:51349090 Serum prostate-specific antigen levels 6.00E-10 NR 21160077 | |
| 19 51361757 rs17632542-T 19:51361757 Serum prostate-specific antigen levels 3.00E-46 39.1 21160077 | |
| 19 51361757 rs17632542-T 19:51361757 Prostate cancer 2.00E-28 0.73 24753544 | |
| 19 51363398 rs1058205-? 19:51363398 Prostate-specific antigen levels 8.00E-21 0.09 24919509 | |
| 19 51364623 rs2735839-G 19:51364623 Prostate-specific antigen levels 6.00E-37 0.19 23269536 | |
| 19 51364623 rs2735839-G 19:51364623 Prostate cancer 2.00E-18 1.2 18264097 | |
| 19 51374967 rs10424878-A 19:51374967 PCA3 expression level 1.00E-08 1.24 23555189 | |
| 19 51393118 rs1354774-G 19:51393118 Prostate-specific antigen levels 6.00E-20 0.06 23359319 | |
| 19 51727962 rs3865444-? 19:51727962 Alzheimer's disease (late onset) 2.00E-09 1.1 21460841 | |
| 19 52324216 rs17695224-A 19:52324216 HDL cholesterol 2.00E-13 0.03 24097068 | |
| 19 52532271 rs2288884-T 19:52532271 Bronchodilator response in asthma (inhaled corticosteroid treatment interaction) 5.00E-08 NR 24280104 | |
| 19 52601399 rs11666341-A 19:52601399 Bronchodilator response in asthma (inhaled corticosteroid treatment interaction) 1.00E-09 NR 24280104 | |
| 19 52607765 rs10411428-T 19:52607765 Bronchodilator response in asthma (inhaled corticosteroid treatment interaction) 1.00E-09 NR 24280104 | |
| 19 53284135 rs10404486-? 19:53284135 Phospholipid levels (plasma) 9.00E-09 0.8 22359512 | |
| 19 54676433 rs2576452-T 19:54676433 Blood metabolite ratios 2.00E-29 0.03 24816252 | |
| 19 54677189 rs8736-T 19:54677189 Blood metabolite levels 8.00E-18 0.02 24816252 | |
| 19 54697079 rs7595-G 19:54697079 Obesity-related traits 3.00E-08 0.05 23251661 | |
| 19 54797848 rs103294-C 19:54797848 Prostate cancer 5.00E-16 1.28 23023329 | |
| 19 55383051 rs11672983-A 19:55383051 Inflammatory bowel disease 7.00E-11 1.09 23128233 | |
| 19 55526345 rs1671152-T 19:55526345 Platelet aggregation 8.00E-14 NR 20526338 | |
| 19 55819845 rs1172822-T 19:55819845 Menarche and menopause (age at onset) 2.00E-19 0.49 19448621 | |
| 19 55819845 rs1172822-T 19:55819845 Menopause (age at onset) 6.00E-11 0.39 19448619 | |
| 19 55833664 rs11668344-G 19:55833664 Menopause (age at onset) 1.00E-59 0.42 22267201 | |
| 19 55833664 rs11668344-A 19:55833664 Menopause (age at onset) 5.00E-26 0.3 23307926 | |
| 19 56320663 rs12461110-A 19:56320663 Menopause (age at onset) 9.00E-10 0.16 22267201 | |
| 19 57678194 rs11672517-A 19:57678194 Dupuytren's disease 7.00E-14 1.34 21732829 | |
| 20 926397 rs502716-? 20:926397 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy) 3.00E-08 28 24554482 | |
| 20 1459060 rs6042507-A 20:1459060 Circulating myeloperoxidase levels (serum) 4.00E-08 0.09 23620142 | |
| 20 1610551 rs2281808-? 20:1610551 Type 1 diabetes 1.00E-11 1.11 19430480 | |
| 20 1759590 rs6080550-? 20:1759590 Non-obstructive azoospermia 2.00E-09 1.27 22197933 | |
| 20 1923734 rs6136489-T 20:1923734 Mean platelet volume 8.00E-11 0.01 19820697 | |
| 20 1924707 rs13042885-C 20:1924707 Mean platelet volume 6.00E-14 0.01 22139419 | |
| 20 1941171 rs6045676-? 20:1941171 Aortic root size 3.00E-08 0.11 21223598 | |
| 20 2220310 rs59586681-T 20:2220310 Basal cell carcinoma 3.00E-09 1.16 24403052 | |
| 20 2281970 rs214782-G 20:2281970 Basal cell carcinoma 6.00E-17 1.29 24403052 | |
| 20 2384972 rs34972666-? 20:2384972 Alzheimer's disease (cognitive decline) 3.00E-08 0.23 23535033 | |
| 20 3185123 rs11697186-A 20:3185123 Response to hepatitis C treatment 9.00E-25 33.33 21659334 | |
| 20 3185123 rs11697186-T 20:3185123 Response to hepatitis C treatment 5.00E-17 4.5 21659334 | |
| 20 3187733 rs6139030-T 20:3187733 Response to hepatitis C treatment 2.00E-25 25 21659334 | |
| 20 3187733 rs6139030-C 20:3187733 Response to hepatitis C treatment 1.00E-15 3.9 21659334 | |
| 20 3193842 rs1127354-A 20:3193842 Chronic hepatitis C infection 2.00E-58 NR 20173735 | |
| 20 3193842 rs1127354-A 20:3193842 Ribavirin-induced anemia 4.00E-44 NR 20637204 | |
| 20 3193893 rs7270101-C 20:3193893 Chronic hepatitis C infection 9.00E-76 NR 20173735 | |
| 20 3381549 rs965469-? 20:3381549 IFN-related cytopenia 1.00E-09 NR 21703177 | |
| 20 4101800 rs1741344-T 20:4101800 Height 3.00E-09 0.02 20881960 | |
| 20 4677092 rs6107516-? 20:4677092 Creutzfeldt-Jakob disease (variant) 3.00E-18 NR 22137330 | |
| 20 4680251 rs1799990-A 20:4680251 Creutzfeldt-Jakob disease 2.00E-21 NR 19081515 | |
| 20 5588449 rs238295-? 20:5588449 Cortical structure 6.00E-09 NR 22343285 | |
| 20 5935385 rs236114-A 20:5935385 Menopause (age at onset) 1.00E-10 0.5 19448619 | |
| 20 5948227 rs16991615-A 20:5948227 Menopause (age at onset) 1.00E-73 0.95 22267201 | |
| 20 5948227 rs16991615-A 20:5948227 Menarche and menopause (age at onset) 1.00E-21 1.07 19448621 | |
| 20 5948227 rs16991615-A 20:5948227 Menopause (age at onset) 5.00E-12 0.46 23307926 | |
| 20 6404281 rs961253-A 20:6404281 Colorectal cancer 2.00E-10 1.12 19011631 | |
| 20 6620893 rs967417-C 20:6620893 Height 2.00E-08 4.3 18391951 | |
| 20 6621685 rs2145270-C 20:6621685 Height 5.00E-18 1.2 23563607 | |
| 20 6626218 rs2145272-A 20:6626218 Height 2.00E-24 0.04 20881960 | |
| 20 6761765 rs235770-T 20:6761765 Refractive error 2.00E-08 0.09 23396134 | |
| 20 7106289 rs1884302-C 20:7106289 Sagittal craniosynostosis 1.00E-39 4.38 23160099 | |
| 20 7812350 rs2423279-C 20:7812350 Colorectal cancer 3.00E-12 1.13 24836286 | |
| 20 7812350 rs2423279-C 20:7812350 Colorectal cancer 7.00E-09 1.1 23263487 | |
| 20 9365303 rs2072910-C 20:9365303 Neutrophil count 3.00E-10 0.11 20172861 | |
| 20 10639543 rs2273061-A 20:10639543 Bone mineral density 5.00E-08 0.07 20096396 | |
| 20 10639988 rs3790160-T 20:10639988 Bone mineral density 3.00E-19 0.05 22504420 | |
| 20 10961935 rs62185668-A 20:10961935 Urinary bladder cancer 2.00E-11 1.19 24861552 | |
| 20 10969030 rs1327235-G 20:10969030 Diastolic blood pressure 1.00E-15 0.3 21909115 | |
| 20 10969030 rs1327235-G 20:10969030 Systolic blood pressure 2.00E-08 0.34 21909115 | |
| 20 10969030 rs1327235-G 20:10969030 Blood pressure 4.00E-08 0.26 21909110 | |
| 20 12959398 rs4814176-T 20:12959398 Blood metabolite ratios 7.00E-33 0.02 24816252 | |
| 20 12959398 rs4814176-T 20:12959398 Blood metabolite levels 3.00E-17 0.02 24816252 | |
| 20 12962718 rs364585-A 20:12962718 LDL cholesterol 4.00E-10 0.03 24097068 | |
| 20 12969400 rs680379-? 20:12969400 Sphingolipid levels 2.00E-16 0 22359512 | |
| 20 12969400 rs680379-A 20:12969400 Sphingolipid levels 8.00E-15 0.1 19798445 | |
| 20 14747471 rs4141463-? 20:14747471 Autism 4.00E-08 1.37 20663923 | |
| 20 16054982 rs16997087-? 20:16054982 Brain connectivity 1.00E-10 NR 23471985 | |
| 20 16054982 rs16997087-? 20:16054982 Brain connectivity 2.00E-09 NR 23471985 | |
| 20 17122593 rs852069-A 20:17122593 Menarche (age at onset) 3.00E-08 2.1 21102462 | |
| 20 17845921 rs2328223-C 20:17845921 LDL cholesterol 6.00E-09 0.03 24097068 | |
| 20 21853100 rs2180439-? 20:21853100 Male-pattern baldness 4.00E-17 2.08 22032556 | |
| 20 21853100 rs2180439-C 20:21853100 Male-pattern baldness 3.00E-15 1.82 18849994 | |
| 20 22037575 rs6047844-T 20:22037575 Male-pattern baldness 2.00E-39 1.6 22693459 | |
| 20 22050503 rs1160312-A 20:22050503 Male-pattern baldness 1.00E-14 1.6 18849991 | |
| 20 22559601 rs6048205-? 20:22559601 Fasting glucose-related traits (interaction with BMI) 2.00E-12 NR 22581228 | |
| 20 22567942 rs1209523-? 20:22567942 Fasting plasma glucose 2.00E-11 NR 20152958 | |
| 20 23578189 rs1158167-? 20:23578189 Cystatin C 9.00E-09 NR 17903292 | |
| 20 23612737 rs911119-? 20:23612737 Chronic kidney disease 2.00E-138 NR 20383146 | |
| 20 25298087 rs7267979-G 20:25298087 Liver enzyme levels (alkaline phosphatase) 7.00E-10 1.5 22001757 | |
| 20 30725648 rs6142618-G 20:30725648 Inflammatory bowel disease 6.00E-10 1.07 23128233 | |
| 20 31376282 rs4911259-G 20:31376282 Inflammatory bowel disease 1.00E-09 1.08 23128233 | |
| 20 31950845 rs291671-G 20:31950845 Hair color 2.00E-15 0.22 20585627 | |
| 20 32304653 rs1074683-C 20:32304653 Height 1.00E-14 1.21 23563607 | |
| 20 32333181 rs7274811-T 20:32333181 Height 6.00E-22 0.04 20881960 | |
| 20 32588095 rs2284378-T 20:32588095 Breast cancer 1.00E-08 1.16 22976474 | |
| 20 32729444 rs4911414-G 20:32729444 Tanning 4.00E-09 0.07 23548203 | |
| 20 33171772 rs910873-T 20:33171772 Melanoma 1.00E-15 1.75 18488026 | |
| 20 33722863 rs2295888-A 20:33722863 Prothrombin time 5.00E-13 0.02 22703881 | |
| 20 33730387 rs6120849-T 20:33730387 Protein C levels 7.00E-37 0.14 20802025 | |
| 20 33764554 rs867186-C 20:33764554 Protein C levels 2.00E-200 0.47 20802025 | |
| 20 33764554 rs867186-G 20:33764554 Coagulation factor levels 6.00E-37 NR 20231535 | |
| 20 33764554 rs867186-G 20:33764554 Anticoagulant levels 4.00E-09 0.85 22216198 | |
| 20 33789142 rs8114671-C 20:33789142 Height 1.00E-15 1.17 23563607 | |
| 20 33799280 rs6088765-G 20:33799280 Ulcerative colitis 2.00E-08 1.08 23128233 | |
| 20 33867697 rs619865-A 20:33867697 Freckling 5.00E-14 0.77 20585627 | |
| 20 33907161 rs6060369-C 20:33907161 Height 1.00E-16 0.44 18391950 | |
| 20 33907161 rs6060369-C 20:33907161 Height 2.00E-16 0.44 18193045 | |
| 20 33914208 rs6060373-A 20:33914208 Height 2.00E-17 0.08 18391952 | |
| 20 33975181 rs6088813-? 20:33975181 Height 1.00E-13 0.09 19343178 | |
| 20 34023962 rs224333-A 20:34023962 Height 8.00E-37 1.31 23563607 | |
| 20 34025756 rs143384-A 20:34025756 Height 1.00E-58 0.06 20881960 | |
| 20 34152782 rs2277862-T 20:34152782 "Cholesterol, total" 5.00E-11 0.04 24097068 | |
| 20 34152782 rs2277862-T 20:34152782 "Cholesterol, total" 4.00E-10 1.19 20686565 | |
| 20 34712310 rs6141600-C 20:34712310 Height 6.00E-12 1.21 23563607 | |
| 20 36824720 rs75727053-? 20:36824720 Antibody status in Tripanosoma cruzi seropositivity 1.00E-08 NR 24324551 | |
| 20 36844038 rs6127471-C 20:36844038 Heart rate 5.00E-29 0.43 23583979 | |
| 20 39028436 rs8124695-A 20:39028436 Dupuytren's disease 8.00E-10 1.48 21732829 | |
| 20 39091487 rs2902940-G 20:39091487 LDL cholesterol 2.00E-11 0.03 24097068 | |
| 20 39091487 rs2902940-G 20:39091487 "Cholesterol, total" 6.00E-11 1.38 20686565 | |
| 20 39091487 rs2902940-G 20:39091487 "Cholesterol, total" 9.00E-10 0.02 24097068 | |
| 20 39091487 rs2902940-G 20:39091487 LDL cholesterol 1.00E-08 0.98 20686565 | |
| 20 39228784 rs6102059-T 20:39228784 LDL cholesterol 4.00E-09 0.06 19060906 | |
| 20 39269074 rs13041247-T 20:39269074 Orofacial clefts 6.00E-09 1.19 22863734 | |
| 20 39672618 rs6029526-A 20:39672618 LDL cholesterol 3.00E-19 1.41 20686565 | |
| 20 39672618 rs6029526-A 20:39672618 LDL cholesterol 5.00E-18 0.04 24097068 | |
| 20 39672618 rs6029526-A 20:39672618 "Cholesterol, total" 1.00E-16 0.04 24097068 | |
| 20 39811275 rs4297946-C 20:39811275 "Cholesterol, total" 3.00E-17 1.52 20686565 | |
| 20 42946966 rs6017317-G 20:42946966 Type 2 diabetes 1.00E-11 1.09 22158537 | |
| 20 42989267 rs4812829-A 20:42989267 Type 2 diabetes 3.00E-10 1.09 21874001 | |
| 20 42989267 rs4812829-A 20:42989267 Type 2 diabetes 5.00E-08 1.07 24509480 | |
| 20 43042364 rs1800961-T 20:43042364 HDL cholesterol 2.00E-34 0.13 24097068 | |
| 20 43042364 rs1800961-T 20:43042364 "Cholesterol, total" 1.00E-24 0.11 24097068 | |
| 20 43042364 rs1800961-T 20:43042364 HDL cholesterol 1.00E-15 1.88 20686565 | |
| 20 43042364 rs1800961-T 20:43042364 "Cholesterol, total" 6.00E-13 4.73 20686565 | |
| 20 43042364 rs1800961-T 20:43042364 HDL cholesterol 8.00E-10 0.19 19060906 | |
| 20 43042364 rs1800961-C 20:43042364 C-reactive protein 2.00E-09 0.09 21300955 | |
| 20 43065028 rs6017342-C 20:43065028 Ulcerative colitis 1.00E-43 1.23 23128233 | |
| 20 43065028 rs6017342-C 20:43065028 Ulcerative colitis 1.00E-20 1.2 21297633 | |
| 20 43065028 rs6017342-C 20:43065028 Ulcerative colitis 9.00E-17 1.17 19915572 | |
| 20 44534651 rs6065904-? 20:44534651 Lipid metabolism phenotypes 4.00E-40 0.69 19936222 | |
| 20 44534651 rs6065904-? 20:44534651 Lipid metabolism phenotypes 2.00E-31 0.22 22286219 | |
| 20 44545048 rs4810479-? 20:44545048 Metabolite levels 2.00E-42 NR 22916037 | |
| 20 44554015 rs6065906-? 20:44554015 Lipid metabolism phenotypes 3.00E-49 0.69 19936222 | |
| 20 44554015 rs6065906-? 20:44554015 Lipid metabolism phenotypes 1.00E-45 0.08 19936222 | |
| 20 44554015 rs6065906-C 20:44554015 HDL cholesterol 5.00E-40 0.06 24097068 | |
| 20 44554015 rs6065906-? 20:44554015 Lipid metabolism phenotypes 8.00E-37 0.09 19936222 | |
| 20 44554015 rs6065906-C 20:44554015 Triglycerides 2.00E-34 0.05 24097068 | |
| 20 44554015 rs6065906-C 20:44554015 HDL cholesterol 2.00E-22 0.93 20686565 | |
| 20 44554015 rs6065906-C 20:44554015 Triglycerides 5.00E-18 3.32 20686565 | |
| 20 44576502 rs7679-C 20:44576502 Triglycerides 7.00E-11 0.07 19060906 | |
| 20 44576502 rs7679-C 20:44576502 HDL cholesterol 4.00E-09 0.07 19060906 | |
| 20 44702120 rs2425752-A 20:44702120 Multiple sclerosis 5.00E-10 1.11 21833088 | |
| 20 44742064 rs1569723-C 20:44742064 Inflammatory bowel disease 1.00E-13 1.09 23128233 | |
| 20 44742064 rs1569723-A 20:44742064 Kawasaki disease 6.00E-09 1.42 22446961 | |
| 20 44747947 rs4810485-T 20:44747947 Rheumatoid arthritis 3.00E-09 1.18 20453842 | |
| 20 44747947 rs4810485-G 20:44747947 Rheumatoid arthritis 8.00E-09 1.15 18794853 | |
| 20 44749251 rs4239702-C 20:44749251 Rheumatoid arthritis 4.00E-18 1.13 24390342 | |
| 20 44749251 rs4239702-C 20:44749251 Rheumatoid arthritis 1.00E-16 1.14 24390342 | |
| 20 44763284 rs4813003-C 20:44763284 Kawasaki disease 5.00E-08 1.41 22446962 | |
| 20 45288453 rs6066043-G 20:45288453 Chronic kidney disease 2.00E-09 2.13 24351856 | |
| 20 45288453 rs6066043-A 20:45288453 Glomerular filtration rate 2.00E-09 12.17 24351856 | |
| 20 46095649 rs6094710-A 20:46095649 Osteoarthritis (hip) 2.00E-10 1.28 23989986 | |
| 20 47903019 rs237743-A 20:47903019 Height 1.00E-20 0.04 20881960 | |
| 20 48522330 rs495337-? 20:48522330 Psoriasis 1.00E-08 1.25 18364390 | |
| 20 48575315 rs11697848-? 20:48575315 Systemic lupus erythematosus 1.00E-11 2.12 24871463 | |
| 20 48955424 rs913678-T 20:48955424 Inflammatory bowel disease 5.00E-08 1.06 23128233 | |
| 20 50141264 rs6021270-C 20:50141264 Self-reported allergy 7.00E-09 0.15 23817569 | |
| 20 51092996 rs13041126-T 20:51092996 Obesity 2.00E-08 1.06 23563607 | |
| 20 51318351 rs6013509-A 20:51318351 Hemoglobin 1.00E-10 0.06 19862010 | |
| 20 52447303 rs6022786-A 20:52447303 Polycystic ovary syndrome 2.00E-09 1.13 22885925 | |
| 20 52774427 rs1570669-A 20:52774427 Calcium levels 9.00E-12 0.02 24068962 | |
| 20 52791518 rs2248359-G 20:52791518 Multiple sclerosis 3.00E-11 1.12 21833088 | |
| 20 52807221 rs16999165-T 20:52807221 Atopic dermatitis 2.00E-08 1.19 23042114 | |
| 20 55018260 rs7274581-T 20:55018260 Alzheimer's disease (late onset) 3.00E-08 1.14 24162737 | |
| 20 55990405 rs737092-C 20:55990405 Red blood cell traits 4.00E-13 0.22 23222517 | |
| 20 55991695 rs6092477-G 20:55991695 Mean corpuscular volume 1.00E-08 0.07 20139978 | |
| 20 56070505 rs6025590-A 20:56070505 Obesity-related traits 4.00E-08 0.04 23251661 | |
| 20 57408426 rs965808-G 20:57408426 DNA methylation (variation) 5.00E-09 NR 23725790 | |
| 20 57469073 rs6026584-T 20:57469073 Renal function-related traits (BUN) 9.00E-09 0.01 22797727 | |
| 20 57587771 rs4812048-C 20:57587771 Mean platelet volume 1.00E-09 0.01 22139419 | |
| 20 57614002 rs151361-A 20:57614002 Mean platelet volume 9.00E-09 4.49 22423221 | |
| 20 57751117 rs6015450-G 20:57751117 Systolic blood pressure 4.00E-23 0.9 21909115 | |
| 20 57751117 rs6015450-G 20:57751117 Diastolic blood pressure 6.00E-23 0.56 21909115 | |
| 20 57751117 rs6015450-G 20:57751117 Hypertension 4.00E-14 0.11 21909115 | |
| 20 57751117 rs6015450-G 20:57751117 Blood pressure 2.00E-12 0.52 21909110 | |
| 20 57824309 rs259964-A 20:57824309 Inflammatory bowel disease 1.00E-12 1.09 23128233 | |
| 20 59853938 rs1970546-? 20:59853938 Volumetric brain MRI 4.00E-08 NR 17903297 | |
| 20 60921044 rs4925386-C 20:60921044 Colorectal cancer 2.00E-10 1.08 20972440 | |
| 20 60969451 rs2427308-C 20:60969451 Colorectal cancer 3.00E-11 1.24 24737748 | |
| 20 61015611 rs2427345-G 20:61015611 Prostate cancer 4.00E-08 1.06 23535732 | |
| 20 62309839 rs6010620-G 20:62309839 Glioma (high-grade) 5.00E-19 1.56 24908248 | |
| 20 62309839 rs6010620-G 20:62309839 Glioma 3.00E-12 1.28 19578367 | |
| 20 62309839 rs6010620-G 20:62309839 Glioma 1.00E-10 1.43 22886559 | |
| 20 62309839 rs6010620-? 20:62309839 Glioma 2.00E-09 1.24 21531791 | |
| 20 62309839 rs6010620-G 20:62309839 Glioma (high-grade) 3.00E-09 1.52 19578366 | |
| 20 62318220 rs4809324-C 20:62318220 Glioma (high-grade) 2.00E-09 1.6 19578366 | |
| 20 62327582 rs2297441-A 20:62327582 Ulcerative colitis 2.00E-10 1.09 21297633 | |
| 20 62343956 rs2315008-G 20:62343956 Inflammatory bowel disease 9.00E-15 1.36 18758464 | |
| 20 62348907 rs6062504-G 20:62348907 Inflammatory bowel disease 1.00E-23 1.1 23128233 | |
| 20 62349586 rs4809330-G 20:62349586 Crohn's disease 3.00E-15 1.12 21102463 | |
| 20 62362563 rs6062509-A 20:62362563 Prostate cancer 4.00E-16 1.12 23535732 | |
| 21 16520832 rs2823093-G 21:16520832 Breast cancer 7.00E-16 1.09 23535729 | |
| 21 16805220 rs1736135-T 21:16805220 Crohn's disease 7.00E-09 1.18 18587394 | |
| 21 16812552 rs1736020-C 21:16812552 Crohn's disease 9.00E-12 1.16 21102463 | |
| 21 16817051 rs1297265-A 21:16817051 Ulcerative colitis 7.00E-13 1.11 21297633 | |
| 21 16817938 rs2823286-G 21:16817938 Inflammatory bowel disease 9.00E-30 1.16 23128233 | |
| 21 17483133 rs2823615-A 21:17483133 Obesity-related traits 5.00E-08 0.04 23251661 | |
| 21 22689344 rs11088859-? 21:22689344 Obesity 4.00E-08 NR 21552555 | |
| 21 30717737 rs372883-T 21:30717737 Pancreatic cancer 2.00E-13 1.27 22158540 | |
| 21 31146169 rs455804-C 21:31146169 Hepatocellular carcinoma 5.00E-10 1.19 22807686 | |
| 21 32918294 rs13048019-T 21:32918294 Amyotrophic lateral sclerosis 3.00E-08 2.02 20801718 | |
| 21 34764288 rs73194058-C 21:34764288 Rheumatoid arthritis 3.00E-08 1.13 24390342 | |
| 21 34776695 rs2284553-G 21:34776695 Crohn's disease 2.00E-16 1.12 23128233 | |
| 21 35354523 rs2032314-T 21:35354523 Red blood cell traits 8.00E-10 0.15 23222517 | |
| 21 35599128 rs9982601-T 21:35599128 Myocardial infarction (early onset) 6.00E-11 1.2 19198609 | |
| 21 35599128 rs9982601-T 21:35599128 Coronary artery disease 3.00E-10 1.18 24262325 | |
| 21 35599128 rs9982601-T 21:35599128 Coronary heart disease 4.00E-10 1.18 21378990 | |
| 21 35652239 rs9978142-T 21:35652239 Pulmonary function 3.00E-08 0.04 21946350 | |
| 21 35690786 rs2834442-A 21:35690786 Height 5.00E-12 0.03 20881960 | |
| 21 35880072 rs727957-T 21:35880072 Electrocardiographic traits 2.00E-12 11.7 20062063 | |
| 21 36357861 rs2014300-G 21:36357861 Esophageal cancer 8.00E-22 1.43 21642993 | |
| 21 36738242 rs8133843-A 21:36738242 Rheumatoid arthritis 3.00E-09 1.08 24390342 | |
| 21 36738242 rs8133843-A 21:36738242 Rheumatoid arthritis 2.00E-08 1.09 24390342 | |
| 21 36849419 rs16993221-A 21:36849419 C-reactive protein and white blood cell count 2.00E-08 0.46 22788528 | |
| 21 37833307 rs219780-C 21:37833307 Kidney stones 4.00E-12 1.25 19561606 | |
| 21 37848334 rs170183-G 21:37848334 Bone mineral density 4.00E-09 1.92 24249740 | |
| 21 38491095 rs1003719-A 21:38491095 Eye color traits 2.00E-10 0.1 20463881 | |
| 21 39027272 rs2835872-G 21:39027272 Electroencephalographic traits in alcoholism 5.00E-10 0.15 22554406 | |
| 21 39852551 rs7275212-T 21:39852551 White blood cell types 2.00E-18 0.2 21738478 | |
| 21 40465178 rs2242944-? 21:40465178 Ankylosing spondylitis 8.00E-20 1.39 20062062 | |
| 21 40465512 rs4817986-T 21:40465512 Fibrinogen 2.00E-11 0.01 23969696 | |
| 21 40465534 rs2836878-G 21:40465534 Inflammatory bowel disease 5.00E-48 1.18 23128233 | |
| 21 40465534 rs2836878-G 21:40465534 Ulcerative colitis 2.00E-22 1.25 21297633 | |
| 21 40465534 rs2836878-? 21:40465534 Inflammatory bowel disease 4.00E-12 1.41 18758464 | |
| 21 40469520 rs378108-G 21:40469520 Ankylosing spondylitis 2.00E-11 NR 21743469 | |
| 21 42583738 rs6517656-G 21:42583738 Glycemic traits (pregnancy) 6.00E-16 0.04 23903356 | |
| 21 42698907 rs441810-G 21:42698907 Tumor biomarkers 3.00E-22 0.07 23300138 | |
| 21 42698907 rs441810-? 21:42698907 Elevated serum carcinoembryonic antigen levels 2.00E-08 NR 24941225 | |
| 21 42746081 rs45430-? 21:42746081 Melanoma 3.00E-09 1.14 21983787 | |
| 21 43036969 rs9977018-? 21:43036969 Amyotrophic lateral sclerosis (sporadic) 2.00E-09 NR 24529757 | |
| 21 43778895 rs1547374-A 21:43778895 Pancreatic cancer 4.00E-13 1.27 22158540 | |
| 21 43836186 rs11203203-A 21:43836186 Vitiligo 1.00E-09 1.27 20410501 | |
| 21 43836186 rs11203203-? 21:43836186 Type 1 diabetes 2.00E-09 NR 19430480 | |
| 21 43836186 rs11203203-A 21:43836186 Celiac disease and Rheumatoid arthritis 1.00E-08 NR 21383967 | |
| 21 43836390 rs9976767-C 21:43836390 Type 1 diabetes 2.00E-08 1.16 18840781 | |
| 21 43855067 rs1893592-A 21:43855067 Rheumatoid arthritis 7.00E-12 1.11 24390342 | |
| 21 44478497 rs6586282-? 21:44478497 Homocysteine levels 3.00E-10 0.03 20031578 | |
| 21 44486964 rs234709-T 21:44486964 Homocysteine levels 4.00E-24 0.07 23824729 | |
| 21 44487404 rs2851391-T 21:44487404 Homocysteine levels 2.00E-12 0.06 23824729 | |
| 21 44487404 rs2851391-T 21:44487404 Blood metabolite levels 1.00E-11 0.01 24816252 | |
| 21 44488033 rs234714-T 21:44488033 Plasma homocysteine levels (post-methionine load test) 3.00E-26 0.4 24651765 | |
| 21 44593140 rs11911275-G 21:44593140 Age-related nuclear cataracts 2.00E-09 0.08 24951543 | |
| 21 45615023 rs2838519-G 21:45615023 Crohn's disease 2.00E-14 1.18 21102463 | |
| 21 45615023 rs2838519-G 21:45615023 Ulcerative colitis 6.00E-11 1.14 21297633 | |
| 21 45615561 rs762421-G 21:45615561 Crohn's disease 1.00E-09 1.13 18587394 | |
| 21 45615741 rs7282490-G 21:45615741 Inflammatory bowel disease 2.00E-26 1.11 23128233 | |
| 21 45647421 rs4819388-? 21:45647421 Celiac disease 2.00E-09 1.14 20190752 | |
| 21 45709153 rs2075876-A 21:45709153 Rheumatoid arthritis 4.00E-09 1.18 21505073 | |
| 21 47690068 rs2839186-T 21:47690068 Testicular germ cell tumor 1.00E-09 1.26 23666240 | |
| 22 18439958 rs1076540-C 22:18439958 Liver enzyme levels (gamma-glutamyl transferase) 1.00E-16 4.8 22001757 | |
| 22 18959684 rs2540641-A 22:18959684 Blood metabolite levels 3.00E-59 0.06 24816252 | |
| 22 18966617 rs2540647-A 22:18966617 Blood metabolite ratios 2.00E-70 0.06 24816252 | |
| 22 18972450 rs2023634-G 22:18972450 Metabolic traits 2.00E-22 0.11 21886157 | |
| 22 19154522 rs807669-? 22:19154522 Metabolite levels 3.00E-16 0.14 22286219 | |
| 22 19156117 rs712964-? 22:19156117 Metabolite levels 3.00E-11 NR 22916037 | |
| 22 19951271 rs4680-A 22:19951271 Blood metabolite levels 5.00E-178 0.05 24816252 | |
| 22 19951271 rs4680-A 22:19951271 Blood metabolite levels 1.00E-13 0.04 24816252 | |
| 22 19984277 rs1034566-T 22:19984277 Platelet counts 3.00E-08 2.13 22139419 | |
| 22 21917190 rs131654-A 22:21917190 Systemic lupus erythematosus 1.00E-16 1.28 19838193 | |
| 22 21922904 rs2266959-T 22:21922904 Inflammatory bowel disease 1.00E-16 1.11 23128233 | |
| 22 21928641 rs181359-T 22:21928641 Crohn's disease 5.00E-16 1.1 21102463 | |
| 22 21932068 rs181362-T 22:21932068 HDL cholesterol 4.00E-18 0.04 24097068 | |
| 22 21932068 rs181362-T 22:21932068 HDL cholesterol 1.00E-08 0.46 20686565 | |
| 22 21939675 rs5754217-G 22:21939675 Red blood cell traits 9.00E-10 0.19 23222517 | |
| 22 21964761 rs4821112-A 22:21964761 Mean corpuscular volume 1.00E-08 0.07 20139978 | |
| 22 21973319 rs4821116-G 22:21973319 Hepatitis B 2.00E-12 1.22 24162738 | |
| 22 21979096 rs11089637-C 22:21979096 Rheumatoid arthritis 2.00E-09 1.08 24390342 | |
| 22 21982892 rs2298428-T 22:21982892 Celiac disease and Rheumatoid arthritis 3.00E-10 NR 21383967 | |
| 22 22131125 rs2283792-C 22:22131125 Multiple sclerosis 5.00E-09 1.1 21833088 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 9.00E-17 0.35 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 9.00E-17 0.35 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 9.00E-17 0.35 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 1.00E-16 0.35 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 7.00E-16 0.34 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 8.00E-15 0.32 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 2.00E-14 0.32 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 3.00E-13 0.3 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 1.00E-12 0.29 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 1.00E-12 0.29 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 1.00E-10 0.27 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 1.00E-10 0.27 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 5.00E-10 0.26 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 9.00E-10 0.26 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 4.00E-09 0.24 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 4.00E-09 0.25 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 2.00E-08 0.23 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 2.00E-08 0.24 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 2.00E-08 0.23 23382691 | |
| 22 24170996 rs2186369-G 22:24170996 IgG glycosylation 3.00E-08 0.23 23382691 | |
| 22 24295286 rs2739330-T 22:24295286 Liver enzyme levels (gamma-glutamyl transferase) 2.00E-09 3.7 22001757 | |
| 22 24582041 rs8141797-G 22:24582041 Amyotrophic lateral sclerosis 2.00E-09 1.52 23624525 | |
| 22 24990213 rs4820599-G 22:24990213 Gamma glutamyl transpeptidase 7.00E-53 0.01 21909109 | |
| 22 24990213 rs4820599-G 22:24990213 Liver enzyme levels 4.00E-11 0.01 18940312 | |
| 22 24996630 rs5751902-T 22:24996630 Hematological and biochemical traits 8.00E-20 0.17 20139978 | |
| 22 24999104 rs2073398-G 22:24999104 Liver enzyme levels (gamma-glutamyl transferase) 1.00E-109 12.3 22001757 | |
| 22 25002081 rs2330809-T 22:25002081 Blood metabolite levels 2.00E-13 0.06 24816252 | |
| 22 26159289 rs133885-? 22:26159289 Mathematical ability in children with dyslexia 8.00E-10 4.87 23423138 | |
| 22 29100711 rs1547014-T 22:29100711 Vertical cup-disc ratio 1.00E-08 0.01 20548946 | |
| 22 29115066 rs4822983-T 22:29115066 Esophageal cancer (squamous cell) 2.00E-22 1.27 22960999 | |
| 22 29121087 rs17879961-A 22:29121087 Lung cancer 1.00E-13 2.63 24880342 | |
| 22 29121087 rs17879961-A 22:29121087 Lung cancer 3.00E-11 1.67 24880342 | |
| 22 29130012 rs738722-T 22:29130012 Esophageal cancer and gastric cancer 1.00E-08 1.3 20729852 | |
| 22 29192670 rs2239815-T 22:29192670 Esophageal cancer (squamous cell) 4.00E-15 1.18 22960999 | |
| 22 29621477 rs132390-C 22:29621477 Breast cancer 3.00E-09 1.12 23535729 | |
| 22 30337586 rs36600-A 22:30337586 Lung cancer 6.00E-13 1.29 21725308 | |
| 22 30378703 rs5763662-T 22:30378703 LDL cholesterol 1.00E-08 0.08 24097068 | |
| 22 30423460 rs12537-C 22:30423460 IgA nephropathy 1.00E-11 1.28 22197929 | |
| 22 30486826 rs2412970-G 22:30486826 Inflammatory bowel disease 3.00E-14 1.08 23128233 | |
| 22 30494371 rs2412971-? 22:30494371 Nephropathy 2.00E-09 1.25 21399633 | |
| 22 30529631 rs2412973-? 22:30529631 Inflammatory bowel disease (early onset) 2.00E-09 1.15 19915574 | |
| 22 30581722 rs5753037-T 22:30581722 Type 1 diabetes 3.00E-16 1.1 19430480 | |
| 22 30592487 rs713875-C 22:30592487 Crohn's disease 7.00E-12 1.08 21102463 | |
| 22 30681257 rs1043099-? 22:30681257 Rheumatoid arthritis 7.00E-09 1.19 24449572 | |
| 22 30681257 rs1043099-? 22:30681257 Rheumatoid arthritis 7.00E-09 1.19 24449572 | |
| 22 31013296 rs2283873-A 22:31013296 Wilms tumor 5.00E-12 2.05 22544364 | |
| 22 32265903 rs1012068-G 22:32265903 Chronic hepatitis C infection 1.00E-13 1.75 21725309 | |
| 22 32867528 rs9609565-G 22:32867528 Hematological parameters 4.00E-10 0.37 19820697 | |
| 22 32880585 rs5749446-T 22:32880585 Red blood cell traits 3.00E-13 0.01 23222517 | |
| 22 33056341 rs4821083-T 22:33056341 Height 3.00E-10 0.03 20881960 | |
| 22 35711098 rs138777-A 22:35711098 "Cholesterol, total" 5.00E-08 0.02 24097068 | |
| 22 36616445 rs4821469-? 22:36616445 End-stage renal disease (non-diabetic) 2.00E-19 2.86 20532800 | |
| 22 36661330 rs2239785-G 22:36661330 Glomerulosclerosis 5.00E-13 NR 20668430 | |
| 22 37462936 rs855791-G 22:37462936 Red blood cell traits 1.00E-69 0.01 23222517 | |
| 22 37462936 rs855791-A 22:37462936 Hemoglobin 3.00E-25 0.09 19862010 | |
| 22 37462936 rs855791-G 22:37462936 Mean corpuscular hemoglobin 5.00E-25 0.12 20139978 | |
| 22 37462936 rs855791-T 22:37462936 Mean corpuscular hemoglobin 7.00E-19 0.23 23263863 | |
| 22 37462936 rs855791-G 22:37462936 Mean corpuscular volume 1.00E-15 0.1 20139978 | |
| 22 37462936 rs855791-A 22:37462936 Iron status biomarkers 2.00E-15 0.02 21149283 | |
| 22 37462936 rs855791-A 22:37462936 Glycated hemoglobin levels 3.00E-14 0.03 20858683 | |
| 22 37462936 rs855791-T 22:37462936 Mean corpuscular hemoglobin 5.00E-14 0.23 23263863 | |
| 22 37462936 rs855791-G 22:37462936 Mean corpuscular hemoglobin concentration 8.00E-14 0.09 20139978 | |
| 22 37462936 rs855791-A 22:37462936 Hemoglobin 2.00E-13 0.13 19820698 | |
| 22 37462936 rs855791-A 22:37462936 Red blood cell traits 1.00E-12 0.29 20927387 | |
| 22 37462936 rs855791-T 22:37462936 Mean corpuscular volume 7.00E-12 0.46 23263863 | |
| 22 37462936 rs855791-? 22:37462936 Hepcidin levels 9.00E-11 0.24 21785125 | |
| 22 37462936 rs855791-T 22:37462936 Iron status biomarkers 1.00E-10 0.13 19820699 | |
| 22 37462936 rs855791-T 22:37462936 Mean corpuscular volume 2.00E-09 0.48 23263863 | |
| 22 37462936 rs855791-? 22:37462936 Hepcidin levels 4.00E-09 0.22 21785125 | |
| 22 37462936 rs855791-A 22:37462936 Red blood cell traits 5.00E-09 0.62 20927387 | |
| 22 37462936 rs855791-T 22:37462936 Hematology traits 3.00E-08 0.09 23263863 | |
| 22 37467270 rs5756504-T 22:37467270 Hematological and biochemical traits 2.00E-10 0.08 20139978 | |
| 22 37467392 rs5756506-C 22:37467392 Hematological parameters 1.00E-09 0.14 19820697 | |
| 22 37469591 rs4820268-G 22:37469591 Red blood cell traits 1.00E-12 0.09 20927387 | |
| 22 37469591 rs4820268-A 22:37469591 Hematology traits 4.00E-12 0.13 19853236 | |
| 22 37469591 rs4820268-G 22:37469591 Iron levels 4.00E-11 4.24 21208937 | |
| 22 37469591 rs4820268-A 22:37469591 Hematology traits 3.00E-10 0.15 19853236 | |
| 22 37469591 rs4820268-A 22:37469591 Iron levels 5.00E-09 4.39 19880490 | |
| 22 37470224 rs2413450-T 22:37470224 Mean corpuscular volume 3.00E-41 0.01 19862010 | |
| 22 37470224 rs2413450-T 22:37470224 Mean corpuscular hemoglobin 9.00E-34 0.01 19862010 | |
| 22 37470224 rs2413450-T 22:37470224 Hematocrit 2.00E-13 0.17 19862010 | |
| 22 37534034 rs2284033-G 22:37534034 Asthma 1.00E-08 1.12 20860503 | |
| 22 37581485 rs229527-? 22:37581485 Graves' disease 5.00E-20 1.23 23612905 | |
| 22 37581485 rs229527-T 22:37581485 Vitiligo 2.00E-16 1.38 20410501 | |
| 22 37591318 rs229541-T 22:37591318 Type 1 diabetes 2.00E-08 1.11 18978792 | |
| 22 37919267 rs9607469-A 22:37919267 Optic disc parameters 3.00E-12 0.05 21307088 | |
| 22 38476276 rs8135665-T 22:38476276 Age-related macular degeneration 2.00E-11 1.15 23455636 | |
| 22 38544298 rs2284063-? 22:38544298 Melanoma 2.00E-09 1.2 19578364 | |
| 22 38544298 rs2284063-G 22:38544298 Cutaneous nevi 3.00E-08 0.08 19578365 | |
| 22 38546033 rs5756931-C 22:38546033 Triglycerides 3.00E-08 0.02 24097068 | |
| 22 38546033 rs5756931-C 22:38546033 Triglycerides 4.00E-08 1.54 20686565 | |
| 22 39332623 rs1014971-? 22:39332623 Bladder cancer 8.00E-12 1.18 20972438 | |
| 22 39332623 rs1014971-T 22:39332623 Bladder cancer 1.00E-11 1.13 24163127 | |
| 22 39519196 rs139371-A 22:39519196 Multiple myeloma (hyperdiploidy) 2.00E-09 1.37 23502783 | |
| 22 39542292 rs877529-A 22:39542292 Multiple myeloma 8.00E-16 1.23 23955597 | |
| 22 39659773 rs2413583-C 22:39659773 Inflammatory bowel disease 4.00E-33 1.21 23128233 | |
| 22 39659773 rs2413583-C 22:39659773 Crohn's disease 1.00E-26 1.23 21102463 | |
| 22 39670851 rs968451-T 22:39670851 Primary biliary cirrhosis 1.00E-09 1.27 21399635 | |
| 22 39739638 rs137686-C 22:39739638 IgG glycosylation 1.00E-11 0.25 23382691 | |
| 22 39747671 rs909685-A 22:39747671 Rheumatoid arthritis 1.00E-16 1.13 24390342 | |
| 22 39747671 rs909685-A 22:39747671 Rheumatoid arthritis 6.00E-12 1.11 24390342 | |
| 22 39835587 rs4821897-G 22:39835587 IgG glycosylation 4.00E-18 0.3 23382691 | |
| 22 39835587 rs4821897-G 22:39835587 IgG glycosylation 3.00E-12 0.24 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 1.00E-24 0.34 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 9.00E-24 0.34 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 1.00E-16 0.28 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 4.00E-16 0.28 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 6.00E-16 0.27 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 2.00E-15 0.27 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 3.00E-13 0.25 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 1.00E-10 0.22 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 2.00E-10 0.07 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 2.00E-10 0.21 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 2.00E-10 0.21 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 5.00E-10 0.21 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 6.00E-10 0.21 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 3.00E-09 0.2 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 3.00E-09 0.2 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 3.00E-08 0.08 23382691 | |
| 22 39859169 rs909674-C 22:39859169 IgG glycosylation 3.00E-08 0.19 23382691 | |
| 22 39972162 rs3788556-C 22:39972162 IgG glycosylation 5.00E-08 0.18 23382691 | |
| 22 40652873 rs12484776-G 22:40652873 Uterine fibroids 3.00E-12 1.23 21460842 | |
| 22 40876234 rs6001930-C 22:40876234 Breast cancer 9.00E-19 1.12 23535729 | |
| 22 41431342 rs4820425-A 22:41431342 Crohn's disease 3.00E-08 1.27 22936669 | |
| 22 41757647 rs4822024-G 22:41757647 Vitiligo 7.00E-10 1.28 22561518 | |
| 22 42523528 rs1058172-? 22:42523528 Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) 2.00E-16 NR 24528284 | |
| 22 42523528 rs1058172-? 22:42523528 Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) 8.00E-16 NR 24528284 | |
| 22 42526694 rs1065852-? 22:42526694 Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) 2.00E-16 NR 24528284 | |
| 22 42526694 rs1065852-? 22:42526694 Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) 8.00E-16 NR 24528284 | |
| 22 43500212 rs5759167-? 22:43500212 Prostate cancer 6.00E-29 1.16 19767753 | |
| 22 44324727 rs738409-G 22:44324727 Liver enzyme levels (alanine transaminase) 1.00E-45 6 22001757 | |
| 22 44324727 rs738409-G 22:44324727 Nonalcoholic fatty liver disease 4.00E-34 0.26 21423719 | |
| 22 44324727 rs738409-G 22:44324727 Nonalcoholic fatty liver disease 1.00E-10 1.66 22719876 | |
| 22 44325996 rs12483959-A 22:44325996 Metabolite levels 2.00E-39 0 21909109 | |
| 22 44325996 rs12483959-A 22:44325996 Metabolite levels 2.00E-18 0 21909109 | |
| 22 44332570 rs2281135-T 22:44332570 Liver enzyme levels 8.00E-16 0.06 18940312 | |
| 22 44333694 rs2896019-G 22:44333694 Non-alcoholic fatty liver disease 2.00E-20 2.02 23535911 | |
| 22 44333694 rs2896019-G 22:44333694 Hematological and biochemical traits 2.00E-12 0.09 20139978 | |
| 22 44333694 rs2896019-G 22:44333694 Hematological and biochemical traits 2.00E-12 0.09 20139978 | |
| 22 45961904 rs1985671-? 22:45961904 Temperament (bipolar disorder) 2.00E-08 1.06 22365631 | |
| 22 46421842 rs6519955-A 22:46421842 Dupuytren's disease 3.00E-33 1.54 21732829 | |
| 22 46627603 rs4253772-T 22:46627603 "Cholesterol, total" 1.00E-08 0.03 24097068 | |
| 22 46627603 rs4253772-T 22:46627603 LDL cholesterol 3.00E-08 0.03 24097068 | |
| 22 48929569 rs5768709-G 22:48929569 Pancreatic cancer 1.00E-10 1.25 22158540 | |
| 22 49812502 rs17000918-A 22:49812502 Immune reponse to smallpox (secreted IL-1beta) 4.00E-09 NR 22610502 | |
| 22 50435480 rs5771069-G 22:50435480 Ulcerative colitis 4.00E-08 1.17 20228798 | |
| 22 50966914 rs470119-T 22:50966914 Mean corpuscular hemoglobin 4.00E-08 0.07 20139978 | |
| 22 50971266 rs140522-C 22:50971266 Red blood cell traits 5.00E-23 0.29 23222517 | |
| 22 50971266 rs140522-A 22:50971266 Multiple sclerosis 2.00E-08 1.1 21833088 | |
| 22 50971752 rs131794-A 22:50971752 Blood metabolite levels 4.00E-16 0.02 24816252 | |
| 22 50971752 rs131794-A 22:50971752 Mean corpuscular volume 1.00E-15 0 19862010 | |
| 22 51063477 rs6151429-T 22:51063477 Blood metabolite levels 7.00E-18 0.03 24816252 | |
| 22 51063477 rs6151429-T 22:51063477 Blood metabolite levels 5.00E-13 0.03 24816252 | |
| 22 51101938 rs6010044-A 22:51101938 Fibrinogen 3.00E-08 0.01 23969696 |
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment